data_2m4n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m4n _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 m -131.61 147.72 52.55 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.39 140.14 49.96 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -84.09 105.56 15.05 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.31 129.24 62.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.724 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 92.3 t80 -109.98 119.55 39.67 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.623 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.53 30.36 2.89 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.274 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.15 -30.4 63.97 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 121.806 -0.235 . . . . 0.0 113.578 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -64.64 -26.66 68.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.039 0.447 . . . . 0.0 110.981 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.9 mt -90.56 -50.92 12.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.99 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.63 96.81 20.11 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.829 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.404 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 48.8 Cg_exo -56.83 -34.96 97.83 Favored 'Trans proline' 0 N--CA 1.475 0.432 0 C-N-CA 123.283 2.656 . . . . 0.0 113.655 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.6 t -71.41 -16.44 62.39 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -133.86 69.64 75.31 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.449 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 47.1 Cg_endo -66.99 -33.11 33.34 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.542 2.161 . . . . 0.0 112.735 -176.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -122.03 132.56 54.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.914 0.387 . . . . 0.0 110.738 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.7 p -136.75 156.88 35.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.304 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -112.95 125.09 54.01 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.314 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.9 pt -123.38 159.13 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.566 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.78 133.79 40.91 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.44 134.59 5.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.832 0.349 . . . . 0.0 111.26 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.699 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 6.5 mp0 -92.56 161.12 14.72 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.462 HG13 ' CB ' ' A' ' 83' ' ' LEU . 19.7 tt -66.98 -25.73 35.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -87.86 4.88 42.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.699 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 12.7 pt-20 -97.42 144.4 27.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.785 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -77.16 170.25 16.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.962 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.25 -24.9 65.26 Favored 'General case' 0 C--O 1.198 -1.612 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.647 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.61 -46.64 88.36 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.938 0.399 . . . . 0.0 111.084 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -70.12 -43.7 70.45 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.674 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -46.17 95.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.298 0.57 . . . . 0.0 110.494 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.6 tp -65.16 -43.09 92.9 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.727 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.421 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -63.78 -37.08 94.17 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.21 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.97 -51.15 67.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.898 0.38 . . . . 0.0 110.778 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.85 -43.79 87.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.16 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.508 ' CD2' ' HA ' ' A' ' 45' ' ' GLU . 29.5 tp -64.71 -35.57 81.48 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.985 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.19 -36.21 82.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.767 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 63.7 mmtt -62.42 -36.33 82.02 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -84.0 -8.1 59.23 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.565 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.28 30.12 71.71 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.423 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.2 mt -120.48 24.53 10.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 42.4 tt0 -58.84 -29.7 67.13 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -62.61 -26.78 68.79 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.054 0.455 . . . . 0.0 110.881 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.5 m -100.54 30.53 3.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.903 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.421 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 36.3 ttmt -61.09 -36.75 80.49 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.443 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 30.8 t70 -62.95 -18.52 63.26 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.178 0.513 . . . . 0.0 111.829 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -82.46 -8.62 59.62 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.73 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -132.42 150.43 52.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.256 0.55 . . . . 0.0 111.79 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.447 HG21 ' HB2' ' A' ' 106' ' ' LYS . 25.6 pt -139.97 171.35 13.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.6 mt -100.07 141.79 32.42 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.356 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.49 136.77 55.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -86.59 117.62 25.47 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.639 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.448 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 40.4 t . . . . . 0 C--N 1.303 -1.431 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.866 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ptt85 -82.37 133.81 49.62 Favored Pre-proline 0 N--CA 1.441 -0.891 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.09 121.15 8.71 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.383 2.055 . . . . 0.0 111.888 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.3 mt -121.27 97.9 47.18 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.89 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -63.5 159.51 40.15 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.25 2.633 . . . . 0.0 112.493 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -55.13 -29.17 64.62 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.609 2.873 . . . . 0.0 113.659 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.5 p -80.69 -1.42 42.51 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -105.37 142.92 34.3 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.251 -0.18 . . . . 0.0 110.612 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.0 p -106.11 92.42 6.59 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 120.986 0.422 . . . . 0.0 110.104 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.73 -23.05 36.37 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.013 2.475 . . . . 0.0 114.871 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.462 ' CB ' HG13 ' A' ' 27' ' ' ILE . 86.2 mt -62.56 -27.88 69.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.452 ' HA ' HD11 ' A' ' 27' ' ' ILE . 20.0 m-85 -58.03 -48.43 80.09 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.148 0.28 . . . . 0.0 111.299 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.08 -36.44 58.96 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.336 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 96.5 mtp -60.53 -61.58 2.49 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.22 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.734 -176.146 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.448 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 27.5 p90 . . . . . 0 N--CA 1.437 -1.118 0 CA-C-O 120.981 0.419 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 34.4 tp -109.03 121.4 45.06 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.43 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.27 174.47 6.69 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.815 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.44 129.74 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.136 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -122.93 160.26 26.55 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -82.46 116.93 22.13 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.68 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HB2' HG21 ' A' ' 52' ' ' ILE . 72.6 tttt . . . . . 0 C--N 1.308 -1.214 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.813 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 p -95.38 139.17 32.05 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.4 mt -123.45 140.85 52.58 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -84.78 108.57 17.53 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.417 HG23 ' CD1' ' A' ' 23' ' ' ILE . 53.2 t -113.19 131.24 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.506 -171.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.422 ' CE2' ' HA3' ' A' ' 12' ' ' GLY . 87.2 t80 -88.04 121.19 30.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.543 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.8 31.69 6.89 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.708 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 10' ' ' TYR . . . -53.95 165.13 2.46 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.534 -0.333 . . . . 0.0 113.371 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 71.99 -47.16 0.66 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.129 0.972 . . . . 0.0 110.907 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.407 HG22 HG23 ' A' ' 15' ' ' VAL . 42.8 mm -62.97 -50.01 81.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.18 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.407 HG23 HG22 ' A' ' 14' ' ' ILE . 64.8 t -142.61 111.12 5.79 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.516 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.45 -24.52 49.4 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.838 2.359 . . . . 0.0 113.461 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.0 t -91.31 -0.9 57.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.991 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -145.8 73.45 13.69 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.407 . . . . 0.0 110.429 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.33 -21.79 30.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.726 2.284 . . . . 0.0 112.891 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -130.11 141.97 50.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.79 160.99 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.534 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 p -108.78 133.27 53.07 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.262 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 38' ' ' ALA . 32.0 pt -128.83 162.54 35.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.695 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.3 tp -112.6 123.85 51.23 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.9 154.04 47.14 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.005 0.431 . . . . 0.0 111.16 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.49 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 46.7 mt-10 -110.86 146.18 36.93 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.7 tt -67.52 -26.82 36.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -87.61 15.41 6.82 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.013 0.435 . . . . 0.0 110.978 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 70.0 mm-40 -106.5 157.38 17.7 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.839 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -88.89 169.25 11.73 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.257 0.551 . . . . 0.0 111.199 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.418 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -62.05 -26.17 68.1 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.089 -177.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.69 -45.08 93.18 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -67.41 -42.73 82.76 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 120.889 0.376 . . . . 0.0 110.487 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.54 -45.2 98.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.222 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.9 tp -63.47 -45.12 92.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.511 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.27 -34.83 89.22 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.301 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.56 -52.41 65.66 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.01 0.405 . . . . 0.0 111.998 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.428 ' HB2' HG21 ' A' ' 23' ' ' ILE . . . -71.59 -37.53 70.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.205 0.526 . . . . 0.0 110.727 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.81 -38.63 88.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.144 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.33 -37.36 83.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.445 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -62.78 -38.39 90.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.901 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -86.71 -0.97 57.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.844 0.354 . . . . 0.0 110.994 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.15 15.53 80.94 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.919 -0.582 . . . . 0.0 114.305 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.1 mt -105.76 14.53 28.11 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.384 0.592 . . . . 0.0 111.352 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -20.04 63.55 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -66.05 -35.08 79.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -83.41 -81.85 0.16 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.605 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt 65.44 -40.8 0.31 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.603 1.161 . . . . 0.0 113.829 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.44 -11.27 41.35 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -100.12 1.78 42.49 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.224 0.535 . . . . 0.0 110.318 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -132.0 151.94 51.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 111.297 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 pt -139.4 172.88 12.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.418 HD11 ' HB1' ' A' ' 31' ' ' ALA . 95.6 mt -100.71 134.88 43.03 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 12.7 m -123.57 128.55 74.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.305 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 4.8 tm-20 -86.81 120.16 27.81 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.416 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 74.7 t . . . . . 0 C--N 1.313 -1.004 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.005 -173.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.801 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.448 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 10.5 ptp180 -96.23 136.11 22.21 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.8 114.36 3.84 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.068 1.845 . . . . 0.0 111.827 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.0 mt -120.79 99.77 46.94 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.072 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.45 158.81 43.32 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.808 2.339 . . . . 0.0 112.086 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.29 -23.13 52.75 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.361 2.708 . . . . 0.0 112.512 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.4 p -67.52 -22.42 65.43 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -78.69 176.54 9.41 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 122.352 1.072 . . . . 0.0 113.264 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 85.6 m -137.6 71.8 50.94 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 112.801 -2.0 . . . . 0.0 106.305 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.412 ' O ' ' HG3' ' A' ' 86' ' ' MET . 44.4 Cg_endo -67.02 -18.42 51.78 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.976 2.451 . . . . 0.0 114.323 -170.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 27' ' ' ILE . 44.6 mt -61.95 -41.33 97.85 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -173.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -60.24 -43.02 96.43 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.696 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.59 -40.63 84.81 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.388 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 96.6 mtp -62.78 -46.95 85.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.622 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 C--N 1.325 -0.47 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.149 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.416 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 30.0 p90 . . . . . 0 N--CA 1.444 -0.755 0 CA-C-O 121.176 0.512 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.0 tp -114.46 128.79 56.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.525 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' A' ' 10' ' ' TYR . . . -122.89 167.84 13.04 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.82 -176.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.427 HD11 ' HB1' ' A' ' 38' ' ' ALA . 84.2 mt -110.07 129.72 64.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.642 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -130.52 161.95 30.34 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.49 0.662 . . . . 0.0 111.028 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -84.07 104.76 14.4 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.486 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 CA--C 1.538 0.496 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.512 179.112 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.441 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 p -95.11 139.96 30.72 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.2 mt -112.87 138.22 50.05 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.089 0.471 . . . . 0.0 111.992 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -82.15 106.24 13.89 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.427 HG11 ' CB ' ' A' ' 38' ' ' ALA . 54.6 t -113.62 129.39 69.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.494 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -103.23 108.35 19.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.649 0.737 . . . . 0.0 112.246 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.82 12.64 9.97 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 19' ' ' PRO . . . -61.55 -24.53 64.12 Favored Glycine 0 CA--C 1.5 -0.889 0 CA-C-N 115.286 -0.457 . . . . 0.0 112.921 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.3 -27.51 67.97 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.344 0.592 . . . . 0.0 109.843 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 76.4 mt -94.47 -51.69 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.862 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.31 97.32 47.5 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.196 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.68 -33.85 94.56 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.82 3.013 . . . . 0.0 114.921 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.4 t -65.77 -16.64 63.98 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.672 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -132.22 75.15 75.15 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.236 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.565 ' HA ' ' HA3' ' A' ' 12' ' ' GLY . 18.1 Cg_endo -59.32 -46.78 19.76 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.445 2.096 . . . . 0.0 112.586 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -122.89 139.11 54.39 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.537 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.23 155.64 39.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -109.15 125.77 52.53 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.24 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.402 ' CD1' HG21 ' A' ' 9' ' ' VAL . 39.2 pt -126.28 156.22 36.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.23 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.3 tp -103.24 121.84 43.53 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.86 156.17 43.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.423 . . . . 0.0 111.792 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -110.6 147.97 33.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.67 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.425 HD11 ' HA ' ' A' ' 84' ' ' PHE . 19.5 tt -64.57 -31.38 53.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -89.33 9.34 26.42 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.035 0.445 . . . . 0.0 110.629 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -98.44 146.73 25.44 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.625 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.506 ' HA ' ' SG ' ' A' ' 81' ' ' CYS . 20.6 p-10 -83.1 163.24 21.01 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.351 0.596 . . . . 0.0 112.17 -176.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' A' ' 78' ' ' PRO . . . -67.15 -17.64 64.93 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.424 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.08 -44.52 94.71 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -69.38 -46.44 66.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.632 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.51 -45.27 98.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.705 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.41 -44.46 91.2 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.268 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.421 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -64.25 -39.53 97.14 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.568 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.12 87.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.938 0.399 . . . . 0.0 111.364 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.427 ' CB ' HG11 ' A' ' 9' ' ' VAL . . . -73.56 -44.91 56.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.67 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.6 -34.3 77.51 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.313 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.7 -39.21 87.69 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.867 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -60.73 -38.64 85.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.03 0.443 . . . . 0.0 110.678 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -84.06 -3.34 57.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.46 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.88 24.83 76.06 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.873 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.15 17.43 18.72 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.891 -0.182 . . . . 0.0 111.327 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -57.27 -34.93 69.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.809 0.443 . . . . 0.0 110.84 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -60.66 -39.32 87.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.173 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.0 m -89.12 21.86 3.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.295 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.421 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 33.2 ttmt -59.68 -15.63 20.87 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.071 0.462 . . . . 0.0 111.759 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.32 -35.42 79.02 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.618 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -104.25 17.32 24.35 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -126.68 150.49 48.96 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.0 pt -139.31 176.31 6.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.487 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.4 mt -101.65 138.69 38.3 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-O 120.548 0.213 . . . . 0.0 110.614 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 27.3 m -124.06 126.78 72.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.123 0.487 . . . . 0.0 110.441 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.434 ' CD ' HH21 ' A' ' 74' ' ' ARG . 13.6 tt0 -89.58 126.04 35.46 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.536 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 87.3 t . . . . . 0 C--N 1.315 -0.899 0 CA-C-O 120.836 0.35 . . . . 0.0 111.479 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.46 ' CA ' HG23 ' A' ' 56' ' ' VAL . . . . . . . . 0 N--CA 1.435 -1.4 0 N-CA-C 112.716 -0.154 . . . . 0.0 112.716 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.462 ' O ' HG13 ' A' ' 76' ' ' ILE . 40.1 mtm180 -88.66 117.17 68.05 Favored Pre-proline 0 C--N 1.314 -0.964 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.65 114.02 2.21 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.118 1.878 . . . . 0.0 111.568 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 74' ' ' ARG . 42.3 mt -120.84 113.73 32.9 Favored Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.543 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.79 159.01 54.95 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.548 2.165 . . . . 0.0 111.434 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . 31.8 Cg_exo -58.5 -29.35 88.47 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.786 2.324 . . . . 0.0 111.972 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 m -77.34 -1.49 30.2 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.218 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.18 158.52 15.62 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 122.092 -0.38 . . . . 0.0 110.525 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' A' ' 30' ' ' ASN . 95.8 m -121.99 85.23 45.56 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -17.14 37.77 Favored 'Trans proline' 0 N--CA 1.475 0.405 0 C-N-CA 123.099 2.533 . . . . 0.0 114.143 -173.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.32 -28.55 70.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HA ' HD11 ' A' ' 27' ' ' ILE . 20.8 m-85 -59.62 -48.21 82.54 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.257 -0.177 . . . . 0.0 111.436 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -69.27 -38.97 78.64 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.016 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.413 ' CE ' ' HG3' ' A' ' 55' ' ' GLU . 48.1 mtt -58.7 -59.27 5.68 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.997 0.427 . . . . 0.0 111.277 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 C--N 1.315 -0.9 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.858 -175.689 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.536 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 26.7 p90 . . . . . 0 N--CA 1.436 -1.167 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.7 tp -115.18 126.68 54.88 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.676 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.75 166.72 11.63 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.1 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.28 127.25 67.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.442 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -135.17 167.4 21.06 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.584 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -73.65 143.01 46.45 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.608 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt . . . . . 0 C--N 1.315 -0.906 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.117 176.903 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.798 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 p -96.23 138.7 33.46 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.6 mt -105.31 138.56 41.32 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -82.65 100.97 10.52 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.9 127.68 59.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.048 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -99.85 129.54 45.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.302 -176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.53 30.57 1.15 Allowed Glycine 0 C--O 1.237 0.326 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.227 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.52 -29.36 66.49 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.62 -0.324 . . . . 0.0 112.906 -177.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -59.48 -50.73 72.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 0.0 110.063 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.0 mt -69.23 -47.86 71.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.914 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.4 t -136.35 103.77 9.51 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.959 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.08 -24.58 59.37 Favored 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 122.589 2.193 . . . . 0.0 113.425 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.4 t -79.98 -9.14 59.66 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.959 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 18' ' ' ARG . 51.9 mtt180 -132.72 69.49 79.4 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.052 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.09 -39.33 70.65 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.427 2.085 . . . . 0.0 112.415 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -128.02 135.47 49.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.236 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.35 162.44 36.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.5 m -119.54 124.91 47.57 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.045 0.45 . . . . 0.0 110.631 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 pt -123.76 159.37 28.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.2 tp -105.97 119.15 38.46 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.7 141.51 21.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.621 0.248 . . . . 0.0 111.185 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -95.22 161.99 13.88 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.5 ' HA ' HD13 ' A' ' 83' ' ' LEU . 18.6 tt -65.15 -26.11 39.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -85.59 7.82 21.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.685 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -92.72 138.77 31.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.546 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 13.7 m120 -82.11 172.7 12.9 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.64 -28.44 69.91 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.546 ' OD1' ' HB2' ' A' ' 30' ' ' ASN . 8.4 p-10 -64.96 -40.35 94.88 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.069 0.461 . . . . 0.0 110.377 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -69.5 -46.34 66.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.061 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.96 -44.24 96.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.031 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.4 tp -62.43 -42.56 99.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.15 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.82 -43.31 99.37 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.089 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.69 84.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.838 0.352 . . . . 0.0 111.0 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.43 ' CB ' HD12 ' A' ' 103' ' ' ILE . . . -71.96 -45.83 59.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.386 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 48' ' ' LYS . 27.6 tp -64.52 -33.46 75.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.492 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -36.9 78.96 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.24 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -63.51 -37.9 89.08 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.453 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -83.33 -3.86 57.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.958 0.409 . . . . 0.0 110.686 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.14 29.86 72.07 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.158 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.1 mt -120.54 22.35 11.27 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.556 -0.379 . . . . 0.0 111.264 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.582 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 43.9 tt0 -59.64 -31.7 69.77 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -58.31 -38.69 77.6 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.9 m -93.93 30.43 1.85 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.623 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.582 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 35.3 ttmt -61.34 -31.25 71.12 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -65.41 -14.1 60.15 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.093 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -103.42 5.15 36.87 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.91 0.386 . . . . 0.0 110.982 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.71 149.07 50.38 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.021 0.439 . . . . 0.0 111.973 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 pt -140.31 169.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.892 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.402 ' O ' ' HB ' ' A' ' 76' ' ' ILE . 96.1 mt -100.52 139.66 35.89 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.69 0.281 . . . . 0.0 110.482 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.83 131.04 62.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.07 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.523 ' OE1' ' HD2' ' A' ' 74' ' ' ARG . 97.1 mt-10 -94.71 121.36 36.22 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 100' ' ' PHE . 57.5 t . . . . . 0 C--N 1.312 -1.031 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.941 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.789 0 N-CA-C 111.859 -0.497 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.523 ' HD2' ' OE1' ' A' ' 55' ' ' GLU . 6.3 ptp180 -85.49 117.76 69.37 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -62.41 116.16 3.33 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.352 2.035 . . . . 0.0 111.946 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 74' ' ' ARG . 35.6 mt -121.95 99.1 44.4 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.701 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -66.15 160.46 44.73 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.573 2.182 . . . . 0.0 111.173 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.13 -32.73 81.18 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.316 2.678 . . . . 0.0 113.7 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.1 p -67.81 -20.65 65.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -67.78 173.43 4.37 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 122.374 1.083 . . . . 0.0 113.189 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.2 m -127.86 68.97 76.11 Favored Pre-proline 0 C--N 1.292 -1.927 0 CA-C-N 113.328 -1.76 . . . . 0.0 106.59 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.431 ' HB2' ' OE2' ' A' ' 55' ' ' GLU . 18.7 Cg_endo -58.11 -32.1 94.78 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.266 2.644 . . . . 0.0 113.913 -168.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' A' ' 27' ' ' ILE . 38.6 mt -63.92 -36.61 84.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.931 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -58.56 -30.19 66.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.916 0.389 . . . . 0.0 110.428 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -76.77 -51.07 12.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.695 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 66.4 mtm -62.98 -42.97 99.99 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.312 -1.058 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.422 -179.067 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 56' ' ' VAL . 31.5 p90 . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.3 tp -92.38 126.38 37.44 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 120.84 0.352 . . . . 0.0 110.223 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.66 160.31 35.78 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.45 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.43 HD12 ' CB ' ' A' ' 38' ' ' ALA . 66.2 mt -105.87 123.8 60.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -119.78 155.37 32.66 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 121.166 0.507 . . . . 0.0 110.176 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -81.19 108.49 14.88 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.026 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt . . . . . 0 C--N 1.327 -0.405 0 O-C-N 124.429 1.081 . . . . 0.0 111.127 178.904 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 26.9 p -99.58 121.57 41.38 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.4 mt -104.24 135.71 45.2 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.103 0.478 . . . . 0.0 112.056 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.99 101.11 10.1 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.4 t -108.01 129.77 61.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.806 -173.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -106.54 103.87 13.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.421 -175.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.0 -33.83 39.87 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.413 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.11 -88.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.793 0 N-CA-C 114.961 0.745 . . . . 0.0 114.961 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.541 ' CD ' ' HZ1' ' A' ' 104' ' ' LYS . 59.0 mt-10 -62.06 -37.79 86.33 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.322 0.649 . . . . 0.0 112.368 -175.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.55 -44.49 99.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.923 -173.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -145.08 105.11 4.43 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.15 -22.67 53.88 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.192 2.595 . . . . 0.0 113.883 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -86.42 -7.25 58.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.035 0.445 . . . . 0.0 110.892 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -142.24 67.01 20.82 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.94 -32.16 84.66 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.53 2.154 . . . . 0.0 112.259 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.11 139.2 51.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.608 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.64 150.91 25.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.223 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.8 p -102.33 124.28 47.63 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.937 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 6' ' ' SER . 20.9 pt -126.22 160.57 33.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.333 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.69 124.15 50.71 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.71 148.17 25.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.911 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -104.01 156.57 17.75 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.534 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.427 HG13 ' CB ' ' A' ' 83' ' ' LEU . 17.7 tt -65.79 -26.61 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.986 0.422 . . . . 0.0 111.827 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -76.11 -3.54 36.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.093 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -99.18 162.58 12.98 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.929 0.395 . . . . 0.0 110.712 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -92.93 178.45 5.76 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.368 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.34 -21.64 65.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.582 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' HA ' ' HB3' ' A' ' 78' ' ' PRO . 14.5 t70 -55.77 -46.51 77.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.599 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -69.07 -42.51 76.11 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 120.942 0.401 . . . . 0.0 110.597 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.61 -45.79 97.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.038 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.9 tp -66.38 -43.9 84.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.477 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.433 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -64.83 -46.98 87.98 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.779 -177.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -61.31 -45.84 92.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.007 0.403 . . . . 0.0 111.115 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.75 77.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.162 0.506 . . . . 0.0 111.251 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 28.3 tp -62.67 -36.05 81.65 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.816 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 37.0 tt0 -57.91 -42.42 84.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.536 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.7 mmtt -64.42 -41.64 96.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.376 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.42 -29.97 65.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.908 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.47 7.15 46.29 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.638 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 83.8 mt -98.32 17.14 19.45 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.341 -0.506 . . . . 0.0 111.157 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 16.6 pt-20 -54.95 -24.81 25.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.439 0.696 . . . . 0.0 112.24 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -71.2 -16.78 62.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.93 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.1 m -98.14 -81.97 0.43 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.737 0.303 . . . . 0.0 110.42 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 31.1 ttmt 70.09 -49.03 0.64 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.596 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 26.7 t70 -60.87 -34.12 74.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.192 0.451 . . . . 0.0 110.758 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -66.0 -9.57 31.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.606 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.6 151.07 49.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.054 0.454 . . . . 0.0 111.647 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 pt -138.16 175.43 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.38 143.58 30.4 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.987 0.422 . . . . 0.0 110.553 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 13.2 m -128.17 129.86 69.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 3.1 tm-20 -86.82 120.83 28.52 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.7 t . . . . . 0 C--N 1.31 -1.124 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.871 -175.53 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.06 0 N-CA-C 112.234 -0.346 . . . . 0.0 112.234 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.453 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 17.6 ptp180 -83.07 140.72 42.87 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.31 117.18 5.02 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.373 2.049 . . . . 0.0 111.866 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.7 mt -120.9 100.87 45.82 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.631 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.68 155.95 67.14 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.022 2.481 . . . . 0.0 112.193 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.418 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 47.3 Cg_exo -54.68 -33.86 81.55 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.414 2.743 . . . . 0.0 113.829 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 t -66.75 -18.06 65.18 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -78.8 153.16 30.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.681 0.277 . . . . 0.0 111.276 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.9 m -111.68 78.58 2.15 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.486 ' O ' ' HG3' ' A' ' 86' ' ' MET . 48.6 Cg_endo -67.31 -29.45 38.49 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.511 2.14 . . . . 0.0 113.599 -174.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.427 ' CB ' HG13 ' A' ' 27' ' ' ILE . 80.6 mt -62.48 -39.15 92.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -53.92 -54.69 35.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.791 0.329 . . . . 0.0 111.485 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -72.08 -40.59 68.16 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.832 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 11.3 mtm -60.77 -45.34 94.72 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 C--N 1.315 -0.905 0 CA-C-O 121.05 0.452 . . . . 0.0 111.723 -178.127 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.1 p90 . . . . . 0 N--CA 1.442 -0.87 0 CA-C-O 121.072 0.463 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 tp -115.81 119.81 37.24 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.693 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.53 178.33 4.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.102 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.7 mt -116.97 129.96 72.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.699 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.541 ' HZ1' ' CD ' ' A' ' 13' ' ' GLU . 27.6 mmmt -130.97 160.98 32.94 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -72.43 142.98 48.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.596 ' HD2' ' O ' ' A' ' 49' ' ' ASP . 21.6 ptmt . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 24' ' ' LEU . . . . . . . . 0 N--CA 1.442 -0.9 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 42.9 m -98.49 121.69 40.75 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.059 0.457 . . . . 0.0 110.355 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.4 mt -105.07 136.55 44.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.038 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -81.38 103.71 11.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.02 128.17 65.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.035 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -92.93 117.96 30.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.201 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.17 28.62 9.06 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.731 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.98 178.44 16.15 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.13 -0.557 . . . . 0.0 111.975 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 72.89 -66.69 0.3 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.6 mt -67.95 -48.11 76.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.765 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.14 85.41 46.45 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.15 -34.1 98.46 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.213 2.608 . . . . 0.0 113.019 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 t -70.09 -19.52 63.25 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.53 81.62 29.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 110.461 -0.199 . . . . 0.0 110.461 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.57 -32.24 87.61 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.625 2.217 . . . . 0.0 113.436 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -131.94 144.74 51.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.19 154.77 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.055 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.9 m -107.78 125.64 51.67 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' A' ' 38' ' ' ALA . 26.1 pt -126.72 160.09 35.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.042 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 8.0 mp -111.79 123.51 50.39 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.21 144.03 26.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.8 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.466 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 2.9 mp0 -90.58 152.78 20.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.475 HG13 ' CB ' ' A' ' 83' ' ' LEU . 19.4 tt -64.53 -26.35 40.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -86.01 6.65 27.8 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.982 0.42 . . . . 0.0 110.898 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 20.2 mm-40 -88.54 146.35 25.21 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.929 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.42 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 32.8 p-10 -83.86 169.49 15.07 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.236 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.408 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -58.81 -26.61 64.29 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.605 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.18 -42.1 97.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.688 0.28 . . . . 0.0 111.181 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.42 ' HG2' ' OD1' ' A' ' 30' ' ' ASN . 38.3 mmt180 -70.44 -42.92 70.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.94 0.4 . . . . 0.0 110.595 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.48 -45.92 94.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.587 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.95 -44.7 92.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.912 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.404 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -65.82 -39.61 95.19 Favored Glycine 0 C--O 1.209 -1.428 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.761 -178.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -61.41 -47.48 85.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 117.324 0.562 . . . . 0.0 111.532 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.437 ' HB2' HG22 ' A' ' 23' ' ' ILE . . . -68.7 -42.71 77.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.378 0.608 . . . . 0.0 110.521 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.51 ' CD2' ' HA ' ' A' ' 45' ' ' GLU . 32.0 tp -63.26 -35.13 79.32 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.796 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.82 -39.72 86.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.677 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 67.7 mmtt -64.6 -32.82 74.64 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.827 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -87.97 -2.87 58.88 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.289 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.31 23.82 74.92 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.725 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.76 17.57 20.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.51 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 44.4 tt0 -58.55 -23.25 57.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -176.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -78.38 -8.4 58.41 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.001 0.429 . . . . 0.0 111.047 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.3 m -113.79 21.55 14.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.41 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.404 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 39.5 ttmt -59.41 -28.74 67.2 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.701 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.37 -9.52 34.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.72 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -102.55 -1.77 29.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.891 0.377 . . . . 0.0 111.183 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -131.2 155.16 47.53 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.528 -0.469 . . . . 0.0 112.097 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 pt -139.95 173.36 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.454 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.408 HD13 ' HB1' ' A' ' 31' ' ' ALA . 97.7 mt -101.38 143.19 31.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.775 0.322 . . . . 0.0 110.687 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.6 m -126.85 128.53 70.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.452 ' HB2' HD13 ' A' ' 76' ' ' ILE . 13.3 tt0 -90.24 123.25 33.88 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.626 -178.057 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.638 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.434 ' O ' HG13 ' A' ' 76' ' ' ILE . 34.7 ttp-105 -81.05 121.31 80.55 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -65.26 115.96 3.61 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.1 1.866 . . . . 0.0 111.3 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.452 HD13 ' HB2' ' A' ' 55' ' ' GLU . 29.9 mt -120.95 103.31 43.04 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.232 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.23 160.21 43.32 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.61 2.207 . . . . 0.0 111.363 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -54.97 -28.69 60.7 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.225 2.617 . . . . 0.0 113.174 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.5 m -62.27 -44.22 97.04 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.85 156.85 28.49 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -174.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.1 p -117.04 93.99 43.57 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 122.75 0.42 . . . . 0.0 110.29 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.431 ' O ' ' HG3' ' A' ' 86' ' ' MET . 57.7 Cg_endo -71.9 -18.19 28.21 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.148 2.565 . . . . 0.0 115.386 -175.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.475 ' CB ' HG13 ' A' ' 27' ' ' ILE . 83.7 mt -60.79 -35.22 75.91 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -56.76 -45.56 81.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.202 0.525 . . . . 0.0 111.07 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -76.01 -37.22 58.7 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.318 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.458 ' SD ' HD23 ' A' ' 83' ' ' LEU . 95.4 mtp -61.66 -48.8 79.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.31 0.576 . . . . 0.0 111.095 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.8 m . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.541 -177.466 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 p90 . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.1 tp -116.74 124.97 50.94 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.242 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.94 167.87 10.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.448 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.6 mt -112.39 129.25 68.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.563 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -130.72 157.71 42.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.252 0.549 . . . . 0.0 110.901 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -93.04 134.36 35.25 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.323 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt . . . . . 0 C--N 1.311 -1.106 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.158 -179.667 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.841 0 N-CA-C 112.624 -0.19 . . . . 0.0 112.624 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.9 p -134.12 155.39 50.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.2 mt -107.55 137.29 45.84 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -84.24 108.13 16.94 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.72 133.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.219 -171.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -114.67 124.68 52.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.888 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.02 28.36 2.94 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.369 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.94 -23.9 62.06 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 114.031 0.372 . . . . 0.0 114.031 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.01 -40.74 97.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.426 0.631 . . . . 0.0 109.558 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.7 mt -85.76 -49.71 15.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.641 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.0 t -120.72 95.43 48.97 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.345 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.77 -23.01 48.85 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.882 2.388 . . . . 0.0 113.467 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.3 t -76.85 -17.15 59.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.136 0.493 . . . . 0.0 111.124 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -137.88 76.59 40.02 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.35 -34.06 67.94 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.287 1.991 . . . . 0.0 113.133 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -123.4 141.62 51.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.363 0.601 . . . . 0.0 112.211 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -142.85 157.57 18.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.2 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.6 p -119.46 131.79 55.68 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.235 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.413 HG22 ' HB2' ' A' ' 38' ' ' ALA . 41.6 pt -125.54 160.48 31.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.495 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.5 108.74 18.83 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.09 153.12 50.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.943 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -106.92 156.69 18.44 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.454 HD13 ' HA ' ' A' ' 84' ' ' PHE . 19.8 tt -65.91 -29.0 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -177.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -84.35 9.82 12.18 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.799 0.333 . . . . 0.0 111.401 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -100.69 148.91 24.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.516 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -80.58 168.78 18.5 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.73 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.96 -26.56 66.1 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.247 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.41 -40.46 96.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.839 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -64.79 -44.74 89.01 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.157 0.503 . . . . 0.0 109.768 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.409 HG22 HD13 ' A' ' 23' ' ' ILE . 96.7 mt -64.53 -45.64 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.642 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.73 -45.89 87.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.745 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.28 -38.29 93.6 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.268 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.518 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -59.46 -49.96 75.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.959 0.409 . . . . 0.0 110.999 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' A' ' 23' ' ' ILE . . . -70.58 -40.37 73.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.19 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.1 tp -61.97 -39.67 92.96 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.639 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.88 -37.78 83.37 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.288 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 69.1 mmtt -63.83 -37.98 89.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.595 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -80.03 -6.08 56.95 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.234 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.23 22.0 74.48 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.79 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -113.7 22.61 13.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.742 0.306 . . . . 0.0 111.114 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -53.15 -40.46 64.29 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.476 0.71 . . . . 0.0 112.393 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -74.75 -11.9 60.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.815 0.34 . . . . 0.0 111.736 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.8 m -110.14 29.83 7.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.345 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -60.96 -32.1 71.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.007 0.432 . . . . 0.0 111.553 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.95 -9.14 13.89 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.755 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -101.97 -2.64 29.27 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.738 0.304 . . . . 0.0 111.575 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -132.39 154.25 49.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.698 -176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.6 pt -137.96 173.26 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.7 mt -101.25 142.95 31.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.731 0.301 . . . . 0.0 110.529 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 18.8 m -125.41 132.11 71.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.087 0.47 . . . . 0.0 110.545 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.529 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 1.9 tm-20 -87.54 124.25 33.28 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 C--N 1.317 -0.844 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.302 -178.076 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.511 0 N-CA-C 112.689 -0.164 . . . . 0.0 112.689 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.529 ' HD2' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -97.28 121.08 59.71 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -178.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.15 115.85 3.38 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.007 2.471 . . . . 0.0 112.513 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 55' ' ' GLU . 33.1 mt -121.16 118.89 29.93 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.404 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.13 158.32 58.22 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.749 2.299 . . . . 0.0 111.473 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.71 -26.49 82.35 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.984 2.456 . . . . 0.0 112.45 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.5 p -68.33 -31.91 71.66 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -82.57 159.48 22.77 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.85 0.357 . . . . 0.0 111.958 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 39.8 m -118.05 86.81 26.82 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.68 -16.87 33.72 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.756 2.304 . . . . 0.0 114.198 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.448 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 53.4 mt -63.72 -39.09 93.45 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HA ' HD13 ' A' ' 27' ' ' ILE . 23.6 m-85 -57.19 -46.12 83.13 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 123.215 0.322 . . . . 0.0 111.634 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -66.05 -43.07 88.55 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.236 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.3 mtm -63.54 -43.44 97.09 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.951 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.31 -1.127 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.564 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.2 p90 . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.5 tp -111.76 121.26 44.62 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.31 174.7 5.91 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.181 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.413 HD11 ' CB ' ' A' ' 38' ' ' ALA . 65.0 mt -110.77 129.49 65.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.656 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -127.55 163.73 23.52 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 121.378 0.609 . . . . 0.0 110.199 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -84.03 134.83 34.61 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.296 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt . . . . . 0 CA--C 1.538 0.519 0 O-C-N 123.632 0.583 . . . . 0.0 112.084 -179.011 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.297 0 N-CA-C 112.798 -0.121 . . . . 0.0 112.798 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 26.4 p -95.11 134.49 37.77 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.4 mt -110.76 143.65 40.97 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -84.69 104.23 14.48 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.86 129.22 57.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.148 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 88.2 t80 -96.26 126.32 41.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.31 0.576 . . . . 0.0 111.78 -176.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.26 18.17 4.46 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.38 -23.11 64.19 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.214 -0.493 . . . . 0.0 113.324 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.3 -57.6 9.88 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.8 mt -70.28 -44.8 77.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.071 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.18 96.08 20.34 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.411 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.36 -24.25 50.34 Favored 'Trans proline' 0 CA--C 1.498 -1.298 0 C-N-CA 122.717 2.278 . . . . 0.0 112.342 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.8 m -68.63 -23.24 64.41 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.727 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.41 67.67 80.47 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.95 -55.38 1.67 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 123.257 2.638 . . . . 0.0 114.376 -172.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -117.95 134.99 54.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.763 0.316 . . . . 0.0 110.998 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.24 161.18 35.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.586 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -110.86 128.87 55.94 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.467 HG23 ' HB1' ' A' ' 38' ' ' ALA . 31.1 pt -126.4 163.06 29.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.445 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.5 tp -111.79 112.5 24.21 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.96 148.16 28.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.267 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.69 162.73 16.84 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.855 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.434 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 19.0 tt -63.49 -24.51 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -175.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -85.1 4.64 33.23 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.88 0.371 . . . . 0.0 110.615 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -101.34 146.25 27.82 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.139 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -81.76 174.02 11.74 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.409 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.431 ' HB3' HD13 ' A' ' 53' ' ' LEU . . . -58.79 -27.12 64.72 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.009 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.28 -41.98 97.86 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -64.89 -41.72 95.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.263 0.554 . . . . 0.0 109.959 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.405 HG23 ' CD1' ' A' ' 23' ' ' ILE . 96.6 mt -65.67 -44.42 93.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.217 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.83 -46.71 88.32 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.457 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA2' ' OE1' ' A' ' 45' ' ' GLU . . . -64.28 -40.93 98.34 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.746 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -64.47 -39.27 93.5 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.467 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -84.88 -42.23 15.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.886 0.374 . . . . 0.0 111.272 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.427 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 27.9 tp -62.92 -35.12 79.01 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.147 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 2.9 tm-20 -59.7 -41.55 91.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.168 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 68.3 mmtt -63.58 -39.69 95.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -79.77 -3.44 47.64 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.984 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.73 28.96 68.15 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.996 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.564 HD12 ' CZ ' ' A' ' 51' ' ' PHE . 82.2 mt -117.79 13.24 14.09 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.141 0.496 . . . . 0.0 110.844 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 48.4 tp10 -60.49 -28.41 68.34 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.917 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -67.8 -12.92 61.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 49' ' ' ASP . 54.6 m -94.36 -88.92 0.23 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.3 mttt 63.96 -39.86 0.22 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 124.265 1.026 . . . . 0.0 113.473 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 47' ' ' SER . 29.2 t70 -60.59 -27.85 68.04 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -89.89 -17.95 27.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.317 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.564 ' CZ ' HD12 ' A' ' 44' ' ' LEU . 73.1 m-85 -125.59 151.64 46.17 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 119.252 -0.979 . . . . 0.0 113.092 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.3 pt -138.42 178.38 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' A' ' 31' ' ' ALA . 91.8 mt -107.81 142.55 37.69 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.469 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 m -127.54 133.19 68.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.505 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.62 121.06 29.57 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.361 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.518 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.017 0 N-CA-C 113.887 0.315 . . . . 0.0 113.887 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -125.54 127.99 24.77 Favored Pre-proline 0 N--CA 1.442 -0.854 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.02 119.22 6.3 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.731 2.287 . . . . 0.0 112.826 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.2 mt -122.28 101.84 40.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.397 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -62.18 155.77 54.42 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.637 2.225 . . . . 0.0 112.121 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -53.91 -33.25 71.19 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.791 2.994 . . . . 0.0 114.067 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.0 m -62.26 -42.9 99.74 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -73.79 154.98 39.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.894 0.378 . . . . 0.0 111.703 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.4 p -106.24 91.5 5.72 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.178 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 44.3 Cg_endo -68.66 -17.91 42.65 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.149 2.566 . . . . 0.0 114.145 -175.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.434 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 43.2 mt -66.37 -33.74 76.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.885 0.374 . . . . 0.0 110.464 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -60.75 -11.76 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.269 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 6.0 mm-40 -95.94 -56.54 2.62 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.794 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 79.0 mtm -61.88 -48.6 79.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 C--N 1.317 -0.825 0 CA-C-O 120.685 0.278 . . . . 0.0 111.487 -179.186 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 p90 . . . . . 0 N--CA 1.444 -0.734 0 CA-C-O 121.049 0.452 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.0 tp -116.41 129.28 56.15 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.941 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -125.4 171.78 10.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.924 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.9 mt -100.12 130.43 49.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.103 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -128.31 142.07 51.25 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.258 0.552 . . . . 0.0 110.65 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -81.65 109.97 16.57 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.805 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? . . . . . 0 CA--C 1.544 0.726 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.772 177.713 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.233 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 p -96.25 139.82 31.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.805 0.336 . . . . 0.0 111.086 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.7 mt -109.18 134.52 51.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.776 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -82.66 99.56 9.67 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.7 t -100.45 112.31 32.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.871 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 78.0 t80 -82.22 122.83 28.41 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.512 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.62 28.2 4.02 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.66 -33.39 82.13 Favored Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 115.268 -0.466 . . . . 0.0 112.97 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.433 ' OE1' ' HG2' ' A' ' 104' ' ' LYS . 40.4 tt0 -64.06 -42.05 97.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.798 0.333 . . . . 0.0 110.485 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.28 -49.85 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.725 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.9 109.85 9.23 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.899 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.53 -27.47 53.91 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.766 2.311 . . . . 0.0 114.035 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -80.05 -7.26 58.76 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.236 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.71 76.87 28.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.401 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 31.0 Cg_endo -62.68 -32.29 78.83 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.706 2.271 . . . . 0.0 113.294 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -129.81 141.42 50.85 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.4 p -131.27 155.04 41.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.4 m -112.55 124.61 52.92 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.724 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.413 HG21 ' HB2' ' A' ' 38' ' ' ALA . 33.3 pt -125.08 166.62 20.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' N ' HD11 ' A' ' 24' ' ' LEU . 5.8 mp -111.35 134.77 52.69 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.956 0.408 . . . . 0.0 110.887 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.45 165.44 30.24 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.704 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 43.8 mt-10 -109.74 -62.16 1.54 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.753 -0.379 . . . . 0.0 109.981 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.512 ' HA ' HD13 ' A' ' 83' ' ' LEU . 18.5 tt 168.34 -43.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.305 1.042 . . . . 0.0 112.832 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -75.49 -11.39 60.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.799 0.809 . . . . 0.0 109.852 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.704 ' OE1' ' HB2' ' A' ' 26' ' ' GLU . 8.8 mp0 -56.59 134.85 54.73 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.229 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 32' ' ' ASP . 36.9 p-10 -84.47 159.69 20.7 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.941 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.46 -26.05 64.91 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.733 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.465 ' HB3' ' ND2' ' A' ' 30' ' ' ASN . 13.3 t70 -59.68 -48.27 82.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.409 ' NH1' ' HG3' ' A' ' 29' ' ' GLU . 58.3 ttt180 -70.31 -44.81 67.51 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.134 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.43 -44.86 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.191 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -64.87 -41.35 95.72 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.732 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.435 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -60.77 -40.54 98.27 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.528 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.53 -41.25 98.74 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.817 0.342 . . . . 0.0 111.398 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.461 ' CB ' HD12 ' A' ' 103' ' ' ILE . . . -78.48 -45.79 21.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.075 0.464 . . . . 0.0 111.743 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.36 -32.02 73.34 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.34 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -56.68 -43.62 80.62 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.168 0.987 . . . . 0.0 110.627 175.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 46.3 mmtm -61.15 -38.54 86.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.772 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -84.69 -7.5 59.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.005 0.431 . . . . 0.0 110.836 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.22 20.5 79.64 Favored Glycine 0 C--O 1.227 -0.29 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.206 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.5 mt -106.52 11.68 30.37 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 122.887 -0.184 . . . . 0.0 111.311 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.582 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 44.8 tt0 -58.55 -29.4 66.34 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.822 0.344 . . . . 0.0 111.756 -178.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -61.06 -26.94 67.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.191 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.3 m -108.76 32.34 4.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.784 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.582 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 33.9 ttmt -60.54 -31.02 70.13 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -176.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -65.02 -9.76 24.4 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.25 0.27 31.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.869 0.366 . . . . 0.0 110.995 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.499 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 89.8 m-85 -129.8 152.27 49.48 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.9 0.381 . . . . 0.0 111.852 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.4 pt -141.16 -180.0 2.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.9 mt -103.32 149.8 24.39 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -137.3 154.24 30.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.89 0.376 . . . . 0.0 110.478 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -109.04 126.87 53.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.0 t . . . . . 0 C--N 1.312 -1.059 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 174.309 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.038 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.527 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 5.4 mpt_? -86.52 119.44 71.41 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.08 117.1 4.14 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.431 2.088 . . . . 0.0 112.357 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 74' ' ' ARG . 39.2 mt -120.9 101.29 45.4 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.981 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.5 163.3 38.58 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.787 2.325 . . . . 0.0 111.125 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.82 -27.67 72.97 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.874 2.383 . . . . 0.0 112.486 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 t -79.11 -9.88 59.67 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.366 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -91.95 151.45 20.5 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.4 m -121.39 88.1 45.65 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.73 -14.59 24.37 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 123.384 2.723 . . . . 0.0 114.527 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.512 HD13 ' HA ' ' A' ' 27' ' ' ILE . 39.6 mt -61.09 -37.83 84.12 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -59.21 -42.43 90.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 110.96 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.63 -40.51 69.69 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.154 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.6 mtp -60.93 -46.82 89.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.385 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.051 -179.304 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.0 p90 . . . . . 0 N--CA 1.438 -1.034 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 tp -104.92 128.09 53.03 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.867 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -127.68 161.72 28.23 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.128 0.49 . . . . 0.0 111.565 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.461 HD12 ' CB ' ' A' ' 38' ' ' ALA . 79.0 mt -104.28 126.68 58.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.345 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.457 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 24.2 mtpp -134.43 164.39 27.54 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.543 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.499 ' HG2' ' CE1' ' A' ' 51' ' ' PHE . 79.7 mtp180 -82.18 140.45 33.72 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt . . . . . 0 C--N 1.313 -1.003 0 CA-C-O 121.122 0.487 . . . . 0.0 111.959 -179.127 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.2 p -104.18 137.83 41.54 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.799 0.333 . . . . 0.0 110.346 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.5 mt -112.46 138.99 48.42 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.198 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -85.09 101.15 12.2 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.7 t -103.76 131.66 51.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.262 -171.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 91.7 t80 -100.42 115.27 29.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.23 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.97 29.04 13.32 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.424 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 10' ' ' TYR . . . -58.46 164.62 8.38 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 65.5 mm-40 72.77 -54.37 0.69 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.126 0.57 . . . . 0.0 110.721 -175.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.6 mt -69.01 -48.59 69.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.488 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.598 HG21 ' CE1' ' A' ' 42' ' ' TYR . 1.7 m -136.48 98.73 10.98 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-O 121.147 0.499 . . . . 0.0 112.144 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.13 -30.06 81.82 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.908 2.405 . . . . 0.0 112.356 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.2 t -66.86 -37.08 83.76 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.072 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -126.93 77.88 74.49 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.558 0.218 . . . . 0.0 110.731 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.53 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 32.8 Cg_endo -64.06 -31.09 65.99 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.5 2.134 . . . . 0.0 112.652 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -129.6 138.71 51.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.109 0.48 . . . . 0.0 112.197 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.55 154.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.402 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.7 p -102.97 121.71 43.1 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.257 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.7 pt -120.84 157.33 23.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.0 mt -106.16 121.81 44.92 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.023 0.439 . . . . 0.0 110.317 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.89 158.65 44.15 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.828 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.546 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 70.6 mm-40 -110.18 155.21 22.28 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 84' ' ' PHE . 19.4 tt -65.43 -27.1 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -83.88 7.69 17.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.272 0.558 . . . . 0.0 110.904 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.57 ' OE1' ' HG2' ' A' ' 33' ' ' ARG . 65.0 mm-40 -92.68 147.52 22.81 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.484 ' OD1' ' HB3' ' A' ' 32' ' ' ASP . 30.3 p30 -84.51 170.78 13.11 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.608 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.5 -26.15 65.05 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.052 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.484 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 17.2 t70 -59.47 -49.54 77.39 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.745 0.307 . . . . 0.0 111.405 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.57 ' HG2' ' OE1' ' A' ' 29' ' ' GLU . 10.4 mpt_? -65.28 -44.9 86.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.94 -45.12 97.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.451 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.97 -43.1 96.8 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.066 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.485 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -62.01 -43.75 98.74 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.621 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.643 ' O ' ' HD3' ' A' ' 41' ' ' LYS . . . -62.9 -49.86 73.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 41' ' ' LYS . . . -66.13 -44.78 83.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.835 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' ' 48' ' ' LYS . 32.2 tp -65.68 -34.6 78.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.184 0.516 . . . . 0.0 109.93 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 36.3 tt0 -61.84 -34.43 75.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.398 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.643 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 4.1 mptp? -60.2 -37.37 80.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.131 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.598 ' CE1' HG21 ' A' ' 15' ' ' VAL . 58.2 m-85 -89.82 -9.13 50.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.121 0.486 . . . . 0.0 110.241 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.49 19.82 79.75 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.733 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.9 mt -100.93 16.55 24.88 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 40.2 tt0 -58.27 -29.11 65.55 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -58.49 -32.89 69.22 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.215 0.531 . . . . 0.0 110.126 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.3 m -95.3 21.86 7.5 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.327 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.494 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 38.6 ttmt -60.04 -35.42 75.09 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -174.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.405 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 32.9 t70 -61.26 -22.7 65.07 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.774 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.428 ' HA ' ' CD ' ' A' ' 106' ' ' LYS . 26.8 t70 -89.43 -2.46 58.4 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -129.39 153.49 47.84 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.748 -0.595 . . . . 0.0 111.888 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.3 174.65 11.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.522 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.2 mt -100.83 145.87 28.02 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 29.7 m -130.03 135.03 61.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.059 0.457 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.26 121.06 29.21 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.78 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.5 t . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.325 178.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 N-CA-C 112.81 -0.116 . . . . 0.0 112.81 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 5.3 mtm180 -103.2 125.18 35.87 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.79 114.45 2.16 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.124 1.883 . . . . 0.0 111.588 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 74' ' ' ARG . 68.2 mt -119.45 105.18 44.36 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.52 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -64.9 158.4 51.47 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.875 2.383 . . . . 0.0 111.52 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.89 -29.99 66.33 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 123.333 2.689 . . . . 0.0 113.588 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.3 t -66.36 -26.2 67.16 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -88.98 147.21 24.42 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.464 ' SG ' ' HA ' ' A' ' 30' ' ' ASN . 36.7 m -111.49 88.36 9.08 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.88 -17.59 32.39 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.861 2.374 . . . . 0.0 113.903 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.433 ' CB ' HG13 ' A' ' 27' ' ' ILE . 57.0 mt -61.58 -35.64 78.39 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.499 ' HA ' HD12 ' A' ' 27' ' ' ILE . 18.1 m-85 -56.6 -46.58 80.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.217 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -74.36 -37.49 63.48 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.6 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.7 mtp -61.45 -48.4 81.32 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.064 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 C--N 1.313 -0.983 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.267 -178.25 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.4 p90 . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 54' ' ' VAL . 17.3 tp -121.54 123.5 42.14 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.535 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -118.57 171.16 8.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.814 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.413 HD11 ' CB ' ' A' ' 38' ' ' ALA . 60.1 mt -109.22 128.02 65.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.356 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.406 ' HE3' ' HG3' ' A' ' 13' ' ' GLU . 13.2 mmmm -132.8 165.36 24.75 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 120.964 0.411 . . . . 0.0 110.115 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 -78.47 138.73 38.6 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.31 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.428 ' CD ' ' HA ' ' A' ' 50' ' ' ASP . 19.0 ptmt . . . . . 0 CA--C 1.542 0.649 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.082 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.44 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 m -102.4 124.02 47.22 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.5 mt -104.47 140.5 37.86 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.201 0.525 . . . . 0.0 112.288 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -85.78 105.2 16.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.7 t -107.97 128.25 63.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.119 -172.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.524 ' CZ ' ' HA3' ' A' ' 12' ' ' GLY . 93.3 t80 -90.1 109.45 20.5 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.364 0.602 . . . . 0.0 110.935 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.99 20.48 45.43 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.987 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.524 ' HA3' ' CZ ' ' A' ' 10' ' ' TYR . . . -64.49 177.62 9.22 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.149 -0.526 . . . . 0.0 112.007 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.453 ' CD ' ' HZ3' ' A' ' 104' ' ' LYS . 36.0 tt0 71.32 -65.55 0.34 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.246 0.618 . . . . 0.0 110.427 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.83 -45.57 83.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.039 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.99 86.81 57.15 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.297 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.55 -27.7 82.21 Favored 'Trans proline' 0 N--CA 1.474 0.339 0 C-N-CA 122.909 2.406 . . . . 0.0 112.989 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.3 t -75.84 -15.12 60.28 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.208 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -138.76 79.36 28.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.06 -31.8 75.85 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.562 2.174 . . . . 0.0 113.51 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.09 144.64 48.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.237 0.542 . . . . 0.0 112.198 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.95 161.63 35.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.294 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.3 p -110.8 130.89 55.45 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.05 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.481 ' CD1' HG23 ' A' ' 34' ' ' ILE . 32.6 pt -128.15 158.82 39.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.1 tp -105.81 113.62 27.28 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.75 140.31 29.89 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.983 0.421 . . . . 0.0 110.988 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.93 153.92 20.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.482 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.7 tt -65.32 -28.01 43.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.022 0.439 . . . . 0.0 111.156 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -79.03 -1.75 37.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.408 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -85.39 147.6 26.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.045 0.45 . . . . 0.0 110.937 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -86.18 170.62 11.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.671 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.54 67.52 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.468 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.46 -44.28 97.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -63.45 -44.49 94.35 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.203 0.525 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.481 HG23 ' CD1' ' A' ' 23' ' ' ILE . 96.9 mt -65.58 -45.39 92.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.588 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 tp -63.49 -43.58 96.83 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.578 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.444 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -63.34 -45.48 94.96 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.389 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.33 -48.51 79.52 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.733 0.302 . . . . 0.0 111.481 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.09 86.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.751 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.414 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 28.9 tp -64.51 -37.75 88.62 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.309 0.576 . . . . 0.0 109.919 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.96 -39.24 71.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.1 178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.9 mmtt -66.98 -15.36 63.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.698 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -108.36 0.45 21.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.784 0.326 . . . . 0.0 111.125 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.53 18.26 76.95 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.198 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.414 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 93.6 mt -99.98 14.21 31.32 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.064 0.459 . . . . 0.0 110.237 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -42.51 -40.79 2.75 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.779 1.232 . . . . 0.0 112.976 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -80.71 -5.78 57.52 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.9 m -112.04 22.44 14.83 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.17 0.509 . . . . 0.0 110.532 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.444 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 35.4 ttmt -60.18 -39.03 85.02 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.52 -6.78 11.69 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -95.24 -10.58 29.93 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.877 0.37 . . . . 0.0 110.797 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.456 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 62.5 m-85 -121.68 162.81 20.08 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.6 pt -145.88 -178.86 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.797 1.239 . . . . 0.0 108.568 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.487 HD12 HD21 ' A' ' 101' ' ' LEU . 96.9 mt -107.39 155.29 20.18 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.313 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 27.5 m -139.29 151.96 23.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 120.682 0.277 . . . . 0.0 110.931 176.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.646 ' OE1' ' HD2' ' A' ' 74' ' ' ARG . 40.1 mt-10 -98.37 123.02 42.26 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.583 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.449 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 15.7 t . . . . . 0 C--N 1.31 -1.124 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.453 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.646 ' HD2' ' OE1' ' A' ' 55' ' ' GLU . 5.4 ptp180 -132.32 129.4 21.56 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.51 116.57 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.006 1.804 . . . . 0.0 112.462 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.416 ' CD1' ' HG3' ' A' ' 55' ' ' GLU . 55.3 mt -119.39 112.8 35.52 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.16 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.69 159.85 51.92 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.521 2.147 . . . . 0.0 111.546 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.22 -27.53 80.88 Favored 'Trans proline' 0 N--CA 1.474 0.335 0 C-N-CA 123.001 2.467 . . . . 0.0 112.108 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -67.02 -23.68 65.93 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.392 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -82.19 153.95 25.7 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 63.2 m -124.73 84.77 57.58 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HG3' HG21 ' A' ' 76' ' ' ILE . 57.8 Cg_endo -83.19 -9.47 10.5 Favored 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 123.021 2.481 . . . . 0.0 115.64 -173.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 27' ' ' ILE . 20.3 mt -63.58 -41.82 98.33 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.467 ' HA ' HD11 ' A' ' 27' ' ' ILE . 60.5 m-85 -60.11 -34.99 74.26 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.038 0.446 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -70.11 -37.71 75.41 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.41 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 47.9 mtm -66.11 -43.21 87.84 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--N 1.324 -0.524 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.09 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.449 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 24.7 p90 . . . . . 0 N--CA 1.429 -1.485 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.487 HD21 HD12 ' A' ' 53' ' ' LEU . 26.2 tp -100.94 123.21 44.79 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.09 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -123.05 171.8 9.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.32 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.6 mt -108.14 128.96 63.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.472 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.453 ' HZ3' ' CD ' ' A' ' 13' ' ' GLU . 26.4 mmmt -132.66 171.43 13.86 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.456 ' HG2' ' CE1' ' A' ' 51' ' ' PHE . 60.7 mtp180 -92.54 140.13 29.87 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt . . . . . 0 CA--C 1.558 1.277 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 178.178 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.434 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 37.7 p -101.41 120.24 39.99 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -106.7 144.49 33.28 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -81.92 112.16 18.77 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.425 HG21 ' CD1' ' A' ' 23' ' ' ILE . 54.1 t -104.86 127.2 59.54 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.222 -174.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -97.88 121.19 39.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.437 0.636 . . . . 0.0 111.794 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.48 26.22 3.21 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.574 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.5 -30.88 72.81 Favored Glycine 0 C--O 1.222 -0.6 0 CA-C-N 115.312 -0.444 . . . . 0.0 113.44 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -64.43 -43.57 93.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.985 0.421 . . . . 0.0 110.148 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.63 -44.72 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 177.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -134.96 104.93 10.52 Favored Pre-proline 0 C--O 1.237 0.424 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.23 -35.43 95.5 Favored 'Trans proline' 0 CA--C 1.493 -1.539 0 C-N-CA 123.908 3.072 . . . . 0.0 113.195 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -65.59 -21.26 66.57 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.361 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -139.28 74.44 35.45 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 48.3 Cg_exo -53.93 -48.25 22.73 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.837 2.358 . . . . 0.0 112.379 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -120.16 137.69 54.03 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.063 0.459 . . . . 0.0 110.998 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.56 161.56 40.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.9 p -118.71 123.23 44.37 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 6' ' ' SER . 41.6 pt -124.72 154.72 32.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.173 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.5 mp -99.02 111.42 23.83 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.228 0.537 . . . . 0.0 110.152 177.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.15 130.51 29.05 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.206 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -89.71 158.18 17.66 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.489 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.483 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 17.1 tt -63.75 -27.37 42.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -89.47 7.24 37.1 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.997 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.39 144.18 25.77 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -78.82 169.1 18.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.719 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.02 -25.51 63.73 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.844 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.07 -41.04 97.76 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.666 0.27 . . . . 0.0 110.833 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -64.88 -47.17 78.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 0.0 110.284 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.47 HG21 HD23 ' A' ' 101' ' ' LEU . 75.0 mt -64.2 -48.85 83.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.725 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.22 -44.88 90.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.462 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.42 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -65.86 -40.61 95.59 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.63 -0.714 . . . . 0.0 113.644 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.66 -48.31 79.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.313 0.557 . . . . 0.0 111.219 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.407 ' HB1' HD12 ' A' ' 103' ' ' ILE . . . -67.59 -41.93 83.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.138 0.494 . . . . 0.0 110.801 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.5 tp -62.95 -37.42 87.0 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.555 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.48 -39.09 92.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.01 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.2 mmtt -61.58 -40.29 94.22 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.988 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.46 -10.09 59.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.376 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.1 34.32 61.63 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.673 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.7 mt -123.13 21.28 9.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.767 0.318 . . . . 0.0 110.253 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.81 -16.66 43.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.288 -176.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -90.65 8.53 33.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.792 0.33 . . . . 0.0 111.29 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.9 m -135.96 32.81 2.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.207 0.527 . . . . 0.0 110.133 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 39.9 ttmt -64.18 -37.33 87.07 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -173.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -64.25 -16.82 62.82 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.904 0.383 . . . . 0.0 111.847 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -84.06 -7.13 59.47 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.942 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -130.98 154.6 47.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.266 0.555 . . . . 0.0 111.805 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.2 pt -137.99 173.58 12.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.34 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.426 HD11 HD22 ' A' ' 101' ' ' LEU . 96.1 mt -99.51 135.19 41.29 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 23.3 m -128.22 134.48 64.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.204 -178.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.513 ' O ' ' HA2' ' A' ' 73' ' ' GLY . 32.7 mt-10 -86.53 122.48 30.53 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 120.962 0.411 . . . . 0.0 111.975 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.453 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 21.2 t . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.576 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 55' ' ' GLU . . . . . . . . 0 N--CA 1.422 -2.264 0 CA-C-O 120.779 0.1 . . . . 0.0 112.943 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.569 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 1.6 mpt_? -90.22 130.03 43.52 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.86 113.67 2.87 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.17 1.913 . . . . 0.0 112.651 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.0 mt -120.53 103.35 44.08 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.097 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.89 155.26 55.97 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.889 2.393 . . . . 0.0 112.73 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.51 -28.22 63.41 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.745 2.964 . . . . 0.0 113.403 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -73.49 -11.69 60.54 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -95.13 156.56 16.27 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.215 -0.303 . . . . 0.0 111.679 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 38.2 m -119.68 82.59 26.73 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 86' ' ' MET . 58.2 Cg_endo -71.21 -16.8 31.6 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.096 2.531 . . . . 0.0 115.115 -174.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.483 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 50.9 mt -61.18 -36.9 81.1 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -173.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.46 ' HA ' HD11 ' A' ' 27' ' ' ILE . 53.5 m-85 -58.88 -44.87 91.23 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.481 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.79 -36.16 67.53 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.406 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 92.9 mtp -61.69 -42.23 98.65 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.202 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.365 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.453 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 27.9 p90 . . . . . 0 N--CA 1.425 -1.7 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.47 HD23 HG21 ' A' ' 34' ' ' ILE . 27.3 tp -104.06 123.3 46.99 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.962 -175.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.29 173.14 7.13 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.451 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.407 HD12 ' HB1' ' A' ' 38' ' ' ALA . 74.4 mt -112.41 128.63 68.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.091 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -133.83 160.37 37.82 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 120.951 0.405 . . . . 0.0 110.244 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -78.7 116.76 19.27 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.947 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.976 174.681 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.324 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 14.1 p -95.16 133.16 39.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.6 mt -113.01 140.02 48.17 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.078 0.466 . . . . 0.0 112.153 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -83.34 111.65 19.19 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -113.26 128.48 70.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.042 -172.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -95.78 125.03 40.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.432 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.24 29.48 2.71 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.242 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.88 88.57 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.976 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -78.17 -6.81 55.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.175 0.512 . . . . 0.0 110.556 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.5 mm -96.38 -53.47 8.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' CG1' HG22 ' A' ' 17' ' ' THR . 95.3 t -139.45 113.52 8.0 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.486 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.83 -25.16 60.59 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.903 2.402 . . . . 0.0 114.413 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.408 HG22 ' CG1' ' A' ' 15' ' ' VAL . 13.8 t -78.3 -13.59 59.79 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.423 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -138.41 79.78 29.32 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.7 -31.77 48.57 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.457 2.104 . . . . 0.0 112.811 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -130.0 138.35 50.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.072 0.463 . . . . 0.0 111.492 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.4 p -136.18 157.61 37.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.689 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.1 m -111.82 126.46 55.1 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.887 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 6' ' ' SER . 34.3 pt -124.32 161.86 26.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.652 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.8 tp -107.68 122.36 46.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.14 148.38 32.51 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.795 0.331 . . . . 0.0 110.567 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 41.6 mt-10 -101.36 148.17 25.47 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.482 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 18.1 tt -64.35 -30.43 50.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -77.49 -7.23 55.91 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 65.2 mm-40 -82.84 160.35 22.22 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.023 0.44 . . . . 0.0 110.937 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -89.92 170.05 10.71 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.872 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.425 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -62.29 -24.56 67.37 Favored 'General case' 0 C--O 1.21 -1.013 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.168 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -60.62 -47.43 86.27 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 120.71 0.291 . . . . 0.0 111.07 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.509 ' HA ' ' HE ' ' A' ' 33' ' ' ARG . 2.0 tpm_? -68.98 -41.61 77.65 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.348 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.09 -45.46 98.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.6 -44.91 92.61 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.924 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.97 -38.27 93.99 Favored Glycine 0 C--O 1.211 -1.297 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.317 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.39 -49.17 78.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.291 0.546 . . . . 0.0 110.829 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.414 ' HB1' HD12 ' A' ' 103' ' ' ILE . . . -69.61 -41.93 75.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.942 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.416 ' CD2' ' HA ' ' A' ' 45' ' ' GLU . 25.8 tp -64.11 -35.21 80.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.891 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.31 -35.67 79.77 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.463 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -61.05 -37.9 84.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 110.321 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -88.19 -0.92 57.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.249 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.24 33.55 83.06 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.064 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.4 mt -121.15 12.59 11.09 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.473 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 44.5 tt0 -63.07 -24.65 68.01 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.867 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -57.26 -35.16 69.4 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 49.2 m -78.59 -85.4 0.07 Allowed 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.322 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.473 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 33.6 ttmt 63.1 -35.36 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.883 1.273 . . . . 0.0 113.915 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 47' ' ' SER . 36.3 t70 -64.64 -20.37 66.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.176 0.512 . . . . 0.0 111.373 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.45 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 12.4 p-10 -103.82 12.32 34.65 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.813 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -133.87 149.1 51.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.678 0.275 . . . . 0.0 111.171 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 pt -138.55 170.84 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.425 HD13 ' HB1' ' A' ' 31' ' ' ALA . 96.3 mt -100.85 137.23 39.51 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.464 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 17.4 m -123.17 129.96 74.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.221 0.534 . . . . 0.0 110.577 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 3.1 tm-20 -88.0 122.64 31.83 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.275 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.8 t . . . . . 0 C--O 1.224 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.369 -179.033 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.538 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -93.03 114.55 63.02 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.2 114.59 3.66 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.44 2.093 . . . . 0.0 111.518 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 74' ' ' ARG . 18.1 mt -120.57 100.84 46.67 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.191 -176.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -59.51 157.29 32.33 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.217 2.611 . . . . 0.0 112.269 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.28 -25.31 71.9 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.352 2.702 . . . . 0.0 114.4 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.2 t -76.64 -12.6 60.03 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -92.35 155.8 17.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.653 0.263 . . . . 0.0 111.357 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 76.6 m -116.14 86.28 16.87 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.857 0.361 . . . . 0.0 110.248 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.97 -22.09 31.58 Favored 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 122.912 2.408 . . . . 0.0 114.249 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.482 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 81.1 mt -61.91 -37.95 86.57 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -175.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.434 ' HA ' HD12 ' A' ' 27' ' ' ILE . 23.1 m-85 -55.24 -46.42 76.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.972 0.415 . . . . 0.0 110.845 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -74.91 -42.51 57.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.557 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.6 mtp -59.96 -46.62 88.83 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.013 0.435 . . . . 0.0 111.197 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.8 m . . . . . 0 C--N 1.312 -1.027 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.066 -179.791 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 29.1 p90 . . . . . 0 N--CA 1.442 -0.866 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.3 tp -117.01 125.68 51.74 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -124.95 171.36 10.26 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.825 -175.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.414 HD12 ' HB1' ' A' ' 38' ' ' ALA . 71.8 mt -102.56 129.73 53.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.891 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -125.07 148.75 48.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.231 0.539 . . . . 0.0 110.912 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -80.09 102.0 9.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.655 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 6.0 ptmm? . . . . . 0 C--N 1.319 -0.733 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.598 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.839 0 N-CA-C 112.597 -0.201 . . . . 0.0 112.597 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 p -95.14 160.32 14.61 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.79 0.329 . . . . 0.0 110.515 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.4 mt -110.85 135.41 51.45 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.193 0.521 . . . . 0.0 111.926 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.18 109.72 17.96 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -116.84 129.98 72.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.706 -172.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -103.89 129.88 51.43 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.098 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.22 28.86 2.66 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.054 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.25 -30.33 75.65 Favored Glycine 0 N--CA 1.465 0.591 0 C-N-CA 121.646 -0.311 . . . . 0.0 113.481 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -61.98 -32.81 73.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 109.722 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.8 mt -91.99 -52.97 9.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.768 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.3 t -124.53 102.91 32.31 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.663 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.81 -22.37 43.05 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.076 2.517 . . . . 0.0 113.796 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -78.13 -15.96 58.38 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.941 0.401 . . . . 0.0 111.189 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -139.16 74.34 36.26 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-O 121.013 0.435 . . . . 0.0 109.855 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.05 -40.02 55.14 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.433 2.088 . . . . 0.0 112.936 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -120.55 135.89 54.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.232 0.539 . . . . 0.0 111.548 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.65 163.29 37.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.96 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -122.94 132.34 54.12 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.253 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.43 HG22 ' HB1' ' A' ' 38' ' ' ALA . 43.3 pt -125.86 161.26 31.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.864 -177.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.37 113.38 25.98 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.61 142.16 23.52 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 72.4 mm-40 -95.56 169.93 9.7 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.071 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 84' ' ' PHE . 16.0 tt -62.96 -26.54 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -84.63 1.61 45.34 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.4 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -80.76 143.53 32.84 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.909 0.385 . . . . 0.0 109.974 176.316 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -96.7 173.41 7.33 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.596 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.11 -24.14 66.96 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.78 -49.16 76.15 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.955 0.407 . . . . 0.0 110.392 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -76.15 -42.37 46.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.551 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.6 -44.76 99.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.857 0.361 . . . . 0.0 110.615 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.6 tp -65.55 -42.7 91.58 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.32 -46.1 94.91 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.74 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.588 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.14 -50.47 73.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.112 0.456 . . . . 0.0 111.449 -178.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.43 ' HB1' HG22 ' A' ' 23' ' ' ILE . . . -69.09 -44.24 72.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.722 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.464 ' HG ' ' C ' ' A' ' 44' ' ' LEU . 29.0 tp -64.94 -36.96 86.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.76 -177.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.46 -38.57 90.31 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.305 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.5 mmtt -60.26 -35.51 75.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 110.226 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -85.18 -2.19 57.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.871 0.367 . . . . 0.0 110.369 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.63 20.11 79.78 Favored Glycine 0 C--O 1.237 0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.905 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.464 ' C ' ' HG ' ' A' ' 39' ' ' LEU . 88.0 mt -116.36 16.08 15.75 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 44.3 tt0 -56.71 -34.15 67.17 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -70.27 -13.34 62.12 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 122.226 -0.296 . . . . 0.0 111.625 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.4 m -104.24 38.51 1.84 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 99.3 mttt -71.13 -11.52 60.99 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.841 -0.537 . . . . 0.0 111.402 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.547 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 7.4 m-20 -74.2 -7.24 51.98 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.176 0.512 . . . . 0.0 109.844 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -117.83 -13.33 10.12 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.118 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -129.24 147.05 51.04 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.528 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.4 HG23 ' HB3' ' A' ' 106' ' ' LYS . 48.5 pt -137.11 177.7 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.025 177.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.5 138.51 37.47 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.745 0.307 . . . . 0.0 110.414 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 15.8 m -126.78 129.39 71.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.105 176.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.94 118.66 29.67 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.7 t . . . . . 0 C--N 1.314 -0.971 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.664 -179.862 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.482 0 N-CA-C 112.188 -0.365 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 63.7 mtp180 -81.87 123.35 80.23 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.41 114.11 3.7 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 122.412 2.075 . . . . 0.0 111.52 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.7 mt -120.42 99.42 47.99 Favored Pre-proline 0 N--CA 1.434 -1.252 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.487 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -63.65 160.69 35.16 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.849 2.366 . . . . 0.0 111.782 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.4 -33.15 45.33 Favored 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 123.863 3.042 . . . . 0.0 114.116 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 m -61.64 -40.72 95.88 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -80.18 154.36 28.02 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 5.3 p -120.19 93.97 48.37 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.139 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.83 -17.66 41.8 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.711 2.274 . . . . 0.0 115.05 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.41 ' CB ' HG13 ' A' ' 27' ' ' ILE . 60.0 mt -62.91 -34.45 77.46 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -176.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.465 ' HA ' HD12 ' A' ' 27' ' ' ILE . 21.8 m-85 -57.61 -30.79 65.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.106 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -86.91 -50.48 6.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.117 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.4 mtp -59.08 -71.92 0.11 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.983 -175.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 m . . . . . 0 C--N 1.32 -0.698 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -175.794 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 29.4 p90 . . . . . 0 CA--C 1.51 -0.591 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 30.6 tp -109.96 125.81 53.26 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.092 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -123.9 169.11 11.92 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.411 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.426 HD12 ' HB3' ' A' ' 38' ' ' ALA . 74.0 mt -111.59 130.03 65.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.716 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -127.91 164.57 21.98 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 121.154 0.502 . . . . 0.0 110.309 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -82.12 111.83 18.61 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.547 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.4 ptmt . . . . . 0 C--N 1.323 -0.558 0 O-C-N 123.6 0.562 . . . . 0.0 112.271 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.41 0 CA-C-O 120.935 0.186 . . . . 0.0 113.047 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.3 p -129.5 141.37 51.01 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.6 mt -109.17 142.22 40.27 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HE2' ' CE1' ' A' ' 20' ' ' TYR . 87.2 tttt -82.05 108.2 15.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.453 HG12 ' CB ' ' A' ' 38' ' ' ALA . 71.0 t -114.7 131.57 66.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 120.832 0.349 . . . . 0.0 110.563 -173.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -114.71 119.62 37.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.296 0.57 . . . . 0.0 111.868 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.27 19.66 4.55 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.527 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.8 -22.61 60.04 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.413 -0.394 . . . . 0.0 113.633 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.01 -35.56 80.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.339 0.59 . . . . 0.0 109.931 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.51 -48.87 13.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.799 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.5 t -119.15 90.93 42.77 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.295 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.13 -30.48 93.28 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.665 2.91 . . . . 0.0 114.079 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -64.96 -23.5 67.24 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.497 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -133.74 79.92 57.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.527 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 18.1 Cg_endo -59.76 -48.83 11.58 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.394 2.063 . . . . 0.0 112.773 -178.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.526 ' CE1' ' HE2' ' A' ' 8' ' ' LYS . 86.6 m-85 -118.04 139.52 51.09 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.232 0.539 . . . . 0.0 111.279 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -134.54 161.01 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.879 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.5 p -119.36 130.85 55.55 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.062 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.438 HD13 HG21 ' A' ' 34' ' ' ILE . 40.5 pt -127.49 157.55 39.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.692 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.97 110.38 22.4 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.98 145.91 27.56 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.216 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -108.89 166.12 11.06 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.419 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.545 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 15.2 tt -64.97 -28.75 45.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.659 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -75.23 -4.32 38.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -92.79 145.14 24.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -83.58 175.38 9.79 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.66 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.23 -25.63 65.79 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.688 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -65.15 -37.46 87.48 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.812 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -67.48 -46.9 71.61 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.071 0.462 . . . . 0.0 110.445 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.438 HG21 HD13 ' A' ' 23' ' ' ILE . 96.9 mt -64.8 -45.5 94.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.529 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 53.9 tp -63.43 -46.58 85.69 Favored 'General case' 0 C--O 1.21 -0.992 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.542 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 40' ' ' GLU . . . -66.88 -43.32 91.78 Favored Glycine 0 C--O 1.22 -0.759 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.095 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.01 -38.98 84.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.815 0.341 . . . . 0.0 111.394 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' A' ' 103' ' ' ILE . . . -84.2 -36.23 22.94 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 35' ' ' LEU . 28.8 tp -62.68 -36.98 84.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.53 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 56.9 mt-10 -58.3 -41.08 83.64 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.576 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 44.7 mmtm -62.61 -38.51 90.47 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.801 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.15 -2.98 58.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.555 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.51 26.78 62.55 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 114.322 0.489 . . . . 0.0 114.322 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.439 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 94.0 mt -118.53 15.56 13.74 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 117.251 0.526 . . . . 0.0 110.761 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -60.98 -29.07 69.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.539 -177.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -61.37 -33.49 73.74 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.886 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.4 m -83.33 -89.58 0.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.061 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt 67.28 -27.95 0.13 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.68 -20.19 65.93 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -113.18 19.52 17.05 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.753 0.311 . . . . 0.0 111.437 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.462 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 98.8 m-85 -124.9 144.14 50.48 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 122.301 -0.249 . . . . 0.0 110.832 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 pt -141.62 169.88 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.336 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.448 HD12 HD23 ' A' ' 101' ' ' LEU . 94.4 mt -102.02 146.66 27.58 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.658 0.266 . . . . 0.0 110.328 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.5 135.36 59.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.013 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -91.86 123.92 35.6 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.121 0.486 . . . . 0.0 111.121 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.1 t . . . . . 0 C--N 1.309 -1.177 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.284 -179.74 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.399 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -86.71 130.24 49.64 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 117.536 0.668 . . . . 0.0 109.795 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.44 117.71 5.15 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.364 2.043 . . . . 0.0 112.034 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.4 mt -119.33 103.0 47.69 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.307 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.23 156.76 48.73 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.922 2.415 . . . . 0.0 111.629 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.87 -16.18 53.36 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.908 2.405 . . . . 0.0 113.384 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.9 p -83.36 -12.46 56.51 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -91.14 158.05 16.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.515 0.198 . . . . 0.0 110.929 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.7 m -115.52 85.29 13.33 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.91 -26.93 58.86 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.628 2.219 . . . . 0.0 113.695 -175.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.545 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 77.1 mt -62.92 -37.96 89.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -65.66 -14.95 62.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.537 0.208 . . . . 0.0 111.535 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -95.66 -41.65 8.79 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.48 ' SD ' HD23 ' A' ' 83' ' ' LEU . 91.3 mtp -61.73 -46.23 90.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.023 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.453 -177.578 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 25.4 p90 . . . . . 0 N--CA 1.437 -1.118 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.448 HD23 HD12 ' A' ' 53' ' ' LEU . 29.8 tp -103.97 125.45 50.36 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.034 0.445 . . . . 0.0 111.309 -172.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.73 171.15 11.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.254 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' A' ' 38' ' ' ALA . 80.4 mt -109.22 129.81 63.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.187 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -135.79 168.0 20.12 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.705 175.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.462 ' HG2' ' CE1' ' A' ' 51' ' ' PHE . 66.5 mtp180 -91.71 139.88 30.25 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.251 -178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt . . . . . 0 C--N 1.3 -1.545 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.101 177.752 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.117 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.3 m -94.29 138.49 32.22 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.5 mt -105.85 140.47 38.83 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -82.27 102.53 11.23 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.895 174.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.41 ' CG2' HG12 ' A' ' 23' ' ' ILE . 41.0 t -108.46 120.36 59.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.103 -175.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -105.07 123.18 47.36 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.219 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.39 17.64 6.54 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.79 -22.17 59.42 Favored Glycine 0 N--CA 1.462 0.416 0 C-N-CA 121.695 -0.288 . . . . 0.0 112.686 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -63.34 -35.38 80.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -92.0 -48.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.73 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.24 106.45 33.28 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -63.86 -22.26 68.98 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.598 2.198 . . . . 0.0 111.32 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -78.68 -15.83 58.01 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.62 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -144.38 71.03 16.0 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.935 0.398 . . . . 0.0 110.199 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.507 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 45.3 Cg_exo -57.09 -45.53 35.05 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.065 2.51 . . . . 0.0 113.594 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.26 140.87 52.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.29 167.41 20.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.6 m -132.03 133.4 44.36 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.428 HD12 HG21 ' A' ' 34' ' ' ILE . 33.8 pt -129.38 163.08 35.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.402 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.7 tp -111.18 121.45 45.34 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.47 143.64 26.85 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.117 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.66 161.36 14.94 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.486 HD11 ' HA ' ' A' ' 84' ' ' PHE . 17.4 tt -62.85 -28.0 44.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.798 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -69.34 -24.04 63.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.312 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.69 139.15 58.74 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.525 0.678 . . . . 0.0 111.197 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -89.67 175.53 7.22 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.437 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.01 -33.79 73.81 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.217 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.08 -50.02 75.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.626 0.25 . . . . 0.0 111.486 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -69.13 -41.05 77.84 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.835 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 23' ' ' ILE . 96.8 mt -64.4 -44.04 97.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.606 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.69 -44.0 97.37 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.978 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.7 -41.02 99.12 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.472 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.03 -49.68 75.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.932 0.396 . . . . 0.0 111.449 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.48 -43.86 72.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.661 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.425 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 26.7 tp -64.29 -32.73 74.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.326 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.09 -39.96 87.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.813 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -62.4 -36.31 81.92 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -80.73 -12.35 59.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.313 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.58 20.69 76.32 Favored Glycine 0 C--O 1.229 -0.169 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.243 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.425 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 85.5 mt -108.52 12.84 25.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.799 0.333 . . . . 0.0 110.615 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -59.26 -24.86 63.58 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.919 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -64.24 -33.29 75.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.002 0.43 . . . . 0.0 110.272 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.2 m -79.23 -89.39 0.05 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.056 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt 68.1 -39.99 0.41 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.598 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 35.2 m-20 -65.58 -19.74 66.04 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 120.728 0.299 . . . . 0.0 111.618 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.501 ' C ' ' HG2' ' A' ' 106' ' ' LYS . 15.2 p-10 -103.79 11.48 35.74 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.82 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -131.91 147.54 52.48 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.708 0.289 . . . . 0.0 110.893 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.3 pt -138.56 170.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.6 mt -100.46 141.8 32.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.749 0.309 . . . . 0.0 110.176 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 28.6 m -125.22 132.71 70.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 120.994 0.426 . . . . 0.0 110.923 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.458 ' HG3' ' HG2' ' A' ' 86' ' ' MET . 1.6 tm-20 -87.58 129.59 35.05 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.484 ' HB ' ' CZ ' ' A' ' 100' ' ' PHE . 16.1 t . . . . . 0 N--CA 1.435 -1.177 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.368 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 113.99 0.356 . . . . 0.0 113.99 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.464 ' O ' HG13 ' A' ' 76' ' ' ILE . 14.2 ttp180 -111.3 112.77 54.55 Favored Pre-proline 0 N--CA 1.437 -1.09 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.62 116.51 3.28 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.024 2.483 . . . . 0.0 113.043 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 74' ' ' ARG . 32.9 mt -121.81 103.71 39.94 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.089 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -62.12 155.54 55.53 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.684 2.256 . . . . 0.0 112.106 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.56 -33.26 77.92 Favored 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.775 2.983 . . . . 0.0 113.939 -176.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 p -66.18 -24.64 66.68 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.3 155.21 19.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.683 0.278 . . . . 0.0 111.7 -177.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 59.0 m -105.8 93.98 8.25 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HB3' HG22 ' A' ' 76' ' ' ILE . 50.6 Cg_endo -69.21 -28.39 27.95 Favored 'Trans proline' 0 C--O 1.218 -0.477 0 C-N-CA 122.842 2.362 . . . . 0.0 115.244 -173.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.483 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 86.7 mt -61.88 -38.69 89.26 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -173.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.486 ' HA ' HD11 ' A' ' 27' ' ' ILE . 58.9 m-85 -59.16 -39.51 82.67 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.189 0.519 . . . . 0.0 110.847 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -83.98 -32.92 24.73 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.663 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.458 ' HG2' ' HG3' ' A' ' 55' ' ' GLU . 85.0 mtp -62.76 -40.97 98.91 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.167 0.508 . . . . 0.0 111.692 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.5 p . . . . . 0 C--N 1.3 -1.569 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.484 ' CZ ' ' HB ' ' A' ' 56' ' ' VAL . 44.3 p90 . . . . . 0 N--CA 1.424 -1.753 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.6 tp -119.54 122.51 41.78 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.987 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.98 167.63 12.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.967 -177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.63 126.03 56.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -120.01 156.83 30.12 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.682 0.753 . . . . 0.0 111.643 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -85.55 112.1 20.63 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.764 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.598 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.6 ptmt . . . . . 0 C--N 1.32 -0.68 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.857 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.452 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.0 p -135.27 151.19 50.34 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.4 mt -122.38 135.65 54.74 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.292 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -87.49 100.57 12.86 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.527 HG13 ' CB ' ' A' ' 38' ' ' ALA . 72.8 t -95.34 122.1 46.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.598 -173.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 82.8 t80 -92.03 120.99 33.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.123 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.47 23.82 4.0 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -61.28 -26.9 66.74 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.279 -0.46 . . . . 0.0 113.375 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.414 ' OE1' ' HG2' ' A' ' 104' ' ' LYS . 44.2 tt0 -64.17 -46.51 83.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.27 -50.1 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.291 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.85 98.14 50.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.131 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.05 -21.77 42.48 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.748 2.298 . . . . 0.0 113.256 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 t -84.78 -6.45 59.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.708 0.29 . . . . 0.0 111.412 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -148.01 80.11 8.89 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.476 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 28.2 Cg_endo -62.87 -48.97 5.8 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.849 2.366 . . . . 0.0 114.111 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -120.21 138.02 53.87 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.017 0.437 . . . . 0.0 111.812 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -127.82 144.27 38.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.793 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 p -96.75 115.73 27.92 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.238 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.44 HD11 HG23 ' A' ' 34' ' ' ILE . 18.5 pt -117.49 158.34 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.817 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.81 122.83 44.71 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.38 144.79 24.83 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -104.06 158.51 16.38 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.917 0.389 . . . . 0.0 110.425 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.486 HD11 ' HA ' ' A' ' 84' ' ' PHE . 14.2 tt -65.24 -26.69 40.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.464 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.47 9.18 11.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.808 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -109.71 146.43 34.9 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.413 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 39.7 m-80 -76.25 174.56 9.99 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.216 0.532 . . . . 0.0 111.236 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.431 ' HB3' HD12 ' A' ' 53' ' ' LEU . . . -61.62 -26.48 68.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.843 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.423 ' CB ' ' HB3' ' A' ' 78' ' ' PRO . 1.4 p30 -63.52 -36.92 85.38 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.502 0.192 . . . . 0.0 110.883 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -66.32 -43.81 85.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.099 0.476 . . . . 0.0 110.014 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.44 HG23 HD11 ' A' ' 23' ' ' ILE . 96.7 mt -64.72 -46.16 93.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.322 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.76 -46.71 84.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.197 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.19 -43.2 93.57 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.257 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.685 ' O ' ' HD3' ' A' ' 41' ' ' LYS . . . -61.6 -48.81 79.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.867 0.365 . . . . 0.0 111.283 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.527 ' CB ' HG13 ' A' ' 9' ' ' VAL . . . -68.22 -40.68 82.0 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.465 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.83 -36.7 84.76 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.517 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.95 -37.18 78.81 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.387 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.685 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 6.5 mptt -61.43 -37.33 83.12 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.62 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -90.68 -0.13 57.59 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.2 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.84 26.28 71.69 Favored Glycine 0 C--O 1.238 0.365 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.879 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.0 mt -113.81 19.98 16.21 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 122.642 -0.328 . . . . 0.0 111.188 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -52.16 -39.47 60.05 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.343 0.657 . . . . 0.0 111.765 -175.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -72.58 -22.06 61.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.547 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.3 m -93.19 21.22 6.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.836 0.35 . . . . 0.0 111.295 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -59.71 -33.84 72.14 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.893 -176.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.89 -7.8 4.2 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.546 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -106.51 -6.95 17.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -127.76 155.03 44.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -173.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.0 pt -138.66 176.28 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.458 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.431 HD12 ' HB3' ' A' ' 31' ' ' ALA . 98.5 mt -101.51 143.45 31.49 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.727 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.7 m -127.9 130.41 69.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.416 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.422 ' HB2' HD11 ' A' ' 76' ' ' ILE . 1.7 tt0 -90.27 121.48 32.32 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.6 t . . . . . 0 C--N 1.315 -0.932 0 CA-C-O 121.132 0.492 . . . . 0.0 111.938 -175.514 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.687 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 18.7 ptt85 -83.56 128.65 63.06 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-N 117.375 0.587 . . . . 0.0 109.443 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 24.2 Cg_exo -61.69 119.2 6.21 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.248 1.965 . . . . 0.0 111.921 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' A' ' 55' ' ' GLU . 65.6 mt -120.33 100.1 47.72 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.153 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -67.12 155.69 69.59 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.734 2.289 . . . . 0.0 111.384 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.423 ' HB3' ' CB ' ' A' ' 32' ' ' ASP . 51.8 Cg_exo -54.66 -32.53 75.78 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 123.489 2.792 . . . . 0.0 113.262 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m -62.69 -41.92 99.37 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.291 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.74 148.91 50.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 5.6 m -104.27 85.96 1.22 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.403 ' O ' ' HG3' ' A' ' 86' ' ' MET . 56.2 Cg_endo -69.46 -24.77 30.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.604 2.203 . . . . 0.0 114.159 -173.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 27' ' ' ILE . 33.3 mt -63.76 -37.89 89.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -175.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.486 ' HA ' HD11 ' A' ' 27' ' ' ILE . 26.7 m-85 -58.21 -46.28 86.16 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.32 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.26 -39.68 82.15 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.005 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 12.1 mtm -64.75 -42.72 94.94 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.788 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 CA--C 1.54 0.57 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.834 -176.867 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.0 p90 . . . . . 0 N--CA 1.438 -1.056 0 CA-C-O 121.118 0.485 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -111.64 127.36 55.73 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.465 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.46 166.18 14.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.209 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.3 mt -106.86 122.84 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.636 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.414 ' HG2' ' OE1' ' A' ' 13' ' ' GLU . 25.3 mtpp -132.31 167.14 20.39 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 177.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -75.11 141.41 43.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.092 176.408 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.216 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.5 m -109.69 146.69 34.44 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.7 mt -114.36 135.09 54.46 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.86 101.48 11.01 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.449 ' CG2' HG12 ' A' ' 23' ' ' ILE . 61.4 t -102.66 121.13 53.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.228 -171.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -92.54 104.33 16.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.41 0.624 . . . . 0.0 110.984 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.22 16.61 22.31 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.885 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.67 -23.7 58.92 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.555 -0.355 . . . . 0.0 112.385 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -65.78 -36.02 82.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.119 0.485 . . . . 0.0 110.185 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.7 mm -86.07 -50.31 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.609 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -128.51 105.31 19.23 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.371 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.16 -36.52 96.6 Favored 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 123.647 2.898 . . . . 0.0 112.228 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 m -63.45 -26.97 68.97 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.723 -176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.07 79.02 69.95 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.49 -43.85 47.48 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.593 2.196 . . . . 0.0 112.927 -178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -128.53 139.73 52.16 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.126 0.489 . . . . 0.0 111.311 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.76 161.35 41.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 p -119.87 130.31 54.8 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.045 0.45 . . . . 0.0 111.265 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.449 HG12 ' CG2' ' A' ' 9' ' ' VAL . 36.7 pt -130.4 157.34 42.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.427 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.5 mp -105.0 121.91 44.76 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.54 145.8 43.35 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.019 0.438 . . . . 0.0 111.194 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 62.3 mt-10 -97.7 152.11 19.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.114 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.473 ' HA ' HD13 ' A' ' 83' ' ' LEU . 19.7 tt -67.11 -29.4 45.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.915 -177.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -93.25 13.32 21.64 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.195 0.521 . . . . 0.0 110.078 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 37.0 tt0 -99.42 137.14 38.34 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -76.85 165.24 24.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.349 0.595 . . . . 0.0 112.479 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.1 -23.19 67.33 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.733 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.8 -45.57 93.27 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.797 0.332 . . . . 0.0 111.015 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -69.89 -42.38 73.5 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.958 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.47 -48.7 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.552 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.2 tp -63.62 -44.52 93.67 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.228 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.11 93.92 Favored Glycine 0 C--O 1.212 -1.265 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.17 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.38 -51.11 70.88 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.256 0.528 . . . . 0.0 111.238 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.426 ' CB ' HD11 ' A' ' 103' ' ' ILE . . . -69.24 -39.83 78.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.317 0.579 . . . . 0.0 111.133 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.5 tp -64.38 -38.24 90.32 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.027 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -65.67 -26.76 67.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.179 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 74.7 mmtt -59.84 -30.37 68.92 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.325 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -101.36 1.68 38.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.244 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.95 27.69 73.69 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.74 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.1 mt -112.81 23.0 13.92 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.34 -30.32 69.46 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -175.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -71.34 -20.17 62.2 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.992 0.425 . . . . 0.0 110.979 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.6 m -90.39 6.73 41.98 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.975 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -56.73 -16.07 5.75 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.368 0.667 . . . . 0.0 112.74 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.34 -34.19 74.87 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.843 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.56 ' OD2' ' HD3' ' A' ' 105' ' ' ARG . 20.6 t0 -107.48 15.94 24.33 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.05 148.83 50.57 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.868 -0.52 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.4 pt -140.17 170.3 15.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.262 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.8 mt -101.39 141.59 34.04 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.691 0.281 . . . . 0.0 110.514 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.434 HG22 ' HG3' ' A' ' 104' ' ' LYS . 28.3 m -124.21 129.26 74.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.15 0.5 . . . . 0.0 109.872 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.423 ' OE1' ' HG2' ' A' ' 86' ' ' MET . 14.8 tt0 -88.17 134.92 33.66 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.9 t . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -175.972 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.685 0 N-CA-C 113.99 0.356 . . . . 0.0 113.99 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HD3' ' HB3' ' A' ' 55' ' ' GLU . 5.8 ptm180 -119.76 121.34 29.87 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 15.9 Cg_exo -66.47 118.4 5.5 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.308 2.005 . . . . 0.0 112.094 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.5 mt -121.64 102.6 41.75 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.143 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.77 154.02 74.79 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.757 2.305 . . . . 0.0 111.905 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -57.05 -26.84 70.88 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.633 2.888 . . . . 0.0 113.536 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.4 m -62.4 -40.22 95.79 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.06 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -82.02 157.63 24.11 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.063 0.545 . . . . 0.0 112.323 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 66.4 m -109.05 91.89 10.03 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.53 -18.91 43.13 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.051 2.501 . . . . 0.0 115.109 -173.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 86' ' ' MET . 33.9 mt -63.01 -28.78 70.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -173.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.434 ' HA ' HD13 ' A' ' 27' ' ' ILE . 44.1 m-85 -59.01 -44.19 91.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 110.489 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -80.13 -34.28 37.9 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.596 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.503 ' HB2' ' HA ' ' A' ' 83' ' ' LEU . 2.3 tmm? -58.83 -43.0 90.56 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.212 0.605 . . . . 0.0 111.082 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.9 m . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.276 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.7 p90 . . . . . 0 N--CA 1.424 -1.729 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.1 tp -118.16 122.33 42.77 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.063 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.07 165.96 12.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.473 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.426 HD11 ' CB ' ' A' ' 38' ' ' ALA . 72.3 mt -107.01 124.84 63.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.8 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.434 ' HG3' HG22 ' A' ' 54' ' ' VAL . 1.4 mmpt? -128.94 152.19 48.84 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.422 0.63 . . . . 0.0 110.537 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.56 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 2.4 tmm_? -79.32 126.36 30.7 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.317 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.213 -179.128 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 N-CA-C 112.188 -0.365 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 p -95.52 137.45 34.56 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.0 mt -112.19 135.16 53.21 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 121.179 0.514 . . . . 0.0 112.029 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -82.67 108.86 16.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.45 HG21 ' CD1' ' A' ' 23' ' ' ILE . 56.6 t -116.82 130.43 71.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.658 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -108.38 116.89 32.81 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.763 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.17 -33.64 7.16 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 45.89 -90.98 0.01 OUTLIER Glycine 0 C--N 1.338 0.692 0 N-CA-C 115.991 1.156 . . . . 0.0 115.991 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.64 -39.13 91.1 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.5 mt -65.26 -44.77 94.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.174 0.511 . . . . 0.0 111.262 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.494 HG22 ' CD1' ' A' ' 42' ' ' TYR . 49.7 t -132.05 88.78 40.01 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.114 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.55 -25.86 81.6 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 123.189 2.593 . . . . 0.0 112.94 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.1 t -79.14 -5.32 53.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.732 0.301 . . . . 0.0 111.468 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -154.29 76.3 5.71 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 121.174 0.512 . . . . 0.0 109.81 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.09 -43.11 61.26 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.031 2.488 . . . . 0.0 113.142 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -118.98 143.77 46.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.14 0.495 . . . . 0.0 112.146 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.98 158.59 39.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.904 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -116.55 124.35 49.65 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.45 ' CD1' HG21 ' A' ' 9' ' ' VAL . 40.6 pt -125.33 161.75 29.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.65 -177.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.0 mp -111.69 125.88 54.44 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.87 148.16 30.55 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.79 0.329 . . . . 0.0 110.897 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.423 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . 74.9 mm-40 -94.81 149.89 20.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.482 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 16.8 tt -63.21 -26.63 41.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.719 -0.392 . . . . 0.0 112.041 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -77.36 -7.64 56.39 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.256 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.542 ' OE2' ' HD3' ' A' ' 33' ' ' ARG . 47.3 mt-10 -84.83 140.22 31.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.087 0.47 . . . . 0.0 110.874 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -78.64 173.87 11.99 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.58 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.36 -27.53 68.57 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.923 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -63.24 -38.57 91.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.755 0.312 . . . . 0.0 110.445 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.542 ' HD3' ' OE2' ' A' ' 29' ' ' GLU . 3.2 mmp_? -69.84 -44.3 70.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.075 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.65 -44.83 96.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.361 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.84 -44.56 95.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.731 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.414 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -66.4 -38.95 93.99 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.999 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.426 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.02 -51.06 71.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.829 0.347 . . . . 0.0 111.046 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -68.04 -40.79 82.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.105 0.478 . . . . 0.0 110.959 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.3 tp -63.13 -39.1 93.7 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.084 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.8 -35.29 77.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.913 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.4 mmtt -61.67 -38.05 86.36 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.836 0.35 . . . . 0.0 110.336 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.494 ' CD1' HG22 ' A' ' 15' ' ' VAL . 79.0 m-85 -85.76 -5.75 59.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.658 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.56 20.27 79.81 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.401 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.0 mt -104.09 23.29 13.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.722 0.296 . . . . 0.0 110.761 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.81 -25.64 20.25 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -78.53 -13.46 59.82 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -177.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.7 m -106.68 22.68 15.5 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.414 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 36.5 ttmt -60.47 -32.93 71.87 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.79 -28.9 66.41 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.846 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.75 -6.13 59.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.279 -176.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 69.7 m-85 -127.39 153.81 45.77 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.161 -174.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.0 pt -136.85 172.57 14.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.555 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.405 ' CD2' HG12 ' A' ' 103' ' ' ILE . 97.0 mt -101.57 139.96 36.51 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.443 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 15.2 m -127.99 128.88 69.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.022 0.439 . . . . 0.0 110.218 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -87.96 124.49 33.76 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.034 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.007 -179.871 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.858 0 N-CA-C 112.603 -0.199 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 12.3 ttp180 -86.07 119.16 71.54 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -63.75 114.6 2.64 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.748 2.299 . . . . 0.0 112.315 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.2 mt -121.91 99.69 43.94 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.724 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.74 159.21 46.51 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.863 2.375 . . . . 0.0 111.764 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -55.8 -32.71 85.69 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.252 2.635 . . . . 0.0 113.532 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.2 p -76.31 -12.58 60.1 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -80.21 155.46 27.36 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.8 m -113.95 83.38 7.67 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.41 -27.58 54.76 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.884 2.389 . . . . 0.0 114.39 -174.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.482 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 82.5 mt -63.96 -39.6 94.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -56.53 -45.44 81.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.47 -43.77 59.51 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.027 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 31.2 mtm -63.25 -42.27 99.15 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.312 -1.047 0 CA-C-O 120.725 0.298 . . . . 0.0 111.738 -178.399 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.7 p90 . . . . . 0 CA--C 1.503 -0.836 0 CA-C-O 121.058 0.456 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.6 tp -113.64 124.9 53.43 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.101 0.477 . . . . 0.0 110.273 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.04 164.56 13.99 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.807 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 38' ' ' ALA . 68.6 mt -112.17 129.97 66.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.825 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -131.54 163.44 28.01 Favored 'General case' 0 CA--C 1.478 -1.793 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 1.7 ptm180 -94.6 120.11 34.32 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.275 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt . . . . . 0 C--N 1.31 -1.12 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.705 179.461 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.02 0 CA-C-O 120.796 0.109 . . . . 0.0 112.849 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -128.31 153.49 46.95 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.5 mt -104.83 137.76 42.13 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.55 105.26 17.52 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 173.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -101.06 127.81 53.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.398 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 86.9 t80 -88.64 119.95 29.59 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.009 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.23 29.97 8.33 Favored Glycine 0 C--O 1.244 0.728 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.262 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 13' ' ' GLU . . . -60.28 168.37 8.83 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 66.1 mm-40 74.6 -34.69 0.28 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.113 0.565 . . . . 0.0 111.397 -176.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.447 ' H ' ' C ' ' A' ' 12' ' ' GLY . 69.0 mt -91.13 -56.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.0 t -130.83 97.74 20.43 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.424 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.65 -23.67 42.33 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.909 2.406 . . . . 0.0 113.489 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.0 t -80.07 -7.95 59.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.246 0.546 . . . . 0.0 110.976 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -139.15 71.3 40.52 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.468 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 23.1 Cg_endo -59.74 -42.9 42.08 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.695 2.263 . . . . 0.0 113.354 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.06 140.36 53.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.174 0.512 . . . . 0.0 111.524 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.3 p -126.75 155.81 37.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.546 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.0 m -102.9 122.56 44.8 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.467 ' CD1' HG22 ' A' ' 34' ' ' ILE . 16.9 pt -119.28 151.98 21.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.125 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.9 mp -100.97 107.17 18.58 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.54 141.66 18.34 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -113.62 173.28 6.49 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.088 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 84' ' ' PHE . 15.1 tt -61.83 -30.12 47.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -172.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -77.32 -6.91 54.97 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.159 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -89.24 147.46 24.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.083 0.468 . . . . 0.0 111.062 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -86.13 178.94 7.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.828 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.92 -15.65 63.71 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.6 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 78' ' ' PRO . 1.9 p-10 -62.27 -40.89 97.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.728 0.299 . . . . 0.0 110.416 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -43.7 66.51 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-O 121.231 0.539 . . . . 0.0 109.63 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.47 HG21 HD22 ' A' ' 101' ' ' LEU . 96.7 mt -63.06 -49.96 81.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.452 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.94 -45.1 83.06 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.026 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.43 -43.2 97.08 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.722 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.553 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -64.47 -48.58 74.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.95 0.375 . . . . 0.0 111.32 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.73 -48.12 78.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.078 0.466 . . . . 0.0 111.287 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.463 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 28.9 tp -63.31 -34.63 78.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.865 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.45 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 38.2 tt0 -60.04 -44.4 94.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.45 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 65.3 mmtt -64.32 -37.39 87.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.549 -177.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -78.41 -6.09 54.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.586 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.91 24.95 57.1 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.962 -0.637 . . . . 0.0 114.201 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 90.6 mt -120.27 22.85 11.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 117.279 0.539 . . . . 0.0 110.736 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 5.0 tm-20 -59.85 -31.46 69.77 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.231 0.612 . . . . 0.0 111.743 -175.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -78.19 -14.38 59.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -90.59 -82.92 0.27 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 16.4 ttmt 64.43 -37.78 0.21 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.546 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 4.5 p-10 -70.53 -2.41 14.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.063 0.458 . . . . 0.0 111.257 -177.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.86 -9.78 20.44 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.39 154.22 48.85 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.1 pt -141.22 -179.86 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.435 HD11 HD21 ' A' ' 101' ' ' LEU . 90.6 mt -103.38 148.67 25.61 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.619 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.43 155.32 31.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.627 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.479 ' HG3' ' CD1' ' A' ' 76' ' ' ILE . 46.3 mt-10 -99.78 123.62 44.22 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 177.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.435 ' HB ' ' CZ ' ' A' ' 100' ' ' PHE . 25.0 t . . . . . 0 C--N 1.316 -0.851 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.168 178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 112.752 -0.139 . . . . 0.0 112.752 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -111.07 139.15 21.51 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.51 120.44 7.39 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.572 2.181 . . . . 0.0 113.266 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.479 ' CD1' ' HG3' ' A' ' 55' ' ' GLU . 33.9 mt -120.87 104.07 42.29 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.345 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -65.26 156.34 63.63 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.086 2.524 . . . . 0.0 112.846 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 32.5 Cg_exo -56.78 -30.55 85.13 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.567 2.844 . . . . 0.0 113.435 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 p -80.62 3.4 22.04 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -97.51 156.52 16.46 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.375 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.1 m -114.25 80.53 5.84 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.02 -20.13 19.66 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.511 2.141 . . . . 0.0 114.614 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 47.9 mt -64.03 -38.59 91.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.479 ' HA ' HD12 ' A' ' 27' ' ' ILE . 22.1 m-85 -59.23 -37.21 76.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.054 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -73.39 -41.67 63.07 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.892 0.377 . . . . 0.0 110.814 177.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.463 ' HE1' ' HB2' ' A' ' 101' ' ' LEU . 67.6 mtt -61.22 -42.87 99.35 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 C--N 1.317 -0.827 0 CA-C-O 120.826 0.346 . . . . 0.0 111.906 -178.056 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.435 ' CZ ' ' HB ' ' A' ' 56' ' ' VAL . 30.4 p90 . . . . . 0 N--CA 1.435 -1.205 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 34' ' ' ILE . 22.1 tp -107.6 125.02 50.81 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.01 0.433 . . . . 0.0 110.793 -173.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -129.07 173.31 10.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.877 -177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.3 mt -110.77 127.61 67.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.376 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -128.72 165.76 20.27 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -88.15 128.96 35.44 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.969 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.5 ptmt . . . . . 0 C--N 1.318 -0.793 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.239 0.532 0 CA-C-O 120.618 0.247 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.3 mtt -139.52 144.11 37.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.824 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -64.11 -43.53 95.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.98 -45.45 2.48 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.781 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.22 2.82 85.34 Favored Glycine 0 C--N 1.319 -0.367 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.496 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 m -131.61 147.72 52.55 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.39 140.14 49.96 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -84.09 105.56 15.05 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.31 129.24 62.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.724 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 92.3 t80 -109.98 119.55 39.67 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.623 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.53 30.36 2.89 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.274 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.15 -30.4 63.97 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 121.806 -0.235 . . . . 0.0 113.578 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -64.64 -26.66 68.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.039 0.447 . . . . 0.0 110.981 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.9 mt -90.56 -50.92 12.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.99 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.63 96.81 20.11 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.829 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.404 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 48.8 Cg_exo -56.83 -34.96 97.83 Favored 'Trans proline' 0 N--CA 1.475 0.432 0 C-N-CA 123.283 2.656 . . . . 0.0 113.655 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.6 t -71.41 -16.44 62.39 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -133.86 69.64 75.31 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.449 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 47.1 Cg_endo -66.99 -33.11 33.34 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.542 2.161 . . . . 0.0 112.735 -176.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -122.03 132.56 54.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.914 0.387 . . . . 0.0 110.738 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.7 p -136.75 156.88 35.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.304 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -112.95 125.09 54.01 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.314 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.9 pt -123.38 159.13 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.566 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.78 133.79 40.91 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.44 134.59 5.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.832 0.349 . . . . 0.0 111.26 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.699 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 6.5 mp0 -92.56 161.12 14.72 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.462 HG13 ' CB ' ' A' ' 83' ' ' LEU . 19.7 tt -66.98 -25.73 35.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -87.86 4.88 42.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.699 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 12.7 pt-20 -97.42 144.4 27.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.785 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -77.16 170.25 16.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.962 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.25 -24.9 65.26 Favored 'General case' 0 C--O 1.198 -1.612 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.647 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.61 -46.64 88.36 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.938 0.399 . . . . 0.0 111.084 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -70.12 -43.7 70.45 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.674 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -46.17 95.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.298 0.57 . . . . 0.0 110.494 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.6 tp -65.16 -43.09 92.9 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.727 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.421 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -63.78 -37.08 94.17 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.21 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.97 -51.15 67.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.898 0.38 . . . . 0.0 110.778 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.85 -43.79 87.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.16 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.508 ' CD2' ' HA ' ' A' ' 45' ' ' GLU . 29.5 tp -64.71 -35.57 81.48 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.985 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.19 -36.21 82.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.767 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 63.7 mmtt -62.42 -36.33 82.02 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -84.0 -8.1 59.23 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.565 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.28 30.12 71.71 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.423 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.2 mt -120.48 24.53 10.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 42.4 tt0 -58.84 -29.7 67.13 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -62.61 -26.78 68.79 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.054 0.455 . . . . 0.0 110.881 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.5 m -100.54 30.53 3.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.903 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.421 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 36.3 ttmt -61.09 -36.75 80.49 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.443 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 30.8 t70 -62.95 -18.52 63.26 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.178 0.513 . . . . 0.0 111.829 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -82.46 -8.62 59.62 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.73 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -132.42 150.43 52.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.256 0.55 . . . . 0.0 111.79 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.447 HG21 ' HB2' ' A' ' 106' ' ' LYS . 25.6 pt -139.97 171.35 13.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.6 mt -100.07 141.79 32.42 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.356 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.49 136.77 55.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -86.59 117.62 25.47 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.639 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.448 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 40.4 t -111.17 125.27 68.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.477 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 48.9 m -85.53 146.22 27.02 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -61.86 -35.84 79.47 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.988 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.516 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 22.2 m-20 -92.37 14.52 16.29 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.477 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 93.3 m-20 -70.09 -5.37 26.39 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.821 -0.55 . . . . 0.0 111.637 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.61 -24.53 67.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.703 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 59' ' ' ASP . 17.4 ptm180 -74.44 -42.33 59.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.184 0.516 . . . . 0.0 110.315 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.91 -47.94 70.21 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.567 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -131.22 134.6 46.61 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.528 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.6 ttt -76.05 1.77 14.6 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.665 0.745 . . . . 0.0 109.848 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.2 t -66.7 -22.81 66.06 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.014 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 63.25 -163.57 0.27 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.573 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.9 mt -84.65 -4.35 58.97 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -64.29 -54.67 29.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.017 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.519 ' O ' ' HB ' ' A' ' 71' ' ' ILE . 36.5 tt0 -89.55 -11.41 42.88 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.799 0.333 . . . . 0.0 111.075 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 70' ' ' GLU . 95.9 mt 70.77 125.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-O 121.519 0.676 . . . . 0.0 111.652 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -147.44 122.77 10.29 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -166.65 -171.95 33.37 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.423 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ptt85 -82.37 133.81 49.62 Favored Pre-proline 0 N--CA 1.441 -0.891 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.09 121.15 8.71 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.383 2.055 . . . . 0.0 111.888 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.3 mt -121.27 97.9 47.18 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.89 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -63.5 159.51 40.15 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.25 2.633 . . . . 0.0 112.493 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -55.13 -29.17 64.62 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.609 2.873 . . . . 0.0 113.659 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.5 p -80.69 -1.42 42.51 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -105.37 142.92 34.3 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.251 -0.18 . . . . 0.0 110.612 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.0 p -106.11 92.42 6.59 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 120.986 0.422 . . . . 0.0 110.104 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.73 -23.05 36.37 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.013 2.475 . . . . 0.0 114.871 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.462 ' CB ' HG13 ' A' ' 27' ' ' ILE . 86.2 mt -62.56 -27.88 69.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.452 ' HA ' HD11 ' A' ' 27' ' ' ILE . 20.0 m-85 -58.03 -48.43 80.09 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.148 0.28 . . . . 0.0 111.299 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.08 -36.44 58.96 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.336 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 96.5 mtp -60.53 -61.58 2.49 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.22 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.0 m -67.39 -24.79 65.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.734 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.64 -61.95 2.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.873 0.368 . . . . 0.0 111.246 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -69.62 -41.37 75.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.136 0.493 . . . . 0.0 109.862 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.619 ' HA ' ' CB ' ' A' ' 97' ' ' PHE . 31.3 p 53.21 24.16 3.54 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.02 171.74 42.49 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.1 m120 67.91 108.88 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.28 0.632 . . . . 0.0 111.333 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.05 94.97 0.19 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.84 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -176.27 -71.23 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -139.54 68.14 1.37 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -163.13 -170.25 27.74 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.087 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.619 ' CB ' ' HA ' ' A' ' 90' ' ' SER . 12.0 t80 -83.71 -1.78 54.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.303 0.573 . . . . 0.0 110.971 -176.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -81.38 -6.83 59.33 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.609 0.719 . . . . 0.0 109.383 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.9 m -100.59 149.72 23.44 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.448 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 27.5 p90 -111.81 165.56 11.96 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.435 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 34.4 tp -109.03 121.4 45.06 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.43 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.27 174.47 6.69 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.815 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.44 129.74 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.136 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -122.93 160.26 26.55 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -82.46 116.93 22.13 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.68 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.473 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 72.6 tttt -49.82 -55.92 20.53 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.813 176.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 106' ' ' LYS . 90.7 Cg_endo -78.36 153.88 27.79 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 123.0 2.467 . . . . 0.0 110.922 176.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 . . . . . 0 C--N 1.305 -1.35 0 CA-C-O 118.409 -0.805 . . . . 0.0 110.391 -178.583 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 120.994 0.426 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.2 mtp -114.8 176.04 5.23 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 120.957 0.408 . . . . 0.0 110.45 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -86.08 118.7 25.71 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.63 -37.06 93.18 Favored Glycine 0 CA--C 1.517 0.211 0 CA-C-N 116.108 -0.497 . . . . 0.0 114.17 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.33 -48.01 2.15 Favored Glycine 0 C--N 1.319 -0.382 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.37 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 p -95.38 139.17 32.05 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.4 mt -123.45 140.85 52.58 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -84.78 108.57 17.53 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.417 HG23 ' CD1' ' A' ' 23' ' ' ILE . 53.2 t -113.19 131.24 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.506 -171.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.422 ' CE2' ' HA3' ' A' ' 12' ' ' GLY . 87.2 t80 -88.04 121.19 30.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.543 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.8 31.69 6.89 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.708 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 10' ' ' TYR . . . -53.95 165.13 2.46 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.534 -0.333 . . . . 0.0 113.371 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 71.99 -47.16 0.66 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.129 0.972 . . . . 0.0 110.907 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.407 HG22 HG23 ' A' ' 15' ' ' VAL . 42.8 mm -62.97 -50.01 81.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.18 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.407 HG23 HG22 ' A' ' 14' ' ' ILE . 64.8 t -142.61 111.12 5.79 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.516 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.45 -24.52 49.4 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.838 2.359 . . . . 0.0 113.461 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.0 t -91.31 -0.9 57.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.991 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -145.8 73.45 13.69 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.407 . . . . 0.0 110.429 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.33 -21.79 30.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.726 2.284 . . . . 0.0 112.891 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -130.11 141.97 50.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.79 160.99 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.534 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 p -108.78 133.27 53.07 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.262 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 38' ' ' ALA . 32.0 pt -128.83 162.54 35.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.695 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.3 tp -112.6 123.85 51.23 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.9 154.04 47.14 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.005 0.431 . . . . 0.0 111.16 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.49 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 46.7 mt-10 -110.86 146.18 36.93 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.435 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.7 tt -67.52 -26.82 36.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -87.61 15.41 6.82 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.013 0.435 . . . . 0.0 110.978 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 70.0 mm-40 -106.5 157.38 17.7 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.839 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -88.89 169.25 11.73 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.257 0.551 . . . . 0.0 111.199 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.418 ' HB1' HD11 ' A' ' 53' ' ' LEU . . . -62.05 -26.17 68.1 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.089 -177.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.69 -45.08 93.18 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -67.41 -42.73 82.76 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 120.889 0.376 . . . . 0.0 110.487 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.54 -45.2 98.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.222 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.9 tp -63.47 -45.12 92.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.511 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.27 -34.83 89.22 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.301 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.56 -52.41 65.66 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.01 0.405 . . . . 0.0 111.998 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.428 ' HB2' HG21 ' A' ' 23' ' ' ILE . . . -71.59 -37.53 70.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.205 0.526 . . . . 0.0 110.727 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.81 -38.63 88.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.144 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.33 -37.36 83.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.445 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -62.78 -38.39 90.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.901 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -86.71 -0.97 57.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.844 0.354 . . . . 0.0 110.994 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.15 15.53 80.94 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.919 -0.582 . . . . 0.0 114.305 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.1 mt -105.76 14.53 28.11 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.384 0.592 . . . . 0.0 111.352 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -20.04 63.55 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -66.05 -35.08 79.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -83.41 -81.85 0.16 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.605 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt 65.44 -40.8 0.31 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.603 1.161 . . . . 0.0 113.829 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.44 -11.27 41.35 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -100.12 1.78 42.49 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.224 0.535 . . . . 0.0 110.318 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -132.0 151.94 51.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 111.297 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 pt -139.4 172.88 12.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.418 HD11 ' HB1' ' A' ' 31' ' ' ALA . 95.6 mt -100.71 134.88 43.03 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 12.7 m -123.57 128.55 74.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.305 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 4.8 tm-20 -86.81 120.16 27.81 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.416 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 74.7 t -118.08 131.26 71.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.005 -173.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 p -73.21 156.27 38.73 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.078 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.39 0.65 55.15 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 122.083 0.944 . . . . 0.0 108.751 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -94.54 20.67 8.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.255 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.64 -36.93 77.35 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.108 -175.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -63.57 -29.5 70.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.716 0.293 . . . . 0.0 111.763 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -105.58 1.77 27.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.995 -176.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -114.17 -63.15 1.49 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.678 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 66' ' ' SER . 41.3 p -90.71 -27.12 19.18 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.112 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.9 ttt 67.42 -9.23 0.43 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.053 0.941 . . . . 0.0 111.47 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 64' ' ' SER . 6.6 t -79.16 -4.65 51.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.948 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 68' ' ' LEU . 12.1 t70 66.88 -162.29 0.23 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.918 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.49 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 87.5 mt -80.37 -4.14 52.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.756 0.312 . . . . 0.0 110.457 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -62.16 -48.87 78.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.38 0.61 . . . . 0.0 110.099 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -86.06 -27.05 24.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.593 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 43.61 95.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.815 1.246 . . . . 0.0 112.839 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -116.56 144.45 44.35 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.421 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.67 -160.36 12.13 Favored Glycine 0 C--N 1.31 -0.876 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.448 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 10.5 ptp180 -96.23 136.11 22.21 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.8 114.36 3.84 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.068 1.845 . . . . 0.0 111.827 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.0 mt -120.79 99.77 46.94 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.072 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.45 158.81 43.32 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.808 2.339 . . . . 0.0 112.086 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.29 -23.13 52.75 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.361 2.708 . . . . 0.0 112.512 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.4 p -67.52 -22.42 65.43 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -78.69 176.54 9.41 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 122.352 1.072 . . . . 0.0 113.264 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 85.6 m -137.6 71.8 50.94 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 112.801 -2.0 . . . . 0.0 106.305 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.412 ' O ' ' HG3' ' A' ' 86' ' ' MET . 44.4 Cg_endo -67.02 -18.42 51.78 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.976 2.451 . . . . 0.0 114.323 -170.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 27' ' ' ILE . 44.6 mt -61.95 -41.33 97.85 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -173.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -60.24 -43.02 96.43 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.696 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.59 -40.63 84.81 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.388 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 96.6 mtp -62.78 -46.95 85.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.622 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.5 p -71.46 -37.41 71.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.73 -41.54 78.85 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -89.76 -54.43 4.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.909 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.606 ' HA ' ' H ' ' A' ' 97' ' ' PHE . 0.4 OUTLIER 49.89 -158.03 0.08 Allowed 'General case' 0 CA--C 1.554 1.13 0 O-C-N 123.524 0.515 . . . . 0.0 110.706 -177.145 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 166.62 -137.56 4.72 Favored Glycine 0 CA--C 1.504 -0.594 0 C-N-CA 119.325 -1.417 . . . . 0.0 113.054 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -109.15 -50.52 2.99 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.59 24.67 0.09 OUTLIER Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 173.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 mp0 -87.5 -95.78 0.09 Allowed 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -130.42 79.55 1.9 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.191 0.519 . . . . 0.0 110.483 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.62 -156.51 10.49 Favored Glycine 0 C--N 1.304 -1.218 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.831 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.606 ' H ' ' HA ' ' A' ' 90' ' ' SER . 23.9 t80 -65.68 -21.04 66.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.294 0.568 . . . . 0.0 110.726 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.11 -9.68 58.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.594 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.5 m -101.3 166.67 10.64 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.359 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.416 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 30.0 p90 -111.7 162.65 14.99 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.586 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.0 tp -114.46 128.79 56.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.525 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' A' ' 10' ' ' TYR . . . -122.89 167.84 13.04 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.82 -176.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.427 HD11 ' HB1' ' A' ' 38' ' ' ALA . 84.2 mt -110.07 129.72 64.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.642 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -130.52 161.95 30.34 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.49 0.662 . . . . 0.0 111.028 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -84.07 104.76 14.4 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.486 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -54.61 155.78 7.15 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.512 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -59.89 149.59 82.86 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 122.368 2.045 . . . . 0.0 112.479 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.4 t60 . . . . . 0 C--N 1.299 -1.588 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.614 -177.755 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 120.797 0.332 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 68.8 mtt -109.95 175.28 5.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.152 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -79.28 105.19 10.42 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.38 -7.98 64.74 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.587 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.68 -29.59 11.3 Favored Glycine 0 CA--C 1.507 -0.441 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.612 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 p -95.11 139.96 30.72 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.2 mt -112.87 138.22 50.05 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.089 0.471 . . . . 0.0 111.992 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -82.15 106.24 13.89 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.427 HG11 ' CB ' ' A' ' 38' ' ' ALA . 54.6 t -113.62 129.39 69.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.494 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -103.23 108.35 19.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.649 0.737 . . . . 0.0 112.246 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.82 12.64 9.97 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 19' ' ' PRO . . . -61.55 -24.53 64.12 Favored Glycine 0 CA--C 1.5 -0.889 0 CA-C-N 115.286 -0.457 . . . . 0.0 112.921 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.3 -27.51 67.97 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.344 0.592 . . . . 0.0 109.843 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 76.4 mt -94.47 -51.69 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.862 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.31 97.32 47.5 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.196 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.68 -33.85 94.56 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.82 3.013 . . . . 0.0 114.921 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.4 t -65.77 -16.64 63.98 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.672 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -132.22 75.15 75.15 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.236 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.565 ' HA ' ' HA3' ' A' ' 12' ' ' GLY . 18.1 Cg_endo -59.32 -46.78 19.76 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.445 2.096 . . . . 0.0 112.586 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -122.89 139.11 54.39 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.537 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.23 155.64 39.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -109.15 125.77 52.53 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.24 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.402 ' CD1' HG21 ' A' ' 9' ' ' VAL . 39.2 pt -126.28 156.22 36.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.23 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.3 tp -103.24 121.84 43.53 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.86 156.17 43.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.423 . . . . 0.0 111.792 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -110.6 147.97 33.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.67 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.425 HD11 ' HA ' ' A' ' 84' ' ' PHE . 19.5 tt -64.57 -31.38 53.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -89.33 9.34 26.42 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.035 0.445 . . . . 0.0 110.629 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -98.44 146.73 25.44 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.625 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.506 ' HA ' ' SG ' ' A' ' 81' ' ' CYS . 20.6 p-10 -83.1 163.24 21.01 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.351 0.596 . . . . 0.0 112.17 -176.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' A' ' 78' ' ' PRO . . . -67.15 -17.64 64.93 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.424 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.08 -44.52 94.71 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -69.38 -46.44 66.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.632 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.51 -45.27 98.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.705 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.41 -44.46 91.2 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.268 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.421 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -64.25 -39.53 97.14 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.568 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.12 87.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.938 0.399 . . . . 0.0 111.364 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.427 ' CB ' HG11 ' A' ' 9' ' ' VAL . . . -73.56 -44.91 56.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.67 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.6 -34.3 77.51 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.313 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.7 -39.21 87.69 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.867 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -60.73 -38.64 85.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.03 0.443 . . . . 0.0 110.678 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -84.06 -3.34 57.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.46 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.88 24.83 76.06 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.873 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.15 17.43 18.72 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.891 -0.182 . . . . 0.0 111.327 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -57.27 -34.93 69.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.809 0.443 . . . . 0.0 110.84 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -60.66 -39.32 87.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.173 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.0 m -89.12 21.86 3.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.295 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.421 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 33.2 ttmt -59.68 -15.63 20.87 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.071 0.462 . . . . 0.0 111.759 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.32 -35.42 79.02 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.618 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -104.25 17.32 24.35 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -126.68 150.49 48.96 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.0 pt -139.31 176.31 6.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.487 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.4 mt -101.65 138.69 38.3 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-O 120.548 0.213 . . . . 0.0 110.614 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 27.3 m -124.06 126.78 72.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.123 0.487 . . . . 0.0 110.441 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.434 ' CD ' HH21 ' A' ' 74' ' ' ARG . 13.6 tt0 -89.58 126.04 35.46 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.536 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 87.3 t -126.59 138.41 54.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.836 0.35 . . . . 0.0 111.479 -177.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 93' ' ' GLY . 8.0 m -60.32 135.56 57.77 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.39 176.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.2 -13.82 59.88 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.268 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.09 90.0 4.23 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 59.37 -127.17 1.25 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.295 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 62' ' ' ARG . 15.8 p-10 -63.96 -36.23 83.28 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 33.7 ptt180 153.04 -11.63 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 126.473 1.909 . . . . 0.0 107.628 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -119.25 -66.75 1.04 Allowed 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.126 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.6 m -169.72 -56.37 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.429 -175.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 66' ' ' SER . 28.0 ttt -140.48 123.86 16.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 65' ' ' MET . 39.0 t 166.67 -31.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.323 1.049 . . . . 0.0 109.178 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.5 t70 64.31 109.41 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.37 -176.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 2.2 pt? -62.6 100.52 0.19 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.474 -176.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.719 ' HA ' ' CZ ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -96.29 -57.12 2.41 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.453 173.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.52 77.87 6.4 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.2 tt -55.74 124.97 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.506 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 73' ' ' GLY . 1.7 p-10 -96.26 -82.8 0.39 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.336 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.46 ' CA ' HG23 ' A' ' 56' ' ' VAL . . . 77.66 173.33 40.03 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.716 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.462 ' O ' HG13 ' A' ' 76' ' ' ILE . 40.1 mtm180 -88.66 117.17 68.05 Favored Pre-proline 0 C--N 1.314 -0.964 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.65 114.02 2.21 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.118 1.878 . . . . 0.0 111.568 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 74' ' ' ARG . 42.3 mt -120.84 113.73 32.9 Favored Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.543 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.79 159.01 54.95 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.548 2.165 . . . . 0.0 111.434 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . 31.8 Cg_exo -58.5 -29.35 88.47 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.786 2.324 . . . . 0.0 111.972 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 m -77.34 -1.49 30.2 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.218 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.18 158.52 15.62 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 122.092 -0.38 . . . . 0.0 110.525 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' A' ' 30' ' ' ASN . 95.8 m -121.99 85.23 45.56 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -17.14 37.77 Favored 'Trans proline' 0 N--CA 1.475 0.405 0 C-N-CA 123.099 2.533 . . . . 0.0 114.143 -173.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.7 mt -63.32 -28.55 70.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HA ' HD11 ' A' ' 27' ' ' ILE . 20.8 m-85 -59.62 -48.21 82.54 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.257 -0.177 . . . . 0.0 111.436 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.576 ' HB3' ' NH2' ' A' ' 89' ' ' ARG . 89.7 mt-10 -69.27 -38.97 78.64 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.016 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.413 ' CE ' ' HG3' ' A' ' 55' ' ' GLU . 48.1 mtt -58.7 -59.27 5.68 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.997 0.427 . . . . 0.0 111.277 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.5 m -62.96 -39.02 93.42 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.858 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.87 -35.05 75.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.925 0.393 . . . . 0.0 110.848 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.576 ' NH2' ' HB3' ' A' ' 85' ' ' GLU . 46.3 mtm-85 -101.21 12.37 37.67 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.542 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.4 p -44.03 133.41 5.11 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 116.65 -34.68 4.54 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.299 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.478 ' C ' ' HB3' ' A' ' 98' ' ' ASP . 10.3 m120 -94.97 132.82 39.4 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.935 0.367 . . . . 0.0 110.051 177.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -81.02 -10.83 84.48 Favored Glycine 0 CA--C 1.5 -0.866 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.612 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.577 ' HG2' ' ND2' ' A' ' 95' ' ' ASN . 39.1 tt0 -61.21 -77.77 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.507 0.323 . . . . 0.0 111.194 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.577 ' ND2' ' HG2' ' A' ' 94' ' ' GLU . 55.2 m-80 -124.61 16.17 8.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.167 0.508 . . . . 0.0 110.126 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -99.62 -171.88 30.52 Favored Glycine 0 C--O 1.212 -1.233 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.498 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -75.54 2.19 12.31 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.331 0.586 . . . . 0.0 111.352 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.478 ' HB3' ' C ' ' A' ' 92' ' ' ASN . 13.7 t70 -91.11 6.22 45.83 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 90.5 p -96.39 -179.93 4.8 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.714 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.536 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 26.7 p90 -123.92 158.03 32.91 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.7 tp -115.18 126.68 54.88 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.676 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.75 166.72 11.63 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.1 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.28 127.25 67.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.442 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -135.17 167.4 21.06 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.584 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -73.65 143.01 46.45 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.608 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -61.27 149.89 81.42 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.117 176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.11 -41.63 76.8 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.589 2.192 . . . . 0.0 112.755 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 C--O 1.244 0.808 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.014 179.877 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.871 0.367 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.2 mtt -84.57 -179.62 7.18 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.683 0.278 . . . . 0.0 111.297 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.3 t80 74.53 -71.5 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.385 1.074 . . . . 0.0 110.301 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.86 -55.05 3.84 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.243 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.23 -37.81 1.72 Allowed Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 p -96.23 138.7 33.46 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.6 mt -105.31 138.56 41.32 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -82.65 100.97 10.52 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.9 127.68 59.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.048 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -99.85 129.54 45.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.302 -176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.53 30.57 1.15 Allowed Glycine 0 C--O 1.237 0.326 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.227 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.52 -29.36 66.49 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.62 -0.324 . . . . 0.0 112.906 -177.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -59.48 -50.73 72.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 0.0 110.063 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.0 mt -69.23 -47.86 71.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.914 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.4 t -136.35 103.77 9.51 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.959 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.08 -24.58 59.37 Favored 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 122.589 2.193 . . . . 0.0 113.425 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.4 t -79.98 -9.14 59.66 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.959 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 18' ' ' ARG . 51.9 mtt180 -132.72 69.49 79.4 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.052 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.09 -39.33 70.65 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.427 2.085 . . . . 0.0 112.415 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -128.02 135.47 49.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.236 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.35 162.44 36.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.5 m -119.54 124.91 47.57 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.045 0.45 . . . . 0.0 110.631 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 pt -123.76 159.37 28.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.2 tp -105.97 119.15 38.46 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.7 141.51 21.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.621 0.248 . . . . 0.0 111.185 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -95.22 161.99 13.88 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.5 ' HA ' HD13 ' A' ' 83' ' ' LEU . 18.6 tt -65.15 -26.11 39.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -85.59 7.82 21.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.685 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -92.72 138.77 31.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.546 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 13.7 m120 -82.11 172.7 12.9 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.64 -28.44 69.91 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.546 ' OD1' ' HB2' ' A' ' 30' ' ' ASN . 8.4 p-10 -64.96 -40.35 94.88 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.069 0.461 . . . . 0.0 110.377 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -69.5 -46.34 66.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.061 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.96 -44.24 96.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.031 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.4 tp -62.43 -42.56 99.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.15 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.82 -43.31 99.37 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.089 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.69 84.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.838 0.352 . . . . 0.0 111.0 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.43 ' CB ' HD12 ' A' ' 103' ' ' ILE . . . -71.96 -45.83 59.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.386 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 48' ' ' LYS . 27.6 tp -64.52 -33.46 75.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.492 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -36.9 78.96 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.24 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -63.51 -37.9 89.08 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.453 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -83.33 -3.86 57.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.958 0.409 . . . . 0.0 110.686 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.14 29.86 72.07 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.158 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.1 mt -120.54 22.35 11.27 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.556 -0.379 . . . . 0.0 111.264 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.582 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 43.9 tt0 -59.64 -31.7 69.77 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -58.31 -38.69 77.6 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.9 m -93.93 30.43 1.85 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.623 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.582 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 35.3 ttmt -61.34 -31.25 71.12 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -65.41 -14.1 60.15 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.093 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -103.42 5.15 36.87 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.91 0.386 . . . . 0.0 110.982 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.71 149.07 50.38 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.021 0.439 . . . . 0.0 111.973 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 pt -140.31 169.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.892 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.402 ' O ' ' HB ' ' A' ' 76' ' ' ILE . 96.1 mt -100.52 139.66 35.89 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.69 0.281 . . . . 0.0 110.482 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.83 131.04 62.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.07 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.523 ' OE1' ' HD2' ' A' ' 74' ' ' ARG . 97.1 mt-10 -94.71 121.36 36.22 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 100' ' ' PHE . 57.5 t -117.48 132.18 68.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.941 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 7.6 t -81.54 143.48 31.98 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.26 62.23 7.03 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.538 0.685 . . . . 0.0 109.986 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.736 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 9.1 p-10 -130.24 24.36 5.21 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.345 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.543 ' OD2' ' HA ' ' A' ' 67' ' ' ASP . 4.4 p-10 -62.28 -22.7 66.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.972 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -63.26 -16.91 61.75 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.238 0.542 . . . . 0.0 110.877 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.736 ' HG2' ' O ' ' A' ' 59' ' ' ASP . 4.8 ptm180 -104.69 -31.15 9.5 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.446 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -66.59 -44.58 81.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.396 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.543 ' C ' ' H ' ' A' ' 66' ' ' SER . 53.8 p -154.67 156.34 36.27 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 mmt -86.21 21.81 1.94 Allowed 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 172.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 64' ' ' SER . 8.1 m -110.7 3.81 19.53 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 113.37 -1.741 . . . . 0.0 111.956 -175.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.543 ' HA ' ' OD2' ' A' ' 60' ' ' ASP . 12.3 t70 65.76 -148.53 0.22 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.18 99.93 2.46 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.035 0.445 . . . . 0.0 109.815 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -94.4 112.52 24.3 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.148 0.499 . . . . 0.0 110.633 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 57.81 23.07 9.23 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.661 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.2 tt 35.24 88.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.813 1.245 . . . . 0.0 113.588 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -104.02 133.84 48.29 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.252 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.22 -164.25 13.45 Favored Glycine 0 CA--C 1.501 -0.789 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.859 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' HD2' ' OE1' ' A' ' 55' ' ' GLU . 6.3 ptp180 -85.49 117.76 69.37 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -62.41 116.16 3.33 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.352 2.035 . . . . 0.0 111.946 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 74' ' ' ARG . 35.6 mt -121.95 99.1 44.4 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.701 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -66.15 160.46 44.73 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.573 2.182 . . . . 0.0 111.173 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.13 -32.73 81.18 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.316 2.678 . . . . 0.0 113.7 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.1 p -67.81 -20.65 65.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -67.78 173.43 4.37 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 122.374 1.083 . . . . 0.0 113.189 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.2 m -127.86 68.97 76.11 Favored Pre-proline 0 C--N 1.292 -1.927 0 CA-C-N 113.328 -1.76 . . . . 0.0 106.59 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.431 ' HB2' ' OE2' ' A' ' 55' ' ' GLU . 18.7 Cg_endo -58.11 -32.1 94.78 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.266 2.644 . . . . 0.0 113.913 -168.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' A' ' 27' ' ' ILE . 38.6 mt -63.92 -36.61 84.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.931 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -58.56 -30.19 66.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.916 0.389 . . . . 0.0 110.428 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -76.77 -51.07 12.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.695 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 66.4 mtm -62.98 -42.97 99.99 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 m -65.33 -42.42 92.96 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.422 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.3 -49.79 39.13 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -79.11 -54.94 5.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.435 ' C ' ' HB3' ' A' ' 98' ' ' ASP . 43.5 p 46.68 -171.14 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.432 0.693 . . . . 0.0 112.491 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.45 -122.0 1.29 Allowed Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.643 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -105.31 -170.13 1.7 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.609 0.242 . . . . 0.0 110.601 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 95' ' ' ASN . . . 110.62 -31.63 7.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.623 -177.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 64.08 -28.49 0.09 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 176.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 93' ' ' GLY . 22.6 m-80 -64.11 -42.23 96.96 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 120.954 0.407 . . . . 0.0 110.853 178.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.67 130.29 1.53 Allowed Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 43.99 -100.94 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.099 0.56 . . . . 0.0 111.904 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.435 ' HB3' ' C ' ' A' ' 90' ' ' SER . 4.7 p-10 -124.52 -14.83 6.77 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.524 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 69.2 m -151.08 166.26 31.31 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.946 0.403 . . . . 0.0 110.678 -176.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 56' ' ' VAL . 31.5 p90 -110.17 152.12 26.45 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.3 tp -92.38 126.38 37.44 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 120.84 0.352 . . . . 0.0 110.223 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.66 160.31 35.78 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.45 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.43 HD12 ' CB ' ' A' ' 38' ' ' ALA . 66.2 mt -105.87 123.8 60.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -119.78 155.37 32.66 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 121.166 0.507 . . . . 0.0 110.176 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -81.19 108.49 14.88 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.026 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -43.39 114.23 1.61 Allowed Pre-proline 0 C--N 1.327 -0.405 0 O-C-N 124.429 1.081 . . . . 0.0 111.127 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.02 -14.68 35.55 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.97 2.447 . . . . 0.0 111.822 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 117.785 -1.103 . . . . 0.0 110.511 179.691 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 120.629 0.252 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 96.0 mmm -101.16 -87.99 0.38 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.7 t80 64.58 -71.65 0.07 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.676 0.791 . . . . 0.0 110.071 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.63 -37.92 2.93 Favored Glycine 0 C--O 1.229 -0.201 0 N-CA-C 114.263 0.465 . . . . 0.0 114.263 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.25 -14.52 61.05 Favored Glycine 0 C--N 1.315 -0.596 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.379 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 26.9 p -99.58 121.57 41.38 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.4 mt -104.24 135.71 45.2 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.103 0.478 . . . . 0.0 112.056 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.99 101.11 10.1 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.4 t -108.01 129.77 61.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.806 -173.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.501 ' HE2' ' CD1' ' A' ' 71' ' ' ILE . 84.3 t80 -106.54 103.87 13.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.421 -175.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.0 -33.83 39.87 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.413 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.11 -88.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.793 0 N-CA-C 114.961 0.745 . . . . 0.0 114.961 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.541 ' CD ' ' HZ1' ' A' ' 104' ' ' LYS . 59.0 mt-10 -62.06 -37.79 86.33 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.322 0.649 . . . . 0.0 112.368 -175.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.55 -44.49 99.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.923 -173.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -145.08 105.11 4.43 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.15 -22.67 53.88 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.192 2.595 . . . . 0.0 113.883 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -86.42 -7.25 58.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.035 0.445 . . . . 0.0 110.892 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -142.24 67.01 20.82 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.94 -32.16 84.66 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.53 2.154 . . . . 0.0 112.259 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.11 139.2 51.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.608 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.64 150.91 25.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.223 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.8 p -102.33 124.28 47.63 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.937 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 6' ' ' SER . 20.9 pt -126.22 160.57 33.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.333 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.69 124.15 50.71 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.71 148.17 25.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.911 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -104.01 156.57 17.75 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.534 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.427 HG13 ' CB ' ' A' ' 83' ' ' LEU . 17.7 tt -65.79 -26.61 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.986 0.422 . . . . 0.0 111.827 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -76.11 -3.54 36.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.093 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -99.18 162.58 12.98 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.929 0.395 . . . . 0.0 110.712 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -92.93 178.45 5.76 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.368 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.34 -21.64 65.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.582 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' HA ' ' HB3' ' A' ' 78' ' ' PRO . 14.5 t70 -55.77 -46.51 77.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.599 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -69.07 -42.51 76.11 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 120.942 0.401 . . . . 0.0 110.597 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.61 -45.79 97.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.038 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.9 tp -66.38 -43.9 84.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.477 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.433 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -64.83 -46.98 87.98 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.779 -177.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -61.31 -45.84 92.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.007 0.403 . . . . 0.0 111.115 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.75 77.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.162 0.506 . . . . 0.0 111.251 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 28.3 tp -62.67 -36.05 81.65 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.816 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 37.0 tt0 -57.91 -42.42 84.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.536 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.7 mmtt -64.42 -41.64 96.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.376 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.42 -29.97 65.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.908 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.47 7.15 46.29 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.638 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 83.8 mt -98.32 17.14 19.45 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.341 -0.506 . . . . 0.0 111.157 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 16.6 pt-20 -54.95 -24.81 25.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.439 0.696 . . . . 0.0 112.24 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -71.2 -16.78 62.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.93 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.1 m -98.14 -81.97 0.43 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.737 0.303 . . . . 0.0 110.42 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 31.1 ttmt 70.09 -49.03 0.64 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.596 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 26.7 t70 -60.87 -34.12 74.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.192 0.451 . . . . 0.0 110.758 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -66.0 -9.57 31.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.606 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.6 151.07 49.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.054 0.454 . . . . 0.0 111.647 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 pt -138.16 175.43 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.38 143.58 30.4 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.987 0.422 . . . . 0.0 110.553 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 13.2 m -128.17 129.86 69.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 3.1 tm-20 -86.82 120.83 28.52 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.461 HG22 HG23 ' A' ' 71' ' ' ILE . 80.7 t -125.18 136.28 61.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.871 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.558 ' CB ' ' HB3' ' A' ' 94' ' ' GLU . 40.1 t -60.67 135.85 57.89 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.203 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -91.36 -2.17 57.41 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -73.15 -41.95 63.36 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.387 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 64' ' ' SER . 3.5 p30 -161.51 -43.2 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.981 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.49 ' C ' ' HB3' ' A' ' 57' ' ' SER . 15.9 t70 166.35 -45.8 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.454 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 11.4 ptp180 136.22 22.52 0.0 OUTLIER 'General case' 0 C--N 1.364 1.234 0 C-N-CA 127.157 2.183 . . . . 0.0 110.103 176.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.434 ' NZ ' ' HB3' ' A' ' 72' ' ' ASP . 57.8 mttp -135.62 -64.13 0.64 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.057 0.456 . . . . 0.0 111.813 -173.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 60' ' ' ASP . 13.2 t -155.74 169.8 23.52 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -177.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 59.3 ttp -77.06 67.32 3.03 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.442 0.639 . . . . 0.0 111.858 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.1 t -100.87 -17.45 16.84 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 173.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 58.78 75.23 0.4 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.591 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.8 mt 58.5 87.77 0.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.702 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -96.72 -76.72 0.5 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.641 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -104.33 1.29 30.14 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.886 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.501 ' CD1' ' HE2' ' A' ' 10' ' ' TYR . 38.7 mt 63.74 97.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.436 0.694 . . . . 0.0 110.595 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.434 ' HB3' ' NZ ' ' A' ' 63' ' ' LYS . 35.0 t70 -123.5 104.5 9.1 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.993 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.95 -172.11 13.08 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.234 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.453 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 17.6 ptp180 -83.07 140.72 42.87 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.31 117.18 5.02 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.373 2.049 . . . . 0.0 111.866 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.7 mt -120.9 100.87 45.82 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.631 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.68 155.95 67.14 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.022 2.481 . . . . 0.0 112.193 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.418 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 47.3 Cg_exo -54.68 -33.86 81.55 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.414 2.743 . . . . 0.0 113.829 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 t -66.75 -18.06 65.18 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -78.8 153.16 30.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.681 0.277 . . . . 0.0 111.276 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.9 m -111.68 78.58 2.15 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.486 ' O ' ' HG3' ' A' ' 86' ' ' MET . 48.6 Cg_endo -67.31 -29.45 38.49 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.511 2.14 . . . . 0.0 113.599 -174.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.427 ' CB ' HG13 ' A' ' 27' ' ' ILE . 80.6 mt -62.48 -39.15 92.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -53.92 -54.69 35.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.791 0.329 . . . . 0.0 111.485 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -72.08 -40.59 68.16 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.832 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 11.3 mtm -60.77 -45.34 94.72 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 m -66.5 -49.45 66.51 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.05 0.452 . . . . 0.0 111.723 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.45 -39.06 71.21 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -89.11 9.05 26.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.43 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.0 t -45.39 120.55 2.55 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.297 0.57 . . . . 0.0 112.049 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.86 -121.77 4.56 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.621 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -138.93 11.53 2.64 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.64 -36.27 0.16 Allowed Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.085 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.558 ' HB3' ' CB ' ' A' ' 57' ' ' SER . 0.8 OUTLIER -150.77 98.62 2.63 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.219 0.533 . . . . 0.0 111.371 178.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -176.29 -30.5 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.658 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.99 -110.07 0.25 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.134 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -73.72 -19.53 60.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.276 0.56 . . . . 0.0 110.946 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -69.45 -24.23 63.78 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.228 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.443 ' HB3' ' HA ' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -102.05 178.66 4.55 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.988 176.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -118.99 165.63 13.86 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.518 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 tp -115.81 119.81 37.24 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.693 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.53 178.33 4.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.102 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.7 mt -116.97 129.96 72.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.699 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.541 ' HZ1' ' CD ' ' A' ' 13' ' ' GLU . 27.6 mmmt -130.97 160.98 32.94 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -72.43 142.98 48.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.596 ' HD2' ' O ' ' A' ' 49' ' ' ASP . 21.6 ptmt -55.22 144.03 52.41 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.86 -45.27 33.81 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.47 2.78 . . . . 0.0 113.458 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.457 ' O ' ' HE2' ' A' ' 106' ' ' LYS . 72.2 m80 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.659 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.0 p . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.2 mtp 59.68 73.9 0.46 Allowed 'General case' 0 C--N 1.343 0.291 0 O-C-N 123.405 0.441 . . . . 0.0 110.883 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 62.5 t80 68.89 -69.61 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.506 0.723 . . . . 0.0 110.838 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 116.89 -78.42 0.29 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 24' ' ' LEU . . . 137.46 -30.3 2.62 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 42.9 m -98.49 121.69 40.75 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.059 0.457 . . . . 0.0 110.355 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.4 mt -105.07 136.55 44.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.038 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -81.38 103.71 11.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.02 128.17 65.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.035 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -92.93 117.96 30.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.201 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.17 28.62 9.06 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.731 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.98 178.44 16.15 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.13 -0.557 . . . . 0.0 111.975 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 72.89 -66.69 0.3 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.6 mt -67.95 -48.11 76.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.765 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.14 85.41 46.45 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.15 -34.1 98.46 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.213 2.608 . . . . 0.0 113.019 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 t -70.09 -19.52 63.25 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.53 81.62 29.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 110.461 -0.199 . . . . 0.0 110.461 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.57 -32.24 87.61 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.625 2.217 . . . . 0.0 113.436 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -131.94 144.74 51.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.19 154.77 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.055 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.9 m -107.78 125.64 51.67 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' A' ' 38' ' ' ALA . 26.1 pt -126.72 160.09 35.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.042 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 8.0 mp -111.79 123.51 50.39 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.21 144.03 26.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.8 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.466 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 2.9 mp0 -90.58 152.78 20.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.475 HG13 ' CB ' ' A' ' 83' ' ' LEU . 19.4 tt -64.53 -26.35 40.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -86.01 6.65 27.8 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.982 0.42 . . . . 0.0 110.898 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 20.2 mm-40 -88.54 146.35 25.21 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.929 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.42 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 32.8 p-10 -83.86 169.49 15.07 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.236 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.408 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -58.81 -26.61 64.29 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.605 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.18 -42.1 97.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.688 0.28 . . . . 0.0 111.181 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.42 ' HG2' ' OD1' ' A' ' 30' ' ' ASN . 38.3 mmt180 -70.44 -42.92 70.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.94 0.4 . . . . 0.0 110.595 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.48 -45.92 94.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.587 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.95 -44.7 92.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.912 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.404 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -65.82 -39.61 95.19 Favored Glycine 0 C--O 1.209 -1.428 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.761 -178.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -61.41 -47.48 85.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 117.324 0.562 . . . . 0.0 111.532 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.437 ' HB2' HG22 ' A' ' 23' ' ' ILE . . . -68.7 -42.71 77.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.378 0.608 . . . . 0.0 110.521 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.51 ' CD2' ' HA ' ' A' ' 45' ' ' GLU . 32.0 tp -63.26 -35.13 79.32 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.796 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.82 -39.72 86.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.677 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 67.7 mmtt -64.6 -32.82 74.64 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.827 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -87.97 -2.87 58.88 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.289 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.31 23.82 74.92 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.725 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.76 17.57 20.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.51 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 44.4 tt0 -58.55 -23.25 57.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -176.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -78.38 -8.4 58.41 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.001 0.429 . . . . 0.0 111.047 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.3 m -113.79 21.55 14.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.41 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.404 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 39.5 ttmt -59.41 -28.74 67.2 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.701 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.37 -9.52 34.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.72 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -102.55 -1.77 29.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.891 0.377 . . . . 0.0 111.183 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -131.2 155.16 47.53 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.528 -0.469 . . . . 0.0 112.097 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 pt -139.95 173.36 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.454 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.408 HD13 ' HB1' ' A' ' 31' ' ' ALA . 97.7 mt -101.38 143.19 31.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.775 0.322 . . . . 0.0 110.687 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.6 m -126.85 128.53 70.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.452 ' HB2' HD13 ' A' ' 76' ' ' ILE . 13.3 tt0 -90.24 123.25 33.88 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.1 t -128.86 130.67 68.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.626 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 15.4 m -72.69 150.35 43.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.817 0.342 . . . . 0.0 110.434 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -75.96 66.7 2.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.06 0.457 . . . . 0.0 110.986 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -144.92 -20.79 0.5 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.727 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 64' ' ' SER . 7.9 m-20 -62.64 -38.16 89.19 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.476 -178.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -64.77 -37.05 86.28 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -71.02 -53.79 13.52 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.453 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -69.34 -44.68 71.16 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.191 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 60' ' ' ASP . 14.9 t -72.34 -32.48 66.54 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.878 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 60.6 ttp 68.12 1.34 2.76 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.091 0.956 . . . . 0.0 111.104 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 69' ' ' ARG . 6.9 t -93.29 3.9 54.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.801 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 59.1 53.45 5.49 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.058 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.9 mt 61.92 67.88 0.72 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.357 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.471 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 50.5 ttp180 -78.37 -50.55 11.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.723 0.773 . . . . 0.0 109.07 176.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.77 127.7 53.79 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.2 tt -125.29 136.12 61.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 120.278 -0.569 . . . . 0.0 112.147 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -167.5 116.79 0.81 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.003 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.82 -143.46 6.58 Favored Glycine 0 C--N 1.312 -0.771 0 C-N-CA 120.713 -0.755 . . . . 0.0 111.884 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.434 ' O ' HG13 ' A' ' 76' ' ' ILE . 34.7 ttp-105 -81.05 121.31 80.55 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -65.26 115.96 3.61 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.1 1.866 . . . . 0.0 111.3 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.452 HD13 ' HB2' ' A' ' 55' ' ' GLU . 29.9 mt -120.95 103.31 43.04 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.232 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.23 160.21 43.32 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.61 2.207 . . . . 0.0 111.363 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -54.97 -28.69 60.7 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.225 2.617 . . . . 0.0 113.174 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.5 m -62.27 -44.22 97.04 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.85 156.85 28.49 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -174.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.1 p -117.04 93.99 43.57 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 122.75 0.42 . . . . 0.0 110.29 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.431 ' O ' ' HG3' ' A' ' 86' ' ' MET . 57.7 Cg_endo -71.9 -18.19 28.21 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.148 2.565 . . . . 0.0 115.386 -175.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.475 ' CB ' HG13 ' A' ' 27' ' ' ILE . 83.7 mt -60.79 -35.22 75.91 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -56.76 -45.56 81.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.202 0.525 . . . . 0.0 111.07 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -76.01 -37.22 58.7 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.318 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.458 ' SD ' HD23 ' A' ' 83' ' ' LEU . 95.4 mtp -61.66 -48.8 79.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.31 0.576 . . . . 0.0 111.095 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.8 m -66.03 -31.7 72.74 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.541 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.45 -32.69 25.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.56 ' HD3' ' OD2' ' A' ' 98' ' ' ASP . 35.3 ttt180 -65.61 -46.83 77.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.473 -176.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 98' ' ' ASP . 11.3 p 15.86 87.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.349 1.46 . . . . 0.0 114.214 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.21 -71.91 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.278 -1.439 . . . . 0.0 114.695 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -71.95 -71.1 0.29 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -173.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.12 93.6 1.71 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.962 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.07 -5.75 41.01 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -63.03 -42.41 99.78 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.927 0.394 . . . . 0.0 109.946 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -118.97 -147.97 8.26 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -87.67 70.94 9.72 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.56 ' OD2' ' HD3' ' A' ' 89' ' ' ARG . 15.8 t70 70.51 -51.06 0.66 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.198 -173.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 49.2 m -131.06 161.97 30.85 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.84 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -110.99 166.51 10.99 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.1 tp -116.74 124.97 50.94 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.242 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.94 167.87 10.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.448 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.6 mt -112.39 129.25 68.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.563 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -130.72 157.71 42.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.252 0.549 . . . . 0.0 110.901 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -93.04 134.36 35.25 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.323 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -66.24 151.42 95.77 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.158 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -76.49 -155.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.378 2.718 . . . . 0.0 111.887 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.5 p80 . . . . . 0 N--CA 1.475 0.807 0 C-N-CA 124.338 1.055 . . . . 0.0 112.692 -179.486 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 120.845 0.355 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 96.4 mtp -82.64 142.16 31.94 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.759 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.4 t80 76.15 -43.32 0.47 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.019 0.928 . . . . 0.0 111.252 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.43 -63.57 4.15 Favored Glycine 0 C--O 1.24 0.475 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.805 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 145.72 -25.53 1.8 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.624 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.9 p -134.12 155.39 50.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.2 mt -107.55 137.29 45.84 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -84.24 108.13 16.94 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.72 133.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.219 -171.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.454 ' CZ ' HD12 ' A' ' 68' ' ' LEU . 47.6 t80 -114.67 124.68 52.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.888 -177.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.02 28.36 2.94 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.369 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.94 -23.9 62.06 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 114.031 0.372 . . . . 0.0 114.031 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.01 -40.74 97.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.426 0.631 . . . . 0.0 109.558 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.7 mt -85.76 -49.71 15.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.641 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.0 t -120.72 95.43 48.97 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.345 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.77 -23.01 48.85 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.882 2.388 . . . . 0.0 113.467 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.3 t -76.85 -17.15 59.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.136 0.493 . . . . 0.0 111.124 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -137.88 76.59 40.02 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.35 -34.06 67.94 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.287 1.991 . . . . 0.0 113.133 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -123.4 141.62 51.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.363 0.601 . . . . 0.0 112.211 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -142.85 157.57 18.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.2 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.6 p -119.46 131.79 55.68 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.235 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.413 HG22 ' HB2' ' A' ' 38' ' ' ALA . 41.6 pt -125.54 160.48 31.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.495 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.5 108.74 18.83 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.09 153.12 50.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.943 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -106.92 156.69 18.44 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.454 HD13 ' HA ' ' A' ' 84' ' ' PHE . 19.8 tt -65.91 -29.0 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -177.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -84.35 9.82 12.18 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.799 0.333 . . . . 0.0 111.401 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -100.69 148.91 24.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.516 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -80.58 168.78 18.5 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.73 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.96 -26.56 66.1 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.247 -178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.41 -40.46 96.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.839 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -64.79 -44.74 89.01 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.157 0.503 . . . . 0.0 109.768 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.409 HG22 HD13 ' A' ' 23' ' ' ILE . 96.7 mt -64.53 -45.64 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.642 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.73 -45.89 87.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.745 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.28 -38.29 93.6 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.268 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.518 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -59.46 -49.96 75.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.959 0.409 . . . . 0.0 110.999 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' A' ' 23' ' ' ILE . . . -70.58 -40.37 73.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.19 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.1 tp -61.97 -39.67 92.96 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.639 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.88 -37.78 83.37 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.288 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 69.1 mmtt -63.83 -37.98 89.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.595 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -80.03 -6.08 56.95 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.234 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.23 22.0 74.48 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.79 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -113.7 22.61 13.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.742 0.306 . . . . 0.0 111.114 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -53.15 -40.46 64.29 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.476 0.71 . . . . 0.0 112.393 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -74.75 -11.9 60.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.815 0.34 . . . . 0.0 111.736 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.8 m -110.14 29.83 7.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.345 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -60.96 -32.1 71.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.007 0.432 . . . . 0.0 111.553 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.95 -9.14 13.89 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.755 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -101.97 -2.64 29.27 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.738 0.304 . . . . 0.0 111.575 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -132.39 154.25 49.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.698 -176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.6 pt -137.96 173.26 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.7 mt -101.25 142.95 31.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.731 0.301 . . . . 0.0 110.529 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 18.8 m -125.41 132.11 71.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.087 0.47 . . . . 0.0 110.545 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.529 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 1.9 tm-20 -87.54 124.25 33.28 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.6 t -122.17 129.9 74.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.302 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 p -73.97 124.01 25.39 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.51 ' HB3' ' O ' ' A' ' 98' ' ' ASP . 26.5 t-20 -84.05 -53.02 5.84 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -173.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.13 -9.83 3.71 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -170.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.441 ' HB2' ' HA ' ' A' ' 64' ' ' SER . 35.9 m-20 -64.13 107.17 1.21 Allowed 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 62' ' ' ARG . 8.3 t70 69.88 -60.14 0.49 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -172.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 30.7 ptt-85 174.76 -22.57 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.398 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' HG3' ' HG3' ' A' ' 62' ' ' ARG . 99.2 mttt -154.17 73.35 0.92 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.986 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 35.3 t 67.8 157.19 0.13 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.64 0.776 . . . . 0.0 110.835 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.4 mtt -63.22 -20.53 65.51 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.05 -12.35 60.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.524 -1.671 . . . . 0.0 111.022 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 p30 53.11 34.74 17.99 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.881 0.872 . . . . 0.0 111.337 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.578 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 40.5 tp 58.45 13.42 2.48 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.882 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -66.06 -41.11 91.21 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -139.53 140.45 37.16 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.3 tt -85.59 119.74 34.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 C-N-CA 119.554 -0.858 . . . . 0.0 111.614 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -123.62 141.55 51.91 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.668 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.75 -175.37 39.35 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 119.704 -1.236 . . . . 0.0 112.689 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.529 ' HD2' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -97.28 121.08 59.71 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -178.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.15 115.85 3.38 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.007 2.471 . . . . 0.0 112.513 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 55' ' ' GLU . 33.1 mt -121.16 118.89 29.93 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.404 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.13 158.32 58.22 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.749 2.299 . . . . 0.0 111.473 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.71 -26.49 82.35 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.984 2.456 . . . . 0.0 112.45 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.5 p -68.33 -31.91 71.66 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -82.57 159.48 22.77 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.85 0.357 . . . . 0.0 111.958 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 39.8 m -118.05 86.81 26.82 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.68 -16.87 33.72 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.756 2.304 . . . . 0.0 114.198 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.448 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 53.4 mt -63.72 -39.09 93.45 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HA ' HD13 ' A' ' 27' ' ' ILE . 23.6 m-85 -57.19 -46.12 83.13 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 123.215 0.322 . . . . 0.0 111.634 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 49.1 mt-10 -66.05 -43.07 88.55 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.236 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 90' ' ' SER . 67.3 mtm -63.54 -43.44 97.09 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.951 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 m -80.8 -42.34 21.85 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.22 -50.99 70.85 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 20.4 ptt-85 -90.59 -28.58 18.35 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.646 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 86' ' ' MET . 1.7 m 55.21 -160.98 0.17 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.372 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -156.01 169.93 33.7 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.497 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -114.72 15.18 17.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.789 0.804 . . . . 0.0 109.135 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.16 49.73 0.61 Allowed Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.547 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -163.75 -82.56 0.03 OUTLIER 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -125.86 85.4 2.39 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.266 0.555 . . . . 0.0 109.983 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 90' ' ' SER . . . -172.02 -111.64 0.26 Allowed Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.354 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -104.01 5.38 35.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.867 0.841 . . . . 0.0 109.391 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 9.4 m-20 -79.28 -6.78 57.47 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.196 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.8 p -98.01 174.18 6.69 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.116 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -131.87 162.65 30.11 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.419 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.5 tp -111.76 121.26 44.62 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.31 174.7 5.91 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.181 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.413 HD11 ' CB ' ' A' ' 38' ' ' ALA . 65.0 mt -110.77 129.49 65.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.656 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -127.55 163.73 23.52 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 121.378 0.609 . . . . 0.0 110.199 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -84.03 134.83 34.61 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.296 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.401 ' HE2' ' OXT' ' A' ' 108' ' ' HIS . 22.0 ptmt -49.71 133.16 20.3 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 123.632 0.583 . . . . 0.0 112.084 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.4 -41.85 14.59 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.74 2.294 . . . . 0.0 112.43 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.401 ' OXT' ' HE2' ' A' ' 106' ' ' LYS . 55.1 m80 . . . . . 0 C--O 1.241 0.624 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.024 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt -103.25 144.22 31.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.079 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.435 ' CZ ' HD13 ' A' ' 83' ' ' LEU . 91.2 t80 -62.65 -46.88 86.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.646 0.26 . . . . 0.0 111.12 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.02 -30.08 5.58 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.049 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.95 -57.9 4.56 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.798 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 26.4 p -95.11 134.49 37.77 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.4 mt -110.76 143.65 40.97 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -84.69 104.23 14.48 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.86 129.22 57.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.148 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 88.2 t80 -96.26 126.32 41.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.31 0.576 . . . . 0.0 111.78 -176.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.26 18.17 4.46 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.38 -23.11 64.19 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.214 -0.493 . . . . 0.0 113.324 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.3 -57.6 9.88 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.8 mt -70.28 -44.8 77.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.071 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.18 96.08 20.34 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.411 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.36 -24.25 50.34 Favored 'Trans proline' 0 CA--C 1.498 -1.298 0 C-N-CA 122.717 2.278 . . . . 0.0 112.342 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.8 m -68.63 -23.24 64.41 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.727 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.41 67.67 80.47 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.95 -55.38 1.67 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 123.257 2.638 . . . . 0.0 114.376 -172.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -117.95 134.99 54.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.763 0.316 . . . . 0.0 110.998 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.24 161.18 35.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.586 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -110.86 128.87 55.94 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.467 HG23 ' HB1' ' A' ' 38' ' ' ALA . 31.1 pt -126.4 163.06 29.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.445 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.5 tp -111.79 112.5 24.21 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.96 148.16 28.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.267 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.69 162.73 16.84 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.855 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.434 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 19.0 tt -63.49 -24.51 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -175.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -85.1 4.64 33.23 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.88 0.371 . . . . 0.0 110.615 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -101.34 146.25 27.82 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.139 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -81.76 174.02 11.74 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.409 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.431 ' HB3' HD13 ' A' ' 53' ' ' LEU . . . -58.79 -27.12 64.72 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.009 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.28 -41.98 97.86 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -64.89 -41.72 95.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.263 0.554 . . . . 0.0 109.959 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.405 HG23 ' CD1' ' A' ' 23' ' ' ILE . 96.6 mt -65.67 -44.42 93.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.217 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.83 -46.71 88.32 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.457 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA2' ' OE1' ' A' ' 45' ' ' GLU . . . -64.28 -40.93 98.34 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.746 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -64.47 -39.27 93.5 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.467 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -84.88 -42.23 15.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.886 0.374 . . . . 0.0 111.272 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.427 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 27.9 tp -62.92 -35.12 79.01 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.147 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 2.9 tm-20 -59.7 -41.55 91.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.168 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 68.3 mmtt -63.58 -39.69 95.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -79.77 -3.44 47.64 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.984 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.73 28.96 68.15 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.996 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.564 HD12 ' CZ ' ' A' ' 51' ' ' PHE . 82.2 mt -117.79 13.24 14.09 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.141 0.496 . . . . 0.0 110.844 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 48.4 tp10 -60.49 -28.41 68.34 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.917 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -67.8 -12.92 61.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.402 ' C ' ' H ' ' A' ' 49' ' ' ASP . 54.6 m -94.36 -88.92 0.23 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.3 mttt 63.96 -39.86 0.22 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 124.265 1.026 . . . . 0.0 113.473 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 47' ' ' SER . 29.2 t70 -60.59 -27.85 68.04 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -89.89 -17.95 27.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.317 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.564 ' CZ ' HD12 ' A' ' 44' ' ' LEU . 73.1 m-85 -125.59 151.64 46.17 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 119.252 -0.979 . . . . 0.0 113.092 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.3 pt -138.42 178.38 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' A' ' 31' ' ' ALA . 91.8 mt -107.81 142.55 37.69 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.469 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 m -127.54 133.19 68.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.505 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.62 121.06 29.57 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.361 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.2 t -137.06 133.32 47.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.2 t -84.32 151.19 24.89 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.513 ' HB2' ' OE2' ' A' ' 94' ' ' GLU . 39.9 t-20 -63.19 -42.87 99.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.303 0.573 . . . . 0.0 109.774 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -98.99 107.97 20.54 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.455 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -89.62 -93.43 0.12 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.931 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.1 t70 52.92 21.12 1.88 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 122.624 1.202 . . . . 0.0 109.53 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -117.6 -54.62 2.35 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.36 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -108.69 -34.92 6.56 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.708 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.5 t -154.41 151.66 29.27 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.733 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 61.3 mtt -83.71 3.51 32.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.493 0.663 . . . . 0.0 109.581 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.4 t -63.8 -41.75 97.85 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.477 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 62.22 -83.47 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.631 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.0 mt -100.37 -139.06 0.33 Allowed 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.442 ' HE ' ' HG3' ' A' ' 70' ' ' GLU . 53.9 ttp180 64.92 -81.69 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.291 0.636 . . . . 0.0 112.636 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.442 ' HG3' ' HE ' ' A' ' 69' ' ' ARG . 50.0 mt-10 -65.97 -35.69 81.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.917 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.503 ' O ' HG22 ' A' ' 71' ' ' ILE . 0.3 OUTLIER 52.82 29.87 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-O 122.485 1.136 . . . . 0.0 111.811 174.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -54.54 -54.19 44.52 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.601 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 47.16 -145.18 4.59 Favored Glycine 0 N--CA 1.471 1.017 0 O-C-N 123.458 0.474 . . . . 0.0 113.887 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -125.54 127.99 24.77 Favored Pre-proline 0 N--CA 1.442 -0.854 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.02 119.22 6.3 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.731 2.287 . . . . 0.0 112.826 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.2 mt -122.28 101.84 40.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.397 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -62.18 155.77 54.42 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.637 2.225 . . . . 0.0 112.121 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -53.91 -33.25 71.19 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.791 2.994 . . . . 0.0 114.067 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.0 m -62.26 -42.9 99.74 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -73.79 154.98 39.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.894 0.378 . . . . 0.0 111.703 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.4 p -106.24 91.5 5.72 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.178 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 44.3 Cg_endo -68.66 -17.91 42.65 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.149 2.566 . . . . 0.0 114.145 -175.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.435 HD13 ' CZ ' ' A' ' 3' ' ' PHE . 43.2 mt -66.37 -33.74 76.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.885 0.374 . . . . 0.0 110.464 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -60.75 -11.76 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.269 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 6.0 mm-40 -95.94 -56.54 2.62 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.794 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 79.0 mtm -61.88 -48.6 79.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.3 m -67.28 -40.29 86.12 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.685 0.278 . . . . 0.0 111.487 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.93 88.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.44 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 2.1 ptm180 -76.88 -51.08 11.91 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.394 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 97' ' ' PHE . 52.5 m 45.95 73.69 0.16 Allowed 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.565 0.746 . . . . 0.0 112.917 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.23 -125.34 3.59 Favored Glycine 0 C--N 1.318 -0.443 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.771 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -153.04 136.6 15.96 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 159.4 -20.27 0.27 Allowed Glycine 0 C--O 1.229 -0.159 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.067 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.59 ' HG3' ' H ' ' A' ' 96' ' ' GLY . 9.1 tp10 -158.72 160.94 36.95 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -64.87 -19.21 65.77 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.258 0.348 . . . . 0.0 110.824 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.59 ' H ' ' HG3' ' A' ' 94' ' ' GLU . . . -83.46 61.65 4.73 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.497 ' HB3' ' HA ' ' A' ' 90' ' ' SER . 86.4 m-85 70.32 -69.08 0.18 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.611 0.764 . . . . 0.0 109.852 -176.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.44 ' OD2' ' HG3' ' A' ' 89' ' ' ARG . 1.5 p30 -144.71 -17.72 0.53 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.4 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.8 p -153.98 174.89 14.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.727 0.299 . . . . 0.0 111.583 -175.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -128.37 165.36 20.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.049 0.452 . . . . 0.0 109.858 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.0 tp -116.41 129.28 56.15 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.941 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 10' ' ' TYR . . . -125.4 171.78 10.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.924 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.9 mt -100.12 130.43 49.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.103 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -128.31 142.07 51.25 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.258 0.552 . . . . 0.0 110.65 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -81.65 109.97 16.57 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.805 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -54.2 152.86 10.4 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.772 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.27 44.65 1.78 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.907 2.405 . . . . 0.0 113.346 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.8 t60 . . . . . 0 C--N 1.279 -2.477 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.691 178.79 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 CA--C 1.513 -0.457 0 CA-C-O 120.788 0.328 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 75.2 mtm -66.27 -40.97 90.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.06 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -80.3 113.29 18.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.689 0.281 . . . . 0.0 110.789 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.08 -38.09 59.73 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.853 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.11 -46.75 1.06 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.424 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 p -96.25 139.82 31.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.805 0.336 . . . . 0.0 111.086 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.7 mt -109.18 134.52 51.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.776 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -82.66 99.56 9.67 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.7 t -100.45 112.31 32.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.871 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 78.0 t80 -82.22 122.83 28.41 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.512 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.62 28.2 4.02 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.66 -33.39 82.13 Favored Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 115.268 -0.466 . . . . 0.0 112.97 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.433 ' OE1' ' HG2' ' A' ' 104' ' ' LYS . 40.4 tt0 -64.06 -42.05 97.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.798 0.333 . . . . 0.0 110.485 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.28 -49.85 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.725 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.9 109.85 9.23 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.899 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.53 -27.47 53.91 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.766 2.311 . . . . 0.0 114.035 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -80.05 -7.26 58.76 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.236 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.71 76.87 28.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.401 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 31.0 Cg_endo -62.68 -32.29 78.83 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.706 2.271 . . . . 0.0 113.294 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -129.81 141.42 50.85 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.4 p -131.27 155.04 41.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.4 m -112.55 124.61 52.92 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.724 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.413 HG21 ' HB2' ' A' ' 38' ' ' ALA . 33.3 pt -125.08 166.62 20.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' N ' HD11 ' A' ' 24' ' ' LEU . 5.8 mp -111.35 134.77 52.69 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.956 0.408 . . . . 0.0 110.887 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.45 165.44 30.24 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.704 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 43.8 mt-10 -109.74 -62.16 1.54 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.753 -0.379 . . . . 0.0 109.981 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.512 ' HA ' HD13 ' A' ' 83' ' ' LEU . 18.5 tt 168.34 -43.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.305 1.042 . . . . 0.0 112.832 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -75.49 -11.39 60.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.799 0.809 . . . . 0.0 109.852 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.704 ' OE1' ' HB2' ' A' ' 26' ' ' GLU . 8.8 mp0 -56.59 134.85 54.73 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.229 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 32' ' ' ASP . 36.9 p-10 -84.47 159.69 20.7 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.941 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.46 -26.05 64.91 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.733 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.465 ' HB3' ' ND2' ' A' ' 30' ' ' ASN . 13.3 t70 -59.68 -48.27 82.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.409 ' NH1' ' HG3' ' A' ' 29' ' ' GLU . 58.3 ttt180 -70.31 -44.81 67.51 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.134 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.43 -44.86 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.191 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -64.87 -41.35 95.72 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.732 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.435 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -60.77 -40.54 98.27 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.528 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.53 -41.25 98.74 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.817 0.342 . . . . 0.0 111.398 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.461 ' CB ' HD12 ' A' ' 103' ' ' ILE . . . -78.48 -45.79 21.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.075 0.464 . . . . 0.0 111.743 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.36 -32.02 73.34 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.34 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -56.68 -43.62 80.62 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.168 0.987 . . . . 0.0 110.627 175.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 46.3 mmtm -61.15 -38.54 86.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.772 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -84.69 -7.5 59.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.005 0.431 . . . . 0.0 110.836 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.22 20.5 79.64 Favored Glycine 0 C--O 1.227 -0.29 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.206 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.5 mt -106.52 11.68 30.37 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 122.887 -0.184 . . . . 0.0 111.311 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.582 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 44.8 tt0 -58.55 -29.4 66.34 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.822 0.344 . . . . 0.0 111.756 -178.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -61.06 -26.94 67.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.191 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.3 m -108.76 32.34 4.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.784 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.582 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 33.9 ttmt -60.54 -31.02 70.13 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -176.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -65.02 -9.76 24.4 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.25 0.27 31.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.869 0.366 . . . . 0.0 110.995 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.499 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 89.8 m-85 -129.8 152.27 49.48 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.9 0.381 . . . . 0.0 111.852 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.4 pt -141.16 -180.0 2.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.9 mt -103.32 149.8 24.39 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -137.3 154.24 30.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.89 0.376 . . . . 0.0 110.478 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -109.04 126.87 53.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 57' ' ' SER . 55.0 t -128.52 135.02 63.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 174.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 56' ' ' VAL . 85.3 p -93.61 -178.05 4.58 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -86.53 6.38 30.9 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.778 0.799 . . . . 0.0 108.863 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.443 ' O ' ' HD3' ' A' ' 63' ' ' LYS . 11.9 t70 -96.02 -54.53 3.28 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.292 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.76 161.87 26.53 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.109 176.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.555 ' CG ' ' H ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER 47.52 47.86 17.15 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.293 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.534 ' HG3' ' N ' ' A' ' 63' ' ' LYS . 5.9 tpt180 -150.12 -64.17 0.21 Allowed 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 113.944 -1.48 . . . . 0.0 108.732 -173.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.534 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -129.59 -19.88 3.32 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.607 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.0 t -77.33 -81.85 0.09 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -67.58 -40.07 84.85 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.9 m 58.74 30.87 20.57 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.313 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -95.63 -69.41 0.76 Allowed 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 119.501 -0.88 . . . . 0.0 113.231 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.555 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 50.9 tp 64.79 -43.05 0.31 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -61.96 -44.17 97.32 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -113.38 65.32 0.65 Allowed 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 171.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.526 ' HA ' ' OD2' ' A' ' 61' ' ' ASP . 14.5 tt -63.46 140.48 19.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.863 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.33 146.95 27.79 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 174.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.57 -139.74 3.5 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.817 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.527 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 5.4 mpt_? -86.52 119.44 71.41 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.08 117.1 4.14 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.431 2.088 . . . . 0.0 112.357 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 74' ' ' ARG . 39.2 mt -120.9 101.29 45.4 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.981 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.5 163.3 38.58 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.787 2.325 . . . . 0.0 111.125 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.82 -27.67 72.97 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.874 2.383 . . . . 0.0 112.486 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 t -79.11 -9.88 59.67 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.366 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -91.95 151.45 20.5 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.4 m -121.39 88.1 45.65 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.73 -14.59 24.37 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 123.384 2.723 . . . . 0.0 114.527 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.512 HD13 ' HA ' ' A' ' 27' ' ' ILE . 39.6 mt -61.09 -37.83 84.12 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -59.21 -42.43 90.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 110.96 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.63 -40.51 69.69 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.154 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.6 mtp -60.93 -46.82 89.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.385 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p -71.58 -34.57 70.03 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.051 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.68 90.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -73.73 -54.72 7.42 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.24 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.2 m 22.32 54.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.963 1.305 . . . . 0.0 114.367 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.33 53.18 0.39 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.463 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -162.89 -80.58 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.747 0.308 . . . . 0.0 110.891 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.89 133.75 14.89 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.853 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -91.6 -3.97 55.82 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 122.914 0.486 . . . . 0.0 110.704 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -64.23 -39.61 94.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.17 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -158.58 -138.98 2.59 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.508 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -80.59 80.41 7.05 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 t70 69.46 -51.68 0.61 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 123.759 0.662 . . . . 0.0 111.342 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.1 m -130.59 163.4 27.21 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -110.3 162.69 14.38 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.988 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 tp -104.92 128.09 53.03 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.867 -176.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -127.68 161.72 28.23 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.128 0.49 . . . . 0.0 111.565 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.461 HD12 ' CB ' ' A' ' 38' ' ' ALA . 79.0 mt -104.28 126.68 58.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.345 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.457 ' HE3' ' HB3' ' A' ' 104' ' ' LYS . 24.2 mtpp -134.43 164.39 27.54 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.543 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.499 ' HG2' ' CE1' ' A' ' 51' ' ' PHE . 79.7 mtp180 -82.18 140.45 33.72 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -58.63 143.06 82.45 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-O 121.122 0.487 . . . . 0.0 111.959 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.79 -163.93 0.24 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.115 2.544 . . . . 0.0 111.488 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 80.9 m80 . . . . . 0 C--N 1.321 -0.644 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.467 179.374 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.574 0.226 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.7 mtt -86.29 157.99 19.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.739 0.304 . . . . 0.0 110.563 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -92.91 124.2 36.72 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.04 -40.07 98.42 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.308 -0.472 . . . . 0.0 113.318 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.73 -43.57 1.68 Allowed Glycine 0 C--N 1.319 -0.363 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.461 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.2 p -104.18 137.83 41.54 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.799 0.333 . . . . 0.0 110.346 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.5 mt -112.46 138.99 48.42 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.198 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -85.09 101.15 12.2 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.7 t -103.76 131.66 51.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.262 -171.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 91.7 t80 -100.42 115.27 29.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.23 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.97 29.04 13.32 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.424 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 10' ' ' TYR . . . -58.46 164.62 8.38 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 65.5 mm-40 72.77 -54.37 0.69 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.126 0.57 . . . . 0.0 110.721 -175.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.6 mt -69.01 -48.59 69.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.488 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.598 HG21 ' CE1' ' A' ' 42' ' ' TYR . 1.7 m -136.48 98.73 10.98 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-O 121.147 0.499 . . . . 0.0 112.144 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.13 -30.06 81.82 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.908 2.405 . . . . 0.0 112.356 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.2 t -66.86 -37.08 83.76 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.072 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -126.93 77.88 74.49 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.558 0.218 . . . . 0.0 110.731 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.53 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 32.8 Cg_endo -64.06 -31.09 65.99 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.5 2.134 . . . . 0.0 112.652 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -129.6 138.71 51.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.109 0.48 . . . . 0.0 112.197 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.55 154.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.402 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.7 p -102.97 121.71 43.1 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.257 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.7 pt -120.84 157.33 23.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.0 mt -106.16 121.81 44.92 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.023 0.439 . . . . 0.0 110.317 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.89 158.65 44.15 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.828 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.546 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 70.6 mm-40 -110.18 155.21 22.28 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 84' ' ' PHE . 19.4 tt -65.43 -27.1 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -83.88 7.69 17.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.272 0.558 . . . . 0.0 110.904 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.57 ' OE1' ' HG2' ' A' ' 33' ' ' ARG . 65.0 mm-40 -92.68 147.52 22.81 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.484 ' OD1' ' HB3' ' A' ' 32' ' ' ASP . 30.3 p30 -84.51 170.78 13.11 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.608 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.5 -26.15 65.05 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.052 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.484 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 17.2 t70 -59.47 -49.54 77.39 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.745 0.307 . . . . 0.0 111.405 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.57 ' HG2' ' OE1' ' A' ' 29' ' ' GLU . 10.4 mpt_? -65.28 -44.9 86.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.94 -45.12 97.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.451 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.97 -43.1 96.8 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.066 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.485 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -62.01 -43.75 98.74 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.621 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.643 ' O ' ' HD3' ' A' ' 41' ' ' LYS . . . -62.9 -49.86 73.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 41' ' ' LYS . . . -66.13 -44.78 83.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.835 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' ' 48' ' ' LYS . 32.2 tp -65.68 -34.6 78.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.184 0.516 . . . . 0.0 109.93 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 36.3 tt0 -61.84 -34.43 75.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.398 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.643 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 4.1 mptp? -60.2 -37.37 80.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.131 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.598 ' CE1' HG21 ' A' ' 15' ' ' VAL . 58.2 m-85 -89.82 -9.13 50.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.121 0.486 . . . . 0.0 110.241 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.49 19.82 79.75 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.733 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.9 mt -100.93 16.55 24.88 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 40.2 tt0 -58.27 -29.11 65.55 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -58.49 -32.89 69.22 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.215 0.531 . . . . 0.0 110.126 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.3 m -95.3 21.86 7.5 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.327 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 38.6 ttmt -60.04 -35.42 75.09 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -174.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.405 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 32.9 t70 -61.26 -22.7 65.07 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.774 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.428 ' HA ' ' CD ' ' A' ' 106' ' ' LYS . 26.8 t70 -89.43 -2.46 58.4 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -129.39 153.49 47.84 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.748 -0.595 . . . . 0.0 111.888 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.3 174.65 11.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.522 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.2 mt -100.83 145.87 28.02 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 29.7 m -130.03 135.03 61.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.059 0.457 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.26 121.06 29.21 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.78 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.5 t -129.42 131.48 67.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.325 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 46.8 t -85.61 162.35 18.88 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.045 0.45 . . . . 0.0 110.122 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.478 ' CB ' ' HA2' ' A' ' 93' ' ' GLY . 5.3 t30 -85.8 -7.58 58.65 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.194 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 11.1 t70 -74.54 103.43 4.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.13 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.539 ' OD2' ' HA ' ' A' ' 65' ' ' MET . 4.2 p-10 -89.53 -9.25 50.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.447 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -71.27 -19.11 62.39 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.815 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 59' ' ' ASP . 31.0 ptt180 -79.68 -18.16 51.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.052 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.512 ' HG3' ' HG3' ' A' ' 62' ' ' ARG . 58.5 mtpt -116.71 -70.87 0.77 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 t -161.39 25.71 0.13 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.47 -174.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.539 ' HA ' ' OD2' ' A' ' 60' ' ' ASP . 74.9 mtm 69.38 7.64 6.34 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.513 0.673 . . . . 0.0 110.268 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.431 ' N ' ' HB2' ' A' ' 60' ' ' ASP . 35.9 t -152.63 87.24 1.29 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.423 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 8.3 t0 -67.27 -43.12 82.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.465 0.65 . . . . 0.0 109.924 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.9 tp -62.57 -24.53 67.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.476 -1.238 . . . . 0.0 113.016 -175.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.6 ttt-85 -55.68 -45.26 77.8 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.028 0.442 . . . . 0.0 110.502 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -116.93 91.15 3.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -92.04 109.86 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 122.366 1.079 . . . . 0.0 111.035 -176.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.99 -55.73 1.58 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.331 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.06 -162.26 39.76 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.81 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 5.3 mtm180 -103.2 125.18 35.87 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.79 114.45 2.16 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.124 1.883 . . . . 0.0 111.588 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 74' ' ' ARG . 68.2 mt -119.45 105.18 44.36 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.52 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -64.9 158.4 51.47 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.875 2.383 . . . . 0.0 111.52 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.89 -29.99 66.33 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 123.333 2.689 . . . . 0.0 113.588 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.3 t -66.36 -26.2 67.16 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -88.98 147.21 24.42 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.464 ' SG ' ' HA ' ' A' ' 30' ' ' ASN . 36.7 m -111.49 88.36 9.08 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.88 -17.59 32.39 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.861 2.374 . . . . 0.0 113.903 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.433 ' CB ' HG13 ' A' ' 27' ' ' ILE . 57.0 mt -61.58 -35.64 78.39 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.499 ' HA ' HD12 ' A' ' 27' ' ' ILE . 18.1 m-85 -56.6 -46.58 80.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.217 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -74.36 -37.49 63.48 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.6 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.7 mtp -61.45 -48.4 81.32 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.064 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.8 m -73.72 -41.74 62.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.267 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.37 -49.88 76.11 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -80.93 -47.72 13.32 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.793 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.415 ' C ' ' HB2' ' A' ' 98' ' ' ASP . 22.7 t 57.39 -173.39 0.08 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 122.727 0.411 . . . . 0.0 110.633 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 150.38 -112.32 0.54 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.245 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -89.48 -157.84 0.48 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.478 ' HA2' ' CB ' ' A' ' 58' ' ' ASN . . . 102.56 96.93 2.35 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 119.574 -1.298 . . . . 0.0 114.395 174.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.1 -34.9 73.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.195 0.522 . . . . 0.0 109.697 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -63.39 -60.81 2.89 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.158 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -144.07 -104.81 0.48 Allowed Glycine 0 CA--C 1.498 -1.007 0 C-N-CA 119.583 -1.294 . . . . 0.0 112.224 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.478 ' O ' ' HA3' ' A' ' 93' ' ' GLY . 86.4 m-85 -88.69 -159.04 0.52 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.415 ' HB2' ' C ' ' A' ' 90' ' ' SER . 31.1 t70 -58.99 -31.0 68.4 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.041 0.924 . . . . 0.0 108.707 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 65.1 m -132.74 154.28 50.36 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.281 177.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -117.22 170.59 8.56 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 54' ' ' VAL . 17.3 tp -121.54 123.5 42.14 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.535 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -118.57 171.16 8.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.814 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.413 HD11 ' CB ' ' A' ' 38' ' ' ALA . 60.1 mt -109.22 128.02 65.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.356 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.456 ' HD3' HG23 ' A' ' 71' ' ' ILE . 13.2 mmmm -132.8 165.36 24.75 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 120.964 0.411 . . . . 0.0 110.115 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 -78.47 138.73 38.6 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.31 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.428 ' CD ' ' HA ' ' A' ' 50' ' ' ASP . 19.0 ptmt -59.73 154.74 44.98 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.082 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.42 -31.07 88.06 Favored 'Trans proline' 0 N--CA 1.476 0.469 0 C-N-CA 122.479 2.119 . . . . 0.0 112.649 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 72.5 m80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.65 -0.691 . . . . 0.0 110.727 -178.516 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.677 0.275 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 98.2 mmm -81.97 88.45 6.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 110.563 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -100.47 -27.91 13.19 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.317 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.12 -64.41 4.04 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.626 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.92 -20.69 28.64 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.634 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 m -102.4 124.02 47.22 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.5 mt -104.47 140.5 37.86 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.201 0.525 . . . . 0.0 112.288 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -85.78 105.2 16.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.7 t -107.97 128.25 63.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.119 -172.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.524 ' CZ ' ' HA3' ' A' ' 12' ' ' GLY . 93.3 t80 -90.1 109.45 20.5 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.364 0.602 . . . . 0.0 110.935 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.99 20.48 45.43 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.987 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.524 ' HA3' ' CZ ' ' A' ' 10' ' ' TYR . . . -64.49 177.62 9.22 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.149 -0.526 . . . . 0.0 112.007 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.453 ' CD ' ' HZ3' ' A' ' 104' ' ' LYS . 36.0 tt0 71.32 -65.55 0.34 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.246 0.618 . . . . 0.0 110.427 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.83 -45.57 83.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.039 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.99 86.81 57.15 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.297 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.55 -27.7 82.21 Favored 'Trans proline' 0 N--CA 1.474 0.339 0 C-N-CA 122.909 2.406 . . . . 0.0 112.989 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.3 t -75.84 -15.12 60.28 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.208 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -138.76 79.36 28.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.06 -31.8 75.85 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.562 2.174 . . . . 0.0 113.51 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.09 144.64 48.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.237 0.542 . . . . 0.0 112.198 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.95 161.63 35.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.294 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.3 p -110.8 130.89 55.45 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.05 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.481 ' CD1' HG23 ' A' ' 34' ' ' ILE . 32.6 pt -128.15 158.82 39.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.1 tp -105.81 113.62 27.28 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.75 140.31 29.89 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.983 0.421 . . . . 0.0 110.988 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.93 153.92 20.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.482 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.7 tt -65.32 -28.01 43.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.022 0.439 . . . . 0.0 111.156 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -79.03 -1.75 37.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.408 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -85.39 147.6 26.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.045 0.45 . . . . 0.0 110.937 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -86.18 170.62 11.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.671 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.54 67.52 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.468 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.46 -44.28 97.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -63.45 -44.49 94.35 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.203 0.525 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.481 HG23 ' CD1' ' A' ' 23' ' ' ILE . 96.9 mt -65.58 -45.39 92.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.588 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 tp -63.49 -43.58 96.83 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.578 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.444 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -63.34 -45.48 94.96 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.389 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.33 -48.51 79.52 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.733 0.302 . . . . 0.0 111.481 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.09 86.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.751 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.414 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 28.9 tp -64.51 -37.75 88.62 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.309 0.576 . . . . 0.0 109.919 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.96 -39.24 71.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.1 178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.9 mmtt -66.98 -15.36 63.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.698 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -108.36 0.45 21.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.784 0.326 . . . . 0.0 111.125 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.53 18.26 76.95 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.198 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.414 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 93.6 mt -99.98 14.21 31.32 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.064 0.459 . . . . 0.0 110.237 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -42.51 -40.79 2.75 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.779 1.232 . . . . 0.0 112.976 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -80.71 -5.78 57.52 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.9 m -112.04 22.44 14.83 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.17 0.509 . . . . 0.0 110.532 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.444 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 35.4 ttmt -60.18 -39.03 85.02 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.52 -6.78 11.69 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -95.24 -10.58 29.93 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.877 0.37 . . . . 0.0 110.797 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.456 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 62.5 m-85 -121.68 162.81 20.08 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.6 pt -145.88 -178.86 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.797 1.239 . . . . 0.0 108.568 176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.487 HD12 HD21 ' A' ' 101' ' ' LEU . 96.9 mt -107.39 155.29 20.18 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.313 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 27.5 m -139.29 151.96 23.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 120.682 0.277 . . . . 0.0 110.931 176.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.646 ' OE1' ' HD2' ' A' ' 74' ' ' ARG . 40.1 mt-10 -98.37 123.02 42.26 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.583 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.449 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 15.7 t -123.48 119.71 58.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 3.2 m -76.01 135.07 39.98 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -83.0 84.02 7.62 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.634 0.73 . . . . 0.0 110.388 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -144.15 102.54 3.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.488 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.405 ' HA ' ' HB2' ' A' ' 64' ' ' SER . 11.7 p-10 -72.81 155.72 39.64 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.943 0.401 . . . . 0.0 111.859 -175.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 64.69 27.08 13.16 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.866 -174.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.514 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 33.5 ttt85 -159.55 -61.43 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.671 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HG3' ' HG2' ' A' ' 62' ' ' ARG . 68.4 mttm -130.29 16.19 5.55 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.31 0.576 . . . . 0.0 109.644 176.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.405 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 42.5 m -154.98 168.84 25.63 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.47 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.9 ttt 58.39 -100.45 0.11 Allowed 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 123.766 0.826 . . . . 0.0 111.872 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 t -59.93 -43.3 95.0 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.701 0.762 . . . . 0.0 109.66 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.23 4.88 53.28 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.92 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.486 HD22 ' HH ' ' A' ' 10' ' ' TYR . 54.9 tp -72.74 -97.52 0.01 OUTLIER 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 175.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 43.77 -81.66 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 68' ' ' LEU . 12.5 pt-20 -77.96 -7.49 56.88 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 122.861 0.465 . . . . 0.0 110.794 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.475 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 97.1 mt 72.16 -51.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.179 0.992 . . . . 0.0 111.902 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.3 t70 65.55 -90.69 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.422 0.689 . . . . 0.0 111.187 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.03 -147.19 34.68 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.605 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.646 ' HD2' ' OE1' ' A' ' 55' ' ' GLU . 5.4 ptp180 -132.32 129.4 21.56 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.51 116.57 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.006 1.804 . . . . 0.0 112.462 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.416 ' CD1' ' HG3' ' A' ' 55' ' ' GLU . 55.3 mt -119.39 112.8 35.52 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.16 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.69 159.85 51.92 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.521 2.147 . . . . 0.0 111.546 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.22 -27.53 80.88 Favored 'Trans proline' 0 N--CA 1.474 0.335 0 C-N-CA 123.001 2.467 . . . . 0.0 112.108 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -67.02 -23.68 65.93 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.392 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -82.19 153.95 25.7 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 63.2 m -124.73 84.77 57.58 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HG3' HG21 ' A' ' 76' ' ' ILE . 57.8 Cg_endo -83.19 -9.47 10.5 Favored 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 123.021 2.481 . . . . 0.0 115.64 -173.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 27' ' ' ILE . 20.3 mt -63.58 -41.82 98.33 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.467 ' HA ' HD11 ' A' ' 27' ' ' ILE . 60.5 m-85 -60.11 -34.99 74.26 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.038 0.446 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -70.11 -37.71 75.41 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.41 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 47.9 mtm -66.11 -43.21 87.84 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.1 p -72.24 -27.74 62.7 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.57 -48.41 79.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.839 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.689 ' HD3' ' OD2' ' A' ' 98' ' ' ASP . 49.6 ttt180 -94.86 -54.13 3.59 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.48 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.9 m 55.98 43.0 27.97 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 123.423 0.452 . . . . 0.0 111.365 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 92' ' ' ASN . . . -114.11 136.17 13.07 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.302 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 91' ' ' GLY . 94.3 m-20 71.16 -179.0 0.22 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.089 0.555 . . . . 0.0 111.224 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 52.59 69.13 1.28 Allowed Glycine 0 C--N 1.34 0.777 0 CA-C-N 116.043 -0.526 . . . . 0.0 113.155 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.411 ' CD ' ' H ' ' A' ' 94' ' ' GLU . 1.2 pm0 -58.37 -17.3 19.12 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -64.98 -41.03 95.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.65 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.44 97.1 0.11 Allowed Glycine 0 C--O 1.221 -0.682 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.496 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 56.89 -162.46 0.19 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.339 0.655 . . . . 0.0 111.612 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.689 ' OD2' ' HD3' ' A' ' 89' ' ' ARG . 1.0 OUTLIER -58.8 -39.09 80.11 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 122.002 0.906 . . . . 0.0 109.716 177.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 60.8 m -152.41 160.7 43.25 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.507 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.449 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 24.7 p90 -108.87 162.77 13.88 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.487 HD21 HD12 ' A' ' 53' ' ' LEU . 26.2 tp -100.94 123.21 44.79 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.09 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -123.05 171.8 9.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.32 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.6 mt -108.14 128.96 63.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.472 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' HD3' ' HB ' ' A' ' 71' ' ' ILE . 26.4 mmmt -132.66 171.43 13.86 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.533 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 60.7 mtp180 -92.54 140.13 29.87 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.557 ' CG ' ' HD3' ' A' ' 107' ' ' PRO . 17.6 ptpt -60.5 -38.5 57.98 Favored Pre-proline 0 CA--C 1.558 1.277 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.557 ' HD3' ' CG ' ' A' ' 106' ' ' LYS . 93.0 Cg_endo -84.15 -5.97 10.31 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.023 2.482 . . . . 0.0 111.385 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 . . . . . 0 C--O 1.247 0.924 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.087 -179.459 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 120.979 0.419 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 98.7 mmm -88.59 140.0 29.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.08 0.467 . . . . 0.0 111.455 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -114.04 132.04 56.15 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.49 -38.77 95.39 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 121.242 -0.504 . . . . 0.0 114.074 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.53 -46.11 3.31 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.155 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 37.7 p -101.41 120.24 39.99 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -106.7 144.49 33.28 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -81.92 112.16 18.77 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.425 HG21 ' CD1' ' A' ' 23' ' ' ILE . 54.1 t -104.86 127.2 59.54 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.222 -174.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -97.88 121.19 39.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.437 0.636 . . . . 0.0 111.794 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.48 26.22 3.21 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.574 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.5 -30.88 72.81 Favored Glycine 0 C--O 1.222 -0.6 0 CA-C-N 115.312 -0.444 . . . . 0.0 113.44 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -64.43 -43.57 93.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.985 0.421 . . . . 0.0 110.148 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.63 -44.72 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 177.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -134.96 104.93 10.52 Favored Pre-proline 0 C--O 1.237 0.424 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.23 -35.43 95.5 Favored 'Trans proline' 0 CA--C 1.493 -1.539 0 C-N-CA 123.908 3.072 . . . . 0.0 113.195 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -65.59 -21.26 66.57 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.361 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -139.28 74.44 35.45 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 48.3 Cg_exo -53.93 -48.25 22.73 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.837 2.358 . . . . 0.0 112.379 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -120.16 137.69 54.03 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.063 0.459 . . . . 0.0 110.998 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.56 161.56 40.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.9 p -118.71 123.23 44.37 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 6' ' ' SER . 41.6 pt -124.72 154.72 32.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.173 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.5 mp -99.02 111.42 23.83 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.228 0.537 . . . . 0.0 110.152 177.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.15 130.51 29.05 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.206 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -89.71 158.18 17.66 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.489 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.483 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 17.1 tt -63.75 -27.37 42.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -89.47 7.24 37.1 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.997 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.39 144.18 25.77 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -78.82 169.1 18.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.719 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.02 -25.51 63.73 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.844 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.07 -41.04 97.76 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.666 0.27 . . . . 0.0 110.833 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -64.88 -47.17 78.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 0.0 110.284 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.47 HG21 HD23 ' A' ' 101' ' ' LEU . 75.0 mt -64.2 -48.85 83.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.725 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.22 -44.88 90.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.462 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.42 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -65.86 -40.61 95.59 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.63 -0.714 . . . . 0.0 113.644 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.66 -48.31 79.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.313 0.557 . . . . 0.0 111.219 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.407 ' HB1' HD12 ' A' ' 103' ' ' ILE . . . -67.59 -41.93 83.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.138 0.494 . . . . 0.0 110.801 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.5 tp -62.95 -37.42 87.0 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.555 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.48 -39.09 92.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.01 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.2 mmtt -61.58 -40.29 94.22 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.988 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.46 -10.09 59.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.376 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.1 34.32 61.63 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.673 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.7 mt -123.13 21.28 9.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.767 0.318 . . . . 0.0 110.253 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.81 -16.66 43.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.288 -176.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -90.65 8.53 33.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.792 0.33 . . . . 0.0 111.29 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.9 m -135.96 32.81 2.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.207 0.527 . . . . 0.0 110.133 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 39.9 ttmt -64.18 -37.33 87.07 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -173.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -64.25 -16.82 62.82 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.904 0.383 . . . . 0.0 111.847 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -84.06 -7.13 59.47 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.942 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -130.98 154.6 47.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.266 0.555 . . . . 0.0 111.805 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.2 pt -137.99 173.58 12.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.34 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.426 HD11 HD22 ' A' ' 101' ' ' LEU . 96.1 mt -99.51 135.19 41.29 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 23.3 m -128.22 134.48 64.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.204 -178.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.513 ' O ' ' HA2' ' A' ' 73' ' ' GLY . 32.7 mt-10 -86.53 122.48 30.53 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 120.962 0.411 . . . . 0.0 111.975 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.453 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 21.2 t -121.14 124.89 73.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.576 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.2 p -83.1 162.01 21.46 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -87.44 13.57 9.75 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.644 0.259 . . . . 0.0 111.13 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -114.36 92.98 4.14 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.258 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' A' ' 67' ' ' ASP . 5.6 p-10 -99.56 0.62 42.62 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.151 0.5 . . . . 0.0 110.054 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.67 -12.17 59.89 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.593 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.414 ' HG3' ' HG3' ' A' ' 63' ' ' LYS . 19.1 ptt-85 -151.27 -166.94 2.66 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.586 -176.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.414 ' HG3' ' HG3' ' A' ' 62' ' ' ARG . 99.5 mttt 68.87 -77.75 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.742 0.651 . . . . 0.0 110.517 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.8 t -102.74 -24.02 13.76 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER 42.21 31.34 0.25 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.175 0.99 . . . . 0.0 112.609 -177.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.3 t -115.95 10.03 15.07 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.539 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.449 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 19.9 t0 69.68 168.96 0.3 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.601 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.5 mt -91.93 28.81 1.72 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.87 0.367 . . . . 0.0 110.051 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -58.31 -45.82 87.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.641 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' O ' ' HB ' ' A' ' 71' ' ' ILE . 3.5 pt-20 -110.31 12.36 23.2 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.818 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 70' ' ' GLU . 96.7 mt 70.07 121.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 121.62 0.724 . . . . 0.0 111.803 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -114.12 111.42 21.56 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 55' ' ' GLU . . . -151.08 166.74 30.54 Favored Glycine 0 N--CA 1.422 -2.264 0 C-N-CA 119.345 -1.407 . . . . 0.0 112.943 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.569 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 1.6 mpt_? -90.22 130.03 43.52 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.86 113.67 2.87 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.17 1.913 . . . . 0.0 112.651 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.0 mt -120.53 103.35 44.08 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.097 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.89 155.26 55.97 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.889 2.393 . . . . 0.0 112.73 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.51 -28.22 63.41 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.745 2.964 . . . . 0.0 113.403 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -73.49 -11.69 60.54 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -95.13 156.56 16.27 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.215 -0.303 . . . . 0.0 111.679 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 38.2 m -119.68 82.59 26.73 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 86' ' ' MET . 58.2 Cg_endo -71.21 -16.8 31.6 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.096 2.531 . . . . 0.0 115.115 -174.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.483 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 50.9 mt -61.18 -36.9 81.1 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -173.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.46 ' HA ' HD11 ' A' ' 27' ' ' ILE . 53.5 m-85 -58.88 -44.87 91.23 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.481 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.79 -36.16 67.53 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.406 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 92.9 mtp -61.69 -42.23 98.65 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.202 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p -65.72 -41.6 92.06 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.98 -41.69 86.37 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.251 0.548 . . . . 0.0 110.852 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -68.1 -35.17 77.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.994 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.7 t -33.72 107.15 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.15 0.907 . . . . 0.0 112.76 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.9 -38.71 0.13 Allowed Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.284 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.551 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 47.7 m-80 -87.53 -173.89 4.55 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 58.86 54.42 38.17 Favored Glycine 0 CA--C 1.506 -0.503 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.949 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 36.8 tt0 65.33 18.19 11.27 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.593 0.711 . . . . 0.0 109.504 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 60.94 30.67 19.76 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.702 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -98.43 61.95 0.87 Allowed Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.328 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.0 t80 69.6 22.3 6.31 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 92' ' ' ASN . 15.3 t70 74.76 -50.73 0.67 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.444 1.098 . . . . 0.0 110.127 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 69.1 m -152.31 159.07 43.54 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.056 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.453 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 27.9 p90 -109.74 160.54 16.23 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.47 HD23 HG21 ' A' ' 34' ' ' ILE . 27.3 tp -104.06 123.3 46.99 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.962 -175.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.29 173.14 7.13 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.451 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.407 HD12 ' HB1' ' A' ' 38' ' ' ALA . 74.4 mt -112.41 128.63 68.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.091 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -133.83 160.37 37.82 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 120.951 0.405 . . . . 0.0 110.244 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -78.7 116.76 19.27 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.947 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -41.26 110.08 0.71 Allowed Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.976 174.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -80.51 176.78 8.8 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.804 2.336 . . . . 0.0 112.447 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 . . . . . 0 C--O 1.243 0.756 0 CA-C-O 118.977 -0.535 . . . . 0.0 111.032 179.128 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--O 1.235 0.336 0 CA-C-O 120.637 0.256 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.1 mtp -120.27 -86.17 0.65 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.991 0.424 . . . . 0.0 110.326 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -156.97 130.4 8.02 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.27 -34.43 89.9 Favored Glycine 0 N--CA 1.46 0.28 0 C-N-CA 121.354 -0.451 . . . . 0.0 113.699 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.76 -46.75 2.3 Favored Glycine 0 C--N 1.317 -0.477 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.646 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 14.1 p -95.16 133.16 39.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.6 mt -113.01 140.02 48.17 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.078 0.466 . . . . 0.0 112.153 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -83.34 111.65 19.19 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -113.26 128.48 70.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.042 -172.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -95.78 125.03 40.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.432 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.24 29.48 2.71 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.242 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.88 88.57 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.976 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -78.17 -6.81 55.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.175 0.512 . . . . 0.0 110.556 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.5 mm -96.38 -53.47 8.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' CG1' HG22 ' A' ' 17' ' ' THR . 95.3 t -139.45 113.52 8.0 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.486 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.83 -25.16 60.59 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.903 2.402 . . . . 0.0 114.413 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.408 HG22 ' CG1' ' A' ' 15' ' ' VAL . 13.8 t -78.3 -13.59 59.79 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.423 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -138.41 79.78 29.32 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.7 -31.77 48.57 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.457 2.104 . . . . 0.0 112.811 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -130.0 138.35 50.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.072 0.463 . . . . 0.0 111.492 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.4 p -136.18 157.61 37.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.689 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.1 m -111.82 126.46 55.1 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.887 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 6' ' ' SER . 34.3 pt -124.32 161.86 26.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.652 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.8 tp -107.68 122.36 46.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.14 148.38 32.51 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.795 0.331 . . . . 0.0 110.567 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 41.6 mt-10 -101.36 148.17 25.47 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.482 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 18.1 tt -64.35 -30.43 50.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -77.49 -7.23 55.91 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 65.2 mm-40 -82.84 160.35 22.22 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.023 0.44 . . . . 0.0 110.937 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -89.92 170.05 10.71 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.872 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.425 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -62.29 -24.56 67.37 Favored 'General case' 0 C--O 1.21 -1.013 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.168 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -60.62 -47.43 86.27 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 120.71 0.291 . . . . 0.0 111.07 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.509 ' HA ' ' HE ' ' A' ' 33' ' ' ARG . 2.0 tpm_? -68.98 -41.61 77.65 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.348 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.09 -45.46 98.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.6 -44.91 92.61 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.924 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.97 -38.27 93.99 Favored Glycine 0 C--O 1.211 -1.297 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.317 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.39 -49.17 78.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.291 0.546 . . . . 0.0 110.829 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.414 ' HB1' HD12 ' A' ' 103' ' ' ILE . . . -69.61 -41.93 75.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.942 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.416 ' CD2' ' HA ' ' A' ' 45' ' ' GLU . 25.8 tp -64.11 -35.21 80.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.891 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.31 -35.67 79.77 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.463 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -61.05 -37.9 84.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 110.321 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -88.19 -0.92 57.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.249 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.24 33.55 83.06 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.064 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.4 mt -121.15 12.59 11.09 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.473 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 44.5 tt0 -63.07 -24.65 68.01 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.867 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -57.26 -35.16 69.4 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 49.2 m -78.59 -85.4 0.07 Allowed 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.322 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.473 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 33.6 ttmt 63.1 -35.36 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.883 1.273 . . . . 0.0 113.915 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 47' ' ' SER . 36.3 t70 -64.64 -20.37 66.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.176 0.512 . . . . 0.0 111.373 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.45 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 12.4 p-10 -103.82 12.32 34.65 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.813 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -133.87 149.1 51.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.678 0.275 . . . . 0.0 111.171 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 pt -138.55 170.84 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.425 HD13 ' HB1' ' A' ' 31' ' ' ALA . 96.3 mt -100.85 137.23 39.51 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.464 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 17.4 m -123.17 129.96 74.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.221 0.534 . . . . 0.0 110.577 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 3.1 tm-20 -88.0 122.64 31.83 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.275 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.8 t -137.14 137.03 46.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.369 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 61' ' ' ASP . 6.3 p -96.53 139.08 33.15 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.258 0.551 . . . . 0.0 110.616 176.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.595 ' H ' ' HG2' ' A' ' 94' ' ' GLU . 24.6 t-20 -64.01 -40.79 97.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.828 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -74.26 81.86 1.85 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.677 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.531 ' HA ' ' H ' ' A' ' 67' ' ' ASP . 2.8 p30 45.44 26.98 0.34 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.092 1.357 . . . . 0.0 113.34 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.754 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 24.9 t70 55.21 27.65 10.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.081 -175.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.754 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 7.7 ptm180 61.7 25.82 15.62 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.228 1.011 . . . . 0.0 112.418 172.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 61.9 mttp -132.89 -77.93 0.49 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.185 0.516 . . . . 0.0 110.862 -176.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 60' ' ' ASP . 21.6 t -137.0 150.91 48.41 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.425 ' O ' ' HG3' ' A' ' 65' ' ' MET . 24.8 ptt? -51.32 93.7 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.837 0.827 . . . . 0.0 112.539 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.8 m -115.39 -51.34 2.7 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.364 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.531 ' H ' ' HA ' ' A' ' 60' ' ' ASP . 29.5 t70 56.08 58.52 4.3 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.99 176.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.5 tp 63.76 90.93 0.08 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.575 0.702 . . . . 0.0 111.827 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -157.53 130.28 7.49 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.978 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 52.25 57.9 5.97 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.5 tt -46.13 108.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.29 84.28 1.26 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.696 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.24 -129.71 4.91 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.343 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -93.03 114.55 63.02 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.2 114.59 3.66 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.44 2.093 . . . . 0.0 111.518 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 74' ' ' ARG . 18.1 mt -120.57 100.84 46.67 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.191 -176.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -59.51 157.29 32.33 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.217 2.611 . . . . 0.0 112.269 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.28 -25.31 71.9 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.352 2.702 . . . . 0.0 114.4 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.2 t -76.64 -12.6 60.03 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -92.35 155.8 17.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.653 0.263 . . . . 0.0 111.357 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 76.6 m -116.14 86.28 16.87 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.857 0.361 . . . . 0.0 110.248 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.97 -22.09 31.58 Favored 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 122.912 2.408 . . . . 0.0 114.249 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.482 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 81.1 mt -61.91 -37.95 86.57 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -175.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.434 ' HA ' HD12 ' A' ' 27' ' ' ILE . 23.1 m-85 -55.24 -46.42 76.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.972 0.415 . . . . 0.0 110.845 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 67.6 mm-40 -74.91 -42.51 57.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.557 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.6 mtp -59.96 -46.62 88.83 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.013 0.435 . . . . 0.0 111.197 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.8 m -65.05 -43.7 91.42 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.066 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.61 -37.49 79.82 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.652 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 27.7 mmt180 -86.1 -1.6 57.54 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.891 -174.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.526 ' HA ' ' HB2' ' A' ' 98' ' ' ASP . 42.5 p -54.14 113.86 1.4 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.45 27.8 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.037 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -123.29 -41.99 2.27 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.78 -161.82 28.5 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.978 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.595 ' HG2' ' H ' ' A' ' 58' ' ' ASN . 1.1 tm-20 69.85 174.53 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.395 0.678 . . . . 0.0 112.047 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.547 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 61.5 t30 -105.4 -20.47 13.48 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.647 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.34 -118.98 0.23 Allowed Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.809 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.507 ' C ' ' H ' ' A' ' 99' ' ' SER . 97.7 m-85 -120.93 84.48 2.24 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.526 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 3.7 t70 72.49 -37.86 0.4 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.113 0.965 . . . . 0.0 110.571 -176.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 97' ' ' PHE . 27.5 p -151.33 174.98 12.67 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.808 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -111.02 162.43 14.87 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.3 tp -117.01 125.68 51.74 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -124.95 171.36 10.26 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.825 -175.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.414 HD12 ' HB1' ' A' ' 38' ' ' ALA . 71.8 mt -102.56 129.73 53.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.891 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -125.07 148.75 48.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.231 0.539 . . . . 0.0 110.912 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -80.09 102.0 9.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.655 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 6.0 ptmm? -63.66 152.63 85.75 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.598 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.48 165.58 32.3 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.76 2.307 . . . . 0.0 111.123 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 . . . . . 0 C--O 1.243 0.761 0 CA-C-O 118.737 -0.649 . . . . 0.0 110.066 -178.281 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 120.901 0.382 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 68.5 mtt -132.7 83.8 2.1 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.9 t80 60.01 -95.09 0.05 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.471 0.709 . . . . 0.0 110.025 -175.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 55.96 67.61 2.12 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 121.488 -0.386 . . . . 0.0 113.214 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.36 171.89 42.15 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.597 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 p -95.14 160.32 14.61 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.79 0.329 . . . . 0.0 110.515 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.4 mt -110.85 135.41 51.45 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.193 0.521 . . . . 0.0 111.926 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.18 109.72 17.96 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -116.84 129.98 72.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.706 -172.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.498 ' CE2' HD12 ' A' ' 71' ' ' ILE . 67.4 t80 -103.89 129.88 51.43 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.098 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.22 28.86 2.66 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.054 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.25 -30.33 75.65 Favored Glycine 0 N--CA 1.465 0.591 0 C-N-CA 121.646 -0.311 . . . . 0.0 113.481 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -61.98 -32.81 73.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 109.722 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.8 mt -91.99 -52.97 9.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.768 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.3 t -124.53 102.91 32.31 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.663 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.81 -22.37 43.05 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.076 2.517 . . . . 0.0 113.796 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -78.13 -15.96 58.38 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.941 0.401 . . . . 0.0 111.189 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -139.16 74.34 36.26 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-O 121.013 0.435 . . . . 0.0 109.855 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.05 -40.02 55.14 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.433 2.088 . . . . 0.0 112.936 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -120.55 135.89 54.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.232 0.539 . . . . 0.0 111.548 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.65 163.29 37.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.96 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -122.94 132.34 54.12 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.253 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.43 HG22 ' HB1' ' A' ' 38' ' ' ALA . 43.3 pt -125.86 161.26 31.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.864 -177.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.37 113.38 25.98 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.61 142.16 23.52 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 72.4 mm-40 -95.56 169.93 9.7 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.071 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 84' ' ' PHE . 16.0 tt -62.96 -26.54 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -84.63 1.61 45.34 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.4 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -80.76 143.53 32.84 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.909 0.385 . . . . 0.0 109.974 176.316 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -96.7 173.41 7.33 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.596 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.11 -24.14 66.96 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.78 -49.16 76.15 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.955 0.407 . . . . 0.0 110.392 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -76.15 -42.37 46.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.551 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.6 -44.76 99.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.857 0.361 . . . . 0.0 110.615 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.6 tp -65.55 -42.7 91.58 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.32 -46.1 94.91 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.74 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.588 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.14 -50.47 73.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.112 0.456 . . . . 0.0 111.449 -178.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.43 ' HB1' HG22 ' A' ' 23' ' ' ILE . . . -69.09 -44.24 72.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.722 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.464 ' HG ' ' C ' ' A' ' 44' ' ' LEU . 29.0 tp -64.94 -36.96 86.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.76 -177.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.46 -38.57 90.31 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.305 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.5 mmtt -60.26 -35.51 75.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 110.226 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -85.18 -2.19 57.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.871 0.367 . . . . 0.0 110.369 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.63 20.11 79.78 Favored Glycine 0 C--O 1.237 0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.905 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.464 ' C ' ' HG ' ' A' ' 39' ' ' LEU . 88.0 mt -116.36 16.08 15.75 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 44.3 tt0 -56.71 -34.15 67.17 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -70.27 -13.34 62.12 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 122.226 -0.296 . . . . 0.0 111.625 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.4 m -104.24 38.51 1.84 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 99.3 mttt -71.13 -11.52 60.99 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.841 -0.537 . . . . 0.0 111.402 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.547 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 7.4 m-20 -74.2 -7.24 51.98 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.176 0.512 . . . . 0.0 109.844 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -117.83 -13.33 10.12 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.118 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -129.24 147.05 51.04 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.528 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.4 HG23 ' HB3' ' A' ' 106' ' ' LYS . 48.5 pt -137.11 177.7 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.025 177.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.5 138.51 37.47 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.745 0.307 . . . . 0.0 110.414 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 15.8 m -126.78 129.39 71.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.105 176.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.94 118.66 29.67 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.7 t -115.69 122.27 69.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.664 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.424 ' HA ' ' CB ' ' A' ' 99' ' ' SER . 6.5 m -72.83 134.35 44.84 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.873 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -65.66 -35.76 81.72 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.182 0.515 . . . . 0.0 109.991 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -77.16 91.93 3.76 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.172 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.595 ' CB ' ' HB3' ' A' ' 67' ' ' ASP . 29.7 t0 -111.36 -145.07 0.39 Allowed 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.72 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.574 ' H ' ' CG ' ' A' ' 60' ' ' ASP . 34.0 m-20 59.27 29.83 19.46 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 -169.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.423 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 22.3 ttt180 -153.91 -52.98 0.1 Allowed 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.69 -1.596 . . . . 0.0 111.596 -171.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HG3' ' HG2' ' A' ' 62' ' ' ARG . 95.8 mttt -92.03 -39.24 11.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.692 -173.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.8 t -128.76 -30.41 2.28 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.2 mtt 62.37 30.07 17.33 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 t -173.84 34.77 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.595 ' HB3' ' CB ' ' A' ' 60' ' ' ASP . 11.0 p-10 -33.33 -70.08 0.08 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.66 1.584 . . . . 0.0 114.898 -173.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.432 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 17.0 tp -90.14 -23.46 21.34 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.446 -174.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -61.74 -45.84 92.19 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.034 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -103.45 -8.83 19.85 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.041 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.498 HD12 ' CE2' ' A' ' 10' ' ' TYR . 4.8 tt 36.66 78.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 122.334 1.064 . . . . 0.0 112.549 -176.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -118.83 111.04 17.92 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.075 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.86 -163.37 10.34 Favored Glycine 0 N--CA 1.434 -1.482 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.188 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 63.7 mtp180 -81.87 123.35 80.23 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.41 114.11 3.7 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 122.412 2.075 . . . . 0.0 111.52 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.7 mt -120.42 99.42 47.99 Favored Pre-proline 0 N--CA 1.434 -1.252 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.487 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -63.65 160.69 35.16 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.849 2.366 . . . . 0.0 111.782 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.4 -33.15 45.33 Favored 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 123.863 3.042 . . . . 0.0 114.116 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 m -61.64 -40.72 95.88 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -80.18 154.36 28.02 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 5.3 p -120.19 93.97 48.37 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.139 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.83 -17.66 41.8 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.711 2.274 . . . . 0.0 115.05 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.41 ' CB ' HG13 ' A' ' 27' ' ' ILE . 60.0 mt -62.91 -34.45 77.46 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -176.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.521 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 21.8 m-85 -57.61 -30.79 65.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.106 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 50.7 mt-10 -86.91 -50.48 6.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.117 175.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.4 mtp -59.08 -71.92 0.11 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.983 -175.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 m -65.09 -47.83 75.86 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -175.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.521 ' HB1' ' O ' ' A' ' 84' ' ' PHE . . . -62.41 -51.12 68.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.564 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 9.1 mpt_? -73.3 -38.01 66.01 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.559 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.421 ' O ' ' HA3' ' A' ' 96' ' ' GLY . 78.0 p 57.04 177.14 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.983 0.913 . . . . 0.0 111.616 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.14 159.34 31.24 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 118.871 -1.633 . . . . 0.0 113.437 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -103.15 -21.85 13.83 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.27 53.87 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.113 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -124.71 -90.59 0.56 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.54 -0.33 . . . . 0.0 110.406 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -153.83 33.9 0.44 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.816 0.846 . . . . 0.0 108.849 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 90' ' ' SER . . . -112.66 -109.59 2.99 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.709 -1.234 . . . . 0.0 113.629 -174.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.402 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 14.3 t80 -106.47 6.01 29.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.108 0.956 . . . . 0.0 109.769 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.53 -6.95 58.08 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.855 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 22.8 p -98.87 172.2 7.58 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.282 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -128.57 158.51 38.25 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 175.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 30.6 tp -109.96 125.81 53.26 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.092 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -123.9 169.11 11.92 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.411 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.426 HD12 ' HB3' ' A' ' 38' ' ' ALA . 74.0 mt -111.59 130.03 65.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.716 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -127.91 164.57 21.98 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 121.154 0.502 . . . . 0.0 110.309 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -82.12 111.83 18.61 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.547 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.4 ptmt -48.26 152.75 1.43 Allowed Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.6 0.562 . . . . 0.0 112.271 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.41 154.98 65.02 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 C-N-CA 122.835 2.356 . . . . 0.0 111.646 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 . . . . . 0 C--N 1.292 -1.91 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.794 -178.769 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.9 m . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.523 0.202 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.2 mmm -66.08 -41.58 90.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.544 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -79.68 122.55 26.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.623 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.42 125.65 7.08 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.44 1.27 44.38 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.047 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.3 p -129.5 141.37 51.01 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.6 mt -109.17 142.22 40.27 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HE2' ' CE1' ' A' ' 20' ' ' TYR . 87.2 tttt -82.05 108.2 15.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.453 HG12 ' CB ' ' A' ' 38' ' ' ALA . 71.0 t -114.7 131.57 66.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 120.832 0.349 . . . . 0.0 110.563 -173.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -114.71 119.62 37.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.296 0.57 . . . . 0.0 111.868 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.27 19.66 4.55 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.527 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.8 -22.61 60.04 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.413 -0.394 . . . . 0.0 113.633 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.01 -35.56 80.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.339 0.59 . . . . 0.0 109.931 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.51 -48.87 13.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.799 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.5 t -119.15 90.93 42.77 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.295 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.13 -30.48 93.28 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.665 2.91 . . . . 0.0 114.079 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -64.96 -23.5 67.24 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.497 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -133.74 79.92 57.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.527 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 18.1 Cg_endo -59.76 -48.83 11.58 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.394 2.063 . . . . 0.0 112.773 -178.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.526 ' CE1' ' HE2' ' A' ' 8' ' ' LYS . 86.6 m-85 -118.04 139.52 51.09 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.232 0.539 . . . . 0.0 111.279 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -134.54 161.01 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.879 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.5 p -119.36 130.85 55.55 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.062 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.438 HD13 HG21 ' A' ' 34' ' ' ILE . 40.5 pt -127.49 157.55 39.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.692 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.97 110.38 22.4 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.98 145.91 27.56 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.216 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -108.89 166.12 11.06 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.419 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.545 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 15.2 tt -64.97 -28.75 45.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.659 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -75.23 -4.32 38.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -92.79 145.14 24.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 -83.58 175.38 9.79 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.66 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.23 -25.63 65.79 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.688 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -65.15 -37.46 87.48 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.812 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -67.48 -46.9 71.61 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.071 0.462 . . . . 0.0 110.445 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.438 HG21 HD13 ' A' ' 23' ' ' ILE . 96.9 mt -64.8 -45.5 94.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.529 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 53.9 tp -63.43 -46.58 85.69 Favored 'General case' 0 C--O 1.21 -0.992 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.542 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 40' ' ' GLU . . . -66.88 -43.32 91.78 Favored Glycine 0 C--O 1.22 -0.759 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.095 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.01 -38.98 84.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.815 0.341 . . . . 0.0 111.394 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' A' ' 103' ' ' ILE . . . -84.2 -36.23 22.94 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 35' ' ' LEU . 28.8 tp -62.68 -36.98 84.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 56.9 mt-10 -58.3 -41.08 83.64 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.576 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 44.7 mmtm -62.61 -38.51 90.47 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.801 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.15 -2.98 58.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.555 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.51 26.78 62.55 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 114.322 0.489 . . . . 0.0 114.322 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.439 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 94.0 mt -118.53 15.56 13.74 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 117.251 0.526 . . . . 0.0 110.761 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -60.98 -29.07 69.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.539 -177.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -61.37 -33.49 73.74 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.886 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.4 m -83.33 -89.58 0.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.061 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt 67.28 -27.95 0.13 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.68 -20.19 65.93 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -113.18 19.52 17.05 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.753 0.311 . . . . 0.0 111.437 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.462 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 98.8 m-85 -124.9 144.14 50.48 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 122.301 -0.249 . . . . 0.0 110.832 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 pt -141.62 169.88 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.336 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.448 HD12 HD23 ' A' ' 101' ' ' LEU . 94.4 mt -102.02 146.66 27.58 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.658 0.266 . . . . 0.0 110.328 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.5 135.36 59.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.013 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -91.86 123.92 35.6 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.121 0.486 . . . . 0.0 111.121 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.531 HG22 ' CG1' ' A' ' 71' ' ' ILE . 63.1 t -128.18 131.81 68.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.284 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 p -103.9 92.17 4.29 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 120.81 0.338 . . . . 0.0 110.328 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -97.39 88.56 4.44 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.447 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.08 -27.29 63.51 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.544 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.454 ' HA ' ' HB3' ' A' ' 64' ' ' SER . 30.9 t70 61.92 23.21 13.63 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.902 0.858 . . . . 0.0 110.979 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -129.78 23.11 5.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.895 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -166.95 -60.25 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 121.144 0.497 . . . . 0.0 109.948 -175.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -82.34 0.42 41.84 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.454 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . 12.0 p -70.03 -19.34 63.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 114.546 -1.207 . . . . 0.0 110.391 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.3 ptp -63.99 -23.55 67.38 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.618 0.723 . . . . 0.0 109.59 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 t -115.98 -20.61 9.87 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.964 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 70.42 178.93 0.25 Allowed 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.632 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 2.6 pt? -72.78 97.83 2.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.538 0.685 . . . . 0.0 110.898 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -106.1 129.12 54.25 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.454 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 36.79 81.36 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.619 1.199 . . . . 0.0 110.599 -177.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.531 ' CG1' HG22 ' A' ' 56' ' ' VAL . 19.6 tt -51.12 123.63 2.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-O 121.795 0.807 . . . . 0.0 113.162 -173.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -143.76 134.76 25.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.199 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.41 -152.56 5.69 Favored Glycine 0 CA--C 1.508 -0.399 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -86.71 130.24 49.64 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 117.536 0.668 . . . . 0.0 109.795 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.44 117.71 5.15 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.364 2.043 . . . . 0.0 112.034 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.4 mt -119.33 103.0 47.69 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.307 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.23 156.76 48.73 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.922 2.415 . . . . 0.0 111.629 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.87 -16.18 53.36 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.908 2.405 . . . . 0.0 113.384 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.9 p -83.36 -12.46 56.51 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -91.14 158.05 16.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.515 0.198 . . . . 0.0 110.929 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.7 m -115.52 85.29 13.33 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.91 -26.93 58.86 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.628 2.219 . . . . 0.0 113.695 -175.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.545 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 77.1 mt -62.92 -37.96 89.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -65.66 -14.95 62.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.537 0.208 . . . . 0.0 111.535 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -95.66 -41.65 8.79 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.48 ' SD ' HD23 ' A' ' 83' ' ' LEU . 91.3 mtp -61.73 -46.23 90.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.023 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.2 m -76.3 -23.19 54.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.453 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.04 -50.54 61.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.92 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.1 ttt-85 -84.27 -47.86 10.35 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.315 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.3 p 47.46 59.58 4.02 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.46 0.704 . . . . 0.0 112.057 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.83 -120.83 0.67 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.504 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -138.36 136.13 36.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.95 0.405 . . . . 0.0 110.596 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.23 -121.52 1.05 Allowed Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.455 ' CD ' ' HZ2' ' A' ' 8' ' ' LYS . 41.2 tt0 -83.46 -83.53 0.14 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -138.78 10.76 2.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.254 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -147.74 98.05 0.19 Allowed Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 119.533 -1.317 . . . . 0.0 112.454 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 58.43 -157.96 0.3 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.001 0.52 . . . . 0.0 111.245 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.33 -44.35 95.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.173 0.511 . . . . 0.0 110.88 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.7 m -138.66 162.7 33.99 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.737 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -108.72 159.69 16.55 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.448 HD23 HD12 ' A' ' 53' ' ' LEU . 29.8 tp -103.97 125.45 50.36 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.034 0.445 . . . . 0.0 111.309 -172.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.73 171.15 11.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.254 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' A' ' 38' ' ' ALA . 80.4 mt -109.22 129.81 63.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.187 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.506 ' HD3' HG21 ' A' ' 71' ' ' ILE . 12.9 mmmm -135.79 168.0 20.12 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.705 175.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.462 ' HG2' ' CE1' ' A' ' 51' ' ' PHE . 66.5 mtp180 -91.71 139.88 30.25 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.251 -178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 108' ' ' HIS . 34.6 ttpt -90.6 141.23 26.95 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.101 177.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -53.66 -38.77 84.67 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.376 2.051 . . . . 0.0 110.894 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.409 ' H ' ' HG2' ' A' ' 106' ' ' LYS . 43.7 t60 . . . . . 0 C--O 1.244 0.777 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.151 175.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.758 0.313 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 71.2 mtm -64.94 -41.86 95.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.108 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.1 t80 70.11 121.75 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.797 0.686 . . . . 0.0 110.844 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.72 -42.96 98.45 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.83 -0.623 . . . . 0.0 114.194 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.92 -55.5 0.55 Allowed Glycine 0 C--N 1.318 -0.459 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.794 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.3 m -94.29 138.49 32.22 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.5 mt -105.85 140.47 38.83 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -82.27 102.53 11.23 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.895 174.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.41 ' CG2' HG12 ' A' ' 23' ' ' ILE . 41.0 t -108.46 120.36 59.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.103 -175.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -105.07 123.18 47.36 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.219 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.39 17.64 6.54 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.79 -22.17 59.42 Favored Glycine 0 N--CA 1.462 0.416 0 C-N-CA 121.695 -0.288 . . . . 0.0 112.686 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -63.34 -35.38 80.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -92.0 -48.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.73 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.24 106.45 33.28 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -63.86 -22.26 68.98 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.598 2.198 . . . . 0.0 111.32 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -78.68 -15.83 58.01 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.62 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -144.38 71.03 16.0 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.935 0.398 . . . . 0.0 110.199 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.507 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 45.3 Cg_exo -57.09 -45.53 35.05 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.065 2.51 . . . . 0.0 113.594 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.26 140.87 52.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.29 167.41 20.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.6 m -132.03 133.4 44.36 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.428 HD12 HG21 ' A' ' 34' ' ' ILE . 33.8 pt -129.38 163.08 35.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.402 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.7 tp -111.18 121.45 45.34 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.47 143.64 26.85 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.117 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.66 161.36 14.94 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.486 HD11 ' HA ' ' A' ' 84' ' ' PHE . 17.4 tt -62.85 -28.0 44.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.798 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -69.34 -24.04 63.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.312 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.69 139.15 58.74 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.525 0.678 . . . . 0.0 111.197 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -89.67 175.53 7.22 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.437 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.01 -33.79 73.81 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.217 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.08 -50.02 75.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.626 0.25 . . . . 0.0 111.486 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -69.13 -41.05 77.84 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.835 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 23' ' ' ILE . 96.8 mt -64.4 -44.04 97.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.606 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.69 -44.0 97.37 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.978 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.7 -41.02 99.12 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.472 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.03 -49.68 75.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.932 0.396 . . . . 0.0 111.449 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.48 -43.86 72.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.661 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.425 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 26.7 tp -64.29 -32.73 74.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.326 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.09 -39.96 87.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.813 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -62.4 -36.31 81.92 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -80.73 -12.35 59.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.313 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.58 20.69 76.32 Favored Glycine 0 C--O 1.229 -0.169 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.243 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.425 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 85.5 mt -108.52 12.84 25.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.799 0.333 . . . . 0.0 110.615 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -59.26 -24.86 63.58 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.919 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -64.24 -33.29 75.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.002 0.43 . . . . 0.0 110.272 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.2 m -79.23 -89.39 0.05 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.056 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt 68.1 -39.99 0.41 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.598 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 35.2 m-20 -65.58 -19.74 66.04 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 120.728 0.299 . . . . 0.0 111.618 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.501 ' C ' ' HG2' ' A' ' 106' ' ' LYS . 15.2 p-10 -103.79 11.48 35.74 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.82 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -131.91 147.54 52.48 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.708 0.289 . . . . 0.0 110.893 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.3 pt -138.56 170.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.6 mt -100.46 141.8 32.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.749 0.309 . . . . 0.0 110.176 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 28.6 m -125.22 132.71 70.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 120.994 0.426 . . . . 0.0 110.923 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.458 ' HG3' ' HG2' ' A' ' 86' ' ' MET . 1.6 tm-20 -87.58 129.59 35.05 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.484 ' HB ' ' CZ ' ' A' ' 100' ' ' PHE . 16.1 t -128.18 117.13 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.368 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 7.5 m -77.77 -1.15 29.96 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 123.59 0.756 . . . . 0.0 110.781 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.582 ' O ' ' HE2' ' A' ' 100' ' ' PHE . 11.3 m120 -84.43 64.0 8.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.56 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -40.05 -50.9 2.6 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 114.586 -1.188 . . . . 0.0 114.099 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -152.04 -160.84 1.2 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.675 0.274 . . . . 0.0 111.313 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.69 -20.79 61.88 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.227 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.45 ' HG3' ' HG3' ' A' ' 63' ' ' LYS . 13.0 ptt180 -59.08 -31.44 68.89 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 120.823 0.344 . . . . 0.0 110.4 177.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' HG3' ' HG3' ' A' ' 62' ' ' ARG . 67.0 mttm -128.53 14.63 6.55 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.7 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.8 t -118.2 -39.35 3.07 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.1 mtt 54.12 25.88 6.06 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.474 0.654 . . . . 0.0 110.288 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.8 t -149.78 2.74 0.53 Allowed 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.303 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 59.11 35.17 23.69 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.687 -176.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.1 mp 65.19 95.81 0.05 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.361 -176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -137.94 -60.99 0.63 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.128 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -93.41 118.75 31.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.005 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 40.1 mt -126.82 127.66 70.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -97.13 -54.29 3.22 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 172.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.09 -178.47 16.58 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.99 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' O ' HG13 ' A' ' 76' ' ' ILE . 14.2 ttp180 -111.3 112.77 54.55 Favored Pre-proline 0 N--CA 1.437 -1.09 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.62 116.51 3.28 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.024 2.483 . . . . 0.0 113.043 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 74' ' ' ARG . 32.9 mt -121.81 103.71 39.94 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.089 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -62.12 155.54 55.53 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.684 2.256 . . . . 0.0 112.106 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.56 -33.26 77.92 Favored 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.775 2.983 . . . . 0.0 113.939 -176.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 p -66.18 -24.64 66.68 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.3 155.21 19.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.683 0.278 . . . . 0.0 111.7 -177.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 59.0 m -105.8 93.98 8.25 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HB3' HG22 ' A' ' 76' ' ' ILE . 50.6 Cg_endo -69.21 -28.39 27.95 Favored 'Trans proline' 0 C--O 1.218 -0.477 0 C-N-CA 122.842 2.362 . . . . 0.0 115.244 -173.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.483 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 86.7 mt -61.88 -38.69 89.26 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -173.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.486 ' HA ' HD11 ' A' ' 27' ' ' ILE . 58.9 m-85 -59.16 -39.51 82.67 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.189 0.519 . . . . 0.0 110.847 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -83.98 -32.92 24.73 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.663 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.643 ' O ' ' HB2' ' A' ' 90' ' ' SER . 85.0 mtp -62.76 -40.97 98.91 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.167 0.508 . . . . 0.0 111.692 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.5 p -72.45 -41.2 66.37 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.36 -60.15 1.64 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -69.89 -43.81 71.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.669 -174.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.643 ' HB2' ' O ' ' A' ' 86' ' ' MET . 69.3 m -69.66 170.08 11.53 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.444 -177.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.461 ' HA3' ' N ' ' A' ' 96' ' ' GLY . . . 115.28 85.06 1.23 Allowed Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.744 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -76.24 -18.99 58.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.221 0.534 . . . . 0.0 110.452 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.02 -78.88 1.14 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.837 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -115.58 23.2 12.54 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.881 -0.188 . . . . 0.0 111.109 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 2.5 t-20 60.17 56.3 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.518 0.675 . . . . 0.0 109.579 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.461 ' N ' ' HA3' ' A' ' 91' ' ' GLY . . . -149.96 -137.8 2.8 Favored Glycine 0 CA--C 1.493 -1.328 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.201 -178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.32 33.12 0.45 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.547 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.44 ' HB2' ' HA2' ' A' ' 91' ' ' GLY . 14.9 m-20 -70.3 -13.37 62.13 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 68.0 m -98.0 130.6 44.83 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.12 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.582 ' HE2' ' O ' ' A' ' 58' ' ' ASN . 44.3 p90 -114.48 169.47 9.02 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.72 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.6 tp -119.54 122.51 41.78 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.987 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.98 167.63 12.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.967 -177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.63 126.03 56.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -120.01 156.83 30.12 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.682 0.753 . . . . 0.0 111.643 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -85.55 112.1 20.63 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.764 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.598 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.6 ptmt -75.19 154.61 86.35 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.857 -178.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.1 -28.9 81.09 Favored 'Trans proline' 0 N--CA 1.477 0.538 0 C-N-CA 122.918 2.412 . . . . 0.0 111.899 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 58.2 t60 . . . . . 0 C--O 1.243 0.733 0 O-C-N 124.036 0.835 . . . . 0.0 110.728 178.381 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.9 p . . . . . 0 C--O 1.239 0.548 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 78.0 mtm 66.97 -69.51 0.13 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.686 0.794 . . . . 0.0 112.148 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -83.57 117.62 23.27 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.89 -35.02 91.41 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.743 -177.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.8 -10.71 64.42 Favored Glycine 0 C--N 1.318 -0.455 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.228 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.0 p -135.27 151.19 50.34 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.4 mt -122.38 135.65 54.74 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.292 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -87.49 100.57 12.86 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.527 HG13 ' CB ' ' A' ' 38' ' ' ALA . 72.8 t -95.34 122.1 46.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.598 -173.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 82.8 t80 -92.03 120.99 33.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.123 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.47 23.82 4.0 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -61.28 -26.9 66.74 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.279 -0.46 . . . . 0.0 113.375 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.414 ' OE1' ' HG2' ' A' ' 104' ' ' LYS . 44.2 tt0 -64.17 -46.51 83.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.27 -50.1 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.291 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.85 98.14 50.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.131 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.05 -21.77 42.48 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.748 2.298 . . . . 0.0 113.256 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 t -84.78 -6.45 59.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.708 0.29 . . . . 0.0 111.412 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -148.01 80.11 8.89 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.476 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 28.2 Cg_endo -62.87 -48.97 5.8 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.849 2.366 . . . . 0.0 114.111 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -120.21 138.02 53.87 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.017 0.437 . . . . 0.0 111.812 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -127.82 144.27 38.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.793 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 p -96.75 115.73 27.92 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.238 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.44 HD11 HG23 ' A' ' 34' ' ' ILE . 18.5 pt -117.49 158.34 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.817 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.81 122.83 44.71 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.38 144.79 24.83 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -104.06 158.51 16.38 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.917 0.389 . . . . 0.0 110.425 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.486 HD11 ' HA ' ' A' ' 84' ' ' PHE . 14.2 tt -65.24 -26.69 40.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.464 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.47 9.18 11.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.808 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -109.71 146.43 34.9 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.413 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 39.7 m-80 -76.25 174.56 9.99 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.216 0.532 . . . . 0.0 111.236 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.431 ' HB3' HD12 ' A' ' 53' ' ' LEU . . . -61.62 -26.48 68.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.843 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.423 ' CB ' ' HB3' ' A' ' 78' ' ' PRO . 1.4 p30 -63.52 -36.92 85.38 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.502 0.192 . . . . 0.0 110.883 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -66.32 -43.81 85.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.099 0.476 . . . . 0.0 110.014 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.44 HG23 HD11 ' A' ' 23' ' ' ILE . 96.7 mt -64.72 -46.16 93.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.322 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.76 -46.71 84.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.197 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.19 -43.2 93.57 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.257 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.685 ' O ' ' HD3' ' A' ' 41' ' ' LYS . . . -61.6 -48.81 79.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.867 0.365 . . . . 0.0 111.283 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.527 ' CB ' HG13 ' A' ' 9' ' ' VAL . . . -68.22 -40.68 82.0 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.465 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.83 -36.7 84.76 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.517 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.95 -37.18 78.81 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.387 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.685 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 6.5 mptt -61.43 -37.33 83.12 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.62 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -90.68 -0.13 57.59 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.2 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.84 26.28 71.69 Favored Glycine 0 C--O 1.238 0.365 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.879 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.0 mt -113.81 19.98 16.21 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 122.642 -0.328 . . . . 0.0 111.188 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -52.16 -39.47 60.05 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.343 0.657 . . . . 0.0 111.765 -175.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -72.58 -22.06 61.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.547 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.3 m -93.19 21.22 6.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.836 0.35 . . . . 0.0 111.295 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -59.71 -33.84 72.14 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.893 -176.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.89 -7.8 4.2 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.546 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -106.51 -6.95 17.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -127.76 155.03 44.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -173.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.0 pt -138.66 176.28 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.458 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.431 HD12 ' HB3' ' A' ' 31' ' ' ALA . 98.5 mt -101.51 143.45 31.49 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.727 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.7 m -127.9 130.41 69.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.416 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.422 ' HB2' HD11 ' A' ' 76' ' ' ILE . 1.7 tt0 -90.27 121.48 32.32 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 61' ' ' ASP . 63.6 t -121.08 137.12 55.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.132 0.492 . . . . 0.0 111.938 -175.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 93' ' ' GLY . 14.0 m -68.48 144.55 54.6 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.364 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -67.92 -24.24 65.18 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.13 76.39 1.76 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.224 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 61' ' ' ASP . 15.2 m-20 42.03 70.38 0.29 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.898 1.279 . . . . 0.0 112.35 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 25.2 t70 73.08 -69.83 0.18 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.373 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -169.82 93.12 0.24 Allowed 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.5 ' HZ2' ' CD ' ' A' ' 94' ' ' GLU . 31.4 mmtt 62.01 10.29 3.54 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 167.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -140.38 176.32 8.87 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.141 -175.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 49.7 ttp -91.36 19.37 6.1 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.4 ' HG ' ' HB3' ' A' ' 61' ' ' ASP . 15.6 p -61.06 -32.3 71.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.297 178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 7.2 t70 67.57 -170.99 0.19 Allowed 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.224 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.403 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 84.8 mt -76.31 -5.38 46.81 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.588 0.232 . . . . 0.0 111.607 -177.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -72.99 129.88 39.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 57.98 36.96 26.6 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.885 0.85 . . . . 0.0 109.542 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.5 tt -54.17 142.74 7.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.594 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -160.55 141.43 11.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.03 0.443 . . . . 0.0 110.958 175.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -131.28 -150.92 6.84 Favored Glycine 0 C--N 1.314 -0.688 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.422 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 18.7 ptt85 -83.56 128.65 63.06 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-N 117.375 0.587 . . . . 0.0 109.443 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 24.2 Cg_exo -61.69 119.2 6.21 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.248 1.965 . . . . 0.0 111.921 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' A' ' 55' ' ' GLU . 65.6 mt -120.33 100.1 47.72 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.153 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -67.12 155.69 69.59 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.734 2.289 . . . . 0.0 111.384 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.423 ' HB3' ' CB ' ' A' ' 32' ' ' ASP . 51.8 Cg_exo -54.66 -32.53 75.78 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 123.489 2.792 . . . . 0.0 113.262 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m -62.69 -41.92 99.37 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.291 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.74 148.91 50.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 5.6 m -104.27 85.96 1.22 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.403 ' O ' ' HG3' ' A' ' 86' ' ' MET . 56.2 Cg_endo -69.46 -24.77 30.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.604 2.203 . . . . 0.0 114.159 -173.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 27' ' ' ILE . 33.3 mt -63.76 -37.89 89.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -175.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.486 ' HA ' HD11 ' A' ' 27' ' ' ILE . 26.7 m-85 -58.21 -46.28 86.16 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.32 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.26 -39.68 82.15 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.005 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.493 ' O ' ' HB2' ' A' ' 97' ' ' PHE . 12.1 mtm -64.75 -42.72 94.94 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.788 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 m -84.9 -22.8 29.17 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.834 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.47 -41.55 98.86 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.611 0.243 . . . . 0.0 111.313 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.48 ' HB3' HD22 ' A' ' 95' ' ' ASN . 57.5 mtm-85 -103.7 -55.45 2.38 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.694 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.5 t 58.56 166.7 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.647 ' O ' ' HB3' ' A' ' 95' ' ' ASN . . . 79.21 158.58 13.83 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.668 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.514 HD21 ' N ' ' A' ' 93' ' ' GLY . 0.2 OUTLIER 67.78 123.32 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.143 0.577 . . . . 0.0 110.343 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.514 ' N ' HD21 ' A' ' 92' ' ' ASN . . . -70.27 62.02 0.8 Allowed Glycine 0 N--CA 1.468 0.819 0 C-N-CA 121.399 -0.429 . . . . 0.0 113.448 -177.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.5 ' CD ' ' HZ2' ' A' ' 63' ' ' LYS . 12.2 pt-20 -175.19 -20.56 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 124.336 1.054 . . . . 0.0 108.887 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.647 ' HB3' ' O ' ' A' ' 91' ' ' GLY . 48.7 t30 -100.83 73.06 1.55 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.537 -174.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 86' ' ' MET . . . 66.2 -96.37 0.27 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 172.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 86' ' ' MET . 5.4 t80 -61.63 -42.26 98.64 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -170.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 92' ' ' ASN . 12.3 t70 -71.65 -8.84 56.58 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.691 0.758 . . . . 0.0 110.196 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 19.8 m -96.8 179.92 4.8 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -123.24 158.59 30.57 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.478 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -111.64 127.36 55.73 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.465 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.46 166.18 14.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.209 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.3 mt -106.86 122.84 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.636 178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.414 ' HG2' ' OE1' ' A' ' 13' ' ' GLU . 25.3 mtpp -132.31 167.14 20.39 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 177.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -75.11 141.41 43.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -60.91 160.51 20.07 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.092 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.62 144.72 84.67 Favored 'Trans proline' 0 CA--C 1.507 -0.872 0 C-N-CA 122.352 2.034 . . . . 0.0 112.464 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 . . . . . 0 C--N 1.297 -1.676 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.526 -176.265 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 120.573 0.225 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.7 mtt -97.43 12.91 31.61 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -61.85 -45.94 91.59 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.114 0.483 . . . . 0.0 110.957 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.55 -60.37 4.27 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.113 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.44 -26.33 8.19 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.187 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.5 m -109.69 146.69 34.44 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.7 mt -114.36 135.09 54.46 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.86 101.48 11.01 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.449 ' CG2' HG12 ' A' ' 23' ' ' ILE . 61.4 t -102.66 121.13 53.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.228 -171.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -92.54 104.33 16.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.41 0.624 . . . . 0.0 110.984 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.22 16.61 22.31 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.885 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.67 -23.7 58.92 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.555 -0.355 . . . . 0.0 112.385 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -65.78 -36.02 82.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.119 0.485 . . . . 0.0 110.185 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.7 mm -86.07 -50.31 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.609 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -128.51 105.31 19.23 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.371 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.16 -36.52 96.6 Favored 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 123.647 2.898 . . . . 0.0 112.228 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 m -63.45 -26.97 68.97 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.723 -176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.07 79.02 69.95 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.49 -43.85 47.48 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.593 2.196 . . . . 0.0 112.927 -178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -128.53 139.73 52.16 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.126 0.489 . . . . 0.0 111.311 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.76 161.35 41.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 p -119.87 130.31 54.8 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.045 0.45 . . . . 0.0 111.265 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.449 HG12 ' CG2' ' A' ' 9' ' ' VAL . 36.7 pt -130.4 157.34 42.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.427 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.5 mp -105.0 121.91 44.76 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.54 145.8 43.35 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.019 0.438 . . . . 0.0 111.194 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 62.3 mt-10 -97.7 152.11 19.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.114 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.473 ' HA ' HD13 ' A' ' 83' ' ' LEU . 19.7 tt -67.11 -29.4 45.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.915 -177.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -93.25 13.32 21.64 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.195 0.521 . . . . 0.0 110.078 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 37.0 tt0 -99.42 137.14 38.34 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -76.85 165.24 24.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.349 0.595 . . . . 0.0 112.479 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.1 -23.19 67.33 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.733 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.8 -45.57 93.27 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.797 0.332 . . . . 0.0 111.015 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -69.89 -42.38 73.5 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.958 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.47 -48.7 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.552 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.2 tp -63.62 -44.52 93.67 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.228 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.11 93.92 Favored Glycine 0 C--O 1.212 -1.265 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.17 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.38 -51.11 70.88 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.256 0.528 . . . . 0.0 111.238 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.426 ' CB ' HD11 ' A' ' 103' ' ' ILE . . . -69.24 -39.83 78.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.317 0.579 . . . . 0.0 111.133 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.5 tp -64.38 -38.24 90.32 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.027 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -65.67 -26.76 67.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.179 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 74.7 mmtt -59.84 -30.37 68.92 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.325 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -101.36 1.68 38.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.244 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.95 27.69 73.69 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.74 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.1 mt -112.81 23.0 13.92 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -60.34 -30.32 69.46 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -175.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -71.34 -20.17 62.2 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.992 0.425 . . . . 0.0 110.979 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.6 m -90.39 6.73 41.98 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.975 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -56.73 -16.07 5.75 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.368 0.667 . . . . 0.0 112.74 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.34 -34.19 74.87 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.843 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.56 ' OD2' ' HD3' ' A' ' 105' ' ' ARG . 20.6 t0 -107.48 15.94 24.33 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.05 148.83 50.57 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.868 -0.52 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.4 pt -140.17 170.3 15.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.262 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.8 mt -101.39 141.59 34.04 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.691 0.281 . . . . 0.0 110.514 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.434 HG22 ' HG3' ' A' ' 104' ' ' LYS . 28.3 m -124.21 129.26 74.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.15 0.5 . . . . 0.0 109.872 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.423 ' OE1' ' HG2' ' A' ' 86' ' ' MET . 14.8 tt0 -88.17 134.92 33.66 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.5 120.45 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -175.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.444 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 12.6 m -71.77 146.46 48.06 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.3 89.74 7.04 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.004 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 62' ' ' ARG . 21.8 t70 -144.57 -85.25 0.13 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.683 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 61' ' ' ASP . 1.7 m-20 56.01 34.79 24.38 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 60' ' ' ASP . 7.8 t70 72.12 -63.76 0.42 Allowed 'General case' 0 C--N 1.362 1.14 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -167.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 59' ' ' ASP . 74.2 ttt180 175.53 79.19 0.0 OUTLIER 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 112.755 -2.021 . . . . 0.0 108.363 167.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 60' ' ' ASP . 67.1 mmtt 58.89 42.38 19.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.431 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.9 t -142.17 -58.09 0.46 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.021 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.6 ttp -60.85 -49.54 77.07 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.074 0.464 . . . . 0.0 110.402 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.437 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 12.2 m -102.26 -20.84 14.49 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.927 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.666 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 22.9 t70 63.34 -85.14 0.02 OUTLIER 'General case' 0 C--N 1.349 0.558 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.882 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 67' ' ' ASP . 15.6 mt 175.13 -41.64 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 126.161 1.784 . . . . 0.0 107.886 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -72.03 127.31 32.15 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.882 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 62.8 95.65 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.166 0.986 . . . . 0.0 110.707 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 80.8 mt -105.07 129.13 58.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.895 -177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.3 -61.74 1.86 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.272 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 52.94 -149.94 10.46 Favored Glycine 0 N--CA 1.466 0.685 0 CA-C-N 115.566 -0.743 . . . . 0.0 113.99 176.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HD3' ' HB3' ' A' ' 55' ' ' GLU . 5.8 ptm180 -119.76 121.34 29.87 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 15.9 Cg_exo -66.47 118.4 5.5 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.308 2.005 . . . . 0.0 112.094 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.5 mt -121.64 102.6 41.75 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.143 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.77 154.02 74.79 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.757 2.305 . . . . 0.0 111.905 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -57.05 -26.84 70.88 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.633 2.888 . . . . 0.0 113.536 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.4 m -62.4 -40.22 95.79 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.06 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -82.02 157.63 24.11 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.063 0.545 . . . . 0.0 112.323 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 66.4 m -109.05 91.89 10.03 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.53 -18.91 43.13 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.051 2.501 . . . . 0.0 115.109 -173.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 86' ' ' MET . 33.9 mt -63.01 -28.78 70.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -173.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.434 ' HA ' HD13 ' A' ' 27' ' ' ILE . 44.1 m-85 -59.01 -44.19 91.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 110.489 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -80.13 -34.28 37.9 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.596 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.542 ' O ' ' HB3' ' A' ' 90' ' ' SER . 2.3 tmm? -58.83 -43.0 90.56 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.212 0.605 . . . . 0.0 111.082 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.418 HG23 ' CE2' ' A' ' 97' ' ' PHE . 11.9 m -74.46 -44.56 51.05 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.28 -63.97 1.11 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -175.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.75 -36.7 83.06 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 86' ' ' MET . 2.9 t -70.03 -176.47 1.14 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.325 0.583 . . . . 0.0 111.613 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.481 ' HA3' ' HA2' ' A' ' 96' ' ' GLY . . . 83.44 36.4 14.45 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -175.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -102.42 12.24 36.83 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.103 -0.549 . . . . 0.0 109.779 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.444 ' CA ' ' HB3' ' A' ' 57' ' ' SER . . . -88.37 -53.94 2.52 Favored Glycine 0 CA--C 1.496 -1.143 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.186 178.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.486 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 1.1 tm-20 -113.23 -70.08 0.83 Allowed 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -157.81 1.42 0.11 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.552 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.481 ' HA2' ' HA3' ' A' ' 91' ' ' GLY . . . 142.38 129.34 2.38 Favored Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 118.062 -2.018 . . . . 0.0 112.881 -175.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.418 ' CE2' HG23 ' A' ' 87' ' ' THR . 2.0 t80 46.18 29.76 0.86 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.255 1.022 . . . . 0.0 111.34 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 94' ' ' GLU . 1.8 p30 -89.26 10.05 23.62 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.681 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.6 p -95.5 148.78 22.13 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.312 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -130.48 169.6 15.33 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.83 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.1 tp -118.16 122.33 42.77 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.063 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.07 165.96 12.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.473 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.426 HD11 ' CB ' ' A' ' 38' ' ' ALA . 72.3 mt -107.01 124.84 63.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.8 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.434 ' HG3' HG22 ' A' ' 54' ' ' VAL . 1.4 mmpt? -128.94 152.19 48.84 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.422 0.63 . . . . 0.0 110.537 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.56 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 2.4 tmm_? -79.32 126.36 30.7 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.317 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -67.35 113.09 12.11 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.213 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.23 -179.97 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.166 2.577 . . . . 0.0 112.594 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 . . . . . 0 C--O 1.243 0.732 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.006 179.784 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.238 0.478 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.5 mtt -74.63 97.52 3.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.8 0.333 . . . . 0.0 111.484 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -64.24 -44.66 91.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.648 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.56 -70.38 1.65 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.017 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.4 -35.28 2.61 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.188 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 p -95.52 137.45 34.56 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 62.0 mt -112.19 135.16 53.21 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 121.179 0.514 . . . . 0.0 112.029 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -82.67 108.86 16.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.45 HG21 ' CD1' ' A' ' 23' ' ' ILE . 56.6 t -116.82 130.43 71.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.658 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -108.38 116.89 32.81 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.763 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.17 -33.64 7.16 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 45.89 -90.98 0.01 OUTLIER Glycine 0 C--N 1.338 0.692 0 N-CA-C 115.991 1.156 . . . . 0.0 115.991 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.64 -39.13 91.1 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.5 mt -65.26 -44.77 94.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.174 0.511 . . . . 0.0 111.262 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.494 HG22 ' CD1' ' A' ' 42' ' ' TYR . 49.7 t -132.05 88.78 40.01 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.114 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.55 -25.86 81.6 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 123.189 2.593 . . . . 0.0 112.94 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.1 t -79.14 -5.32 53.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.732 0.301 . . . . 0.0 111.468 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -154.29 76.3 5.71 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 121.174 0.512 . . . . 0.0 109.81 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.09 -43.11 61.26 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.031 2.488 . . . . 0.0 113.142 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -118.98 143.77 46.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.14 0.495 . . . . 0.0 112.146 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.98 158.59 39.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.904 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -116.55 124.35 49.65 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.45 ' CD1' HG21 ' A' ' 9' ' ' VAL . 40.6 pt -125.33 161.75 29.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.65 -177.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.0 mp -111.69 125.88 54.44 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.87 148.16 30.55 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.79 0.329 . . . . 0.0 110.897 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.423 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . 74.9 mm-40 -94.81 149.89 20.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.482 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 16.8 tt -63.21 -26.63 41.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.719 -0.392 . . . . 0.0 112.041 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -77.36 -7.64 56.39 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.256 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.542 ' OE2' ' HD3' ' A' ' 33' ' ' ARG . 47.3 mt-10 -84.83 140.22 31.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.087 0.47 . . . . 0.0 110.874 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -78.64 173.87 11.99 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.58 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.36 -27.53 68.57 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.923 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -63.24 -38.57 91.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.755 0.312 . . . . 0.0 110.445 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.542 ' HD3' ' OE2' ' A' ' 29' ' ' GLU . 3.2 mmp_? -69.84 -44.3 70.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.075 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.65 -44.83 96.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.361 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.84 -44.56 95.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.731 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.414 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -66.4 -38.95 93.99 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.999 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.426 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.02 -51.06 71.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.829 0.347 . . . . 0.0 111.046 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -68.04 -40.79 82.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.105 0.478 . . . . 0.0 110.959 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.3 tp -63.13 -39.1 93.7 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.084 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.8 -35.29 77.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.913 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.4 mmtt -61.67 -38.05 86.36 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.836 0.35 . . . . 0.0 110.336 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.494 ' CD1' HG22 ' A' ' 15' ' ' VAL . 79.0 m-85 -85.76 -5.75 59.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.658 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.56 20.27 79.81 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.401 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.0 mt -104.09 23.29 13.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.722 0.296 . . . . 0.0 110.761 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.81 -25.64 20.25 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -78.53 -13.46 59.82 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -177.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.7 m -106.68 22.68 15.5 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.414 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 36.5 ttmt -60.47 -32.93 71.87 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.79 -28.9 66.41 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.846 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.75 -6.13 59.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.279 -176.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 69.7 m-85 -127.39 153.81 45.77 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.161 -174.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.0 pt -136.85 172.57 14.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.555 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.405 ' CD2' HG12 ' A' ' 103' ' ' ILE . 97.0 mt -101.57 139.96 36.51 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.443 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 15.2 m -127.99 128.88 69.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.022 0.439 . . . . 0.0 110.218 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.528 ' OE2' ' HB3' ' A' ' 99' ' ' SER . 3.1 tm-20 -87.96 124.49 33.76 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.034 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.6 t -137.47 136.0 46.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.007 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 62' ' ' ARG . 30.1 m -97.07 160.36 14.39 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -86.27 7.09 26.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.945 -0.472 . . . . 0.0 111.156 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -82.96 83.46 7.8 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.322 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 50.95 93.83 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.58 0.55 . . . . 0.0 112.278 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.54 ' HB2' ' N ' ' A' ' 67' ' ' ASP . 19.7 t70 72.89 -59.48 0.57 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.371 0.669 . . . . 0.0 110.801 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 57' ' ' SER . 19.7 ptp180 -165.28 -26.22 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.32 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HG2' ' HG3' ' A' ' 62' ' ' ARG . 24.8 pttm -158.73 -45.83 0.06 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.976 -176.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.6 m -157.53 124.49 5.06 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 111.352 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.584 ' HG3' ' H ' ' A' ' 66' ' ' SER . 6.2 tpt 51.98 -154.5 0.18 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.946 0.898 . . . . 0.0 111.629 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.584 ' H ' ' HG3' ' A' ' 65' ' ' MET . 46.8 t 72.12 -47.27 0.66 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.488 0.715 . . . . 0.0 111.504 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.54 ' N ' ' HB2' ' A' ' 61' ' ' ASP . 47.1 t0 69.15 120.65 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.618 0.767 . . . . 0.0 111.34 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.5 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 2.0 pt? -70.06 72.71 0.43 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.98 -37.55 75.79 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -124.68 145.08 49.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.088 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.29 129.31 37.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.698 0.761 . . . . 0.0 110.577 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -165.14 141.3 5.54 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.637 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.71 -142.6 3.51 Favored Glycine 0 CA--C 1.5 -0.858 0 C-N-CA 120.023 -1.084 . . . . 0.0 112.603 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 12.3 ttp180 -86.07 119.16 71.54 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -63.75 114.6 2.64 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.748 2.299 . . . . 0.0 112.315 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.2 mt -121.91 99.69 43.94 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.724 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.74 159.21 46.51 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.863 2.375 . . . . 0.0 111.764 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -55.8 -32.71 85.69 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.252 2.635 . . . . 0.0 113.532 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.2 p -76.31 -12.58 60.1 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -80.21 155.46 27.36 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.8 m -113.95 83.38 7.67 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.41 -27.58 54.76 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.884 2.389 . . . . 0.0 114.39 -174.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.482 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 82.5 mt -63.96 -39.6 94.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -56.53 -45.44 81.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.47 -43.77 59.51 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.027 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 31.2 mtm -63.25 -42.27 99.15 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.0 m -64.4 -44.66 90.58 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.725 0.298 . . . . 0.0 111.738 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.57 -38.78 21.21 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -91.87 9.02 34.62 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.7 p -58.52 139.09 56.25 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.057 0.456 . . . . 0.0 111.39 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 98' ' ' ASP . . . 171.03 -123.93 1.08 Allowed Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.767 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 70.73 -63.24 0.42 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.375 0.67 . . . . 0.0 112.103 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.82 -44.43 0.24 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.382 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.731 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 8.9 tp10 -61.88 151.56 34.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.825 0.345 . . . . 0.0 110.761 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -105.74 12.68 30.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.724 0.297 . . . . 0.0 111.708 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.589 ' H ' ' HG3' ' A' ' 94' ' ' GLU . . . -95.23 71.57 1.0 Allowed Glycine 0 CA--C 1.496 -1.102 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.436 ' C ' ' H ' ' A' ' 99' ' ' SER . 7.3 t80 68.53 13.01 8.9 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.731 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 8.6 m-20 72.33 -45.07 0.61 Allowed 'General case' 0 C--N 1.356 0.882 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.251 -176.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.528 ' HB3' ' OE2' ' A' ' 55' ' ' GLU . 20.1 m -133.24 147.12 51.96 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -117.22 163.93 15.57 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.0 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.6 tp -113.64 124.9 53.43 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.101 0.477 . . . . 0.0 110.273 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.04 164.56 13.99 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.807 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 38' ' ' ALA . 68.6 mt -112.17 129.97 66.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.825 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -131.54 163.44 28.01 Favored 'General case' 0 CA--C 1.478 -1.793 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 1.7 ptm180 -94.6 120.11 34.32 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.275 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -52.1 142.15 28.03 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.705 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.58 -40.83 82.13 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 123.151 2.567 . . . . 0.0 112.212 178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 . . . . . 0 C--O 1.242 0.706 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.493 -179.695 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.794 0.331 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.8 mtt -99.59 132.91 44.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.356 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -115.39 -79.47 0.59 Allowed 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 44.47 76.6 0.12 Allowed Glycine 0 C--N 1.346 1.105 0 O-C-N 123.647 0.592 . . . . 0.0 113.964 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.82 -166.1 31.51 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.849 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -128.31 153.49 46.95 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.5 mt -104.83 137.76 42.13 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.55 105.26 17.52 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 173.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -101.06 127.81 53.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.398 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 86.9 t80 -88.64 119.95 29.59 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.009 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.23 29.97 8.33 Favored Glycine 0 C--O 1.244 0.728 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.262 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 13' ' ' GLU . . . -60.28 168.37 8.83 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 66.1 mm-40 74.6 -34.69 0.28 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.113 0.565 . . . . 0.0 111.397 -176.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.447 ' H ' ' C ' ' A' ' 12' ' ' GLY . 69.0 mt -91.13 -56.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.0 t -130.83 97.74 20.43 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.424 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.65 -23.67 42.33 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.909 2.406 . . . . 0.0 113.489 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.0 t -80.07 -7.95 59.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.246 0.546 . . . . 0.0 110.976 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -139.15 71.3 40.52 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.468 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 23.1 Cg_endo -59.74 -42.9 42.08 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.695 2.263 . . . . 0.0 113.354 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.06 140.36 53.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.174 0.512 . . . . 0.0 111.524 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.3 p -126.75 155.81 37.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.546 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.0 m -102.9 122.56 44.8 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.467 ' CD1' HG22 ' A' ' 34' ' ' ILE . 16.9 pt -119.28 151.98 21.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.125 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.9 mp -100.97 107.17 18.58 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.54 141.66 18.34 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -113.62 173.28 6.49 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.088 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 84' ' ' PHE . 15.1 tt -61.83 -30.12 47.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -172.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -77.32 -6.91 54.97 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.159 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -89.24 147.46 24.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.083 0.468 . . . . 0.0 111.062 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -86.13 178.94 7.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.828 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.92 -15.65 63.71 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.6 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 78' ' ' PRO . 1.9 p-10 -62.27 -40.89 97.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.728 0.299 . . . . 0.0 110.416 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -43.7 66.51 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-O 121.231 0.539 . . . . 0.0 109.63 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.47 HG21 HD22 ' A' ' 101' ' ' LEU . 96.7 mt -63.06 -49.96 81.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.452 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.94 -45.1 83.06 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.026 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.43 -43.2 97.08 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.722 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.553 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -64.47 -48.58 74.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.95 0.375 . . . . 0.0 111.32 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.73 -48.12 78.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.078 0.466 . . . . 0.0 111.287 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.463 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 28.9 tp -63.31 -34.63 78.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.865 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.45 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 38.2 tt0 -60.04 -44.4 94.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.45 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 65.3 mmtt -64.32 -37.39 87.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.549 -177.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -78.41 -6.09 54.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.586 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.91 24.95 57.1 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.962 -0.637 . . . . 0.0 114.201 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 90.6 mt -120.27 22.85 11.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 117.279 0.539 . . . . 0.0 110.736 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 5.0 tm-20 -59.85 -31.46 69.77 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.231 0.612 . . . . 0.0 111.743 -175.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -78.19 -14.38 59.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -90.59 -82.92 0.27 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 16.4 ttmt 64.43 -37.78 0.21 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.546 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 4.5 p-10 -70.53 -2.41 14.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.063 0.458 . . . . 0.0 111.257 -177.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.86 -9.78 20.44 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.39 154.22 48.85 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.1 pt -141.22 -179.86 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.435 HD11 HD21 ' A' ' 101' ' ' LEU . 90.6 mt -103.38 148.67 25.61 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.619 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.43 155.32 31.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.627 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.479 ' HG3' ' CD1' ' A' ' 76' ' ' ILE . 46.3 mt-10 -99.78 123.62 44.22 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 177.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.435 ' HB ' ' CZ ' ' A' ' 100' ' ' PHE . 25.0 t -112.7 125.5 69.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.168 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 50.3 m -78.51 136.94 37.69 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.247 0.546 . . . . 0.0 110.972 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -64.09 -40.21 95.73 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.598 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -101.31 67.3 1.15 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.586 0.708 . . . . 0.0 110.521 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.847 ' OD2' ' HA ' ' A' ' 67' ' ' ASP . 3.3 p-10 -63.94 -47.41 80.57 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.661 -1.154 . . . . 0.0 113.124 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -61.15 -37.44 82.86 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -80.0 -15.15 57.83 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.52 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HZ1' ' CG ' ' A' ' 98' ' ' ASP . 59.4 mtpt -101.81 -61.05 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.924 0.392 . . . . 0.0 111.662 -178.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.7 p -99.06 -15.57 18.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.511 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 65.8 mtt 69.55 5.46 5.19 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.363 0.602 . . . . 0.0 110.299 -175.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -111.66 112.69 24.58 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.847 ' HA ' ' OD2' ' A' ' 60' ' ' ASP . 6.1 p-10 -60.84 162.6 6.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.906 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.43 73.09 9.62 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 121.918 0.866 . . . . 0.0 109.71 -177.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -66.07 -24.84 66.8 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.396 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 71' ' ' ILE . 0.7 OUTLIER -141.26 -88.89 0.16 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.576 174.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.497 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 96.8 mt -139.41 -76.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 120.507 0.194 . . . . 0.0 111.252 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 71' ' ' ILE . 15.5 m-20 64.89 -177.94 0.18 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.985 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.25 -162.27 21.99 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.752 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -111.07 139.15 21.51 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.51 120.44 7.39 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.572 2.181 . . . . 0.0 113.266 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.479 ' CD1' ' HG3' ' A' ' 55' ' ' GLU . 33.9 mt -120.87 104.07 42.29 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.345 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -65.26 156.34 63.63 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.086 2.524 . . . . 0.0 112.846 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 32.5 Cg_exo -56.78 -30.55 85.13 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.567 2.844 . . . . 0.0 113.435 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 p -80.62 3.4 22.04 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -97.51 156.52 16.46 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.375 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.1 m -114.25 80.53 5.84 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.02 -20.13 19.66 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.511 2.141 . . . . 0.0 114.614 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 47.9 mt -64.03 -38.59 91.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.479 ' HA ' HD12 ' A' ' 27' ' ' ILE . 22.1 m-85 -59.23 -37.21 76.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.054 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 45.6 mt-10 -73.39 -41.67 63.07 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.892 0.377 . . . . 0.0 110.814 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.463 ' HE1' ' HB2' ' A' ' 101' ' ' LEU . 67.6 mtt -61.22 -42.87 99.35 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.5 p -65.22 -30.47 71.36 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.826 0.346 . . . . 0.0 111.906 -178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.25 -10.67 56.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.85 0.357 . . . . 0.0 111.132 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 15.9 mmt180 -104.03 8.58 36.64 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.216 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.6 m -63.86 139.58 58.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.877 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 172.82 -80.3 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.707 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -92.09 176.49 6.48 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.76 115.32 2.04 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.193 -1.004 . . . . 0.0 112.324 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -84.13 -28.48 27.44 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.56 0.219 . . . . 0.0 111.144 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -67.37 -54.29 21.88 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.972 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -145.54 -107.1 0.52 Allowed Glycine 0 CA--C 1.503 -0.702 0 C-N-CA 119.663 -1.256 . . . . 0.0 111.679 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -95.92 -153.47 0.4 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.403 ' CG ' ' HZ1' ' A' ' 63' ' ' LYS . 3.2 t70 -55.79 -43.24 76.65 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 172.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 50.7 m -130.87 152.83 49.78 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.398 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.435 ' CZ ' ' HB ' ' A' ' 56' ' ' VAL . 30.4 p90 -110.81 173.94 6.1 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 34' ' ' ILE . 22.1 tp -107.6 125.02 50.81 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.01 0.433 . . . . 0.0 110.793 -173.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -129.07 173.31 10.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.877 -177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.3 mt -110.77 127.61 67.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.376 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.428 ' HD3' ' HB ' ' A' ' 71' ' ' ILE . 21.7 mmmt -128.72 165.76 20.27 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -88.15 128.96 35.44 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.969 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.5 ptmt -71.89 148.94 92.43 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -67.82 150.09 78.57 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.147 1.898 . . . . 0.0 111.548 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 . . . . . 0 C--N 1.303 -1.442 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.661 -178.647 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 m -131.61 147.72 52.55 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.39 140.14 49.96 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -84.09 105.56 15.05 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.31 129.24 62.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.724 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 92.3 t80 -109.98 119.55 39.67 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.623 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.53 30.36 2.89 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.274 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.15 -30.4 63.97 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 121.806 -0.235 . . . . 0.0 113.578 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -64.64 -26.66 68.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.039 0.447 . . . . 0.0 110.981 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.9 mt -90.56 -50.92 12.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.99 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.63 96.81 20.11 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.829 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.4 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 48.8 Cg_exo -56.83 -34.96 97.83 Favored 'Trans proline' 0 N--CA 1.475 0.432 0 C-N-CA 123.283 2.656 . . . . 0.0 113.655 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.6 t -71.41 -16.44 62.39 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -133.86 69.64 75.31 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.484 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 47.1 Cg_endo -66.99 -33.11 33.34 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.542 2.161 . . . . 0.0 112.735 -176.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -122.03 132.56 54.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.914 0.387 . . . . 0.0 110.738 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.7 p -136.75 156.88 35.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.304 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -112.95 125.09 54.01 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.314 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.402 HD11 HG23 ' A' ' 34' ' ' ILE . 33.9 pt -123.38 159.13 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.566 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.78 133.79 40.91 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.44 134.59 5.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.832 0.349 . . . . 0.0 111.26 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.714 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 6.5 mp0 -92.56 161.12 14.72 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.473 HG13 ' CB ' ' A' ' 83' ' ' LEU . 19.7 tt -66.98 -25.73 35.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -87.86 4.88 42.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.714 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 12.7 pt-20 -97.42 144.4 27.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.785 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -77.16 170.25 16.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.962 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.55 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -60.25 -24.9 65.26 Favored 'General case' 0 C--O 1.198 -1.612 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.647 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.61 -46.64 88.36 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.938 0.399 . . . . 0.0 111.084 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -70.12 -43.7 70.45 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.674 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 23' ' ' ILE . 97.0 mt -63.8 -46.17 95.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.298 0.57 . . . . 0.0 110.494 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.6 tp -65.16 -43.09 92.9 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.727 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.455 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -63.78 -37.08 94.17 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.21 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.97 -51.15 67.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.898 0.38 . . . . 0.0 110.778 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.85 -43.79 87.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.16 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.52 ' CD2' ' HA ' ' A' ' 45' ' ' GLU . 29.5 tp -64.71 -35.57 81.48 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.985 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.19 -36.21 82.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.767 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 63.7 mmtt -62.42 -36.33 82.02 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -84.0 -8.1 59.23 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.565 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.28 30.12 71.71 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.423 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.2 mt -120.48 24.53 10.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.52 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 42.4 tt0 -58.84 -29.7 67.13 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -62.61 -26.78 68.79 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.054 0.455 . . . . 0.0 110.881 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.5 m -100.54 30.53 3.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.903 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.455 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 36.3 ttmt -61.09 -36.75 80.49 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.453 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 30.8 t70 -62.95 -18.52 63.26 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.178 0.513 . . . . 0.0 111.829 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -82.46 -8.62 59.62 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.73 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -132.42 150.43 52.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.256 0.55 . . . . 0.0 111.79 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.677 HG23 ' HB2' ' A' ' 106' ' ' LYS . 25.6 pt -139.97 171.35 13.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.568 HD13 HD21 ' A' ' 101' ' ' LEU . 97.6 mt -100.07 141.79 32.42 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.356 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.49 136.77 55.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -86.59 117.62 25.47 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.639 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.455 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 40.4 t . . . . . 0 C--N 1.303 -1.431 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.866 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ptt85 -82.37 133.81 49.62 Favored Pre-proline 0 N--CA 1.441 -0.891 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.09 121.15 8.71 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.383 2.055 . . . . 0.0 111.888 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.3 mt -121.27 97.9 47.18 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.89 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -63.5 159.51 40.15 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.25 2.633 . . . . 0.0 112.493 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 47.3 Cg_exo -55.13 -29.17 64.62 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.609 2.873 . . . . 0.0 113.659 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.5 p -80.69 -1.42 42.51 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -105.37 142.92 34.3 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.251 -0.18 . . . . 0.0 110.612 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.0 p -106.11 92.42 6.59 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 120.986 0.422 . . . . 0.0 110.104 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.73 -23.05 36.37 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.013 2.475 . . . . 0.0 114.871 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.473 ' CB ' HG13 ' A' ' 27' ' ' ILE . 86.2 mt -62.56 -27.88 69.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.468 ' HA ' HD11 ' A' ' 27' ' ' ILE . 20.0 m-85 -58.03 -48.43 80.09 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.148 0.28 . . . . 0.0 111.299 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.08 -36.44 58.96 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.336 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 96.5 mtp -60.53 -61.58 2.49 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.22 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.734 -176.146 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.455 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 27.5 p90 . . . . . 0 N--CA 1.437 -1.118 0 CA-C-O 120.981 0.419 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.568 HD21 HD13 ' A' ' 53' ' ' LEU . 34.4 tp -109.03 121.4 45.06 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.43 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.27 174.47 6.69 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.815 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.44 129.74 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.136 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -122.93 160.26 26.55 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -82.46 116.93 22.13 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.68 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.677 ' HB2' HG23 ' A' ' 52' ' ' ILE . 72.6 tttt . . . . . 0 C--N 1.308 -1.214 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.813 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 p -95.38 139.17 32.05 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.4 mt -123.45 140.85 52.58 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -84.78 108.57 17.53 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.426 HG21 ' CD1' ' A' ' 23' ' ' ILE . 53.2 t -113.19 131.24 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.506 -171.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 87.2 t80 -88.04 121.19 30.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.543 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.8 31.69 6.89 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.708 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 10' ' ' TYR . . . -53.95 165.13 2.46 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.534 -0.333 . . . . 0.0 113.371 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 71.99 -47.16 0.66 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.129 0.972 . . . . 0.0 110.907 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.478 HG22 HG23 ' A' ' 15' ' ' VAL . 42.8 mm -62.97 -50.01 81.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.18 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.478 HG23 HG22 ' A' ' 14' ' ' ILE . 64.8 t -142.61 111.12 5.79 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.516 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.45 -24.52 49.4 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.838 2.359 . . . . 0.0 113.461 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.0 t -91.31 -0.9 57.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.991 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -145.8 73.45 13.69 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.407 . . . . 0.0 110.429 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.33 -21.79 30.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.726 2.284 . . . . 0.0 112.891 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -130.11 141.97 50.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.79 160.99 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.534 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 p -108.78 133.27 53.07 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.262 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 38' ' ' ALA . 32.0 pt -128.83 162.54 35.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.695 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.3 tp -112.6 123.85 51.23 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.9 154.04 47.14 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.005 0.431 . . . . 0.0 111.16 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.56 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 46.7 mt-10 -110.86 146.18 36.93 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.595 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.7 tt -67.52 -26.82 36.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -87.61 15.41 6.82 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.013 0.435 . . . . 0.0 110.978 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.56 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 70.0 mm-40 -106.5 157.38 17.7 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.839 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -88.89 169.25 11.73 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.257 0.551 . . . . 0.0 111.199 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -62.05 -26.17 68.1 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.089 -177.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.69 -45.08 93.18 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -67.41 -42.73 82.76 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 120.889 0.376 . . . . 0.0 110.487 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.54 -45.2 98.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.222 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.9 tp -63.47 -45.12 92.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.511 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.27 -34.83 89.22 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.301 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.56 -52.41 65.66 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.01 0.405 . . . . 0.0 111.998 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -71.59 -37.53 70.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.205 0.526 . . . . 0.0 110.727 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.81 -38.63 88.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.144 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.33 -37.36 83.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.445 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -62.78 -38.39 90.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.901 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -86.71 -0.97 57.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.844 0.354 . . . . 0.0 110.994 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.15 15.53 80.94 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.919 -0.582 . . . . 0.0 114.305 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.1 mt -105.76 14.53 28.11 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.384 0.592 . . . . 0.0 111.352 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -20.04 63.55 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -66.05 -35.08 79.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -83.41 -81.85 0.16 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.605 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt 65.44 -40.8 0.31 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.603 1.161 . . . . 0.0 113.829 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.44 -11.27 41.35 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -100.12 1.78 42.49 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.224 0.535 . . . . 0.0 110.318 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -132.0 151.94 51.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 111.297 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 pt -139.4 172.88 12.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.61 HD12 ' HB1' ' A' ' 31' ' ' ALA . 95.6 mt -100.71 134.88 43.03 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 12.7 m -123.57 128.55 74.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.305 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 4.8 tm-20 -86.81 120.16 27.81 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.421 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 74.7 t . . . . . 0 C--N 1.313 -1.004 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.005 -173.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.801 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.49 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 10.5 ptp180 -96.23 136.11 22.21 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.8 114.36 3.84 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.068 1.845 . . . . 0.0 111.827 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.0 mt -120.79 99.77 46.94 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.072 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.45 158.81 43.32 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.808 2.339 . . . . 0.0 112.086 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.476 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 31.2 Cg_exo -57.29 -23.13 52.75 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.361 2.708 . . . . 0.0 112.512 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.4 p -67.52 -22.42 65.43 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -78.69 176.54 9.41 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 122.352 1.072 . . . . 0.0 113.264 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 85.6 m -137.6 71.8 50.94 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 112.801 -2.0 . . . . 0.0 106.305 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.404 ' O ' ' HG3' ' A' ' 86' ' ' MET . 44.4 Cg_endo -67.02 -18.42 51.78 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.976 2.451 . . . . 0.0 114.323 -170.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 27' ' ' ILE . 44.6 mt -61.95 -41.33 97.85 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -173.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HA ' HD11 ' A' ' 27' ' ' ILE . 41.1 m-85 -60.24 -43.02 96.43 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.696 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.59 -40.63 84.81 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.388 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 96.6 mtp -62.78 -46.95 85.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.622 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 C--N 1.325 -0.47 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.149 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.421 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 30.0 p90 . . . . . 0 N--CA 1.444 -0.755 0 CA-C-O 121.176 0.512 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.444 HD21 HD13 ' A' ' 53' ' ' LEU . 31.0 tp -114.46 128.79 56.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.525 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . . . -122.89 167.84 13.04 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.82 -176.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 38' ' ' ALA . 84.2 mt -110.07 129.72 64.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.642 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -130.52 161.95 30.34 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.49 0.662 . . . . 0.0 111.028 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -84.07 104.76 14.4 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.486 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 CA--C 1.538 0.496 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.512 179.112 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.441 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 p -95.11 139.96 30.72 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.2 mt -112.87 138.22 50.05 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.089 0.471 . . . . 0.0 111.992 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -82.15 106.24 13.89 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.45 HG11 ' CB ' ' A' ' 38' ' ' ALA . 54.6 t -113.62 129.39 69.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.494 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -103.23 108.35 19.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.649 0.737 . . . . 0.0 112.246 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.82 12.64 9.97 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' A' ' 19' ' ' PRO . . . -61.55 -24.53 64.12 Favored Glycine 0 CA--C 1.5 -0.889 0 CA-C-N 115.286 -0.457 . . . . 0.0 112.921 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.3 -27.51 67.97 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.344 0.592 . . . . 0.0 109.843 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 76.4 mt -94.47 -51.69 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.862 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.31 97.32 47.5 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.196 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.68 -33.85 94.56 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.82 3.013 . . . . 0.0 114.921 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.4 t -65.77 -16.64 63.98 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.672 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -132.22 75.15 75.15 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.236 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HA ' ' HA3' ' A' ' 12' ' ' GLY . 18.1 Cg_endo -59.32 -46.78 19.76 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.445 2.096 . . . . 0.0 112.586 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -122.89 139.11 54.39 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.537 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.23 155.64 39.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -109.15 125.77 52.53 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.24 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' CD1' HG21 ' A' ' 9' ' ' VAL . 39.2 pt -126.28 156.22 36.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.23 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.3 tp -103.24 121.84 43.53 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.86 156.17 43.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.423 . . . . 0.0 111.792 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 43.8 mt-10 -110.6 147.97 33.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.67 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.579 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.5 tt -64.57 -31.38 53.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -89.33 9.34 26.42 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.035 0.445 . . . . 0.0 110.629 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 26' ' ' GLU . 38.2 tt0 -98.44 146.73 25.44 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.625 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.511 ' HA ' ' SG ' ' A' ' 81' ' ' CYS . 20.6 p-10 -83.1 163.24 21.01 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.351 0.596 . . . . 0.0 112.17 -176.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.573 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -67.15 -17.64 64.93 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.424 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.08 -44.52 94.71 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -69.38 -46.44 66.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.632 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.51 -45.27 98.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.705 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.41 -44.46 91.2 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.268 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.446 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -64.25 -39.53 97.14 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.568 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.12 87.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.938 0.399 . . . . 0.0 111.364 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.45 ' CB ' HG11 ' A' ' 9' ' ' VAL . . . -73.56 -44.91 56.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.67 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.6 -34.3 77.51 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.313 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.7 -39.21 87.69 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.867 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -60.73 -38.64 85.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.03 0.443 . . . . 0.0 110.678 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -84.06 -3.34 57.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.46 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.88 24.83 76.06 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.873 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.15 17.43 18.72 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.891 -0.182 . . . . 0.0 111.327 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -57.27 -34.93 69.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.809 0.443 . . . . 0.0 110.84 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -60.66 -39.32 87.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.173 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.0 m -89.12 21.86 3.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.295 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.446 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 33.2 ttmt -59.68 -15.63 20.87 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.071 0.462 . . . . 0.0 111.759 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.32 -35.42 79.02 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.618 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 106' ' ' LYS . 3.9 p-10 -104.25 17.32 24.35 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -176.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -126.68 150.49 48.96 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.0 pt -139.31 176.31 6.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.487 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.428 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.4 mt -101.65 138.69 38.3 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-O 120.548 0.213 . . . . 0.0 110.614 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.451 HG11 ' HD3' ' A' ' 104' ' ' LYS . 27.3 m -124.06 126.78 72.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.123 0.487 . . . . 0.0 110.441 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.439 ' CD ' HH21 ' A' ' 74' ' ' ARG . 13.6 tt0 -89.58 126.04 35.46 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.547 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 87.3 t . . . . . 0 C--N 1.315 -0.899 0 CA-C-O 120.836 0.35 . . . . 0.0 111.479 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.472 ' CA ' HG22 ' A' ' 56' ' ' VAL . . . . . . . . 0 N--CA 1.435 -1.4 0 N-CA-C 112.716 -0.154 . . . . 0.0 112.716 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.46 ' O ' HG13 ' A' ' 76' ' ' ILE . 40.1 mtm180 -88.66 117.17 68.05 Favored Pre-proline 0 C--N 1.314 -0.964 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.65 114.02 2.21 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.118 1.878 . . . . 0.0 111.568 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 74' ' ' ARG . 42.3 mt -120.84 113.73 32.9 Favored Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.543 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.79 159.01 54.95 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.548 2.165 . . . . 0.0 111.434 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.573 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 31.8 Cg_exo -58.5 -29.35 88.47 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.786 2.324 . . . . 0.0 111.972 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 m -77.34 -1.49 30.2 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.218 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.18 158.52 15.62 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 122.092 -0.38 . . . . 0.0 110.525 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.511 ' SG ' ' HA ' ' A' ' 30' ' ' ASN . 95.8 m -121.99 85.23 45.56 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.454 ' HB3' HD13 ' A' ' 76' ' ' ILE . 53.6 Cg_endo -69.75 -17.14 37.77 Favored 'Trans proline' 0 N--CA 1.475 0.405 0 C-N-CA 123.099 2.533 . . . . 0.0 114.143 -173.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 27' ' ' ILE . 51.7 mt -63.32 -28.55 70.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.437 ' HA ' HD11 ' A' ' 27' ' ' ILE . 20.8 m-85 -59.62 -48.21 82.54 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.257 -0.177 . . . . 0.0 111.436 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -69.27 -38.97 78.64 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.016 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.414 ' CE ' ' HG3' ' A' ' 55' ' ' GLU . 48.1 mtt -58.7 -59.27 5.68 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.997 0.427 . . . . 0.0 111.277 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 C--N 1.315 -0.9 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.858 -175.689 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.547 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 26.7 p90 . . . . . 0 N--CA 1.436 -1.167 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 9' ' ' VAL . 16.7 tp -115.18 126.68 54.88 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.676 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.75 166.72 11.63 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.1 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.28 127.25 67.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.442 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.451 ' HD3' HG11 ' A' ' 54' ' ' VAL . 54.8 mtpt -135.17 167.4 21.06 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.584 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -73.65 143.01 46.45 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.608 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 50' ' ' ASP . 19.7 ptmt . . . . . 0 C--N 1.315 -0.906 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.117 176.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.798 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 p -96.23 138.7 33.46 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.6 mt -105.31 138.56 41.32 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -82.65 100.97 10.52 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.9 127.68 59.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.048 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -99.85 129.54 45.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.302 -176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.53 30.57 1.15 Allowed Glycine 0 C--O 1.237 0.326 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.227 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.52 -29.36 66.49 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.62 -0.324 . . . . 0.0 112.906 -177.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -59.48 -50.73 72.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 0.0 110.063 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.0 mt -69.23 -47.86 71.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.914 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.4 t -136.35 103.77 9.51 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.959 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.08 -24.58 59.37 Favored 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 122.589 2.193 . . . . 0.0 113.425 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.415 HG23 ' HG3' ' A' ' 18' ' ' ARG . 6.4 t -79.98 -9.14 59.66 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.959 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HG3' HG23 ' A' ' 17' ' ' THR . 51.9 mtt180 -132.72 69.49 79.4 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.052 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.09 -39.33 70.65 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.427 2.085 . . . . 0.0 112.415 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -128.02 135.47 49.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.236 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.35 162.44 36.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.5 m -119.54 124.91 47.57 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.045 0.45 . . . . 0.0 110.631 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 pt -123.76 159.37 28.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.2 tp -105.97 119.15 38.46 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.7 141.51 21.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.621 0.248 . . . . 0.0 111.185 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -95.22 161.99 13.88 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.584 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.6 tt -65.15 -26.11 39.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -85.59 7.82 21.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.685 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -92.72 138.77 31.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.552 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 19.2 m-80 -82.11 172.7 12.9 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -62.64 -28.44 69.91 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.552 ' OD1' ' HB2' ' A' ' 30' ' ' ASN . 8.4 p-10 -64.96 -40.35 94.88 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.069 0.461 . . . . 0.0 110.377 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -69.5 -46.34 66.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.061 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.412 HG21 HD21 ' A' ' 101' ' ' LEU . 96.8 mt -64.96 -44.24 96.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.031 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.4 tp -62.43 -42.56 99.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.15 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.82 -43.31 99.37 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.089 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.69 84.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.838 0.352 . . . . 0.0 111.0 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.447 ' CB ' HD11 ' A' ' 103' ' ' ILE . . . -71.96 -45.83 59.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.386 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 48' ' ' LYS . 27.6 tp -64.52 -33.46 75.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.492 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -36.9 78.96 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.24 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -63.51 -37.9 89.08 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.453 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -83.33 -3.86 57.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.958 0.409 . . . . 0.0 110.686 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.14 29.86 72.07 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.158 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.1 mt -120.54 22.35 11.27 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.556 -0.379 . . . . 0.0 111.264 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.606 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 43.9 tt0 -59.64 -31.7 69.77 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -58.31 -38.69 77.6 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.9 m -93.93 30.43 1.85 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.623 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.606 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 35.3 ttmt -61.34 -31.25 71.12 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -65.41 -14.1 60.15 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.093 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -103.42 5.15 36.87 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.91 0.386 . . . . 0.0 110.982 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.71 149.07 50.38 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.021 0.439 . . . . 0.0 111.973 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 pt -140.31 169.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.892 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.501 ' HB3' HD11 ' A' ' 101' ' ' LEU . 96.1 mt -100.52 139.66 35.89 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.69 0.281 . . . . 0.0 110.482 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.83 131.04 62.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.07 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.534 ' OE1' ' HD2' ' A' ' 74' ' ' ARG . 97.1 mt-10 -94.71 121.36 36.22 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 100' ' ' PHE . 57.5 t . . . . . 0 C--N 1.312 -1.031 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.941 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.789 0 N-CA-C 111.859 -0.497 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.534 ' HD2' ' OE1' ' A' ' 55' ' ' GLU . 6.3 ptp180 -85.49 117.76 69.37 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -62.41 116.16 3.33 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.352 2.035 . . . . 0.0 111.946 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.469 HG21 ' HB3' ' A' ' 82' ' ' PRO . 35.6 mt -121.95 99.1 44.4 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.701 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -66.15 160.46 44.73 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.573 2.182 . . . . 0.0 111.173 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 51.5 Cg_exo -55.13 -32.73 81.18 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.316 2.678 . . . . 0.0 113.7 -176.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.1 p -67.81 -20.65 65.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -67.78 173.43 4.37 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 122.374 1.083 . . . . 0.0 113.189 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.2 m -127.86 68.97 76.11 Favored Pre-proline 0 C--N 1.292 -1.927 0 CA-C-N 113.328 -1.76 . . . . 0.0 106.59 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.469 ' HB3' HG21 ' A' ' 76' ' ' ILE . 18.7 Cg_endo -58.11 -32.1 94.78 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.266 2.644 . . . . 0.0 113.913 -168.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 27' ' ' ILE . 38.6 mt -63.92 -36.61 84.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.931 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -58.56 -30.19 66.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.916 0.389 . . . . 0.0 110.428 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -76.77 -51.07 12.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.695 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 66.4 mtm -62.98 -42.97 99.99 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.312 -1.058 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.422 -179.067 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.464 ' CZ ' ' HB ' ' A' ' 56' ' ' VAL . 31.5 p90 . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 53' ' ' LEU . 49.3 tp -92.38 126.38 37.44 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 120.84 0.352 . . . . 0.0 110.223 -177.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.66 160.31 35.78 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.45 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.447 HD11 ' CB ' ' A' ' 38' ' ' ALA . 66.2 mt -105.87 123.8 60.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -119.78 155.37 32.66 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 121.166 0.507 . . . . 0.0 110.176 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -81.19 108.49 14.88 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.026 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt . . . . . 0 C--N 1.327 -0.405 0 O-C-N 124.429 1.081 . . . . 0.0 111.127 178.904 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 26.9 p -99.58 121.57 41.38 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.4 mt -104.24 135.71 45.2 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.103 0.478 . . . . 0.0 112.056 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.99 101.11 10.1 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.404 HG11 ' CB ' ' A' ' 38' ' ' ALA . 55.4 t -108.01 129.77 61.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.806 -173.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -106.54 103.87 13.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.421 -175.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.0 -33.83 39.87 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.413 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.11 -88.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.793 0 N-CA-C 114.961 0.745 . . . . 0.0 114.961 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -62.06 -37.79 86.33 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.322 0.649 . . . . 0.0 112.368 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.408 HG22 HG23 ' A' ' 15' ' ' VAL . 96.7 mt -62.55 -44.49 99.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.923 -173.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.408 HG23 HG22 ' A' ' 14' ' ' ILE . 54.7 t -145.08 105.11 4.43 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.15 -22.67 53.88 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.192 2.595 . . . . 0.0 113.883 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -86.42 -7.25 58.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.035 0.445 . . . . 0.0 110.892 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -142.24 67.01 20.82 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.94 -32.16 84.66 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.53 2.154 . . . . 0.0 112.259 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.11 139.2 51.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.608 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.64 150.91 25.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.223 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.8 p -102.33 124.28 47.63 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.937 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 6' ' ' SER . 20.9 pt -126.22 160.57 33.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.333 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.69 124.15 50.71 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.71 148.17 25.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.911 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -104.01 156.57 17.75 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.534 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.434 HG13 ' CB ' ' A' ' 83' ' ' LEU . 17.7 tt -65.79 -26.61 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.986 0.422 . . . . 0.0 111.827 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -76.11 -3.54 36.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.093 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -99.18 162.58 12.98 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.929 0.395 . . . . 0.0 110.712 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -92.93 178.45 5.76 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.368 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.622 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -62.34 -21.64 65.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.582 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.415 ' HA ' ' HB3' ' A' ' 78' ' ' PRO . 14.5 t70 -55.77 -46.51 77.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.599 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -69.07 -42.51 76.11 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 120.942 0.401 . . . . 0.0 110.597 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.61 -45.79 97.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.038 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.9 tp -66.38 -43.9 84.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.477 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.458 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -64.83 -46.98 87.98 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.779 -177.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.452 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -61.31 -45.84 92.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.007 0.403 . . . . 0.0 111.115 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.404 ' CB ' HG11 ' A' ' 9' ' ' VAL . . . -65.75 -46.75 77.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.162 0.506 . . . . 0.0 111.251 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 44' ' ' LEU . 28.3 tp -62.67 -36.05 81.65 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.816 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 37.0 tt0 -57.91 -42.42 84.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.536 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.7 mmtt -64.42 -41.64 96.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.376 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.42 -29.97 65.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.908 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.47 7.15 46.29 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.638 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.461 ' HB2' HD11 ' A' ' 39' ' ' LEU . 83.8 mt -98.32 17.14 19.45 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.341 -0.506 . . . . 0.0 111.157 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 16.6 pt-20 -54.95 -24.81 25.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.439 0.696 . . . . 0.0 112.24 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -71.2 -16.78 62.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.93 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.1 m -98.14 -81.97 0.43 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.737 0.303 . . . . 0.0 110.42 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 31.1 ttmt 70.09 -49.03 0.64 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.599 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 26.7 t70 -60.87 -34.12 74.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.192 0.451 . . . . 0.0 110.758 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -66.0 -9.57 31.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.606 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.6 151.07 49.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.054 0.454 . . . . 0.0 111.647 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 pt -138.16 175.43 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.622 HD12 ' HB1' ' A' ' 31' ' ' ALA . 95.0 mt -100.38 143.58 30.4 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.987 0.422 . . . . 0.0 110.553 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.435 HG21 ' CG ' ' A' ' 104' ' ' LYS . 13.2 m -128.17 129.86 69.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.482 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 3.1 tm-20 -86.82 120.83 28.52 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.7 t . . . . . 0 C--N 1.31 -1.124 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.871 -175.53 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.06 0 N-CA-C 112.234 -0.346 . . . . 0.0 112.234 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 17.6 ptp180 -83.07 140.72 42.87 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 9.9 Cg_exo -71.31 117.18 5.02 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.373 2.049 . . . . 0.0 111.866 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.7 mt -120.9 100.87 45.82 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.631 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.68 155.95 67.14 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.022 2.481 . . . . 0.0 112.193 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.605 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 47.3 Cg_exo -54.68 -33.86 81.55 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.414 2.743 . . . . 0.0 113.829 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 t -66.75 -18.06 65.18 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -78.8 153.16 30.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.681 0.277 . . . . 0.0 111.276 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.9 m -111.68 78.58 2.15 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.495 ' O ' ' HG3' ' A' ' 86' ' ' MET . 48.6 Cg_endo -67.31 -29.45 38.49 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.511 2.14 . . . . 0.0 113.599 -174.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.434 ' CB ' HG13 ' A' ' 27' ' ' ILE . 80.6 mt -62.48 -39.15 92.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -53.92 -54.69 35.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.791 0.329 . . . . 0.0 111.485 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -72.08 -40.59 68.16 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.832 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 11.3 mtm -60.77 -45.34 94.72 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 C--N 1.315 -0.905 0 CA-C-O 121.05 0.452 . . . . 0.0 111.723 -178.127 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.1 p90 . . . . . 0 N--CA 1.442 -0.87 0 CA-C-O 121.072 0.463 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 tp -115.81 119.81 37.24 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.693 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.53 178.33 4.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.102 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.7 mt -116.97 129.96 72.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.699 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.435 ' CG ' HG21 ' A' ' 54' ' ' VAL . 27.6 mmmt -130.97 160.98 32.94 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -72.43 142.98 48.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.599 ' HD2' ' O ' ' A' ' 49' ' ' ASP . 21.6 ptmt . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 24' ' ' LEU . . . . . . . . 0 N--CA 1.442 -0.9 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 42.9 m -98.49 121.69 40.75 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.059 0.457 . . . . 0.0 110.355 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.4 mt -105.07 136.55 44.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.038 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -81.38 103.71 11.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.02 128.17 65.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.035 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -92.93 117.96 30.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.201 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.17 28.62 9.06 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.731 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.98 178.44 16.15 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.13 -0.557 . . . . 0.0 111.975 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 72.89 -66.69 0.3 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.6 mt -67.95 -48.11 76.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.765 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.14 85.41 46.45 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.15 -34.1 98.46 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.213 2.608 . . . . 0.0 113.019 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 t -70.09 -19.52 63.25 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.53 81.62 29.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 110.461 -0.199 . . . . 0.0 110.461 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.57 -32.24 87.61 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.625 2.217 . . . . 0.0 113.436 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -131.94 144.74 51.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.19 154.77 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.055 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.9 m -107.78 125.64 51.67 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.465 HG21 ' HB2' ' A' ' 38' ' ' ALA . 26.1 pt -126.72 160.09 35.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.042 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 8.0 mp -111.79 123.51 50.39 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.21 144.03 26.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.8 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.528 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 2.9 mp0 -90.58 152.78 20.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.4 tt -64.53 -26.35 40.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -86.01 6.65 27.8 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.982 0.42 . . . . 0.0 110.898 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.528 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 20.2 mm-40 -88.54 146.35 25.21 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.929 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.44 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 32.8 p-10 -83.86 169.49 15.07 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.236 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.565 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -58.81 -26.61 64.29 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.605 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.18 -42.1 97.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.688 0.28 . . . . 0.0 111.181 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.44 ' HG2' ' OD1' ' A' ' 30' ' ' ASN . 38.3 mmt180 -70.44 -42.92 70.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.94 0.4 . . . . 0.0 110.595 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.48 -45.92 94.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.587 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.95 -44.7 92.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.912 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.443 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -65.82 -39.61 95.19 Favored Glycine 0 C--O 1.209 -1.428 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.761 -178.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -61.41 -47.48 85.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 117.324 0.562 . . . . 0.0 111.532 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.465 ' HB2' HG21 ' A' ' 23' ' ' ILE . . . -68.7 -42.71 77.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.378 0.608 . . . . 0.0 110.521 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 45' ' ' GLU . 32.0 tp -63.26 -35.13 79.32 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.796 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.82 -39.72 86.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.677 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 67.7 mmtt -64.6 -32.82 74.64 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.827 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -87.97 -2.87 58.88 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.289 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.31 23.82 74.92 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.725 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.76 17.57 20.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.524 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 44.4 tt0 -58.55 -23.25 57.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -176.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -78.38 -8.4 58.41 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.001 0.429 . . . . 0.0 111.047 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.3 m -113.79 21.55 14.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.41 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 39.5 ttmt -59.41 -28.74 67.2 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.701 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.37 -9.52 34.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.72 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -102.55 -1.77 29.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.891 0.377 . . . . 0.0 111.183 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -131.2 155.16 47.53 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.528 -0.469 . . . . 0.0 112.097 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 pt -139.95 173.36 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.454 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.565 HD12 ' HB1' ' A' ' 31' ' ' ALA . 97.7 mt -101.38 143.19 31.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.775 0.322 . . . . 0.0 110.687 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.6 m -126.85 128.53 70.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.519 ' HB2' HD11 ' A' ' 76' ' ' ILE . 13.3 tt0 -90.24 123.25 33.88 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.626 -178.057 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.638 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.433 ' O ' HG13 ' A' ' 76' ' ' ILE . 34.7 ttp-105 -81.05 121.31 80.55 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -65.26 115.96 3.61 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.1 1.866 . . . . 0.0 111.3 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 55' ' ' GLU . 29.9 mt -120.95 103.31 43.04 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.232 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.23 160.21 43.32 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.61 2.207 . . . . 0.0 111.363 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.466 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 44.2 Cg_exo -54.97 -28.69 60.7 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.225 2.617 . . . . 0.0 113.174 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.5 m -62.27 -44.22 97.04 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.85 156.85 28.49 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -174.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.1 p -117.04 93.99 43.57 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 122.75 0.42 . . . . 0.0 110.29 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.431 ' O ' ' HG3' ' A' ' 86' ' ' MET . 57.7 Cg_endo -71.9 -18.19 28.21 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.148 2.565 . . . . 0.0 115.386 -175.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 27' ' ' ILE . 83.7 mt -60.79 -35.22 75.91 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -56.76 -45.56 81.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.202 0.525 . . . . 0.0 111.07 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -76.01 -37.22 58.7 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.318 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.467 ' SD ' HD23 ' A' ' 83' ' ' LEU . 95.4 mtp -61.66 -48.8 79.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.31 0.576 . . . . 0.0 111.095 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.8 m . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.541 -177.466 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 p90 . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.472 HD21 HD13 ' A' ' 53' ' ' LEU . 18.1 tp -116.74 124.97 50.94 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.242 -176.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.94 167.87 10.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.448 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 38' ' ' ALA . 68.6 mt -112.39 129.25 68.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.563 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -130.72 157.71 42.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.252 0.549 . . . . 0.0 110.901 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -93.04 134.36 35.25 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.323 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt . . . . . 0 C--N 1.311 -1.106 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.158 -179.667 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.841 0 N-CA-C 112.624 -0.19 . . . . 0.0 112.624 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.9 p -134.12 155.39 50.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.2 mt -107.55 137.29 45.84 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -84.24 108.13 16.94 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.72 133.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.219 -171.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -114.67 124.68 52.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.888 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.02 28.36 2.94 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.369 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.94 -23.9 62.06 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 114.031 0.372 . . . . 0.0 114.031 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.01 -40.74 97.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.426 0.631 . . . . 0.0 109.558 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.7 mt -85.76 -49.71 15.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.641 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.0 t -120.72 95.43 48.97 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.345 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.77 -23.01 48.85 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.882 2.388 . . . . 0.0 113.467 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.3 t -76.85 -17.15 59.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.136 0.493 . . . . 0.0 111.124 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -137.88 76.59 40.02 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.35 -34.06 67.94 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.287 1.991 . . . . 0.0 113.133 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -123.4 141.62 51.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.363 0.601 . . . . 0.0 112.211 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -142.85 157.57 18.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.2 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.6 p -119.46 131.79 55.68 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.235 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 38' ' ' ALA . 41.6 pt -125.54 160.48 31.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.495 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.5 108.74 18.83 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.09 153.12 50.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.943 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -106.92 156.69 18.44 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.526 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.8 tt -65.91 -29.0 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -177.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -84.35 9.82 12.18 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.799 0.333 . . . . 0.0 111.401 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -100.69 148.91 24.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.516 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -80.58 168.78 18.5 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.73 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -59.96 -26.56 66.1 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.247 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.41 -40.46 96.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.839 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -64.79 -44.74 89.01 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.157 0.503 . . . . 0.0 109.768 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 23' ' ' ILE . 96.7 mt -64.53 -45.64 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.642 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.73 -45.89 87.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.745 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.28 -38.29 93.6 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.268 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -59.46 -49.96 75.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.959 0.409 . . . . 0.0 110.999 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 23' ' ' ILE . . . -70.58 -40.37 73.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.19 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.1 tp -61.97 -39.67 92.96 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.639 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.88 -37.78 83.37 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.288 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 69.1 mmtt -63.83 -37.98 89.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.595 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -80.03 -6.08 56.95 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.234 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.23 22.0 74.48 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.79 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -113.7 22.61 13.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.742 0.306 . . . . 0.0 111.114 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -53.15 -40.46 64.29 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.476 0.71 . . . . 0.0 112.393 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -74.75 -11.9 60.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.815 0.34 . . . . 0.0 111.736 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.8 m -110.14 29.83 7.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.345 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -60.96 -32.1 71.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.007 0.432 . . . . 0.0 111.553 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.95 -9.14 13.89 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.755 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.445 ' HA ' ' HD2' ' A' ' 106' ' ' LYS . 18.0 t70 -101.97 -2.64 29.27 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.738 0.304 . . . . 0.0 111.575 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -132.39 154.25 49.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.698 -176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.6 pt -137.96 173.26 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.61 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.7 mt -101.25 142.95 31.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.731 0.301 . . . . 0.0 110.529 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 18.8 m -125.41 132.11 71.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.087 0.47 . . . . 0.0 110.545 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.539 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 1.9 tm-20 -87.54 124.25 33.28 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 C--N 1.317 -0.844 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.302 -178.076 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.511 0 N-CA-C 112.689 -0.164 . . . . 0.0 112.689 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -97.28 121.08 59.71 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -178.311 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.15 115.85 3.38 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.007 2.471 . . . . 0.0 112.513 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 55' ' ' GLU . 33.1 mt -121.16 118.89 29.93 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.404 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.13 158.32 58.22 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.749 2.299 . . . . 0.0 111.473 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 31.7 Cg_exo -59.71 -26.49 82.35 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.984 2.456 . . . . 0.0 112.45 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.5 p -68.33 -31.91 71.66 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -82.57 159.48 22.77 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.85 0.357 . . . . 0.0 111.958 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 39.8 m -118.05 86.81 26.82 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.68 -16.87 33.72 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.756 2.304 . . . . 0.0 114.198 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' A' ' 27' ' ' ILE . 53.4 mt -63.72 -39.09 93.45 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.47 ' HA ' HD11 ' A' ' 27' ' ' ILE . 23.6 m-85 -57.19 -46.12 83.13 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 123.215 0.322 . . . . 0.0 111.634 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -66.05 -43.07 88.55 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.236 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.3 mtm -63.54 -43.44 97.09 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.951 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.31 -1.127 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.564 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.2 p90 . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.492 HD21 HD13 ' A' ' 53' ' ' LEU . 29.5 tp -111.76 121.26 44.62 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.31 174.7 5.91 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.181 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 38' ' ' ALA . 65.0 mt -110.77 129.49 65.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.656 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 17.1 mmmt -127.55 163.73 23.52 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 121.378 0.609 . . . . 0.0 110.199 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -84.03 134.83 34.61 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.296 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.445 ' HD2' ' HA ' ' A' ' 50' ' ' ASP . 22.0 ptmt . . . . . 0 CA--C 1.538 0.519 0 O-C-N 123.632 0.583 . . . . 0.0 112.084 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.297 0 N-CA-C 112.798 -0.121 . . . . 0.0 112.798 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 26.4 p -95.11 134.49 37.77 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.4 mt -110.76 143.65 40.97 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -84.69 104.23 14.48 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.86 129.22 57.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.148 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.429 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 88.2 t80 -96.26 126.32 41.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.31 0.576 . . . . 0.0 111.78 -176.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.26 18.17 4.46 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.38 -23.11 64.19 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.214 -0.493 . . . . 0.0 113.324 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.3 -57.6 9.88 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.8 mt -70.28 -44.8 77.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.071 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.18 96.08 20.34 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.411 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.36 -24.25 50.34 Favored 'Trans proline' 0 CA--C 1.498 -1.298 0 C-N-CA 122.717 2.278 . . . . 0.0 112.342 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.8 m -68.63 -23.24 64.41 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.727 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.41 67.67 80.47 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.95 -55.38 1.67 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 123.257 2.638 . . . . 0.0 114.376 -172.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -117.95 134.99 54.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.763 0.316 . . . . 0.0 110.998 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.24 161.18 35.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.586 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -110.86 128.87 55.94 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.513 HG21 ' HB2' ' A' ' 38' ' ' ALA . 31.1 pt -126.4 163.06 29.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.445 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.5 tp -111.79 112.5 24.21 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.96 148.16 28.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.267 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.69 162.73 16.84 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.855 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.638 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.0 tt -63.49 -24.51 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -175.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -85.1 4.64 33.23 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.88 0.371 . . . . 0.0 110.615 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -101.34 146.25 27.82 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.139 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -81.76 174.02 11.74 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.409 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.601 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -58.79 -27.12 64.72 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.009 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.28 -41.98 97.86 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -64.89 -41.72 95.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.263 0.554 . . . . 0.0 109.959 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.409 HG23 ' CD1' ' A' ' 23' ' ' ILE . 96.6 mt -65.67 -44.42 93.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.217 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.83 -46.71 88.32 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.457 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA2' ' OE1' ' A' ' 45' ' ' GLU . . . -64.28 -40.93 98.34 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.746 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -64.47 -39.27 93.5 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -84.88 -42.23 15.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.886 0.374 . . . . 0.0 111.272 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 27.9 tp -62.92 -35.12 79.01 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.147 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 2.9 tm-20 -59.7 -41.55 91.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.168 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 68.3 mmtt -63.58 -39.69 95.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -79.77 -3.44 47.64 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.984 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.73 28.96 68.15 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.996 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.573 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 82.2 mt -117.79 13.24 14.09 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.141 0.496 . . . . 0.0 110.844 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 48.4 tp10 -60.49 -28.41 68.34 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.917 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -67.8 -12.92 61.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.6 m -94.36 -88.92 0.23 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.3 mttt 63.96 -39.86 0.22 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 124.265 1.026 . . . . 0.0 113.473 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.59 -27.85 68.04 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -89.89 -17.95 27.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.317 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.573 ' CZ ' HD13 ' A' ' 44' ' ' LEU . 73.1 m-85 -125.59 151.64 46.17 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 119.252 -0.979 . . . . 0.0 113.092 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.3 pt -138.42 178.38 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.601 HD12 ' HB1' ' A' ' 31' ' ' ALA . 91.8 mt -107.81 142.55 37.69 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.469 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 m -127.54 133.19 68.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.505 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.62 121.06 29.57 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.361 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.518 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.017 0 N-CA-C 113.887 0.315 . . . . 0.0 113.887 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -125.54 127.99 24.77 Favored Pre-proline 0 N--CA 1.442 -0.854 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.02 119.22 6.3 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.731 2.287 . . . . 0.0 112.826 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.2 mt -122.28 101.84 40.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.397 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 48.7 Cg_exo -62.18 155.77 54.42 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.637 2.225 . . . . 0.0 112.121 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 49.4 Cg_exo -53.91 -33.25 71.19 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.791 2.994 . . . . 0.0 114.067 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.0 m -62.26 -42.9 99.74 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -73.79 154.98 39.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.894 0.378 . . . . 0.0 111.703 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.4 p -106.24 91.5 5.72 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.178 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 44.3 Cg_endo -68.66 -17.91 42.65 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.149 2.566 . . . . 0.0 114.145 -175.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 27' ' ' ILE . 43.2 mt -66.37 -33.74 76.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.885 0.374 . . . . 0.0 110.464 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -60.75 -11.76 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.269 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 6.0 mm-40 -95.94 -56.54 2.62 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.794 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 79.0 mtm -61.88 -48.6 79.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 C--N 1.317 -0.825 0 CA-C-O 120.685 0.278 . . . . 0.0 111.487 -179.186 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 p90 . . . . . 0 N--CA 1.444 -0.734 0 CA-C-O 121.049 0.452 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.0 tp -116.41 129.28 56.15 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.941 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . . . -125.4 171.78 10.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.924 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 38' ' ' ALA . 70.9 mt -100.12 130.43 49.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.103 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -128.31 142.07 51.25 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.258 0.552 . . . . 0.0 110.65 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -81.65 109.97 16.57 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.805 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? . . . . . 0 CA--C 1.544 0.726 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.772 177.713 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.233 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 p -96.25 139.82 31.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.805 0.336 . . . . 0.0 111.086 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.7 mt -109.18 134.52 51.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.776 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -82.66 99.56 9.67 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 91.7 t -100.45 112.31 32.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.871 -176.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 78.0 t80 -82.22 122.83 28.41 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.512 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.62 28.2 4.02 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.66 -33.39 82.13 Favored Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 115.268 -0.466 . . . . 0.0 112.97 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.436 ' OE1' ' HG2' ' A' ' 104' ' ' LYS . 40.4 tt0 -64.06 -42.05 97.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.798 0.333 . . . . 0.0 110.485 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.28 -49.85 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.725 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.9 109.85 9.23 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.899 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.53 -27.47 53.91 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.766 2.311 . . . . 0.0 114.035 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -80.05 -7.26 58.76 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.236 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.71 76.87 28.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.423 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 31.0 Cg_endo -62.68 -32.29 78.83 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.706 2.271 . . . . 0.0 113.294 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -129.81 141.42 50.85 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.4 p -131.27 155.04 41.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.4 m -112.55 124.61 52.92 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.724 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.503 HG21 ' HB2' ' A' ' 38' ' ' ALA . 33.3 pt -125.08 166.62 20.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.35 134.77 52.69 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.956 0.408 . . . . 0.0 110.887 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.45 165.44 30.24 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.71 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 43.8 mt-10 -109.74 -62.16 1.54 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.753 -0.379 . . . . 0.0 109.981 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.638 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.5 tt 168.34 -43.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.305 1.042 . . . . 0.0 112.832 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -75.49 -11.39 60.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.799 0.809 . . . . 0.0 109.852 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.71 ' OE1' ' HB2' ' A' ' 26' ' ' GLU . 8.8 mp0 -56.59 134.85 54.73 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.229 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.484 ' ND2' ' HB3' ' A' ' 32' ' ' ASP . 36.9 p-10 -84.47 159.69 20.7 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.941 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.5 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -59.46 -26.05 64.91 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.733 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.484 ' HB3' ' ND2' ' A' ' 30' ' ' ASN . 13.3 t70 -59.68 -48.27 82.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.421 ' NH1' ' HG3' ' A' ' 29' ' ' GLU . 58.3 ttt180 -70.31 -44.81 67.51 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.134 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.43 -44.86 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.191 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -64.87 -41.35 95.72 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.732 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -60.77 -40.54 98.27 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.528 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.53 -41.25 98.74 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.817 0.342 . . . . 0.0 111.398 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.503 ' HB2' HG21 ' A' ' 23' ' ' ILE . . . -78.48 -45.79 21.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.075 0.464 . . . . 0.0 111.743 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 45' ' ' GLU . 26.1 tp -63.36 -32.02 73.34 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.34 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -56.68 -43.62 80.62 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.168 0.987 . . . . 0.0 110.627 175.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 46.3 mmtm -61.15 -38.54 86.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.772 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -84.69 -7.5 59.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.005 0.431 . . . . 0.0 110.836 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.22 20.5 79.64 Favored Glycine 0 C--O 1.227 -0.29 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.206 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.407 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 83.5 mt -106.52 11.68 30.37 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 122.887 -0.184 . . . . 0.0 111.311 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.6 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 44.8 tt0 -58.55 -29.4 66.34 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.822 0.344 . . . . 0.0 111.756 -178.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -61.06 -26.94 67.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.191 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.3 m -108.76 32.34 4.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.784 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.6 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 33.9 ttmt -60.54 -31.02 70.13 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -176.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -65.02 -9.76 24.4 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.25 0.27 31.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.869 0.366 . . . . 0.0 110.995 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.517 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 89.8 m-85 -129.8 152.27 49.48 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.9 0.381 . . . . 0.0 111.852 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.4 pt -141.16 -180.0 2.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.491 ' HB3' HD11 ' A' ' 101' ' ' LEU . 95.9 mt -103.32 149.8 24.39 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -137.3 154.24 30.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.89 0.376 . . . . 0.0 110.478 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HG3' HD11 ' A' ' 76' ' ' ILE . 30.0 mt-10 -109.04 126.87 53.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 176.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.0 t . . . . . 0 C--N 1.312 -1.059 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 174.309 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.038 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.528 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 5.4 mpt_? -86.52 119.44 71.41 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.08 117.1 4.14 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.431 2.088 . . . . 0.0 112.357 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 74' ' ' ARG . 39.2 mt -120.9 101.29 45.4 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.981 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.5 163.3 38.58 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.787 2.325 . . . . 0.0 111.125 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.5 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 45.1 Cg_exo -56.82 -27.67 72.97 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.874 2.383 . . . . 0.0 112.486 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 t -79.11 -9.88 59.67 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.366 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -91.95 151.45 20.5 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.4 m -121.39 88.1 45.65 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.73 -14.59 24.37 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 123.384 2.723 . . . . 0.0 114.527 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 27' ' ' ILE . 39.6 mt -61.09 -37.83 84.12 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.408 ' HA ' HD11 ' A' ' 27' ' ' ILE . 74.0 m-85 -59.21 -42.43 90.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 110.96 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.63 -40.51 69.69 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.154 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.6 mtp -60.93 -46.82 89.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.385 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.051 -179.304 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.0 p90 . . . . . 0 N--CA 1.438 -1.034 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 53' ' ' LEU . 36.6 tp -104.92 128.09 53.03 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.867 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -127.68 161.72 28.23 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.128 0.49 . . . . 0.0 111.565 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.489 HD11 ' HB1' ' A' ' 38' ' ' ALA . 79.0 mt -104.28 126.68 58.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.345 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 104' ' ' LYS . 24.2 mtpp -134.43 164.39 27.54 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.543 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.517 ' HG2' ' CE1' ' A' ' 51' ' ' PHE . 79.7 mtp180 -82.18 140.45 33.72 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt . . . . . 0 C--N 1.313 -1.003 0 CA-C-O 121.122 0.487 . . . . 0.0 111.959 -179.127 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.2 p -104.18 137.83 41.54 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.799 0.333 . . . . 0.0 110.346 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.5 mt -112.46 138.99 48.42 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.198 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -85.09 101.15 12.2 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.41 HG11 ' CB ' ' A' ' 38' ' ' ALA . 78.7 t -103.76 131.66 51.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.262 -171.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 91.7 t80 -100.42 115.27 29.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.23 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.97 29.04 13.32 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.424 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 10' ' ' TYR . . . -58.46 164.62 8.38 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 65.5 mm-40 72.77 -54.37 0.69 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.126 0.57 . . . . 0.0 110.721 -175.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.6 mt -69.01 -48.59 69.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.488 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.597 HG21 ' CE1' ' A' ' 42' ' ' TYR . 1.7 m -136.48 98.73 10.98 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-O 121.147 0.499 . . . . 0.0 112.144 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.13 -30.06 81.82 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.908 2.405 . . . . 0.0 112.356 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.2 t -66.86 -37.08 83.76 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.072 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -126.93 77.88 74.49 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.558 0.218 . . . . 0.0 110.731 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.557 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 32.8 Cg_endo -64.06 -31.09 65.99 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.5 2.134 . . . . 0.0 112.652 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -129.6 138.71 51.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.109 0.48 . . . . 0.0 112.197 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.55 154.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.402 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.7 p -102.97 121.71 43.1 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.257 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.402 ' CD1' HG21 ' A' ' 9' ' ' VAL . 29.7 pt -120.84 157.33 23.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.0 mt -106.16 121.81 44.92 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.023 0.439 . . . . 0.0 110.317 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.89 158.65 44.15 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.828 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.603 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 70.6 mm-40 -110.18 155.21 22.28 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 84' ' ' PHE . 19.4 tt -65.43 -27.1 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -83.88 7.69 17.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.272 0.558 . . . . 0.0 110.904 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.603 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 65.0 mm-40 -92.68 147.52 22.81 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 32' ' ' ASP . 30.3 p30 -84.51 170.78 13.11 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.608 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -59.5 -26.15 65.05 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.052 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.492 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 17.2 t70 -59.47 -49.54 77.39 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.745 0.307 . . . . 0.0 111.405 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.579 ' HG2' ' OE1' ' A' ' 29' ' ' GLU . 10.4 mpt_? -65.28 -44.9 86.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.94 -45.12 97.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.451 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.97 -43.1 96.8 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.066 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.521 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -62.01 -43.75 98.74 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.621 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.662 ' O ' ' HD3' ' A' ' 41' ' ' LYS . . . -62.9 -49.86 73.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.433 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -66.13 -44.78 83.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.835 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 48' ' ' LYS . 32.2 tp -65.68 -34.6 78.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.184 0.516 . . . . 0.0 109.93 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 36.3 tt0 -61.84 -34.43 75.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.398 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.662 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 4.1 mptp? -60.2 -37.37 80.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.131 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.597 ' CE1' HG21 ' A' ' 15' ' ' VAL . 58.2 m-85 -89.82 -9.13 50.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.121 0.486 . . . . 0.0 110.241 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.49 19.82 79.75 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.733 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.9 mt -100.93 16.55 24.88 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 40.2 tt0 -58.27 -29.11 65.55 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -58.49 -32.89 69.22 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.215 0.531 . . . . 0.0 110.126 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.3 m -95.3 21.86 7.5 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.327 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 38.6 ttmt -60.04 -35.42 75.09 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -174.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 32.9 t70 -61.26 -22.7 65.07 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.774 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.476 ' HA ' ' HD2' ' A' ' 106' ' ' LYS . 26.8 t70 -89.43 -2.46 58.4 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -129.39 153.49 47.84 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.748 -0.595 . . . . 0.0 111.888 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.3 174.65 11.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.522 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.514 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.2 mt -100.83 145.87 28.02 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 29.7 m -130.03 135.03 61.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.059 0.457 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.41 ' HB2' HD11 ' A' ' 76' ' ' ILE . 1.8 tm-20 -87.26 121.06 29.21 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.78 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.5 t . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.325 178.975 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 N-CA-C 112.81 -0.116 . . . . 0.0 112.81 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 5.3 mtm180 -103.2 125.18 35.87 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.79 114.45 2.16 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.124 1.883 . . . . 0.0 111.588 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 55' ' ' GLU . 68.2 mt -119.45 105.18 44.36 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.52 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -64.9 158.4 51.47 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.875 2.383 . . . . 0.0 111.52 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.547 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 52.7 Cg_exo -54.89 -29.99 66.33 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 123.333 2.689 . . . . 0.0 113.588 -177.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.3 t -66.36 -26.2 67.16 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -88.98 147.21 24.42 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 30' ' ' ASN . 36.7 m -111.49 88.36 9.08 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.88 -17.59 32.39 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.861 2.374 . . . . 0.0 113.903 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 27' ' ' ILE . 57.0 mt -61.58 -35.64 78.39 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.519 ' HA ' HD11 ' A' ' 27' ' ' ILE . 18.1 m-85 -56.6 -46.58 80.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.217 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -74.36 -37.49 63.48 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.6 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.7 mtp -61.45 -48.4 81.32 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.064 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 C--N 1.313 -0.983 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.267 -178.25 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.4 p90 . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 54' ' ' VAL . 17.3 tp -121.54 123.5 42.14 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.535 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -118.57 171.16 8.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.814 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 38' ' ' ALA . 60.1 mt -109.22 128.02 65.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.356 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.402 ' HE3' ' HG3' ' A' ' 13' ' ' GLU . 13.2 mmmm -132.8 165.36 24.75 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 120.964 0.411 . . . . 0.0 110.115 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 -78.47 138.73 38.6 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.31 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.476 ' HD2' ' HA ' ' A' ' 50' ' ' ASP . 19.0 ptmt . . . . . 0 CA--C 1.542 0.649 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.082 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.44 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 m -102.4 124.02 47.22 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.5 mt -104.47 140.5 37.86 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.201 0.525 . . . . 0.0 112.288 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -85.78 105.2 16.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.7 t -107.97 128.25 63.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.119 -172.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.523 ' CZ ' ' HA3' ' A' ' 12' ' ' GLY . 93.3 t80 -90.1 109.45 20.5 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.364 0.602 . . . . 0.0 110.935 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.99 20.48 45.43 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.987 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.523 ' HA3' ' CZ ' ' A' ' 10' ' ' TYR . . . -64.49 177.62 9.22 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.149 -0.526 . . . . 0.0 112.007 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 12' ' ' GLY . 36.0 tt0 71.32 -65.55 0.34 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.246 0.618 . . . . 0.0 110.427 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.83 -45.57 83.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.039 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.99 86.81 57.15 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.297 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.55 -27.7 82.21 Favored 'Trans proline' 0 N--CA 1.474 0.339 0 C-N-CA 122.909 2.406 . . . . 0.0 112.989 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.3 t -75.84 -15.12 60.28 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.208 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -138.76 79.36 28.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.06 -31.8 75.85 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.562 2.174 . . . . 0.0 113.51 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.09 144.64 48.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.237 0.542 . . . . 0.0 112.198 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.95 161.63 35.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.294 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.3 p -110.8 130.89 55.45 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.05 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.498 ' CD1' HG23 ' A' ' 34' ' ' ILE . 32.6 pt -128.15 158.82 39.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.1 tp -105.81 113.62 27.28 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.75 140.31 29.89 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.983 0.421 . . . . 0.0 110.988 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.93 153.92 20.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.691 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.7 tt -65.32 -28.01 43.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.022 0.439 . . . . 0.0 111.156 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -79.03 -1.75 37.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.408 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -85.39 147.6 26.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.045 0.45 . . . . 0.0 110.937 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -86.18 170.62 11.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.671 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.614 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -59.79 -28.54 67.52 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.468 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.46 -44.28 97.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -63.45 -44.49 94.35 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.203 0.525 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.529 HG21 HD23 ' A' ' 101' ' ' LEU . 96.9 mt -65.58 -45.39 92.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.588 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 tp -63.49 -43.58 96.83 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.578 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -63.34 -45.48 94.96 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.389 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.33 -48.51 79.52 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.733 0.302 . . . . 0.0 111.481 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.09 86.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.751 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.434 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 28.9 tp -64.51 -37.75 88.62 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.309 0.576 . . . . 0.0 109.919 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.96 -39.24 71.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.1 178.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.9 mmtt -66.98 -15.36 63.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.698 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -108.36 0.45 21.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.784 0.326 . . . . 0.0 111.125 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.53 18.26 76.95 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.198 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 93.6 mt -99.98 14.21 31.32 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.064 0.459 . . . . 0.0 110.237 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -42.51 -40.79 2.75 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.779 1.232 . . . . 0.0 112.976 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -80.71 -5.78 57.52 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.9 m -112.04 22.44 14.83 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.17 0.509 . . . . 0.0 110.532 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.459 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 35.4 ttmt -60.18 -39.03 85.02 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.52 -6.78 11.69 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -174.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -95.24 -10.58 29.93 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.877 0.37 . . . . 0.0 110.797 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.479 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 62.5 m-85 -121.68 162.81 20.08 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' A' ' 106' ' ' LYS . 26.6 pt -145.88 -178.86 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.797 1.239 . . . . 0.0 108.568 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.614 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.9 mt -107.39 155.29 20.18 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.313 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG11 ' HG3' ' A' ' 104' ' ' LYS . 27.5 m -139.29 151.96 23.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 120.682 0.277 . . . . 0.0 110.931 176.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.66 ' OE1' ' HD2' ' A' ' 74' ' ' ARG . 40.1 mt-10 -98.37 123.02 42.26 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.583 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.454 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 15.7 t . . . . . 0 C--N 1.31 -1.124 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.453 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.66 ' HD2' ' OE1' ' A' ' 55' ' ' GLU . 5.4 ptp180 -132.32 129.4 21.56 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.51 116.57 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.006 1.804 . . . . 0.0 112.462 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.428 HG21 ' HG3' ' A' ' 82' ' ' PRO . 55.3 mt -119.39 112.8 35.52 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.16 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.69 159.85 51.92 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.521 2.147 . . . . 0.0 111.546 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 36.5 Cg_exo -58.22 -27.53 80.88 Favored 'Trans proline' 0 N--CA 1.474 0.335 0 C-N-CA 123.001 2.467 . . . . 0.0 112.108 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -67.02 -23.68 65.93 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.392 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -82.19 153.95 25.7 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 63.2 m -124.73 84.77 57.58 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.428 ' HG3' HG21 ' A' ' 76' ' ' ILE . 57.8 Cg_endo -83.19 -9.47 10.5 Favored 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 123.021 2.481 . . . . 0.0 115.64 -173.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' A' ' 27' ' ' ILE . 20.3 mt -63.58 -41.82 98.33 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.495 ' HA ' HD11 ' A' ' 27' ' ' ILE . 60.5 m-85 -60.11 -34.99 74.26 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.038 0.446 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -70.11 -37.71 75.41 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.41 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.451 ' HE2' ' HA ' ' A' ' 83' ' ' LEU . 47.9 mtm -66.11 -43.21 87.84 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--N 1.324 -0.524 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.09 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.454 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 24.7 p90 . . . . . 0 N--CA 1.429 -1.485 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.593 HD21 HD13 ' A' ' 53' ' ' LEU . 26.2 tp -100.94 123.21 44.79 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.09 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.474 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . . . -123.05 171.8 9.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.32 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.6 mt -108.14 128.96 63.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.472 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.457 ' HG3' HG11 ' A' ' 54' ' ' VAL . 26.4 mmmt -132.66 171.43 13.86 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.479 ' HG2' ' CE1' ' A' ' 51' ' ' PHE . 60.7 mtp180 -92.54 140.13 29.87 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.488 ' HB3' HG23 ' A' ' 52' ' ' ILE . 17.6 ptpt . . . . . 0 CA--C 1.558 1.277 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.434 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 37.7 p -101.41 120.24 39.99 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -106.7 144.49 33.28 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.529 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -81.92 112.16 18.77 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.786 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.45 HG21 ' CD1' ' A' ' 23' ' ' ILE . 54.1 t -104.86 127.2 59.54 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.222 -174.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -97.88 121.19 39.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.437 0.636 . . . . 0.0 111.794 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.48 26.22 3.21 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.589 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.5 -30.88 72.81 Favored Glycine 0 C--O 1.222 -0.6 0 CA-C-N 115.312 -0.444 . . . . 0.0 113.44 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -64.43 -43.57 93.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.985 0.421 . . . . 0.0 110.148 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.63 -44.72 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 177.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -134.96 104.93 10.52 Favored Pre-proline 0 C--O 1.237 0.424 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.23 -35.43 95.5 Favored 'Trans proline' 0 CA--C 1.493 -1.539 0 C-N-CA 123.908 3.072 . . . . 0.0 113.195 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -65.59 -21.26 66.57 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.361 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -139.28 74.44 35.45 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.589 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 48.3 Cg_exo -53.93 -48.25 22.73 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.837 2.358 . . . . 0.0 112.379 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -120.16 137.69 54.03 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.063 0.459 . . . . 0.0 110.998 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.56 161.56 40.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.9 p -118.71 123.23 44.37 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 6' ' ' SER . 41.6 pt -124.72 154.72 32.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.173 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.5 mp -99.02 111.42 23.83 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.228 0.537 . . . . 0.0 110.152 177.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.15 130.51 29.05 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.206 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -89.71 158.18 17.66 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.489 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.616 ' HA ' HD12 ' A' ' 83' ' ' LEU . 17.1 tt -63.75 -27.37 42.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -89.47 7.24 37.1 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.997 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.39 144.18 25.77 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -78.82 169.1 18.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.719 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.644 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -59.02 -25.51 63.73 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.844 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.07 -41.04 97.76 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.666 0.27 . . . . 0.0 110.833 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -64.88 -47.17 78.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 0.0 110.284 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.478 HG21 HD23 ' A' ' 101' ' ' LEU . 75.0 mt -64.2 -48.85 83.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.725 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.22 -44.88 90.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.462 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.469 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -65.86 -40.61 95.59 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.63 -0.714 . . . . 0.0 113.644 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.66 -48.31 79.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.313 0.557 . . . . 0.0 111.219 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.474 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -67.59 -41.93 83.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.138 0.494 . . . . 0.0 110.801 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.5 tp -62.95 -37.42 87.0 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.555 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.48 -39.09 92.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.01 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.2 mmtt -61.58 -40.29 94.22 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.988 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.46 -10.09 59.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.376 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.1 34.32 61.63 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.673 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.7 mt -123.13 21.28 9.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.767 0.318 . . . . 0.0 110.253 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.81 -16.66 43.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.288 -176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -90.65 8.53 33.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.792 0.33 . . . . 0.0 111.29 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.9 m -135.96 32.81 2.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.207 0.527 . . . . 0.0 110.133 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 39.9 ttmt -64.18 -37.33 87.07 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -173.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -64.25 -16.82 62.82 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.904 0.383 . . . . 0.0 111.847 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -84.06 -7.13 59.47 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.942 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -130.98 154.6 47.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.266 0.555 . . . . 0.0 111.805 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.2 pt -137.99 173.58 12.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.34 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.704 HD13 HD21 ' A' ' 101' ' ' LEU . 96.1 mt -99.51 135.19 41.29 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.526 ' HB ' ' HA3' ' A' ' 73' ' ' GLY . 23.3 m -128.22 134.48 64.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.204 -178.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.532 ' O ' ' HA2' ' A' ' 73' ' ' GLY . 32.7 mt-10 -86.53 122.48 30.53 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 120.962 0.411 . . . . 0.0 111.975 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.458 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 21.2 t . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.576 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 55' ' ' GLU . . . . . . . . 0 N--CA 1.422 -2.264 0 CA-C-O 120.779 0.1 . . . . 0.0 112.943 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.569 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 1.6 mpt_? -90.22 130.03 43.52 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.86 113.67 2.87 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.17 1.913 . . . . 0.0 112.651 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.0 mt -120.53 103.35 44.08 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.097 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.89 155.26 55.97 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.889 2.393 . . . . 0.0 112.73 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.603 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 33.7 Cg_exo -55.51 -28.22 63.41 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.745 2.964 . . . . 0.0 113.403 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -73.49 -11.69 60.54 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -95.13 156.56 16.27 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.215 -0.303 . . . . 0.0 111.679 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 38.2 m -119.68 82.59 26.73 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 86' ' ' MET . 58.2 Cg_endo -71.21 -16.8 31.6 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.096 2.531 . . . . 0.0 115.115 -174.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.616 HD12 ' HA ' ' A' ' 27' ' ' ILE . 50.9 mt -61.18 -36.9 81.1 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -173.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.542 ' HA ' HD11 ' A' ' 27' ' ' ILE . 53.5 m-85 -58.88 -44.87 91.23 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.481 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.79 -36.16 67.53 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.406 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.474 ' SD ' HD23 ' A' ' 83' ' ' LEU . 92.9 mtp -61.69 -42.23 98.65 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.202 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.365 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.458 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 27.9 p90 . . . . . 0 N--CA 1.425 -1.7 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.704 HD21 HD13 ' A' ' 53' ' ' LEU . 27.3 tp -104.06 123.3 46.99 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.962 -175.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.29 173.14 7.13 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.451 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.474 HD11 ' HB3' ' A' ' 38' ' ' ALA . 74.4 mt -112.41 128.63 68.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.091 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -133.83 160.37 37.82 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 120.951 0.405 . . . . 0.0 110.244 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 105' ' ' ARG . 38.2 ttm180 -78.7 116.76 19.27 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.947 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.976 174.681 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.324 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 14.1 p -95.16 133.16 39.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.6 mt -113.01 140.02 48.17 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.078 0.466 . . . . 0.0 112.153 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -83.34 111.65 19.19 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -113.26 128.48 70.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.042 -172.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -95.78 125.03 40.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.432 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.24 29.48 2.71 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.242 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.88 88.57 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.976 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -78.17 -6.81 55.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.175 0.512 . . . . 0.0 110.556 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.42 HG22 HG23 ' A' ' 15' ' ' VAL . 43.5 mm -96.38 -53.47 8.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.439 ' CG1' HG22 ' A' ' 17' ' ' THR . 95.3 t -139.45 113.52 8.0 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.486 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.83 -25.16 60.59 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.903 2.402 . . . . 0.0 114.413 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.439 HG22 ' CG1' ' A' ' 15' ' ' VAL . 13.8 t -78.3 -13.59 59.79 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.423 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -138.41 79.78 29.32 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.7 -31.77 48.57 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.457 2.104 . . . . 0.0 112.811 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -130.0 138.35 50.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.072 0.463 . . . . 0.0 111.492 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.4 p -136.18 157.61 37.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.689 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.1 m -111.82 126.46 55.1 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.887 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' SER . 34.3 pt -124.32 161.86 26.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.652 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.8 tp -107.68 122.36 46.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.14 148.38 32.51 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.795 0.331 . . . . 0.0 110.567 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.586 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 41.6 mt-10 -101.36 148.17 25.47 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.495 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 18.1 tt -64.35 -30.43 50.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -77.49 -7.23 55.91 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.586 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 65.2 mm-40 -82.84 160.35 22.22 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.023 0.44 . . . . 0.0 110.937 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -89.92 170.05 10.71 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.872 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -62.29 -24.56 67.37 Favored 'General case' 0 C--O 1.21 -1.013 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.168 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' A' ' 78' ' ' PRO . 15.4 t70 -60.62 -47.43 86.27 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 120.71 0.291 . . . . 0.0 111.07 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.563 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 2.0 tpm_? -68.98 -41.61 77.65 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.348 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.09 -45.46 98.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.6 -44.91 92.61 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.924 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.97 -38.27 93.99 Favored Glycine 0 C--O 1.211 -1.297 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.317 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.39 -49.17 78.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.291 0.546 . . . . 0.0 110.829 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.465 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -69.61 -41.93 75.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.942 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 45' ' ' GLU . 25.8 tp -64.11 -35.21 80.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.891 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.31 -35.67 79.77 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.463 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -61.05 -37.9 84.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 110.321 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -88.19 -0.92 57.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.249 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.24 33.55 83.06 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.064 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.4 mt -121.15 12.59 11.09 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.538 ' HA ' HD23 ' A' ' 39' ' ' LEU . 44.5 tt0 -63.07 -24.65 68.01 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.867 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -57.26 -35.16 69.4 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.466 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 49.2 m -78.59 -85.4 0.07 Allowed 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.322 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.491 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 33.6 ttmt 63.1 -35.36 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.883 1.273 . . . . 0.0 113.915 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 47' ' ' SER . 36.3 t70 -64.64 -20.37 66.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.176 0.512 . . . . 0.0 111.373 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.466 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 12.4 p-10 -103.82 12.32 34.65 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.813 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -133.87 149.1 51.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.678 0.275 . . . . 0.0 111.171 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 pt -138.55 170.84 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.515 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.3 mt -100.85 137.23 39.51 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.464 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 17.4 m -123.17 129.96 74.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.221 0.534 . . . . 0.0 110.577 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 3.1 tm-20 -88.0 122.64 31.83 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.275 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.8 t . . . . . 0 C--O 1.224 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.369 -179.033 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.538 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.443 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . 0.5 OUTLIER -93.03 114.55 63.02 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.703 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.2 114.59 3.66 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.44 2.093 . . . . 0.0 111.518 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 74' ' ' ARG . 18.1 mt -120.57 100.84 46.67 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.191 -176.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -59.51 157.29 32.33 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.217 2.611 . . . . 0.0 112.269 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 2.3 Cg_endo -58.28 -25.31 71.9 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.352 2.702 . . . . 0.0 114.4 -175.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.2 t -76.64 -12.6 60.03 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -92.35 155.8 17.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.653 0.263 . . . . 0.0 111.357 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 76.6 m -116.14 86.28 16.87 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.857 0.361 . . . . 0.0 110.248 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.404 ' HB3' HD13 ' A' ' 76' ' ' ILE . 49.5 Cg_endo -69.97 -22.09 31.58 Favored 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 122.912 2.408 . . . . 0.0 114.249 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.495 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 81.1 mt -61.91 -37.95 86.57 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -175.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.45 ' HA ' HD11 ' A' ' 27' ' ' ILE . 23.1 m-85 -55.24 -46.42 76.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.972 0.415 . . . . 0.0 110.845 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -74.91 -42.51 57.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.557 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.6 mtp -59.96 -46.62 88.83 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.013 0.435 . . . . 0.0 111.197 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.8 m . . . . . 0 C--N 1.312 -1.027 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.066 -179.791 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 29.1 p90 . . . . . 0 N--CA 1.442 -0.866 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.3 tp -117.01 125.68 51.74 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -124.95 171.36 10.26 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.825 -175.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 38' ' ' ALA . 71.8 mt -102.56 129.73 53.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.891 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -125.07 148.75 48.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.231 0.539 . . . . 0.0 110.912 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -80.09 102.0 9.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.655 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? . . . . . 0 C--N 1.319 -0.733 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.598 179.489 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.839 0 N-CA-C 112.597 -0.201 . . . . 0.0 112.597 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 p -95.14 160.32 14.61 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.79 0.329 . . . . 0.0 110.515 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.4 mt -110.85 135.41 51.45 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.193 0.521 . . . . 0.0 111.926 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.18 109.72 17.96 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -116.84 129.98 72.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.706 -172.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -103.89 129.88 51.43 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.098 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.22 28.86 2.66 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.054 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.25 -30.33 75.65 Favored Glycine 0 N--CA 1.465 0.591 0 C-N-CA 121.646 -0.311 . . . . 0.0 113.481 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -61.98 -32.81 73.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 109.722 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.8 mt -91.99 -52.97 9.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.768 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.3 t -124.53 102.91 32.31 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.663 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.81 -22.37 43.05 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.076 2.517 . . . . 0.0 113.796 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -78.13 -15.96 58.38 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.941 0.401 . . . . 0.0 111.189 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -139.16 74.34 36.26 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-O 121.013 0.435 . . . . 0.0 109.855 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.05 -40.02 55.14 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.433 2.088 . . . . 0.0 112.936 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -120.55 135.89 54.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.232 0.539 . . . . 0.0 111.548 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.65 163.29 37.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.96 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -122.94 132.34 54.12 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.253 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 38' ' ' ALA . 43.3 pt -125.86 161.26 31.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.864 -177.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.37 113.38 25.98 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.61 142.16 23.52 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 72.4 mm-40 -95.56 169.93 9.7 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.071 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.473 HD11 ' HA ' ' A' ' 84' ' ' PHE . 16.0 tt -62.96 -26.54 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -84.63 1.61 45.34 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.4 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -80.76 143.53 32.84 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.909 0.385 . . . . 0.0 109.974 176.316 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -96.7 173.41 7.33 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.596 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -62.11 -24.14 66.96 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.78 -49.16 76.15 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.955 0.407 . . . . 0.0 110.392 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -76.15 -42.37 46.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.551 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.6 -44.76 99.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.857 0.361 . . . . 0.0 110.615 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.6 tp -65.55 -42.7 91.58 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.32 -46.1 94.91 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.74 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.598 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.14 -50.47 73.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.112 0.456 . . . . 0.0 111.449 -178.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.553 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -69.09 -44.24 72.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.722 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 45' ' ' GLU . 29.0 tp -64.94 -36.96 86.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.76 -177.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.46 -38.57 90.31 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.305 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.598 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.5 mmtt -60.26 -35.51 75.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 110.226 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -85.18 -2.19 57.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.871 0.367 . . . . 0.0 110.369 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.63 20.11 79.78 Favored Glycine 0 C--O 1.237 0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.905 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' C ' ' HG ' ' A' ' 39' ' ' LEU . 88.0 mt -116.36 16.08 15.75 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 44.3 tt0 -56.71 -34.15 67.17 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -70.27 -13.34 62.12 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 122.226 -0.296 . . . . 0.0 111.625 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.4 m -104.24 38.51 1.84 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 99.3 mttt -71.13 -11.52 60.99 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.841 -0.537 . . . . 0.0 111.402 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.558 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 7.4 m-20 -74.2 -7.24 51.98 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.176 0.512 . . . . 0.0 109.844 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -117.83 -13.33 10.12 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.118 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -129.24 147.05 51.04 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.528 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.5 HG23 ' HB3' ' A' ' 106' ' ' LYS . 48.5 pt -137.11 177.7 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.025 177.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.523 HD12 ' HB1' ' A' ' 31' ' ' ALA . 97.0 mt -100.5 138.51 37.47 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.745 0.307 . . . . 0.0 110.414 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 15.8 m -126.78 129.39 71.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.105 176.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.94 118.66 29.67 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.7 t . . . . . 0 C--N 1.314 -0.971 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.664 -179.862 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.482 0 N-CA-C 112.188 -0.365 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 63.7 mtp180 -81.87 123.35 80.23 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.41 114.11 3.7 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 122.412 2.075 . . . . 0.0 111.52 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.7 mt -120.42 99.42 47.99 Favored Pre-proline 0 N--CA 1.434 -1.252 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.487 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -63.65 160.69 35.16 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.849 2.366 . . . . 0.0 111.782 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.601 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 50.6 Cg_exo -51.4 -33.15 45.33 Favored 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 123.863 3.042 . . . . 0.0 114.116 -176.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 m -61.64 -40.72 95.88 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -80.18 154.36 28.02 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 5.3 p -120.19 93.97 48.37 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.139 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.83 -17.66 41.8 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.711 2.274 . . . . 0.0 115.05 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 27' ' ' ILE . 60.0 mt -62.91 -34.45 77.46 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -176.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.473 ' HA ' HD11 ' A' ' 27' ' ' ILE . 21.8 m-85 -57.61 -30.79 65.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.106 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -86.91 -50.48 6.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.117 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.4 mtp -59.08 -71.92 0.11 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.983 -175.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 m . . . . . 0 C--N 1.32 -0.698 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -175.794 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 29.4 p90 . . . . . 0 CA--C 1.51 -0.591 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.403 HD21 HD13 ' A' ' 53' ' ' LEU . 30.6 tp -109.96 125.81 53.26 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.092 -177.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -123.9 169.11 11.92 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.411 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 38' ' ' ALA . 74.0 mt -111.59 130.03 65.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.716 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -127.91 164.57 21.98 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 121.154 0.502 . . . . 0.0 110.309 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -82.12 111.83 18.61 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.558 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.4 ptmt . . . . . 0 C--N 1.323 -0.558 0 O-C-N 123.6 0.562 . . . . 0.0 112.271 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.41 0 CA-C-O 120.935 0.186 . . . . 0.0 113.047 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.3 p -129.5 141.37 51.01 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.6 mt -109.17 142.22 40.27 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.544 ' HE2' ' CE1' ' A' ' 20' ' ' TYR . 87.2 tttt -82.05 108.2 15.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.473 HG11 ' CB ' ' A' ' 38' ' ' ALA . 71.0 t -114.7 131.57 66.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 120.832 0.349 . . . . 0.0 110.563 -173.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -114.71 119.62 37.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.296 0.57 . . . . 0.0 111.868 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.27 19.66 4.55 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.8 -22.61 60.04 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.413 -0.394 . . . . 0.0 113.633 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.01 -35.56 80.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.339 0.59 . . . . 0.0 109.931 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.51 -48.87 13.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.799 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.5 t -119.15 90.93 42.77 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.295 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.13 -30.48 93.28 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.665 2.91 . . . . 0.0 114.079 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -64.96 -23.5 67.24 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.497 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -133.74 79.92 57.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 18.1 Cg_endo -59.76 -48.83 11.58 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.394 2.063 . . . . 0.0 112.773 -178.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.544 ' CE1' ' HE2' ' A' ' 8' ' ' LYS . 86.6 m-85 -118.04 139.52 51.09 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.232 0.539 . . . . 0.0 111.279 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -134.54 161.01 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.879 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.5 p -119.36 130.85 55.55 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.062 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.49 HD11 HG23 ' A' ' 34' ' ' ILE . 40.5 pt -127.49 157.55 39.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.692 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.97 110.38 22.4 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.98 145.91 27.56 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.216 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -108.89 166.12 11.06 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.419 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.561 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 15.2 tt -64.97 -28.75 45.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.659 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -75.23 -4.32 38.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -92.79 145.14 24.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.401 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 32.9 m-20 -83.58 175.38 9.79 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.66 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.543 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -60.23 -25.63 65.79 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.688 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 30' ' ' ASN . 3.5 p-10 -65.15 -37.46 87.48 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.812 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -67.48 -46.9 71.61 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.071 0.462 . . . . 0.0 110.445 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.498 HG21 HD23 ' A' ' 101' ' ' LEU . 96.9 mt -64.8 -45.5 94.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.529 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 53.9 tp -63.43 -46.58 85.69 Favored 'General case' 0 C--O 1.21 -0.992 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.542 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 40' ' ' GLU . . . -66.88 -43.32 91.78 Favored Glycine 0 C--O 1.22 -0.759 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.095 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.01 -38.98 84.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.815 0.341 . . . . 0.0 111.394 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.606 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -84.2 -36.23 22.94 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 35' ' ' LEU . 28.8 tp -62.68 -36.98 84.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.565 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 56.9 mt-10 -58.3 -41.08 83.64 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.576 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 44.7 mmtm -62.61 -38.51 90.47 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.801 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.15 -2.98 58.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.555 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.51 26.78 62.55 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 114.322 0.489 . . . . 0.0 114.322 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 94.0 mt -118.53 15.56 13.74 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 117.251 0.526 . . . . 0.0 110.761 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -60.98 -29.07 69.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.539 -177.048 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -61.37 -33.49 73.74 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.886 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.4 m -83.33 -89.58 0.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.061 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt 67.28 -27.95 0.13 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.68 -20.19 65.93 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -113.18 19.52 17.05 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.753 0.311 . . . . 0.0 111.437 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.472 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 98.8 m-85 -124.9 144.14 50.48 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 122.301 -0.249 . . . . 0.0 110.832 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.472 HG23 ' HB2' ' A' ' 106' ' ' LYS . 43.1 pt -141.62 169.88 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.336 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.529 HD13 HD21 ' A' ' 101' ' ' LEU . 94.4 mt -102.02 146.66 27.58 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.658 0.266 . . . . 0.0 110.328 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.5 135.36 59.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.013 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -91.86 123.92 35.6 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.121 0.486 . . . . 0.0 111.121 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.1 t . . . . . 0 C--N 1.309 -1.177 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.284 -179.74 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.399 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -86.71 130.24 49.64 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 117.536 0.668 . . . . 0.0 109.795 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.44 117.71 5.15 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.364 2.043 . . . . 0.0 112.034 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.4 mt -119.33 103.0 47.69 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.307 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.23 156.76 48.73 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.922 2.415 . . . . 0.0 111.629 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.543 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 27.5 Cg_endo -63.87 -16.18 53.36 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.908 2.405 . . . . 0.0 113.384 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.9 p -83.36 -12.46 56.51 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -91.14 158.05 16.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.515 0.198 . . . . 0.0 110.929 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.7 m -115.52 85.29 13.33 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.91 -26.93 58.86 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.628 2.219 . . . . 0.0 113.695 -175.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.561 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 77.1 mt -62.92 -37.96 89.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.414 ' HA ' HD11 ' A' ' 27' ' ' ILE . 35.2 m-85 -65.66 -14.95 62.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.537 0.208 . . . . 0.0 111.535 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -95.66 -41.65 8.79 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.484 ' SD ' HD23 ' A' ' 83' ' ' LEU . 91.3 mtp -61.73 -46.23 90.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.023 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.453 -177.578 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 25.4 p90 . . . . . 0 N--CA 1.437 -1.118 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.529 HD21 HD13 ' A' ' 53' ' ' LEU . 29.8 tp -103.97 125.45 50.36 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.034 0.445 . . . . 0.0 111.309 -172.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.73 171.15 11.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.254 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 38' ' ' ALA . 80.4 mt -109.22 129.81 63.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.187 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -135.79 168.0 20.12 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.705 175.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.472 ' HG2' ' CE1' ' A' ' 51' ' ' PHE . 66.5 mtp180 -91.71 139.88 30.25 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.251 -178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HB2' HG23 ' A' ' 52' ' ' ILE . 34.6 ttpt . . . . . 0 C--N 1.3 -1.545 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.101 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.117 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.3 m -94.29 138.49 32.22 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.5 mt -105.85 140.47 38.83 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -82.27 102.53 11.23 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.895 174.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.427 HG21 HG12 ' A' ' 23' ' ' ILE . 41.0 t -108.46 120.36 59.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.103 -175.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -105.07 123.18 47.36 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.219 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.39 17.64 6.54 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.79 -22.17 59.42 Favored Glycine 0 N--CA 1.462 0.416 0 C-N-CA 121.695 -0.288 . . . . 0.0 112.686 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -63.34 -35.38 80.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -92.0 -48.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.73 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.24 106.45 33.28 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -63.86 -22.26 68.98 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.598 2.198 . . . . 0.0 111.32 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -78.68 -15.83 58.01 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.62 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -144.38 71.03 16.0 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.935 0.398 . . . . 0.0 110.199 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 45.3 Cg_exo -57.09 -45.53 35.05 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.065 2.51 . . . . 0.0 113.594 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.26 140.87 52.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 22' ' ' SER . 9.7 p -139.29 167.41 20.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.411 ' H ' HG22 ' A' ' 21' ' ' VAL . 37.6 m -132.03 133.4 44.36 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.483 HD11 HG23 ' A' ' 34' ' ' ILE . 33.8 pt -129.38 163.08 35.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.402 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.7 tp -111.18 121.45 45.34 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.47 143.64 26.85 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.117 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.66 161.36 14.94 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.507 HD11 ' HA ' ' A' ' 84' ' ' PHE . 17.4 tt -62.85 -28.0 44.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.798 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -69.34 -24.04 63.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.312 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.69 139.15 58.74 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.525 0.678 . . . . 0.0 111.197 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -89.67 175.53 7.22 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.437 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -61.01 -33.79 73.81 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.217 -178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.08 -50.02 75.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.626 0.25 . . . . 0.0 111.486 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -69.13 -41.05 77.84 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.835 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.483 HG23 HD11 ' A' ' 23' ' ' ILE . 96.8 mt -64.4 -44.04 97.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.606 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.69 -44.0 97.37 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.978 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.7 -41.02 99.12 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.472 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.03 -49.68 75.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.932 0.396 . . . . 0.0 111.449 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.48 -43.86 72.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.661 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 26.7 tp -64.29 -32.73 74.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.326 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.09 -39.96 87.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.813 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -62.4 -36.31 81.92 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -80.73 -12.35 59.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.313 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.58 20.69 76.32 Favored Glycine 0 C--O 1.229 -0.169 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.243 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 85.5 mt -108.52 12.84 25.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.799 0.333 . . . . 0.0 110.615 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -59.26 -24.86 63.58 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.919 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -64.24 -33.29 75.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.002 0.43 . . . . 0.0 110.272 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.406 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 33.2 m -79.23 -89.39 0.05 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.056 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt 68.1 -39.99 0.41 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.613 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 35.2 m-20 -65.58 -19.74 66.04 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 120.728 0.299 . . . . 0.0 111.618 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.507 ' C ' ' HG2' ' A' ' 106' ' ' LYS . 15.2 p-10 -103.79 11.48 35.74 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.82 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -131.91 147.54 52.48 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.708 0.289 . . . . 0.0 110.893 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.3 pt -138.56 170.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.6 mt -100.46 141.8 32.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.749 0.309 . . . . 0.0 110.176 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 28.6 m -125.22 132.71 70.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 120.994 0.426 . . . . 0.0 110.923 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.521 ' HG3' ' HG2' ' A' ' 86' ' ' MET . 1.6 tm-20 -87.58 129.59 35.05 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.487 ' HB ' ' CZ ' ' A' ' 100' ' ' PHE . 16.1 t . . . . . 0 N--CA 1.435 -1.177 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.368 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 113.99 0.356 . . . . 0.0 113.99 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 76' ' ' ILE . 14.2 ttp180 -111.3 112.77 54.55 Favored Pre-proline 0 N--CA 1.437 -1.09 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.62 116.51 3.28 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.024 2.483 . . . . 0.0 113.043 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 74' ' ' ARG . 32.9 mt -121.81 103.71 39.94 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.089 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 46.6 Cg_exo -62.12 155.54 55.53 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.684 2.256 . . . . 0.0 112.106 177.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.441 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 52.2 Cg_exo -54.56 -33.26 77.92 Favored 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.775 2.983 . . . . 0.0 113.939 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 p -66.18 -24.64 66.68 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.3 155.21 19.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.683 0.278 . . . . 0.0 111.7 -177.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 59.0 m -105.8 93.98 8.25 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.465 ' HB3' HD13 ' A' ' 76' ' ' ILE . 50.6 Cg_endo -69.21 -28.39 27.95 Favored 'Trans proline' 0 C--O 1.218 -0.477 0 C-N-CA 122.842 2.362 . . . . 0.0 115.244 -173.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.49 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 86.7 mt -61.88 -38.69 89.26 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -173.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.507 ' HA ' HD11 ' A' ' 27' ' ' ILE . 58.9 m-85 -59.16 -39.51 82.67 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.189 0.519 . . . . 0.0 110.847 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -83.98 -32.92 24.73 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.663 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.521 ' HG2' ' HG3' ' A' ' 55' ' ' GLU . 85.0 mtp -62.76 -40.97 98.91 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.167 0.508 . . . . 0.0 111.692 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.5 p . . . . . 0 C--N 1.3 -1.569 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.962 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.487 ' CZ ' ' HB ' ' A' ' 56' ' ' VAL . 44.3 p90 . . . . . 0 N--CA 1.424 -1.753 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.6 tp -119.54 122.51 41.78 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.987 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.98 167.63 12.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.967 -177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.63 126.03 56.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -120.01 156.83 30.12 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.682 0.753 . . . . 0.0 111.643 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -85.55 112.1 20.63 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.764 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.613 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.6 ptmt . . . . . 0 C--N 1.32 -0.68 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.857 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.452 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.0 p -135.27 151.19 50.34 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.4 mt -122.38 135.65 54.74 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.292 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -87.49 100.57 12.86 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.554 HG11 ' CB ' ' A' ' 38' ' ' ALA . 72.8 t -95.34 122.1 46.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.598 -173.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 82.8 t80 -92.03 120.99 33.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.123 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.47 23.82 4.0 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -61.28 -26.9 66.74 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.279 -0.46 . . . . 0.0 113.375 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.413 ' OE1' ' HG2' ' A' ' 104' ' ' LYS . 44.2 tt0 -64.17 -46.51 83.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.27 -50.1 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.291 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.85 98.14 50.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.131 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.05 -21.77 42.48 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.748 2.298 . . . . 0.0 113.256 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 t -84.78 -6.45 59.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.708 0.29 . . . . 0.0 111.412 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -148.01 80.11 8.89 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.497 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 28.2 Cg_endo -62.87 -48.97 5.8 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.849 2.366 . . . . 0.0 114.111 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -120.21 138.02 53.87 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.017 0.437 . . . . 0.0 111.812 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -127.82 144.27 38.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.793 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 p -96.75 115.73 27.92 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.238 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 34' ' ' ILE . 18.5 pt -117.49 158.34 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.817 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.81 122.83 44.71 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.38 144.79 24.83 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -104.06 158.51 16.38 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.917 0.389 . . . . 0.0 110.425 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 84' ' ' PHE . 14.2 tt -65.24 -26.69 40.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.464 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.47 9.18 11.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.808 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -109.71 146.43 34.9 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.421 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 39.7 m-80 -76.25 174.56 9.99 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.216 0.532 . . . . 0.0 111.236 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.606 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -61.62 -26.48 68.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.843 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.433 ' CB ' ' HB3' ' A' ' 78' ' ' PRO . 1.4 p30 -63.52 -36.92 85.38 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.502 0.192 . . . . 0.0 110.883 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -66.32 -43.81 85.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.099 0.476 . . . . 0.0 110.014 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.494 HG23 HD11 ' A' ' 23' ' ' ILE . 96.7 mt -64.72 -46.16 93.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.322 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.76 -46.71 84.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.197 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -66.19 -43.2 93.57 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.257 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.688 ' O ' ' HD3' ' A' ' 41' ' ' LYS . . . -61.6 -48.81 79.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.867 0.365 . . . . 0.0 111.283 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.554 ' CB ' HG11 ' A' ' 9' ' ' VAL . . . -68.22 -40.68 82.0 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.465 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.83 -36.7 84.76 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.517 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.95 -37.18 78.81 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.387 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.688 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 6.5 mptt -61.43 -37.33 83.12 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.62 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -90.68 -0.13 57.59 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.2 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.84 26.28 71.69 Favored Glycine 0 C--O 1.238 0.365 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.879 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.0 mt -113.81 19.98 16.21 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 122.642 -0.328 . . . . 0.0 111.188 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -52.16 -39.47 60.05 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.343 0.657 . . . . 0.0 111.765 -175.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -72.58 -22.06 61.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.547 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.3 m -93.19 21.22 6.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.836 0.35 . . . . 0.0 111.295 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 32.2 ttmt -59.71 -33.84 72.14 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.893 -176.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.89 -7.8 4.2 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.546 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -106.51 -6.95 17.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -127.76 155.03 44.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -173.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.0 pt -138.66 176.28 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.458 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.606 HD12 ' HB1' ' A' ' 31' ' ' ALA . 98.5 mt -101.51 143.45 31.49 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.727 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.552 HG21 ' HD3' ' A' ' 104' ' ' LYS . 25.7 m -127.9 130.41 69.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.416 177.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.457 ' HB2' HD11 ' A' ' 76' ' ' ILE . 1.7 tt0 -90.27 121.48 32.32 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.6 t . . . . . 0 C--N 1.315 -0.932 0 CA-C-O 121.132 0.492 . . . . 0.0 111.938 -175.514 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.687 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 18.7 ptt85 -83.56 128.65 63.06 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-N 117.375 0.587 . . . . 0.0 109.443 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 24.2 Cg_exo -61.69 119.2 6.21 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.248 1.965 . . . . 0.0 111.921 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.457 HD11 ' HB2' ' A' ' 55' ' ' GLU . 65.6 mt -120.33 100.1 47.72 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.153 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 27.1 Cg_exo -67.12 155.69 69.59 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.734 2.289 . . . . 0.0 111.384 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.433 ' HB3' ' CB ' ' A' ' 32' ' ' ASP . 51.8 Cg_exo -54.66 -32.53 75.78 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 123.489 2.792 . . . . 0.0 113.262 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m -62.69 -41.92 99.37 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.291 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.74 148.91 50.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 5.6 m -104.27 85.96 1.22 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.411 ' O ' ' HG3' ' A' ' 86' ' ' MET . 56.2 Cg_endo -69.46 -24.77 30.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.604 2.203 . . . . 0.0 114.159 -173.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 27' ' ' ILE . 33.3 mt -63.76 -37.89 89.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -175.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.678 ' HA ' HD11 ' A' ' 27' ' ' ILE . 26.7 m-85 -58.21 -46.28 86.16 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.32 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.26 -39.68 82.15 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.005 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 12.1 mtm -64.75 -42.72 94.94 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.788 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 CA--C 1.54 0.57 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.834 -176.867 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.0 p90 . . . . . 0 N--CA 1.438 -1.056 0 CA-C-O 121.118 0.485 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -111.64 127.36 55.73 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.465 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.46 166.18 14.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.209 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.428 HD11 ' HB3' ' A' ' 38' ' ' ALA . 68.3 mt -106.86 122.84 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.636 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.552 ' HD3' HG21 ' A' ' 54' ' ' VAL . 25.3 mtpp -132.31 167.14 20.39 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 177.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -75.11 141.41 43.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.092 176.408 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.216 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.5 m -109.69 146.69 34.44 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.7 mt -114.36 135.09 54.46 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.86 101.48 11.01 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.473 HG21 HG12 ' A' ' 23' ' ' ILE . 61.4 t -102.66 121.13 53.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.228 -171.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.413 ' CE2' ' HG2' ' A' ' 13' ' ' GLU . 69.9 t80 -92.54 104.33 16.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.41 0.624 . . . . 0.0 110.984 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.22 16.61 22.31 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.885 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.67 -23.7 58.92 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.555 -0.355 . . . . 0.0 112.385 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.413 ' HG2' ' CE2' ' A' ' 10' ' ' TYR . 59.7 mm-40 -65.78 -36.02 82.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.119 0.485 . . . . 0.0 110.185 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.7 mm -86.07 -50.31 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.609 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -128.51 105.31 19.23 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.371 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.16 -36.52 96.6 Favored 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 123.647 2.898 . . . . 0.0 112.228 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 m -63.45 -26.97 68.97 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.723 -176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.07 79.02 69.95 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.49 -43.85 47.48 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.593 2.196 . . . . 0.0 112.927 -178.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -128.53 139.73 52.16 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.126 0.489 . . . . 0.0 111.311 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.76 161.35 41.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 p -119.87 130.31 54.8 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.045 0.45 . . . . 0.0 111.265 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.473 HG12 HG21 ' A' ' 9' ' ' VAL . 36.7 pt -130.4 157.34 42.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.427 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.5 mp -105.0 121.91 44.76 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.54 145.8 43.35 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.019 0.438 . . . . 0.0 111.194 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 62.3 mt-10 -97.7 152.11 19.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.114 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.572 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.7 tt -67.11 -29.4 45.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.915 -177.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -93.25 13.32 21.64 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.195 0.521 . . . . 0.0 110.078 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 37.0 tt0 -99.42 137.14 38.34 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -76.85 165.24 24.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.349 0.595 . . . . 0.0 112.479 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.549 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -63.1 -23.19 67.33 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.733 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.8 -45.57 93.27 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.797 0.332 . . . . 0.0 111.015 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -69.89 -42.38 73.5 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.958 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.47 -48.7 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.552 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.2 tp -63.62 -44.52 93.67 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.228 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.11 93.92 Favored Glycine 0 C--O 1.212 -1.265 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.17 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.38 -51.11 70.88 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.256 0.528 . . . . 0.0 111.238 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.445 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -69.24 -39.83 78.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.317 0.579 . . . . 0.0 111.133 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 45' ' ' GLU . 30.5 tp -64.38 -38.24 90.32 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.027 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -65.67 -26.76 67.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.179 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 74.7 mmtt -59.84 -30.37 68.92 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.325 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -101.36 1.68 38.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.244 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.95 27.69 73.69 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.74 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.1 mt -112.81 23.0 13.92 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.418 ' HA ' HD23 ' A' ' 39' ' ' LEU . 13.1 pt-20 -60.34 -30.32 69.46 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -175.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -71.34 -20.17 62.2 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.992 0.425 . . . . 0.0 110.979 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.6 m -90.39 6.73 41.98 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.975 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -56.73 -16.07 5.75 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.368 0.667 . . . . 0.0 112.74 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.34 -34.19 74.87 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.843 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.577 ' OD2' ' HD3' ' A' ' 105' ' ' ARG . 20.6 t0 -107.48 15.94 24.33 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.05 148.83 50.57 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.868 -0.52 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.4 pt -140.17 170.3 15.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.262 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.452 HD12 ' HB1' ' A' ' 31' ' ' ALA . 97.8 mt -101.39 141.59 34.04 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.691 0.281 . . . . 0.0 110.514 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.568 HG21 ' HG3' ' A' ' 104' ' ' LYS . 28.3 m -124.21 129.26 74.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.15 0.5 . . . . 0.0 109.872 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.446 ' HB3' ' HD3' ' A' ' 74' ' ' ARG . 14.8 tt0 -88.17 134.92 33.66 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.9 t . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -175.972 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.685 0 N-CA-C 113.99 0.356 . . . . 0.0 113.99 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.446 ' HD3' ' HB3' ' A' ' 55' ' ' GLU . 5.8 ptm180 -119.76 121.34 29.87 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 15.9 Cg_exo -66.47 118.4 5.5 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.308 2.005 . . . . 0.0 112.094 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.413 HG21 ' HB3' ' A' ' 82' ' ' PRO . 36.5 mt -121.64 102.6 41.75 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.143 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.77 154.02 74.79 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.757 2.305 . . . . 0.0 111.905 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.549 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 4.2 Cg_endo -57.05 -26.84 70.88 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.633 2.888 . . . . 0.0 113.536 -177.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.4 m -62.4 -40.22 95.79 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.06 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -82.02 157.63 24.11 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.063 0.545 . . . . 0.0 112.323 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 66.4 m -109.05 91.89 10.03 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HB3' HG21 ' A' ' 76' ' ' ILE . 47.6 Cg_endo -68.53 -18.91 43.13 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.051 2.501 . . . . 0.0 115.109 -173.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 27' ' ' ILE . 33.9 mt -63.01 -28.78 70.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -173.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.441 ' HA ' HD11 ' A' ' 27' ' ' ILE . 44.1 m-85 -59.01 -44.19 91.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 110.489 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -80.13 -34.28 37.9 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.596 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.562 ' HB2' ' HA ' ' A' ' 83' ' ' LEU . 2.3 tmm? -58.83 -43.0 90.56 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.212 0.605 . . . . 0.0 111.082 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.9 m . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.276 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.7 p90 . . . . . 0 N--CA 1.424 -1.729 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.1 tp -118.16 122.33 42.77 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.063 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.07 165.96 12.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.473 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 38' ' ' ALA . 72.3 mt -107.01 124.84 63.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.8 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.568 ' HG3' HG21 ' A' ' 54' ' ' VAL . 1.4 mmpt? -128.94 152.19 48.84 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.422 0.63 . . . . 0.0 110.537 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.577 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 2.4 tmm_? -79.32 126.36 30.7 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.317 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.213 -179.128 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 N-CA-C 112.188 -0.365 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 p -95.52 137.45 34.56 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.448 HD11 HD21 ' A' ' 83' ' ' LEU . 62.0 mt -112.19 135.16 53.21 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 121.179 0.514 . . . . 0.0 112.029 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -82.67 108.86 16.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' A' ' 23' ' ' ILE . 56.6 t -116.82 130.43 71.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.658 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -108.38 116.89 32.81 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.763 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.17 -33.64 7.16 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 45.89 -90.98 0.01 OUTLIER Glycine 0 C--N 1.338 0.692 0 N-CA-C 115.991 1.156 . . . . 0.0 115.991 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.64 -39.13 91.1 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.5 mt -65.26 -44.77 94.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.174 0.511 . . . . 0.0 111.262 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 42' ' ' TYR . 49.7 t -132.05 88.78 40.01 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.114 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.55 -25.86 81.6 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 123.189 2.593 . . . . 0.0 112.94 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.1 t -79.14 -5.32 53.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.732 0.301 . . . . 0.0 111.468 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -154.29 76.3 5.71 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 121.174 0.512 . . . . 0.0 109.81 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.09 -43.11 61.26 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.031 2.488 . . . . 0.0 113.142 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -118.98 143.77 46.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.14 0.495 . . . . 0.0 112.146 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.98 158.59 39.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.904 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -116.55 124.35 49.65 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.465 ' CD1' HG21 ' A' ' 9' ' ' VAL . 40.6 pt -125.33 161.75 29.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.65 -177.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.0 mp -111.69 125.88 54.44 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.87 148.16 30.55 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.79 0.329 . . . . 0.0 110.897 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . 74.9 mm-40 -94.81 149.89 20.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.492 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 16.8 tt -63.21 -26.63 41.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.719 -0.392 . . . . 0.0 112.041 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -77.36 -7.64 56.39 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.256 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.544 ' OE2' ' HD3' ' A' ' 33' ' ' ARG . 47.3 mt-10 -84.83 140.22 31.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.087 0.47 . . . . 0.0 110.874 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -78.64 173.87 11.99 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.58 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.577 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -61.36 -27.53 68.57 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.923 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -63.24 -38.57 91.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.755 0.312 . . . . 0.0 110.445 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.544 ' HD3' ' OE2' ' A' ' 29' ' ' GLU . 3.2 mmp_? -69.84 -44.3 70.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.075 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.442 HG23 HD11 ' A' ' 23' ' ' ILE . 97.1 mt -64.65 -44.83 96.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.361 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.84 -44.56 95.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.731 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.452 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -66.4 -38.95 93.99 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.999 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.02 -51.06 71.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.829 0.347 . . . . 0.0 111.046 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.472 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -68.04 -40.79 82.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.105 0.478 . . . . 0.0 110.959 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.3 tp -63.13 -39.1 93.7 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.084 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.8 -35.29 77.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.913 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.4 mmtt -61.67 -38.05 86.36 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.836 0.35 . . . . 0.0 110.336 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.506 ' CD1' HG21 ' A' ' 15' ' ' VAL . 79.0 m-85 -85.76 -5.75 59.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.658 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.56 20.27 79.81 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.401 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.0 mt -104.09 23.29 13.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.722 0.296 . . . . 0.0 110.761 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.81 -25.64 20.25 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -78.53 -13.46 59.82 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -177.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.7 m -106.68 22.68 15.5 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 36.5 ttmt -60.47 -32.93 71.87 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.79 -28.9 66.41 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.846 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.75 -6.13 59.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.279 -176.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 69.7 m-85 -127.39 153.81 45.77 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.161 -174.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.0 pt -136.85 172.57 14.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.555 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.609 HD13 HD21 ' A' ' 101' ' ' LEU . 97.0 mt -101.57 139.96 36.51 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.443 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 15.2 m -127.99 128.88 69.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.022 0.439 . . . . 0.0 110.218 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -87.96 124.49 33.76 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.034 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.442 HG22 ' HA3' ' A' ' 73' ' ' GLY . 39.6 t . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.007 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.442 ' HA3' HG22 ' A' ' 56' ' ' VAL . . . . . . . . 0 CA--C 1.5 -0.858 0 N-CA-C 112.603 -0.199 . . . . 0.0 112.603 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 12.3 ttp180 -86.07 119.16 71.54 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -63.75 114.6 2.64 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.748 2.299 . . . . 0.0 112.315 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.2 mt -121.91 99.69 43.94 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.724 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.74 159.21 46.51 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.863 2.375 . . . . 0.0 111.764 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 38.3 Cg_exo -55.8 -32.71 85.69 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.252 2.635 . . . . 0.0 113.532 -176.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.2 p -76.31 -12.58 60.1 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -80.21 155.46 27.36 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.8 m -113.95 83.38 7.67 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.41 -27.58 54.76 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.884 2.389 . . . . 0.0 114.39 -174.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.492 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 82.5 mt -63.96 -39.6 94.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HA ' HD11 ' A' ' 27' ' ' ILE . 31.5 m-85 -56.53 -45.44 81.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.47 -43.77 59.51 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.027 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 31.2 mtm -63.25 -42.27 99.15 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.312 -1.047 0 CA-C-O 120.725 0.298 . . . . 0.0 111.738 -178.399 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.7 p90 . . . . . 0 CA--C 1.503 -0.836 0 CA-C-O 121.058 0.456 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.609 HD21 HD13 ' A' ' 53' ' ' LEU . 25.6 tp -113.64 124.9 53.43 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.101 0.477 . . . . 0.0 110.273 -177.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.04 164.56 13.99 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.807 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.472 HD11 ' HB3' ' A' ' 38' ' ' ALA . 68.6 mt -112.17 129.97 66.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.825 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -131.54 163.44 28.01 Favored 'General case' 0 CA--C 1.478 -1.793 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 1.7 ptm180 -94.6 120.11 34.32 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.275 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt . . . . . 0 C--N 1.31 -1.12 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.705 179.461 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.02 0 CA-C-O 120.796 0.109 . . . . 0.0 112.849 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -128.31 153.49 46.95 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.5 mt -104.83 137.76 42.13 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.55 105.26 17.52 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 173.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -101.06 127.81 53.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.398 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 86.9 t80 -88.64 119.95 29.59 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.009 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.23 29.97 8.33 Favored Glycine 0 C--O 1.244 0.728 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.262 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 13' ' ' GLU . . . -60.28 168.37 8.83 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 66.1 mm-40 74.6 -34.69 0.28 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.113 0.565 . . . . 0.0 111.397 -176.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.437 HG22 HG23 ' A' ' 15' ' ' VAL . 69.0 mt -91.13 -56.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.437 HG23 HG22 ' A' ' 14' ' ' ILE . 56.0 t -130.83 97.74 20.43 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.424 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.65 -23.67 42.33 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.909 2.406 . . . . 0.0 113.489 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.0 t -80.07 -7.95 59.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.246 0.546 . . . . 0.0 110.976 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -139.15 71.3 40.52 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.496 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 23.1 Cg_endo -59.74 -42.9 42.08 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.695 2.263 . . . . 0.0 113.354 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.06 140.36 53.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.174 0.512 . . . . 0.0 111.524 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.3 p -126.75 155.81 37.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.546 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.0 m -102.9 122.56 44.8 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.494 ' CD1' HG23 ' A' ' 34' ' ' ILE . 16.9 pt -119.28 151.98 21.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.125 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.9 mp -100.97 107.17 18.58 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.54 141.66 18.34 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -113.62 173.28 6.49 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.088 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 84' ' ' PHE . 15.1 tt -61.83 -30.12 47.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -172.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -77.32 -6.91 54.97 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.159 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -89.24 147.46 24.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.083 0.468 . . . . 0.0 111.062 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -86.13 178.94 7.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.828 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.745 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -67.92 -15.65 63.71 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.6 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' A' ' 78' ' ' PRO . 1.9 p-10 -62.27 -40.89 97.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.728 0.299 . . . . 0.0 110.416 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -43.7 66.51 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-O 121.231 0.539 . . . . 0.0 109.63 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.573 HG21 HD23 ' A' ' 101' ' ' LEU . 96.7 mt -63.06 -49.96 81.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.452 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.94 -45.1 83.06 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.026 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.43 -43.2 97.08 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.722 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -64.47 -48.58 74.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.95 0.375 . . . . 0.0 111.32 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.73 -48.12 78.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.078 0.466 . . . . 0.0 111.287 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.48 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 28.9 tp -63.31 -34.63 78.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.865 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 38.2 tt0 -60.04 -44.4 94.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.45 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 65.3 mmtt -64.32 -37.39 87.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.549 -177.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -78.41 -6.09 54.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.586 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.91 24.95 57.1 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.962 -0.637 . . . . 0.0 114.201 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.48 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 90.6 mt -120.27 22.85 11.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 117.279 0.539 . . . . 0.0 110.736 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 5.0 tm-20 -59.85 -31.46 69.77 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.231 0.612 . . . . 0.0 111.743 -175.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -78.19 -14.38 59.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -90.59 -82.92 0.27 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.442 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 16.4 ttmt 64.43 -37.78 0.21 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.553 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 4.5 p-10 -70.53 -2.41 14.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.063 0.458 . . . . 0.0 111.257 -177.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.86 -9.78 20.44 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.39 154.22 48.85 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 106' ' ' LYS . 48.1 pt -141.22 -179.86 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 174.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.745 HD12 ' HB1' ' A' ' 31' ' ' ALA . 90.6 mt -103.38 148.67 25.61 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.619 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.43 155.32 31.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.627 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.489 ' HG3' ' CD1' ' A' ' 76' ' ' ILE . 46.3 mt-10 -99.78 123.62 44.22 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 177.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.443 ' HB ' ' CZ ' ' A' ' 100' ' ' PHE . 25.0 t . . . . . 0 C--N 1.316 -0.851 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.168 178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 112.752 -0.139 . . . . 0.0 112.752 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -111.07 139.15 21.51 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.51 120.44 7.39 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.572 2.181 . . . . 0.0 113.266 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.489 ' CD1' ' HG3' ' A' ' 55' ' ' GLU . 33.9 mt -120.87 104.07 42.29 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.345 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 32.1 Cg_exo -65.26 156.34 63.63 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.086 2.524 . . . . 0.0 112.846 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.526 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 32.5 Cg_exo -56.78 -30.55 85.13 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.567 2.844 . . . . 0.0 113.435 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 p -80.62 3.4 22.04 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -97.51 156.52 16.46 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.375 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.1 m -114.25 80.53 5.84 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.02 -20.13 19.66 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.511 2.141 . . . . 0.0 114.614 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 27' ' ' ILE . 47.9 mt -64.03 -38.59 91.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.589 ' HA ' HD11 ' A' ' 27' ' ' ILE . 22.1 m-85 -59.23 -37.21 76.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.054 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -73.39 -41.67 63.07 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.892 0.377 . . . . 0.0 110.814 177.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.6 mtt -61.22 -42.87 99.35 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.412 HG21 HD12 ' A' ' 27' ' ' ILE . 18.5 p . . . . . 0 C--N 1.317 -0.827 0 CA-C-O 120.826 0.346 . . . . 0.0 111.906 -178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.443 ' CZ ' ' HB ' ' A' ' 56' ' ' VAL . 30.4 p90 . . . . . 0 N--CA 1.435 -1.205 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.597 HD21 HD13 ' A' ' 53' ' ' LEU . 22.1 tp -107.6 125.02 50.81 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.01 0.433 . . . . 0.0 110.793 -173.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -129.07 173.31 10.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.877 -177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.3 mt -110.77 127.61 67.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.376 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -128.72 165.76 20.27 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -88.15 128.96 35.44 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.969 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.553 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.5 ptmt . . . . . 0 C--N 1.318 -0.793 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.239 0.532 0 CA-C-O 120.618 0.247 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.3 mtt -139.52 144.11 37.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.824 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -64.11 -43.53 95.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.98 -45.45 2.48 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.781 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.22 2.82 85.34 Favored Glycine 0 C--N 1.319 -0.367 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.496 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 m -131.61 147.72 52.55 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.39 140.14 49.96 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -84.09 105.56 15.05 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.31 129.24 62.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.724 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 92.3 t80 -109.98 119.55 39.67 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.623 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.53 30.36 2.89 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.274 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.15 -30.4 63.97 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 121.806 -0.235 . . . . 0.0 113.578 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -64.64 -26.66 68.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.039 0.447 . . . . 0.0 110.981 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.9 mt -90.56 -50.92 12.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.99 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.63 96.81 20.11 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.829 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.4 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 48.8 Cg_exo -56.83 -34.96 97.83 Favored 'Trans proline' 0 N--CA 1.475 0.432 0 C-N-CA 123.283 2.656 . . . . 0.0 113.655 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.6 t -71.41 -16.44 62.39 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -133.86 69.64 75.31 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.484 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 47.1 Cg_endo -66.99 -33.11 33.34 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.542 2.161 . . . . 0.0 112.735 -176.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -122.03 132.56 54.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.914 0.387 . . . . 0.0 110.738 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.7 p -136.75 156.88 35.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.304 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -112.95 125.09 54.01 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.314 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.402 HD11 HG23 ' A' ' 34' ' ' ILE . 33.9 pt -123.38 159.13 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.566 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.78 133.79 40.91 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.44 134.59 5.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.832 0.349 . . . . 0.0 111.26 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.714 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 6.5 mp0 -92.56 161.12 14.72 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.473 HG13 ' CB ' ' A' ' 83' ' ' LEU . 19.7 tt -66.98 -25.73 35.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -87.86 4.88 42.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.714 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 12.7 pt-20 -97.42 144.4 27.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.785 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -77.16 170.25 16.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.962 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.55 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -60.25 -24.9 65.26 Favored 'General case' 0 C--O 1.198 -1.612 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.647 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.61 -46.64 88.36 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.938 0.399 . . . . 0.0 111.084 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -70.12 -43.7 70.45 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.674 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 23' ' ' ILE . 97.0 mt -63.8 -46.17 95.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.298 0.57 . . . . 0.0 110.494 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.6 tp -65.16 -43.09 92.9 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.727 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.455 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -63.78 -37.08 94.17 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.21 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.97 -51.15 67.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.898 0.38 . . . . 0.0 110.778 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.85 -43.79 87.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.16 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.52 ' CD2' ' HA ' ' A' ' 45' ' ' GLU . 29.5 tp -64.71 -35.57 81.48 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.985 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.19 -36.21 82.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.767 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 63.7 mmtt -62.42 -36.33 82.02 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -84.0 -8.1 59.23 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.565 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.28 30.12 71.71 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.423 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.2 mt -120.48 24.53 10.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.52 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 42.4 tt0 -58.84 -29.7 67.13 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -62.61 -26.78 68.79 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.054 0.455 . . . . 0.0 110.881 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.5 m -100.54 30.53 3.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.903 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.455 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 36.3 ttmt -61.09 -36.75 80.49 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.453 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 30.8 t70 -62.95 -18.52 63.26 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.178 0.513 . . . . 0.0 111.829 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -82.46 -8.62 59.62 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.73 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -132.42 150.43 52.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.256 0.55 . . . . 0.0 111.79 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.677 HG23 ' HB2' ' A' ' 106' ' ' LYS . 25.6 pt -139.97 171.35 13.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.568 HD13 HD21 ' A' ' 101' ' ' LEU . 97.6 mt -100.07 141.79 32.42 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.356 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.49 136.77 55.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -86.59 117.62 25.47 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.639 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.455 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 40.4 t -111.17 125.27 68.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.484 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 48.9 m -85.53 146.22 27.02 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -61.86 -35.84 79.47 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.988 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 22.2 m-20 -92.37 14.52 16.29 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.484 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 93.3 m-20 -70.09 -5.37 26.39 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.821 -0.55 . . . . 0.0 111.637 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.61 -24.53 67.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.703 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 59' ' ' ASP . 17.4 ptm180 -74.44 -42.33 59.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.184 0.516 . . . . 0.0 110.315 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.91 -47.94 70.21 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.567 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -131.22 134.6 46.61 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.528 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.6 ttt -76.05 1.77 14.6 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.665 0.745 . . . . 0.0 109.848 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' ' 70' ' ' GLU . 6.2 t -66.7 -22.81 66.06 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.014 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 63.25 -163.57 0.27 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.573 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.9 mt -84.65 -4.35 58.97 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -64.29 -54.67 29.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.017 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 71' ' ' ILE . 36.5 tt0 -89.55 -11.41 42.88 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.799 0.333 . . . . 0.0 111.075 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 70' ' ' GLU . 95.9 mt 70.77 125.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-O 121.519 0.676 . . . . 0.0 111.652 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -147.44 122.77 10.29 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -166.65 -171.95 33.37 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.423 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ptt85 -82.37 133.81 49.62 Favored Pre-proline 0 N--CA 1.441 -0.891 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.09 121.15 8.71 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.383 2.055 . . . . 0.0 111.888 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.3 mt -121.27 97.9 47.18 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.89 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -63.5 159.51 40.15 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.25 2.633 . . . . 0.0 112.493 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 47.3 Cg_exo -55.13 -29.17 64.62 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.609 2.873 . . . . 0.0 113.659 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.5 p -80.69 -1.42 42.51 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -105.37 142.92 34.3 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.251 -0.18 . . . . 0.0 110.612 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.0 p -106.11 92.42 6.59 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 120.986 0.422 . . . . 0.0 110.104 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.73 -23.05 36.37 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.013 2.475 . . . . 0.0 114.871 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.473 ' CB ' HG13 ' A' ' 27' ' ' ILE . 86.2 mt -62.56 -27.88 69.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.468 ' HA ' HD11 ' A' ' 27' ' ' ILE . 20.0 m-85 -58.03 -48.43 80.09 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.148 0.28 . . . . 0.0 111.299 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.08 -36.44 58.96 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.336 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 96.5 mtp -60.53 -61.58 2.49 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.22 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.0 m -67.39 -24.79 65.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.734 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.64 -61.95 2.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.873 0.368 . . . . 0.0 111.246 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -69.62 -41.37 75.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.136 0.493 . . . . 0.0 109.862 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.636 ' HA ' ' CB ' ' A' ' 97' ' ' PHE . 31.3 p 53.21 24.16 3.54 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.02 171.74 42.49 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 67.91 108.88 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.28 0.632 . . . . 0.0 111.333 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.05 94.97 0.19 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.84 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -176.27 -71.23 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -139.54 68.14 1.37 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -163.13 -170.25 27.74 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.087 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.636 ' CB ' ' HA ' ' A' ' 90' ' ' SER . 12.0 t80 -83.71 -1.78 54.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.303 0.573 . . . . 0.0 110.971 -176.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -81.38 -6.83 59.33 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.609 0.719 . . . . 0.0 109.383 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.9 m -100.59 149.72 23.44 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.455 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 27.5 p90 -111.81 165.56 11.96 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.435 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.568 HD21 HD13 ' A' ' 53' ' ' LEU . 34.4 tp -109.03 121.4 45.06 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.43 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.27 174.47 6.69 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.815 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.44 129.74 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.136 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -122.93 160.26 26.55 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -82.46 116.93 22.13 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.68 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.677 ' HB2' HG23 ' A' ' 52' ' ' ILE . 72.6 tttt -49.82 -55.92 20.53 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.813 176.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 106' ' ' LYS . 90.7 Cg_endo -78.36 153.88 27.79 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 123.0 2.467 . . . . 0.0 110.922 176.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 . . . . . 0 C--N 1.305 -1.35 0 CA-C-O 118.409 -0.805 . . . . 0.0 110.391 -178.583 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 120.994 0.426 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.2 mtp -114.8 176.04 5.23 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 120.957 0.408 . . . . 0.0 110.45 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -86.08 118.7 25.71 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.63 -37.06 93.18 Favored Glycine 0 CA--C 1.517 0.211 0 CA-C-N 116.108 -0.497 . . . . 0.0 114.17 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.33 -48.01 2.15 Favored Glycine 0 C--N 1.319 -0.382 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.37 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 p -95.38 139.17 32.05 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.4 mt -123.45 140.85 52.58 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -84.78 108.57 17.53 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.426 HG21 ' CD1' ' A' ' 23' ' ' ILE . 53.2 t -113.19 131.24 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.506 -171.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 87.2 t80 -88.04 121.19 30.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.543 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.8 31.69 6.89 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.708 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 10' ' ' TYR . . . -53.95 165.13 2.46 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.534 -0.333 . . . . 0.0 113.371 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 71.99 -47.16 0.66 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.129 0.972 . . . . 0.0 110.907 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.478 HG22 HG23 ' A' ' 15' ' ' VAL . 42.8 mm -62.97 -50.01 81.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.18 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.478 HG23 HG22 ' A' ' 14' ' ' ILE . 64.8 t -142.61 111.12 5.79 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.516 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.45 -24.52 49.4 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.838 2.359 . . . . 0.0 113.461 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.0 t -91.31 -0.9 57.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.991 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -145.8 73.45 13.69 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.407 . . . . 0.0 110.429 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.33 -21.79 30.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.726 2.284 . . . . 0.0 112.891 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -130.11 141.97 50.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.79 160.99 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.534 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 p -108.78 133.27 53.07 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.262 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 38' ' ' ALA . 32.0 pt -128.83 162.54 35.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.695 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.3 tp -112.6 123.85 51.23 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.9 154.04 47.14 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.005 0.431 . . . . 0.0 111.16 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.56 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 46.7 mt-10 -110.86 146.18 36.93 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.595 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.7 tt -67.52 -26.82 36.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -87.61 15.41 6.82 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.013 0.435 . . . . 0.0 110.978 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.56 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 70.0 mm-40 -106.5 157.38 17.7 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.839 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -88.89 169.25 11.73 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.257 0.551 . . . . 0.0 111.199 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -62.05 -26.17 68.1 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.089 -177.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.69 -45.08 93.18 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -67.41 -42.73 82.76 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 120.889 0.376 . . . . 0.0 110.487 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.54 -45.2 98.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.222 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.9 tp -63.47 -45.12 92.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.511 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.27 -34.83 89.22 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.301 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.56 -52.41 65.66 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.01 0.405 . . . . 0.0 111.998 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -71.59 -37.53 70.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.205 0.526 . . . . 0.0 110.727 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.81 -38.63 88.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.144 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.33 -37.36 83.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.445 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -62.78 -38.39 90.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.901 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -86.71 -0.97 57.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.844 0.354 . . . . 0.0 110.994 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.15 15.53 80.94 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.919 -0.582 . . . . 0.0 114.305 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.1 mt -105.76 14.53 28.11 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.384 0.592 . . . . 0.0 111.352 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -20.04 63.55 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -66.05 -35.08 79.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -83.41 -81.85 0.16 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.605 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt 65.44 -40.8 0.31 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.603 1.161 . . . . 0.0 113.829 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.44 -11.27 41.35 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -100.12 1.78 42.49 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.224 0.535 . . . . 0.0 110.318 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -132.0 151.94 51.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 111.297 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 pt -139.4 172.88 12.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.61 HD12 ' HB1' ' A' ' 31' ' ' ALA . 95.6 mt -100.71 134.88 43.03 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 12.7 m -123.57 128.55 74.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.305 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 4.8 tm-20 -86.81 120.16 27.81 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.421 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 74.7 t -118.08 131.26 71.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.005 -173.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 p -73.21 156.27 38.73 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.078 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.39 0.65 55.15 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 122.083 0.944 . . . . 0.0 108.751 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -94.54 20.67 8.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.255 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.64 -36.93 77.35 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.108 -175.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -63.57 -29.5 70.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.716 0.293 . . . . 0.0 111.763 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 62' ' ' ARG . 16.4 ptt180 -105.58 1.77 27.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.995 -176.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -114.17 -63.15 1.49 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.678 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 66' ' ' SER . 41.3 p -90.71 -27.12 19.18 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.112 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.9 ttt 67.42 -9.23 0.43 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.053 0.941 . . . . 0.0 111.47 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.446 ' H ' ' C ' ' A' ' 64' ' ' SER . 6.6 t -79.16 -4.65 51.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.948 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 68' ' ' LEU . 12.1 t70 66.88 -162.29 0.23 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.918 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.455 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 87.5 mt -80.37 -4.14 52.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.756 0.312 . . . . 0.0 110.457 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 69' ' ' ARG . 55.2 mtt180 -62.16 -48.87 78.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.38 0.61 . . . . 0.0 110.099 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -86.06 -27.05 24.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.593 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 43.61 95.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.815 1.246 . . . . 0.0 112.839 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -116.56 144.45 44.35 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.421 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.67 -160.36 12.13 Favored Glycine 0 C--N 1.31 -0.876 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.49 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 10.5 ptp180 -96.23 136.11 22.21 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.8 114.36 3.84 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.068 1.845 . . . . 0.0 111.827 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.0 mt -120.79 99.77 46.94 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.072 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.45 158.81 43.32 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.808 2.339 . . . . 0.0 112.086 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.476 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 31.2 Cg_exo -57.29 -23.13 52.75 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.361 2.708 . . . . 0.0 112.512 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.4 p -67.52 -22.42 65.43 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -78.69 176.54 9.41 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 122.352 1.072 . . . . 0.0 113.264 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 85.6 m -137.6 71.8 50.94 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 112.801 -2.0 . . . . 0.0 106.305 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.404 ' O ' ' HG3' ' A' ' 86' ' ' MET . 44.4 Cg_endo -67.02 -18.42 51.78 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.976 2.451 . . . . 0.0 114.323 -170.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 27' ' ' ILE . 44.6 mt -61.95 -41.33 97.85 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -173.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HA ' HD11 ' A' ' 27' ' ' ILE . 41.1 m-85 -60.24 -43.02 96.43 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.696 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.59 -40.63 84.81 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.388 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 96.6 mtp -62.78 -46.95 85.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.622 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.5 p -71.46 -37.41 71.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.73 -41.54 78.85 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -89.76 -54.43 4.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.909 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.627 ' HA ' ' H ' ' A' ' 97' ' ' PHE . 0.4 OUTLIER 49.89 -158.03 0.08 Allowed 'General case' 0 CA--C 1.554 1.13 0 O-C-N 123.524 0.515 . . . . 0.0 110.706 -177.145 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 166.62 -137.56 4.72 Favored Glycine 0 CA--C 1.504 -0.594 0 C-N-CA 119.325 -1.417 . . . . 0.0 113.054 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -109.15 -50.52 2.99 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.59 24.67 0.09 OUTLIER Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 173.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 mp0 -87.5 -95.78 0.09 Allowed 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -130.42 79.55 1.9 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.191 0.519 . . . . 0.0 110.483 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.62 -156.51 10.49 Favored Glycine 0 C--N 1.304 -1.218 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.831 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.627 ' H ' ' HA ' ' A' ' 90' ' ' SER . 23.9 t80 -65.68 -21.04 66.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.294 0.568 . . . . 0.0 110.726 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.11 -9.68 58.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.594 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.5 m -101.3 166.67 10.64 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.359 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.421 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 30.0 p90 -111.7 162.65 14.99 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.586 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.444 HD21 HD13 ' A' ' 53' ' ' LEU . 31.0 tp -114.46 128.79 56.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.525 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . . . -122.89 167.84 13.04 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.82 -176.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 38' ' ' ALA . 84.2 mt -110.07 129.72 64.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.642 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -130.52 161.95 30.34 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.49 0.662 . . . . 0.0 111.028 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -84.07 104.76 14.4 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.486 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -54.61 155.78 7.15 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.512 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -59.89 149.59 82.86 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 122.368 2.045 . . . . 0.0 112.479 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.4 t60 . . . . . 0 C--N 1.299 -1.588 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.614 -177.755 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 120.797 0.332 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 68.8 mtt -109.95 175.28 5.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.152 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -79.28 105.19 10.42 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.38 -7.98 64.74 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.587 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.68 -29.59 11.3 Favored Glycine 0 CA--C 1.507 -0.441 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.612 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 p -95.11 139.96 30.72 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.2 mt -112.87 138.22 50.05 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.089 0.471 . . . . 0.0 111.992 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -82.15 106.24 13.89 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.45 HG11 ' CB ' ' A' ' 38' ' ' ALA . 54.6 t -113.62 129.39 69.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.494 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -103.23 108.35 19.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.649 0.737 . . . . 0.0 112.246 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.82 12.64 9.97 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' A' ' 19' ' ' PRO . . . -61.55 -24.53 64.12 Favored Glycine 0 CA--C 1.5 -0.889 0 CA-C-N 115.286 -0.457 . . . . 0.0 112.921 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.3 -27.51 67.97 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.344 0.592 . . . . 0.0 109.843 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 76.4 mt -94.47 -51.69 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.862 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.31 97.32 47.5 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.196 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.68 -33.85 94.56 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.82 3.013 . . . . 0.0 114.921 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.4 t -65.77 -16.64 63.98 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.672 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -132.22 75.15 75.15 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.236 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HA ' ' HA3' ' A' ' 12' ' ' GLY . 18.1 Cg_endo -59.32 -46.78 19.76 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.445 2.096 . . . . 0.0 112.586 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -122.89 139.11 54.39 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.537 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.23 155.64 39.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -109.15 125.77 52.53 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.24 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' CD1' HG21 ' A' ' 9' ' ' VAL . 39.2 pt -126.28 156.22 36.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.23 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.3 tp -103.24 121.84 43.53 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.86 156.17 43.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.423 . . . . 0.0 111.792 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 43.8 mt-10 -110.6 147.97 33.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.67 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.579 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.5 tt -64.57 -31.38 53.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -89.33 9.34 26.42 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.035 0.445 . . . . 0.0 110.629 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 26' ' ' GLU . 38.2 tt0 -98.44 146.73 25.44 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.625 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.511 ' HA ' ' SG ' ' A' ' 81' ' ' CYS . 20.6 p-10 -83.1 163.24 21.01 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.351 0.596 . . . . 0.0 112.17 -176.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.573 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -67.15 -17.64 64.93 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.424 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.08 -44.52 94.71 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -69.38 -46.44 66.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.632 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.51 -45.27 98.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.705 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.41 -44.46 91.2 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.268 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.446 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -64.25 -39.53 97.14 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.568 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.12 87.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.938 0.399 . . . . 0.0 111.364 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.45 ' CB ' HG11 ' A' ' 9' ' ' VAL . . . -73.56 -44.91 56.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.67 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.6 -34.3 77.51 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.313 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.7 -39.21 87.69 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.867 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -60.73 -38.64 85.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.03 0.443 . . . . 0.0 110.678 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -84.06 -3.34 57.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.46 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.88 24.83 76.06 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.873 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.15 17.43 18.72 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.891 -0.182 . . . . 0.0 111.327 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -57.27 -34.93 69.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.809 0.443 . . . . 0.0 110.84 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -60.66 -39.32 87.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.173 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.0 m -89.12 21.86 3.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.295 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.446 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 33.2 ttmt -59.68 -15.63 20.87 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.071 0.462 . . . . 0.0 111.759 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.32 -35.42 79.02 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.618 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 106' ' ' LYS . 3.9 p-10 -104.25 17.32 24.35 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -176.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -126.68 150.49 48.96 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.0 pt -139.31 176.31 6.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.487 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.428 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.4 mt -101.65 138.69 38.3 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-O 120.548 0.213 . . . . 0.0 110.614 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.451 HG11 ' HD3' ' A' ' 104' ' ' LYS . 27.3 m -124.06 126.78 72.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.123 0.487 . . . . 0.0 110.441 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' CD ' HH21 ' A' ' 74' ' ' ARG . 13.6 tt0 -89.58 126.04 35.46 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.547 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 87.3 t -126.59 138.41 54.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.836 0.35 . . . . 0.0 111.479 -177.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 93' ' ' GLY . 8.0 m -60.32 135.56 57.77 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.39 176.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.2 -13.82 59.88 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.268 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.09 90.0 4.23 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 59.37 -127.17 1.25 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.295 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 62' ' ' ARG . 15.8 p-10 -63.96 -36.23 83.28 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 33.7 ptt180 153.04 -11.63 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 126.473 1.909 . . . . 0.0 107.628 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -119.25 -66.75 1.04 Allowed 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.126 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.6 m -169.72 -56.37 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.429 -175.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.444 ' O ' ' HB2' ' A' ' 66' ' ' SER . 28.0 ttt -140.48 123.86 16.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 65' ' ' MET . 39.0 t 166.67 -31.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.323 1.049 . . . . 0.0 109.178 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.404 ' N ' ' HB3' ' A' ' 61' ' ' ASP . 34.5 t70 64.31 109.41 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.37 -176.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 68' ' ' LEU . 2.2 pt? -62.6 100.52 0.19 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.474 -176.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.731 ' HA ' ' CZ ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -96.29 -57.12 2.41 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.453 173.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.52 77.87 6.4 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.41 HD11 HG21 ' A' ' 56' ' ' VAL . 18.2 tt -55.74 124.97 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.506 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -96.26 -82.8 0.39 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.336 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.472 ' CA ' HG22 ' A' ' 56' ' ' VAL . . . 77.66 173.33 40.03 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.716 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.46 ' O ' HG13 ' A' ' 76' ' ' ILE . 40.1 mtm180 -88.66 117.17 68.05 Favored Pre-proline 0 C--N 1.314 -0.964 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.65 114.02 2.21 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.118 1.878 . . . . 0.0 111.568 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 74' ' ' ARG . 42.3 mt -120.84 113.73 32.9 Favored Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.543 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.79 159.01 54.95 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.548 2.165 . . . . 0.0 111.434 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.573 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 31.8 Cg_exo -58.5 -29.35 88.47 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.786 2.324 . . . . 0.0 111.972 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 m -77.34 -1.49 30.2 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.218 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.18 158.52 15.62 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 122.092 -0.38 . . . . 0.0 110.525 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.511 ' SG ' ' HA ' ' A' ' 30' ' ' ASN . 95.8 m -121.99 85.23 45.56 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.454 ' HB3' HD13 ' A' ' 76' ' ' ILE . 53.6 Cg_endo -69.75 -17.14 37.77 Favored 'Trans proline' 0 N--CA 1.475 0.405 0 C-N-CA 123.099 2.533 . . . . 0.0 114.143 -173.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 27' ' ' ILE . 51.7 mt -63.32 -28.55 70.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.437 ' HA ' HD11 ' A' ' 27' ' ' ILE . 20.8 m-85 -59.62 -48.21 82.54 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.257 -0.177 . . . . 0.0 111.436 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.593 ' HB3' ' NH2' ' A' ' 89' ' ' ARG . 89.7 mt-10 -69.27 -38.97 78.64 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.016 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.414 ' CE ' ' HG3' ' A' ' 55' ' ' GLU . 48.1 mtt -58.7 -59.27 5.68 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.997 0.427 . . . . 0.0 111.277 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.5 m -62.96 -39.02 93.42 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.858 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.87 -35.05 75.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.925 0.393 . . . . 0.0 110.848 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.593 ' NH2' ' HB3' ' A' ' 85' ' ' GLU . 46.3 mtm-85 -101.21 12.37 37.67 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.542 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.479 ' HA ' ' H ' ' A' ' 97' ' ' PHE . 24.4 p -44.03 133.41 5.11 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 116.65 -34.68 4.54 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.299 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.494 ' C ' ' HB3' ' A' ' 98' ' ' ASP . 88.4 m-20 -94.97 132.82 39.4 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.935 0.367 . . . . 0.0 110.051 177.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -81.02 -10.83 84.48 Favored Glycine 0 CA--C 1.5 -0.866 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.612 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.576 ' HG2' ' ND2' ' A' ' 95' ' ' ASN . 39.1 tt0 -61.21 -77.77 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.507 0.323 . . . . 0.0 111.194 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.576 ' ND2' ' HG2' ' A' ' 94' ' ' GLU . 55.2 m-80 -124.61 16.17 8.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.167 0.508 . . . . 0.0 110.126 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -99.62 -171.88 30.52 Favored Glycine 0 C--O 1.212 -1.233 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.498 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.479 ' H ' ' HA ' ' A' ' 90' ' ' SER . 51.5 t80 -75.54 2.19 12.31 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.331 0.586 . . . . 0.0 111.352 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.494 ' HB3' ' C ' ' A' ' 92' ' ' ASN . 13.7 t70 -91.11 6.22 45.83 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 90.5 p -96.39 -179.93 4.8 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.714 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.547 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 26.7 p90 -123.92 158.03 32.91 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 9' ' ' VAL . 16.7 tp -115.18 126.68 54.88 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.676 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.75 166.72 11.63 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.1 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.28 127.25 67.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.442 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.451 ' HD3' HG11 ' A' ' 54' ' ' VAL . 54.8 mtpt -135.17 167.4 21.06 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.584 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -73.65 143.01 46.45 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.608 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 50' ' ' ASP . 19.7 ptmt -61.27 149.89 81.42 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.117 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.11 -41.63 76.8 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.589 2.192 . . . . 0.0 112.755 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 C--O 1.244 0.808 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.014 179.877 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.871 0.367 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.2 mtt -84.57 -179.62 7.18 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.683 0.278 . . . . 0.0 111.297 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.3 t80 74.53 -71.5 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.385 1.074 . . . . 0.0 110.301 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.86 -55.05 3.84 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.243 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.23 -37.81 1.72 Allowed Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 p -96.23 138.7 33.46 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.6 mt -105.31 138.56 41.32 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -82.65 100.97 10.52 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.9 127.68 59.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.048 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -99.85 129.54 45.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.302 -176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.53 30.57 1.15 Allowed Glycine 0 C--O 1.237 0.326 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.227 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.52 -29.36 66.49 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.62 -0.324 . . . . 0.0 112.906 -177.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -59.48 -50.73 72.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 0.0 110.063 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.0 mt -69.23 -47.86 71.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.914 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.4 t -136.35 103.77 9.51 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.959 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.08 -24.58 59.37 Favored 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 122.589 2.193 . . . . 0.0 113.425 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.415 HG23 ' HG3' ' A' ' 18' ' ' ARG . 6.4 t -79.98 -9.14 59.66 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.959 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HG3' HG23 ' A' ' 17' ' ' THR . 51.9 mtt180 -132.72 69.49 79.4 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.052 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.09 -39.33 70.65 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.427 2.085 . . . . 0.0 112.415 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -128.02 135.47 49.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.236 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.35 162.44 36.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.5 m -119.54 124.91 47.57 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.045 0.45 . . . . 0.0 110.631 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 pt -123.76 159.37 28.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.2 tp -105.97 119.15 38.46 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.7 141.51 21.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.621 0.248 . . . . 0.0 111.185 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -95.22 161.99 13.88 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.584 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.6 tt -65.15 -26.11 39.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -85.59 7.82 21.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.685 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -92.72 138.77 31.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.552 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 19.2 m-80 -82.11 172.7 12.9 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -62.64 -28.44 69.91 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.552 ' OD1' ' HB2' ' A' ' 30' ' ' ASN . 8.4 p-10 -64.96 -40.35 94.88 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.069 0.461 . . . . 0.0 110.377 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -69.5 -46.34 66.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.061 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.412 HG21 HD21 ' A' ' 101' ' ' LEU . 96.8 mt -64.96 -44.24 96.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.031 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.4 tp -62.43 -42.56 99.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.15 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.82 -43.31 99.37 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.089 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.69 84.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.838 0.352 . . . . 0.0 111.0 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.447 ' CB ' HD11 ' A' ' 103' ' ' ILE . . . -71.96 -45.83 59.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.386 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 48' ' ' LYS . 27.6 tp -64.52 -33.46 75.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.492 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -36.9 78.96 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.24 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -63.51 -37.9 89.08 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.453 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -83.33 -3.86 57.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.958 0.409 . . . . 0.0 110.686 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.14 29.86 72.07 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.158 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.1 mt -120.54 22.35 11.27 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.556 -0.379 . . . . 0.0 111.264 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.606 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 43.9 tt0 -59.64 -31.7 69.77 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -58.31 -38.69 77.6 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.9 m -93.93 30.43 1.85 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.623 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.606 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 35.3 ttmt -61.34 -31.25 71.12 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -65.41 -14.1 60.15 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.093 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -103.42 5.15 36.87 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.91 0.386 . . . . 0.0 110.982 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.71 149.07 50.38 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.021 0.439 . . . . 0.0 111.973 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 pt -140.31 169.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.892 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.501 ' HB3' HD11 ' A' ' 101' ' ' LEU . 96.1 mt -100.52 139.66 35.89 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.69 0.281 . . . . 0.0 110.482 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.83 131.04 62.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.07 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.534 ' OE1' ' HD2' ' A' ' 74' ' ' ARG . 97.1 mt-10 -94.71 121.36 36.22 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 100' ' ' PHE . 57.5 t -117.48 132.18 68.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.941 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 7.6 t -81.54 143.48 31.98 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -84.26 62.23 7.03 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.538 0.685 . . . . 0.0 109.986 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.745 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 9.1 p-10 -130.24 24.36 5.21 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.345 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.568 ' OD2' ' HA ' ' A' ' 67' ' ' ASP . 4.4 p-10 -62.28 -22.7 66.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.972 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -63.26 -16.91 61.75 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.238 0.542 . . . . 0.0 110.877 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.745 ' HG2' ' O ' ' A' ' 59' ' ' ASP . 4.8 ptm180 -104.69 -31.15 9.5 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.446 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -66.59 -44.58 81.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.396 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.536 ' C ' ' H ' ' A' ' 66' ' ' SER . 53.8 p -154.67 156.34 36.27 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 mmt -86.21 21.81 1.94 Allowed 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 172.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.536 ' H ' ' C ' ' A' ' 64' ' ' SER . 8.1 m -110.7 3.81 19.53 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 113.37 -1.741 . . . . 0.0 111.956 -175.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.568 ' HA ' ' OD2' ' A' ' 60' ' ' ASP . 12.3 t70 65.76 -148.53 0.22 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.18 99.93 2.46 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.035 0.445 . . . . 0.0 109.815 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -94.4 112.52 24.3 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.148 0.499 . . . . 0.0 110.633 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 57.81 23.07 9.23 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.661 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.2 tt 35.24 88.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.813 1.245 . . . . 0.0 113.588 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -104.02 133.84 48.29 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.252 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.22 -164.25 13.45 Favored Glycine 0 CA--C 1.501 -0.789 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.859 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.534 ' HD2' ' OE1' ' A' ' 55' ' ' GLU . 6.3 ptp180 -85.49 117.76 69.37 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -62.41 116.16 3.33 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.352 2.035 . . . . 0.0 111.946 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.469 HG21 ' HB3' ' A' ' 82' ' ' PRO . 35.6 mt -121.95 99.1 44.4 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.701 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -66.15 160.46 44.73 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.573 2.182 . . . . 0.0 111.173 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 51.5 Cg_exo -55.13 -32.73 81.18 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.316 2.678 . . . . 0.0 113.7 -176.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.1 p -67.81 -20.65 65.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -67.78 173.43 4.37 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 122.374 1.083 . . . . 0.0 113.189 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.2 m -127.86 68.97 76.11 Favored Pre-proline 0 C--N 1.292 -1.927 0 CA-C-N 113.328 -1.76 . . . . 0.0 106.59 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.469 ' HB3' HG21 ' A' ' 76' ' ' ILE . 18.7 Cg_endo -58.11 -32.1 94.78 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.266 2.644 . . . . 0.0 113.913 -168.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 27' ' ' ILE . 38.6 mt -63.92 -36.61 84.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.931 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -58.56 -30.19 66.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.916 0.389 . . . . 0.0 110.428 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -76.77 -51.07 12.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.695 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 66.4 mtm -62.98 -42.97 99.99 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 m -65.33 -42.42 92.96 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.422 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.3 -49.79 39.13 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -79.11 -54.94 5.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.45 ' C ' ' HB3' ' A' ' 98' ' ' ASP . 43.5 p 46.68 -171.14 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.432 0.693 . . . . 0.0 112.491 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.45 -122.0 1.29 Allowed Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.643 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -105.31 -170.13 1.7 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.609 0.242 . . . . 0.0 110.601 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.62 -31.63 7.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.623 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 64.08 -28.49 0.09 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 176.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -64.11 -42.23 96.96 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 120.954 0.407 . . . . 0.0 110.853 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.67 130.29 1.53 Allowed Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 43.99 -100.94 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.099 0.56 . . . . 0.0 111.904 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.45 ' HB3' ' C ' ' A' ' 90' ' ' SER . 4.7 p-10 -124.52 -14.83 6.77 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.524 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 69.2 m -151.08 166.26 31.31 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.946 0.403 . . . . 0.0 110.678 -176.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.464 ' CZ ' ' HB ' ' A' ' 56' ' ' VAL . 31.5 p90 -110.17 152.12 26.45 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 53' ' ' LEU . 49.3 tp -92.38 126.38 37.44 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 120.84 0.352 . . . . 0.0 110.223 -177.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.66 160.31 35.78 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.45 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.447 HD11 ' CB ' ' A' ' 38' ' ' ALA . 66.2 mt -105.87 123.8 60.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -119.78 155.37 32.66 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 121.166 0.507 . . . . 0.0 110.176 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -81.19 108.49 14.88 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.026 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -43.39 114.23 1.61 Allowed Pre-proline 0 C--N 1.327 -0.405 0 O-C-N 124.429 1.081 . . . . 0.0 111.127 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.02 -14.68 35.55 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.97 2.447 . . . . 0.0 111.822 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 117.785 -1.103 . . . . 0.0 110.511 179.691 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 120.629 0.252 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 96.0 mmm -101.16 -87.99 0.38 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.7 t80 64.58 -71.65 0.07 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.676 0.791 . . . . 0.0 110.071 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.63 -37.92 2.93 Favored Glycine 0 C--O 1.229 -0.201 0 N-CA-C 114.263 0.465 . . . . 0.0 114.263 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.25 -14.52 61.05 Favored Glycine 0 C--N 1.315 -0.596 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.379 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 26.9 p -99.58 121.57 41.38 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.4 mt -104.24 135.71 45.2 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.103 0.478 . . . . 0.0 112.056 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.99 101.11 10.1 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.404 HG11 ' CB ' ' A' ' 38' ' ' ALA . 55.4 t -108.01 129.77 61.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.806 -173.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.492 ' HE2' ' CD1' ' A' ' 71' ' ' ILE . 84.3 t80 -106.54 103.87 13.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.421 -175.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.0 -33.83 39.87 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.413 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.11 -88.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.793 0 N-CA-C 114.961 0.745 . . . . 0.0 114.961 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -62.06 -37.79 86.33 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.322 0.649 . . . . 0.0 112.368 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.408 HG22 HG23 ' A' ' 15' ' ' VAL . 96.7 mt -62.55 -44.49 99.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.923 -173.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.408 HG23 HG22 ' A' ' 14' ' ' ILE . 54.7 t -145.08 105.11 4.43 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.15 -22.67 53.88 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.192 2.595 . . . . 0.0 113.883 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -86.42 -7.25 58.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.035 0.445 . . . . 0.0 110.892 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -142.24 67.01 20.82 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.94 -32.16 84.66 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.53 2.154 . . . . 0.0 112.259 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.11 139.2 51.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.608 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.64 150.91 25.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.223 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.8 p -102.33 124.28 47.63 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.937 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 6' ' ' SER . 20.9 pt -126.22 160.57 33.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.333 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.69 124.15 50.71 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.71 148.17 25.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.911 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -104.01 156.57 17.75 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.534 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.434 HG13 ' CB ' ' A' ' 83' ' ' LEU . 17.7 tt -65.79 -26.61 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.986 0.422 . . . . 0.0 111.827 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -76.11 -3.54 36.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.093 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -99.18 162.58 12.98 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.929 0.395 . . . . 0.0 110.712 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -92.93 178.45 5.76 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.368 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.622 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -62.34 -21.64 65.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.582 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.415 ' HA ' ' HB3' ' A' ' 78' ' ' PRO . 14.5 t70 -55.77 -46.51 77.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.599 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -69.07 -42.51 76.11 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 120.942 0.401 . . . . 0.0 110.597 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.61 -45.79 97.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.038 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.9 tp -66.38 -43.9 84.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.477 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.458 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -64.83 -46.98 87.98 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.779 -177.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.452 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -61.31 -45.84 92.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.007 0.403 . . . . 0.0 111.115 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.404 ' CB ' HG11 ' A' ' 9' ' ' VAL . . . -65.75 -46.75 77.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.162 0.506 . . . . 0.0 111.251 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 44' ' ' LEU . 28.3 tp -62.67 -36.05 81.65 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.816 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 37.0 tt0 -57.91 -42.42 84.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.536 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.7 mmtt -64.42 -41.64 96.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.376 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.42 -29.97 65.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.908 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.47 7.15 46.29 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.638 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.461 ' HB2' HD11 ' A' ' 39' ' ' LEU . 83.8 mt -98.32 17.14 19.45 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.341 -0.506 . . . . 0.0 111.157 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 16.6 pt-20 -54.95 -24.81 25.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.439 0.696 . . . . 0.0 112.24 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -71.2 -16.78 62.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.93 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.1 m -98.14 -81.97 0.43 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.737 0.303 . . . . 0.0 110.42 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 31.1 ttmt 70.09 -49.03 0.64 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.599 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 26.7 t70 -60.87 -34.12 74.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.192 0.451 . . . . 0.0 110.758 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -66.0 -9.57 31.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.606 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.6 151.07 49.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.054 0.454 . . . . 0.0 111.647 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 pt -138.16 175.43 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.622 HD12 ' HB1' ' A' ' 31' ' ' ALA . 95.0 mt -100.38 143.58 30.4 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.987 0.422 . . . . 0.0 110.553 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.435 HG21 ' CG ' ' A' ' 104' ' ' LYS . 13.2 m -128.17 129.86 69.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.482 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 3.1 tm-20 -86.82 120.83 28.52 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.601 HG21 HG23 ' A' ' 71' ' ' ILE . 80.7 t -125.18 136.28 61.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.871 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.586 ' CB ' ' HB3' ' A' ' 94' ' ' GLU . 40.1 t -60.67 135.85 57.89 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.203 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -91.36 -2.17 57.41 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -73.15 -41.95 63.36 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.387 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -161.51 -43.2 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.981 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.512 ' C ' ' HB3' ' A' ' 57' ' ' SER . 15.9 t70 166.35 -45.8 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 11.4 ptp180 136.22 22.52 0.0 OUTLIER 'General case' 0 C--N 1.364 1.234 0 C-N-CA 127.157 2.183 . . . . 0.0 110.103 176.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' NZ ' ' HB3' ' A' ' 72' ' ' ASP . 57.8 mttp -135.62 -64.13 0.64 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.057 0.456 . . . . 0.0 111.813 -173.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.2 t -155.74 169.8 23.52 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 59.3 ttp -77.06 67.32 3.03 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.442 0.639 . . . . 0.0 111.858 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.1 t -100.87 -17.45 16.84 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 173.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 58.78 75.23 0.4 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.591 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.8 mt 58.5 87.77 0.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.702 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -96.72 -76.72 0.5 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.641 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -104.33 1.29 30.14 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.886 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.601 HG23 HG21 ' A' ' 56' ' ' VAL . 38.7 mt 63.74 97.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.436 0.694 . . . . 0.0 110.595 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.433 ' HB3' ' NZ ' ' A' ' 63' ' ' LYS . 35.0 t70 -123.5 104.5 9.1 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.993 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.95 -172.11 13.08 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.234 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 17.6 ptp180 -83.07 140.72 42.87 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 9.9 Cg_exo -71.31 117.18 5.02 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.373 2.049 . . . . 0.0 111.866 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.7 mt -120.9 100.87 45.82 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.631 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.68 155.95 67.14 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.022 2.481 . . . . 0.0 112.193 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.605 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 47.3 Cg_exo -54.68 -33.86 81.55 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.414 2.743 . . . . 0.0 113.829 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 t -66.75 -18.06 65.18 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -78.8 153.16 30.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.681 0.277 . . . . 0.0 111.276 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.9 m -111.68 78.58 2.15 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.495 ' O ' ' HG3' ' A' ' 86' ' ' MET . 48.6 Cg_endo -67.31 -29.45 38.49 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.511 2.14 . . . . 0.0 113.599 -174.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.434 ' CB ' HG13 ' A' ' 27' ' ' ILE . 80.6 mt -62.48 -39.15 92.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -53.92 -54.69 35.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.791 0.329 . . . . 0.0 111.485 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -72.08 -40.59 68.16 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.832 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 11.3 mtm -60.77 -45.34 94.72 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 m -66.5 -49.45 66.51 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.05 0.452 . . . . 0.0 111.723 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.45 -39.06 71.21 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -89.11 9.05 26.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.43 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.0 t -45.39 120.55 2.55 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.297 0.57 . . . . 0.0 112.049 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.425 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . -98.86 -121.77 4.56 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.621 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -138.93 11.53 2.64 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.64 -36.27 0.16 Allowed Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.085 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.586 ' HB3' ' CB ' ' A' ' 57' ' ' SER . 0.8 OUTLIER -150.77 98.62 2.63 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.219 0.533 . . . . 0.0 111.371 178.33 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -176.29 -30.5 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.658 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.99 -110.07 0.25 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.134 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -73.72 -19.53 60.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.276 0.56 . . . . 0.0 110.946 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' A' ' 91' ' ' GLY . 8.0 p-10 -69.45 -24.23 63.78 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.228 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.455 ' HB3' ' HA ' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -102.05 178.66 4.55 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.988 176.512 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -118.99 165.63 13.86 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.518 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 tp -115.81 119.81 37.24 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.693 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.53 178.33 4.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.102 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.7 mt -116.97 129.96 72.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.699 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.464 ' HD3' ' HB ' ' A' ' 71' ' ' ILE . 27.6 mmmt -130.97 160.98 32.94 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -72.43 142.98 48.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.599 ' HD2' ' O ' ' A' ' 49' ' ' ASP . 21.6 ptmt -55.22 144.03 52.41 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.86 -45.27 33.81 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.47 2.78 . . . . 0.0 113.458 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.457 ' O ' ' HE2' ' A' ' 106' ' ' LYS . 72.2 m80 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.659 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.0 p . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.2 mtp 59.68 73.9 0.46 Allowed 'General case' 0 C--N 1.343 0.291 0 O-C-N 123.405 0.441 . . . . 0.0 110.883 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.413 ' CZ ' HD13 ' A' ' 83' ' ' LEU . 62.5 t80 68.89 -69.61 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.506 0.723 . . . . 0.0 110.838 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 116.89 -78.42 0.29 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 24' ' ' LEU . . . 137.46 -30.3 2.62 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 42.9 m -98.49 121.69 40.75 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.059 0.457 . . . . 0.0 110.355 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.4 mt -105.07 136.55 44.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.038 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -81.38 103.71 11.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.02 128.17 65.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.035 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -92.93 117.96 30.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.201 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.17 28.62 9.06 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.731 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.98 178.44 16.15 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.13 -0.557 . . . . 0.0 111.975 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 72.89 -66.69 0.3 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.6 mt -67.95 -48.11 76.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.765 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.14 85.41 46.45 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.15 -34.1 98.46 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.213 2.608 . . . . 0.0 113.019 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 t -70.09 -19.52 63.25 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.53 81.62 29.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 110.461 -0.199 . . . . 0.0 110.461 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.57 -32.24 87.61 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.625 2.217 . . . . 0.0 113.436 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -131.94 144.74 51.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.19 154.77 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.055 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.9 m -107.78 125.64 51.67 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.465 HG21 ' HB2' ' A' ' 38' ' ' ALA . 26.1 pt -126.72 160.09 35.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.042 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 8.0 mp -111.79 123.51 50.39 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.21 144.03 26.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.8 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.528 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 2.9 mp0 -90.58 152.78 20.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.4 tt -64.53 -26.35 40.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -86.01 6.65 27.8 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.982 0.42 . . . . 0.0 110.898 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.528 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 20.2 mm-40 -88.54 146.35 25.21 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.929 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.44 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 32.8 p-10 -83.86 169.49 15.07 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.236 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.565 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -58.81 -26.61 64.29 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.605 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.18 -42.1 97.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.688 0.28 . . . . 0.0 111.181 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.44 ' HG2' ' OD1' ' A' ' 30' ' ' ASN . 38.3 mmt180 -70.44 -42.92 70.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.94 0.4 . . . . 0.0 110.595 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.48 -45.92 94.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.587 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.95 -44.7 92.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.912 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.443 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -65.82 -39.61 95.19 Favored Glycine 0 C--O 1.209 -1.428 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.761 -178.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -61.41 -47.48 85.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 117.324 0.562 . . . . 0.0 111.532 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.465 ' HB2' HG21 ' A' ' 23' ' ' ILE . . . -68.7 -42.71 77.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.378 0.608 . . . . 0.0 110.521 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 45' ' ' GLU . 32.0 tp -63.26 -35.13 79.32 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.796 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.82 -39.72 86.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.677 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 67.7 mmtt -64.6 -32.82 74.64 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.827 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -87.97 -2.87 58.88 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.289 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.31 23.82 74.92 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.725 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.76 17.57 20.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.524 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 44.4 tt0 -58.55 -23.25 57.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -176.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -78.38 -8.4 58.41 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.001 0.429 . . . . 0.0 111.047 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.3 m -113.79 21.55 14.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.41 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 39.5 ttmt -59.41 -28.74 67.2 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.701 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.37 -9.52 34.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.72 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -102.55 -1.77 29.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.891 0.377 . . . . 0.0 111.183 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -131.2 155.16 47.53 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.528 -0.469 . . . . 0.0 112.097 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 pt -139.95 173.36 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.454 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.565 HD12 ' HB1' ' A' ' 31' ' ' ALA . 97.7 mt -101.38 143.19 31.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.775 0.322 . . . . 0.0 110.687 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.6 m -126.85 128.53 70.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.519 ' HB2' HD11 ' A' ' 76' ' ' ILE . 13.3 tt0 -90.24 123.25 33.88 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.1 t -128.86 130.67 68.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.626 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 15.4 m -72.69 150.35 43.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.817 0.342 . . . . 0.0 110.434 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -75.96 66.7 2.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.06 0.457 . . . . 0.0 110.986 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -144.92 -20.79 0.5 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.727 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 64' ' ' SER . 7.9 m-20 -62.64 -38.16 89.19 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.476 -178.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -64.77 -37.05 86.28 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -71.02 -53.79 13.52 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.453 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -69.34 -44.68 71.16 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.191 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 60' ' ' ASP . 14.9 t -72.34 -32.48 66.54 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.878 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 60.6 ttp 68.12 1.34 2.76 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.091 0.956 . . . . 0.0 111.104 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.485 ' OG ' ' HB2' ' A' ' 69' ' ' ARG . 6.9 t -93.29 3.9 54.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.801 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 59.1 53.45 5.49 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.058 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.9 mt 61.92 67.88 0.72 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.357 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.485 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 50.5 ttp180 -78.37 -50.55 11.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.723 0.773 . . . . 0.0 109.07 176.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.77 127.7 53.79 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.2 tt -125.29 136.12 61.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 120.278 -0.569 . . . . 0.0 112.147 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -167.5 116.79 0.81 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.003 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.82 -143.46 6.58 Favored Glycine 0 C--N 1.312 -0.771 0 C-N-CA 120.713 -0.755 . . . . 0.0 111.884 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' O ' HG13 ' A' ' 76' ' ' ILE . 34.7 ttp-105 -81.05 121.31 80.55 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -65.26 115.96 3.61 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.1 1.866 . . . . 0.0 111.3 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 55' ' ' GLU . 29.9 mt -120.95 103.31 43.04 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.232 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.23 160.21 43.32 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.61 2.207 . . . . 0.0 111.363 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.466 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 44.2 Cg_exo -54.97 -28.69 60.7 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.225 2.617 . . . . 0.0 113.174 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.5 m -62.27 -44.22 97.04 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.85 156.85 28.49 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -174.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.1 p -117.04 93.99 43.57 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 122.75 0.42 . . . . 0.0 110.29 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.431 ' O ' ' HG3' ' A' ' 86' ' ' MET . 57.7 Cg_endo -71.9 -18.19 28.21 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.148 2.565 . . . . 0.0 115.386 -175.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 27' ' ' ILE . 83.7 mt -60.79 -35.22 75.91 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -56.76 -45.56 81.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.202 0.525 . . . . 0.0 111.07 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -76.01 -37.22 58.7 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.318 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.467 ' SD ' HD23 ' A' ' 83' ' ' LEU . 95.4 mtp -61.66 -48.8 79.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.31 0.576 . . . . 0.0 111.095 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.8 m -66.03 -31.7 72.74 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.541 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.45 -32.69 25.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.568 ' HD3' ' OD2' ' A' ' 98' ' ' ASP . 35.3 ttt180 -65.61 -46.83 77.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.473 -176.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.511 ' HA ' ' HB2' ' A' ' 98' ' ' ASP . 11.3 p 15.86 87.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.349 1.46 . . . . 0.0 114.214 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.21 -71.91 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.278 -1.439 . . . . 0.0 114.695 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -71.95 -71.1 0.29 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -173.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.12 93.6 1.71 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.962 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.07 -5.75 41.01 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -63.03 -42.41 99.78 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.927 0.394 . . . . 0.0 109.946 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -118.97 -147.97 8.26 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -87.67 70.94 9.72 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.568 ' OD2' ' HD3' ' A' ' 89' ' ' ARG . 15.8 t70 70.51 -51.06 0.66 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.198 -173.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 49.2 m -131.06 161.97 30.85 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.84 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -110.99 166.51 10.99 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.472 HD21 HD13 ' A' ' 53' ' ' LEU . 18.1 tp -116.74 124.97 50.94 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.242 -176.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.94 167.87 10.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.448 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 38' ' ' ALA . 68.6 mt -112.39 129.25 68.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.563 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -130.72 157.71 42.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.252 0.549 . . . . 0.0 110.901 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -93.04 134.36 35.25 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.323 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 18.9 ptpt -66.24 151.42 95.77 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.158 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 106' ' ' LYS . 4.8 Cg_exo -76.49 -155.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.378 2.718 . . . . 0.0 111.887 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.5 p80 . . . . . 0 N--CA 1.475 0.807 0 C-N-CA 124.338 1.055 . . . . 0.0 112.692 -179.486 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 120.845 0.355 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 96.4 mtp -82.64 142.16 31.94 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.759 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.4 t80 76.15 -43.32 0.47 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.019 0.928 . . . . 0.0 111.252 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.43 -63.57 4.15 Favored Glycine 0 C--O 1.24 0.475 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.805 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 145.72 -25.53 1.8 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.624 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.9 p -134.12 155.39 50.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.2 mt -107.55 137.29 45.84 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -84.24 108.13 16.94 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.72 133.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.219 -171.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.457 ' CZ ' HD11 ' A' ' 68' ' ' LEU . 47.6 t80 -114.67 124.68 52.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.888 -177.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.02 28.36 2.94 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.369 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.94 -23.9 62.06 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 114.031 0.372 . . . . 0.0 114.031 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.01 -40.74 97.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.426 0.631 . . . . 0.0 109.558 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.7 mt -85.76 -49.71 15.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.641 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.0 t -120.72 95.43 48.97 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.345 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.77 -23.01 48.85 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.882 2.388 . . . . 0.0 113.467 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.3 t -76.85 -17.15 59.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.136 0.493 . . . . 0.0 111.124 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -137.88 76.59 40.02 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.35 -34.06 67.94 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.287 1.991 . . . . 0.0 113.133 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -123.4 141.62 51.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.363 0.601 . . . . 0.0 112.211 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -142.85 157.57 18.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.2 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.6 p -119.46 131.79 55.68 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.235 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 38' ' ' ALA . 41.6 pt -125.54 160.48 31.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.495 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.5 108.74 18.83 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.09 153.12 50.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.943 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -106.92 156.69 18.44 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.526 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.8 tt -65.91 -29.0 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -177.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -84.35 9.82 12.18 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.799 0.333 . . . . 0.0 111.401 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -100.69 148.91 24.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.516 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -80.58 168.78 18.5 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.73 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -59.96 -26.56 66.1 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.247 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.41 -40.46 96.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.839 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -64.79 -44.74 89.01 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.157 0.503 . . . . 0.0 109.768 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 23' ' ' ILE . 96.7 mt -64.53 -45.64 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.642 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.73 -45.89 87.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.745 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.28 -38.29 93.6 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.268 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -59.46 -49.96 75.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.959 0.409 . . . . 0.0 110.999 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 23' ' ' ILE . . . -70.58 -40.37 73.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.19 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.1 tp -61.97 -39.67 92.96 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.639 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.88 -37.78 83.37 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.288 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 69.1 mmtt -63.83 -37.98 89.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.595 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -80.03 -6.08 56.95 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.234 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.23 22.0 74.48 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.79 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -113.7 22.61 13.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.742 0.306 . . . . 0.0 111.114 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -53.15 -40.46 64.29 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.476 0.71 . . . . 0.0 112.393 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -74.75 -11.9 60.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.815 0.34 . . . . 0.0 111.736 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.8 m -110.14 29.83 7.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.345 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -60.96 -32.1 71.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.007 0.432 . . . . 0.0 111.553 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.95 -9.14 13.89 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.755 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.445 ' HA ' ' HD2' ' A' ' 106' ' ' LYS . 18.0 t70 -101.97 -2.64 29.27 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.738 0.304 . . . . 0.0 111.575 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -132.39 154.25 49.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.698 -176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.6 pt -137.96 173.26 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.61 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.7 mt -101.25 142.95 31.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.731 0.301 . . . . 0.0 110.529 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 18.8 m -125.41 132.11 71.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.087 0.47 . . . . 0.0 110.545 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.539 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 1.9 tm-20 -87.54 124.25 33.28 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.6 t -122.17 129.9 74.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.302 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 p -73.97 124.01 25.39 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' A' ' 98' ' ' ASP . 26.5 t-20 -84.05 -53.02 5.84 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -173.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.13 -9.83 3.71 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -170.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.435 ' HB2' ' HA ' ' A' ' 64' ' ' SER . 35.9 m-20 -64.13 107.17 1.21 Allowed 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 62' ' ' ARG . 8.3 t70 69.88 -60.14 0.49 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -172.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 30.7 ptt-85 174.76 -22.57 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.398 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.437 ' HD3' HD22 ' A' ' 68' ' ' LEU . 99.2 mttt -154.17 73.35 0.92 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.986 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.435 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 35.3 t 67.8 157.19 0.13 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.64 0.776 . . . . 0.0 110.835 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.4 mtt -63.22 -20.53 65.51 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.05 -12.35 60.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.524 -1.671 . . . . 0.0 111.022 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 p30 53.11 34.74 17.99 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.881 0.872 . . . . 0.0 111.337 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 68' ' ' LEU . 40.5 tp 58.45 13.42 2.48 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.882 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -66.06 -41.11 91.21 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -139.53 140.45 37.16 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.3 tt -85.59 119.74 34.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 C-N-CA 119.554 -0.858 . . . . 0.0 111.614 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -123.62 141.55 51.91 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.668 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.75 -175.37 39.35 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 119.704 -1.236 . . . . 0.0 112.689 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -97.28 121.08 59.71 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -178.311 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.15 115.85 3.38 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.007 2.471 . . . . 0.0 112.513 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 55' ' ' GLU . 33.1 mt -121.16 118.89 29.93 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.404 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.13 158.32 58.22 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.749 2.299 . . . . 0.0 111.473 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 31.7 Cg_exo -59.71 -26.49 82.35 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.984 2.456 . . . . 0.0 112.45 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.5 p -68.33 -31.91 71.66 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -82.57 159.48 22.77 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.85 0.357 . . . . 0.0 111.958 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 39.8 m -118.05 86.81 26.82 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.68 -16.87 33.72 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.756 2.304 . . . . 0.0 114.198 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' A' ' 27' ' ' ILE . 53.4 mt -63.72 -39.09 93.45 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.47 ' HA ' HD11 ' A' ' 27' ' ' ILE . 23.6 m-85 -57.19 -46.12 83.13 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 123.215 0.322 . . . . 0.0 111.634 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.569 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 49.1 mt-10 -66.05 -43.07 88.55 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.236 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 90' ' ' SER . 67.3 mtm -63.54 -43.44 97.09 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.951 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 m -80.8 -42.34 21.85 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.22 -50.99 70.85 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 20.4 ptt-85 -90.59 -28.58 18.35 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.646 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 86' ' ' MET . 1.7 m 55.21 -160.98 0.17 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.372 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -156.01 169.93 33.7 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.497 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -114.72 15.18 17.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.789 0.804 . . . . 0.0 109.135 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.16 49.73 0.61 Allowed Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.547 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -163.75 -82.56 0.03 OUTLIER 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -125.86 85.4 2.39 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.266 0.555 . . . . 0.0 109.983 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 90' ' ' SER . . . -172.02 -111.64 0.26 Allowed Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.354 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -104.01 5.38 35.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.867 0.841 . . . . 0.0 109.391 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 9.4 m-20 -79.28 -6.78 57.47 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.196 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.8 p -98.01 174.18 6.69 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.116 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -131.87 162.65 30.11 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.419 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.492 HD21 HD13 ' A' ' 53' ' ' LEU . 29.5 tp -111.76 121.26 44.62 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.31 174.7 5.91 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.181 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 38' ' ' ALA . 65.0 mt -110.77 129.49 65.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.656 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 17.1 mmmt -127.55 163.73 23.52 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 121.378 0.609 . . . . 0.0 110.199 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -84.03 134.83 34.61 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.296 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.445 ' HD2' ' HA ' ' A' ' 50' ' ' ASP . 22.0 ptmt -49.71 133.16 20.3 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 123.632 0.583 . . . . 0.0 112.084 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.4 -41.85 14.59 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.74 2.294 . . . . 0.0 112.43 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.418 ' OXT' ' HE2' ' A' ' 106' ' ' LYS . 55.1 m80 . . . . . 0 C--O 1.241 0.624 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.024 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt -103.25 144.22 31.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.079 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.568 ' CZ ' HD13 ' A' ' 83' ' ' LEU . 91.2 t80 -62.65 -46.88 86.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.646 0.26 . . . . 0.0 111.12 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.02 -30.08 5.58 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.049 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.406 ' H ' ' HD2' ' A' ' 3' ' ' PHE . . . 79.95 -57.9 4.56 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.798 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 26.4 p -95.11 134.49 37.77 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.4 mt -110.76 143.65 40.97 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -84.69 104.23 14.48 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.86 129.22 57.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.148 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.429 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 88.2 t80 -96.26 126.32 41.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.31 0.576 . . . . 0.0 111.78 -176.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.26 18.17 4.46 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.38 -23.11 64.19 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.214 -0.493 . . . . 0.0 113.324 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.3 -57.6 9.88 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.8 mt -70.28 -44.8 77.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.071 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.18 96.08 20.34 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.411 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.36 -24.25 50.34 Favored 'Trans proline' 0 CA--C 1.498 -1.298 0 C-N-CA 122.717 2.278 . . . . 0.0 112.342 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.8 m -68.63 -23.24 64.41 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.727 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.41 67.67 80.47 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.95 -55.38 1.67 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 123.257 2.638 . . . . 0.0 114.376 -172.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -117.95 134.99 54.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.763 0.316 . . . . 0.0 110.998 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.24 161.18 35.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.586 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -110.86 128.87 55.94 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.513 HG21 ' HB2' ' A' ' 38' ' ' ALA . 31.1 pt -126.4 163.06 29.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.445 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.5 tp -111.79 112.5 24.21 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.96 148.16 28.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.267 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.69 162.73 16.84 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.855 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.638 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.0 tt -63.49 -24.51 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -175.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -85.1 4.64 33.23 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.88 0.371 . . . . 0.0 110.615 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -101.34 146.25 27.82 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.139 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -81.76 174.02 11.74 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.409 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.601 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -58.79 -27.12 64.72 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.009 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.28 -41.98 97.86 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -64.89 -41.72 95.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.263 0.554 . . . . 0.0 109.959 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.409 HG23 ' CD1' ' A' ' 23' ' ' ILE . 96.6 mt -65.67 -44.42 93.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.217 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.83 -46.71 88.32 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.457 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA2' ' OE1' ' A' ' 45' ' ' GLU . . . -64.28 -40.93 98.34 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.746 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -64.47 -39.27 93.5 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -84.88 -42.23 15.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.886 0.374 . . . . 0.0 111.272 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 27.9 tp -62.92 -35.12 79.01 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.147 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 2.9 tm-20 -59.7 -41.55 91.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.168 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 68.3 mmtt -63.58 -39.69 95.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -79.77 -3.44 47.64 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.984 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.73 28.96 68.15 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.996 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.573 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 82.2 mt -117.79 13.24 14.09 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.141 0.496 . . . . 0.0 110.844 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 48.4 tp10 -60.49 -28.41 68.34 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.917 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -67.8 -12.92 61.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.6 m -94.36 -88.92 0.23 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.3 mttt 63.96 -39.86 0.22 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 124.265 1.026 . . . . 0.0 113.473 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.59 -27.85 68.04 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -89.89 -17.95 27.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.317 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.573 ' CZ ' HD13 ' A' ' 44' ' ' LEU . 73.1 m-85 -125.59 151.64 46.17 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 119.252 -0.979 . . . . 0.0 113.092 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.3 pt -138.42 178.38 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.601 HD12 ' HB1' ' A' ' 31' ' ' ALA . 91.8 mt -107.81 142.55 37.69 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.469 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 m -127.54 133.19 68.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.505 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.62 121.06 29.57 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.361 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 71' ' ' ILE . 85.2 t -137.06 133.32 47.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 28.2 t -84.32 151.19 24.89 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.512 ' HB2' ' OE2' ' A' ' 94' ' ' GLU . 39.9 t-20 -63.19 -42.87 99.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.303 0.573 . . . . 0.0 109.774 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -98.99 107.97 20.54 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.455 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -89.62 -93.43 0.12 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.931 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.1 t70 52.92 21.12 1.88 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 122.624 1.202 . . . . 0.0 109.53 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -117.6 -54.62 2.35 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.36 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -108.69 -34.92 6.56 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.708 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.5 t -154.41 151.66 29.27 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.733 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 61.3 mtt -83.71 3.51 32.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.493 0.663 . . . . 0.0 109.581 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.4 t -63.8 -41.75 97.85 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.477 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 62.22 -83.47 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.631 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.0 mt -100.37 -139.06 0.33 Allowed 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.503 ' HE ' ' HG3' ' A' ' 70' ' ' GLU . 53.9 ttp180 64.92 -81.69 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.291 0.636 . . . . 0.0 112.636 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.503 ' HG3' ' HE ' ' A' ' 69' ' ' ARG . 50.0 mt-10 -65.97 -35.69 81.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.917 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 71' ' ' ILE . 0.3 OUTLIER 52.82 29.87 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-O 122.485 1.136 . . . . 0.0 111.811 174.304 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -54.54 -54.19 44.52 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.601 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 47.16 -145.18 4.59 Favored Glycine 0 N--CA 1.471 1.017 0 O-C-N 123.458 0.474 . . . . 0.0 113.887 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -125.54 127.99 24.77 Favored Pre-proline 0 N--CA 1.442 -0.854 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.02 119.22 6.3 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.731 2.287 . . . . 0.0 112.826 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.2 mt -122.28 101.84 40.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.397 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 48.7 Cg_exo -62.18 155.77 54.42 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.637 2.225 . . . . 0.0 112.121 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 49.4 Cg_exo -53.91 -33.25 71.19 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.791 2.994 . . . . 0.0 114.067 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.0 m -62.26 -42.9 99.74 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -73.79 154.98 39.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.894 0.378 . . . . 0.0 111.703 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.4 p -106.24 91.5 5.72 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.178 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 44.3 Cg_endo -68.66 -17.91 42.65 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.149 2.566 . . . . 0.0 114.145 -175.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 27' ' ' ILE . 43.2 mt -66.37 -33.74 76.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.885 0.374 . . . . 0.0 110.464 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -60.75 -11.76 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.269 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 6.0 mm-40 -95.94 -56.54 2.62 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.794 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 79.0 mtm -61.88 -48.6 79.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.3 m -67.28 -40.29 86.12 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.685 0.278 . . . . 0.0 111.487 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.93 88.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.459 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 2.1 ptm180 -76.88 -51.08 11.91 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.394 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.533 ' HA ' ' HB3' ' A' ' 97' ' ' PHE . 52.5 m 45.95 73.69 0.16 Allowed 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.565 0.746 . . . . 0.0 112.917 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.23 -125.34 3.59 Favored Glycine 0 C--N 1.318 -0.443 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.771 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -153.04 136.6 15.96 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 159.4 -20.27 0.27 Allowed Glycine 0 C--O 1.229 -0.159 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.067 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.655 ' HG3' ' H ' ' A' ' 96' ' ' GLY . 9.1 tp10 -158.72 160.94 36.95 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -64.87 -19.21 65.77 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.258 0.348 . . . . 0.0 110.824 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.655 ' H ' ' HG3' ' A' ' 94' ' ' GLU . . . -83.46 61.65 4.73 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.533 ' HB3' ' HA ' ' A' ' 90' ' ' SER . 86.4 m-85 70.32 -69.08 0.18 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.611 0.764 . . . . 0.0 109.852 -176.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.459 ' OD2' ' HG3' ' A' ' 89' ' ' ARG . 1.5 p30 -144.71 -17.72 0.53 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.4 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 11.8 p -153.98 174.89 14.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.727 0.299 . . . . 0.0 111.583 -175.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -128.37 165.36 20.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.049 0.452 . . . . 0.0 109.858 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.0 tp -116.41 129.28 56.15 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.941 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.474 ' HB3' HD11 ' A' ' 71' ' ' ILE . . . -125.4 171.78 10.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.924 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 38' ' ' ALA . 70.9 mt -100.12 130.43 49.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.103 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -128.31 142.07 51.25 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.258 0.552 . . . . 0.0 110.65 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -81.65 109.97 16.57 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.805 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -54.2 152.86 10.4 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.772 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.27 44.65 1.78 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.907 2.405 . . . . 0.0 113.346 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.8 t60 . . . . . 0 C--N 1.279 -2.477 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.691 178.79 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 CA--C 1.513 -0.457 0 CA-C-O 120.788 0.328 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 75.2 mtm -66.27 -40.97 90.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.06 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -80.3 113.29 18.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.689 0.281 . . . . 0.0 110.789 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.08 -38.09 59.73 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.853 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.11 -46.75 1.06 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.424 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 p -96.25 139.82 31.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.805 0.336 . . . . 0.0 111.086 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.7 mt -109.18 134.52 51.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.776 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -82.66 99.56 9.67 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 91.7 t -100.45 112.31 32.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.871 -176.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 78.0 t80 -82.22 122.83 28.41 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.512 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.62 28.2 4.02 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.66 -33.39 82.13 Favored Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 115.268 -0.466 . . . . 0.0 112.97 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.436 ' OE1' ' HG2' ' A' ' 104' ' ' LYS . 40.4 tt0 -64.06 -42.05 97.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.798 0.333 . . . . 0.0 110.485 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.28 -49.85 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.725 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.9 109.85 9.23 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.899 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.53 -27.47 53.91 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.766 2.311 . . . . 0.0 114.035 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -80.05 -7.26 58.76 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.236 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.71 76.87 28.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.423 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 31.0 Cg_endo -62.68 -32.29 78.83 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.706 2.271 . . . . 0.0 113.294 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -129.81 141.42 50.85 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.4 p -131.27 155.04 41.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.4 m -112.55 124.61 52.92 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.724 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.503 HG21 ' HB2' ' A' ' 38' ' ' ALA . 33.3 pt -125.08 166.62 20.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.35 134.77 52.69 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.956 0.408 . . . . 0.0 110.887 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.45 165.44 30.24 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.71 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 43.8 mt-10 -109.74 -62.16 1.54 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.753 -0.379 . . . . 0.0 109.981 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.638 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.5 tt 168.34 -43.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.305 1.042 . . . . 0.0 112.832 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -75.49 -11.39 60.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.799 0.809 . . . . 0.0 109.852 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.71 ' OE1' ' HB2' ' A' ' 26' ' ' GLU . 8.8 mp0 -56.59 134.85 54.73 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.229 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.484 ' ND2' ' HB3' ' A' ' 32' ' ' ASP . 36.9 p-10 -84.47 159.69 20.7 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.941 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.5 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -59.46 -26.05 64.91 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.733 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.484 ' HB3' ' ND2' ' A' ' 30' ' ' ASN . 13.3 t70 -59.68 -48.27 82.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.421 ' NH1' ' HG3' ' A' ' 29' ' ' GLU . 58.3 ttt180 -70.31 -44.81 67.51 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.134 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.43 -44.86 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.191 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -64.87 -41.35 95.72 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.732 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -60.77 -40.54 98.27 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.528 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.53 -41.25 98.74 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.817 0.342 . . . . 0.0 111.398 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.503 ' HB2' HG21 ' A' ' 23' ' ' ILE . . . -78.48 -45.79 21.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.075 0.464 . . . . 0.0 111.743 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 45' ' ' GLU . 26.1 tp -63.36 -32.02 73.34 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.34 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -56.68 -43.62 80.62 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.168 0.987 . . . . 0.0 110.627 175.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 46.3 mmtm -61.15 -38.54 86.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.772 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -84.69 -7.5 59.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.005 0.431 . . . . 0.0 110.836 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.22 20.5 79.64 Favored Glycine 0 C--O 1.227 -0.29 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.206 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.407 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 83.5 mt -106.52 11.68 30.37 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 122.887 -0.184 . . . . 0.0 111.311 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.6 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 44.8 tt0 -58.55 -29.4 66.34 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.822 0.344 . . . . 0.0 111.756 -178.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -61.06 -26.94 67.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.191 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.3 m -108.76 32.34 4.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.784 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.6 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 33.9 ttmt -60.54 -31.02 70.13 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -176.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -65.02 -9.76 24.4 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.25 0.27 31.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.869 0.366 . . . . 0.0 110.995 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.517 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 89.8 m-85 -129.8 152.27 49.48 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.9 0.381 . . . . 0.0 111.852 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.4 pt -141.16 -180.0 2.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.491 ' HB3' HD11 ' A' ' 101' ' ' LEU . 95.9 mt -103.32 149.8 24.39 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -137.3 154.24 30.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.89 0.376 . . . . 0.0 110.478 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HG3' HD11 ' A' ' 76' ' ' ILE . 30.0 mt-10 -109.04 126.87 53.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 176.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 57' ' ' SER . 55.0 t -128.52 135.02 63.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 174.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.41 ' O ' HG12 ' A' ' 56' ' ' VAL . 85.3 p -93.61 -178.05 4.58 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -86.53 6.38 30.9 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.778 0.799 . . . . 0.0 108.863 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.434 ' O ' ' HD3' ' A' ' 63' ' ' LYS . 11.9 t70 -96.02 -54.53 3.28 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.292 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.76 161.87 26.53 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.109 176.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.577 ' CG ' ' H ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER 47.52 47.86 17.15 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.293 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.552 ' HG3' ' N ' ' A' ' 63' ' ' LYS . 5.9 tpt180 -150.12 -64.17 0.21 Allowed 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 113.944 -1.48 . . . . 0.0 108.732 -173.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.552 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -129.59 -19.88 3.32 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.607 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.0 t -77.33 -81.85 0.09 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -67.58 -40.07 84.85 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.9 m 58.74 30.87 20.57 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.313 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -95.63 -69.41 0.76 Allowed 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 119.501 -0.88 . . . . 0.0 113.231 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.577 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 50.9 tp 64.79 -43.05 0.31 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -61.96 -44.17 97.32 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -113.38 65.32 0.65 Allowed 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 171.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.509 ' HA ' ' OD2' ' A' ' 61' ' ' ASP . 14.5 tt -63.46 140.48 19.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.863 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.33 146.95 27.79 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 174.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.57 -139.74 3.5 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.817 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.528 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 5.4 mpt_? -86.52 119.44 71.41 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.08 117.1 4.14 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.431 2.088 . . . . 0.0 112.357 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 74' ' ' ARG . 39.2 mt -120.9 101.29 45.4 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.981 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.5 163.3 38.58 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.787 2.325 . . . . 0.0 111.125 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.5 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 45.1 Cg_exo -56.82 -27.67 72.97 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.874 2.383 . . . . 0.0 112.486 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 t -79.11 -9.88 59.67 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.366 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -91.95 151.45 20.5 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.4 m -121.39 88.1 45.65 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.73 -14.59 24.37 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 123.384 2.723 . . . . 0.0 114.527 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 27' ' ' ILE . 39.6 mt -61.09 -37.83 84.12 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.408 ' HA ' HD11 ' A' ' 27' ' ' ILE . 74.0 m-85 -59.21 -42.43 90.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 110.96 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.63 -40.51 69.69 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.154 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.6 mtp -60.93 -46.82 89.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.385 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p -71.58 -34.57 70.03 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.051 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.68 90.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -73.73 -54.72 7.42 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.24 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.2 m 22.32 54.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.963 1.305 . . . . 0.0 114.367 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.33 53.18 0.39 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.463 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -162.89 -80.58 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.747 0.308 . . . . 0.0 110.891 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.89 133.75 14.89 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.853 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -91.6 -3.97 55.82 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 122.914 0.486 . . . . 0.0 110.704 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -64.23 -39.61 94.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.17 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -158.58 -138.98 2.59 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.508 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -80.59 80.41 7.05 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 t70 69.46 -51.68 0.61 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 123.759 0.662 . . . . 0.0 111.342 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.1 m -130.59 163.4 27.21 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -110.3 162.69 14.38 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.988 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 53' ' ' LEU . 36.6 tp -104.92 128.09 53.03 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.867 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -127.68 161.72 28.23 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.128 0.49 . . . . 0.0 111.565 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.489 HD11 ' HB1' ' A' ' 38' ' ' ALA . 79.0 mt -104.28 126.68 58.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.345 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 104' ' ' LYS . 24.2 mtpp -134.43 164.39 27.54 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.543 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.517 ' HG2' ' CE1' ' A' ' 51' ' ' PHE . 79.7 mtp180 -82.18 140.45 33.72 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -58.63 143.06 82.45 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-O 121.122 0.487 . . . . 0.0 111.959 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.79 -163.93 0.24 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.115 2.544 . . . . 0.0 111.488 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 80.9 m80 . . . . . 0 C--N 1.321 -0.644 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.467 179.374 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.574 0.226 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.7 mtt -86.29 157.99 19.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.739 0.304 . . . . 0.0 110.563 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -92.91 124.2 36.72 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.04 -40.07 98.42 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.308 -0.472 . . . . 0.0 113.318 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.73 -43.57 1.68 Allowed Glycine 0 C--N 1.319 -0.363 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.461 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.2 p -104.18 137.83 41.54 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.799 0.333 . . . . 0.0 110.346 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.5 mt -112.46 138.99 48.42 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.198 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -85.09 101.15 12.2 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.41 HG11 ' CB ' ' A' ' 38' ' ' ALA . 78.7 t -103.76 131.66 51.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.262 -171.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 91.7 t80 -100.42 115.27 29.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.23 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.97 29.04 13.32 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.424 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 10' ' ' TYR . . . -58.46 164.62 8.38 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 65.5 mm-40 72.77 -54.37 0.69 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.126 0.57 . . . . 0.0 110.721 -175.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.6 mt -69.01 -48.59 69.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.488 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.597 HG21 ' CE1' ' A' ' 42' ' ' TYR . 1.7 m -136.48 98.73 10.98 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-O 121.147 0.499 . . . . 0.0 112.144 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.13 -30.06 81.82 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.908 2.405 . . . . 0.0 112.356 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.2 t -66.86 -37.08 83.76 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.072 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -126.93 77.88 74.49 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.558 0.218 . . . . 0.0 110.731 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.557 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 32.8 Cg_endo -64.06 -31.09 65.99 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.5 2.134 . . . . 0.0 112.652 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -129.6 138.71 51.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.109 0.48 . . . . 0.0 112.197 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.55 154.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.402 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.7 p -102.97 121.71 43.1 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.257 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.402 ' CD1' HG21 ' A' ' 9' ' ' VAL . 29.7 pt -120.84 157.33 23.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.0 mt -106.16 121.81 44.92 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.023 0.439 . . . . 0.0 110.317 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.89 158.65 44.15 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.828 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.603 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 70.6 mm-40 -110.18 155.21 22.28 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 84' ' ' PHE . 19.4 tt -65.43 -27.1 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -83.88 7.69 17.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.272 0.558 . . . . 0.0 110.904 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.603 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 65.0 mm-40 -92.68 147.52 22.81 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 32' ' ' ASP . 30.3 p30 -84.51 170.78 13.11 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.608 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -59.5 -26.15 65.05 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.052 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.492 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 17.2 t70 -59.47 -49.54 77.39 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.745 0.307 . . . . 0.0 111.405 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.579 ' HG2' ' OE1' ' A' ' 29' ' ' GLU . 10.4 mpt_? -65.28 -44.9 86.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.94 -45.12 97.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.451 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.97 -43.1 96.8 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.066 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.521 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -62.01 -43.75 98.74 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.621 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.662 ' O ' ' HD3' ' A' ' 41' ' ' LYS . . . -62.9 -49.86 73.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.433 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -66.13 -44.78 83.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.835 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 48' ' ' LYS . 32.2 tp -65.68 -34.6 78.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.184 0.516 . . . . 0.0 109.93 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 36.3 tt0 -61.84 -34.43 75.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.398 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.662 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 4.1 mptp? -60.2 -37.37 80.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.131 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.597 ' CE1' HG21 ' A' ' 15' ' ' VAL . 58.2 m-85 -89.82 -9.13 50.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.121 0.486 . . . . 0.0 110.241 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.49 19.82 79.75 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.733 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.9 mt -100.93 16.55 24.88 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 40.2 tt0 -58.27 -29.11 65.55 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -58.49 -32.89 69.22 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.215 0.531 . . . . 0.0 110.126 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.3 m -95.3 21.86 7.5 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.327 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 38.6 ttmt -60.04 -35.42 75.09 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -174.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 32.9 t70 -61.26 -22.7 65.07 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.774 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.476 ' HA ' ' HD2' ' A' ' 106' ' ' LYS . 26.8 t70 -89.43 -2.46 58.4 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -129.39 153.49 47.84 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.748 -0.595 . . . . 0.0 111.888 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.3 174.65 11.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.522 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.514 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.2 mt -100.83 145.87 28.02 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 29.7 m -130.03 135.03 61.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.059 0.457 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.41 ' HB2' HD11 ' A' ' 76' ' ' ILE . 1.8 tm-20 -87.26 121.06 29.21 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.78 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.5 t -129.42 131.48 67.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.325 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 46.8 t -85.61 162.35 18.88 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.045 0.45 . . . . 0.0 110.122 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.516 ' HB3' ' HA2' ' A' ' 93' ' ' GLY . 5.3 t30 -85.8 -7.58 58.65 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.194 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 11.1 t70 -74.54 103.43 4.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.13 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.538 ' OD2' ' HA ' ' A' ' 65' ' ' MET . 4.2 p-10 -89.53 -9.25 50.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.447 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -71.27 -19.11 62.39 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.815 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.537 ' HG3' ' HG3' ' A' ' 63' ' ' LYS . 31.0 ptt180 -79.68 -18.16 51.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.052 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.537 ' HG3' ' HG3' ' A' ' 62' ' ' ARG . 58.5 mtpt -116.71 -70.87 0.77 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 t -161.39 25.71 0.13 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.47 -174.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.538 ' HA ' ' OD2' ' A' ' 60' ' ' ASP . 74.9 mtm 69.38 7.64 6.34 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.513 0.673 . . . . 0.0 110.268 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.44 ' N ' ' HB2' ' A' ' 60' ' ' ASP . 35.9 t -152.63 87.24 1.29 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.423 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 8.3 t0 -67.27 -43.12 82.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.465 0.65 . . . . 0.0 109.924 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.9 tp -62.57 -24.53 67.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.476 -1.238 . . . . 0.0 113.016 -175.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.6 ttt-85 -55.68 -45.26 77.8 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.028 0.442 . . . . 0.0 110.502 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -116.93 91.15 3.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.526 HG23 ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -92.04 109.86 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 122.366 1.079 . . . . 0.0 111.035 -176.34 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.99 -55.73 1.58 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.331 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.06 -162.26 39.76 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.81 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 5.3 mtm180 -103.2 125.18 35.87 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.79 114.45 2.16 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.124 1.883 . . . . 0.0 111.588 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 55' ' ' GLU . 68.2 mt -119.45 105.18 44.36 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.52 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -64.9 158.4 51.47 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.875 2.383 . . . . 0.0 111.52 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.547 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 52.7 Cg_exo -54.89 -29.99 66.33 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 123.333 2.689 . . . . 0.0 113.588 -177.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.3 t -66.36 -26.2 67.16 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -88.98 147.21 24.42 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 30' ' ' ASN . 36.7 m -111.49 88.36 9.08 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.88 -17.59 32.39 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.861 2.374 . . . . 0.0 113.903 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 27' ' ' ILE . 57.0 mt -61.58 -35.64 78.39 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.519 ' HA ' HD11 ' A' ' 27' ' ' ILE . 18.1 m-85 -56.6 -46.58 80.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.217 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -74.36 -37.49 63.48 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.6 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.7 mtp -61.45 -48.4 81.32 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.064 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.8 m -73.72 -41.74 62.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.267 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.37 -49.88 76.11 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -80.93 -47.72 13.32 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.793 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.428 ' C ' ' HB2' ' A' ' 98' ' ' ASP . 22.7 t 57.39 -173.39 0.08 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 122.727 0.411 . . . . 0.0 110.633 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 150.38 -112.32 0.54 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.245 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -89.48 -157.84 0.48 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 58' ' ' ASN . . . 102.56 96.93 2.35 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 119.574 -1.298 . . . . 0.0 114.395 174.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.1 -34.9 73.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.195 0.522 . . . . 0.0 109.697 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -63.39 -60.81 2.89 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.158 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -144.07 -104.81 0.48 Allowed Glycine 0 CA--C 1.498 -1.007 0 C-N-CA 119.583 -1.294 . . . . 0.0 112.224 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.489 ' O ' ' HA3' ' A' ' 93' ' ' GLY . 86.4 m-85 -88.69 -159.04 0.52 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.428 ' HB2' ' C ' ' A' ' 90' ' ' SER . 31.1 t70 -58.99 -31.0 68.4 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.041 0.924 . . . . 0.0 108.707 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 65.1 m -132.74 154.28 50.36 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.281 177.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -117.22 170.59 8.56 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 54' ' ' VAL . 17.3 tp -121.54 123.5 42.14 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.535 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -118.57 171.16 8.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.814 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 38' ' ' ALA . 60.1 mt -109.22 128.02 65.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.356 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.526 ' HD3' HG23 ' A' ' 71' ' ' ILE . 13.2 mmmm -132.8 165.36 24.75 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 120.964 0.411 . . . . 0.0 110.115 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 -78.47 138.73 38.6 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.31 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.476 ' HD2' ' HA ' ' A' ' 50' ' ' ASP . 19.0 ptmt -59.73 154.74 44.98 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.082 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.42 -31.07 88.06 Favored 'Trans proline' 0 N--CA 1.476 0.469 0 C-N-CA 122.479 2.119 . . . . 0.0 112.649 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 72.5 m80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.65 -0.691 . . . . 0.0 110.727 -178.516 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.677 0.275 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 98.2 mmm -81.97 88.45 6.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 110.563 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -100.47 -27.91 13.19 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.317 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.12 -64.41 4.04 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.626 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.92 -20.69 28.64 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.634 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 m -102.4 124.02 47.22 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.5 mt -104.47 140.5 37.86 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.201 0.525 . . . . 0.0 112.288 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -85.78 105.2 16.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.7 t -107.97 128.25 63.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.119 -172.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.523 ' CZ ' ' HA3' ' A' ' 12' ' ' GLY . 93.3 t80 -90.1 109.45 20.5 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.364 0.602 . . . . 0.0 110.935 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.99 20.48 45.43 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.987 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.523 ' HA3' ' CZ ' ' A' ' 10' ' ' TYR . . . -64.49 177.62 9.22 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.149 -0.526 . . . . 0.0 112.007 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.494 ' CD ' ' HZ2' ' A' ' 104' ' ' LYS . 36.0 tt0 71.32 -65.55 0.34 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.246 0.618 . . . . 0.0 110.427 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.83 -45.57 83.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.039 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.99 86.81 57.15 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.297 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.55 -27.7 82.21 Favored 'Trans proline' 0 N--CA 1.474 0.339 0 C-N-CA 122.909 2.406 . . . . 0.0 112.989 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.3 t -75.84 -15.12 60.28 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.208 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -138.76 79.36 28.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.06 -31.8 75.85 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.562 2.174 . . . . 0.0 113.51 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.09 144.64 48.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.237 0.542 . . . . 0.0 112.198 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.95 161.63 35.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.294 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.3 p -110.8 130.89 55.45 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.05 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.498 ' CD1' HG23 ' A' ' 34' ' ' ILE . 32.6 pt -128.15 158.82 39.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.1 tp -105.81 113.62 27.28 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.75 140.31 29.89 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.983 0.421 . . . . 0.0 110.988 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.93 153.92 20.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.691 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.7 tt -65.32 -28.01 43.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.022 0.439 . . . . 0.0 111.156 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -79.03 -1.75 37.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.408 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -85.39 147.6 26.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.045 0.45 . . . . 0.0 110.937 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -86.18 170.62 11.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.671 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.614 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -59.79 -28.54 67.52 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.468 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.46 -44.28 97.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -63.45 -44.49 94.35 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.203 0.525 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.529 HG21 HD23 ' A' ' 101' ' ' LEU . 96.9 mt -65.58 -45.39 92.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.588 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 tp -63.49 -43.58 96.83 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.578 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -63.34 -45.48 94.96 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.389 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.33 -48.51 79.52 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.733 0.302 . . . . 0.0 111.481 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.09 86.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.751 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.434 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 28.9 tp -64.51 -37.75 88.62 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.309 0.576 . . . . 0.0 109.919 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.96 -39.24 71.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.1 178.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.9 mmtt -66.98 -15.36 63.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.698 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -108.36 0.45 21.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.784 0.326 . . . . 0.0 111.125 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.53 18.26 76.95 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.198 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 93.6 mt -99.98 14.21 31.32 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.064 0.459 . . . . 0.0 110.237 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -42.51 -40.79 2.75 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.779 1.232 . . . . 0.0 112.976 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -80.71 -5.78 57.52 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.9 m -112.04 22.44 14.83 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.17 0.509 . . . . 0.0 110.532 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.459 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 35.4 ttmt -60.18 -39.03 85.02 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.52 -6.78 11.69 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -174.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -95.24 -10.58 29.93 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.877 0.37 . . . . 0.0 110.797 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.479 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 62.5 m-85 -121.68 162.81 20.08 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' A' ' 106' ' ' LYS . 26.6 pt -145.88 -178.86 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.797 1.239 . . . . 0.0 108.568 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.614 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.9 mt -107.39 155.29 20.18 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.313 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG11 ' HG3' ' A' ' 104' ' ' LYS . 27.5 m -139.29 151.96 23.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 120.682 0.277 . . . . 0.0 110.931 176.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.66 ' OE1' ' HD2' ' A' ' 74' ' ' ARG . 40.1 mt-10 -98.37 123.02 42.26 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.583 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.454 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 15.7 t -123.48 119.71 58.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 3.2 m -76.01 135.07 39.98 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -83.0 84.02 7.62 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.634 0.73 . . . . 0.0 110.388 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -144.15 102.54 3.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.488 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 64' ' ' SER . 11.7 p-10 -72.81 155.72 39.64 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.943 0.401 . . . . 0.0 111.859 -175.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 64.69 27.08 13.16 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.866 -174.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.597 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 33.5 ttt85 -159.55 -61.43 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.671 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.597 ' HG3' ' HG2' ' A' ' 62' ' ' ARG . 68.4 mttm -130.29 16.19 5.55 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.31 0.576 . . . . 0.0 109.644 176.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 42.5 m -154.98 168.84 25.63 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.47 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.9 ttt 58.39 -100.45 0.11 Allowed 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 123.766 0.826 . . . . 0.0 111.872 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 t -59.93 -43.3 95.0 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.701 0.762 . . . . 0.0 109.66 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.23 4.88 53.28 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.92 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 71' ' ' ILE . 54.9 tp -72.74 -97.52 0.01 OUTLIER 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 175.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 43.77 -81.66 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 68' ' ' LEU . 12.5 pt-20 -77.96 -7.49 56.88 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 122.861 0.465 . . . . 0.0 110.794 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.488 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 97.1 mt 72.16 -51.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.179 0.992 . . . . 0.0 111.902 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.3 t70 65.55 -90.69 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.422 0.689 . . . . 0.0 111.187 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.03 -147.19 34.68 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.605 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.66 ' HD2' ' OE1' ' A' ' 55' ' ' GLU . 5.4 ptp180 -132.32 129.4 21.56 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.51 116.57 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.006 1.804 . . . . 0.0 112.462 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.428 HG21 ' HG3' ' A' ' 82' ' ' PRO . 55.3 mt -119.39 112.8 35.52 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.16 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.69 159.85 51.92 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.521 2.147 . . . . 0.0 111.546 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 36.5 Cg_exo -58.22 -27.53 80.88 Favored 'Trans proline' 0 N--CA 1.474 0.335 0 C-N-CA 123.001 2.467 . . . . 0.0 112.108 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -67.02 -23.68 65.93 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.392 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -82.19 153.95 25.7 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 63.2 m -124.73 84.77 57.58 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.428 ' HG3' HG21 ' A' ' 76' ' ' ILE . 57.8 Cg_endo -83.19 -9.47 10.5 Favored 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 123.021 2.481 . . . . 0.0 115.64 -173.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' A' ' 27' ' ' ILE . 20.3 mt -63.58 -41.82 98.33 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.495 ' HA ' HD11 ' A' ' 27' ' ' ILE . 60.5 m-85 -60.11 -34.99 74.26 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.038 0.446 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -70.11 -37.71 75.41 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.41 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.451 ' HE2' ' HA ' ' A' ' 83' ' ' LEU . 47.9 mtm -66.11 -43.21 87.84 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.1 p -72.24 -27.74 62.7 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.57 -48.41 79.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.839 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.696 ' HD3' ' OD2' ' A' ' 98' ' ' ASP . 49.6 ttt180 -94.86 -54.13 3.59 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.48 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.9 m 55.98 43.0 27.97 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 123.423 0.452 . . . . 0.0 111.365 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 92' ' ' ASN . . . -114.11 136.17 13.07 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.302 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 91' ' ' GLY . 94.3 m-20 71.16 -179.0 0.22 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.089 0.555 . . . . 0.0 111.224 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 52.59 69.13 1.28 Allowed Glycine 0 C--N 1.34 0.777 0 CA-C-N 116.043 -0.526 . . . . 0.0 113.155 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 1.2 pm0 -58.37 -17.3 19.12 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -64.98 -41.03 95.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.65 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.44 97.1 0.11 Allowed Glycine 0 C--O 1.221 -0.682 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.496 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 56.89 -162.46 0.19 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.339 0.655 . . . . 0.0 111.612 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.696 ' OD2' ' HD3' ' A' ' 89' ' ' ARG . 1.0 OUTLIER -58.8 -39.09 80.11 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 122.002 0.906 . . . . 0.0 109.716 177.399 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 60.8 m -152.41 160.7 43.25 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.507 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.454 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 24.7 p90 -108.87 162.77 13.88 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.593 HD21 HD13 ' A' ' 53' ' ' LEU . 26.2 tp -100.94 123.21 44.79 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.09 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.474 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . . . -123.05 171.8 9.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.32 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.6 mt -108.14 128.96 63.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.472 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.494 ' HZ2' ' CD ' ' A' ' 13' ' ' GLU . 26.4 mmmt -132.66 171.43 13.86 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.577 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 60.7 mtp180 -92.54 140.13 29.87 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.541 ' CG ' ' HD3' ' A' ' 107' ' ' PRO . 17.6 ptpt -60.5 -38.5 57.98 Favored Pre-proline 0 CA--C 1.558 1.277 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.577 ' HD2' ' HB3' ' A' ' 105' ' ' ARG . 93.0 Cg_endo -84.15 -5.97 10.31 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.023 2.482 . . . . 0.0 111.385 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 . . . . . 0 C--O 1.247 0.924 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.087 -179.459 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 120.979 0.419 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 98.7 mmm -88.59 140.0 29.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.08 0.467 . . . . 0.0 111.455 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -114.04 132.04 56.15 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.49 -38.77 95.39 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 121.242 -0.504 . . . . 0.0 114.074 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.53 -46.11 3.31 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.155 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 37.7 p -101.41 120.24 39.99 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -106.7 144.49 33.28 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.529 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -81.92 112.16 18.77 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.45 HG21 ' CD1' ' A' ' 23' ' ' ILE . 54.1 t -104.86 127.2 59.54 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.222 -174.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -97.88 121.19 39.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.437 0.636 . . . . 0.0 111.794 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.48 26.22 3.21 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.589 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.5 -30.88 72.81 Favored Glycine 0 C--O 1.222 -0.6 0 CA-C-N 115.312 -0.444 . . . . 0.0 113.44 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -64.43 -43.57 93.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.985 0.421 . . . . 0.0 110.148 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.63 -44.72 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 177.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -134.96 104.93 10.52 Favored Pre-proline 0 C--O 1.237 0.424 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.23 -35.43 95.5 Favored 'Trans proline' 0 CA--C 1.493 -1.539 0 C-N-CA 123.908 3.072 . . . . 0.0 113.195 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -65.59 -21.26 66.57 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.361 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -139.28 74.44 35.45 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.589 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 48.3 Cg_exo -53.93 -48.25 22.73 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.837 2.358 . . . . 0.0 112.379 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -120.16 137.69 54.03 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.063 0.459 . . . . 0.0 110.998 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.56 161.56 40.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.9 p -118.71 123.23 44.37 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 6' ' ' SER . 41.6 pt -124.72 154.72 32.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.173 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.5 mp -99.02 111.42 23.83 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.228 0.537 . . . . 0.0 110.152 177.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.15 130.51 29.05 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.206 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -89.71 158.18 17.66 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.489 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.616 ' HA ' HD12 ' A' ' 83' ' ' LEU . 17.1 tt -63.75 -27.37 42.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -89.47 7.24 37.1 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.997 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.39 144.18 25.77 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -78.82 169.1 18.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.719 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.644 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -59.02 -25.51 63.73 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.844 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.07 -41.04 97.76 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.666 0.27 . . . . 0.0 110.833 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -64.88 -47.17 78.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 0.0 110.284 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.478 HG21 HD23 ' A' ' 101' ' ' LEU . 75.0 mt -64.2 -48.85 83.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.725 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.22 -44.88 90.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.462 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.469 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -65.86 -40.61 95.59 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.63 -0.714 . . . . 0.0 113.644 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.66 -48.31 79.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.313 0.557 . . . . 0.0 111.219 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.474 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -67.59 -41.93 83.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.138 0.494 . . . . 0.0 110.801 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.5 tp -62.95 -37.42 87.0 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.555 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.48 -39.09 92.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.01 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.2 mmtt -61.58 -40.29 94.22 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.988 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.46 -10.09 59.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.376 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.1 34.32 61.63 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.673 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.7 mt -123.13 21.28 9.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.767 0.318 . . . . 0.0 110.253 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.81 -16.66 43.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.288 -176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -90.65 8.53 33.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.792 0.33 . . . . 0.0 111.29 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.9 m -135.96 32.81 2.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.207 0.527 . . . . 0.0 110.133 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 39.9 ttmt -64.18 -37.33 87.07 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -173.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -64.25 -16.82 62.82 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.904 0.383 . . . . 0.0 111.847 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -84.06 -7.13 59.47 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.942 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -130.98 154.6 47.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.266 0.555 . . . . 0.0 111.805 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.2 pt -137.99 173.58 12.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.34 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.704 HD13 HD21 ' A' ' 101' ' ' LEU . 96.1 mt -99.51 135.19 41.29 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.526 ' HB ' ' HA3' ' A' ' 73' ' ' GLY . 23.3 m -128.22 134.48 64.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.204 -178.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.532 ' O ' ' HA2' ' A' ' 73' ' ' GLY . 32.7 mt-10 -86.53 122.48 30.53 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 120.962 0.411 . . . . 0.0 111.975 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.512 HG21 HG23 ' A' ' 71' ' ' ILE . 21.2 t -121.14 124.89 73.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.576 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.2 p -83.1 162.01 21.46 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -87.44 13.57 9.75 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.644 0.259 . . . . 0.0 111.13 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -114.36 92.98 4.14 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.258 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 65' ' ' MET . 5.6 p-10 -99.56 0.62 42.62 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.151 0.5 . . . . 0.0 110.054 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.67 -12.17 59.89 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.593 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.432 ' HG3' ' HG3' ' A' ' 63' ' ' LYS . 19.1 ptt-85 -151.27 -166.94 2.66 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.586 -176.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HG3' ' HG3' ' A' ' 62' ' ' ARG . 99.5 mttt 68.87 -77.75 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.742 0.651 . . . . 0.0 110.517 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.8 t -102.74 -24.02 13.76 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER 42.21 31.34 0.25 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.175 0.99 . . . . 0.0 112.609 -177.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.3 t -115.95 10.03 15.07 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.539 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.429 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 19.9 t0 69.68 168.96 0.3 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.601 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.5 mt -91.93 28.81 1.72 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.87 0.367 . . . . 0.0 110.051 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -58.31 -45.82 87.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.641 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.505 ' O ' ' HB ' ' A' ' 71' ' ' ILE . 3.5 pt-20 -110.31 12.36 23.2 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.818 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.512 HG23 HG21 ' A' ' 56' ' ' VAL . 96.7 mt 70.07 121.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 121.62 0.724 . . . . 0.0 111.803 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -114.12 111.42 21.56 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 55' ' ' GLU . . . -151.08 166.74 30.54 Favored Glycine 0 N--CA 1.422 -2.264 0 C-N-CA 119.345 -1.407 . . . . 0.0 112.943 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.569 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 1.6 mpt_? -90.22 130.03 43.52 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.86 113.67 2.87 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.17 1.913 . . . . 0.0 112.651 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.0 mt -120.53 103.35 44.08 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.097 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.89 155.26 55.97 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.889 2.393 . . . . 0.0 112.73 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.603 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 33.7 Cg_exo -55.51 -28.22 63.41 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.745 2.964 . . . . 0.0 113.403 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -73.49 -11.69 60.54 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -95.13 156.56 16.27 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.215 -0.303 . . . . 0.0 111.679 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 38.2 m -119.68 82.59 26.73 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 86' ' ' MET . 58.2 Cg_endo -71.21 -16.8 31.6 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.096 2.531 . . . . 0.0 115.115 -174.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.616 HD12 ' HA ' ' A' ' 27' ' ' ILE . 50.9 mt -61.18 -36.9 81.1 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -173.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.542 ' HA ' HD11 ' A' ' 27' ' ' ILE . 53.5 m-85 -58.88 -44.87 91.23 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.481 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.79 -36.16 67.53 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.406 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.474 ' SD ' HD23 ' A' ' 83' ' ' LEU . 92.9 mtp -61.69 -42.23 98.65 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.202 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p -65.72 -41.6 92.06 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.98 -41.69 86.37 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.251 0.548 . . . . 0.0 110.852 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -68.1 -35.17 77.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.994 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.7 t -33.72 107.15 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.15 0.907 . . . . 0.0 112.76 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.9 -38.71 0.13 Allowed Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.284 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 47.7 m-80 -87.53 -173.89 4.55 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 58.86 54.42 38.17 Favored Glycine 0 CA--C 1.506 -0.503 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.949 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 36.8 tt0 65.33 18.19 11.27 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.593 0.711 . . . . 0.0 109.504 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 60.94 30.67 19.76 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.702 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -98.43 61.95 0.87 Allowed Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.328 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.0 t80 69.6 22.3 6.31 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.541 ' HA ' ' O ' ' A' ' 92' ' ' ASN . 15.3 t70 74.76 -50.73 0.67 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.444 1.098 . . . . 0.0 110.127 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 69.1 m -152.31 159.07 43.54 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.056 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.458 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 27.9 p90 -109.74 160.54 16.23 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.704 HD21 HD13 ' A' ' 53' ' ' LEU . 27.3 tp -104.06 123.3 46.99 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.962 -175.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.29 173.14 7.13 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.451 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.474 HD11 ' HB3' ' A' ' 38' ' ' ALA . 74.4 mt -112.41 128.63 68.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.091 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -133.83 160.37 37.82 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 120.951 0.405 . . . . 0.0 110.244 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 105' ' ' ARG . 38.2 ttm180 -78.7 116.76 19.27 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.947 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -41.26 110.08 0.71 Allowed Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.976 174.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -80.51 176.78 8.8 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.804 2.336 . . . . 0.0 112.447 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 . . . . . 0 C--O 1.243 0.756 0 CA-C-O 118.977 -0.535 . . . . 0.0 111.032 179.128 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--O 1.235 0.336 0 CA-C-O 120.637 0.256 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.1 mtp -120.27 -86.17 0.65 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.991 0.424 . . . . 0.0 110.326 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.432 ' CZ ' HD13 ' A' ' 83' ' ' LEU . 41.2 t80 -156.97 130.4 8.02 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.27 -34.43 89.9 Favored Glycine 0 N--CA 1.46 0.28 0 C-N-CA 121.354 -0.451 . . . . 0.0 113.699 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.76 -46.75 2.3 Favored Glycine 0 C--N 1.317 -0.477 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.646 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 14.1 p -95.16 133.16 39.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.6 mt -113.01 140.02 48.17 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.078 0.466 . . . . 0.0 112.153 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -83.34 111.65 19.19 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -113.26 128.48 70.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.042 -172.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -95.78 125.03 40.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.432 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.24 29.48 2.71 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.242 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.88 88.57 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.976 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.427 ' HG3' ' CG2' ' A' ' 71' ' ' ILE . 19.9 mm-40 -78.17 -6.81 55.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.175 0.512 . . . . 0.0 110.556 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.42 HG22 HG23 ' A' ' 15' ' ' VAL . 43.5 mm -96.38 -53.47 8.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.439 ' CG1' HG22 ' A' ' 17' ' ' THR . 95.3 t -139.45 113.52 8.0 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.486 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.83 -25.16 60.59 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.903 2.402 . . . . 0.0 114.413 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.439 HG22 ' CG1' ' A' ' 15' ' ' VAL . 13.8 t -78.3 -13.59 59.79 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.423 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -138.41 79.78 29.32 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.7 -31.77 48.57 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.457 2.104 . . . . 0.0 112.811 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -130.0 138.35 50.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.072 0.463 . . . . 0.0 111.492 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.4 p -136.18 157.61 37.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.689 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.1 m -111.82 126.46 55.1 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.887 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' SER . 34.3 pt -124.32 161.86 26.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.652 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.8 tp -107.68 122.36 46.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.14 148.38 32.51 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.795 0.331 . . . . 0.0 110.567 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.586 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 41.6 mt-10 -101.36 148.17 25.47 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.495 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 18.1 tt -64.35 -30.43 50.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -77.49 -7.23 55.91 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.586 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 65.2 mm-40 -82.84 160.35 22.22 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.023 0.44 . . . . 0.0 110.937 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -89.92 170.05 10.71 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.872 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -62.29 -24.56 67.37 Favored 'General case' 0 C--O 1.21 -1.013 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.168 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' A' ' 78' ' ' PRO . 15.4 t70 -60.62 -47.43 86.27 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 120.71 0.291 . . . . 0.0 111.07 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.563 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 2.0 tpm_? -68.98 -41.61 77.65 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.348 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.09 -45.46 98.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.6 -44.91 92.61 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.924 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.97 -38.27 93.99 Favored Glycine 0 C--O 1.211 -1.297 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.317 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.39 -49.17 78.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.291 0.546 . . . . 0.0 110.829 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.465 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -69.61 -41.93 75.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.942 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 45' ' ' GLU . 25.8 tp -64.11 -35.21 80.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.891 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.31 -35.67 79.77 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.463 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -61.05 -37.9 84.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 110.321 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -88.19 -0.92 57.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.249 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.24 33.55 83.06 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.064 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.4 mt -121.15 12.59 11.09 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.538 ' HA ' HD23 ' A' ' 39' ' ' LEU . 44.5 tt0 -63.07 -24.65 68.01 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.867 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -57.26 -35.16 69.4 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.466 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 49.2 m -78.59 -85.4 0.07 Allowed 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.322 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.491 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 33.6 ttmt 63.1 -35.36 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.883 1.273 . . . . 0.0 113.915 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 47' ' ' SER . 36.3 t70 -64.64 -20.37 66.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.176 0.512 . . . . 0.0 111.373 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.466 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 12.4 p-10 -103.82 12.32 34.65 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.813 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -133.87 149.1 51.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.678 0.275 . . . . 0.0 111.171 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 pt -138.55 170.84 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.515 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.3 mt -100.85 137.23 39.51 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.464 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 17.4 m -123.17 129.96 74.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.221 0.534 . . . . 0.0 110.577 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 3.1 tm-20 -88.0 122.64 31.83 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.275 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.409 HG21 HG13 ' A' ' 71' ' ' ILE . 99.8 t -137.14 137.03 46.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.369 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.487 ' OG ' ' HA ' ' A' ' 61' ' ' ASP . 6.3 p -96.53 139.08 33.15 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.258 0.551 . . . . 0.0 110.616 176.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.704 ' H ' ' HG2' ' A' ' 94' ' ' GLU . 24.6 t-20 -64.01 -40.79 97.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.828 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -74.26 81.86 1.85 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.677 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.599 ' HA ' ' H ' ' A' ' 67' ' ' ASP . 2.8 p30 45.44 26.98 0.34 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.092 1.357 . . . . 0.0 113.34 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.756 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 24.9 t70 55.21 27.65 10.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.081 -175.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.756 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 7.7 ptm180 61.7 25.82 15.62 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.228 1.011 . . . . 0.0 112.418 172.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 61.9 mttp -132.89 -77.93 0.49 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.185 0.516 . . . . 0.0 110.862 -176.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 60' ' ' ASP . 21.6 t -137.0 150.91 48.41 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.441 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 24.8 ptt? -51.32 93.7 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.837 0.827 . . . . 0.0 112.539 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.8 m -115.39 -51.34 2.7 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.364 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.599 ' H ' ' HA ' ' A' ' 60' ' ' ASP . 29.5 t70 56.08 58.52 4.3 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.99 176.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.5 tp 63.76 90.93 0.08 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.575 0.702 . . . . 0.0 111.827 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -157.53 130.28 7.49 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.978 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 52.25 57.9 5.97 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.427 ' CG2' ' HG3' ' A' ' 13' ' ' GLU . 12.5 tt -46.13 108.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -173.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.29 84.28 1.26 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.696 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.24 -129.71 4.91 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.343 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.443 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . 0.5 OUTLIER -93.03 114.55 63.02 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.703 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.2 114.59 3.66 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.44 2.093 . . . . 0.0 111.518 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 74' ' ' ARG . 18.1 mt -120.57 100.84 46.67 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.191 -176.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -59.51 157.29 32.33 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.217 2.611 . . . . 0.0 112.269 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 2.3 Cg_endo -58.28 -25.31 71.9 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.352 2.702 . . . . 0.0 114.4 -175.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.2 t -76.64 -12.6 60.03 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -92.35 155.8 17.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.653 0.263 . . . . 0.0 111.357 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 76.6 m -116.14 86.28 16.87 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.857 0.361 . . . . 0.0 110.248 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.404 ' HB3' HD13 ' A' ' 76' ' ' ILE . 49.5 Cg_endo -69.97 -22.09 31.58 Favored 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 122.912 2.408 . . . . 0.0 114.249 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.495 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 81.1 mt -61.91 -37.95 86.57 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -175.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.45 ' HA ' HD11 ' A' ' 27' ' ' ILE . 23.1 m-85 -55.24 -46.42 76.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.972 0.415 . . . . 0.0 110.845 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.662 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 67.6 mm-40 -74.91 -42.51 57.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.557 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.6 mtp -59.96 -46.62 88.83 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.013 0.435 . . . . 0.0 111.197 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.8 m -65.05 -43.7 91.42 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.066 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.61 -37.49 79.82 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 27.7 mmt180 -86.1 -1.6 57.54 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.891 -174.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.54 ' HA ' ' HB2' ' A' ' 98' ' ' ASP . 42.5 p -54.14 113.86 1.4 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.45 27.8 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.037 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -123.29 -41.99 2.27 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.78 -161.82 28.5 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.978 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.704 ' HG2' ' H ' ' A' ' 58' ' ' ASN . 1.1 tm-20 69.85 174.53 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.395 0.678 . . . . 0.0 112.047 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.538 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 61.5 t30 -105.4 -20.47 13.48 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.647 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.34 -118.98 0.23 Allowed Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.809 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.479 ' C ' ' H ' ' A' ' 99' ' ' SER . 97.7 m-85 -120.93 84.48 2.24 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 3.7 t70 72.49 -37.86 0.4 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.113 0.965 . . . . 0.0 110.571 -176.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 97' ' ' PHE . 27.5 p -151.33 174.98 12.67 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.808 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -111.02 162.43 14.87 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.3 tp -117.01 125.68 51.74 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -124.95 171.36 10.26 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.825 -175.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 38' ' ' ALA . 71.8 mt -102.56 129.73 53.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.891 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -125.07 148.75 48.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.231 0.539 . . . . 0.0 110.912 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -80.09 102.0 9.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.655 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -63.66 152.63 85.75 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.598 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.48 165.58 32.3 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.76 2.307 . . . . 0.0 111.123 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 . . . . . 0 C--O 1.243 0.761 0 CA-C-O 118.737 -0.649 . . . . 0.0 110.066 -178.281 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 120.901 0.382 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 68.5 mtt -132.7 83.8 2.1 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.9 t80 60.01 -95.09 0.05 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.471 0.709 . . . . 0.0 110.025 -175.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 55.96 67.61 2.12 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 121.488 -0.386 . . . . 0.0 113.214 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.36 171.89 42.15 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.597 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 p -95.14 160.32 14.61 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.79 0.329 . . . . 0.0 110.515 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.4 mt -110.85 135.41 51.45 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.193 0.521 . . . . 0.0 111.926 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.18 109.72 17.96 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -116.84 129.98 72.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.706 -172.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.555 ' CE2' HD12 ' A' ' 71' ' ' ILE . 67.4 t80 -103.89 129.88 51.43 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.098 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.22 28.86 2.66 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.054 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.25 -30.33 75.65 Favored Glycine 0 N--CA 1.465 0.591 0 C-N-CA 121.646 -0.311 . . . . 0.0 113.481 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -61.98 -32.81 73.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 109.722 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.8 mt -91.99 -52.97 9.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.768 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.3 t -124.53 102.91 32.31 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.663 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.81 -22.37 43.05 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.076 2.517 . . . . 0.0 113.796 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -78.13 -15.96 58.38 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.941 0.401 . . . . 0.0 111.189 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -139.16 74.34 36.26 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-O 121.013 0.435 . . . . 0.0 109.855 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.05 -40.02 55.14 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.433 2.088 . . . . 0.0 112.936 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -120.55 135.89 54.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.232 0.539 . . . . 0.0 111.548 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.65 163.29 37.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.96 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -122.94 132.34 54.12 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.253 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 38' ' ' ALA . 43.3 pt -125.86 161.26 31.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.864 -177.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.37 113.38 25.98 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.61 142.16 23.52 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 72.4 mm-40 -95.56 169.93 9.7 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.071 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.473 HD11 ' HA ' ' A' ' 84' ' ' PHE . 16.0 tt -62.96 -26.54 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -84.63 1.61 45.34 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.4 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -80.76 143.53 32.84 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.909 0.385 . . . . 0.0 109.974 176.316 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -96.7 173.41 7.33 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.596 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -62.11 -24.14 66.96 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.78 -49.16 76.15 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.955 0.407 . . . . 0.0 110.392 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -76.15 -42.37 46.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.551 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.6 -44.76 99.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.857 0.361 . . . . 0.0 110.615 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.6 tp -65.55 -42.7 91.58 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.32 -46.1 94.91 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.74 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.598 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.14 -50.47 73.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.112 0.456 . . . . 0.0 111.449 -178.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.553 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -69.09 -44.24 72.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.722 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 45' ' ' GLU . 29.0 tp -64.94 -36.96 86.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.76 -177.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.46 -38.57 90.31 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.305 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.598 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.5 mmtt -60.26 -35.51 75.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 110.226 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -85.18 -2.19 57.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.871 0.367 . . . . 0.0 110.369 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.63 20.11 79.78 Favored Glycine 0 C--O 1.237 0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.905 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' C ' ' HG ' ' A' ' 39' ' ' LEU . 88.0 mt -116.36 16.08 15.75 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 44.3 tt0 -56.71 -34.15 67.17 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -70.27 -13.34 62.12 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 122.226 -0.296 . . . . 0.0 111.625 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.4 m -104.24 38.51 1.84 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 99.3 mttt -71.13 -11.52 60.99 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.841 -0.537 . . . . 0.0 111.402 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.558 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 7.4 m-20 -74.2 -7.24 51.98 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.176 0.512 . . . . 0.0 109.844 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -117.83 -13.33 10.12 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.118 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -129.24 147.05 51.04 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.528 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.5 HG23 ' HB3' ' A' ' 106' ' ' LYS . 48.5 pt -137.11 177.7 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.025 177.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.523 HD12 ' HB1' ' A' ' 31' ' ' ALA . 97.0 mt -100.5 138.51 37.47 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.745 0.307 . . . . 0.0 110.414 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 15.8 m -126.78 129.39 71.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.105 176.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.94 118.66 29.67 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.7 t -115.69 122.27 69.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.664 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.423 ' HA ' ' CB ' ' A' ' 99' ' ' SER . 6.5 m -72.83 134.35 44.84 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.873 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -65.66 -35.76 81.72 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.182 0.515 . . . . 0.0 109.991 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -77.16 91.93 3.76 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.172 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.611 ' CB ' ' HB3' ' A' ' 67' ' ' ASP . 29.7 t0 -111.36 -145.07 0.39 Allowed 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.72 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.565 ' H ' ' CG ' ' A' ' 60' ' ' ASP . 34.0 m-20 59.27 29.83 19.46 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 -169.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.446 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 22.3 ttt180 -153.91 -52.98 0.1 Allowed 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.69 -1.596 . . . . 0.0 111.596 -171.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.446 ' HG3' ' HG2' ' A' ' 62' ' ' ARG . 95.8 mttt -92.03 -39.24 11.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.692 -173.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.8 t -128.76 -30.41 2.28 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.2 mtt 62.37 30.07 17.33 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 t -173.84 34.77 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -176.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.611 ' HB3' ' CB ' ' A' ' 60' ' ' ASP . 11.0 p-10 -33.33 -70.08 0.08 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.66 1.584 . . . . 0.0 114.898 -173.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.0 tp -90.14 -23.46 21.34 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.446 -174.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -61.74 -45.84 92.19 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.034 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -103.45 -8.83 19.85 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.041 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.555 HD12 ' CE2' ' A' ' 10' ' ' TYR . 4.8 tt 36.66 78.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 122.334 1.064 . . . . 0.0 112.549 -176.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -118.83 111.04 17.92 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.075 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.86 -163.37 10.34 Favored Glycine 0 N--CA 1.434 -1.482 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.188 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 63.7 mtp180 -81.87 123.35 80.23 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.41 114.11 3.7 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 122.412 2.075 . . . . 0.0 111.52 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.7 mt -120.42 99.42 47.99 Favored Pre-proline 0 N--CA 1.434 -1.252 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.487 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -63.65 160.69 35.16 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.849 2.366 . . . . 0.0 111.782 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.601 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 50.6 Cg_exo -51.4 -33.15 45.33 Favored 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 123.863 3.042 . . . . 0.0 114.116 -176.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 m -61.64 -40.72 95.88 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -80.18 154.36 28.02 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 5.3 p -120.19 93.97 48.37 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.139 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.83 -17.66 41.8 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.711 2.274 . . . . 0.0 115.05 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 27' ' ' ILE . 60.0 mt -62.91 -34.45 77.46 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -176.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.562 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 21.8 m-85 -57.61 -30.79 65.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.106 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.57 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 50.7 mt-10 -86.91 -50.48 6.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.117 175.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.4 mtp -59.08 -71.92 0.11 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.983 -175.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 m -65.09 -47.83 75.86 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -175.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 84' ' ' PHE . . . -62.41 -51.12 68.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.57 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 9.1 mpt_? -73.3 -38.01 66.01 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.559 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 97' ' ' PHE . 78.0 p 57.04 177.14 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.983 0.913 . . . . 0.0 111.616 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.14 159.34 31.24 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 118.871 -1.633 . . . . 0.0 113.437 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -103.15 -21.85 13.83 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.27 53.87 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.113 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -124.71 -90.59 0.56 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.54 -0.33 . . . . 0.0 110.406 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -153.83 33.9 0.44 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.816 0.846 . . . . 0.0 108.849 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 90' ' ' SER . . . -112.66 -109.59 2.99 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.709 -1.234 . . . . 0.0 113.629 -174.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.455 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 14.3 t80 -106.47 6.01 29.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.108 0.956 . . . . 0.0 109.769 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.53 -6.95 58.08 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.855 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 22.8 p -98.87 172.2 7.58 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.282 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -128.57 158.51 38.25 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 175.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.403 HD21 HD13 ' A' ' 53' ' ' LEU . 30.6 tp -109.96 125.81 53.26 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.092 -177.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -123.9 169.11 11.92 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.411 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 38' ' ' ALA . 74.0 mt -111.59 130.03 65.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.716 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -127.91 164.57 21.98 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 121.154 0.502 . . . . 0.0 110.309 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -82.12 111.83 18.61 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.558 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.4 ptmt -48.26 152.75 1.43 Allowed Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.6 0.562 . . . . 0.0 112.271 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.41 154.98 65.02 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 C-N-CA 122.835 2.356 . . . . 0.0 111.646 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 . . . . . 0 C--N 1.292 -1.91 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.794 -178.769 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.9 m . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.523 0.202 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.2 mmm -66.08 -41.58 90.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.544 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -79.68 122.55 26.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.623 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.42 125.65 7.08 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.44 1.27 44.38 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.047 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.3 p -129.5 141.37 51.01 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.6 mt -109.17 142.22 40.27 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.544 ' HE2' ' CE1' ' A' ' 20' ' ' TYR . 87.2 tttt -82.05 108.2 15.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.473 HG11 ' CB ' ' A' ' 38' ' ' ALA . 71.0 t -114.7 131.57 66.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 120.832 0.349 . . . . 0.0 110.563 -173.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -114.71 119.62 37.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.296 0.57 . . . . 0.0 111.868 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.27 19.66 4.55 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.8 -22.61 60.04 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.413 -0.394 . . . . 0.0 113.633 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.01 -35.56 80.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.339 0.59 . . . . 0.0 109.931 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.51 -48.87 13.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.799 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.5 t -119.15 90.93 42.77 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.295 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.13 -30.48 93.28 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.665 2.91 . . . . 0.0 114.079 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -64.96 -23.5 67.24 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.497 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -133.74 79.92 57.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 18.1 Cg_endo -59.76 -48.83 11.58 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.394 2.063 . . . . 0.0 112.773 -178.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.544 ' CE1' ' HE2' ' A' ' 8' ' ' LYS . 86.6 m-85 -118.04 139.52 51.09 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.232 0.539 . . . . 0.0 111.279 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -134.54 161.01 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.879 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.5 p -119.36 130.85 55.55 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.062 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.49 HD11 HG23 ' A' ' 34' ' ' ILE . 40.5 pt -127.49 157.55 39.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.692 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.97 110.38 22.4 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.98 145.91 27.56 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.216 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -108.89 166.12 11.06 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.419 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.561 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 15.2 tt -64.97 -28.75 45.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.659 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -75.23 -4.32 38.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -92.79 145.14 24.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.401 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 32.9 m-20 -83.58 175.38 9.79 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.66 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.543 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -60.23 -25.63 65.79 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.688 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 30' ' ' ASN . 3.5 p-10 -65.15 -37.46 87.48 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.812 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -67.48 -46.9 71.61 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.071 0.462 . . . . 0.0 110.445 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.498 HG21 HD23 ' A' ' 101' ' ' LEU . 96.9 mt -64.8 -45.5 94.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.529 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 53.9 tp -63.43 -46.58 85.69 Favored 'General case' 0 C--O 1.21 -0.992 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.542 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 40' ' ' GLU . . . -66.88 -43.32 91.78 Favored Glycine 0 C--O 1.22 -0.759 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.095 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.01 -38.98 84.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.815 0.341 . . . . 0.0 111.394 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.606 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -84.2 -36.23 22.94 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 35' ' ' LEU . 28.8 tp -62.68 -36.98 84.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.565 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 56.9 mt-10 -58.3 -41.08 83.64 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.576 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 44.7 mmtm -62.61 -38.51 90.47 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.801 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.15 -2.98 58.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.555 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.51 26.78 62.55 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 114.322 0.489 . . . . 0.0 114.322 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 94.0 mt -118.53 15.56 13.74 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 117.251 0.526 . . . . 0.0 110.761 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -60.98 -29.07 69.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.539 -177.048 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -61.37 -33.49 73.74 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.886 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.4 m -83.33 -89.58 0.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.061 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt 67.28 -27.95 0.13 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.68 -20.19 65.93 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -113.18 19.52 17.05 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.753 0.311 . . . . 0.0 111.437 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.472 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 98.8 m-85 -124.9 144.14 50.48 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 122.301 -0.249 . . . . 0.0 110.832 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.472 HG23 ' HB2' ' A' ' 106' ' ' LYS . 43.1 pt -141.62 169.88 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.336 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.529 HD13 HD21 ' A' ' 101' ' ' LEU . 94.4 mt -102.02 146.66 27.58 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.658 0.266 . . . . 0.0 110.328 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.5 135.36 59.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.013 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -91.86 123.92 35.6 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.121 0.486 . . . . 0.0 111.121 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.541 HG21 ' CG1' ' A' ' 71' ' ' ILE . 63.1 t -128.18 131.81 68.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.284 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 p -103.9 92.17 4.29 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 120.81 0.338 . . . . 0.0 110.328 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -97.39 88.56 4.44 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.447 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.08 -27.29 63.51 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.544 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.495 ' HA ' ' HB3' ' A' ' 64' ' ' SER . 30.9 t70 61.92 23.21 13.63 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.902 0.858 . . . . 0.0 110.979 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -129.78 23.11 5.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.895 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.417 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 8.5 ttm180 -166.95 -60.25 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 121.144 0.497 . . . . 0.0 109.948 -175.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HG3' ' HG2' ' A' ' 62' ' ' ARG . 54.3 mtpt -82.34 0.42 41.84 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.495 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . 12.0 p -70.03 -19.34 63.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 114.546 -1.207 . . . . 0.0 110.391 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.3 ptp -63.99 -23.55 67.38 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.618 0.723 . . . . 0.0 109.59 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 t -115.98 -20.61 9.87 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.964 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 70.42 178.93 0.25 Allowed 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.632 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 68' ' ' LEU . 2.6 pt? -72.78 97.83 2.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.538 0.685 . . . . 0.0 110.898 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -106.1 129.12 54.25 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.454 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 36.79 81.36 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.619 1.199 . . . . 0.0 110.599 -177.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.563 HG23 ' HD3' ' A' ' 104' ' ' LYS . 19.6 tt -51.12 123.63 2.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-O 121.795 0.807 . . . . 0.0 113.162 -173.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -143.76 134.76 25.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.199 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.41 -152.56 5.69 Favored Glycine 0 CA--C 1.508 -0.399 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -86.71 130.24 49.64 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 117.536 0.668 . . . . 0.0 109.795 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.44 117.71 5.15 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.364 2.043 . . . . 0.0 112.034 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.4 mt -119.33 103.0 47.69 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.307 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.23 156.76 48.73 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.922 2.415 . . . . 0.0 111.629 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.543 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 27.5 Cg_endo -63.87 -16.18 53.36 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.908 2.405 . . . . 0.0 113.384 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.9 p -83.36 -12.46 56.51 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -91.14 158.05 16.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.515 0.198 . . . . 0.0 110.929 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.7 m -115.52 85.29 13.33 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.91 -26.93 58.86 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.628 2.219 . . . . 0.0 113.695 -175.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.561 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 77.1 mt -62.92 -37.96 89.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.414 ' HA ' HD11 ' A' ' 27' ' ' ILE . 35.2 m-85 -65.66 -14.95 62.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.537 0.208 . . . . 0.0 111.535 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -95.66 -41.65 8.79 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.484 ' SD ' HD23 ' A' ' 83' ' ' LEU . 91.3 mtp -61.73 -46.23 90.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.023 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.2 m -76.3 -23.19 54.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.453 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.04 -50.54 61.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.92 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.1 ttt-85 -84.27 -47.86 10.35 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.315 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.3 p 47.46 59.58 4.02 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.46 0.704 . . . . 0.0 112.057 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.83 -120.83 0.67 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.504 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -138.36 136.13 36.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.95 0.405 . . . . 0.0 110.596 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.23 -121.52 1.05 Allowed Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -83.46 -83.53 0.14 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -138.78 10.76 2.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.254 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -147.74 98.05 0.19 Allowed Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 119.533 -1.317 . . . . 0.0 112.454 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 58.43 -157.96 0.3 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.001 0.52 . . . . 0.0 111.245 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.33 -44.35 95.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.173 0.511 . . . . 0.0 110.88 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.7 m -138.66 162.7 33.99 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.737 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -108.72 159.69 16.55 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.529 HD21 HD13 ' A' ' 53' ' ' LEU . 29.8 tp -103.97 125.45 50.36 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.034 0.445 . . . . 0.0 111.309 -172.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.73 171.15 11.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.254 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 38' ' ' ALA . 80.4 mt -109.22 129.81 63.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.187 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.563 ' HD3' HG23 ' A' ' 71' ' ' ILE . 12.9 mmmm -135.79 168.0 20.12 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.705 175.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.472 ' HG2' ' CE1' ' A' ' 51' ' ' PHE . 66.5 mtp180 -91.71 139.88 30.25 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.251 -178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.487 ' HG2' ' H ' ' A' ' 108' ' ' HIS . 34.6 ttpt -90.6 141.23 26.95 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.101 177.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -53.66 -38.77 84.67 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.376 2.051 . . . . 0.0 110.894 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.487 ' H ' ' HG2' ' A' ' 106' ' ' LYS . 43.7 t60 . . . . . 0 C--O 1.244 0.777 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.151 175.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.758 0.313 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 71.2 mtm -64.94 -41.86 95.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.108 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.1 t80 70.11 121.75 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.797 0.686 . . . . 0.0 110.844 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.72 -42.96 98.45 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.83 -0.623 . . . . 0.0 114.194 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.92 -55.5 0.55 Allowed Glycine 0 C--N 1.318 -0.459 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.794 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.3 m -94.29 138.49 32.22 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.5 mt -105.85 140.47 38.83 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -82.27 102.53 11.23 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.895 174.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.427 HG21 HG12 ' A' ' 23' ' ' ILE . 41.0 t -108.46 120.36 59.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.103 -175.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -105.07 123.18 47.36 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.219 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.39 17.64 6.54 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.79 -22.17 59.42 Favored Glycine 0 N--CA 1.462 0.416 0 C-N-CA 121.695 -0.288 . . . . 0.0 112.686 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -63.34 -35.38 80.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -92.0 -48.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.73 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.24 106.45 33.28 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -63.86 -22.26 68.98 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.598 2.198 . . . . 0.0 111.32 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -78.68 -15.83 58.01 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.62 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -144.38 71.03 16.0 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.935 0.398 . . . . 0.0 110.199 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 45.3 Cg_exo -57.09 -45.53 35.05 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.065 2.51 . . . . 0.0 113.594 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.26 140.87 52.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 22' ' ' SER . 9.7 p -139.29 167.41 20.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.411 ' H ' HG22 ' A' ' 21' ' ' VAL . 37.6 m -132.03 133.4 44.36 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.483 HD11 HG23 ' A' ' 34' ' ' ILE . 33.8 pt -129.38 163.08 35.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.402 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.7 tp -111.18 121.45 45.34 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.47 143.64 26.85 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.117 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.66 161.36 14.94 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.507 HD11 ' HA ' ' A' ' 84' ' ' PHE . 17.4 tt -62.85 -28.0 44.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.798 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -69.34 -24.04 63.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.312 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.69 139.15 58.74 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.525 0.678 . . . . 0.0 111.197 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -89.67 175.53 7.22 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.437 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -61.01 -33.79 73.81 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.217 -178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.08 -50.02 75.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.626 0.25 . . . . 0.0 111.486 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -69.13 -41.05 77.84 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.835 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.483 HG23 HD11 ' A' ' 23' ' ' ILE . 96.8 mt -64.4 -44.04 97.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.606 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.69 -44.0 97.37 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.978 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.7 -41.02 99.12 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.472 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.03 -49.68 75.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.932 0.396 . . . . 0.0 111.449 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.48 -43.86 72.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.661 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 26.7 tp -64.29 -32.73 74.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.326 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.09 -39.96 87.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.813 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -62.4 -36.31 81.92 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -80.73 -12.35 59.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.313 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.58 20.69 76.32 Favored Glycine 0 C--O 1.229 -0.169 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.243 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 85.5 mt -108.52 12.84 25.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.799 0.333 . . . . 0.0 110.615 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -59.26 -24.86 63.58 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.919 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -64.24 -33.29 75.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.002 0.43 . . . . 0.0 110.272 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.406 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 33.2 m -79.23 -89.39 0.05 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.056 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt 68.1 -39.99 0.41 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.613 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 35.2 m-20 -65.58 -19.74 66.04 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 120.728 0.299 . . . . 0.0 111.618 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.507 ' C ' ' HG2' ' A' ' 106' ' ' LYS . 15.2 p-10 -103.79 11.48 35.74 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.82 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -131.91 147.54 52.48 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.708 0.289 . . . . 0.0 110.893 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.3 pt -138.56 170.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.6 mt -100.46 141.8 32.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.749 0.309 . . . . 0.0 110.176 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 28.6 m -125.22 132.71 70.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 120.994 0.426 . . . . 0.0 110.923 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.521 ' HG3' ' HG2' ' A' ' 86' ' ' MET . 1.6 tm-20 -87.58 129.59 35.05 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 58' ' ' ASN . 16.1 t -128.18 117.13 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.368 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 7.5 m -77.77 -1.15 29.96 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 123.59 0.756 . . . . 0.0 110.781 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.581 ' O ' ' HE2' ' A' ' 100' ' ' PHE . 11.3 m120 -84.43 64.0 8.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.56 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -40.05 -50.9 2.6 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 114.586 -1.188 . . . . 0.0 114.099 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -152.04 -160.84 1.2 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.675 0.274 . . . . 0.0 111.313 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.69 -20.79 61.88 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.227 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.453 ' HG3' ' HG3' ' A' ' 63' ' ' LYS . 13.0 ptt180 -59.08 -31.44 68.89 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 120.823 0.344 . . . . 0.0 110.4 177.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.453 ' HG3' ' HG3' ' A' ' 62' ' ' ARG . 67.0 mttm -128.53 14.63 6.55 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.7 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.8 t -118.2 -39.35 3.07 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.1 mtt 54.12 25.88 6.06 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.474 0.654 . . . . 0.0 110.288 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.8 t -149.78 2.74 0.53 Allowed 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.303 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 59.11 35.17 23.69 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.687 -176.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.1 mp 65.19 95.81 0.05 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.361 -176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -137.94 -60.99 0.63 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.128 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -93.41 118.75 31.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.005 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 40.1 mt -126.82 127.66 70.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -97.13 -54.29 3.22 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 172.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.09 -178.47 16.58 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.99 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 76' ' ' ILE . 14.2 ttp180 -111.3 112.77 54.55 Favored Pre-proline 0 N--CA 1.437 -1.09 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.62 116.51 3.28 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.024 2.483 . . . . 0.0 113.043 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 74' ' ' ARG . 32.9 mt -121.81 103.71 39.94 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.089 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 46.6 Cg_exo -62.12 155.54 55.53 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.684 2.256 . . . . 0.0 112.106 177.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.441 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 52.2 Cg_exo -54.56 -33.26 77.92 Favored 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.775 2.983 . . . . 0.0 113.939 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 p -66.18 -24.64 66.68 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.3 155.21 19.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.683 0.278 . . . . 0.0 111.7 -177.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 59.0 m -105.8 93.98 8.25 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.465 ' HB3' HD13 ' A' ' 76' ' ' ILE . 50.6 Cg_endo -69.21 -28.39 27.95 Favored 'Trans proline' 0 C--O 1.218 -0.477 0 C-N-CA 122.842 2.362 . . . . 0.0 115.244 -173.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.49 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 86.7 mt -61.88 -38.69 89.26 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -173.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.507 ' HA ' HD11 ' A' ' 27' ' ' ILE . 58.9 m-85 -59.16 -39.51 82.67 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.189 0.519 . . . . 0.0 110.847 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -83.98 -32.92 24.73 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.663 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.642 ' O ' ' HB2' ' A' ' 90' ' ' SER . 85.0 mtp -62.76 -40.97 98.91 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.167 0.508 . . . . 0.0 111.692 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.5 p -72.45 -41.2 66.37 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.36 -60.15 1.64 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -69.89 -43.81 71.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.669 -174.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.642 ' HB2' ' O ' ' A' ' 86' ' ' MET . 69.3 m -69.66 170.08 11.53 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.444 -177.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.481 ' HA3' ' N ' ' A' ' 96' ' ' GLY . . . 115.28 85.06 1.23 Allowed Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.744 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 57' ' ' SER . 58.2 t30 -76.24 -18.99 58.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.221 0.534 . . . . 0.0 110.452 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.02 -78.88 1.14 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.837 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -115.58 23.2 12.54 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.881 -0.188 . . . . 0.0 111.109 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 55.3 t30 60.17 56.3 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.518 0.675 . . . . 0.0 109.579 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.481 ' N ' ' HA3' ' A' ' 91' ' ' GLY . . . -149.96 -137.8 2.8 Favored Glycine 0 CA--C 1.493 -1.328 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.201 -178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.32 33.12 0.45 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.547 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.456 ' HB2' ' HA2' ' A' ' 91' ' ' GLY . 14.9 m-20 -70.3 -13.37 62.13 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 68.0 m -98.0 130.6 44.83 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.12 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.581 ' HE2' ' O ' ' A' ' 58' ' ' ASN . 44.3 p90 -114.48 169.47 9.02 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.72 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.6 tp -119.54 122.51 41.78 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.987 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.98 167.63 12.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.967 -177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.63 126.03 56.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -120.01 156.83 30.12 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.682 0.753 . . . . 0.0 111.643 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -85.55 112.1 20.63 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.764 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.613 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.6 ptmt -75.19 154.61 86.35 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.857 -178.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.1 -28.9 81.09 Favored 'Trans proline' 0 N--CA 1.477 0.538 0 C-N-CA 122.918 2.412 . . . . 0.0 111.899 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 58.2 t60 . . . . . 0 C--O 1.243 0.733 0 O-C-N 124.036 0.835 . . . . 0.0 110.728 178.381 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.9 p . . . . . 0 C--O 1.239 0.548 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 78.0 mtm 66.97 -69.51 0.13 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.686 0.794 . . . . 0.0 112.148 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -83.57 117.62 23.27 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.89 -35.02 91.41 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.743 -177.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.8 -10.71 64.42 Favored Glycine 0 C--N 1.318 -0.455 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.228 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.0 p -135.27 151.19 50.34 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.4 mt -122.38 135.65 54.74 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.292 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -87.49 100.57 12.86 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.554 HG11 ' CB ' ' A' ' 38' ' ' ALA . 72.8 t -95.34 122.1 46.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.598 -173.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 82.8 t80 -92.03 120.99 33.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.123 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.47 23.82 4.0 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -61.28 -26.9 66.74 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.279 -0.46 . . . . 0.0 113.375 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.413 ' OE1' ' HG2' ' A' ' 104' ' ' LYS . 44.2 tt0 -64.17 -46.51 83.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.27 -50.1 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.291 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.85 98.14 50.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.131 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.05 -21.77 42.48 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.748 2.298 . . . . 0.0 113.256 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 t -84.78 -6.45 59.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.708 0.29 . . . . 0.0 111.412 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -148.01 80.11 8.89 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.497 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 28.2 Cg_endo -62.87 -48.97 5.8 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.849 2.366 . . . . 0.0 114.111 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -120.21 138.02 53.87 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.017 0.437 . . . . 0.0 111.812 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -127.82 144.27 38.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.793 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 p -96.75 115.73 27.92 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.238 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 34' ' ' ILE . 18.5 pt -117.49 158.34 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.817 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.81 122.83 44.71 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.38 144.79 24.83 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -104.06 158.51 16.38 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.917 0.389 . . . . 0.0 110.425 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 84' ' ' PHE . 14.2 tt -65.24 -26.69 40.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.464 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.47 9.18 11.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.808 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -109.71 146.43 34.9 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.421 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 39.7 m-80 -76.25 174.56 9.99 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.216 0.532 . . . . 0.0 111.236 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.606 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -61.62 -26.48 68.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.843 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.433 ' CB ' ' HB3' ' A' ' 78' ' ' PRO . 1.4 p30 -63.52 -36.92 85.38 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.502 0.192 . . . . 0.0 110.883 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -66.32 -43.81 85.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.099 0.476 . . . . 0.0 110.014 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.494 HG23 HD11 ' A' ' 23' ' ' ILE . 96.7 mt -64.72 -46.16 93.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.322 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.76 -46.71 84.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.197 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -66.19 -43.2 93.57 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.257 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.688 ' O ' ' HD3' ' A' ' 41' ' ' LYS . . . -61.6 -48.81 79.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.867 0.365 . . . . 0.0 111.283 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.554 ' CB ' HG11 ' A' ' 9' ' ' VAL . . . -68.22 -40.68 82.0 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.465 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.83 -36.7 84.76 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.517 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.95 -37.18 78.81 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.387 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.688 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 6.5 mptt -61.43 -37.33 83.12 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.62 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -90.68 -0.13 57.59 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.2 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.84 26.28 71.69 Favored Glycine 0 C--O 1.238 0.365 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.879 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.0 mt -113.81 19.98 16.21 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 122.642 -0.328 . . . . 0.0 111.188 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -52.16 -39.47 60.05 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.343 0.657 . . . . 0.0 111.765 -175.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -72.58 -22.06 61.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.547 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.3 m -93.19 21.22 6.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.836 0.35 . . . . 0.0 111.295 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 32.2 ttmt -59.71 -33.84 72.14 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.893 -176.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.89 -7.8 4.2 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.546 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -106.51 -6.95 17.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -127.76 155.03 44.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -173.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.0 pt -138.66 176.28 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.458 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.606 HD12 ' HB1' ' A' ' 31' ' ' ALA . 98.5 mt -101.51 143.45 31.49 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.727 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.552 HG21 ' HD3' ' A' ' 104' ' ' LYS . 25.7 m -127.9 130.41 69.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.416 177.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.457 ' HB2' HD11 ' A' ' 76' ' ' ILE . 1.7 tt0 -90.27 121.48 32.32 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 61' ' ' ASP . 63.6 t -121.08 137.12 55.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.132 0.492 . . . . 0.0 111.938 -175.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 93' ' ' GLY . 14.0 m -68.48 144.55 54.6 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.364 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -67.92 -24.24 65.18 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.13 76.39 1.76 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.224 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 61' ' ' ASP . 15.2 m-20 42.03 70.38 0.29 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.898 1.279 . . . . 0.0 112.35 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 25.2 t70 73.08 -69.83 0.18 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.373 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -169.82 93.12 0.24 Allowed 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt 62.01 10.29 3.54 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 167.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -140.38 176.32 8.87 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.141 -175.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 49.7 ttp -91.36 19.37 6.1 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 p -61.06 -32.3 71.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.297 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 7.2 t70 67.57 -170.99 0.19 Allowed 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.224 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.8 mt -76.31 -5.38 46.81 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.588 0.232 . . . . 0.0 111.607 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -72.99 129.88 39.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 57.98 36.96 26.6 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.885 0.85 . . . . 0.0 109.542 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.5 tt -54.17 142.74 7.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.594 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -160.55 141.43 11.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.03 0.443 . . . . 0.0 110.958 175.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -131.28 -150.92 6.84 Favored Glycine 0 C--N 1.314 -0.688 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 18.7 ptt85 -83.56 128.65 63.06 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-N 117.375 0.587 . . . . 0.0 109.443 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 24.2 Cg_exo -61.69 119.2 6.21 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.248 1.965 . . . . 0.0 111.921 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.457 HD11 ' HB2' ' A' ' 55' ' ' GLU . 65.6 mt -120.33 100.1 47.72 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.153 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 27.1 Cg_exo -67.12 155.69 69.59 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.734 2.289 . . . . 0.0 111.384 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.433 ' HB3' ' CB ' ' A' ' 32' ' ' ASP . 51.8 Cg_exo -54.66 -32.53 75.78 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 123.489 2.792 . . . . 0.0 113.262 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m -62.69 -41.92 99.37 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.291 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.74 148.91 50.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 5.6 m -104.27 85.96 1.22 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.411 ' O ' ' HG3' ' A' ' 86' ' ' MET . 56.2 Cg_endo -69.46 -24.77 30.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.604 2.203 . . . . 0.0 114.159 -173.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 27' ' ' ILE . 33.3 mt -63.76 -37.89 89.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -175.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.678 ' HA ' HD11 ' A' ' 27' ' ' ILE . 26.7 m-85 -58.21 -46.28 86.16 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.32 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.26 -39.68 82.15 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.005 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 97' ' ' PHE . 12.1 mtm -64.75 -42.72 94.94 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.788 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 m -84.9 -22.8 29.17 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.834 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.47 -41.55 98.86 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.611 0.243 . . . . 0.0 111.313 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.551 ' HB3' HD21 ' A' ' 95' ' ' ASN . 57.5 mtm-85 -103.7 -55.45 2.38 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.694 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.5 t 58.56 166.7 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.655 ' O ' ' HB3' ' A' ' 95' ' ' ASN . . . 79.21 158.58 13.83 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.668 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.483 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 32.1 t-20 67.78 123.32 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.143 0.577 . . . . 0.0 110.343 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 57' ' ' SER . . . -70.27 62.02 0.8 Allowed Glycine 0 N--CA 1.468 0.819 0 C-N-CA 121.399 -0.429 . . . . 0.0 113.448 -177.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.421 ' H ' ' H ' ' A' ' 95' ' ' ASN . 12.2 pt-20 -175.19 -20.56 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 124.336 1.054 . . . . 0.0 108.887 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.655 ' HB3' ' O ' ' A' ' 91' ' ' GLY . 48.7 t30 -100.83 73.06 1.55 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.537 -174.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 86' ' ' MET . . . 66.2 -96.37 0.27 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 172.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.505 ' HB2' ' O ' ' A' ' 86' ' ' MET . 5.4 t80 -61.63 -42.26 98.64 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -170.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 92' ' ' ASN . 12.3 t70 -71.65 -8.84 56.58 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.691 0.758 . . . . 0.0 110.196 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 19.8 m -96.8 179.92 4.8 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -123.24 158.59 30.57 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.478 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -111.64 127.36 55.73 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.465 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.46 166.18 14.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.209 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.428 HD11 ' HB3' ' A' ' 38' ' ' ALA . 68.3 mt -106.86 122.84 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.636 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.552 ' HD3' HG21 ' A' ' 54' ' ' VAL . 25.3 mtpp -132.31 167.14 20.39 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 177.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -75.11 141.41 43.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -60.91 160.51 20.07 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.092 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.62 144.72 84.67 Favored 'Trans proline' 0 CA--C 1.507 -0.872 0 C-N-CA 122.352 2.034 . . . . 0.0 112.464 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 . . . . . 0 C--N 1.297 -1.676 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.526 -176.265 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 120.573 0.225 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.7 mtt -97.43 12.91 31.61 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -61.85 -45.94 91.59 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.114 0.483 . . . . 0.0 110.957 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.55 -60.37 4.27 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.113 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.44 -26.33 8.19 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.187 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.5 m -109.69 146.69 34.44 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.7 mt -114.36 135.09 54.46 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.86 101.48 11.01 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.473 HG21 HG12 ' A' ' 23' ' ' ILE . 61.4 t -102.66 121.13 53.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.228 -171.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.413 ' CE2' ' HG2' ' A' ' 13' ' ' GLU . 69.9 t80 -92.54 104.33 16.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.41 0.624 . . . . 0.0 110.984 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.22 16.61 22.31 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.885 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.67 -23.7 58.92 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.555 -0.355 . . . . 0.0 112.385 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.413 ' HG2' ' CE2' ' A' ' 10' ' ' TYR . 59.7 mm-40 -65.78 -36.02 82.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.119 0.485 . . . . 0.0 110.185 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.7 mm -86.07 -50.31 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.609 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -128.51 105.31 19.23 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.371 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.16 -36.52 96.6 Favored 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 123.647 2.898 . . . . 0.0 112.228 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 m -63.45 -26.97 68.97 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.723 -176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.07 79.02 69.95 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.49 -43.85 47.48 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.593 2.196 . . . . 0.0 112.927 -178.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -128.53 139.73 52.16 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.126 0.489 . . . . 0.0 111.311 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.76 161.35 41.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 p -119.87 130.31 54.8 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.045 0.45 . . . . 0.0 111.265 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.473 HG12 HG21 ' A' ' 9' ' ' VAL . 36.7 pt -130.4 157.34 42.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.427 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.5 mp -105.0 121.91 44.76 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.54 145.8 43.35 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.019 0.438 . . . . 0.0 111.194 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 62.3 mt-10 -97.7 152.11 19.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.114 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.572 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.7 tt -67.11 -29.4 45.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.915 -177.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -93.25 13.32 21.64 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.195 0.521 . . . . 0.0 110.078 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 37.0 tt0 -99.42 137.14 38.34 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -76.85 165.24 24.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.349 0.595 . . . . 0.0 112.479 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.549 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -63.1 -23.19 67.33 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.733 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.8 -45.57 93.27 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.797 0.332 . . . . 0.0 111.015 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -69.89 -42.38 73.5 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.958 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.47 -48.7 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.552 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.2 tp -63.62 -44.52 93.67 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.228 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.11 93.92 Favored Glycine 0 C--O 1.212 -1.265 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.17 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.38 -51.11 70.88 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.256 0.528 . . . . 0.0 111.238 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.445 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -69.24 -39.83 78.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.317 0.579 . . . . 0.0 111.133 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 45' ' ' GLU . 30.5 tp -64.38 -38.24 90.32 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.027 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -65.67 -26.76 67.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.179 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 74.7 mmtt -59.84 -30.37 68.92 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.325 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -101.36 1.68 38.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.244 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.95 27.69 73.69 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.74 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.1 mt -112.81 23.0 13.92 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' HA ' HD23 ' A' ' 39' ' ' LEU . 13.1 pt-20 -60.34 -30.32 69.46 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -175.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -71.34 -20.17 62.2 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.992 0.425 . . . . 0.0 110.979 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.6 m -90.39 6.73 41.98 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.975 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -56.73 -16.07 5.75 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.368 0.667 . . . . 0.0 112.74 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.34 -34.19 74.87 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.843 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.577 ' OD2' ' HD3' ' A' ' 105' ' ' ARG . 20.6 t0 -107.48 15.94 24.33 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.05 148.83 50.57 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.868 -0.52 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.4 pt -140.17 170.3 15.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.262 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.452 HD12 ' HB1' ' A' ' 31' ' ' ALA . 97.8 mt -101.39 141.59 34.04 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.691 0.281 . . . . 0.0 110.514 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.568 HG21 ' HG3' ' A' ' 104' ' ' LYS . 28.3 m -124.21 129.26 74.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.15 0.5 . . . . 0.0 109.872 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.446 ' HB3' ' HD3' ' A' ' 74' ' ' ARG . 14.8 tt0 -88.17 134.92 33.66 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.427 HG21 HD13 ' A' ' 71' ' ' ILE . 18.9 t -131.5 120.45 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -175.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.468 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 12.6 m -71.77 146.46 48.06 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.3 89.74 7.04 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.004 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -144.57 -85.25 0.13 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.683 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.529 ' HB2' ' H ' ' A' ' 63' ' ' LYS . 1.7 m-20 56.01 34.79 24.38 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.507 ' HB3' ' O ' ' A' ' 60' ' ' ASP . 7.8 t70 72.12 -63.76 0.42 Allowed 'General case' 0 C--N 1.362 1.14 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -167.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 175.53 79.19 0.0 OUTLIER 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 112.755 -2.021 . . . . 0.0 108.363 167.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.529 ' H ' ' HB2' ' A' ' 60' ' ' ASP . 67.1 mmtt 58.89 42.38 19.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.431 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.9 t -142.17 -58.09 0.46 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.021 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.6 ttp -60.85 -49.54 77.07 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.074 0.464 . . . . 0.0 110.402 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.447 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 12.2 m -102.26 -20.84 14.49 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.927 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.684 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 22.9 t70 63.34 -85.14 0.02 OUTLIER 'General case' 0 C--N 1.349 0.558 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.882 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' A' ' 67' ' ' ASP . 15.6 mt 175.13 -41.64 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 126.161 1.784 . . . . 0.0 107.886 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -72.03 127.31 32.15 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.882 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 62.8 95.65 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.166 0.986 . . . . 0.0 110.707 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 56' ' ' VAL . 80.8 mt -105.07 129.13 58.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.895 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.3 -61.74 1.86 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.272 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 52.94 -149.94 10.46 Favored Glycine 0 N--CA 1.466 0.685 0 CA-C-N 115.566 -0.743 . . . . 0.0 113.99 176.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.446 ' HD3' ' HB3' ' A' ' 55' ' ' GLU . 5.8 ptm180 -119.76 121.34 29.87 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 15.9 Cg_exo -66.47 118.4 5.5 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.308 2.005 . . . . 0.0 112.094 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.413 HG21 ' HB3' ' A' ' 82' ' ' PRO . 36.5 mt -121.64 102.6 41.75 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.143 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.77 154.02 74.79 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.757 2.305 . . . . 0.0 111.905 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.549 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 4.2 Cg_endo -57.05 -26.84 70.88 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.633 2.888 . . . . 0.0 113.536 -177.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.4 m -62.4 -40.22 95.79 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.06 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -82.02 157.63 24.11 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.063 0.545 . . . . 0.0 112.323 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 66.4 m -109.05 91.89 10.03 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HB3' HG21 ' A' ' 76' ' ' ILE . 47.6 Cg_endo -68.53 -18.91 43.13 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.051 2.501 . . . . 0.0 115.109 -173.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 27' ' ' ILE . 33.9 mt -63.01 -28.78 70.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -173.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.441 ' HA ' HD11 ' A' ' 27' ' ' ILE . 44.1 m-85 -59.01 -44.19 91.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 110.489 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -80.13 -34.28 37.9 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.596 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.562 ' HB2' ' HA ' ' A' ' 83' ' ' LEU . 2.3 tmm? -58.83 -43.0 90.56 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.212 0.605 . . . . 0.0 111.082 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.464 HG23 ' HE2' ' A' ' 97' ' ' PHE . 11.9 m -74.46 -44.56 51.05 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.28 -63.97 1.11 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -175.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.75 -36.7 83.06 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.561 ' HB2' ' HA ' ' A' ' 86' ' ' MET . 2.9 t -70.03 -176.47 1.14 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.325 0.583 . . . . 0.0 111.613 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.513 ' HA3' ' HA2' ' A' ' 96' ' ' GLY . . . 83.44 36.4 14.45 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -175.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -102.42 12.24 36.83 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.103 -0.549 . . . . 0.0 109.779 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.468 ' CA ' ' HB3' ' A' ' 57' ' ' SER . . . -88.37 -53.94 2.52 Favored Glycine 0 CA--C 1.496 -1.143 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.186 178.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.526 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 1.1 tm-20 -113.23 -70.08 0.83 Allowed 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -157.81 1.42 0.11 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.552 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.513 ' HA2' ' HA3' ' A' ' 91' ' ' GLY . . . 142.38 129.34 2.38 Favored Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 118.062 -2.018 . . . . 0.0 112.881 -175.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.464 ' HE2' HG23 ' A' ' 87' ' ' THR . 2.0 t80 46.18 29.76 0.86 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.255 1.022 . . . . 0.0 111.34 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 94' ' ' GLU . 1.8 p30 -89.26 10.05 23.62 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.681 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.6 p -95.5 148.78 22.13 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.312 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -130.48 169.6 15.33 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.83 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.1 tp -118.16 122.33 42.77 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.063 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.07 165.96 12.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.473 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 38' ' ' ALA . 72.3 mt -107.01 124.84 63.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.8 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.568 ' HG3' HG21 ' A' ' 54' ' ' VAL . 1.4 mmpt? -128.94 152.19 48.84 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.422 0.63 . . . . 0.0 110.537 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.577 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 2.4 tmm_? -79.32 126.36 30.7 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.317 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -67.35 113.09 12.11 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.213 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.23 -179.97 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.166 2.577 . . . . 0.0 112.594 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 . . . . . 0 C--O 1.243 0.732 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.006 179.784 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.238 0.478 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.5 mtt -74.63 97.52 3.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.8 0.333 . . . . 0.0 111.484 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.453 ' CZ ' HD13 ' A' ' 83' ' ' LEU . 79.4 t80 -64.24 -44.66 91.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.648 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.56 -70.38 1.65 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.017 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.4 -35.28 2.61 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.188 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 p -95.52 137.45 34.56 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.448 HD11 HD21 ' A' ' 83' ' ' LEU . 62.0 mt -112.19 135.16 53.21 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 121.179 0.514 . . . . 0.0 112.029 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -82.67 108.86 16.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' A' ' 23' ' ' ILE . 56.6 t -116.82 130.43 71.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.658 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -108.38 116.89 32.81 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.763 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.17 -33.64 7.16 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 45.89 -90.98 0.01 OUTLIER Glycine 0 C--N 1.338 0.692 0 N-CA-C 115.991 1.156 . . . . 0.0 115.991 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.64 -39.13 91.1 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.5 mt -65.26 -44.77 94.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.174 0.511 . . . . 0.0 111.262 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 42' ' ' TYR . 49.7 t -132.05 88.78 40.01 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.114 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.55 -25.86 81.6 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 123.189 2.593 . . . . 0.0 112.94 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.1 t -79.14 -5.32 53.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.732 0.301 . . . . 0.0 111.468 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -154.29 76.3 5.71 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 121.174 0.512 . . . . 0.0 109.81 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.09 -43.11 61.26 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.031 2.488 . . . . 0.0 113.142 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -118.98 143.77 46.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.14 0.495 . . . . 0.0 112.146 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.98 158.59 39.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.904 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -116.55 124.35 49.65 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.465 ' CD1' HG21 ' A' ' 9' ' ' VAL . 40.6 pt -125.33 161.75 29.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.65 -177.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.0 mp -111.69 125.88 54.44 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.87 148.16 30.55 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.79 0.329 . . . . 0.0 110.897 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . 74.9 mm-40 -94.81 149.89 20.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.492 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 16.8 tt -63.21 -26.63 41.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.719 -0.392 . . . . 0.0 112.041 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -77.36 -7.64 56.39 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.256 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.544 ' OE2' ' HD3' ' A' ' 33' ' ' ARG . 47.3 mt-10 -84.83 140.22 31.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.087 0.47 . . . . 0.0 110.874 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -78.64 173.87 11.99 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.58 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.577 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -61.36 -27.53 68.57 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.923 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -63.24 -38.57 91.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.755 0.312 . . . . 0.0 110.445 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.544 ' HD3' ' OE2' ' A' ' 29' ' ' GLU . 3.2 mmp_? -69.84 -44.3 70.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.075 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.442 HG23 HD11 ' A' ' 23' ' ' ILE . 97.1 mt -64.65 -44.83 96.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.361 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.84 -44.56 95.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.731 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.452 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -66.4 -38.95 93.99 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.999 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.02 -51.06 71.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.829 0.347 . . . . 0.0 111.046 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.472 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -68.04 -40.79 82.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.105 0.478 . . . . 0.0 110.959 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.3 tp -63.13 -39.1 93.7 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.084 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.8 -35.29 77.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.913 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.4 mmtt -61.67 -38.05 86.36 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.836 0.35 . . . . 0.0 110.336 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.506 ' CD1' HG21 ' A' ' 15' ' ' VAL . 79.0 m-85 -85.76 -5.75 59.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.658 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.56 20.27 79.81 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.401 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.0 mt -104.09 23.29 13.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.722 0.296 . . . . 0.0 110.761 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.81 -25.64 20.25 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -78.53 -13.46 59.82 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -177.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.7 m -106.68 22.68 15.5 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 36.5 ttmt -60.47 -32.93 71.87 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.79 -28.9 66.41 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.846 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.75 -6.13 59.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.279 -176.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 69.7 m-85 -127.39 153.81 45.77 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.161 -174.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.0 pt -136.85 172.57 14.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.555 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.609 HD13 HD21 ' A' ' 101' ' ' LEU . 97.0 mt -101.57 139.96 36.51 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.443 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 15.2 m -127.99 128.88 69.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.022 0.439 . . . . 0.0 110.218 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.534 ' OE2' ' HB3' ' A' ' 99' ' ' SER . 3.1 tm-20 -87.96 124.49 33.76 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.034 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.442 HG22 ' HA3' ' A' ' 73' ' ' GLY . 39.6 t -137.47 136.0 46.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.007 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 62' ' ' ARG . 30.1 m -97.07 160.36 14.39 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -86.27 7.09 26.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.945 -0.472 . . . . 0.0 111.156 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -82.96 83.46 7.8 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.322 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 50.95 93.83 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.58 0.55 . . . . 0.0 112.278 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.55 ' HB2' ' N ' ' A' ' 67' ' ' ASP . 19.7 t70 72.89 -59.48 0.57 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.371 0.669 . . . . 0.0 110.801 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 57' ' ' SER . 19.7 ptp180 -165.28 -26.22 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.32 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HG2' ' HG3' ' A' ' 62' ' ' ARG . 24.8 pttm -158.73 -45.83 0.06 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.976 -176.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.6 m -157.53 124.49 5.06 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 111.352 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.603 ' HG3' ' H ' ' A' ' 66' ' ' SER . 6.2 tpt 51.98 -154.5 0.18 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.946 0.898 . . . . 0.0 111.629 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.603 ' H ' ' HG3' ' A' ' 65' ' ' MET . 46.8 t 72.12 -47.27 0.66 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.488 0.715 . . . . 0.0 111.504 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.55 ' N ' ' HB2' ' A' ' 61' ' ' ASP . 47.1 t0 69.15 120.65 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.618 0.767 . . . . 0.0 111.34 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.684 HD23 ' H ' ' A' ' 68' ' ' LEU . 2.0 pt? -70.06 72.71 0.43 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.98 -37.55 75.79 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -124.68 145.08 49.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.088 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.29 129.31 37.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.698 0.761 . . . . 0.0 110.577 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -165.14 141.3 5.54 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.637 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.442 ' HA3' HG22 ' A' ' 56' ' ' VAL . . . -152.71 -142.6 3.51 Favored Glycine 0 CA--C 1.5 -0.858 0 C-N-CA 120.023 -1.084 . . . . 0.0 112.603 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 12.3 ttp180 -86.07 119.16 71.54 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -63.75 114.6 2.64 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.748 2.299 . . . . 0.0 112.315 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.2 mt -121.91 99.69 43.94 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.724 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.74 159.21 46.51 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.863 2.375 . . . . 0.0 111.764 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 38.3 Cg_exo -55.8 -32.71 85.69 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.252 2.635 . . . . 0.0 113.532 -176.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.2 p -76.31 -12.58 60.1 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -80.21 155.46 27.36 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.8 m -113.95 83.38 7.67 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.41 -27.58 54.76 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.884 2.389 . . . . 0.0 114.39 -174.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.492 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 82.5 mt -63.96 -39.6 94.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HA ' HD11 ' A' ' 27' ' ' ILE . 31.5 m-85 -56.53 -45.44 81.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.47 -43.77 59.51 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.027 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 31.2 mtm -63.25 -42.27 99.15 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.0 m -64.4 -44.66 90.58 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.725 0.298 . . . . 0.0 111.738 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.57 -38.78 21.21 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -91.87 9.02 34.62 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.7 p -58.52 139.09 56.25 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.057 0.456 . . . . 0.0 111.39 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 98' ' ' ASP . . . 171.03 -123.93 1.08 Allowed Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.767 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 70.73 -63.24 0.42 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.375 0.67 . . . . 0.0 112.103 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.82 -44.43 0.24 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.382 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.736 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 8.9 tp10 -61.88 151.56 34.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.825 0.345 . . . . 0.0 110.761 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -105.74 12.68 30.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.724 0.297 . . . . 0.0 111.708 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.654 ' H ' ' HG3' ' A' ' 94' ' ' GLU . . . -95.23 71.57 1.0 Allowed Glycine 0 CA--C 1.496 -1.102 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.41 ' C ' ' H ' ' A' ' 99' ' ' SER . 7.3 t80 68.53 13.01 8.9 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.736 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 8.6 m-20 72.33 -45.07 0.61 Allowed 'General case' 0 C--N 1.356 0.882 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.251 -176.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.534 ' HB3' ' OE2' ' A' ' 55' ' ' GLU . 20.1 m -133.24 147.12 51.96 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -117.22 163.93 15.57 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.0 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.609 HD21 HD13 ' A' ' 53' ' ' LEU . 25.6 tp -113.64 124.9 53.43 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.101 0.477 . . . . 0.0 110.273 -177.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.04 164.56 13.99 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.807 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.472 HD11 ' HB3' ' A' ' 38' ' ' ALA . 68.6 mt -112.17 129.97 66.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.825 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -131.54 163.44 28.01 Favored 'General case' 0 CA--C 1.478 -1.793 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 1.7 ptm180 -94.6 120.11 34.32 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.275 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 18.1 ptpt -52.1 142.15 28.03 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.705 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 106' ' ' LYS . 51.0 Cg_exo -54.58 -40.83 82.13 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 123.151 2.567 . . . . 0.0 112.212 178.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 . . . . . 0 C--O 1.242 0.706 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.493 -179.695 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.794 0.331 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.8 mtt -99.59 132.91 44.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.356 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -115.39 -79.47 0.59 Allowed 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 44.47 76.6 0.12 Allowed Glycine 0 C--N 1.346 1.105 0 O-C-N 123.647 0.592 . . . . 0.0 113.964 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.82 -166.1 31.51 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.849 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -128.31 153.49 46.95 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.5 mt -104.83 137.76 42.13 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.55 105.26 17.52 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 173.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -101.06 127.81 53.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.398 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 86.9 t80 -88.64 119.95 29.59 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.009 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.23 29.97 8.33 Favored Glycine 0 C--O 1.244 0.728 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.262 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 13' ' ' GLU . . . -60.28 168.37 8.83 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 66.1 mm-40 74.6 -34.69 0.28 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.113 0.565 . . . . 0.0 111.397 -176.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.437 HG22 HG23 ' A' ' 15' ' ' VAL . 69.0 mt -91.13 -56.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.437 HG23 HG22 ' A' ' 14' ' ' ILE . 56.0 t -130.83 97.74 20.43 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.424 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.65 -23.67 42.33 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.909 2.406 . . . . 0.0 113.489 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.0 t -80.07 -7.95 59.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.246 0.546 . . . . 0.0 110.976 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -139.15 71.3 40.52 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.496 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 23.1 Cg_endo -59.74 -42.9 42.08 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.695 2.263 . . . . 0.0 113.354 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.06 140.36 53.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.174 0.512 . . . . 0.0 111.524 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.3 p -126.75 155.81 37.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.546 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.0 m -102.9 122.56 44.8 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.494 ' CD1' HG23 ' A' ' 34' ' ' ILE . 16.9 pt -119.28 151.98 21.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.125 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.9 mp -100.97 107.17 18.58 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.54 141.66 18.34 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -113.62 173.28 6.49 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.088 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 84' ' ' PHE . 15.1 tt -61.83 -30.12 47.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -172.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -77.32 -6.91 54.97 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.159 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -89.24 147.46 24.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.083 0.468 . . . . 0.0 111.062 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -86.13 178.94 7.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.828 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.745 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -67.92 -15.65 63.71 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.6 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' A' ' 78' ' ' PRO . 1.9 p-10 -62.27 -40.89 97.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.728 0.299 . . . . 0.0 110.416 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -43.7 66.51 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-O 121.231 0.539 . . . . 0.0 109.63 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.573 HG21 HD23 ' A' ' 101' ' ' LEU . 96.7 mt -63.06 -49.96 81.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.452 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.94 -45.1 83.06 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.026 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.43 -43.2 97.08 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.722 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -64.47 -48.58 74.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.95 0.375 . . . . 0.0 111.32 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.73 -48.12 78.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.078 0.466 . . . . 0.0 111.287 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.48 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 28.9 tp -63.31 -34.63 78.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.865 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 38.2 tt0 -60.04 -44.4 94.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.45 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 65.3 mmtt -64.32 -37.39 87.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.549 -177.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -78.41 -6.09 54.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.586 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.91 24.95 57.1 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.962 -0.637 . . . . 0.0 114.201 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.48 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 90.6 mt -120.27 22.85 11.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 117.279 0.539 . . . . 0.0 110.736 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 5.0 tm-20 -59.85 -31.46 69.77 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.231 0.612 . . . . 0.0 111.743 -175.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -78.19 -14.38 59.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -90.59 -82.92 0.27 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.442 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 16.4 ttmt 64.43 -37.78 0.21 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.553 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 4.5 p-10 -70.53 -2.41 14.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.063 0.458 . . . . 0.0 111.257 -177.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.86 -9.78 20.44 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.39 154.22 48.85 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 106' ' ' LYS . 48.1 pt -141.22 -179.86 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 174.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.745 HD12 ' HB1' ' A' ' 31' ' ' ALA . 90.6 mt -103.38 148.67 25.61 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.619 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.43 155.32 31.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.627 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.489 ' HG3' ' CD1' ' A' ' 76' ' ' ILE . 46.3 mt-10 -99.78 123.62 44.22 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 177.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.472 HG21 HG23 ' A' ' 71' ' ' ILE . 25.0 t -112.7 125.5 69.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.168 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 50.3 m -78.51 136.94 37.69 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.247 0.546 . . . . 0.0 110.972 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -64.09 -40.21 95.73 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.598 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -101.31 67.3 1.15 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.586 0.708 . . . . 0.0 110.521 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.851 ' OD2' ' HA ' ' A' ' 67' ' ' ASP . 3.3 p-10 -63.94 -47.41 80.57 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.661 -1.154 . . . . 0.0 113.124 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 65' ' ' MET . 28.2 t70 -61.15 -37.44 82.86 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -80.0 -15.15 57.83 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.52 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -101.81 -61.05 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.924 0.392 . . . . 0.0 111.662 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.7 p -99.06 -15.57 18.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.511 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 65.8 mtt 69.55 5.46 5.19 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.363 0.602 . . . . 0.0 110.299 -175.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -111.66 112.69 24.58 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.851 ' HA ' ' OD2' ' A' ' 60' ' ' ASP . 6.1 p-10 -60.84 162.6 6.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.906 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.43 73.09 9.62 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 121.918 0.866 . . . . 0.0 109.71 -177.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -66.07 -24.84 66.8 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.396 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 71' ' ' ILE . 0.7 OUTLIER -141.26 -88.89 0.16 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.576 174.721 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.497 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 96.8 mt -139.41 -76.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 120.507 0.194 . . . . 0.0 111.252 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.405 ' O ' HG22 ' A' ' 71' ' ' ILE . 15.5 m-20 64.89 -177.94 0.18 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.985 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.25 -162.27 21.99 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.752 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -111.07 139.15 21.51 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.51 120.44 7.39 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.572 2.181 . . . . 0.0 113.266 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.489 ' CD1' ' HG3' ' A' ' 55' ' ' GLU . 33.9 mt -120.87 104.07 42.29 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.345 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 32.1 Cg_exo -65.26 156.34 63.63 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.086 2.524 . . . . 0.0 112.846 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.526 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 32.5 Cg_exo -56.78 -30.55 85.13 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.567 2.844 . . . . 0.0 113.435 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 p -80.62 3.4 22.04 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -97.51 156.52 16.46 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.375 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.1 m -114.25 80.53 5.84 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.02 -20.13 19.66 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.511 2.141 . . . . 0.0 114.614 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 27' ' ' ILE . 47.9 mt -64.03 -38.59 91.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.589 ' HA ' HD11 ' A' ' 27' ' ' ILE . 22.1 m-85 -59.23 -37.21 76.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.054 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 45.6 mt-10 -73.39 -41.67 63.07 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.892 0.377 . . . . 0.0 110.814 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.6 mtt -61.22 -42.87 99.35 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.412 HG21 HD12 ' A' ' 27' ' ' ILE . 18.5 p -65.22 -30.47 71.36 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.826 0.346 . . . . 0.0 111.906 -178.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.25 -10.67 56.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.85 0.357 . . . . 0.0 111.132 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 15.9 mmt180 -104.03 8.58 36.64 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.216 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.6 m -63.86 139.58 58.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.877 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 172.82 -80.3 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.707 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -92.09 176.49 6.48 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.76 115.32 2.04 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.193 -1.004 . . . . 0.0 112.324 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -84.13 -28.48 27.44 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.56 0.219 . . . . 0.0 111.144 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -67.37 -54.29 21.88 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.972 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -145.54 -107.1 0.52 Allowed Glycine 0 CA--C 1.503 -0.702 0 C-N-CA 119.663 -1.256 . . . . 0.0 111.679 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -95.92 -153.47 0.4 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -55.79 -43.24 76.65 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 50.7 m -130.87 152.83 49.78 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.398 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.443 ' CZ ' ' HB ' ' A' ' 56' ' ' VAL . 30.4 p90 -110.81 173.94 6.1 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.597 HD21 HD13 ' A' ' 53' ' ' LEU . 22.1 tp -107.6 125.02 50.81 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.01 0.433 . . . . 0.0 110.793 -173.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -129.07 173.31 10.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.877 -177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.3 mt -110.77 127.61 67.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.376 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.447 ' HD3' ' HB ' ' A' ' 71' ' ' ILE . 21.7 mmmt -128.72 165.76 20.27 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -88.15 128.96 35.44 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.969 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.553 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.5 ptmt -71.89 148.94 92.43 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -67.82 150.09 78.57 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.147 1.898 . . . . 0.0 111.548 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 . . . . . 0 C--N 1.303 -1.442 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.661 -178.647 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 m -131.61 147.72 52.55 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.39 140.14 49.96 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -84.09 105.56 15.05 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.31 129.24 62.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.724 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 92.3 t80 -109.98 119.55 39.67 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.623 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.53 30.36 2.89 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.274 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.15 -30.4 63.97 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 121.806 -0.235 . . . . 0.0 113.578 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -64.64 -26.66 68.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.039 0.447 . . . . 0.0 110.981 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.9 mt -90.56 -50.92 12.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.99 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.63 96.81 20.11 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.829 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.4 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 48.8 Cg_exo -56.83 -34.96 97.83 Favored 'Trans proline' 0 N--CA 1.475 0.432 0 C-N-CA 123.283 2.656 . . . . 0.0 113.655 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.6 t -71.41 -16.44 62.39 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -133.86 69.64 75.31 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.484 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 47.1 Cg_endo -66.99 -33.11 33.34 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.542 2.161 . . . . 0.0 112.735 -176.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -122.03 132.56 54.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.914 0.387 . . . . 0.0 110.738 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.7 p -136.75 156.88 35.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.304 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -112.95 125.09 54.01 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.314 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.402 HD11 HG23 ' A' ' 34' ' ' ILE . 33.9 pt -123.38 159.13 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.566 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.78 133.79 40.91 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.44 134.59 5.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.832 0.349 . . . . 0.0 111.26 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.714 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 6.5 mp0 -92.56 161.12 14.72 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.473 HG13 ' CB ' ' A' ' 83' ' ' LEU . 19.7 tt -66.98 -25.73 35.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -87.86 4.88 42.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.714 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 12.7 pt-20 -97.42 144.4 27.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.785 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -77.16 170.25 16.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.962 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.55 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -60.25 -24.9 65.26 Favored 'General case' 0 C--O 1.198 -1.612 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.647 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.61 -46.64 88.36 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.938 0.399 . . . . 0.0 111.084 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -70.12 -43.7 70.45 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.674 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 23' ' ' ILE . 97.0 mt -63.8 -46.17 95.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.298 0.57 . . . . 0.0 110.494 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.6 tp -65.16 -43.09 92.9 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.727 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.455 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -63.78 -37.08 94.17 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.21 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.97 -51.15 67.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.898 0.38 . . . . 0.0 110.778 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.85 -43.79 87.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.16 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.52 ' CD2' ' HA ' ' A' ' 45' ' ' GLU . 29.5 tp -64.71 -35.57 81.48 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.985 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.19 -36.21 82.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.767 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 63.7 mmtt -62.42 -36.33 82.02 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -84.0 -8.1 59.23 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.565 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.28 30.12 71.71 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.423 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.2 mt -120.48 24.53 10.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.52 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 42.4 tt0 -58.84 -29.7 67.13 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -62.61 -26.78 68.79 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.054 0.455 . . . . 0.0 110.881 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.5 m -100.54 30.53 3.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.903 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.455 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 36.3 ttmt -61.09 -36.75 80.49 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.453 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 30.8 t70 -62.95 -18.52 63.26 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.178 0.513 . . . . 0.0 111.829 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -82.46 -8.62 59.62 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.73 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -132.42 150.43 52.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.256 0.55 . . . . 0.0 111.79 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.677 HG23 ' HB2' ' A' ' 106' ' ' LYS . 25.6 pt -139.97 171.35 13.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.568 HD13 HD21 ' A' ' 101' ' ' LEU . 97.6 mt -100.07 141.79 32.42 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.356 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.49 136.77 55.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -86.59 117.62 25.47 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.639 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.455 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 40.4 t . . . . . 0 C--N 1.303 -1.431 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.866 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ptt85 -82.37 133.81 49.62 Favored Pre-proline 0 N--CA 1.441 -0.891 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.09 121.15 8.71 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.383 2.055 . . . . 0.0 111.888 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.3 mt -121.27 97.9 47.18 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.89 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -63.5 159.51 40.15 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.25 2.633 . . . . 0.0 112.493 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 47.3 Cg_exo -55.13 -29.17 64.62 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.609 2.873 . . . . 0.0 113.659 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.5 p -80.69 -1.42 42.51 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -105.37 142.92 34.3 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.251 -0.18 . . . . 0.0 110.612 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.0 p -106.11 92.42 6.59 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 120.986 0.422 . . . . 0.0 110.104 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.73 -23.05 36.37 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.013 2.475 . . . . 0.0 114.871 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.473 ' CB ' HG13 ' A' ' 27' ' ' ILE . 86.2 mt -62.56 -27.88 69.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.468 ' HA ' HD11 ' A' ' 27' ' ' ILE . 20.0 m-85 -58.03 -48.43 80.09 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.148 0.28 . . . . 0.0 111.299 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.08 -36.44 58.96 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.336 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 96.5 mtp -60.53 -61.58 2.49 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.22 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.734 -176.146 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.455 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 27.5 p90 . . . . . 0 N--CA 1.437 -1.118 0 CA-C-O 120.981 0.419 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.568 HD21 HD13 ' A' ' 53' ' ' LEU . 34.4 tp -109.03 121.4 45.06 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.43 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.27 174.47 6.69 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.815 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.44 129.74 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.136 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -122.93 160.26 26.55 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -82.46 116.93 22.13 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.68 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.677 ' HB2' HG23 ' A' ' 52' ' ' ILE . 72.6 tttt . . . . . 0 C--N 1.308 -1.214 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.813 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 p -95.38 139.17 32.05 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.4 mt -123.45 140.85 52.58 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -84.78 108.57 17.53 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.426 HG21 ' CD1' ' A' ' 23' ' ' ILE . 53.2 t -113.19 131.24 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.506 -171.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 87.2 t80 -88.04 121.19 30.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.543 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.8 31.69 6.89 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.708 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 10' ' ' TYR . . . -53.95 165.13 2.46 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.534 -0.333 . . . . 0.0 113.371 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 71.99 -47.16 0.66 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.129 0.972 . . . . 0.0 110.907 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.478 HG22 HG23 ' A' ' 15' ' ' VAL . 42.8 mm -62.97 -50.01 81.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.18 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.478 HG23 HG22 ' A' ' 14' ' ' ILE . 64.8 t -142.61 111.12 5.79 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.516 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.45 -24.52 49.4 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.838 2.359 . . . . 0.0 113.461 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.0 t -91.31 -0.9 57.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.991 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -145.8 73.45 13.69 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.407 . . . . 0.0 110.429 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.33 -21.79 30.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.726 2.284 . . . . 0.0 112.891 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -130.11 141.97 50.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.79 160.99 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.534 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 p -108.78 133.27 53.07 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.262 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 38' ' ' ALA . 32.0 pt -128.83 162.54 35.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.695 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.3 tp -112.6 123.85 51.23 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.9 154.04 47.14 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.005 0.431 . . . . 0.0 111.16 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.56 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 46.7 mt-10 -110.86 146.18 36.93 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.595 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.7 tt -67.52 -26.82 36.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -87.61 15.41 6.82 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.013 0.435 . . . . 0.0 110.978 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.56 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 70.0 mm-40 -106.5 157.38 17.7 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.839 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -88.89 169.25 11.73 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.257 0.551 . . . . 0.0 111.199 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -62.05 -26.17 68.1 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.089 -177.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.69 -45.08 93.18 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -67.41 -42.73 82.76 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 120.889 0.376 . . . . 0.0 110.487 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.54 -45.2 98.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.222 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.9 tp -63.47 -45.12 92.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.511 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.27 -34.83 89.22 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.301 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.56 -52.41 65.66 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.01 0.405 . . . . 0.0 111.998 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -71.59 -37.53 70.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.205 0.526 . . . . 0.0 110.727 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.81 -38.63 88.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.144 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.33 -37.36 83.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.445 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -62.78 -38.39 90.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.901 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -86.71 -0.97 57.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.844 0.354 . . . . 0.0 110.994 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.15 15.53 80.94 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.919 -0.582 . . . . 0.0 114.305 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.1 mt -105.76 14.53 28.11 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.384 0.592 . . . . 0.0 111.352 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -20.04 63.55 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -66.05 -35.08 79.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -83.41 -81.85 0.16 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.605 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt 65.44 -40.8 0.31 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.603 1.161 . . . . 0.0 113.829 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.44 -11.27 41.35 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -100.12 1.78 42.49 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.224 0.535 . . . . 0.0 110.318 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -132.0 151.94 51.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 111.297 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 pt -139.4 172.88 12.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.61 HD12 ' HB1' ' A' ' 31' ' ' ALA . 95.6 mt -100.71 134.88 43.03 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 12.7 m -123.57 128.55 74.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.305 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 4.8 tm-20 -86.81 120.16 27.81 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.421 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 74.7 t . . . . . 0 C--N 1.313 -1.004 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.005 -173.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.801 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.49 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 10.5 ptp180 -96.23 136.11 22.21 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.8 114.36 3.84 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.068 1.845 . . . . 0.0 111.827 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.0 mt -120.79 99.77 46.94 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.072 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.45 158.81 43.32 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.808 2.339 . . . . 0.0 112.086 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.476 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 31.2 Cg_exo -57.29 -23.13 52.75 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.361 2.708 . . . . 0.0 112.512 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.4 p -67.52 -22.42 65.43 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -78.69 176.54 9.41 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 122.352 1.072 . . . . 0.0 113.264 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 85.6 m -137.6 71.8 50.94 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 112.801 -2.0 . . . . 0.0 106.305 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.404 ' O ' ' HG3' ' A' ' 86' ' ' MET . 44.4 Cg_endo -67.02 -18.42 51.78 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.976 2.451 . . . . 0.0 114.323 -170.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 27' ' ' ILE . 44.6 mt -61.95 -41.33 97.85 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -173.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HA ' HD11 ' A' ' 27' ' ' ILE . 41.1 m-85 -60.24 -43.02 96.43 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.696 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.59 -40.63 84.81 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.388 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 96.6 mtp -62.78 -46.95 85.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.622 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 C--N 1.325 -0.47 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.149 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.421 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 30.0 p90 . . . . . 0 N--CA 1.444 -0.755 0 CA-C-O 121.176 0.512 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.444 HD21 HD13 ' A' ' 53' ' ' LEU . 31.0 tp -114.46 128.79 56.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.525 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . . . -122.89 167.84 13.04 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.82 -176.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 38' ' ' ALA . 84.2 mt -110.07 129.72 64.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.642 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -130.52 161.95 30.34 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.49 0.662 . . . . 0.0 111.028 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -84.07 104.76 14.4 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.486 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 CA--C 1.538 0.496 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.512 179.112 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.441 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 p -95.11 139.96 30.72 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.2 mt -112.87 138.22 50.05 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.089 0.471 . . . . 0.0 111.992 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -82.15 106.24 13.89 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.45 HG11 ' CB ' ' A' ' 38' ' ' ALA . 54.6 t -113.62 129.39 69.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.494 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -103.23 108.35 19.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.649 0.737 . . . . 0.0 112.246 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.82 12.64 9.97 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' A' ' 19' ' ' PRO . . . -61.55 -24.53 64.12 Favored Glycine 0 CA--C 1.5 -0.889 0 CA-C-N 115.286 -0.457 . . . . 0.0 112.921 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.3 -27.51 67.97 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.344 0.592 . . . . 0.0 109.843 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 76.4 mt -94.47 -51.69 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.862 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.31 97.32 47.5 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.196 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.68 -33.85 94.56 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.82 3.013 . . . . 0.0 114.921 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.4 t -65.77 -16.64 63.98 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.672 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -132.22 75.15 75.15 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.236 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HA ' ' HA3' ' A' ' 12' ' ' GLY . 18.1 Cg_endo -59.32 -46.78 19.76 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.445 2.096 . . . . 0.0 112.586 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -122.89 139.11 54.39 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.537 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.23 155.64 39.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -109.15 125.77 52.53 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.24 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' CD1' HG21 ' A' ' 9' ' ' VAL . 39.2 pt -126.28 156.22 36.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.23 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.3 tp -103.24 121.84 43.53 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.86 156.17 43.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.423 . . . . 0.0 111.792 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 43.8 mt-10 -110.6 147.97 33.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.67 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.579 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.5 tt -64.57 -31.38 53.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -89.33 9.34 26.42 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.035 0.445 . . . . 0.0 110.629 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 26' ' ' GLU . 38.2 tt0 -98.44 146.73 25.44 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.625 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.511 ' HA ' ' SG ' ' A' ' 81' ' ' CYS . 20.6 p-10 -83.1 163.24 21.01 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.351 0.596 . . . . 0.0 112.17 -176.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.573 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -67.15 -17.64 64.93 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.424 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.08 -44.52 94.71 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -69.38 -46.44 66.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.632 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.51 -45.27 98.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.705 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.41 -44.46 91.2 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.268 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.446 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -64.25 -39.53 97.14 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.568 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.12 87.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.938 0.399 . . . . 0.0 111.364 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.45 ' CB ' HG11 ' A' ' 9' ' ' VAL . . . -73.56 -44.91 56.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.67 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.6 -34.3 77.51 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.313 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.7 -39.21 87.69 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.867 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -60.73 -38.64 85.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.03 0.443 . . . . 0.0 110.678 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -84.06 -3.34 57.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.46 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.88 24.83 76.06 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.873 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.15 17.43 18.72 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.891 -0.182 . . . . 0.0 111.327 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -57.27 -34.93 69.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.809 0.443 . . . . 0.0 110.84 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -60.66 -39.32 87.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.173 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.0 m -89.12 21.86 3.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.295 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.446 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 33.2 ttmt -59.68 -15.63 20.87 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.071 0.462 . . . . 0.0 111.759 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.32 -35.42 79.02 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.618 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 106' ' ' LYS . 3.9 p-10 -104.25 17.32 24.35 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -176.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -126.68 150.49 48.96 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.0 pt -139.31 176.31 6.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.487 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.428 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.4 mt -101.65 138.69 38.3 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-O 120.548 0.213 . . . . 0.0 110.614 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.451 HG11 ' HD3' ' A' ' 104' ' ' LYS . 27.3 m -124.06 126.78 72.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.123 0.487 . . . . 0.0 110.441 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.439 ' CD ' HH21 ' A' ' 74' ' ' ARG . 13.6 tt0 -89.58 126.04 35.46 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.547 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 87.3 t . . . . . 0 C--N 1.315 -0.899 0 CA-C-O 120.836 0.35 . . . . 0.0 111.479 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.472 ' CA ' HG22 ' A' ' 56' ' ' VAL . . . . . . . . 0 N--CA 1.435 -1.4 0 N-CA-C 112.716 -0.154 . . . . 0.0 112.716 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.46 ' O ' HG13 ' A' ' 76' ' ' ILE . 40.1 mtm180 -88.66 117.17 68.05 Favored Pre-proline 0 C--N 1.314 -0.964 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.65 114.02 2.21 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.118 1.878 . . . . 0.0 111.568 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 74' ' ' ARG . 42.3 mt -120.84 113.73 32.9 Favored Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.543 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.79 159.01 54.95 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.548 2.165 . . . . 0.0 111.434 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.573 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 31.8 Cg_exo -58.5 -29.35 88.47 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.786 2.324 . . . . 0.0 111.972 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 m -77.34 -1.49 30.2 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.218 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.18 158.52 15.62 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 122.092 -0.38 . . . . 0.0 110.525 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.511 ' SG ' ' HA ' ' A' ' 30' ' ' ASN . 95.8 m -121.99 85.23 45.56 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.454 ' HB3' HD13 ' A' ' 76' ' ' ILE . 53.6 Cg_endo -69.75 -17.14 37.77 Favored 'Trans proline' 0 N--CA 1.475 0.405 0 C-N-CA 123.099 2.533 . . . . 0.0 114.143 -173.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 27' ' ' ILE . 51.7 mt -63.32 -28.55 70.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.437 ' HA ' HD11 ' A' ' 27' ' ' ILE . 20.8 m-85 -59.62 -48.21 82.54 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.257 -0.177 . . . . 0.0 111.436 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -69.27 -38.97 78.64 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.016 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.414 ' CE ' ' HG3' ' A' ' 55' ' ' GLU . 48.1 mtt -58.7 -59.27 5.68 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.997 0.427 . . . . 0.0 111.277 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 C--N 1.315 -0.9 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.858 -175.689 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.547 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 26.7 p90 . . . . . 0 N--CA 1.436 -1.167 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 9' ' ' VAL . 16.7 tp -115.18 126.68 54.88 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.676 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.75 166.72 11.63 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.1 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.28 127.25 67.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.442 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.451 ' HD3' HG11 ' A' ' 54' ' ' VAL . 54.8 mtpt -135.17 167.4 21.06 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.584 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -73.65 143.01 46.45 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.608 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 50' ' ' ASP . 19.7 ptmt . . . . . 0 C--N 1.315 -0.906 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.117 176.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.798 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 p -96.23 138.7 33.46 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.6 mt -105.31 138.56 41.32 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -82.65 100.97 10.52 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.9 127.68 59.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.048 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -99.85 129.54 45.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.302 -176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.53 30.57 1.15 Allowed Glycine 0 C--O 1.237 0.326 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.227 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.52 -29.36 66.49 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.62 -0.324 . . . . 0.0 112.906 -177.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -59.48 -50.73 72.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 0.0 110.063 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.0 mt -69.23 -47.86 71.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.914 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.4 t -136.35 103.77 9.51 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.959 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.08 -24.58 59.37 Favored 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 122.589 2.193 . . . . 0.0 113.425 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.415 HG23 ' HG3' ' A' ' 18' ' ' ARG . 6.4 t -79.98 -9.14 59.66 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.959 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HG3' HG23 ' A' ' 17' ' ' THR . 51.9 mtt180 -132.72 69.49 79.4 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.052 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.09 -39.33 70.65 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.427 2.085 . . . . 0.0 112.415 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -128.02 135.47 49.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.236 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.35 162.44 36.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.5 m -119.54 124.91 47.57 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.045 0.45 . . . . 0.0 110.631 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 pt -123.76 159.37 28.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.2 tp -105.97 119.15 38.46 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.7 141.51 21.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.621 0.248 . . . . 0.0 111.185 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -95.22 161.99 13.88 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.584 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.6 tt -65.15 -26.11 39.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -85.59 7.82 21.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.685 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -92.72 138.77 31.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.552 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 13.7 m120 -82.11 172.7 12.9 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -62.64 -28.44 69.91 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.552 ' OD1' ' HB2' ' A' ' 30' ' ' ASN . 8.4 p-10 -64.96 -40.35 94.88 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.069 0.461 . . . . 0.0 110.377 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -69.5 -46.34 66.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.061 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.412 HG21 HD21 ' A' ' 101' ' ' LEU . 96.8 mt -64.96 -44.24 96.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.031 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.4 tp -62.43 -42.56 99.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.15 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.82 -43.31 99.37 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.089 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.69 84.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.838 0.352 . . . . 0.0 111.0 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.447 ' CB ' HD11 ' A' ' 103' ' ' ILE . . . -71.96 -45.83 59.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.386 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 48' ' ' LYS . 27.6 tp -64.52 -33.46 75.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.492 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -36.9 78.96 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.24 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -63.51 -37.9 89.08 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.453 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -83.33 -3.86 57.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.958 0.409 . . . . 0.0 110.686 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.14 29.86 72.07 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.158 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.1 mt -120.54 22.35 11.27 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.556 -0.379 . . . . 0.0 111.264 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.606 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 43.9 tt0 -59.64 -31.7 69.77 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -58.31 -38.69 77.6 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.9 m -93.93 30.43 1.85 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.623 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.606 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 35.3 ttmt -61.34 -31.25 71.12 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -65.41 -14.1 60.15 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.093 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -103.42 5.15 36.87 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.91 0.386 . . . . 0.0 110.982 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.71 149.07 50.38 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.021 0.439 . . . . 0.0 111.973 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 pt -140.31 169.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.892 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.501 ' HB3' HD11 ' A' ' 101' ' ' LEU . 96.1 mt -100.52 139.66 35.89 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.69 0.281 . . . . 0.0 110.482 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.83 131.04 62.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.07 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.534 ' OE1' ' HD2' ' A' ' 74' ' ' ARG . 97.1 mt-10 -94.71 121.36 36.22 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 100' ' ' PHE . 57.5 t . . . . . 0 C--N 1.312 -1.031 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.941 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.789 0 N-CA-C 111.859 -0.497 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.534 ' HD2' ' OE1' ' A' ' 55' ' ' GLU . 6.3 ptp180 -85.49 117.76 69.37 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -62.41 116.16 3.33 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.352 2.035 . . . . 0.0 111.946 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.469 HG21 ' HB3' ' A' ' 82' ' ' PRO . 35.6 mt -121.95 99.1 44.4 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.701 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -66.15 160.46 44.73 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.573 2.182 . . . . 0.0 111.173 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 51.5 Cg_exo -55.13 -32.73 81.18 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.316 2.678 . . . . 0.0 113.7 -176.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.1 p -67.81 -20.65 65.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -67.78 173.43 4.37 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 122.374 1.083 . . . . 0.0 113.189 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.2 m -127.86 68.97 76.11 Favored Pre-proline 0 C--N 1.292 -1.927 0 CA-C-N 113.328 -1.76 . . . . 0.0 106.59 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.469 ' HB3' HG21 ' A' ' 76' ' ' ILE . 18.7 Cg_endo -58.11 -32.1 94.78 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.266 2.644 . . . . 0.0 113.913 -168.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 27' ' ' ILE . 38.6 mt -63.92 -36.61 84.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.931 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -58.56 -30.19 66.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.916 0.389 . . . . 0.0 110.428 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -76.77 -51.07 12.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.695 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 66.4 mtm -62.98 -42.97 99.99 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.312 -1.058 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.422 -179.067 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.464 ' CZ ' ' HB ' ' A' ' 56' ' ' VAL . 31.5 p90 . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 53' ' ' LEU . 49.3 tp -92.38 126.38 37.44 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 120.84 0.352 . . . . 0.0 110.223 -177.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.66 160.31 35.78 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.45 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.447 HD11 ' CB ' ' A' ' 38' ' ' ALA . 66.2 mt -105.87 123.8 60.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -119.78 155.37 32.66 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 121.166 0.507 . . . . 0.0 110.176 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -81.19 108.49 14.88 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.026 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt . . . . . 0 C--N 1.327 -0.405 0 O-C-N 124.429 1.081 . . . . 0.0 111.127 178.904 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 26.9 p -99.58 121.57 41.38 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.4 mt -104.24 135.71 45.2 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.103 0.478 . . . . 0.0 112.056 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.99 101.11 10.1 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.404 HG11 ' CB ' ' A' ' 38' ' ' ALA . 55.4 t -108.01 129.77 61.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.806 -173.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -106.54 103.87 13.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.421 -175.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.0 -33.83 39.87 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.413 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.11 -88.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.793 0 N-CA-C 114.961 0.745 . . . . 0.0 114.961 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -62.06 -37.79 86.33 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.322 0.649 . . . . 0.0 112.368 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.408 HG22 HG23 ' A' ' 15' ' ' VAL . 96.7 mt -62.55 -44.49 99.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.923 -173.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.408 HG23 HG22 ' A' ' 14' ' ' ILE . 54.7 t -145.08 105.11 4.43 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.15 -22.67 53.88 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.192 2.595 . . . . 0.0 113.883 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -86.42 -7.25 58.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.035 0.445 . . . . 0.0 110.892 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -142.24 67.01 20.82 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.94 -32.16 84.66 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.53 2.154 . . . . 0.0 112.259 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.11 139.2 51.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.608 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.64 150.91 25.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.223 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.8 p -102.33 124.28 47.63 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.937 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 6' ' ' SER . 20.9 pt -126.22 160.57 33.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.333 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.69 124.15 50.71 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.71 148.17 25.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.911 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -104.01 156.57 17.75 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.534 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.434 HG13 ' CB ' ' A' ' 83' ' ' LEU . 17.7 tt -65.79 -26.61 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.986 0.422 . . . . 0.0 111.827 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -76.11 -3.54 36.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.093 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -99.18 162.58 12.98 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.929 0.395 . . . . 0.0 110.712 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -92.93 178.45 5.76 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.368 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.622 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -62.34 -21.64 65.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.582 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.415 ' HA ' ' HB3' ' A' ' 78' ' ' PRO . 14.5 t70 -55.77 -46.51 77.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.599 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -69.07 -42.51 76.11 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 120.942 0.401 . . . . 0.0 110.597 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.61 -45.79 97.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.038 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.9 tp -66.38 -43.9 84.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.477 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.458 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -64.83 -46.98 87.98 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.779 -177.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.452 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -61.31 -45.84 92.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.007 0.403 . . . . 0.0 111.115 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.404 ' CB ' HG11 ' A' ' 9' ' ' VAL . . . -65.75 -46.75 77.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.162 0.506 . . . . 0.0 111.251 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 44' ' ' LEU . 28.3 tp -62.67 -36.05 81.65 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.816 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 37.0 tt0 -57.91 -42.42 84.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.536 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.7 mmtt -64.42 -41.64 96.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.376 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.42 -29.97 65.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.908 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.47 7.15 46.29 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.638 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.461 ' HB2' HD11 ' A' ' 39' ' ' LEU . 83.8 mt -98.32 17.14 19.45 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.341 -0.506 . . . . 0.0 111.157 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 16.6 pt-20 -54.95 -24.81 25.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.439 0.696 . . . . 0.0 112.24 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -71.2 -16.78 62.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.93 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.1 m -98.14 -81.97 0.43 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.737 0.303 . . . . 0.0 110.42 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 31.1 ttmt 70.09 -49.03 0.64 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.599 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 26.7 t70 -60.87 -34.12 74.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.192 0.451 . . . . 0.0 110.758 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -66.0 -9.57 31.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.606 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.6 151.07 49.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.054 0.454 . . . . 0.0 111.647 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 pt -138.16 175.43 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.622 HD12 ' HB1' ' A' ' 31' ' ' ALA . 95.0 mt -100.38 143.58 30.4 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.987 0.422 . . . . 0.0 110.553 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.435 HG21 ' CG ' ' A' ' 104' ' ' LYS . 13.2 m -128.17 129.86 69.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.482 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 3.1 tm-20 -86.82 120.83 28.52 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.7 t . . . . . 0 C--N 1.31 -1.124 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.871 -175.53 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.06 0 N-CA-C 112.234 -0.346 . . . . 0.0 112.234 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 17.6 ptp180 -83.07 140.72 42.87 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 9.9 Cg_exo -71.31 117.18 5.02 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.373 2.049 . . . . 0.0 111.866 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.7 mt -120.9 100.87 45.82 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.631 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.68 155.95 67.14 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.022 2.481 . . . . 0.0 112.193 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.605 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 47.3 Cg_exo -54.68 -33.86 81.55 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.414 2.743 . . . . 0.0 113.829 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 t -66.75 -18.06 65.18 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -78.8 153.16 30.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.681 0.277 . . . . 0.0 111.276 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.9 m -111.68 78.58 2.15 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.495 ' O ' ' HG3' ' A' ' 86' ' ' MET . 48.6 Cg_endo -67.31 -29.45 38.49 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.511 2.14 . . . . 0.0 113.599 -174.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.434 ' CB ' HG13 ' A' ' 27' ' ' ILE . 80.6 mt -62.48 -39.15 92.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -53.92 -54.69 35.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.791 0.329 . . . . 0.0 111.485 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -72.08 -40.59 68.16 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.832 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 11.3 mtm -60.77 -45.34 94.72 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 C--N 1.315 -0.905 0 CA-C-O 121.05 0.452 . . . . 0.0 111.723 -178.127 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.1 p90 . . . . . 0 N--CA 1.442 -0.87 0 CA-C-O 121.072 0.463 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 tp -115.81 119.81 37.24 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.693 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.53 178.33 4.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.102 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.7 mt -116.97 129.96 72.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.699 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.435 ' CG ' HG21 ' A' ' 54' ' ' VAL . 27.6 mmmt -130.97 160.98 32.94 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -72.43 142.98 48.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.599 ' HD2' ' O ' ' A' ' 49' ' ' ASP . 21.6 ptmt . . . . . 0 CA--C 1.548 0.883 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 24' ' ' LEU . . . . . . . . 0 N--CA 1.442 -0.9 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 42.9 m -98.49 121.69 40.75 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.059 0.457 . . . . 0.0 110.355 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.4 mt -105.07 136.55 44.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.038 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -81.38 103.71 11.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.02 128.17 65.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.035 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -92.93 117.96 30.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.201 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.17 28.62 9.06 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.731 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.98 178.44 16.15 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.13 -0.557 . . . . 0.0 111.975 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 72.89 -66.69 0.3 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.6 mt -67.95 -48.11 76.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.765 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.14 85.41 46.45 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.15 -34.1 98.46 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.213 2.608 . . . . 0.0 113.019 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 t -70.09 -19.52 63.25 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.53 81.62 29.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 110.461 -0.199 . . . . 0.0 110.461 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.57 -32.24 87.61 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.625 2.217 . . . . 0.0 113.436 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -131.94 144.74 51.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.19 154.77 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.055 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.9 m -107.78 125.64 51.67 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.465 HG21 ' HB2' ' A' ' 38' ' ' ALA . 26.1 pt -126.72 160.09 35.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.042 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 8.0 mp -111.79 123.51 50.39 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.21 144.03 26.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.8 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.528 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 2.9 mp0 -90.58 152.78 20.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.4 tt -64.53 -26.35 40.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -86.01 6.65 27.8 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.982 0.42 . . . . 0.0 110.898 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.528 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 20.2 mm-40 -88.54 146.35 25.21 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.929 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.44 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 32.8 p-10 -83.86 169.49 15.07 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.236 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.565 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -58.81 -26.61 64.29 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.605 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.18 -42.1 97.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.688 0.28 . . . . 0.0 111.181 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.44 ' HG2' ' OD1' ' A' ' 30' ' ' ASN . 38.3 mmt180 -70.44 -42.92 70.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.94 0.4 . . . . 0.0 110.595 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.48 -45.92 94.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.587 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.95 -44.7 92.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.912 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.443 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -65.82 -39.61 95.19 Favored Glycine 0 C--O 1.209 -1.428 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.761 -178.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -61.41 -47.48 85.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 117.324 0.562 . . . . 0.0 111.532 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.465 ' HB2' HG21 ' A' ' 23' ' ' ILE . . . -68.7 -42.71 77.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.378 0.608 . . . . 0.0 110.521 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 45' ' ' GLU . 32.0 tp -63.26 -35.13 79.32 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.796 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.82 -39.72 86.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.677 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 67.7 mmtt -64.6 -32.82 74.64 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.827 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -87.97 -2.87 58.88 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.289 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.31 23.82 74.92 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.725 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.76 17.57 20.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.524 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 44.4 tt0 -58.55 -23.25 57.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -176.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -78.38 -8.4 58.41 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.001 0.429 . . . . 0.0 111.047 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.3 m -113.79 21.55 14.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.41 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 39.5 ttmt -59.41 -28.74 67.2 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.701 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.37 -9.52 34.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.72 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -102.55 -1.77 29.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.891 0.377 . . . . 0.0 111.183 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -131.2 155.16 47.53 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.528 -0.469 . . . . 0.0 112.097 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 pt -139.95 173.36 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.454 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.565 HD12 ' HB1' ' A' ' 31' ' ' ALA . 97.7 mt -101.38 143.19 31.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.775 0.322 . . . . 0.0 110.687 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.6 m -126.85 128.53 70.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.519 ' HB2' HD11 ' A' ' 76' ' ' ILE . 13.3 tt0 -90.24 123.25 33.88 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.626 -178.057 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.638 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.433 ' O ' HG13 ' A' ' 76' ' ' ILE . 34.7 ttp-105 -81.05 121.31 80.55 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -65.26 115.96 3.61 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.1 1.866 . . . . 0.0 111.3 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 55' ' ' GLU . 29.9 mt -120.95 103.31 43.04 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.232 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.23 160.21 43.32 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.61 2.207 . . . . 0.0 111.363 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.466 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 44.2 Cg_exo -54.97 -28.69 60.7 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.225 2.617 . . . . 0.0 113.174 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.5 m -62.27 -44.22 97.04 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.85 156.85 28.49 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -174.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.1 p -117.04 93.99 43.57 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 122.75 0.42 . . . . 0.0 110.29 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.431 ' O ' ' HG3' ' A' ' 86' ' ' MET . 57.7 Cg_endo -71.9 -18.19 28.21 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.148 2.565 . . . . 0.0 115.386 -175.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 27' ' ' ILE . 83.7 mt -60.79 -35.22 75.91 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -56.76 -45.56 81.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.202 0.525 . . . . 0.0 111.07 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -76.01 -37.22 58.7 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.318 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.467 ' SD ' HD23 ' A' ' 83' ' ' LEU . 95.4 mtp -61.66 -48.8 79.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.31 0.576 . . . . 0.0 111.095 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.8 m . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.541 -177.466 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 p90 . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.472 HD21 HD13 ' A' ' 53' ' ' LEU . 18.1 tp -116.74 124.97 50.94 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.242 -176.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.94 167.87 10.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.448 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 38' ' ' ALA . 68.6 mt -112.39 129.25 68.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.563 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -130.72 157.71 42.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.252 0.549 . . . . 0.0 110.901 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -93.04 134.36 35.25 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.323 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt . . . . . 0 C--N 1.311 -1.106 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.158 -179.667 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.841 0 N-CA-C 112.624 -0.19 . . . . 0.0 112.624 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.9 p -134.12 155.39 50.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.2 mt -107.55 137.29 45.84 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -84.24 108.13 16.94 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.72 133.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.219 -171.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -114.67 124.68 52.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.888 -177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.02 28.36 2.94 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.369 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.94 -23.9 62.06 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 114.031 0.372 . . . . 0.0 114.031 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.01 -40.74 97.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.426 0.631 . . . . 0.0 109.558 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.7 mt -85.76 -49.71 15.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.641 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.0 t -120.72 95.43 48.97 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.345 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.77 -23.01 48.85 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.882 2.388 . . . . 0.0 113.467 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.3 t -76.85 -17.15 59.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.136 0.493 . . . . 0.0 111.124 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -137.88 76.59 40.02 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.35 -34.06 67.94 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.287 1.991 . . . . 0.0 113.133 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -123.4 141.62 51.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.363 0.601 . . . . 0.0 112.211 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -142.85 157.57 18.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.2 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.6 p -119.46 131.79 55.68 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.235 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 38' ' ' ALA . 41.6 pt -125.54 160.48 31.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.495 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.5 108.74 18.83 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.09 153.12 50.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.943 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -106.92 156.69 18.44 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.526 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.8 tt -65.91 -29.0 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -177.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -84.35 9.82 12.18 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.799 0.333 . . . . 0.0 111.401 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -100.69 148.91 24.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.516 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -80.58 168.78 18.5 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.73 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -59.96 -26.56 66.1 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.247 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.41 -40.46 96.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.839 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -64.79 -44.74 89.01 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.157 0.503 . . . . 0.0 109.768 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 23' ' ' ILE . 96.7 mt -64.53 -45.64 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.642 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.73 -45.89 87.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.745 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.28 -38.29 93.6 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.268 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -59.46 -49.96 75.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.959 0.409 . . . . 0.0 110.999 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 23' ' ' ILE . . . -70.58 -40.37 73.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.19 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.1 tp -61.97 -39.67 92.96 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.639 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.88 -37.78 83.37 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.288 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 69.1 mmtt -63.83 -37.98 89.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.595 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -80.03 -6.08 56.95 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.234 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.23 22.0 74.48 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.79 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -113.7 22.61 13.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.742 0.306 . . . . 0.0 111.114 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -53.15 -40.46 64.29 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.476 0.71 . . . . 0.0 112.393 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -74.75 -11.9 60.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.815 0.34 . . . . 0.0 111.736 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.8 m -110.14 29.83 7.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.345 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -60.96 -32.1 71.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.007 0.432 . . . . 0.0 111.553 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.95 -9.14 13.89 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.755 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.445 ' HA ' ' HD2' ' A' ' 106' ' ' LYS . 18.0 t70 -101.97 -2.64 29.27 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.738 0.304 . . . . 0.0 111.575 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -132.39 154.25 49.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.698 -176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.6 pt -137.96 173.26 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.61 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.7 mt -101.25 142.95 31.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.731 0.301 . . . . 0.0 110.529 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 18.8 m -125.41 132.11 71.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.087 0.47 . . . . 0.0 110.545 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.539 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 1.9 tm-20 -87.54 124.25 33.28 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 C--N 1.317 -0.844 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.302 -178.076 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.511 0 N-CA-C 112.689 -0.164 . . . . 0.0 112.689 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -97.28 121.08 59.71 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -178.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.15 115.85 3.38 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.007 2.471 . . . . 0.0 112.513 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 55' ' ' GLU . 33.1 mt -121.16 118.89 29.93 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.404 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.13 158.32 58.22 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.749 2.299 . . . . 0.0 111.473 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 31.7 Cg_exo -59.71 -26.49 82.35 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.984 2.456 . . . . 0.0 112.45 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.5 p -68.33 -31.91 71.66 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -82.57 159.48 22.77 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.85 0.357 . . . . 0.0 111.958 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 39.8 m -118.05 86.81 26.82 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.68 -16.87 33.72 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.756 2.304 . . . . 0.0 114.198 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' A' ' 27' ' ' ILE . 53.4 mt -63.72 -39.09 93.45 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.47 ' HA ' HD11 ' A' ' 27' ' ' ILE . 23.6 m-85 -57.19 -46.12 83.13 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 123.215 0.322 . . . . 0.0 111.634 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -66.05 -43.07 88.55 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.236 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.3 mtm -63.54 -43.44 97.09 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.951 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.31 -1.127 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.564 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.2 p90 . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.492 HD21 HD13 ' A' ' 53' ' ' LEU . 29.5 tp -111.76 121.26 44.62 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.31 174.7 5.91 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.181 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 38' ' ' ALA . 65.0 mt -110.77 129.49 65.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.656 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 17.1 mmmt -127.55 163.73 23.52 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 121.378 0.609 . . . . 0.0 110.199 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -84.03 134.83 34.61 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.296 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.445 ' HD2' ' HA ' ' A' ' 50' ' ' ASP . 22.0 ptmt . . . . . 0 CA--C 1.538 0.519 0 O-C-N 123.632 0.583 . . . . 0.0 112.084 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.297 0 N-CA-C 112.798 -0.121 . . . . 0.0 112.798 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 26.4 p -95.11 134.49 37.77 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.4 mt -110.76 143.65 40.97 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -84.69 104.23 14.48 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.86 129.22 57.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.148 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.429 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 88.2 t80 -96.26 126.32 41.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.31 0.576 . . . . 0.0 111.78 -176.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.26 18.17 4.46 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.38 -23.11 64.19 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.214 -0.493 . . . . 0.0 113.324 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.3 -57.6 9.88 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.8 mt -70.28 -44.8 77.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.071 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.18 96.08 20.34 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.411 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.36 -24.25 50.34 Favored 'Trans proline' 0 CA--C 1.498 -1.298 0 C-N-CA 122.717 2.278 . . . . 0.0 112.342 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.8 m -68.63 -23.24 64.41 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.727 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.41 67.67 80.47 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.95 -55.38 1.67 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 123.257 2.638 . . . . 0.0 114.376 -172.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -117.95 134.99 54.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.763 0.316 . . . . 0.0 110.998 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.24 161.18 35.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.586 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -110.86 128.87 55.94 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.513 HG21 ' HB2' ' A' ' 38' ' ' ALA . 31.1 pt -126.4 163.06 29.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.445 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.5 tp -111.79 112.5 24.21 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.96 148.16 28.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.267 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.69 162.73 16.84 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.855 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.638 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.0 tt -63.49 -24.51 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -175.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -85.1 4.64 33.23 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.88 0.371 . . . . 0.0 110.615 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -101.34 146.25 27.82 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.139 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -81.76 174.02 11.74 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.409 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.601 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -58.79 -27.12 64.72 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.009 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.28 -41.98 97.86 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -64.89 -41.72 95.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.263 0.554 . . . . 0.0 109.959 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.409 HG23 ' CD1' ' A' ' 23' ' ' ILE . 96.6 mt -65.67 -44.42 93.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.217 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.83 -46.71 88.32 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.457 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA2' ' OE1' ' A' ' 45' ' ' GLU . . . -64.28 -40.93 98.34 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.746 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -64.47 -39.27 93.5 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -84.88 -42.23 15.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.886 0.374 . . . . 0.0 111.272 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 27.9 tp -62.92 -35.12 79.01 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.147 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 2.9 tm-20 -59.7 -41.55 91.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.168 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 68.3 mmtt -63.58 -39.69 95.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -79.77 -3.44 47.64 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.984 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.73 28.96 68.15 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.996 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.573 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 82.2 mt -117.79 13.24 14.09 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.141 0.496 . . . . 0.0 110.844 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 48.4 tp10 -60.49 -28.41 68.34 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.917 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -67.8 -12.92 61.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.6 m -94.36 -88.92 0.23 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.3 mttt 63.96 -39.86 0.22 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 124.265 1.026 . . . . 0.0 113.473 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.59 -27.85 68.04 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -89.89 -17.95 27.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.317 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.573 ' CZ ' HD13 ' A' ' 44' ' ' LEU . 73.1 m-85 -125.59 151.64 46.17 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 119.252 -0.979 . . . . 0.0 113.092 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.3 pt -138.42 178.38 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.601 HD12 ' HB1' ' A' ' 31' ' ' ALA . 91.8 mt -107.81 142.55 37.69 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.469 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 m -127.54 133.19 68.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.505 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.62 121.06 29.57 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.361 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.518 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.017 0 N-CA-C 113.887 0.315 . . . . 0.0 113.887 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -125.54 127.99 24.77 Favored Pre-proline 0 N--CA 1.442 -0.854 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.02 119.22 6.3 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.731 2.287 . . . . 0.0 112.826 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.2 mt -122.28 101.84 40.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.397 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 48.7 Cg_exo -62.18 155.77 54.42 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.637 2.225 . . . . 0.0 112.121 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 49.4 Cg_exo -53.91 -33.25 71.19 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.791 2.994 . . . . 0.0 114.067 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.0 m -62.26 -42.9 99.74 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -73.79 154.98 39.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.894 0.378 . . . . 0.0 111.703 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.4 p -106.24 91.5 5.72 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.178 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 44.3 Cg_endo -68.66 -17.91 42.65 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.149 2.566 . . . . 0.0 114.145 -175.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 27' ' ' ILE . 43.2 mt -66.37 -33.74 76.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.885 0.374 . . . . 0.0 110.464 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -60.75 -11.76 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.269 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 6.0 mm-40 -95.94 -56.54 2.62 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.794 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 79.0 mtm -61.88 -48.6 79.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 C--N 1.317 -0.825 0 CA-C-O 120.685 0.278 . . . . 0.0 111.487 -179.186 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 p90 . . . . . 0 N--CA 1.444 -0.734 0 CA-C-O 121.049 0.452 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.0 tp -116.41 129.28 56.15 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.941 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . . . -125.4 171.78 10.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.924 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 38' ' ' ALA . 70.9 mt -100.12 130.43 49.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.103 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -128.31 142.07 51.25 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.258 0.552 . . . . 0.0 110.65 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -81.65 109.97 16.57 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.805 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? . . . . . 0 CA--C 1.544 0.726 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.772 177.713 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.233 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 p -96.25 139.82 31.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.805 0.336 . . . . 0.0 111.086 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.7 mt -109.18 134.52 51.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.776 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -82.66 99.56 9.67 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 91.7 t -100.45 112.31 32.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.871 -176.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 78.0 t80 -82.22 122.83 28.41 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.512 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.62 28.2 4.02 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.66 -33.39 82.13 Favored Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 115.268 -0.466 . . . . 0.0 112.97 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.436 ' OE1' ' HG2' ' A' ' 104' ' ' LYS . 40.4 tt0 -64.06 -42.05 97.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.798 0.333 . . . . 0.0 110.485 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.28 -49.85 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.725 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.9 109.85 9.23 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.899 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.53 -27.47 53.91 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.766 2.311 . . . . 0.0 114.035 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -80.05 -7.26 58.76 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.236 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.71 76.87 28.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.423 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 31.0 Cg_endo -62.68 -32.29 78.83 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.706 2.271 . . . . 0.0 113.294 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -129.81 141.42 50.85 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.4 p -131.27 155.04 41.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.4 m -112.55 124.61 52.92 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.724 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.503 HG21 ' HB2' ' A' ' 38' ' ' ALA . 33.3 pt -125.08 166.62 20.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.35 134.77 52.69 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.956 0.408 . . . . 0.0 110.887 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.45 165.44 30.24 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.71 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 43.8 mt-10 -109.74 -62.16 1.54 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.753 -0.379 . . . . 0.0 109.981 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.638 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.5 tt 168.34 -43.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.305 1.042 . . . . 0.0 112.832 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -75.49 -11.39 60.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.799 0.809 . . . . 0.0 109.852 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.71 ' OE1' ' HB2' ' A' ' 26' ' ' GLU . 8.8 mp0 -56.59 134.85 54.73 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.229 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.484 ' ND2' ' HB3' ' A' ' 32' ' ' ASP . 36.9 p-10 -84.47 159.69 20.7 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.941 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.5 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -59.46 -26.05 64.91 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.733 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.484 ' HB3' ' ND2' ' A' ' 30' ' ' ASN . 13.3 t70 -59.68 -48.27 82.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.421 ' NH1' ' HG3' ' A' ' 29' ' ' GLU . 58.3 ttt180 -70.31 -44.81 67.51 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.134 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.43 -44.86 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.191 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -64.87 -41.35 95.72 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.732 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -60.77 -40.54 98.27 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.528 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.53 -41.25 98.74 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.817 0.342 . . . . 0.0 111.398 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.503 ' HB2' HG21 ' A' ' 23' ' ' ILE . . . -78.48 -45.79 21.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.075 0.464 . . . . 0.0 111.743 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 45' ' ' GLU . 26.1 tp -63.36 -32.02 73.34 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.34 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -56.68 -43.62 80.62 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.168 0.987 . . . . 0.0 110.627 175.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 46.3 mmtm -61.15 -38.54 86.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.772 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -84.69 -7.5 59.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.005 0.431 . . . . 0.0 110.836 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.22 20.5 79.64 Favored Glycine 0 C--O 1.227 -0.29 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.206 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.407 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 83.5 mt -106.52 11.68 30.37 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 122.887 -0.184 . . . . 0.0 111.311 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.6 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 44.8 tt0 -58.55 -29.4 66.34 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.822 0.344 . . . . 0.0 111.756 -178.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -61.06 -26.94 67.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.191 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.3 m -108.76 32.34 4.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.784 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.6 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 33.9 ttmt -60.54 -31.02 70.13 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -176.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -65.02 -9.76 24.4 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.25 0.27 31.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.869 0.366 . . . . 0.0 110.995 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.517 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 89.8 m-85 -129.8 152.27 49.48 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.9 0.381 . . . . 0.0 111.852 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.4 pt -141.16 -180.0 2.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.491 ' HB3' HD11 ' A' ' 101' ' ' LEU . 95.9 mt -103.32 149.8 24.39 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -137.3 154.24 30.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.89 0.376 . . . . 0.0 110.478 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HG3' HD11 ' A' ' 76' ' ' ILE . 30.0 mt-10 -109.04 126.87 53.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 176.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.0 t . . . . . 0 C--N 1.312 -1.059 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 174.309 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.038 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.528 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 5.4 mpt_? -86.52 119.44 71.41 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.08 117.1 4.14 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.431 2.088 . . . . 0.0 112.357 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 74' ' ' ARG . 39.2 mt -120.9 101.29 45.4 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.981 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.5 163.3 38.58 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.787 2.325 . . . . 0.0 111.125 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.5 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 45.1 Cg_exo -56.82 -27.67 72.97 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.874 2.383 . . . . 0.0 112.486 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 t -79.11 -9.88 59.67 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.366 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -91.95 151.45 20.5 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.4 m -121.39 88.1 45.65 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.73 -14.59 24.37 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 123.384 2.723 . . . . 0.0 114.527 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 27' ' ' ILE . 39.6 mt -61.09 -37.83 84.12 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.408 ' HA ' HD11 ' A' ' 27' ' ' ILE . 74.0 m-85 -59.21 -42.43 90.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 110.96 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.63 -40.51 69.69 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.154 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.6 mtp -60.93 -46.82 89.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.385 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 C--N 1.316 -0.889 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.051 -179.304 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.0 p90 . . . . . 0 N--CA 1.438 -1.034 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 53' ' ' LEU . 36.6 tp -104.92 128.09 53.03 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.867 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -127.68 161.72 28.23 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.128 0.49 . . . . 0.0 111.565 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.489 HD11 ' HB1' ' A' ' 38' ' ' ALA . 79.0 mt -104.28 126.68 58.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.345 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 104' ' ' LYS . 24.2 mtpp -134.43 164.39 27.54 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.543 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.517 ' HG2' ' CE1' ' A' ' 51' ' ' PHE . 79.7 mtp180 -82.18 140.45 33.72 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt . . . . . 0 C--N 1.313 -1.003 0 CA-C-O 121.122 0.487 . . . . 0.0 111.959 -179.127 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.2 p -104.18 137.83 41.54 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.799 0.333 . . . . 0.0 110.346 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.5 mt -112.46 138.99 48.42 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.198 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -85.09 101.15 12.2 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.41 HG11 ' CB ' ' A' ' 38' ' ' ALA . 78.7 t -103.76 131.66 51.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.262 -171.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 91.7 t80 -100.42 115.27 29.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.23 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.97 29.04 13.32 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.424 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 10' ' ' TYR . . . -58.46 164.62 8.38 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 65.5 mm-40 72.77 -54.37 0.69 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.126 0.57 . . . . 0.0 110.721 -175.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.6 mt -69.01 -48.59 69.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.488 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.597 HG21 ' CE1' ' A' ' 42' ' ' TYR . 1.7 m -136.48 98.73 10.98 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-O 121.147 0.499 . . . . 0.0 112.144 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.13 -30.06 81.82 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.908 2.405 . . . . 0.0 112.356 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.2 t -66.86 -37.08 83.76 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.072 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -126.93 77.88 74.49 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.558 0.218 . . . . 0.0 110.731 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.557 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 32.8 Cg_endo -64.06 -31.09 65.99 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.5 2.134 . . . . 0.0 112.652 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -129.6 138.71 51.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.109 0.48 . . . . 0.0 112.197 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.55 154.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.402 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.7 p -102.97 121.71 43.1 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.257 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.402 ' CD1' HG21 ' A' ' 9' ' ' VAL . 29.7 pt -120.84 157.33 23.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.0 mt -106.16 121.81 44.92 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.023 0.439 . . . . 0.0 110.317 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.89 158.65 44.15 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.828 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.603 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 70.6 mm-40 -110.18 155.21 22.28 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 84' ' ' PHE . 19.4 tt -65.43 -27.1 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -83.88 7.69 17.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.272 0.558 . . . . 0.0 110.904 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.603 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 65.0 mm-40 -92.68 147.52 22.81 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 32' ' ' ASP . 30.3 p30 -84.51 170.78 13.11 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.608 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -59.5 -26.15 65.05 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.052 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.492 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 17.2 t70 -59.47 -49.54 77.39 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.745 0.307 . . . . 0.0 111.405 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.579 ' HG2' ' OE1' ' A' ' 29' ' ' GLU . 10.4 mpt_? -65.28 -44.9 86.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.94 -45.12 97.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.451 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.97 -43.1 96.8 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.066 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.521 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -62.01 -43.75 98.74 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.621 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.662 ' O ' ' HD3' ' A' ' 41' ' ' LYS . . . -62.9 -49.86 73.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.433 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -66.13 -44.78 83.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.835 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 48' ' ' LYS . 32.2 tp -65.68 -34.6 78.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.184 0.516 . . . . 0.0 109.93 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 36.3 tt0 -61.84 -34.43 75.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.398 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.662 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 4.1 mptp? -60.2 -37.37 80.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.131 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.597 ' CE1' HG21 ' A' ' 15' ' ' VAL . 58.2 m-85 -89.82 -9.13 50.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.121 0.486 . . . . 0.0 110.241 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.49 19.82 79.75 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.733 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.9 mt -100.93 16.55 24.88 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 40.2 tt0 -58.27 -29.11 65.55 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -58.49 -32.89 69.22 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.215 0.531 . . . . 0.0 110.126 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.3 m -95.3 21.86 7.5 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.327 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 38.6 ttmt -60.04 -35.42 75.09 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -174.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 32.9 t70 -61.26 -22.7 65.07 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.774 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.476 ' HA ' ' HD2' ' A' ' 106' ' ' LYS . 26.8 t70 -89.43 -2.46 58.4 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -129.39 153.49 47.84 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.748 -0.595 . . . . 0.0 111.888 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.3 174.65 11.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.522 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.514 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.2 mt -100.83 145.87 28.02 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 29.7 m -130.03 135.03 61.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.059 0.457 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.41 ' HB2' HD11 ' A' ' 76' ' ' ILE . 1.8 tm-20 -87.26 121.06 29.21 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.78 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.5 t . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.325 178.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 N-CA-C 112.81 -0.116 . . . . 0.0 112.81 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 5.3 mtm180 -103.2 125.18 35.87 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.79 114.45 2.16 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.124 1.883 . . . . 0.0 111.588 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 55' ' ' GLU . 68.2 mt -119.45 105.18 44.36 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.52 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -64.9 158.4 51.47 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.875 2.383 . . . . 0.0 111.52 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.547 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 52.7 Cg_exo -54.89 -29.99 66.33 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 123.333 2.689 . . . . 0.0 113.588 -177.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.3 t -66.36 -26.2 67.16 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -88.98 147.21 24.42 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 30' ' ' ASN . 36.7 m -111.49 88.36 9.08 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.88 -17.59 32.39 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.861 2.374 . . . . 0.0 113.903 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 27' ' ' ILE . 57.0 mt -61.58 -35.64 78.39 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.519 ' HA ' HD11 ' A' ' 27' ' ' ILE . 18.1 m-85 -56.6 -46.58 80.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.217 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -74.36 -37.49 63.48 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.6 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.7 mtp -61.45 -48.4 81.32 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.064 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 C--N 1.313 -0.983 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.267 -178.25 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.4 p90 . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 54' ' ' VAL . 17.3 tp -121.54 123.5 42.14 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.535 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -118.57 171.16 8.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.814 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 38' ' ' ALA . 60.1 mt -109.22 128.02 65.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.356 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.402 ' HE3' ' HG3' ' A' ' 13' ' ' GLU . 13.2 mmmm -132.8 165.36 24.75 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 120.964 0.411 . . . . 0.0 110.115 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 -78.47 138.73 38.6 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.31 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.476 ' HD2' ' HA ' ' A' ' 50' ' ' ASP . 19.0 ptmt . . . . . 0 CA--C 1.542 0.649 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.082 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.44 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 m -102.4 124.02 47.22 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.5 mt -104.47 140.5 37.86 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.201 0.525 . . . . 0.0 112.288 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -85.78 105.2 16.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.7 t -107.97 128.25 63.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.119 -172.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.523 ' CZ ' ' HA3' ' A' ' 12' ' ' GLY . 93.3 t80 -90.1 109.45 20.5 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.364 0.602 . . . . 0.0 110.935 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.99 20.48 45.43 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.987 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.523 ' HA3' ' CZ ' ' A' ' 10' ' ' TYR . . . -64.49 177.62 9.22 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.149 -0.526 . . . . 0.0 112.007 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 12' ' ' GLY . 36.0 tt0 71.32 -65.55 0.34 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.246 0.618 . . . . 0.0 110.427 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.83 -45.57 83.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.039 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.99 86.81 57.15 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.297 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.55 -27.7 82.21 Favored 'Trans proline' 0 N--CA 1.474 0.339 0 C-N-CA 122.909 2.406 . . . . 0.0 112.989 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.3 t -75.84 -15.12 60.28 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.208 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -138.76 79.36 28.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.06 -31.8 75.85 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.562 2.174 . . . . 0.0 113.51 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.09 144.64 48.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.237 0.542 . . . . 0.0 112.198 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.95 161.63 35.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.294 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.3 p -110.8 130.89 55.45 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.05 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.498 ' CD1' HG23 ' A' ' 34' ' ' ILE . 32.6 pt -128.15 158.82 39.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.1 tp -105.81 113.62 27.28 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.75 140.31 29.89 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.983 0.421 . . . . 0.0 110.988 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.93 153.92 20.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.691 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.7 tt -65.32 -28.01 43.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.022 0.439 . . . . 0.0 111.156 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -79.03 -1.75 37.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.408 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -85.39 147.6 26.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.045 0.45 . . . . 0.0 110.937 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -86.18 170.62 11.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.671 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.614 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -59.79 -28.54 67.52 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.468 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.46 -44.28 97.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -63.45 -44.49 94.35 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.203 0.525 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.529 HG21 HD23 ' A' ' 101' ' ' LEU . 96.9 mt -65.58 -45.39 92.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.588 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 tp -63.49 -43.58 96.83 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.578 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -63.34 -45.48 94.96 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.389 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.33 -48.51 79.52 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.733 0.302 . . . . 0.0 111.481 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.09 86.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.751 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.434 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 28.9 tp -64.51 -37.75 88.62 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.309 0.576 . . . . 0.0 109.919 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.96 -39.24 71.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.1 178.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.9 mmtt -66.98 -15.36 63.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.698 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -108.36 0.45 21.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.784 0.326 . . . . 0.0 111.125 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.53 18.26 76.95 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.198 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 93.6 mt -99.98 14.21 31.32 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.064 0.459 . . . . 0.0 110.237 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -42.51 -40.79 2.75 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.779 1.232 . . . . 0.0 112.976 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -80.71 -5.78 57.52 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.9 m -112.04 22.44 14.83 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.17 0.509 . . . . 0.0 110.532 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.459 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 35.4 ttmt -60.18 -39.03 85.02 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.52 -6.78 11.69 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -174.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -95.24 -10.58 29.93 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.877 0.37 . . . . 0.0 110.797 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.479 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 62.5 m-85 -121.68 162.81 20.08 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' A' ' 106' ' ' LYS . 26.6 pt -145.88 -178.86 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.797 1.239 . . . . 0.0 108.568 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.614 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.9 mt -107.39 155.29 20.18 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.313 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG11 ' HG3' ' A' ' 104' ' ' LYS . 27.5 m -139.29 151.96 23.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 120.682 0.277 . . . . 0.0 110.931 176.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.66 ' OE1' ' HD2' ' A' ' 74' ' ' ARG . 40.1 mt-10 -98.37 123.02 42.26 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.583 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.454 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 15.7 t . . . . . 0 C--N 1.31 -1.124 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.453 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.66 ' HD2' ' OE1' ' A' ' 55' ' ' GLU . 5.4 ptp180 -132.32 129.4 21.56 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.51 116.57 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.006 1.804 . . . . 0.0 112.462 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.428 HG21 ' HG3' ' A' ' 82' ' ' PRO . 55.3 mt -119.39 112.8 35.52 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.16 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.69 159.85 51.92 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.521 2.147 . . . . 0.0 111.546 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 36.5 Cg_exo -58.22 -27.53 80.88 Favored 'Trans proline' 0 N--CA 1.474 0.335 0 C-N-CA 123.001 2.467 . . . . 0.0 112.108 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -67.02 -23.68 65.93 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.392 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -82.19 153.95 25.7 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 63.2 m -124.73 84.77 57.58 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.428 ' HG3' HG21 ' A' ' 76' ' ' ILE . 57.8 Cg_endo -83.19 -9.47 10.5 Favored 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 123.021 2.481 . . . . 0.0 115.64 -173.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' A' ' 27' ' ' ILE . 20.3 mt -63.58 -41.82 98.33 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.495 ' HA ' HD11 ' A' ' 27' ' ' ILE . 60.5 m-85 -60.11 -34.99 74.26 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.038 0.446 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -70.11 -37.71 75.41 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.41 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.451 ' HE2' ' HA ' ' A' ' 83' ' ' LEU . 47.9 mtm -66.11 -43.21 87.84 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.1 p . . . . . 0 C--N 1.324 -0.524 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.09 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.454 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 24.7 p90 . . . . . 0 N--CA 1.429 -1.485 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.593 HD21 HD13 ' A' ' 53' ' ' LEU . 26.2 tp -100.94 123.21 44.79 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.09 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.474 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . . . -123.05 171.8 9.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.32 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.6 mt -108.14 128.96 63.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.472 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.457 ' HG3' HG11 ' A' ' 54' ' ' VAL . 26.4 mmmt -132.66 171.43 13.86 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.479 ' HG2' ' CE1' ' A' ' 51' ' ' PHE . 60.7 mtp180 -92.54 140.13 29.87 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.488 ' HB3' HG23 ' A' ' 52' ' ' ILE . 17.6 ptpt . . . . . 0 CA--C 1.558 1.277 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.434 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 37.7 p -101.41 120.24 39.99 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -106.7 144.49 33.28 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.529 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -81.92 112.16 18.77 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.45 HG21 ' CD1' ' A' ' 23' ' ' ILE . 54.1 t -104.86 127.2 59.54 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.222 -174.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -97.88 121.19 39.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.437 0.636 . . . . 0.0 111.794 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.48 26.22 3.21 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.589 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.5 -30.88 72.81 Favored Glycine 0 C--O 1.222 -0.6 0 CA-C-N 115.312 -0.444 . . . . 0.0 113.44 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -64.43 -43.57 93.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.985 0.421 . . . . 0.0 110.148 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.63 -44.72 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 177.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -134.96 104.93 10.52 Favored Pre-proline 0 C--O 1.237 0.424 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.23 -35.43 95.5 Favored 'Trans proline' 0 CA--C 1.493 -1.539 0 C-N-CA 123.908 3.072 . . . . 0.0 113.195 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -65.59 -21.26 66.57 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.361 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -139.28 74.44 35.45 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.589 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 48.3 Cg_exo -53.93 -48.25 22.73 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.837 2.358 . . . . 0.0 112.379 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -120.16 137.69 54.03 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.063 0.459 . . . . 0.0 110.998 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.56 161.56 40.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.9 p -118.71 123.23 44.37 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 6' ' ' SER . 41.6 pt -124.72 154.72 32.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.173 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.5 mp -99.02 111.42 23.83 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.228 0.537 . . . . 0.0 110.152 177.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.15 130.51 29.05 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.206 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -89.71 158.18 17.66 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.489 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.616 ' HA ' HD12 ' A' ' 83' ' ' LEU . 17.1 tt -63.75 -27.37 42.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -89.47 7.24 37.1 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.997 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.39 144.18 25.77 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -78.82 169.1 18.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.719 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.644 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -59.02 -25.51 63.73 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.844 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.07 -41.04 97.76 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.666 0.27 . . . . 0.0 110.833 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -64.88 -47.17 78.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 0.0 110.284 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.478 HG21 HD23 ' A' ' 101' ' ' LEU . 75.0 mt -64.2 -48.85 83.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.725 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.22 -44.88 90.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.462 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.469 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -65.86 -40.61 95.59 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.63 -0.714 . . . . 0.0 113.644 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.66 -48.31 79.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.313 0.557 . . . . 0.0 111.219 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.474 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -67.59 -41.93 83.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.138 0.494 . . . . 0.0 110.801 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.5 tp -62.95 -37.42 87.0 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.555 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.48 -39.09 92.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.01 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.2 mmtt -61.58 -40.29 94.22 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.988 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.46 -10.09 59.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.376 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.1 34.32 61.63 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.673 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.7 mt -123.13 21.28 9.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.767 0.318 . . . . 0.0 110.253 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.81 -16.66 43.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.288 -176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -90.65 8.53 33.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.792 0.33 . . . . 0.0 111.29 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.9 m -135.96 32.81 2.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.207 0.527 . . . . 0.0 110.133 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 39.9 ttmt -64.18 -37.33 87.07 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -173.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -64.25 -16.82 62.82 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.904 0.383 . . . . 0.0 111.847 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -84.06 -7.13 59.47 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.942 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -130.98 154.6 47.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.266 0.555 . . . . 0.0 111.805 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.2 pt -137.99 173.58 12.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.34 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.704 HD13 HD21 ' A' ' 101' ' ' LEU . 96.1 mt -99.51 135.19 41.29 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.526 ' HB ' ' HA3' ' A' ' 73' ' ' GLY . 23.3 m -128.22 134.48 64.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.204 -178.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.532 ' O ' ' HA2' ' A' ' 73' ' ' GLY . 32.7 mt-10 -86.53 122.48 30.53 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 120.962 0.411 . . . . 0.0 111.975 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.458 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 21.2 t . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.576 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 55' ' ' GLU . . . . . . . . 0 N--CA 1.422 -2.264 0 CA-C-O 120.779 0.1 . . . . 0.0 112.943 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.569 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 1.6 mpt_? -90.22 130.03 43.52 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.86 113.67 2.87 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.17 1.913 . . . . 0.0 112.651 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.0 mt -120.53 103.35 44.08 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.097 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.89 155.26 55.97 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.889 2.393 . . . . 0.0 112.73 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.603 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 33.7 Cg_exo -55.51 -28.22 63.41 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.745 2.964 . . . . 0.0 113.403 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -73.49 -11.69 60.54 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -95.13 156.56 16.27 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.215 -0.303 . . . . 0.0 111.679 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 38.2 m -119.68 82.59 26.73 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 86' ' ' MET . 58.2 Cg_endo -71.21 -16.8 31.6 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.096 2.531 . . . . 0.0 115.115 -174.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.616 HD12 ' HA ' ' A' ' 27' ' ' ILE . 50.9 mt -61.18 -36.9 81.1 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -173.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.542 ' HA ' HD11 ' A' ' 27' ' ' ILE . 53.5 m-85 -58.88 -44.87 91.23 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.481 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.79 -36.16 67.53 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.406 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.474 ' SD ' HD23 ' A' ' 83' ' ' LEU . 92.9 mtp -61.69 -42.23 98.65 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.202 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.365 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.458 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 27.9 p90 . . . . . 0 N--CA 1.425 -1.7 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.704 HD21 HD13 ' A' ' 53' ' ' LEU . 27.3 tp -104.06 123.3 46.99 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.962 -175.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.29 173.14 7.13 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.451 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.474 HD11 ' HB3' ' A' ' 38' ' ' ALA . 74.4 mt -112.41 128.63 68.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.091 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -133.83 160.37 37.82 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 120.951 0.405 . . . . 0.0 110.244 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 105' ' ' ARG . 38.2 ttm180 -78.7 116.76 19.27 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.947 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.976 174.681 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.324 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 14.1 p -95.16 133.16 39.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.6 mt -113.01 140.02 48.17 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.078 0.466 . . . . 0.0 112.153 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -83.34 111.65 19.19 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -113.26 128.48 70.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.042 -172.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -95.78 125.03 40.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.432 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.24 29.48 2.71 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.242 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.88 88.57 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.976 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -78.17 -6.81 55.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.175 0.512 . . . . 0.0 110.556 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.42 HG22 HG23 ' A' ' 15' ' ' VAL . 43.5 mm -96.38 -53.47 8.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.439 ' CG1' HG22 ' A' ' 17' ' ' THR . 95.3 t -139.45 113.52 8.0 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.486 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.83 -25.16 60.59 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.903 2.402 . . . . 0.0 114.413 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.439 HG22 ' CG1' ' A' ' 15' ' ' VAL . 13.8 t -78.3 -13.59 59.79 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.423 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -138.41 79.78 29.32 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.7 -31.77 48.57 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.457 2.104 . . . . 0.0 112.811 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -130.0 138.35 50.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.072 0.463 . . . . 0.0 111.492 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.4 p -136.18 157.61 37.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.689 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.1 m -111.82 126.46 55.1 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.887 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' SER . 34.3 pt -124.32 161.86 26.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.652 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.8 tp -107.68 122.36 46.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.14 148.38 32.51 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.795 0.331 . . . . 0.0 110.567 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.586 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 41.6 mt-10 -101.36 148.17 25.47 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.495 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 18.1 tt -64.35 -30.43 50.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -77.49 -7.23 55.91 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.586 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 65.2 mm-40 -82.84 160.35 22.22 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.023 0.44 . . . . 0.0 110.937 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -89.92 170.05 10.71 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.872 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -62.29 -24.56 67.37 Favored 'General case' 0 C--O 1.21 -1.013 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.168 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' A' ' 78' ' ' PRO . 15.4 t70 -60.62 -47.43 86.27 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 120.71 0.291 . . . . 0.0 111.07 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.563 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 2.0 tpm_? -68.98 -41.61 77.65 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.348 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.09 -45.46 98.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.6 -44.91 92.61 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.924 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.97 -38.27 93.99 Favored Glycine 0 C--O 1.211 -1.297 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.317 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.39 -49.17 78.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.291 0.546 . . . . 0.0 110.829 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.465 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -69.61 -41.93 75.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.942 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 45' ' ' GLU . 25.8 tp -64.11 -35.21 80.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.891 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.31 -35.67 79.77 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.463 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -61.05 -37.9 84.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 110.321 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -88.19 -0.92 57.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.249 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.24 33.55 83.06 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.064 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.4 mt -121.15 12.59 11.09 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.538 ' HA ' HD23 ' A' ' 39' ' ' LEU . 44.5 tt0 -63.07 -24.65 68.01 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.867 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -57.26 -35.16 69.4 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.466 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 49.2 m -78.59 -85.4 0.07 Allowed 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.322 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.491 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 33.6 ttmt 63.1 -35.36 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.883 1.273 . . . . 0.0 113.915 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 47' ' ' SER . 36.3 t70 -64.64 -20.37 66.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.176 0.512 . . . . 0.0 111.373 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.466 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 12.4 p-10 -103.82 12.32 34.65 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.813 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -133.87 149.1 51.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.678 0.275 . . . . 0.0 111.171 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 pt -138.55 170.84 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.515 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.3 mt -100.85 137.23 39.51 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.464 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 17.4 m -123.17 129.96 74.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.221 0.534 . . . . 0.0 110.577 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 3.1 tm-20 -88.0 122.64 31.83 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.275 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 99.8 t . . . . . 0 C--O 1.224 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.369 -179.033 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.538 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.443 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . 0.5 OUTLIER -93.03 114.55 63.02 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.2 114.59 3.66 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.44 2.093 . . . . 0.0 111.518 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 74' ' ' ARG . 18.1 mt -120.57 100.84 46.67 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.191 -176.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -59.51 157.29 32.33 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.217 2.611 . . . . 0.0 112.269 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 2.3 Cg_endo -58.28 -25.31 71.9 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.352 2.702 . . . . 0.0 114.4 -175.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.2 t -76.64 -12.6 60.03 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -92.35 155.8 17.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.653 0.263 . . . . 0.0 111.357 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 76.6 m -116.14 86.28 16.87 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.857 0.361 . . . . 0.0 110.248 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.404 ' HB3' HD13 ' A' ' 76' ' ' ILE . 49.5 Cg_endo -69.97 -22.09 31.58 Favored 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 122.912 2.408 . . . . 0.0 114.249 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.495 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 81.1 mt -61.91 -37.95 86.57 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -175.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.45 ' HA ' HD11 ' A' ' 27' ' ' ILE . 23.1 m-85 -55.24 -46.42 76.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.972 0.415 . . . . 0.0 110.845 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -74.91 -42.51 57.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.557 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.6 mtp -59.96 -46.62 88.83 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.013 0.435 . . . . 0.0 111.197 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.8 m . . . . . 0 C--N 1.312 -1.027 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.066 -179.791 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 29.1 p90 . . . . . 0 N--CA 1.442 -0.866 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.3 tp -117.01 125.68 51.74 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -124.95 171.36 10.26 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.825 -175.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 38' ' ' ALA . 71.8 mt -102.56 129.73 53.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.891 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -125.07 148.75 48.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.231 0.539 . . . . 0.0 110.912 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -80.09 102.0 9.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.655 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? . . . . . 0 C--N 1.319 -0.733 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.598 179.489 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.839 0 N-CA-C 112.597 -0.201 . . . . 0.0 112.597 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 p -95.14 160.32 14.61 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.79 0.329 . . . . 0.0 110.515 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.4 mt -110.85 135.41 51.45 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.193 0.521 . . . . 0.0 111.926 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.18 109.72 17.96 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -116.84 129.98 72.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.706 -172.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -103.89 129.88 51.43 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.098 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.22 28.86 2.66 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.054 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.25 -30.33 75.65 Favored Glycine 0 N--CA 1.465 0.591 0 C-N-CA 121.646 -0.311 . . . . 0.0 113.481 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -61.98 -32.81 73.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 109.722 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.8 mt -91.99 -52.97 9.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.768 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.3 t -124.53 102.91 32.31 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.663 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.81 -22.37 43.05 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.076 2.517 . . . . 0.0 113.796 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -78.13 -15.96 58.38 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.941 0.401 . . . . 0.0 111.189 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -139.16 74.34 36.26 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-O 121.013 0.435 . . . . 0.0 109.855 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.05 -40.02 55.14 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.433 2.088 . . . . 0.0 112.936 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -120.55 135.89 54.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.232 0.539 . . . . 0.0 111.548 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.65 163.29 37.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.96 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -122.94 132.34 54.12 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.253 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 38' ' ' ALA . 43.3 pt -125.86 161.26 31.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.864 -177.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.37 113.38 25.98 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.61 142.16 23.52 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 72.4 mm-40 -95.56 169.93 9.7 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.071 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.473 HD11 ' HA ' ' A' ' 84' ' ' PHE . 16.0 tt -62.96 -26.54 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -84.63 1.61 45.34 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.4 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -80.76 143.53 32.84 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.909 0.385 . . . . 0.0 109.974 176.316 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -96.7 173.41 7.33 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.596 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -62.11 -24.14 66.96 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.78 -49.16 76.15 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.955 0.407 . . . . 0.0 110.392 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -76.15 -42.37 46.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.551 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.6 -44.76 99.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.857 0.361 . . . . 0.0 110.615 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.6 tp -65.55 -42.7 91.58 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.32 -46.1 94.91 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.74 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.598 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.14 -50.47 73.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.112 0.456 . . . . 0.0 111.449 -178.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.553 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -69.09 -44.24 72.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.722 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 45' ' ' GLU . 29.0 tp -64.94 -36.96 86.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.76 -177.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.46 -38.57 90.31 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.305 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.598 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.5 mmtt -60.26 -35.51 75.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 110.226 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -85.18 -2.19 57.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.871 0.367 . . . . 0.0 110.369 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.63 20.11 79.78 Favored Glycine 0 C--O 1.237 0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.905 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' C ' ' HG ' ' A' ' 39' ' ' LEU . 88.0 mt -116.36 16.08 15.75 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 44.3 tt0 -56.71 -34.15 67.17 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -70.27 -13.34 62.12 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 122.226 -0.296 . . . . 0.0 111.625 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.4 m -104.24 38.51 1.84 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 99.3 mttt -71.13 -11.52 60.99 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.841 -0.537 . . . . 0.0 111.402 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.558 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 7.4 m-20 -74.2 -7.24 51.98 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.176 0.512 . . . . 0.0 109.844 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -117.83 -13.33 10.12 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.118 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -129.24 147.05 51.04 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.528 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.5 HG23 ' HB3' ' A' ' 106' ' ' LYS . 48.5 pt -137.11 177.7 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.025 177.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.523 HD12 ' HB1' ' A' ' 31' ' ' ALA . 97.0 mt -100.5 138.51 37.47 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.745 0.307 . . . . 0.0 110.414 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 15.8 m -126.78 129.39 71.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.105 176.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.94 118.66 29.67 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.7 t . . . . . 0 C--N 1.314 -0.971 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.664 -179.862 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.482 0 N-CA-C 112.188 -0.365 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 63.7 mtp180 -81.87 123.35 80.23 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.41 114.11 3.7 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 122.412 2.075 . . . . 0.0 111.52 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.7 mt -120.42 99.42 47.99 Favored Pre-proline 0 N--CA 1.434 -1.252 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.487 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -63.65 160.69 35.16 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.849 2.366 . . . . 0.0 111.782 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.601 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 50.6 Cg_exo -51.4 -33.15 45.33 Favored 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 123.863 3.042 . . . . 0.0 114.116 -176.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 m -61.64 -40.72 95.88 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -80.18 154.36 28.02 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 5.3 p -120.19 93.97 48.37 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.139 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.83 -17.66 41.8 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.711 2.274 . . . . 0.0 115.05 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 27' ' ' ILE . 60.0 mt -62.91 -34.45 77.46 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -176.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.473 ' HA ' HD11 ' A' ' 27' ' ' ILE . 21.8 m-85 -57.61 -30.79 65.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.106 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -86.91 -50.48 6.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.117 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.4 mtp -59.08 -71.92 0.11 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.983 -175.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 m . . . . . 0 C--N 1.32 -0.698 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -175.794 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 29.4 p90 . . . . . 0 CA--C 1.51 -0.591 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.403 HD21 HD13 ' A' ' 53' ' ' LEU . 30.6 tp -109.96 125.81 53.26 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.092 -177.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -123.9 169.11 11.92 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.411 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 38' ' ' ALA . 74.0 mt -111.59 130.03 65.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.716 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -127.91 164.57 21.98 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 121.154 0.502 . . . . 0.0 110.309 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -82.12 111.83 18.61 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.558 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.4 ptmt . . . . . 0 C--N 1.323 -0.558 0 O-C-N 123.6 0.562 . . . . 0.0 112.271 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.41 0 CA-C-O 120.935 0.186 . . . . 0.0 113.047 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.3 p -129.5 141.37 51.01 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.6 mt -109.17 142.22 40.27 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.544 ' HE2' ' CE1' ' A' ' 20' ' ' TYR . 87.2 tttt -82.05 108.2 15.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.473 HG11 ' CB ' ' A' ' 38' ' ' ALA . 71.0 t -114.7 131.57 66.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 120.832 0.349 . . . . 0.0 110.563 -173.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -114.71 119.62 37.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.296 0.57 . . . . 0.0 111.868 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.27 19.66 4.55 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.8 -22.61 60.04 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.413 -0.394 . . . . 0.0 113.633 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.01 -35.56 80.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.339 0.59 . . . . 0.0 109.931 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.51 -48.87 13.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.799 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.5 t -119.15 90.93 42.77 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.295 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.13 -30.48 93.28 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.665 2.91 . . . . 0.0 114.079 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -64.96 -23.5 67.24 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.497 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -133.74 79.92 57.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 18.1 Cg_endo -59.76 -48.83 11.58 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.394 2.063 . . . . 0.0 112.773 -178.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.544 ' CE1' ' HE2' ' A' ' 8' ' ' LYS . 86.6 m-85 -118.04 139.52 51.09 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.232 0.539 . . . . 0.0 111.279 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -134.54 161.01 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.879 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.5 p -119.36 130.85 55.55 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.062 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.49 HD11 HG23 ' A' ' 34' ' ' ILE . 40.5 pt -127.49 157.55 39.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.692 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.97 110.38 22.4 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.98 145.91 27.56 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.216 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -108.89 166.12 11.06 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.419 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.561 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 15.2 tt -64.97 -28.75 45.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.659 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -75.23 -4.32 38.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -92.79 145.14 24.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.401 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 32.9 m-20 -83.58 175.38 9.79 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.66 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.543 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -60.23 -25.63 65.79 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.688 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 30' ' ' ASN . 3.5 p-10 -65.15 -37.46 87.48 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.812 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -67.48 -46.9 71.61 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.071 0.462 . . . . 0.0 110.445 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.498 HG21 HD23 ' A' ' 101' ' ' LEU . 96.9 mt -64.8 -45.5 94.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.529 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 53.9 tp -63.43 -46.58 85.69 Favored 'General case' 0 C--O 1.21 -0.992 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.542 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 40' ' ' GLU . . . -66.88 -43.32 91.78 Favored Glycine 0 C--O 1.22 -0.759 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.095 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.01 -38.98 84.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.815 0.341 . . . . 0.0 111.394 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.606 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -84.2 -36.23 22.94 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 35' ' ' LEU . 28.8 tp -62.68 -36.98 84.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.565 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 56.9 mt-10 -58.3 -41.08 83.64 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.576 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 44.7 mmtm -62.61 -38.51 90.47 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.801 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.15 -2.98 58.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.555 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.51 26.78 62.55 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 114.322 0.489 . . . . 0.0 114.322 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 94.0 mt -118.53 15.56 13.74 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 117.251 0.526 . . . . 0.0 110.761 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -60.98 -29.07 69.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.539 -177.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -61.37 -33.49 73.74 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.886 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.4 m -83.33 -89.58 0.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.061 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt 67.28 -27.95 0.13 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.68 -20.19 65.93 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -113.18 19.52 17.05 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.753 0.311 . . . . 0.0 111.437 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.472 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 98.8 m-85 -124.9 144.14 50.48 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 122.301 -0.249 . . . . 0.0 110.832 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.472 HG23 ' HB2' ' A' ' 106' ' ' LYS . 43.1 pt -141.62 169.88 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.336 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.529 HD13 HD21 ' A' ' 101' ' ' LEU . 94.4 mt -102.02 146.66 27.58 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.658 0.266 . . . . 0.0 110.328 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.5 135.36 59.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.013 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -91.86 123.92 35.6 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.121 0.486 . . . . 0.0 111.121 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.1 t . . . . . 0 C--N 1.309 -1.177 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.284 -179.74 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.399 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -86.71 130.24 49.64 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 117.536 0.668 . . . . 0.0 109.795 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.44 117.71 5.15 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.364 2.043 . . . . 0.0 112.034 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.4 mt -119.33 103.0 47.69 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.307 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.23 156.76 48.73 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.922 2.415 . . . . 0.0 111.629 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.543 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 27.5 Cg_endo -63.87 -16.18 53.36 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.908 2.405 . . . . 0.0 113.384 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.9 p -83.36 -12.46 56.51 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -91.14 158.05 16.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.515 0.198 . . . . 0.0 110.929 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.7 m -115.52 85.29 13.33 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.91 -26.93 58.86 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.628 2.219 . . . . 0.0 113.695 -175.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.561 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 77.1 mt -62.92 -37.96 89.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.414 ' HA ' HD11 ' A' ' 27' ' ' ILE . 35.2 m-85 -65.66 -14.95 62.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.537 0.208 . . . . 0.0 111.535 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -95.66 -41.65 8.79 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.484 ' SD ' HD23 ' A' ' 83' ' ' LEU . 91.3 mtp -61.73 -46.23 90.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.023 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.453 -177.578 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 25.4 p90 . . . . . 0 N--CA 1.437 -1.118 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.529 HD21 HD13 ' A' ' 53' ' ' LEU . 29.8 tp -103.97 125.45 50.36 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.034 0.445 . . . . 0.0 111.309 -172.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.73 171.15 11.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.254 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 38' ' ' ALA . 80.4 mt -109.22 129.81 63.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.187 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -135.79 168.0 20.12 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.705 175.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.472 ' HG2' ' CE1' ' A' ' 51' ' ' PHE . 66.5 mtp180 -91.71 139.88 30.25 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.251 -178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HB2' HG23 ' A' ' 52' ' ' ILE . 34.6 ttpt . . . . . 0 C--N 1.3 -1.545 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.101 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.117 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.3 m -94.29 138.49 32.22 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.5 mt -105.85 140.47 38.83 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -82.27 102.53 11.23 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.895 174.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.427 HG21 HG12 ' A' ' 23' ' ' ILE . 41.0 t -108.46 120.36 59.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.103 -175.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -105.07 123.18 47.36 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.219 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.39 17.64 6.54 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.79 -22.17 59.42 Favored Glycine 0 N--CA 1.462 0.416 0 C-N-CA 121.695 -0.288 . . . . 0.0 112.686 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -63.34 -35.38 80.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -92.0 -48.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.73 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.24 106.45 33.28 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -63.86 -22.26 68.98 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.598 2.198 . . . . 0.0 111.32 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -78.68 -15.83 58.01 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.62 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -144.38 71.03 16.0 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.935 0.398 . . . . 0.0 110.199 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 45.3 Cg_exo -57.09 -45.53 35.05 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.065 2.51 . . . . 0.0 113.594 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.26 140.87 52.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 22' ' ' SER . 9.7 p -139.29 167.41 20.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.411 ' H ' HG22 ' A' ' 21' ' ' VAL . 37.6 m -132.03 133.4 44.36 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.483 HD11 HG23 ' A' ' 34' ' ' ILE . 33.8 pt -129.38 163.08 35.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.402 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.7 tp -111.18 121.45 45.34 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.47 143.64 26.85 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.117 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.66 161.36 14.94 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.507 HD11 ' HA ' ' A' ' 84' ' ' PHE . 17.4 tt -62.85 -28.0 44.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.798 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -69.34 -24.04 63.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.312 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.69 139.15 58.74 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.525 0.678 . . . . 0.0 111.197 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -89.67 175.53 7.22 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.437 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -61.01 -33.79 73.81 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.217 -178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.08 -50.02 75.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.626 0.25 . . . . 0.0 111.486 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -69.13 -41.05 77.84 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.835 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.483 HG23 HD11 ' A' ' 23' ' ' ILE . 96.8 mt -64.4 -44.04 97.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.606 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.69 -44.0 97.37 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.978 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.7 -41.02 99.12 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.472 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.03 -49.68 75.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.932 0.396 . . . . 0.0 111.449 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.48 -43.86 72.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.661 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 26.7 tp -64.29 -32.73 74.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.326 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.09 -39.96 87.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.813 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -62.4 -36.31 81.92 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -80.73 -12.35 59.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.313 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.58 20.69 76.32 Favored Glycine 0 C--O 1.229 -0.169 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.243 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 85.5 mt -108.52 12.84 25.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.799 0.333 . . . . 0.0 110.615 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -59.26 -24.86 63.58 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.919 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -64.24 -33.29 75.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.002 0.43 . . . . 0.0 110.272 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.406 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 33.2 m -79.23 -89.39 0.05 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.056 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt 68.1 -39.99 0.41 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.613 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 35.2 m-20 -65.58 -19.74 66.04 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 120.728 0.299 . . . . 0.0 111.618 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.507 ' C ' ' HG2' ' A' ' 106' ' ' LYS . 15.2 p-10 -103.79 11.48 35.74 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.82 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -131.91 147.54 52.48 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.708 0.289 . . . . 0.0 110.893 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.3 pt -138.56 170.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.6 mt -100.46 141.8 32.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.749 0.309 . . . . 0.0 110.176 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 28.6 m -125.22 132.71 70.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 120.994 0.426 . . . . 0.0 110.923 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.521 ' HG3' ' HG2' ' A' ' 86' ' ' MET . 1.6 tm-20 -87.58 129.59 35.05 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.487 ' HB ' ' CZ ' ' A' ' 100' ' ' PHE . 16.1 t . . . . . 0 N--CA 1.435 -1.177 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.368 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 113.99 0.356 . . . . 0.0 113.99 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 76' ' ' ILE . 14.2 ttp180 -111.3 112.77 54.55 Favored Pre-proline 0 N--CA 1.437 -1.09 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.62 116.51 3.28 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.024 2.483 . . . . 0.0 113.043 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 74' ' ' ARG . 32.9 mt -121.81 103.71 39.94 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.089 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 46.6 Cg_exo -62.12 155.54 55.53 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.684 2.256 . . . . 0.0 112.106 177.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.441 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 52.2 Cg_exo -54.56 -33.26 77.92 Favored 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.775 2.983 . . . . 0.0 113.939 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 p -66.18 -24.64 66.68 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.3 155.21 19.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.683 0.278 . . . . 0.0 111.7 -177.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 59.0 m -105.8 93.98 8.25 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.465 ' HB3' HD13 ' A' ' 76' ' ' ILE . 50.6 Cg_endo -69.21 -28.39 27.95 Favored 'Trans proline' 0 C--O 1.218 -0.477 0 C-N-CA 122.842 2.362 . . . . 0.0 115.244 -173.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.49 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 86.7 mt -61.88 -38.69 89.26 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -173.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.507 ' HA ' HD11 ' A' ' 27' ' ' ILE . 58.9 m-85 -59.16 -39.51 82.67 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.189 0.519 . . . . 0.0 110.847 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -83.98 -32.92 24.73 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.663 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.521 ' HG2' ' HG3' ' A' ' 55' ' ' GLU . 85.0 mtp -62.76 -40.97 98.91 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.167 0.508 . . . . 0.0 111.692 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.5 p . . . . . 0 C--N 1.3 -1.569 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.487 ' CZ ' ' HB ' ' A' ' 56' ' ' VAL . 44.3 p90 . . . . . 0 N--CA 1.424 -1.753 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.6 tp -119.54 122.51 41.78 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.987 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.98 167.63 12.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.967 -177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.63 126.03 56.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -120.01 156.83 30.12 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.682 0.753 . . . . 0.0 111.643 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -85.55 112.1 20.63 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.764 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.613 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.6 ptmt . . . . . 0 C--N 1.32 -0.68 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.857 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.452 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.0 p -135.27 151.19 50.34 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.4 mt -122.38 135.65 54.74 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.292 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -87.49 100.57 12.86 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.554 HG11 ' CB ' ' A' ' 38' ' ' ALA . 72.8 t -95.34 122.1 46.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.598 -173.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 82.8 t80 -92.03 120.99 33.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.123 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.47 23.82 4.0 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -61.28 -26.9 66.74 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.279 -0.46 . . . . 0.0 113.375 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.413 ' OE1' ' HG2' ' A' ' 104' ' ' LYS . 44.2 tt0 -64.17 -46.51 83.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.27 -50.1 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.291 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.85 98.14 50.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.131 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.05 -21.77 42.48 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.748 2.298 . . . . 0.0 113.256 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 t -84.78 -6.45 59.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.708 0.29 . . . . 0.0 111.412 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -148.01 80.11 8.89 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.497 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 28.2 Cg_endo -62.87 -48.97 5.8 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.849 2.366 . . . . 0.0 114.111 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -120.21 138.02 53.87 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.017 0.437 . . . . 0.0 111.812 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -127.82 144.27 38.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.793 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 p -96.75 115.73 27.92 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.238 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 34' ' ' ILE . 18.5 pt -117.49 158.34 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.817 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.81 122.83 44.71 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.38 144.79 24.83 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -104.06 158.51 16.38 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.917 0.389 . . . . 0.0 110.425 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 84' ' ' PHE . 14.2 tt -65.24 -26.69 40.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.464 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.47 9.18 11.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.808 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -109.71 146.43 34.9 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.421 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 39.7 m-80 -76.25 174.56 9.99 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.216 0.532 . . . . 0.0 111.236 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.606 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -61.62 -26.48 68.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.843 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.433 ' CB ' ' HB3' ' A' ' 78' ' ' PRO . 1.4 p30 -63.52 -36.92 85.38 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.502 0.192 . . . . 0.0 110.883 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -66.32 -43.81 85.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.099 0.476 . . . . 0.0 110.014 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.494 HG23 HD11 ' A' ' 23' ' ' ILE . 96.7 mt -64.72 -46.16 93.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.322 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.76 -46.71 84.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.197 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -66.19 -43.2 93.57 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.257 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.688 ' O ' ' HD3' ' A' ' 41' ' ' LYS . . . -61.6 -48.81 79.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.867 0.365 . . . . 0.0 111.283 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.554 ' CB ' HG11 ' A' ' 9' ' ' VAL . . . -68.22 -40.68 82.0 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.465 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.83 -36.7 84.76 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.517 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.95 -37.18 78.81 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.387 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.688 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 6.5 mptt -61.43 -37.33 83.12 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.62 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -90.68 -0.13 57.59 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.2 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.84 26.28 71.69 Favored Glycine 0 C--O 1.238 0.365 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.879 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.0 mt -113.81 19.98 16.21 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 122.642 -0.328 . . . . 0.0 111.188 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -52.16 -39.47 60.05 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.343 0.657 . . . . 0.0 111.765 -175.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -72.58 -22.06 61.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.547 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.3 m -93.19 21.22 6.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.836 0.35 . . . . 0.0 111.295 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 32.2 ttmt -59.71 -33.84 72.14 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.893 -176.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.89 -7.8 4.2 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.546 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -106.51 -6.95 17.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -127.76 155.03 44.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -173.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.0 pt -138.66 176.28 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.458 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.606 HD12 ' HB1' ' A' ' 31' ' ' ALA . 98.5 mt -101.51 143.45 31.49 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.727 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.552 HG21 ' HD3' ' A' ' 104' ' ' LYS . 25.7 m -127.9 130.41 69.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.416 177.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.457 ' HB2' HD11 ' A' ' 76' ' ' ILE . 1.7 tt0 -90.27 121.48 32.32 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.6 t . . . . . 0 C--N 1.315 -0.932 0 CA-C-O 121.132 0.492 . . . . 0.0 111.938 -175.514 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.687 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 18.7 ptt85 -83.56 128.65 63.06 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-N 117.375 0.587 . . . . 0.0 109.443 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 24.2 Cg_exo -61.69 119.2 6.21 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.248 1.965 . . . . 0.0 111.921 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.457 HD11 ' HB2' ' A' ' 55' ' ' GLU . 65.6 mt -120.33 100.1 47.72 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.153 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 27.1 Cg_exo -67.12 155.69 69.59 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.734 2.289 . . . . 0.0 111.384 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.433 ' HB3' ' CB ' ' A' ' 32' ' ' ASP . 51.8 Cg_exo -54.66 -32.53 75.78 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 123.489 2.792 . . . . 0.0 113.262 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m -62.69 -41.92 99.37 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.291 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.74 148.91 50.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 5.6 m -104.27 85.96 1.22 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.411 ' O ' ' HG3' ' A' ' 86' ' ' MET . 56.2 Cg_endo -69.46 -24.77 30.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.604 2.203 . . . . 0.0 114.159 -173.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 27' ' ' ILE . 33.3 mt -63.76 -37.89 89.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -175.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.678 ' HA ' HD11 ' A' ' 27' ' ' ILE . 26.7 m-85 -58.21 -46.28 86.16 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.32 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.26 -39.68 82.15 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.005 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 12.1 mtm -64.75 -42.72 94.94 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.788 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 CA--C 1.54 0.57 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.834 -176.867 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.0 p90 . . . . . 0 N--CA 1.438 -1.056 0 CA-C-O 121.118 0.485 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -111.64 127.36 55.73 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.465 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.46 166.18 14.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.209 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.428 HD11 ' HB3' ' A' ' 38' ' ' ALA . 68.3 mt -106.86 122.84 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.636 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.552 ' HD3' HG21 ' A' ' 54' ' ' VAL . 25.3 mtpp -132.31 167.14 20.39 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 177.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -75.11 141.41 43.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.092 176.408 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.216 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.5 m -109.69 146.69 34.44 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.7 mt -114.36 135.09 54.46 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.86 101.48 11.01 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.473 HG21 HG12 ' A' ' 23' ' ' ILE . 61.4 t -102.66 121.13 53.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.228 -171.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.413 ' CE2' ' HG2' ' A' ' 13' ' ' GLU . 69.9 t80 -92.54 104.33 16.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.41 0.624 . . . . 0.0 110.984 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.22 16.61 22.31 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.885 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.67 -23.7 58.92 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.555 -0.355 . . . . 0.0 112.385 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.413 ' HG2' ' CE2' ' A' ' 10' ' ' TYR . 59.7 mm-40 -65.78 -36.02 82.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.119 0.485 . . . . 0.0 110.185 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.7 mm -86.07 -50.31 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.609 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -128.51 105.31 19.23 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.371 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.16 -36.52 96.6 Favored 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 123.647 2.898 . . . . 0.0 112.228 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 m -63.45 -26.97 68.97 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.723 -176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.07 79.02 69.95 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.49 -43.85 47.48 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.593 2.196 . . . . 0.0 112.927 -178.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -128.53 139.73 52.16 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.126 0.489 . . . . 0.0 111.311 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.76 161.35 41.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 p -119.87 130.31 54.8 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.045 0.45 . . . . 0.0 111.265 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.473 HG12 HG21 ' A' ' 9' ' ' VAL . 36.7 pt -130.4 157.34 42.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.427 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.5 mp -105.0 121.91 44.76 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.54 145.8 43.35 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.019 0.438 . . . . 0.0 111.194 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 62.3 mt-10 -97.7 152.11 19.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.114 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.572 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.7 tt -67.11 -29.4 45.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.915 -177.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -93.25 13.32 21.64 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.195 0.521 . . . . 0.0 110.078 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 37.0 tt0 -99.42 137.14 38.34 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -76.85 165.24 24.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.349 0.595 . . . . 0.0 112.479 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.549 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -63.1 -23.19 67.33 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.733 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.8 -45.57 93.27 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.797 0.332 . . . . 0.0 111.015 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -69.89 -42.38 73.5 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.958 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.47 -48.7 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.552 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.2 tp -63.62 -44.52 93.67 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.228 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.11 93.92 Favored Glycine 0 C--O 1.212 -1.265 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.17 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.38 -51.11 70.88 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.256 0.528 . . . . 0.0 111.238 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.445 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -69.24 -39.83 78.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.317 0.579 . . . . 0.0 111.133 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 45' ' ' GLU . 30.5 tp -64.38 -38.24 90.32 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.027 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -65.67 -26.76 67.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.179 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 74.7 mmtt -59.84 -30.37 68.92 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.325 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -101.36 1.68 38.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.244 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.95 27.69 73.69 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.74 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.1 mt -112.81 23.0 13.92 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.418 ' HA ' HD23 ' A' ' 39' ' ' LEU . 13.1 pt-20 -60.34 -30.32 69.46 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -175.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -71.34 -20.17 62.2 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.992 0.425 . . . . 0.0 110.979 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.6 m -90.39 6.73 41.98 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.975 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -56.73 -16.07 5.75 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.368 0.667 . . . . 0.0 112.74 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.34 -34.19 74.87 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.843 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.577 ' OD2' ' HD3' ' A' ' 105' ' ' ARG . 20.6 t0 -107.48 15.94 24.33 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.05 148.83 50.57 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.868 -0.52 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.4 pt -140.17 170.3 15.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.262 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.452 HD12 ' HB1' ' A' ' 31' ' ' ALA . 97.8 mt -101.39 141.59 34.04 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.691 0.281 . . . . 0.0 110.514 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.568 HG21 ' HG3' ' A' ' 104' ' ' LYS . 28.3 m -124.21 129.26 74.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.15 0.5 . . . . 0.0 109.872 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.446 ' HB3' ' HD3' ' A' ' 74' ' ' ARG . 14.8 tt0 -88.17 134.92 33.66 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.9 t . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -175.972 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.685 0 N-CA-C 113.99 0.356 . . . . 0.0 113.99 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.446 ' HD3' ' HB3' ' A' ' 55' ' ' GLU . 5.8 ptm180 -119.76 121.34 29.87 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 15.9 Cg_exo -66.47 118.4 5.5 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.308 2.005 . . . . 0.0 112.094 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.413 HG21 ' HB3' ' A' ' 82' ' ' PRO . 36.5 mt -121.64 102.6 41.75 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.143 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.77 154.02 74.79 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.757 2.305 . . . . 0.0 111.905 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.549 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 4.2 Cg_endo -57.05 -26.84 70.88 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.633 2.888 . . . . 0.0 113.536 -177.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.4 m -62.4 -40.22 95.79 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.06 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -82.02 157.63 24.11 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.063 0.545 . . . . 0.0 112.323 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 66.4 m -109.05 91.89 10.03 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HB3' HG21 ' A' ' 76' ' ' ILE . 47.6 Cg_endo -68.53 -18.91 43.13 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.051 2.501 . . . . 0.0 115.109 -173.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 27' ' ' ILE . 33.9 mt -63.01 -28.78 70.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -173.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.441 ' HA ' HD11 ' A' ' 27' ' ' ILE . 44.1 m-85 -59.01 -44.19 91.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 110.489 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -80.13 -34.28 37.9 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.596 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.562 ' HB2' ' HA ' ' A' ' 83' ' ' LEU . 2.3 tmm? -58.83 -43.0 90.56 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.212 0.605 . . . . 0.0 111.082 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.9 m . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.276 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.7 p90 . . . . . 0 N--CA 1.424 -1.729 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.1 tp -118.16 122.33 42.77 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.063 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.07 165.96 12.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.473 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 38' ' ' ALA . 72.3 mt -107.01 124.84 63.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.8 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.568 ' HG3' HG21 ' A' ' 54' ' ' VAL . 1.4 mmpt? -128.94 152.19 48.84 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.422 0.63 . . . . 0.0 110.537 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.577 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 2.4 tmm_? -79.32 126.36 30.7 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.317 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.213 -179.128 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 N-CA-C 112.188 -0.365 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 p -95.52 137.45 34.56 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.448 HD11 HD21 ' A' ' 83' ' ' LEU . 62.0 mt -112.19 135.16 53.21 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 121.179 0.514 . . . . 0.0 112.029 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -82.67 108.86 16.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' A' ' 23' ' ' ILE . 56.6 t -116.82 130.43 71.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.658 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -108.38 116.89 32.81 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.763 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.17 -33.64 7.16 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 45.89 -90.98 0.01 OUTLIER Glycine 0 C--N 1.338 0.692 0 N-CA-C 115.991 1.156 . . . . 0.0 115.991 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.64 -39.13 91.1 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.5 mt -65.26 -44.77 94.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.174 0.511 . . . . 0.0 111.262 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 42' ' ' TYR . 49.7 t -132.05 88.78 40.01 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.114 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.55 -25.86 81.6 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 123.189 2.593 . . . . 0.0 112.94 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.1 t -79.14 -5.32 53.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.732 0.301 . . . . 0.0 111.468 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -154.29 76.3 5.71 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 121.174 0.512 . . . . 0.0 109.81 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.09 -43.11 61.26 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.031 2.488 . . . . 0.0 113.142 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -118.98 143.77 46.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.14 0.495 . . . . 0.0 112.146 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.98 158.59 39.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.904 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -116.55 124.35 49.65 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.465 ' CD1' HG21 ' A' ' 9' ' ' VAL . 40.6 pt -125.33 161.75 29.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.65 -177.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.0 mp -111.69 125.88 54.44 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.87 148.16 30.55 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.79 0.329 . . . . 0.0 110.897 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . 74.9 mm-40 -94.81 149.89 20.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.492 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 16.8 tt -63.21 -26.63 41.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.719 -0.392 . . . . 0.0 112.041 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -77.36 -7.64 56.39 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.256 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.544 ' OE2' ' HD3' ' A' ' 33' ' ' ARG . 47.3 mt-10 -84.83 140.22 31.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.087 0.47 . . . . 0.0 110.874 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -78.64 173.87 11.99 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.58 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.577 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -61.36 -27.53 68.57 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.923 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -63.24 -38.57 91.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.755 0.312 . . . . 0.0 110.445 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.544 ' HD3' ' OE2' ' A' ' 29' ' ' GLU . 3.2 mmp_? -69.84 -44.3 70.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.075 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.442 HG23 HD11 ' A' ' 23' ' ' ILE . 97.1 mt -64.65 -44.83 96.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.361 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.84 -44.56 95.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.731 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.452 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -66.4 -38.95 93.99 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.999 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.02 -51.06 71.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.829 0.347 . . . . 0.0 111.046 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.472 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -68.04 -40.79 82.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.105 0.478 . . . . 0.0 110.959 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.3 tp -63.13 -39.1 93.7 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.084 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.8 -35.29 77.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.913 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.4 mmtt -61.67 -38.05 86.36 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.836 0.35 . . . . 0.0 110.336 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.506 ' CD1' HG21 ' A' ' 15' ' ' VAL . 79.0 m-85 -85.76 -5.75 59.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.658 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.56 20.27 79.81 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.401 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.0 mt -104.09 23.29 13.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.722 0.296 . . . . 0.0 110.761 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.81 -25.64 20.25 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -78.53 -13.46 59.82 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -177.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.7 m -106.68 22.68 15.5 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 36.5 ttmt -60.47 -32.93 71.87 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.79 -28.9 66.41 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.846 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.75 -6.13 59.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.279 -176.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 69.7 m-85 -127.39 153.81 45.77 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.161 -174.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.0 pt -136.85 172.57 14.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.555 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.609 HD13 HD21 ' A' ' 101' ' ' LEU . 97.0 mt -101.57 139.96 36.51 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.443 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 15.2 m -127.99 128.88 69.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.022 0.439 . . . . 0.0 110.218 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -87.96 124.49 33.76 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.034 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.442 HG22 ' HA3' ' A' ' 73' ' ' GLY . 39.6 t . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.007 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.442 ' HA3' HG22 ' A' ' 56' ' ' VAL . . . . . . . . 0 CA--C 1.5 -0.858 0 N-CA-C 112.603 -0.199 . . . . 0.0 112.603 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 12.3 ttp180 -86.07 119.16 71.54 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -63.75 114.6 2.64 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.748 2.299 . . . . 0.0 112.315 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.2 mt -121.91 99.69 43.94 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.724 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.74 159.21 46.51 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.863 2.375 . . . . 0.0 111.764 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 38.3 Cg_exo -55.8 -32.71 85.69 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.252 2.635 . . . . 0.0 113.532 -176.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.2 p -76.31 -12.58 60.1 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -80.21 155.46 27.36 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.8 m -113.95 83.38 7.67 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.41 -27.58 54.76 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.884 2.389 . . . . 0.0 114.39 -174.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.492 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 82.5 mt -63.96 -39.6 94.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HA ' HD11 ' A' ' 27' ' ' ILE . 31.5 m-85 -56.53 -45.44 81.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.47 -43.77 59.51 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.027 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 31.2 mtm -63.25 -42.27 99.15 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.312 -1.047 0 CA-C-O 120.725 0.298 . . . . 0.0 111.738 -178.399 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.7 p90 . . . . . 0 CA--C 1.503 -0.836 0 CA-C-O 121.058 0.456 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.609 HD21 HD13 ' A' ' 53' ' ' LEU . 25.6 tp -113.64 124.9 53.43 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.101 0.477 . . . . 0.0 110.273 -177.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.04 164.56 13.99 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.807 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.472 HD11 ' HB3' ' A' ' 38' ' ' ALA . 68.6 mt -112.17 129.97 66.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.825 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -131.54 163.44 28.01 Favored 'General case' 0 CA--C 1.478 -1.793 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 1.7 ptm180 -94.6 120.11 34.32 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.275 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt . . . . . 0 C--N 1.31 -1.12 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.705 179.461 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.02 0 CA-C-O 120.796 0.109 . . . . 0.0 112.849 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -128.31 153.49 46.95 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.5 mt -104.83 137.76 42.13 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.55 105.26 17.52 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 173.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -101.06 127.81 53.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.398 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 86.9 t80 -88.64 119.95 29.59 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.009 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.23 29.97 8.33 Favored Glycine 0 C--O 1.244 0.728 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.262 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 13' ' ' GLU . . . -60.28 168.37 8.83 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 66.1 mm-40 74.6 -34.69 0.28 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.113 0.565 . . . . 0.0 111.397 -176.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.437 HG22 HG23 ' A' ' 15' ' ' VAL . 69.0 mt -91.13 -56.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.437 HG23 HG22 ' A' ' 14' ' ' ILE . 56.0 t -130.83 97.74 20.43 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.424 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.65 -23.67 42.33 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.909 2.406 . . . . 0.0 113.489 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.0 t -80.07 -7.95 59.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.246 0.546 . . . . 0.0 110.976 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -139.15 71.3 40.52 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.496 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 23.1 Cg_endo -59.74 -42.9 42.08 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.695 2.263 . . . . 0.0 113.354 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.06 140.36 53.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.174 0.512 . . . . 0.0 111.524 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.3 p -126.75 155.81 37.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.546 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.0 m -102.9 122.56 44.8 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.494 ' CD1' HG23 ' A' ' 34' ' ' ILE . 16.9 pt -119.28 151.98 21.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.125 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.9 mp -100.97 107.17 18.58 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.54 141.66 18.34 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -113.62 173.28 6.49 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.088 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 84' ' ' PHE . 15.1 tt -61.83 -30.12 47.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -172.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -77.32 -6.91 54.97 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.159 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -89.24 147.46 24.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.083 0.468 . . . . 0.0 111.062 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -86.13 178.94 7.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.828 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.745 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -67.92 -15.65 63.71 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.6 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' A' ' 78' ' ' PRO . 1.9 p-10 -62.27 -40.89 97.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.728 0.299 . . . . 0.0 110.416 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -43.7 66.51 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-O 121.231 0.539 . . . . 0.0 109.63 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.573 HG21 HD23 ' A' ' 101' ' ' LEU . 96.7 mt -63.06 -49.96 81.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.452 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.94 -45.1 83.06 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.026 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.43 -43.2 97.08 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.722 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -64.47 -48.58 74.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.95 0.375 . . . . 0.0 111.32 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.73 -48.12 78.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.078 0.466 . . . . 0.0 111.287 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.48 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 28.9 tp -63.31 -34.63 78.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.865 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 38.2 tt0 -60.04 -44.4 94.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.45 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 65.3 mmtt -64.32 -37.39 87.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.549 -177.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -78.41 -6.09 54.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.586 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.91 24.95 57.1 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.962 -0.637 . . . . 0.0 114.201 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.48 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 90.6 mt -120.27 22.85 11.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 117.279 0.539 . . . . 0.0 110.736 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 5.0 tm-20 -59.85 -31.46 69.77 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.231 0.612 . . . . 0.0 111.743 -175.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -78.19 -14.38 59.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -90.59 -82.92 0.27 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.442 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 16.4 ttmt 64.43 -37.78 0.21 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.553 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 4.5 p-10 -70.53 -2.41 14.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.063 0.458 . . . . 0.0 111.257 -177.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.86 -9.78 20.44 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.39 154.22 48.85 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 106' ' ' LYS . 48.1 pt -141.22 -179.86 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 174.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.745 HD12 ' HB1' ' A' ' 31' ' ' ALA . 90.6 mt -103.38 148.67 25.61 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.619 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.43 155.32 31.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.627 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.489 ' HG3' ' CD1' ' A' ' 76' ' ' ILE . 46.3 mt-10 -99.78 123.62 44.22 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 177.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.443 ' HB ' ' CZ ' ' A' ' 100' ' ' PHE . 25.0 t . . . . . 0 C--N 1.316 -0.851 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.168 178.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 112.752 -0.139 . . . . 0.0 112.752 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -111.07 139.15 21.51 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.51 120.44 7.39 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.572 2.181 . . . . 0.0 113.266 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.489 ' CD1' ' HG3' ' A' ' 55' ' ' GLU . 33.9 mt -120.87 104.07 42.29 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.345 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 32.1 Cg_exo -65.26 156.34 63.63 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.086 2.524 . . . . 0.0 112.846 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.526 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 32.5 Cg_exo -56.78 -30.55 85.13 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.567 2.844 . . . . 0.0 113.435 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 p -80.62 3.4 22.04 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -97.51 156.52 16.46 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.375 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.1 m -114.25 80.53 5.84 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.02 -20.13 19.66 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.511 2.141 . . . . 0.0 114.614 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 27' ' ' ILE . 47.9 mt -64.03 -38.59 91.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.589 ' HA ' HD11 ' A' ' 27' ' ' ILE . 22.1 m-85 -59.23 -37.21 76.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.054 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -73.39 -41.67 63.07 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.892 0.377 . . . . 0.0 110.814 177.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.6 mtt -61.22 -42.87 99.35 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.412 HG21 HD12 ' A' ' 27' ' ' ILE . 18.5 p . . . . . 0 C--N 1.317 -0.827 0 CA-C-O 120.826 0.346 . . . . 0.0 111.906 -178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.443 ' CZ ' ' HB ' ' A' ' 56' ' ' VAL . 30.4 p90 . . . . . 0 N--CA 1.435 -1.205 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.597 HD21 HD13 ' A' ' 53' ' ' LEU . 22.1 tp -107.6 125.02 50.81 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.01 0.433 . . . . 0.0 110.793 -173.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -129.07 173.31 10.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.877 -177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.3 mt -110.77 127.61 67.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.376 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -128.72 165.76 20.27 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -88.15 128.96 35.44 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.969 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.553 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.5 ptmt . . . . . 0 C--N 1.318 -0.793 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.239 0.532 0 CA-C-O 120.618 0.247 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.3 mtt -139.52 144.11 37.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.824 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -64.11 -43.53 95.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.98 -45.45 2.48 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.781 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.22 2.82 85.34 Favored Glycine 0 C--N 1.319 -0.367 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.496 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 m -131.61 147.72 52.55 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.5 mt -117.39 140.14 49.96 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -84.09 105.56 15.05 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.31 129.24 62.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.724 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 92.3 t80 -109.98 119.55 39.67 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.623 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.53 30.36 2.89 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.274 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.15 -30.4 63.97 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 121.806 -0.235 . . . . 0.0 113.578 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -64.64 -26.66 68.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.039 0.447 . . . . 0.0 110.981 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.9 mt -90.56 -50.92 12.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.99 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.63 96.81 20.11 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.829 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.4 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 48.8 Cg_exo -56.83 -34.96 97.83 Favored 'Trans proline' 0 N--CA 1.475 0.432 0 C-N-CA 123.283 2.656 . . . . 0.0 113.655 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.6 t -71.41 -16.44 62.39 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -133.86 69.64 75.31 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.484 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 47.1 Cg_endo -66.99 -33.11 33.34 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.542 2.161 . . . . 0.0 112.735 -176.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -122.03 132.56 54.57 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.914 0.387 . . . . 0.0 110.738 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.7 p -136.75 156.88 35.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.304 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -112.95 125.09 54.01 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.314 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.402 HD11 HG23 ' A' ' 34' ' ' ILE . 33.9 pt -123.38 159.13 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.566 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.78 133.79 40.91 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.44 134.59 5.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.832 0.349 . . . . 0.0 111.26 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.714 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 6.5 mp0 -92.56 161.12 14.72 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.473 HG13 ' CB ' ' A' ' 83' ' ' LEU . 19.7 tt -66.98 -25.73 35.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -87.86 4.88 42.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.714 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 12.7 pt-20 -97.42 144.4 27.19 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.785 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -77.16 170.25 16.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.962 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.55 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -60.25 -24.9 65.26 Favored 'General case' 0 C--O 1.198 -1.612 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.647 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.61 -46.64 88.36 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.938 0.399 . . . . 0.0 111.084 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -70.12 -43.7 70.45 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.674 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 23' ' ' ILE . 97.0 mt -63.8 -46.17 95.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.298 0.57 . . . . 0.0 110.494 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.6 tp -65.16 -43.09 92.9 Favored 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.727 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.455 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -63.78 -37.08 94.17 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.21 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.97 -51.15 67.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.898 0.38 . . . . 0.0 110.778 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.85 -43.79 87.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.16 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.52 ' CD2' ' HA ' ' A' ' 45' ' ' GLU . 29.5 tp -64.71 -35.57 81.48 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.985 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -63.19 -36.21 82.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.767 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 63.7 mmtt -62.42 -36.33 82.02 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -84.0 -8.1 59.23 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.565 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.28 30.12 71.71 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.423 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.2 mt -120.48 24.53 10.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.52 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 42.4 tt0 -58.84 -29.7 67.13 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -62.61 -26.78 68.79 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.054 0.455 . . . . 0.0 110.881 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.5 m -100.54 30.53 3.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.903 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.455 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 36.3 ttmt -61.09 -36.75 80.49 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.453 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 30.8 t70 -62.95 -18.52 63.26 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.178 0.513 . . . . 0.0 111.829 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -82.46 -8.62 59.62 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.73 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -132.42 150.43 52.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.256 0.55 . . . . 0.0 111.79 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.677 HG23 ' HB2' ' A' ' 106' ' ' LYS . 25.6 pt -139.97 171.35 13.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.568 HD13 HD21 ' A' ' 101' ' ' LEU . 97.6 mt -100.07 141.79 32.42 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.356 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.49 136.77 55.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -86.59 117.62 25.47 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.639 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.455 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 40.4 t -111.17 125.27 68.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.484 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 48.9 m -85.53 146.22 27.02 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -61.86 -35.84 79.47 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.988 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 22.2 m-20 -92.37 14.52 16.29 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -177.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.484 ' OD1' ' HB2' ' A' ' 57' ' ' SER . 93.3 m-20 -70.09 -5.37 26.39 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.821 -0.55 . . . . 0.0 111.637 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -64.61 -24.53 67.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.703 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 59' ' ' ASP . 17.4 ptm180 -74.44 -42.33 59.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.184 0.516 . . . . 0.0 110.315 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.91 -47.94 70.21 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.567 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -131.22 134.6 46.61 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.528 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.6 ttt -76.05 1.77 14.6 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.665 0.745 . . . . 0.0 109.848 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' ' 70' ' ' GLU . 6.2 t -66.7 -22.81 66.06 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.014 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 63.25 -163.57 0.27 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.573 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.9 mt -84.65 -4.35 58.97 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -64.29 -54.67 29.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.017 -176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 71' ' ' ILE . 36.5 tt0 -89.55 -11.41 42.88 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.799 0.333 . . . . 0.0 111.075 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 70' ' ' GLU . 95.9 mt 70.77 125.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-O 121.519 0.676 . . . . 0.0 111.652 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -147.44 122.77 10.29 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -166.65 -171.95 33.37 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.423 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ptt85 -82.37 133.81 49.62 Favored Pre-proline 0 N--CA 1.441 -0.891 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.09 121.15 8.71 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.383 2.055 . . . . 0.0 111.888 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.3 mt -121.27 97.9 47.18 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.89 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -63.5 159.51 40.15 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.25 2.633 . . . . 0.0 112.493 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 47.3 Cg_exo -55.13 -29.17 64.62 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.609 2.873 . . . . 0.0 113.659 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.5 p -80.69 -1.42 42.51 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -105.37 142.92 34.3 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.251 -0.18 . . . . 0.0 110.612 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.0 p -106.11 92.42 6.59 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 120.986 0.422 . . . . 0.0 110.104 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.73 -23.05 36.37 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.013 2.475 . . . . 0.0 114.871 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.473 ' CB ' HG13 ' A' ' 27' ' ' ILE . 86.2 mt -62.56 -27.88 69.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.468 ' HA ' HD11 ' A' ' 27' ' ' ILE . 20.0 m-85 -58.03 -48.43 80.09 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.148 0.28 . . . . 0.0 111.299 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.08 -36.44 58.96 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.336 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 96.5 mtp -60.53 -61.58 2.49 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.22 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.0 m -67.39 -24.79 65.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.734 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.64 -61.95 2.22 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.873 0.368 . . . . 0.0 111.246 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -69.62 -41.37 75.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.136 0.493 . . . . 0.0 109.862 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.636 ' HA ' ' CB ' ' A' ' 97' ' ' PHE . 31.3 p 53.21 24.16 3.54 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -168.02 171.74 42.49 Favored Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.1 m120 67.91 108.88 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.28 0.632 . . . . 0.0 111.333 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.05 94.97 0.19 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.089 -0.577 . . . . 0.0 111.84 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -176.27 -71.23 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -139.54 68.14 1.37 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -163.13 -170.25 27.74 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.253 -0.885 . . . . 0.0 112.087 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.636 ' CB ' ' HA ' ' A' ' 90' ' ' SER . 12.0 t80 -83.71 -1.78 54.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.303 0.573 . . . . 0.0 110.971 -176.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -81.38 -6.83 59.33 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.609 0.719 . . . . 0.0 109.383 172.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.9 m -100.59 149.72 23.44 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.455 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 27.5 p90 -111.81 165.56 11.96 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.435 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.568 HD21 HD13 ' A' ' 53' ' ' LEU . 34.4 tp -109.03 121.4 45.06 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.43 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.27 174.47 6.69 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.815 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.44 129.74 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.136 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -122.93 160.26 26.55 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -82.46 116.93 22.13 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.374 -0.931 . . . . 0.0 109.68 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.677 ' HB2' HG23 ' A' ' 52' ' ' ILE . 72.6 tttt -49.82 -55.92 20.53 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.813 176.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 106' ' ' LYS . 90.7 Cg_endo -78.36 153.88 27.79 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 123.0 2.467 . . . . 0.0 110.922 176.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 . . . . . 0 C--N 1.305 -1.35 0 CA-C-O 118.409 -0.805 . . . . 0.0 110.391 -178.583 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 120.994 0.426 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.2 mtp -114.8 176.04 5.23 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 120.957 0.408 . . . . 0.0 110.45 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -86.08 118.7 25.71 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.63 -37.06 93.18 Favored Glycine 0 CA--C 1.517 0.211 0 CA-C-N 116.108 -0.497 . . . . 0.0 114.17 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.33 -48.01 2.15 Favored Glycine 0 C--N 1.319 -0.382 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.37 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 p -95.38 139.17 32.05 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.4 mt -123.45 140.85 52.58 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -84.78 108.57 17.53 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.426 HG21 ' CD1' ' A' ' 23' ' ' ILE . 53.2 t -113.19 131.24 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.506 -171.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 87.2 t80 -88.04 121.19 30.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.543 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.8 31.69 6.89 Favored Glycine 0 CA--C 1.507 -0.441 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.708 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 10' ' ' TYR . . . -53.95 165.13 2.46 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.534 -0.333 . . . . 0.0 113.371 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 71.99 -47.16 0.66 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.129 0.972 . . . . 0.0 110.907 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.478 HG22 HG23 ' A' ' 15' ' ' VAL . 42.8 mm -62.97 -50.01 81.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.18 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.478 HG23 HG22 ' A' ' 14' ' ' ILE . 64.8 t -142.61 111.12 5.79 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.516 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.45 -24.52 49.4 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.838 2.359 . . . . 0.0 113.461 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.0 t -91.31 -0.9 57.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.991 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -145.8 73.45 13.69 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.407 . . . . 0.0 110.429 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.33 -21.79 30.35 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.726 2.284 . . . . 0.0 112.891 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -130.11 141.97 50.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.79 160.99 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.534 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.5 p -108.78 133.27 53.07 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.262 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 38' ' ' ALA . 32.0 pt -128.83 162.54 35.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.695 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.3 tp -112.6 123.85 51.23 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.9 154.04 47.14 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.005 0.431 . . . . 0.0 111.16 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.56 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 46.7 mt-10 -110.86 146.18 36.93 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.595 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.7 tt -67.52 -26.82 36.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -176.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -87.61 15.41 6.82 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.013 0.435 . . . . 0.0 110.978 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.56 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 70.0 mm-40 -106.5 157.38 17.7 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.839 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -88.89 169.25 11.73 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.257 0.551 . . . . 0.0 111.199 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -62.05 -26.17 68.1 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.089 -177.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.69 -45.08 93.18 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -67.41 -42.73 82.76 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 120.889 0.376 . . . . 0.0 110.487 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.54 -45.2 98.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.222 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.9 tp -63.47 -45.12 92.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.511 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.27 -34.83 89.22 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.301 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.56 -52.41 65.66 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.01 0.405 . . . . 0.0 111.998 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -71.59 -37.53 70.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.205 0.526 . . . . 0.0 110.727 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.81 -38.63 88.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.144 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.33 -37.36 83.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.445 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -62.78 -38.39 90.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.901 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -86.71 -0.97 57.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.844 0.354 . . . . 0.0 110.994 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.15 15.53 80.94 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.919 -0.582 . . . . 0.0 114.305 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.1 mt -105.76 14.53 28.11 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.384 0.592 . . . . 0.0 111.352 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.06 -20.04 63.55 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -66.05 -35.08 79.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -83.41 -81.85 0.16 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.605 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt 65.44 -40.8 0.31 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.603 1.161 . . . . 0.0 113.829 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.44 -11.27 41.35 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -100.12 1.78 42.49 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.224 0.535 . . . . 0.0 110.318 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -132.0 151.94 51.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 111.297 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.4 pt -139.4 172.88 12.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.61 HD12 ' HB1' ' A' ' 31' ' ' ALA . 95.6 mt -100.71 134.88 43.03 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 12.7 m -123.57 128.55 74.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.305 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 4.8 tm-20 -86.81 120.16 27.81 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.421 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 74.7 t -118.08 131.26 71.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.005 -173.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 p -73.21 156.27 38.73 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.078 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.39 0.65 55.15 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 122.083 0.944 . . . . 0.0 108.751 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -94.54 20.67 8.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.255 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.64 -36.93 77.35 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.108 -175.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -63.57 -29.5 70.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.716 0.293 . . . . 0.0 111.763 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 62' ' ' ARG . 16.4 ptt180 -105.58 1.77 27.7 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.995 -176.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -114.17 -63.15 1.49 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.678 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 66' ' ' SER . 41.3 p -90.71 -27.12 19.18 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.112 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.9 ttt 67.42 -9.23 0.43 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.053 0.941 . . . . 0.0 111.47 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.446 ' H ' ' C ' ' A' ' 64' ' ' SER . 6.6 t -79.16 -4.65 51.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.948 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 68' ' ' LEU . 12.1 t70 66.88 -162.29 0.23 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.918 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.455 ' H ' ' CG ' ' A' ' 67' ' ' ASP . 87.5 mt -80.37 -4.14 52.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.756 0.312 . . . . 0.0 110.457 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 69' ' ' ARG . 55.2 mtt180 -62.16 -48.87 78.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.38 0.61 . . . . 0.0 110.099 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -86.06 -27.05 24.99 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.593 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 43.61 95.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.815 1.246 . . . . 0.0 112.839 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -116.56 144.45 44.35 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.421 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -164.67 -160.36 12.13 Favored Glycine 0 C--N 1.31 -0.876 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.49 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 10.5 ptp180 -96.23 136.11 22.21 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -70.8 114.36 3.84 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.068 1.845 . . . . 0.0 111.827 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.0 mt -120.79 99.77 46.94 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.072 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.45 158.81 43.32 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.808 2.339 . . . . 0.0 112.086 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.476 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 31.2 Cg_exo -57.29 -23.13 52.75 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.361 2.708 . . . . 0.0 112.512 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.4 p -67.52 -22.42 65.43 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -78.69 176.54 9.41 Favored 'General case' 0 CA--C 1.498 -1.032 0 CA-C-O 122.352 1.072 . . . . 0.0 113.264 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 85.6 m -137.6 71.8 50.94 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 112.801 -2.0 . . . . 0.0 106.305 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.404 ' O ' ' HG3' ' A' ' 86' ' ' MET . 44.4 Cg_endo -67.02 -18.42 51.78 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.976 2.451 . . . . 0.0 114.323 -170.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 27' ' ' ILE . 44.6 mt -61.95 -41.33 97.85 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -173.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HA ' HD11 ' A' ' 27' ' ' ILE . 41.1 m-85 -60.24 -43.02 96.43 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.696 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.59 -40.63 84.81 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.388 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 96.6 mtp -62.78 -46.95 85.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.622 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.5 p -71.46 -37.41 71.37 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.73 -41.54 78.85 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -89.76 -54.43 4.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.909 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.627 ' HA ' ' H ' ' A' ' 97' ' ' PHE . 0.4 OUTLIER 49.89 -158.03 0.08 Allowed 'General case' 0 CA--C 1.554 1.13 0 O-C-N 123.524 0.515 . . . . 0.0 110.706 -177.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 166.62 -137.56 4.72 Favored Glycine 0 CA--C 1.504 -0.594 0 C-N-CA 119.325 -1.417 . . . . 0.0 113.054 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -109.15 -50.52 2.99 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.59 24.67 0.09 OUTLIER Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 173.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 mp0 -87.5 -95.78 0.09 Allowed 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -130.42 79.55 1.9 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.191 0.519 . . . . 0.0 110.483 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.62 -156.51 10.49 Favored Glycine 0 C--N 1.304 -1.218 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.831 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.627 ' H ' ' HA ' ' A' ' 90' ' ' SER . 23.9 t80 -65.68 -21.04 66.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.294 0.568 . . . . 0.0 110.726 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.11 -9.68 58.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.594 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.5 m -101.3 166.67 10.64 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.359 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.421 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 30.0 p90 -111.7 162.65 14.99 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.586 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.444 HD21 HD13 ' A' ' 53' ' ' LEU . 31.0 tp -114.46 128.79 56.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.525 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . . . -122.89 167.84 13.04 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.82 -176.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 38' ' ' ALA . 84.2 mt -110.07 129.72 64.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.642 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -130.52 161.95 30.34 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.49 0.662 . . . . 0.0 111.028 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -84.07 104.76 14.4 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.486 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -54.61 155.78 7.15 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.512 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -59.89 149.59 82.86 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 122.368 2.045 . . . . 0.0 112.479 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.4 t60 . . . . . 0 C--N 1.299 -1.588 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.614 -177.755 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 120.797 0.332 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 68.8 mtt -109.95 175.28 5.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.152 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -79.28 105.19 10.42 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.38 -7.98 64.74 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.587 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.68 -29.59 11.3 Favored Glycine 0 CA--C 1.507 -0.441 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.612 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 p -95.11 139.96 30.72 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.2 mt -112.87 138.22 50.05 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-O 121.089 0.471 . . . . 0.0 111.992 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -82.15 106.24 13.89 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.45 HG11 ' CB ' ' A' ' 38' ' ' ALA . 54.6 t -113.62 129.39 69.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.494 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -103.23 108.35 19.52 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.649 0.737 . . . . 0.0 112.246 -174.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.82 12.64 9.97 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' A' ' 19' ' ' PRO . . . -61.55 -24.53 64.12 Favored Glycine 0 CA--C 1.5 -0.889 0 CA-C-N 115.286 -0.457 . . . . 0.0 112.921 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -66.3 -27.51 67.97 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.344 0.592 . . . . 0.0 109.843 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 76.4 mt -94.47 -51.69 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.862 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.31 97.32 47.5 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.196 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.68 -33.85 94.56 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.82 3.013 . . . . 0.0 114.921 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.4 t -65.77 -16.64 63.98 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.672 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -132.22 75.15 75.15 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.236 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HA ' ' HA3' ' A' ' 12' ' ' GLY . 18.1 Cg_endo -59.32 -46.78 19.76 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.445 2.096 . . . . 0.0 112.586 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -122.89 139.11 54.39 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.537 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.23 155.64 39.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -109.15 125.77 52.53 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.24 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' CD1' HG21 ' A' ' 9' ' ' VAL . 39.2 pt -126.28 156.22 36.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.23 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.3 tp -103.24 121.84 43.53 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.86 156.17 43.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.987 0.423 . . . . 0.0 111.792 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 43.8 mt-10 -110.6 147.97 33.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.67 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.579 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.5 tt -64.57 -31.38 53.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -89.33 9.34 26.42 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.035 0.445 . . . . 0.0 110.629 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 26' ' ' GLU . 38.2 tt0 -98.44 146.73 25.44 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.625 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.511 ' HA ' ' SG ' ' A' ' 81' ' ' CYS . 20.6 p-10 -83.1 163.24 21.01 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.351 0.596 . . . . 0.0 112.17 -176.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.573 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -67.15 -17.64 64.93 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.424 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -60.08 -44.52 94.71 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -69.38 -46.44 66.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.632 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.51 -45.27 98.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.705 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.41 -44.46 91.2 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.268 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.446 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -64.25 -39.53 97.14 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.568 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.36 -47.12 87.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.938 0.399 . . . . 0.0 111.364 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.45 ' CB ' HG11 ' A' ' 9' ' ' VAL . . . -73.56 -44.91 56.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.67 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.6 -34.3 77.51 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.313 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.7 -39.21 87.69 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.867 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -60.73 -38.64 85.81 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.03 0.443 . . . . 0.0 110.678 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -84.06 -3.34 57.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.46 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.88 24.83 76.06 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.873 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.0 mt -113.15 17.43 18.72 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 122.891 -0.182 . . . . 0.0 111.327 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -57.27 -34.93 69.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.809 0.443 . . . . 0.0 110.84 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -60.66 -39.32 87.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.173 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.0 m -89.12 21.86 3.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.295 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.446 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 33.2 ttmt -59.68 -15.63 20.87 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.071 0.462 . . . . 0.0 111.759 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.32 -35.42 79.02 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.618 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 106' ' ' LYS . 3.9 p-10 -104.25 17.32 24.35 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -176.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -126.68 150.49 48.96 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.0 pt -139.31 176.31 6.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.487 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.428 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.4 mt -101.65 138.69 38.3 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-O 120.548 0.213 . . . . 0.0 110.614 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.451 HG11 ' HD3' ' A' ' 104' ' ' LYS . 27.3 m -124.06 126.78 72.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.123 0.487 . . . . 0.0 110.441 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' CD ' HH21 ' A' ' 74' ' ' ARG . 13.6 tt0 -89.58 126.04 35.46 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.547 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 87.3 t -126.59 138.41 54.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.836 0.35 . . . . 0.0 111.479 -177.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 93' ' ' GLY . 8.0 m -60.32 135.56 57.77 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.39 176.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.2 -13.82 59.88 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.268 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.09 90.0 4.23 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 59.37 -127.17 1.25 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.295 177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 62' ' ' ARG . 15.8 p-10 -63.96 -36.23 83.28 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 33.7 ptt180 153.04 -11.63 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 126.473 1.909 . . . . 0.0 107.628 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -119.25 -66.75 1.04 Allowed 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.126 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.6 m -169.72 -56.37 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.429 -175.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.444 ' O ' ' HB2' ' A' ' 66' ' ' SER . 28.0 ttt -140.48 123.86 16.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 65' ' ' MET . 39.0 t 166.67 -31.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.323 1.049 . . . . 0.0 109.178 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.404 ' N ' ' HB3' ' A' ' 61' ' ' ASP . 34.5 t70 64.31 109.41 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.37 -176.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 68' ' ' LEU . 2.2 pt? -62.6 100.52 0.19 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.474 -176.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.731 ' HA ' ' CZ ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -96.29 -57.12 2.41 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.453 173.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -90.52 77.87 6.4 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 173.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.41 HD11 HG21 ' A' ' 56' ' ' VAL . 18.2 tt -55.74 124.97 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.506 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -96.26 -82.8 0.39 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.336 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.472 ' CA ' HG22 ' A' ' 56' ' ' VAL . . . 77.66 173.33 40.03 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.716 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.46 ' O ' HG13 ' A' ' 76' ' ' ILE . 40.1 mtm180 -88.66 117.17 68.05 Favored Pre-proline 0 C--N 1.314 -0.964 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.65 114.02 2.21 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.118 1.878 . . . . 0.0 111.568 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 74' ' ' ARG . 42.3 mt -120.84 113.73 32.9 Favored Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.543 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.79 159.01 54.95 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.548 2.165 . . . . 0.0 111.434 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.573 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 31.8 Cg_exo -58.5 -29.35 88.47 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.786 2.324 . . . . 0.0 111.972 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 m -77.34 -1.49 30.2 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.218 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.18 158.52 15.62 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 122.092 -0.38 . . . . 0.0 110.525 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.511 ' SG ' ' HA ' ' A' ' 30' ' ' ASN . 95.8 m -121.99 85.23 45.56 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.454 ' HB3' HD13 ' A' ' 76' ' ' ILE . 53.6 Cg_endo -69.75 -17.14 37.77 Favored 'Trans proline' 0 N--CA 1.475 0.405 0 C-N-CA 123.099 2.533 . . . . 0.0 114.143 -173.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 27' ' ' ILE . 51.7 mt -63.32 -28.55 70.08 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.437 ' HA ' HD11 ' A' ' 27' ' ' ILE . 20.8 m-85 -59.62 -48.21 82.54 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.257 -0.177 . . . . 0.0 111.436 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.593 ' HB3' ' NH2' ' A' ' 89' ' ' ARG . 89.7 mt-10 -69.27 -38.97 78.64 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.016 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.414 ' CE ' ' HG3' ' A' ' 55' ' ' GLU . 48.1 mtt -58.7 -59.27 5.68 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.997 0.427 . . . . 0.0 111.277 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.5 m -62.96 -39.02 93.42 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.858 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.87 -35.05 75.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.925 0.393 . . . . 0.0 110.848 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.593 ' NH2' ' HB3' ' A' ' 85' ' ' GLU . 46.3 mtm-85 -101.21 12.37 37.67 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.542 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.479 ' HA ' ' H ' ' A' ' 97' ' ' PHE . 24.4 p -44.03 133.41 5.11 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 116.65 -34.68 4.54 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.299 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.494 ' C ' ' HB3' ' A' ' 98' ' ' ASP . 10.3 m120 -94.97 132.82 39.4 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.935 0.367 . . . . 0.0 110.051 177.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 57' ' ' SER . . . -81.02 -10.83 84.48 Favored Glycine 0 CA--C 1.5 -0.866 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.612 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.576 ' HG2' ' ND2' ' A' ' 95' ' ' ASN . 39.1 tt0 -61.21 -77.77 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.507 0.323 . . . . 0.0 111.194 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.576 ' ND2' ' HG2' ' A' ' 94' ' ' GLU . 55.2 m-80 -124.61 16.17 8.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.167 0.508 . . . . 0.0 110.126 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -99.62 -171.88 30.52 Favored Glycine 0 C--O 1.212 -1.233 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.498 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.479 ' H ' ' HA ' ' A' ' 90' ' ' SER . 51.5 t80 -75.54 2.19 12.31 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.331 0.586 . . . . 0.0 111.352 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.494 ' HB3' ' C ' ' A' ' 92' ' ' ASN . 13.7 t70 -91.11 6.22 45.83 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 90.5 p -96.39 -179.93 4.8 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.714 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.547 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 26.7 p90 -123.92 158.03 32.91 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 175.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 9' ' ' VAL . 16.7 tp -115.18 126.68 54.88 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.676 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.75 166.72 11.63 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.1 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 81.1 mt -110.28 127.25 67.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.442 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.451 ' HD3' HG11 ' A' ' 54' ' ' VAL . 54.8 mtpt -135.17 167.4 21.06 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.584 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -73.65 143.01 46.45 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.608 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 50' ' ' ASP . 19.7 ptmt -61.27 149.89 81.42 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.117 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.11 -41.63 76.8 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.589 2.192 . . . . 0.0 112.755 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 C--O 1.244 0.808 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.014 179.877 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.871 0.367 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.2 mtt -84.57 -179.62 7.18 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 120.683 0.278 . . . . 0.0 111.297 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.3 t80 74.53 -71.5 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.385 1.074 . . . . 0.0 110.301 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.86 -55.05 3.84 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.243 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.23 -37.81 1.72 Allowed Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 p -96.23 138.7 33.46 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.6 mt -105.31 138.56 41.32 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -82.65 100.97 10.52 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.9 t -104.9 127.68 59.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.048 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -99.85 129.54 45.96 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.302 -176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.53 30.57 1.15 Allowed Glycine 0 C--O 1.237 0.326 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.227 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.52 -29.36 66.49 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.62 -0.324 . . . . 0.0 112.906 -177.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -59.48 -50.73 72.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.316 0.579 . . . . 0.0 110.063 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.0 mt -69.23 -47.86 71.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.914 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.4 t -136.35 103.77 9.51 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.959 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.08 -24.58 59.37 Favored 'Trans proline' 0 CA--C 1.528 0.176 0 C-N-CA 122.589 2.193 . . . . 0.0 113.425 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.415 HG23 ' HG3' ' A' ' 18' ' ' ARG . 6.4 t -79.98 -9.14 59.66 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.959 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HG3' HG23 ' A' ' 17' ' ' THR . 51.9 mtt180 -132.72 69.49 79.4 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.052 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.09 -39.33 70.65 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.427 2.085 . . . . 0.0 112.415 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -128.02 135.47 49.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.236 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.35 162.44 36.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 55.5 m -119.54 124.91 47.57 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-O 121.045 0.45 . . . . 0.0 110.631 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 pt -123.76 159.37 28.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.2 tp -105.97 119.15 38.46 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.7 141.51 21.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.621 0.248 . . . . 0.0 111.185 -177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -95.22 161.99 13.88 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.584 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.6 tt -65.15 -26.11 39.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -85.59 7.82 21.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.685 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -92.72 138.77 31.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.552 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 13.7 m120 -82.11 172.7 12.9 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -62.64 -28.44 69.91 Favored 'General case' 0 C--O 1.2 -1.523 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.552 ' OD1' ' HB2' ' A' ' 30' ' ' ASN . 8.4 p-10 -64.96 -40.35 94.88 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.069 0.461 . . . . 0.0 110.377 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -69.5 -46.34 66.81 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.061 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.412 HG21 HD21 ' A' ' 101' ' ' LEU . 96.8 mt -64.96 -44.24 96.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.031 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.4 tp -62.43 -42.56 99.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.15 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.82 -43.31 99.37 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.089 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.75 -47.69 84.67 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.838 0.352 . . . . 0.0 111.0 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.447 ' CB ' HD11 ' A' ' 103' ' ' ILE . . . -71.96 -45.83 59.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.386 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.425 ' CD2' ' HA ' ' A' ' 48' ' ' LYS . 27.6 tp -64.52 -33.46 75.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.492 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -36.9 78.96 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.24 176.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -63.51 -37.9 89.08 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.453 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -83.33 -3.86 57.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.958 0.409 . . . . 0.0 110.686 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.14 29.86 72.07 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.158 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.1 mt -120.54 22.35 11.27 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.556 -0.379 . . . . 0.0 111.264 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.606 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 43.9 tt0 -59.64 -31.7 69.77 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -58.31 -38.69 77.6 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.9 m -93.93 30.43 1.85 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.623 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.606 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 35.3 ttmt -61.34 -31.25 71.12 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -65.41 -14.1 60.15 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.242 -0.435 . . . . 0.0 112.093 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -103.42 5.15 36.87 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.91 0.386 . . . . 0.0 110.982 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.71 149.07 50.38 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.021 0.439 . . . . 0.0 111.973 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 pt -140.31 169.28 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.892 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.501 ' HB3' HD11 ' A' ' 101' ' ' LEU . 96.1 mt -100.52 139.66 35.89 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.69 0.281 . . . . 0.0 110.482 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.8 m -131.83 131.04 62.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.07 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.534 ' OE1' ' HD2' ' A' ' 74' ' ' ARG . 97.1 mt-10 -94.71 121.36 36.22 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 100' ' ' PHE . 57.5 t -117.48 132.18 68.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.941 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 7.6 t -81.54 143.48 31.98 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.26 62.23 7.03 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.538 0.685 . . . . 0.0 109.986 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.745 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 9.1 p-10 -130.24 24.36 5.21 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.345 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.568 ' OD2' ' HA ' ' A' ' 67' ' ' ASP . 4.4 p-10 -62.28 -22.7 66.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.972 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -63.26 -16.91 61.75 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.238 0.542 . . . . 0.0 110.877 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.745 ' HG2' ' O ' ' A' ' 59' ' ' ASP . 4.8 ptm180 -104.69 -31.15 9.5 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.446 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -66.59 -44.58 81.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.396 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.536 ' C ' ' H ' ' A' ' 66' ' ' SER . 53.8 p -154.67 156.34 36.27 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 mmt -86.21 21.81 1.94 Allowed 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 172.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.536 ' H ' ' C ' ' A' ' 64' ' ' SER . 8.1 m -110.7 3.81 19.53 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-N 113.37 -1.741 . . . . 0.0 111.956 -175.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.568 ' HA ' ' OD2' ' A' ' 60' ' ' ASP . 12.3 t70 65.76 -148.53 0.22 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.18 99.93 2.46 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.035 0.445 . . . . 0.0 109.815 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -94.4 112.52 24.3 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.148 0.499 . . . . 0.0 110.633 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 57.81 23.07 9.23 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.661 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.2 tt 35.24 88.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.813 1.245 . . . . 0.0 113.588 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -104.02 133.84 48.29 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.252 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.22 -164.25 13.45 Favored Glycine 0 CA--C 1.501 -0.789 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.859 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.534 ' HD2' ' OE1' ' A' ' 55' ' ' GLU . 6.3 ptp180 -85.49 117.76 69.37 Favored Pre-proline 0 N--CA 1.433 -1.283 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -62.41 116.16 3.33 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.352 2.035 . . . . 0.0 111.946 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.469 HG21 ' HB3' ' A' ' 82' ' ' PRO . 35.6 mt -121.95 99.1 44.4 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.701 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -66.15 160.46 44.73 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.573 2.182 . . . . 0.0 111.173 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 51.5 Cg_exo -55.13 -32.73 81.18 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 123.316 2.678 . . . . 0.0 113.7 -176.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.1 p -67.81 -20.65 65.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -67.78 173.43 4.37 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 122.374 1.083 . . . . 0.0 113.189 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.2 m -127.86 68.97 76.11 Favored Pre-proline 0 C--N 1.292 -1.927 0 CA-C-N 113.328 -1.76 . . . . 0.0 106.59 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.469 ' HB3' HG21 ' A' ' 76' ' ' ILE . 18.7 Cg_endo -58.11 -32.1 94.78 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.266 2.644 . . . . 0.0 113.913 -168.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 27' ' ' ILE . 38.6 mt -63.92 -36.61 84.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.931 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -58.56 -30.19 66.96 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.916 0.389 . . . . 0.0 110.428 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -76.77 -51.07 12.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.695 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 66.4 mtm -62.98 -42.97 99.99 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.9 m -65.33 -42.42 92.96 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.422 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.3 -49.79 39.13 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -79.11 -54.94 5.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.45 ' C ' ' HB3' ' A' ' 98' ' ' ASP . 43.5 p 46.68 -171.14 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.432 0.693 . . . . 0.0 112.491 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.45 -122.0 1.29 Allowed Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.643 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -105.31 -170.13 1.7 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.609 0.242 . . . . 0.0 110.601 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.62 -31.63 7.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.623 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 64.08 -28.49 0.09 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 176.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -64.11 -42.23 96.96 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 120.954 0.407 . . . . 0.0 110.853 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.67 130.29 1.53 Allowed Glycine 0 N--CA 1.436 -1.301 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 43.99 -100.94 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.099 0.56 . . . . 0.0 111.904 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.45 ' HB3' ' C ' ' A' ' 90' ' ' SER . 4.7 p-10 -124.52 -14.83 6.77 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.524 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 69.2 m -151.08 166.26 31.31 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.946 0.403 . . . . 0.0 110.678 -176.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.464 ' CZ ' ' HB ' ' A' ' 56' ' ' VAL . 31.5 p90 -110.17 152.12 26.45 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 174.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 53' ' ' LEU . 49.3 tp -92.38 126.38 37.44 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 120.84 0.352 . . . . 0.0 110.223 -177.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.66 160.31 35.78 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.45 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.447 HD11 ' CB ' ' A' ' 38' ' ' ALA . 66.2 mt -105.87 123.8 60.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -119.78 155.37 32.66 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 121.166 0.507 . . . . 0.0 110.176 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -81.19 108.49 14.88 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.026 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -43.39 114.23 1.61 Allowed Pre-proline 0 C--N 1.327 -0.405 0 O-C-N 124.429 1.081 . . . . 0.0 111.127 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.02 -14.68 35.55 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.97 2.447 . . . . 0.0 111.822 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 117.785 -1.103 . . . . 0.0 110.511 179.691 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 120.629 0.252 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 96.0 mmm -101.16 -87.99 0.38 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.7 t80 64.58 -71.65 0.07 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.676 0.791 . . . . 0.0 110.071 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.63 -37.92 2.93 Favored Glycine 0 C--O 1.229 -0.201 0 N-CA-C 114.263 0.465 . . . . 0.0 114.263 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.25 -14.52 61.05 Favored Glycine 0 C--N 1.315 -0.596 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.379 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 26.9 p -99.58 121.57 41.38 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.4 mt -104.24 135.71 45.2 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.103 0.478 . . . . 0.0 112.056 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -81.99 101.11 10.1 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.404 HG11 ' CB ' ' A' ' 38' ' ' ALA . 55.4 t -108.01 129.77 61.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.806 -173.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.492 ' HE2' ' CD1' ' A' ' 71' ' ' ILE . 84.3 t80 -106.54 103.87 13.43 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.421 -175.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.0 -33.83 39.87 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.413 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.11 -88.96 0.01 OUTLIER Glycine 0 CA--C 1.527 0.793 0 N-CA-C 114.961 0.745 . . . . 0.0 114.961 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -62.06 -37.79 86.33 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.322 0.649 . . . . 0.0 112.368 -175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.408 HG22 HG23 ' A' ' 15' ' ' VAL . 96.7 mt -62.55 -44.49 99.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.923 -173.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.408 HG23 HG22 ' A' ' 14' ' ' ILE . 54.7 t -145.08 105.11 4.43 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.15 -22.67 53.88 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.192 2.595 . . . . 0.0 113.883 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -86.42 -7.25 58.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.035 0.445 . . . . 0.0 110.892 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -142.24 67.01 20.82 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.94 -32.16 84.66 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.53 2.154 . . . . 0.0 112.259 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.11 139.2 51.58 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.608 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.64 150.91 25.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.223 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.8 p -102.33 124.28 47.63 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.937 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 6' ' ' SER . 20.9 pt -126.22 160.57 33.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.333 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.69 124.15 50.71 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.71 148.17 25.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.911 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -104.01 156.57 17.75 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.534 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.434 HG13 ' CB ' ' A' ' 83' ' ' LEU . 17.7 tt -65.79 -26.61 39.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.986 0.422 . . . . 0.0 111.827 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -76.11 -3.54 36.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.093 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -99.18 162.58 12.98 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 120.929 0.395 . . . . 0.0 110.712 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -92.93 178.45 5.76 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.368 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.622 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -62.34 -21.64 65.46 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.582 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.415 ' HA ' ' HB3' ' A' ' 78' ' ' PRO . 14.5 t70 -55.77 -46.51 77.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.599 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -69.07 -42.51 76.11 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 120.942 0.401 . . . . 0.0 110.597 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.61 -45.79 97.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.038 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.9 tp -66.38 -43.9 84.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.477 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.458 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -64.83 -46.98 87.98 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.832 -0.622 . . . . 0.0 113.779 -177.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.452 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -61.31 -45.84 92.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 117.007 0.403 . . . . 0.0 111.115 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.404 ' CB ' HG11 ' A' ' 9' ' ' VAL . . . -65.75 -46.75 77.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.162 0.506 . . . . 0.0 111.251 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD11 ' HB2' ' A' ' 44' ' ' LEU . 28.3 tp -62.67 -36.05 81.65 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.816 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 37.0 tt0 -57.91 -42.42 84.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.536 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.7 mmtt -64.42 -41.64 96.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.376 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.42 -29.97 65.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.908 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.47 7.15 46.29 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.638 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.461 ' HB2' HD11 ' A' ' 39' ' ' LEU . 83.8 mt -98.32 17.14 19.45 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.341 -0.506 . . . . 0.0 111.157 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 16.6 pt-20 -54.95 -24.81 25.64 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.439 0.696 . . . . 0.0 112.24 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -71.2 -16.78 62.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.93 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.1 m -98.14 -81.97 0.43 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.737 0.303 . . . . 0.0 110.42 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 31.1 ttmt 70.09 -49.03 0.64 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 176.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.599 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 26.7 t70 -60.87 -34.12 74.12 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.192 0.451 . . . . 0.0 110.758 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -66.0 -9.57 31.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.606 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.6 151.07 49.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.054 0.454 . . . . 0.0 111.647 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 pt -138.16 175.43 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.622 HD12 ' HB1' ' A' ' 31' ' ' ALA . 95.0 mt -100.38 143.58 30.4 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.987 0.422 . . . . 0.0 110.553 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.435 HG21 ' CG ' ' A' ' 104' ' ' LYS . 13.2 m -128.17 129.86 69.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.482 ' HB3' ' HG2' ' A' ' 74' ' ' ARG . 3.1 tm-20 -86.82 120.83 28.52 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.601 HG21 HG23 ' A' ' 71' ' ' ILE . 80.7 t -125.18 136.28 61.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.871 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.586 ' CB ' ' HB3' ' A' ' 94' ' ' GLU . 40.1 t -60.67 135.85 57.89 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.203 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -91.36 -2.17 57.41 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -73.15 -41.95 63.36 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.387 178.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -161.51 -43.2 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.981 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.512 ' C ' ' HB3' ' A' ' 57' ' ' SER . 15.9 t70 166.35 -45.8 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 11.4 ptp180 136.22 22.52 0.0 OUTLIER 'General case' 0 C--N 1.364 1.234 0 C-N-CA 127.157 2.183 . . . . 0.0 110.103 176.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' NZ ' ' HB3' ' A' ' 72' ' ' ASP . 57.8 mttp -135.62 -64.13 0.64 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.057 0.456 . . . . 0.0 111.813 -173.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.2 t -155.74 169.8 23.52 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 59.3 ttp -77.06 67.32 3.03 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.442 0.639 . . . . 0.0 111.858 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.1 t -100.87 -17.45 16.84 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 173.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 58.78 75.23 0.4 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.591 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.8 mt 58.5 87.77 0.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.702 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -96.72 -76.72 0.5 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.641 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -104.33 1.29 30.14 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.886 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.601 HG23 HG21 ' A' ' 56' ' ' VAL . 38.7 mt 63.74 97.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.436 0.694 . . . . 0.0 110.595 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.433 ' HB3' ' NZ ' ' A' ' 63' ' ' LYS . 35.0 t70 -123.5 104.5 9.1 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.993 177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.95 -172.11 13.08 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.234 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 17.6 ptp180 -83.07 140.72 42.87 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 9.9 Cg_exo -71.31 117.18 5.02 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.373 2.049 . . . . 0.0 111.866 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.7 mt -120.9 100.87 45.82 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.631 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.68 155.95 67.14 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.022 2.481 . . . . 0.0 112.193 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.605 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 47.3 Cg_exo -54.68 -33.86 81.55 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.414 2.743 . . . . 0.0 113.829 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.4 t -66.75 -18.06 65.18 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -78.8 153.16 30.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.681 0.277 . . . . 0.0 111.276 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.9 m -111.68 78.58 2.15 Favored Pre-proline 0 C--O 1.235 0.31 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.495 ' O ' ' HG3' ' A' ' 86' ' ' MET . 48.6 Cg_endo -67.31 -29.45 38.49 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.511 2.14 . . . . 0.0 113.599 -174.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.434 ' CB ' HG13 ' A' ' 27' ' ' ILE . 80.6 mt -62.48 -39.15 92.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -53.92 -54.69 35.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.791 0.329 . . . . 0.0 111.485 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -72.08 -40.59 68.16 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.832 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 82' ' ' PRO . 11.3 mtm -60.77 -45.34 94.72 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -176.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.0 m -66.5 -49.45 66.51 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.05 0.452 . . . . 0.0 111.723 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.45 -39.06 71.21 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -89.11 9.05 26.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.43 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.0 t -45.39 120.55 2.55 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.297 0.57 . . . . 0.0 112.049 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.425 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . -98.86 -121.77 4.56 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.621 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -138.93 11.53 2.64 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.64 -36.27 0.16 Allowed Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.085 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.586 ' HB3' ' CB ' ' A' ' 57' ' ' SER . 0.8 OUTLIER -150.77 98.62 2.63 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.219 0.533 . . . . 0.0 111.371 178.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -176.29 -30.5 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.658 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.99 -110.07 0.25 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.134 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -73.72 -19.53 60.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.276 0.56 . . . . 0.0 110.946 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' A' ' 91' ' ' GLY . 8.0 p-10 -69.45 -24.23 63.78 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.228 175.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.455 ' HB3' ' HA ' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -102.05 178.66 4.55 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.988 176.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -118.99 165.63 13.86 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.518 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 20.2 tp -115.81 119.81 37.24 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.693 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.53 178.33 4.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.102 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.7 mt -116.97 129.96 72.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.699 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.464 ' HD3' ' HB ' ' A' ' 71' ' ' ILE . 27.6 mmmt -130.97 160.98 32.94 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -72.43 142.98 48.65 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.599 ' HD2' ' O ' ' A' ' 49' ' ' ASP . 21.6 ptmt -55.22 144.03 52.41 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.86 -45.27 33.81 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.47 2.78 . . . . 0.0 113.458 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.457 ' O ' ' HE2' ' A' ' 106' ' ' LYS . 72.2 m80 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.659 -177.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.0 p . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.2 mtp 59.68 73.9 0.46 Allowed 'General case' 0 C--N 1.343 0.291 0 O-C-N 123.405 0.441 . . . . 0.0 110.883 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.413 ' CZ ' HD13 ' A' ' 83' ' ' LEU . 62.5 t80 68.89 -69.61 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.506 0.723 . . . . 0.0 110.838 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 116.89 -78.42 0.29 Allowed Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 24' ' ' LEU . . . 137.46 -30.3 2.62 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 42.9 m -98.49 121.69 40.75 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.059 0.457 . . . . 0.0 110.355 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.4 mt -105.07 136.55 44.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.038 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -81.38 103.71 11.32 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.02 128.17 65.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.035 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -92.93 117.96 30.63 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.201 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.17 28.62 9.06 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.731 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.98 178.44 16.15 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.13 -0.557 . . . . 0.0 111.975 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 72.89 -66.69 0.3 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.6 mt -67.95 -48.11 76.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.765 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.14 85.41 46.45 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.15 -34.1 98.46 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.213 2.608 . . . . 0.0 113.019 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.4 t -70.09 -19.52 63.25 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.53 81.62 29.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 110.461 -0.199 . . . . 0.0 110.461 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.57 -32.24 87.61 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.625 2.217 . . . . 0.0 113.436 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -131.94 144.74 51.04 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.19 154.77 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.055 175.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.9 m -107.78 125.64 51.67 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.465 HG21 ' HB2' ' A' ' 38' ' ' ALA . 26.1 pt -126.72 160.09 35.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.042 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 8.0 mp -111.79 123.51 50.39 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.21 144.03 26.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.8 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.528 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 2.9 mp0 -90.58 152.78 20.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 176.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.4 tt -64.53 -26.35 40.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -86.01 6.65 27.8 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.982 0.42 . . . . 0.0 110.898 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.528 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 20.2 mm-40 -88.54 146.35 25.21 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.929 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.44 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 32.8 p-10 -83.86 169.49 15.07 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.236 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.565 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -58.81 -26.61 64.29 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.605 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.18 -42.1 97.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.688 0.28 . . . . 0.0 111.181 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.44 ' HG2' ' OD1' ' A' ' 30' ' ' ASN . 38.3 mmt180 -70.44 -42.92 70.91 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.94 0.4 . . . . 0.0 110.595 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.48 -45.92 94.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.587 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.95 -44.7 92.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.912 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.443 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -65.82 -39.61 95.19 Favored Glycine 0 C--O 1.209 -1.428 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.761 -178.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -61.41 -47.48 85.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 117.324 0.562 . . . . 0.0 111.532 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.465 ' HB2' HG21 ' A' ' 23' ' ' ILE . . . -68.7 -42.71 77.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.378 0.608 . . . . 0.0 110.521 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 45' ' ' GLU . 32.0 tp -63.26 -35.13 79.32 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.796 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -59.82 -39.72 86.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.677 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 67.7 mmtt -64.6 -32.82 74.64 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.827 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -87.97 -2.87 58.88 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.289 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.31 23.82 74.92 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.725 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.76 17.57 20.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.524 ' HA ' ' CD2' ' A' ' 39' ' ' LEU . 44.4 tt0 -58.55 -23.25 57.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -176.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -78.38 -8.4 58.41 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.001 0.429 . . . . 0.0 111.047 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.3 m -113.79 21.55 14.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.41 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 39.5 ttmt -59.41 -28.74 67.2 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.701 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -66.37 -9.52 34.35 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.72 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -102.55 -1.77 29.78 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.891 0.377 . . . . 0.0 111.183 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -131.2 155.16 47.53 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.528 -0.469 . . . . 0.0 112.097 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.9 pt -139.95 173.36 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.454 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.565 HD12 ' HB1' ' A' ' 31' ' ' ALA . 97.7 mt -101.38 143.19 31.71 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.775 0.322 . . . . 0.0 110.687 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.6 m -126.85 128.53 70.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.519 ' HB2' HD11 ' A' ' 76' ' ' ILE . 13.3 tt0 -90.24 123.25 33.88 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.1 t -128.86 130.67 68.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.626 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 15.4 m -72.69 150.35 43.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.817 0.342 . . . . 0.0 110.434 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -75.96 66.7 2.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.06 0.457 . . . . 0.0 110.986 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -144.92 -20.79 0.5 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.727 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 64' ' ' SER . 7.9 m-20 -62.64 -38.16 89.19 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.476 -178.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -64.77 -37.05 86.28 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -71.02 -53.79 13.52 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.453 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -69.34 -44.68 71.16 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.191 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 60' ' ' ASP . 14.9 t -72.34 -32.48 66.54 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.878 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 60.6 ttp 68.12 1.34 2.76 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.091 0.956 . . . . 0.0 111.104 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.485 ' OG ' ' HB2' ' A' ' 69' ' ' ARG . 6.9 t -93.29 3.9 54.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.801 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 59.1 53.45 5.49 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.058 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.9 mt 61.92 67.88 0.72 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.357 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.485 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 50.5 ttp180 -78.37 -50.55 11.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.723 0.773 . . . . 0.0 109.07 176.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.77 127.7 53.79 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.2 tt -125.29 136.12 61.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 120.278 -0.569 . . . . 0.0 112.147 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -167.5 116.79 0.81 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.003 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.82 -143.46 6.58 Favored Glycine 0 C--N 1.312 -0.771 0 C-N-CA 120.713 -0.755 . . . . 0.0 111.884 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' O ' HG13 ' A' ' 76' ' ' ILE . 34.7 ttp-105 -81.05 121.31 80.55 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -65.26 115.96 3.61 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.1 1.866 . . . . 0.0 111.3 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 55' ' ' GLU . 29.9 mt -120.95 103.31 43.04 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.232 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.23 160.21 43.32 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.61 2.207 . . . . 0.0 111.363 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.466 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 44.2 Cg_exo -54.97 -28.69 60.7 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.225 2.617 . . . . 0.0 113.174 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.5 m -62.27 -44.22 97.04 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.85 156.85 28.49 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -174.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.1 p -117.04 93.99 43.57 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 122.75 0.42 . . . . 0.0 110.29 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.431 ' O ' ' HG3' ' A' ' 86' ' ' MET . 57.7 Cg_endo -71.9 -18.19 28.21 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.148 2.565 . . . . 0.0 115.386 -175.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 27' ' ' ILE . 83.7 mt -60.79 -35.22 75.91 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -174.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -56.76 -45.56 81.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.202 0.525 . . . . 0.0 111.07 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -76.01 -37.22 58.7 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.318 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.467 ' SD ' HD23 ' A' ' 83' ' ' LEU . 95.4 mtp -61.66 -48.8 79.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.31 0.576 . . . . 0.0 111.095 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.8 m -66.03 -31.7 72.74 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.541 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.45 -32.69 25.92 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.568 ' HD3' ' OD2' ' A' ' 98' ' ' ASP . 35.3 ttt180 -65.61 -46.83 77.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.473 -176.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.511 ' HA ' ' HB2' ' A' ' 98' ' ' ASP . 11.3 p 15.86 87.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 125.349 1.46 . . . . 0.0 114.214 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.21 -71.91 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.278 -1.439 . . . . 0.0 114.695 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -71.95 -71.1 0.29 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -173.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.12 93.6 1.71 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.962 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.07 -5.75 41.01 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -63.03 -42.41 99.78 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.927 0.394 . . . . 0.0 109.946 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -118.97 -147.97 8.26 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -87.67 70.94 9.72 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.568 ' OD2' ' HD3' ' A' ' 89' ' ' ARG . 15.8 t70 70.51 -51.06 0.66 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.198 -173.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 49.2 m -131.06 161.97 30.85 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.84 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -110.99 166.51 10.99 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.472 HD21 HD13 ' A' ' 53' ' ' LEU . 18.1 tp -116.74 124.97 50.94 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.242 -176.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.94 167.87 10.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.448 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 38' ' ' ALA . 68.6 mt -112.39 129.25 68.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.563 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -130.72 157.71 42.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.252 0.549 . . . . 0.0 110.901 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -93.04 134.36 35.25 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.323 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 18.9 ptpt -66.24 151.42 95.77 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.158 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 106' ' ' LYS . 4.8 Cg_exo -76.49 -155.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.378 2.718 . . . . 0.0 111.887 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.5 p80 . . . . . 0 N--CA 1.475 0.807 0 C-N-CA 124.338 1.055 . . . . 0.0 112.692 -179.486 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 120.845 0.355 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 96.4 mtp -82.64 142.16 31.94 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.759 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.4 t80 76.15 -43.32 0.47 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.019 0.928 . . . . 0.0 111.252 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.43 -63.57 4.15 Favored Glycine 0 C--O 1.24 0.475 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.805 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 145.72 -25.53 1.8 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.624 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.9 p -134.12 155.39 50.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.2 mt -107.55 137.29 45.84 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -84.24 108.13 16.94 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 174.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.0 t -114.72 133.96 59.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.219 -171.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.457 ' CZ ' HD11 ' A' ' 68' ' ' LEU . 47.6 t80 -114.67 124.68 52.44 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.888 -177.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.02 28.36 2.94 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.369 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.94 -23.9 62.06 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 114.031 0.372 . . . . 0.0 114.031 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.01 -40.74 97.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.426 0.631 . . . . 0.0 109.558 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.7 mt -85.76 -49.71 15.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.641 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.0 t -120.72 95.43 48.97 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.345 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.77 -23.01 48.85 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.882 2.388 . . . . 0.0 113.467 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.3 t -76.85 -17.15 59.16 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.136 0.493 . . . . 0.0 111.124 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -137.88 76.59 40.02 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.35 -34.06 67.94 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.287 1.991 . . . . 0.0 113.133 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -123.4 141.62 51.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.363 0.601 . . . . 0.0 112.211 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -142.85 157.57 18.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.2 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.6 p -119.46 131.79 55.68 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.235 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 38' ' ' ALA . 41.6 pt -125.54 160.48 31.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.495 -177.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.5 108.74 18.83 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.09 153.12 50.63 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.943 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -106.92 156.69 18.44 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.526 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.8 tt -65.91 -29.0 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -177.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -84.35 9.82 12.18 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.799 0.333 . . . . 0.0 111.401 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -100.69 148.91 24.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.516 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -80.58 168.78 18.5 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.73 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -59.96 -26.56 66.1 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.247 -178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.41 -40.46 96.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.839 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -64.79 -44.74 89.01 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.157 0.503 . . . . 0.0 109.768 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 23' ' ' ILE . 96.7 mt -64.53 -45.64 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.642 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.73 -45.89 87.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.745 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.28 -38.29 93.6 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.268 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -59.46 -49.96 75.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.959 0.409 . . . . 0.0 110.999 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 23' ' ' ILE . . . -70.58 -40.37 73.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.19 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.1 tp -61.97 -39.67 92.96 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.639 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.88 -37.78 83.37 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.288 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 69.1 mmtt -63.83 -37.98 89.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.595 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -80.03 -6.08 56.95 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.234 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.23 22.0 74.48 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.79 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.0 mt -113.7 22.61 13.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.742 0.306 . . . . 0.0 111.114 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -53.15 -40.46 64.29 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.476 0.71 . . . . 0.0 112.393 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -74.75 -11.9 60.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.815 0.34 . . . . 0.0 111.736 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.8 m -110.14 29.83 7.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.345 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -60.96 -32.1 71.64 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.007 0.432 . . . . 0.0 111.553 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -63.95 -9.14 13.89 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.755 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.445 ' HA ' ' HD2' ' A' ' 106' ' ' LYS . 18.0 t70 -101.97 -2.64 29.27 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.738 0.304 . . . . 0.0 111.575 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -132.39 154.25 49.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.698 -176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.6 pt -137.96 173.26 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.61 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.7 mt -101.25 142.95 31.93 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.731 0.301 . . . . 0.0 110.529 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 18.8 m -125.41 132.11 71.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.087 0.47 . . . . 0.0 110.545 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.539 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 1.9 tm-20 -87.54 124.25 33.28 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.6 t -122.17 129.9 74.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.302 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 p -73.97 124.01 25.39 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' A' ' 98' ' ' ASP . 26.5 t-20 -84.05 -53.02 5.84 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -173.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.13 -9.83 3.71 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -170.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.435 ' HB2' ' HA ' ' A' ' 64' ' ' SER . 35.9 m-20 -64.13 107.17 1.21 Allowed 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 62' ' ' ARG . 8.3 t70 69.88 -60.14 0.49 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -172.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 61' ' ' ASP . 30.7 ptt-85 174.76 -22.57 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.398 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.437 ' HD3' HD22 ' A' ' 68' ' ' LEU . 99.2 mttt -154.17 73.35 0.92 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.986 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.435 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 35.3 t 67.8 157.19 0.13 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.64 0.776 . . . . 0.0 110.835 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.4 mtt -63.22 -20.53 65.51 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.05 -12.35 60.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.524 -1.671 . . . . 0.0 111.022 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.3 p30 53.11 34.74 17.99 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.881 0.872 . . . . 0.0 111.337 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 68' ' ' LEU . 40.5 tp 58.45 13.42 2.48 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.882 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -66.06 -41.11 91.21 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -139.53 140.45 37.16 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.3 tt -85.59 119.74 34.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 C-N-CA 119.554 -0.858 . . . . 0.0 111.614 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -123.62 141.55 51.91 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.668 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.75 -175.37 39.35 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 119.704 -1.236 . . . . 0.0 112.689 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -97.28 121.08 59.71 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -178.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.15 115.85 3.38 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.007 2.471 . . . . 0.0 112.513 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 55' ' ' GLU . 33.1 mt -121.16 118.89 29.93 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.404 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.13 158.32 58.22 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.749 2.299 . . . . 0.0 111.473 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 31.7 Cg_exo -59.71 -26.49 82.35 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.984 2.456 . . . . 0.0 112.45 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.5 p -68.33 -31.91 71.66 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -82.57 159.48 22.77 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.85 0.357 . . . . 0.0 111.958 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 39.8 m -118.05 86.81 26.82 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.68 -16.87 33.72 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.756 2.304 . . . . 0.0 114.198 -175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' A' ' 27' ' ' ILE . 53.4 mt -63.72 -39.09 93.45 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.47 ' HA ' HD11 ' A' ' 27' ' ' ILE . 23.6 m-85 -57.19 -46.12 83.13 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 123.215 0.322 . . . . 0.0 111.634 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.569 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 49.1 mt-10 -66.05 -43.07 88.55 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.236 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 90' ' ' SER . 67.3 mtm -63.54 -43.44 97.09 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.951 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 m -80.8 -42.34 21.85 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.22 -50.99 70.85 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 20.4 ptt-85 -90.59 -28.58 18.35 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.646 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 86' ' ' MET . 1.7 m 55.21 -160.98 0.17 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.372 -177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -156.01 169.93 33.7 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.497 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -114.72 15.18 17.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.789 0.804 . . . . 0.0 109.135 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.16 49.73 0.61 Allowed Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.547 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -163.75 -82.56 0.03 OUTLIER 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -125.86 85.4 2.39 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.266 0.555 . . . . 0.0 109.983 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 90' ' ' SER . . . -172.02 -111.64 0.26 Allowed Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.354 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -104.01 5.38 35.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.867 0.841 . . . . 0.0 109.391 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 9.4 m-20 -79.28 -6.78 57.47 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.196 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.8 p -98.01 174.18 6.69 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.116 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -131.87 162.65 30.11 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.419 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.492 HD21 HD13 ' A' ' 53' ' ' LEU . 29.5 tp -111.76 121.26 44.62 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.31 174.7 5.91 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.181 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 38' ' ' ALA . 65.0 mt -110.77 129.49 65.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.656 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 104' ' ' LYS . 17.1 mmmt -127.55 163.73 23.52 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 121.378 0.609 . . . . 0.0 110.199 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -84.03 134.83 34.61 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.296 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.445 ' HD2' ' HA ' ' A' ' 50' ' ' ASP . 22.0 ptmt -49.71 133.16 20.3 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 123.632 0.583 . . . . 0.0 112.084 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.4 -41.85 14.59 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.74 2.294 . . . . 0.0 112.43 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.418 ' OXT' ' HE2' ' A' ' 106' ' ' LYS . 55.1 m80 . . . . . 0 C--O 1.241 0.624 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.024 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 121.005 0.431 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt -103.25 144.22 31.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.079 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.568 ' CZ ' HD13 ' A' ' 83' ' ' LEU . 91.2 t80 -62.65 -46.88 86.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.646 0.26 . . . . 0.0 111.12 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.02 -30.08 5.58 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.049 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.406 ' H ' ' HD2' ' A' ' 3' ' ' PHE . . . 79.95 -57.9 4.56 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.798 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 26.4 p -95.11 134.49 37.77 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.4 mt -110.76 143.65 40.97 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -84.69 104.23 14.48 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.86 129.22 57.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.148 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.429 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 88.2 t80 -96.26 126.32 41.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.31 0.576 . . . . 0.0 111.78 -176.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.26 18.17 4.46 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.38 -23.11 64.19 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 115.214 -0.493 . . . . 0.0 113.324 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.3 -57.6 9.88 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.8 mt -70.28 -44.8 77.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.071 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.18 96.08 20.34 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.411 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.36 -24.25 50.34 Favored 'Trans proline' 0 CA--C 1.498 -1.298 0 C-N-CA 122.717 2.278 . . . . 0.0 112.342 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 89.8 m -68.63 -23.24 64.41 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.727 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.41 67.67 80.47 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.95 -55.38 1.67 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 123.257 2.638 . . . . 0.0 114.376 -172.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -117.95 134.99 54.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.763 0.316 . . . . 0.0 110.998 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.24 161.18 35.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.586 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 p -110.86 128.87 55.94 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.513 HG21 ' HB2' ' A' ' 38' ' ' ALA . 31.1 pt -126.4 163.06 29.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.445 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.5 tp -111.79 112.5 24.21 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.96 148.16 28.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.267 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.69 162.73 16.84 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.855 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.638 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.0 tt -63.49 -24.51 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -175.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -85.1 4.64 33.23 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.88 0.371 . . . . 0.0 110.615 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -101.34 146.25 27.82 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.139 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -81.76 174.02 11.74 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.409 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.601 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -58.79 -27.12 64.72 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.009 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.28 -41.98 97.86 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -64.89 -41.72 95.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.263 0.554 . . . . 0.0 109.959 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.409 HG23 ' CD1' ' A' ' 23' ' ' ILE . 96.6 mt -65.67 -44.42 93.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.217 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.83 -46.71 88.32 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.457 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA2' ' OE1' ' A' ' 45' ' ' GLU . . . -64.28 -40.93 98.34 Favored Glycine 0 C--O 1.223 -0.558 0 C-N-CA 121.082 -0.58 . . . . 0.0 113.746 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -64.47 -39.27 93.5 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -84.88 -42.23 15.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.886 0.374 . . . . 0.0 111.272 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 27.9 tp -62.92 -35.12 79.01 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.147 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 2.9 tm-20 -59.7 -41.55 91.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.168 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 68.3 mmtt -63.58 -39.69 95.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -79.77 -3.44 47.64 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.984 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.73 28.96 68.15 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.996 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.573 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 82.2 mt -117.79 13.24 14.09 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.141 0.496 . . . . 0.0 110.844 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 48.4 tp10 -60.49 -28.41 68.34 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.917 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -67.8 -12.92 61.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.6 m -94.36 -88.92 0.23 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.3 mttt 63.96 -39.86 0.22 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 124.265 1.026 . . . . 0.0 113.473 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.59 -27.85 68.04 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -89.89 -17.95 27.06 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.317 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.573 ' CZ ' HD13 ' A' ' 44' ' ' LEU . 73.1 m-85 -125.59 151.64 46.17 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 119.252 -0.979 . . . . 0.0 113.092 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.3 pt -138.42 178.38 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.601 HD12 ' HB1' ' A' ' 31' ' ' ALA . 91.8 mt -107.81 142.55 37.69 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.469 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 m -127.54 133.19 68.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.505 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.62 121.06 29.57 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.361 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 71' ' ' ILE . 85.2 t -137.06 133.32 47.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 28.2 t -84.32 151.19 24.89 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.512 ' HB2' ' OE2' ' A' ' 94' ' ' GLU . 39.9 t-20 -63.19 -42.87 99.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.303 0.573 . . . . 0.0 109.774 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -98.99 107.97 20.54 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.455 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -89.62 -93.43 0.12 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.931 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.1 t70 52.92 21.12 1.88 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 122.624 1.202 . . . . 0.0 109.53 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -117.6 -54.62 2.35 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 113.735 -1.575 . . . . 0.0 110.36 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -108.69 -34.92 6.56 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.708 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.5 t -154.41 151.66 29.27 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.733 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 61.3 mtt -83.71 3.51 32.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.493 0.663 . . . . 0.0 109.581 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.4 t -63.8 -41.75 97.85 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.477 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 62.22 -83.47 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.631 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.0 mt -100.37 -139.06 0.33 Allowed 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.503 ' HE ' ' HG3' ' A' ' 70' ' ' GLU . 53.9 ttp180 64.92 -81.69 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.291 0.636 . . . . 0.0 112.636 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.503 ' HG3' ' HE ' ' A' ' 69' ' ' ARG . 50.0 mt-10 -65.97 -35.69 81.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.917 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 71' ' ' ILE . 0.3 OUTLIER 52.82 29.87 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-O 122.485 1.136 . . . . 0.0 111.811 174.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -54.54 -54.19 44.52 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.601 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 47.16 -145.18 4.59 Favored Glycine 0 N--CA 1.471 1.017 0 O-C-N 123.458 0.474 . . . . 0.0 113.887 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -125.54 127.99 24.77 Favored Pre-proline 0 N--CA 1.442 -0.854 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.02 119.22 6.3 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.731 2.287 . . . . 0.0 112.826 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 37.2 mt -122.28 101.84 40.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.397 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 48.7 Cg_exo -62.18 155.77 54.42 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.637 2.225 . . . . 0.0 112.121 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 49.4 Cg_exo -53.91 -33.25 71.19 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.791 2.994 . . . . 0.0 114.067 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.0 m -62.26 -42.9 99.74 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -73.79 154.98 39.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.894 0.378 . . . . 0.0 111.703 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.4 p -106.24 91.5 5.72 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.178 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 44.3 Cg_endo -68.66 -17.91 42.65 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.149 2.566 . . . . 0.0 114.145 -175.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 27' ' ' ILE . 43.2 mt -66.37 -33.74 76.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.885 0.374 . . . . 0.0 110.464 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -60.75 -11.76 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.269 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 82' ' ' PRO . 6.0 mm-40 -95.94 -56.54 2.62 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.794 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 79.0 mtm -61.88 -48.6 79.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.3 m -67.28 -40.29 86.12 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.685 0.278 . . . . 0.0 111.487 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.93 88.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.459 ' HG3' ' OD2' ' A' ' 98' ' ' ASP . 2.1 ptm180 -76.88 -51.08 11.91 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.394 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.533 ' HA ' ' HB3' ' A' ' 97' ' ' PHE . 52.5 m 45.95 73.69 0.16 Allowed 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.565 0.746 . . . . 0.0 112.917 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.23 -125.34 3.59 Favored Glycine 0 C--N 1.318 -0.443 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.771 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -153.04 136.6 15.96 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 159.4 -20.27 0.27 Allowed Glycine 0 C--O 1.229 -0.159 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.067 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.655 ' HG3' ' H ' ' A' ' 96' ' ' GLY . 9.1 tp10 -158.72 160.94 36.95 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -64.87 -19.21 65.77 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.258 0.348 . . . . 0.0 110.824 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.655 ' H ' ' HG3' ' A' ' 94' ' ' GLU . . . -83.46 61.65 4.73 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.533 ' HB3' ' HA ' ' A' ' 90' ' ' SER . 86.4 m-85 70.32 -69.08 0.18 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.611 0.764 . . . . 0.0 109.852 -176.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.459 ' OD2' ' HG3' ' A' ' 89' ' ' ARG . 1.5 p30 -144.71 -17.72 0.53 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.4 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 11.8 p -153.98 174.89 14.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.727 0.299 . . . . 0.0 111.583 -175.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -128.37 165.36 20.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.049 0.452 . . . . 0.0 109.858 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.0 tp -116.41 129.28 56.15 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.941 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.474 ' HB3' HD11 ' A' ' 71' ' ' ILE . . . -125.4 171.78 10.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.924 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 38' ' ' ALA . 70.9 mt -100.12 130.43 49.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.103 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -128.31 142.07 51.25 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.258 0.552 . . . . 0.0 110.65 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -81.65 109.97 16.57 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.805 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -54.2 152.86 10.4 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.772 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.27 44.65 1.78 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.907 2.405 . . . . 0.0 113.346 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.8 t60 . . . . . 0 C--N 1.279 -2.477 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.691 178.79 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 CA--C 1.513 -0.457 0 CA-C-O 120.788 0.328 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 75.2 mtm -66.27 -40.97 90.47 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.06 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -80.3 113.29 18.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.689 0.281 . . . . 0.0 110.789 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.08 -38.09 59.73 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.853 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.11 -46.75 1.06 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.424 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.5 p -96.25 139.82 31.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.805 0.336 . . . . 0.0 111.086 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.7 mt -109.18 134.52 51.62 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.776 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -82.66 99.56 9.67 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 173.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 91.7 t -100.45 112.31 32.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.871 -176.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 78.0 t80 -82.22 122.83 28.41 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.512 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.62 28.2 4.02 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.66 -33.39 82.13 Favored Glycine 0 CA--C 1.506 -0.475 0 CA-C-N 115.268 -0.466 . . . . 0.0 112.97 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.436 ' OE1' ' HG2' ' A' ' 104' ' ' LYS . 40.4 tt0 -64.06 -42.05 97.15 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.798 0.333 . . . . 0.0 110.485 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.28 -49.85 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.725 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -136.9 109.85 9.23 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.899 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.53 -27.47 53.91 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.766 2.311 . . . . 0.0 114.035 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -80.05 -7.26 58.76 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.046 0.451 . . . . 0.0 111.236 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.71 76.87 28.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.423 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 31.0 Cg_endo -62.68 -32.29 78.83 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.706 2.271 . . . . 0.0 113.294 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -129.81 141.42 50.85 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.4 p -131.27 155.04 41.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 25.4 m -112.55 124.61 52.92 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.724 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.503 HG21 ' HB2' ' A' ' 38' ' ' ALA . 33.3 pt -125.08 166.62 20.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.35 134.77 52.69 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.956 0.408 . . . . 0.0 110.887 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.45 165.44 30.24 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.71 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 43.8 mt-10 -109.74 -62.16 1.54 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.753 -0.379 . . . . 0.0 109.981 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.638 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.5 tt 168.34 -43.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.305 1.042 . . . . 0.0 112.832 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -75.49 -11.39 60.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.799 0.809 . . . . 0.0 109.852 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.71 ' OE1' ' HB2' ' A' ' 26' ' ' GLU . 8.8 mp0 -56.59 134.85 54.73 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.229 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.484 ' ND2' ' HB3' ' A' ' 32' ' ' ASP . 36.9 p-10 -84.47 159.69 20.7 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.941 -178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.5 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -59.46 -26.05 64.91 Favored 'General case' 0 C--O 1.196 -1.748 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.733 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.484 ' HB3' ' ND2' ' A' ' 30' ' ' ASN . 13.3 t70 -59.68 -48.27 82.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 177.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.421 ' NH1' ' HG3' ' A' ' 29' ' ' GLU . 58.3 ttt180 -70.31 -44.81 67.51 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.134 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.43 -44.86 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.191 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.2 tp -64.87 -41.35 95.72 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.732 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -60.77 -40.54 98.27 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.528 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.53 -41.25 98.74 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.817 0.342 . . . . 0.0 111.398 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.503 ' HB2' HG21 ' A' ' 23' ' ' ILE . . . -78.48 -45.79 21.24 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.075 0.464 . . . . 0.0 111.743 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 45' ' ' GLU . 26.1 tp -63.36 -32.02 73.34 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.34 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -56.68 -43.62 80.62 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.168 0.987 . . . . 0.0 110.627 175.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 46.3 mmtm -61.15 -38.54 86.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.772 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -84.69 -7.5 59.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.005 0.431 . . . . 0.0 110.836 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.22 20.5 79.64 Favored Glycine 0 C--O 1.227 -0.29 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.206 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.407 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 83.5 mt -106.52 11.68 30.37 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 122.887 -0.184 . . . . 0.0 111.311 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.6 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 44.8 tt0 -58.55 -29.4 66.34 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.822 0.344 . . . . 0.0 111.756 -178.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -61.06 -26.94 67.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.191 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.3 m -108.76 32.34 4.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.784 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.6 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 33.9 ttmt -60.54 -31.02 70.13 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -176.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -65.02 -9.76 24.4 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -103.25 0.27 31.34 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.869 0.366 . . . . 0.0 110.995 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.517 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 89.8 m-85 -129.8 152.27 49.48 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.9 0.381 . . . . 0.0 111.852 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.4 pt -141.16 -180.0 2.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.491 ' HB3' HD11 ' A' ' 101' ' ' LEU . 95.9 mt -103.32 149.8 24.39 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.9 m -137.3 154.24 30.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.89 0.376 . . . . 0.0 110.478 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' HG3' HD11 ' A' ' 76' ' ' ILE . 30.0 mt-10 -109.04 126.87 53.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.198 176.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 57' ' ' SER . 55.0 t -128.52 135.02 63.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 174.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.41 ' O ' HG12 ' A' ' 56' ' ' VAL . 85.3 p -93.61 -178.05 4.58 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -86.53 6.38 30.9 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.778 0.799 . . . . 0.0 108.863 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.434 ' O ' ' HD3' ' A' ' 63' ' ' LYS . 11.9 t70 -96.02 -54.53 3.28 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.292 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.76 161.87 26.53 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.109 176.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.577 ' CG ' ' H ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER 47.52 47.86 17.15 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.293 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.552 ' HG3' ' N ' ' A' ' 63' ' ' LYS . 5.9 tpt180 -150.12 -64.17 0.21 Allowed 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 113.944 -1.48 . . . . 0.0 108.732 -173.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.552 ' N ' ' HG3' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -129.59 -19.88 3.32 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.607 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.0 t -77.33 -81.85 0.09 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -67.58 -40.07 84.85 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.9 m 58.74 30.87 20.57 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.313 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -95.63 -69.41 0.76 Allowed 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 119.501 -0.88 . . . . 0.0 113.231 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.577 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 50.9 tp 64.79 -43.05 0.31 Allowed 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -61.96 -44.17 97.32 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -113.38 65.32 0.65 Allowed 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 171.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.509 ' HA ' ' OD2' ' A' ' 61' ' ' ASP . 14.5 tt -63.46 140.48 19.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.863 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.33 146.95 27.79 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 174.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.57 -139.74 3.5 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.817 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.528 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 5.4 mpt_? -86.52 119.44 71.41 Favored Pre-proline 0 C--N 1.318 -0.799 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.08 117.1 4.14 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.431 2.088 . . . . 0.0 112.357 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 74' ' ' ARG . 39.2 mt -120.9 101.29 45.4 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.981 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.5 163.3 38.58 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.787 2.325 . . . . 0.0 111.125 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.5 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 45.1 Cg_exo -56.82 -27.67 72.97 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.874 2.383 . . . . 0.0 112.486 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 t -79.11 -9.88 59.67 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.366 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -91.95 151.45 20.5 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.4 m -121.39 88.1 45.65 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.73 -14.59 24.37 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 123.384 2.723 . . . . 0.0 114.527 -174.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 27' ' ' ILE . 39.6 mt -61.09 -37.83 84.12 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.408 ' HA ' HD11 ' A' ' 27' ' ' ILE . 74.0 m-85 -59.21 -42.43 90.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.866 0.365 . . . . 0.0 110.96 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.63 -40.51 69.69 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.154 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.6 mtp -60.93 -46.82 89.15 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.385 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 21.6 p -71.58 -34.57 70.03 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.051 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.68 90.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -73.73 -54.72 7.42 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.24 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.2 m 22.32 54.75 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.963 1.305 . . . . 0.0 114.367 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.33 53.18 0.39 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.463 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -162.89 -80.58 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.747 0.308 . . . . 0.0 110.891 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.89 133.75 14.89 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.853 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 0.7 OUTLIER -91.6 -3.97 55.82 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 122.914 0.486 . . . . 0.0 110.704 -179.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -64.23 -39.61 94.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.17 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -158.58 -138.98 2.59 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.508 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -80.59 80.41 7.05 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 t70 69.46 -51.68 0.61 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 123.759 0.662 . . . . 0.0 111.342 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.1 m -130.59 163.4 27.21 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -110.3 162.69 14.38 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.988 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 53' ' ' LEU . 36.6 tp -104.92 128.09 53.03 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.867 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -127.68 161.72 28.23 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.128 0.49 . . . . 0.0 111.565 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.489 HD11 ' HB1' ' A' ' 38' ' ' ALA . 79.0 mt -104.28 126.68 58.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.345 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 104' ' ' LYS . 24.2 mtpp -134.43 164.39 27.54 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.543 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.517 ' HG2' ' CE1' ' A' ' 51' ' ' PHE . 79.7 mtp180 -82.18 140.45 33.72 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -58.63 143.06 82.45 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-O 121.122 0.487 . . . . 0.0 111.959 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.79 -163.93 0.24 Allowed 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.115 2.544 . . . . 0.0 111.488 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 80.9 m80 . . . . . 0 C--N 1.321 -0.644 0 CA-C-O 118.472 -0.775 . . . . 0.0 110.467 179.374 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.574 0.226 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.7 mtt -86.29 157.99 19.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.739 0.304 . . . . 0.0 110.563 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -92.91 124.2 36.72 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.04 -40.07 98.42 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.308 -0.472 . . . . 0.0 113.318 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.73 -43.57 1.68 Allowed Glycine 0 C--N 1.319 -0.363 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.461 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.2 p -104.18 137.83 41.54 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.799 0.333 . . . . 0.0 110.346 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.5 mt -112.46 138.99 48.42 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.198 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -85.09 101.15 12.2 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.41 HG11 ' CB ' ' A' ' 38' ' ' ALA . 78.7 t -103.76 131.66 51.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.262 -171.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 91.7 t80 -100.42 115.27 29.64 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.23 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.97 29.04 13.32 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.424 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.504 ' HA3' ' CZ ' ' A' ' 10' ' ' TYR . . . -58.46 164.62 8.38 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 65.5 mm-40 72.77 -54.37 0.69 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.126 0.57 . . . . 0.0 110.721 -175.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.6 mt -69.01 -48.59 69.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.488 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.597 HG21 ' CE1' ' A' ' 42' ' ' TYR . 1.7 m -136.48 98.73 10.98 Favored Pre-proline 0 N--CA 1.465 0.319 0 CA-C-O 121.147 0.499 . . . . 0.0 112.144 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.13 -30.06 81.82 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.908 2.405 . . . . 0.0 112.356 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.2 t -66.86 -37.08 83.76 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.072 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -126.93 77.88 74.49 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.558 0.218 . . . . 0.0 110.731 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.557 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 32.8 Cg_endo -64.06 -31.09 65.99 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.5 2.134 . . . . 0.0 112.652 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -129.6 138.71 51.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.109 0.48 . . . . 0.0 112.197 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.55 154.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.402 175.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.7 p -102.97 121.71 43.1 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.257 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.402 ' CD1' HG21 ' A' ' 9' ' ' VAL . 29.7 pt -120.84 157.33 23.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.0 mt -106.16 121.81 44.92 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.023 0.439 . . . . 0.0 110.317 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.89 158.65 44.15 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.828 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.603 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 70.6 mm-40 -110.18 155.21 22.28 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 84' ' ' PHE . 19.4 tt -65.43 -27.1 40.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -83.88 7.69 17.32 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.272 0.558 . . . . 0.0 110.904 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.603 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 65.0 mm-40 -92.68 147.52 22.81 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 32' ' ' ASP . 30.3 p30 -84.51 170.78 13.11 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.608 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.547 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -59.5 -26.15 65.05 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.052 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.492 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 17.2 t70 -59.47 -49.54 77.39 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.745 0.307 . . . . 0.0 111.405 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.579 ' HG2' ' OE1' ' A' ' 29' ' ' GLU . 10.4 mpt_? -65.28 -44.9 86.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.94 -45.12 97.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.451 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.97 -43.1 96.8 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.066 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.521 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -62.01 -43.75 98.74 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.621 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.662 ' O ' ' HD3' ' A' ' 41' ' ' LYS . . . -62.9 -49.86 73.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.829 0.347 . . . . 0.0 111.312 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.433 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -66.13 -44.78 83.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.835 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 48' ' ' LYS . 32.2 tp -65.68 -34.6 78.59 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.184 0.516 . . . . 0.0 109.93 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 36.3 tt0 -61.84 -34.43 75.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.398 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.662 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 4.1 mptp? -60.2 -37.37 80.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.131 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.597 ' CE1' HG21 ' A' ' 15' ' ' VAL . 58.2 m-85 -89.82 -9.13 50.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.121 0.486 . . . . 0.0 110.241 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.49 19.82 79.75 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.733 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.9 mt -100.93 16.55 24.88 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HG3' ' CE ' ' A' ' 48' ' ' LYS . 40.2 tt0 -58.27 -29.11 65.55 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -176.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -58.49 -32.89 69.22 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.215 0.531 . . . . 0.0 110.126 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.3 m -95.3 21.86 7.5 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.327 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 38.6 ttmt -60.04 -35.42 75.09 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -174.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 106' ' ' LYS . 32.9 t70 -61.26 -22.7 65.07 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.774 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.476 ' HA ' ' HD2' ' A' ' 106' ' ' LYS . 26.8 t70 -89.43 -2.46 58.4 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -129.39 153.49 47.84 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.748 -0.595 . . . . 0.0 111.888 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 pt -137.3 174.65 11.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.522 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.514 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.2 mt -100.83 145.87 28.02 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 29.7 m -130.03 135.03 61.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.059 0.457 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.41 ' HB2' HD11 ' A' ' 76' ' ' ILE . 1.8 tm-20 -87.26 121.06 29.21 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.78 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 70.5 t -129.42 131.48 67.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.325 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 46.8 t -85.61 162.35 18.88 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.045 0.45 . . . . 0.0 110.122 177.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.516 ' HB3' ' HA2' ' A' ' 93' ' ' GLY . 5.3 t30 -85.8 -7.58 58.65 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.194 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 11.1 t70 -74.54 103.43 4.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.13 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.538 ' OD2' ' HA ' ' A' ' 65' ' ' MET . 4.2 p-10 -89.53 -9.25 50.63 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.447 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -71.27 -19.11 62.39 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.815 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.537 ' HG3' ' HG3' ' A' ' 63' ' ' LYS . 31.0 ptt180 -79.68 -18.16 51.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.052 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.537 ' HG3' ' HG3' ' A' ' 62' ' ' ARG . 58.5 mtpt -116.71 -70.87 0.77 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 t -161.39 25.71 0.13 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.47 -174.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.538 ' HA ' ' OD2' ' A' ' 60' ' ' ASP . 74.9 mtm 69.38 7.64 6.34 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.513 0.673 . . . . 0.0 110.268 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.44 ' N ' ' HB2' ' A' ' 60' ' ' ASP . 35.9 t -152.63 87.24 1.29 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.423 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 8.3 t0 -67.27 -43.12 82.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.465 0.65 . . . . 0.0 109.924 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.9 tp -62.57 -24.53 67.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.476 -1.238 . . . . 0.0 113.016 -175.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.6 ttt-85 -55.68 -45.26 77.8 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.028 0.442 . . . . 0.0 110.502 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -116.93 91.15 3.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.526 HG23 ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -92.04 109.86 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 122.366 1.079 . . . . 0.0 111.035 -176.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.99 -55.73 1.58 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.331 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 65.06 -162.26 39.76 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.81 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 5.3 mtm180 -103.2 125.18 35.87 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.79 114.45 2.16 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.124 1.883 . . . . 0.0 111.588 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 55' ' ' GLU . 68.2 mt -119.45 105.18 44.36 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.52 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -64.9 158.4 51.47 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.875 2.383 . . . . 0.0 111.52 176.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.547 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 52.7 Cg_exo -54.89 -29.99 66.33 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 123.333 2.689 . . . . 0.0 113.588 -177.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.3 t -66.36 -26.2 67.16 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -88.98 147.21 24.42 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 30' ' ' ASN . 36.7 m -111.49 88.36 9.08 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.88 -17.59 32.39 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.861 2.374 . . . . 0.0 113.903 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 27' ' ' ILE . 57.0 mt -61.58 -35.64 78.39 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.519 ' HA ' HD11 ' A' ' 27' ' ' ILE . 18.1 m-85 -56.6 -46.58 80.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.217 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -74.36 -37.49 63.48 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.6 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 91.7 mtp -61.45 -48.4 81.32 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.064 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.8 m -73.72 -41.74 62.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.267 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.37 -49.88 76.11 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -80.93 -47.72 13.32 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.793 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.428 ' C ' ' HB2' ' A' ' 98' ' ' ASP . 22.7 t 57.39 -173.39 0.08 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 122.727 0.411 . . . . 0.0 110.633 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 150.38 -112.32 0.54 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.245 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -89.48 -157.84 0.48 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 58' ' ' ASN . . . 102.56 96.93 2.35 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 119.574 -1.298 . . . . 0.0 114.395 174.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.1 -34.9 73.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.195 0.522 . . . . 0.0 109.697 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -63.39 -60.81 2.89 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.158 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -144.07 -104.81 0.48 Allowed Glycine 0 CA--C 1.498 -1.007 0 C-N-CA 119.583 -1.294 . . . . 0.0 112.224 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.489 ' O ' ' HA3' ' A' ' 93' ' ' GLY . 86.4 m-85 -88.69 -159.04 0.52 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.428 ' HB2' ' C ' ' A' ' 90' ' ' SER . 31.1 t70 -58.99 -31.0 68.4 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.041 0.924 . . . . 0.0 108.707 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 65.1 m -132.74 154.28 50.36 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.281 177.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -117.22 170.59 8.56 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 54' ' ' VAL . 17.3 tp -121.54 123.5 42.14 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.535 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -118.57 171.16 8.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.814 -177.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 38' ' ' ALA . 60.1 mt -109.22 128.02 65.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.356 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.526 ' HD3' HG23 ' A' ' 71' ' ' ILE . 13.2 mmmm -132.8 165.36 24.75 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 120.964 0.411 . . . . 0.0 110.115 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 -78.47 138.73 38.6 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.31 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.476 ' HD2' ' HA ' ' A' ' 50' ' ' ASP . 19.0 ptmt -59.73 154.74 44.98 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.082 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.42 -31.07 88.06 Favored 'Trans proline' 0 N--CA 1.476 0.469 0 C-N-CA 122.479 2.119 . . . . 0.0 112.649 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 72.5 m80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.65 -0.691 . . . . 0.0 110.727 -178.516 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.677 0.275 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 98.2 mmm -81.97 88.45 6.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 110.563 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -100.47 -27.91 13.19 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.317 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.12 -64.41 4.04 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.626 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.92 -20.69 28.64 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.634 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 m -102.4 124.02 47.22 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.5 mt -104.47 140.5 37.86 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 121.201 0.525 . . . . 0.0 112.288 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -85.78 105.2 16.13 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.7 t -107.97 128.25 63.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.119 -172.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.523 ' CZ ' ' HA3' ' A' ' 12' ' ' GLY . 93.3 t80 -90.1 109.45 20.5 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.364 0.602 . . . . 0.0 110.935 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.99 20.48 45.43 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.987 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.523 ' HA3' ' CZ ' ' A' ' 10' ' ' TYR . . . -64.49 177.62 9.22 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.149 -0.526 . . . . 0.0 112.007 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.494 ' CD ' ' HZ2' ' A' ' 104' ' ' LYS . 36.0 tt0 71.32 -65.55 0.34 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.246 0.618 . . . . 0.0 110.427 -176.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.83 -45.57 83.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.039 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.99 86.81 57.15 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.297 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.55 -27.7 82.21 Favored 'Trans proline' 0 N--CA 1.474 0.339 0 C-N-CA 122.909 2.406 . . . . 0.0 112.989 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.3 t -75.84 -15.12 60.28 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.208 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -138.76 79.36 28.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.06 -31.8 75.85 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.562 2.174 . . . . 0.0 113.51 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.09 144.64 48.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.237 0.542 . . . . 0.0 112.198 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.7 p -136.95 161.63 35.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.294 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.3 p -110.8 130.89 55.45 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.05 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.498 ' CD1' HG23 ' A' ' 34' ' ' ILE . 32.6 pt -128.15 158.82 39.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.1 tp -105.81 113.62 27.28 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.75 140.31 29.89 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 120.983 0.421 . . . . 0.0 110.988 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.93 153.92 20.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.691 ' HA ' HD12 ' A' ' 83' ' ' LEU . 18.7 tt -65.32 -28.01 43.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.022 0.439 . . . . 0.0 111.156 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -79.03 -1.75 37.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.408 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -85.39 147.6 26.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.045 0.45 . . . . 0.0 110.937 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -86.18 170.62 11.98 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.671 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.614 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -59.79 -28.54 67.52 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.468 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.46 -44.28 97.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -63.45 -44.49 94.35 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.203 0.525 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.529 HG21 HD23 ' A' ' 101' ' ' LEU . 96.9 mt -65.58 -45.39 92.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.588 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.1 tp -63.49 -43.58 96.83 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.578 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -63.34 -45.48 94.96 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.389 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.33 -48.51 79.52 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.733 0.302 . . . . 0.0 111.481 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.09 86.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.751 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.434 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 28.9 tp -64.51 -37.75 88.62 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.309 0.576 . . . . 0.0 109.919 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.96 -39.24 71.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.1 178.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.9 mmtt -66.98 -15.36 63.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.698 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -108.36 0.45 21.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.784 0.326 . . . . 0.0 111.125 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.53 18.26 76.95 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.198 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 93.6 mt -99.98 14.21 31.32 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.064 0.459 . . . . 0.0 110.237 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -42.51 -40.79 2.75 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.779 1.232 . . . . 0.0 112.976 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -80.71 -5.78 57.52 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.9 m -112.04 22.44 14.83 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.17 0.509 . . . . 0.0 110.532 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.459 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 35.4 ttmt -60.18 -39.03 85.02 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.52 -6.78 11.69 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -174.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -95.24 -10.58 29.93 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.877 0.37 . . . . 0.0 110.797 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.479 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 62.5 m-85 -121.68 162.81 20.08 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' A' ' 106' ' ' LYS . 26.6 pt -145.88 -178.86 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.797 1.239 . . . . 0.0 108.568 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.614 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.9 mt -107.39 155.29 20.18 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.313 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG11 ' HG3' ' A' ' 104' ' ' LYS . 27.5 m -139.29 151.96 23.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 120.682 0.277 . . . . 0.0 110.931 176.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.66 ' OE1' ' HD2' ' A' ' 74' ' ' ARG . 40.1 mt-10 -98.37 123.02 42.26 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.583 174.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.454 ' HB ' ' CE1' ' A' ' 100' ' ' PHE . 15.7 t -123.48 119.71 58.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 3.2 m -76.01 135.07 39.98 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -83.0 84.02 7.62 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.634 0.73 . . . . 0.0 110.388 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -144.15 102.54 3.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.488 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 64' ' ' SER . 11.7 p-10 -72.81 155.72 39.64 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.943 0.401 . . . . 0.0 111.859 -175.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 64.69 27.08 13.16 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.866 -174.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.597 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 33.5 ttt85 -159.55 -61.43 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.671 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.597 ' HG3' ' HG2' ' A' ' 62' ' ' ARG . 68.4 mttm -130.29 16.19 5.55 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.31 0.576 . . . . 0.0 109.644 176.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' A' ' 60' ' ' ASP . 42.5 m -154.98 168.84 25.63 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.47 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.9 ttt 58.39 -100.45 0.11 Allowed 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 123.766 0.826 . . . . 0.0 111.872 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 t -59.93 -43.3 95.0 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.701 0.762 . . . . 0.0 109.66 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.23 4.88 53.28 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.92 -177.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 71' ' ' ILE . 54.9 tp -72.74 -97.52 0.01 OUTLIER 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 175.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 43.77 -81.66 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 68' ' ' LEU . 12.5 pt-20 -77.96 -7.49 56.88 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 122.861 0.465 . . . . 0.0 110.794 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.488 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 97.1 mt 72.16 -51.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.179 0.992 . . . . 0.0 111.902 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.3 t70 65.55 -90.69 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.422 0.689 . . . . 0.0 111.187 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 57.03 -147.19 34.68 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.605 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.66 ' HD2' ' OE1' ' A' ' 55' ' ' GLU . 5.4 ptp180 -132.32 129.4 21.56 Favored Pre-proline 0 N--CA 1.436 -1.164 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.51 116.57 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.006 1.804 . . . . 0.0 112.462 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.428 HG21 ' HG3' ' A' ' 82' ' ' PRO . 55.3 mt -119.39 112.8 35.52 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.16 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.69 159.85 51.92 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.521 2.147 . . . . 0.0 111.546 177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 36.5 Cg_exo -58.22 -27.53 80.88 Favored 'Trans proline' 0 N--CA 1.474 0.335 0 C-N-CA 123.001 2.467 . . . . 0.0 112.108 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 m -67.02 -23.68 65.93 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.392 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -82.19 153.95 25.7 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 63.2 m -124.73 84.77 57.58 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.428 ' HG3' HG21 ' A' ' 76' ' ' ILE . 57.8 Cg_endo -83.19 -9.47 10.5 Favored 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 123.021 2.481 . . . . 0.0 115.64 -173.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' A' ' 27' ' ' ILE . 20.3 mt -63.58 -41.82 98.33 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.495 ' HA ' HD11 ' A' ' 27' ' ' ILE . 60.5 m-85 -60.11 -34.99 74.26 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.038 0.446 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -70.11 -37.71 75.41 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.41 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.451 ' HE2' ' HA ' ' A' ' 83' ' ' LEU . 47.9 mtm -66.11 -43.21 87.84 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.1 p -72.24 -27.74 62.7 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.57 -48.41 79.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.839 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.696 ' HD3' ' OD2' ' A' ' 98' ' ' ASP . 49.6 ttt180 -94.86 -54.13 3.59 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.48 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.9 m 55.98 43.0 27.97 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 123.423 0.452 . . . . 0.0 111.365 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 92' ' ' ASN . . . -114.11 136.17 13.07 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.302 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 91' ' ' GLY . 94.3 m-20 71.16 -179.0 0.22 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.089 0.555 . . . . 0.0 111.224 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 52.59 69.13 1.28 Allowed Glycine 0 C--N 1.34 0.777 0 CA-C-N 116.043 -0.526 . . . . 0.0 113.155 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 1.2 pm0 -58.37 -17.3 19.12 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -64.98 -41.03 95.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.65 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.44 97.1 0.11 Allowed Glycine 0 C--O 1.221 -0.682 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.496 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 56.89 -162.46 0.19 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.339 0.655 . . . . 0.0 111.612 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.696 ' OD2' ' HD3' ' A' ' 89' ' ' ARG . 1.0 OUTLIER -58.8 -39.09 80.11 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 122.002 0.906 . . . . 0.0 109.716 177.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 60.8 m -152.41 160.7 43.25 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.507 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.454 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 24.7 p90 -108.87 162.77 13.88 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.593 HD21 HD13 ' A' ' 53' ' ' LEU . 26.2 tp -100.94 123.21 44.79 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.09 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.474 ' HB2' ' HB3' ' A' ' 10' ' ' TYR . . . -123.05 171.8 9.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.32 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.6 mt -108.14 128.96 63.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.472 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.494 ' HZ2' ' CD ' ' A' ' 13' ' ' GLU . 26.4 mmmt -132.66 171.43 13.86 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.577 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 60.7 mtp180 -92.54 140.13 29.87 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.541 ' CG ' ' HD3' ' A' ' 107' ' ' PRO . 17.6 ptpt -60.5 -38.5 57.98 Favored Pre-proline 0 CA--C 1.558 1.277 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 178.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.577 ' HD2' ' HB3' ' A' ' 105' ' ' ARG . 93.0 Cg_endo -84.15 -5.97 10.31 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.023 2.482 . . . . 0.0 111.385 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 . . . . . 0 C--O 1.247 0.924 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.087 -179.459 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 120.979 0.419 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 98.7 mmm -88.59 140.0 29.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.08 0.467 . . . . 0.0 111.455 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -114.04 132.04 56.15 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.49 -38.77 95.39 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 121.242 -0.504 . . . . 0.0 114.074 -175.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.53 -46.11 3.31 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.155 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 37.7 p -101.41 120.24 39.99 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -106.7 144.49 33.28 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.529 ' O ' ' HG2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -81.92 112.16 18.77 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 172.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.45 HG21 ' CD1' ' A' ' 23' ' ' ILE . 54.1 t -104.86 127.2 59.54 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.222 -174.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -97.88 121.19 39.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.437 0.636 . . . . 0.0 111.794 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.48 26.22 3.21 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.589 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.5 -30.88 72.81 Favored Glycine 0 C--O 1.222 -0.6 0 CA-C-N 115.312 -0.444 . . . . 0.0 113.44 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -64.43 -43.57 93.91 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.985 0.421 . . . . 0.0 110.148 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.63 -44.72 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 177.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -134.96 104.93 10.52 Favored Pre-proline 0 C--O 1.237 0.424 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.23 -35.43 95.5 Favored 'Trans proline' 0 CA--C 1.493 -1.539 0 C-N-CA 123.908 3.072 . . . . 0.0 113.195 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -65.59 -21.26 66.57 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.476 -1.238 . . . . 0.0 112.361 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -139.28 74.44 35.45 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.589 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 48.3 Cg_exo -53.93 -48.25 22.73 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.837 2.358 . . . . 0.0 112.379 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -120.16 137.69 54.03 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.063 0.459 . . . . 0.0 110.998 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.8 p -130.56 161.56 40.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.9 p -118.71 123.23 44.37 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 6' ' ' SER . 41.6 pt -124.72 154.72 32.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.173 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.5 mp -99.02 111.42 23.83 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.228 0.537 . . . . 0.0 110.152 177.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.15 130.51 29.05 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.206 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -89.71 158.18 17.66 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.489 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.616 ' HA ' HD12 ' A' ' 83' ' ' LEU . 17.1 tt -63.75 -27.37 42.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -89.47 7.24 37.1 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.997 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.39 144.18 25.77 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -78.82 169.1 18.75 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.719 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.644 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -59.02 -25.51 63.73 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.844 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.07 -41.04 97.76 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.666 0.27 . . . . 0.0 110.833 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -64.88 -47.17 78.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 0.0 110.284 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.478 HG21 HD23 ' A' ' 101' ' ' LEU . 75.0 mt -64.2 -48.85 83.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.725 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.22 -44.88 90.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.462 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.469 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -65.86 -40.61 95.59 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 115.63 -0.714 . . . . 0.0 113.644 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -62.66 -48.31 79.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 117.313 0.557 . . . . 0.0 111.219 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.474 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -67.59 -41.93 83.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.138 0.494 . . . . 0.0 110.801 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 35.5 tp -62.95 -37.42 87.0 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.555 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -62.48 -39.09 92.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.01 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.2 mmtt -61.58 -40.29 94.22 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.988 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -79.46 -10.09 59.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.376 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.1 34.32 61.63 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.673 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.7 mt -123.13 21.28 9.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.767 0.318 . . . . 0.0 110.253 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.81 -16.66 43.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.288 -176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -90.65 8.53 33.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.792 0.33 . . . . 0.0 111.29 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.9 m -135.96 32.81 2.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.207 0.527 . . . . 0.0 110.133 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.469 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 39.9 ttmt -64.18 -37.33 87.07 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -173.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -64.25 -16.82 62.82 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.904 0.383 . . . . 0.0 111.847 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -84.06 -7.13 59.47 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.942 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -130.98 154.6 47.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.266 0.555 . . . . 0.0 111.805 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.2 pt -137.99 173.58 12.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.34 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.704 HD13 HD21 ' A' ' 101' ' ' LEU . 96.1 mt -99.51 135.19 41.29 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.526 ' HB ' ' HA3' ' A' ' 73' ' ' GLY . 23.3 m -128.22 134.48 64.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.204 -178.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.532 ' O ' ' HA2' ' A' ' 73' ' ' GLY . 32.7 mt-10 -86.53 122.48 30.53 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 120.962 0.411 . . . . 0.0 111.975 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.512 HG21 HG23 ' A' ' 71' ' ' ILE . 21.2 t -121.14 124.89 73.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.576 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.2 p -83.1 162.01 21.46 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -87.44 13.57 9.75 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 120.644 0.259 . . . . 0.0 111.13 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -114.36 92.98 4.14 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.258 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 65' ' ' MET . 5.6 p-10 -99.56 0.62 42.62 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.151 0.5 . . . . 0.0 110.054 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.67 -12.17 59.89 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.593 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.432 ' HG3' ' HG3' ' A' ' 63' ' ' LYS . 19.1 ptt-85 -151.27 -166.94 2.66 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.586 -176.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HG3' ' HG3' ' A' ' 62' ' ' ARG . 99.5 mttt 68.87 -77.75 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.742 0.651 . . . . 0.0 110.517 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.8 t -102.74 -24.02 13.76 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER 42.21 31.34 0.25 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.175 0.99 . . . . 0.0 112.609 -177.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.3 t -115.95 10.03 15.07 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.539 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.429 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 19.9 t0 69.68 168.96 0.3 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.601 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.5 mt -91.93 28.81 1.72 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.87 0.367 . . . . 0.0 110.051 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -58.31 -45.82 87.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.641 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.505 ' O ' ' HB ' ' A' ' 71' ' ' ILE . 3.5 pt-20 -110.31 12.36 23.2 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.818 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.512 HG23 HG21 ' A' ' 56' ' ' VAL . 96.7 mt 70.07 121.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 121.62 0.724 . . . . 0.0 111.803 -177.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -114.12 111.42 21.56 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 55' ' ' GLU . . . -151.08 166.74 30.54 Favored Glycine 0 N--CA 1.422 -2.264 0 C-N-CA 119.345 -1.407 . . . . 0.0 112.943 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.569 ' HD2' ' N ' ' A' ' 74' ' ' ARG . 1.6 mpt_? -90.22 130.03 43.52 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.86 113.67 2.87 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.17 1.913 . . . . 0.0 112.651 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.0 mt -120.53 103.35 44.08 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.097 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.89 155.26 55.97 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.889 2.393 . . . . 0.0 112.73 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.603 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 33.7 Cg_exo -55.51 -28.22 63.41 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.745 2.964 . . . . 0.0 113.403 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -73.49 -11.69 60.54 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -95.13 156.56 16.27 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.215 -0.303 . . . . 0.0 111.679 -178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 38.2 m -119.68 82.59 26.73 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 86' ' ' MET . 58.2 Cg_endo -71.21 -16.8 31.6 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.096 2.531 . . . . 0.0 115.115 -174.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.616 HD12 ' HA ' ' A' ' 27' ' ' ILE . 50.9 mt -61.18 -36.9 81.1 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -173.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.542 ' HA ' HD11 ' A' ' 27' ' ' ILE . 53.5 m-85 -58.88 -44.87 91.23 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.481 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.79 -36.16 67.53 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.406 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.474 ' SD ' HD23 ' A' ' 83' ' ' LEU . 92.9 mtp -61.69 -42.23 98.65 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.202 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.1 p -65.72 -41.6 92.06 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.98 -41.69 86.37 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.251 0.548 . . . . 0.0 110.852 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -68.1 -35.17 77.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.994 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.7 t -33.72 107.15 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.15 0.907 . . . . 0.0 112.76 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.9 -38.71 0.13 Allowed Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.284 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 47.7 m-80 -87.53 -173.89 4.55 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 58.86 54.42 38.17 Favored Glycine 0 CA--C 1.506 -0.503 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.949 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 36.8 tt0 65.33 18.19 11.27 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.593 0.711 . . . . 0.0 109.504 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 60.94 30.67 19.76 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.702 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -98.43 61.95 0.87 Allowed Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.328 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.0 t80 69.6 22.3 6.31 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.541 ' HA ' ' O ' ' A' ' 92' ' ' ASN . 15.3 t70 74.76 -50.73 0.67 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.444 1.098 . . . . 0.0 110.127 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 69.1 m -152.31 159.07 43.54 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.056 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.458 ' CE1' ' HB ' ' A' ' 56' ' ' VAL . 27.9 p90 -109.74 160.54 16.23 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 175.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.704 HD21 HD13 ' A' ' 53' ' ' LEU . 27.3 tp -104.06 123.3 46.99 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.962 -175.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -119.29 173.14 7.13 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.451 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.474 HD11 ' HB3' ' A' ' 38' ' ' ALA . 74.4 mt -112.41 128.63 68.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.091 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -133.83 160.37 37.82 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-O 120.951 0.405 . . . . 0.0 110.244 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 105' ' ' ARG . 38.2 ttm180 -78.7 116.76 19.27 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.947 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -41.26 110.08 0.71 Allowed Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.976 174.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -80.51 176.78 8.8 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.804 2.336 . . . . 0.0 112.447 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 . . . . . 0 C--O 1.243 0.756 0 CA-C-O 118.977 -0.535 . . . . 0.0 111.032 179.128 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--O 1.235 0.336 0 CA-C-O 120.637 0.256 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 89.1 mtp -120.27 -86.17 0.65 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.991 0.424 . . . . 0.0 110.326 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.432 ' CZ ' HD13 ' A' ' 83' ' ' LEU . 41.2 t80 -156.97 130.4 8.02 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.27 -34.43 89.9 Favored Glycine 0 N--CA 1.46 0.28 0 C-N-CA 121.354 -0.451 . . . . 0.0 113.699 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.76 -46.75 2.3 Favored Glycine 0 C--N 1.317 -0.477 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.646 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 14.1 p -95.16 133.16 39.31 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.6 mt -113.01 140.02 48.17 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.078 0.466 . . . . 0.0 112.153 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -83.34 111.65 19.19 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.4 t -113.26 128.48 70.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.042 -172.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -95.78 125.03 40.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.432 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -137.24 29.48 2.71 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.242 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.0 -35.88 88.57 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.976 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.427 ' HG3' ' CG2' ' A' ' 71' ' ' ILE . 19.9 mm-40 -78.17 -6.81 55.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.175 0.512 . . . . 0.0 110.556 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.42 HG22 HG23 ' A' ' 15' ' ' VAL . 43.5 mm -96.38 -53.47 8.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.439 ' CG1' HG22 ' A' ' 17' ' ' THR . 95.3 t -139.45 113.52 8.0 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.486 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.83 -25.16 60.59 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.903 2.402 . . . . 0.0 114.413 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.439 HG22 ' CG1' ' A' ' 15' ' ' VAL . 13.8 t -78.3 -13.59 59.79 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.423 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -138.41 79.78 29.32 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.7 -31.77 48.57 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.457 2.104 . . . . 0.0 112.811 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -130.0 138.35 50.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 121.072 0.463 . . . . 0.0 111.492 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.4 p -136.18 157.61 37.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.689 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.1 m -111.82 126.46 55.1 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.887 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' SER . 34.3 pt -124.32 161.86 26.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.652 -178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.8 tp -107.68 122.36 46.55 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.14 148.38 32.51 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 120.795 0.331 . . . . 0.0 110.567 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.586 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 41.6 mt-10 -101.36 148.17 25.47 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.495 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 18.1 tt -64.35 -30.43 50.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -77.49 -7.23 55.91 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.935 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.586 ' HG2' ' HB2' ' A' ' 26' ' ' GLU . 65.2 mm-40 -82.84 160.35 22.22 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.023 0.44 . . . . 0.0 110.937 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -89.92 170.05 10.71 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.872 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -62.29 -24.56 67.37 Favored 'General case' 0 C--O 1.21 -1.013 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.168 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' A' ' 78' ' ' PRO . 15.4 t70 -60.62 -47.43 86.27 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 120.71 0.291 . . . . 0.0 111.07 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.563 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 2.0 tpm_? -68.98 -41.61 77.65 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.348 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.09 -45.46 98.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.6 -44.91 92.61 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.924 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.97 -38.27 93.99 Favored Glycine 0 C--O 1.211 -1.297 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.317 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.39 -49.17 78.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.291 0.546 . . . . 0.0 110.829 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.465 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -69.61 -41.93 75.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.942 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 45' ' ' GLU . 25.8 tp -64.11 -35.21 80.0 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.891 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -62.31 -35.67 79.77 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.463 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -61.05 -37.9 84.26 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 110.321 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -88.19 -0.92 57.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.249 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.24 33.55 83.06 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.064 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.4 mt -121.15 12.59 11.09 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.538 ' HA ' HD23 ' A' ' 39' ' ' LEU . 44.5 tt0 -63.07 -24.65 68.01 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.867 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -57.26 -35.16 69.4 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.466 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 49.2 m -78.59 -85.4 0.07 Allowed 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.322 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.491 ' CE ' ' HG3' ' A' ' 45' ' ' GLU . 33.6 ttmt 63.1 -35.36 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.883 1.273 . . . . 0.0 113.915 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 47' ' ' SER . 36.3 t70 -64.64 -20.37 66.25 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.176 0.512 . . . . 0.0 111.373 -176.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.466 ' OD1' ' HB3' ' A' ' 47' ' ' SER . 12.4 p-10 -103.82 12.32 34.65 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.813 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -133.87 149.1 51.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.678 0.275 . . . . 0.0 111.171 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.4 pt -138.55 170.84 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.515 HD12 ' HB1' ' A' ' 31' ' ' ALA . 96.3 mt -100.85 137.23 39.51 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.464 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 17.4 m -123.17 129.96 74.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.221 0.534 . . . . 0.0 110.577 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 74' ' ' ARG . 3.1 tm-20 -88.0 122.64 31.83 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.275 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.409 HG21 HG13 ' A' ' 71' ' ' ILE . 99.8 t -137.14 137.03 46.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.369 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.487 ' OG ' ' HA ' ' A' ' 61' ' ' ASP . 6.3 p -96.53 139.08 33.15 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.258 0.551 . . . . 0.0 110.616 176.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.704 ' H ' ' HG2' ' A' ' 94' ' ' GLU . 24.6 t-20 -64.01 -40.79 97.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.828 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -74.26 81.86 1.85 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.677 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.599 ' HA ' ' H ' ' A' ' 67' ' ' ASP . 2.8 p30 45.44 26.98 0.34 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.092 1.357 . . . . 0.0 113.34 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.756 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 24.9 t70 55.21 27.65 10.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.081 -175.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.756 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 7.7 ptm180 61.7 25.82 15.62 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.228 1.011 . . . . 0.0 112.418 172.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 61' ' ' ASP . 61.9 mttp -132.89 -77.93 0.49 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.185 0.516 . . . . 0.0 110.862 -176.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 60' ' ' ASP . 21.6 t -137.0 150.91 48.41 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.441 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 24.8 ptt? -51.32 93.7 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.837 0.827 . . . . 0.0 112.539 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.8 m -115.39 -51.34 2.7 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.364 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.599 ' H ' ' HA ' ' A' ' 60' ' ' ASP . 29.5 t70 56.08 58.52 4.3 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.99 176.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.5 tp 63.76 90.93 0.08 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.575 0.702 . . . . 0.0 111.827 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -157.53 130.28 7.49 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.35 -0.841 . . . . 0.0 108.978 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 52.25 57.9 5.97 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.427 ' CG2' ' HG3' ' A' ' 13' ' ' GLU . 12.5 tt -46.13 108.0 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -173.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.29 84.28 1.26 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.696 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.24 -129.71 4.91 Favored Glycine 0 N--CA 1.433 -1.538 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.343 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.443 ' HB2' ' HB3' ' A' ' 55' ' ' GLU . 0.5 OUTLIER -93.03 114.55 63.02 Favored Pre-proline 0 C--N 1.304 -1.407 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.2 114.59 3.66 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.44 2.093 . . . . 0.0 111.518 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 74' ' ' ARG . 18.1 mt -120.57 100.84 46.67 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.191 -176.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -59.51 157.29 32.33 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.217 2.611 . . . . 0.0 112.269 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 2.3 Cg_endo -58.28 -25.31 71.9 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.352 2.702 . . . . 0.0 114.4 -175.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.2 t -76.64 -12.6 60.03 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -92.35 155.8 17.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.653 0.263 . . . . 0.0 111.357 -177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 76.6 m -116.14 86.28 16.87 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.857 0.361 . . . . 0.0 110.248 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.404 ' HB3' HD13 ' A' ' 76' ' ' ILE . 49.5 Cg_endo -69.97 -22.09 31.58 Favored 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 122.912 2.408 . . . . 0.0 114.249 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.495 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 81.1 mt -61.91 -37.95 86.57 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -175.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.45 ' HA ' HD11 ' A' ' 27' ' ' ILE . 23.1 m-85 -55.24 -46.42 76.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.972 0.415 . . . . 0.0 110.845 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.662 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 67.6 mm-40 -74.91 -42.51 57.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.557 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.6 mtp -59.96 -46.62 88.83 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.013 0.435 . . . . 0.0 111.197 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.8 m -65.05 -43.7 91.42 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.066 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.61 -37.49 79.82 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 27.7 mmt180 -86.1 -1.6 57.54 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.891 -174.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.54 ' HA ' ' HB2' ' A' ' 98' ' ' ASP . 42.5 p -54.14 113.86 1.4 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.45 27.8 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.037 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -123.29 -41.99 2.27 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.78 -161.82 28.5 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.978 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.704 ' HG2' ' H ' ' A' ' 58' ' ' ASN . 1.1 tm-20 69.85 174.53 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.395 0.678 . . . . 0.0 112.047 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.538 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 61.5 t30 -105.4 -20.47 13.48 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.647 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.34 -118.98 0.23 Allowed Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.809 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.479 ' C ' ' H ' ' A' ' 99' ' ' SER . 97.7 m-85 -120.93 84.48 2.24 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.54 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 3.7 t70 72.49 -37.86 0.4 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.113 0.965 . . . . 0.0 110.571 -176.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 97' ' ' PHE . 27.5 p -151.33 174.98 12.67 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.808 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -111.02 162.43 14.87 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.3 tp -117.01 125.68 51.74 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -124.95 171.36 10.26 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.825 -175.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 38' ' ' ALA . 71.8 mt -102.56 129.73 53.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.891 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -125.07 148.75 48.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.231 0.539 . . . . 0.0 110.912 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -80.09 102.0 9.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.655 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -63.66 152.63 85.75 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.598 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.48 165.58 32.3 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.76 2.307 . . . . 0.0 111.123 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 . . . . . 0 C--O 1.243 0.761 0 CA-C-O 118.737 -0.649 . . . . 0.0 110.066 -178.281 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 120.901 0.382 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 68.5 mtt -132.7 83.8 2.1 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.9 t80 60.01 -95.09 0.05 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.471 0.709 . . . . 0.0 110.025 -175.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 55.96 67.61 2.12 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 121.488 -0.386 . . . . 0.0 113.214 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.36 171.89 42.15 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.597 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 p -95.14 160.32 14.61 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 120.79 0.329 . . . . 0.0 110.515 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.4 mt -110.85 135.41 51.45 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.193 0.521 . . . . 0.0 111.926 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.18 109.72 17.96 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -116.84 129.98 72.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.706 -172.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.555 ' CE2' HD12 ' A' ' 71' ' ' ILE . 67.4 t80 -103.89 129.88 51.43 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.098 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.22 28.86 2.66 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.054 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.25 -30.33 75.65 Favored Glycine 0 N--CA 1.465 0.591 0 C-N-CA 121.646 -0.311 . . . . 0.0 113.481 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -61.98 -32.81 73.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 0.0 109.722 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.8 mt -91.99 -52.97 9.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.768 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.3 t -124.53 102.91 32.31 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.663 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.81 -22.37 43.05 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.076 2.517 . . . . 0.0 113.796 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -78.13 -15.96 58.38 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.941 0.401 . . . . 0.0 111.189 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -139.16 74.34 36.26 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-O 121.013 0.435 . . . . 0.0 109.855 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.05 -40.02 55.14 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.433 2.088 . . . . 0.0 112.936 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -120.55 135.89 54.95 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.232 0.539 . . . . 0.0 111.548 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.65 163.29 37.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.96 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 p -122.94 132.34 54.12 Favored 'General case' 0 C--N 1.292 -1.891 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.253 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 38' ' ' ALA . 43.3 pt -125.86 161.26 31.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.864 -177.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -110.37 113.38 25.98 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.61 142.16 23.52 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 72.4 mm-40 -95.56 169.93 9.7 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.071 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.473 HD11 ' HA ' ' A' ' 84' ' ' PHE . 16.0 tt -62.96 -26.54 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -84.63 1.61 45.34 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.4 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -80.76 143.53 32.84 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.909 0.385 . . . . 0.0 109.974 176.316 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -96.7 173.41 7.33 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.596 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -62.11 -24.14 66.96 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.78 -49.16 76.15 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.955 0.407 . . . . 0.0 110.392 176.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -76.15 -42.37 46.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.551 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.3 mt -62.6 -44.76 99.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.857 0.361 . . . . 0.0 110.615 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.6 tp -65.55 -42.7 91.58 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.32 -46.1 94.91 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.74 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.598 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.14 -50.47 73.56 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.112 0.456 . . . . 0.0 111.449 -178.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.553 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -69.09 -44.24 72.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.722 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 45' ' ' GLU . 29.0 tp -64.94 -36.96 86.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.76 -177.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.46 -38.57 90.31 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.305 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.598 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 73.5 mmtt -60.26 -35.51 75.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.8 0.333 . . . . 0.0 110.226 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -85.18 -2.19 57.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.871 0.367 . . . . 0.0 110.369 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.63 20.11 79.78 Favored Glycine 0 C--O 1.237 0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.905 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' C ' ' HG ' ' A' ' 39' ' ' LEU . 88.0 mt -116.36 16.08 15.75 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 44.3 tt0 -56.71 -34.15 67.17 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -70.27 -13.34 62.12 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 122.226 -0.296 . . . . 0.0 111.625 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 30.4 m -104.24 38.51 1.84 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 45' ' ' GLU . 99.3 mttt -71.13 -11.52 60.99 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.841 -0.537 . . . . 0.0 111.402 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.558 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 7.4 m-20 -74.2 -7.24 51.98 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.176 0.512 . . . . 0.0 109.844 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -117.83 -13.33 10.12 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.118 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -129.24 147.05 51.04 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.528 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.5 HG23 ' HB3' ' A' ' 106' ' ' LYS . 48.5 pt -137.11 177.7 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.025 177.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.523 HD12 ' HB1' ' A' ' 31' ' ' ALA . 97.0 mt -100.5 138.51 37.47 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 120.745 0.307 . . . . 0.0 110.414 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 15.8 m -126.78 129.39 71.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.105 176.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.94 118.66 29.67 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 91.7 t -115.69 122.27 69.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.664 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.423 ' HA ' ' CB ' ' A' ' 99' ' ' SER . 6.5 m -72.83 134.35 44.84 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.873 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -65.66 -35.76 81.72 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.182 0.515 . . . . 0.0 109.991 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -77.16 91.93 3.76 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.172 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.611 ' CB ' ' HB3' ' A' ' 67' ' ' ASP . 29.7 t0 -111.36 -145.07 0.39 Allowed 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.72 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.565 ' H ' ' CG ' ' A' ' 60' ' ' ASP . 34.0 m-20 59.27 29.83 19.46 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 -169.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.446 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 22.3 ttt180 -153.91 -52.98 0.1 Allowed 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.69 -1.596 . . . . 0.0 111.596 -171.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.446 ' HG3' ' HG2' ' A' ' 62' ' ' ARG . 95.8 mttt -92.03 -39.24 11.76 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.692 -173.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.8 t -128.76 -30.41 2.28 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.2 mtt 62.37 30.07 17.33 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 t -173.84 34.77 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -176.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.611 ' HB3' ' CB ' ' A' ' 60' ' ' ASP . 11.0 p-10 -33.33 -70.08 0.08 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.66 1.584 . . . . 0.0 114.898 -173.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.0 tp -90.14 -23.46 21.34 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.446 -174.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -61.74 -45.84 92.19 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.034 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -103.45 -8.83 19.85 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.041 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.555 HD12 ' CE2' ' A' ' 10' ' ' TYR . 4.8 tt 36.66 78.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 122.334 1.064 . . . . 0.0 112.549 -176.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -118.83 111.04 17.92 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.075 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.86 -163.37 10.34 Favored Glycine 0 N--CA 1.434 -1.482 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.188 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 63.7 mtp180 -81.87 123.35 80.23 Favored Pre-proline 0 C--N 1.316 -0.849 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.41 114.11 3.7 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 122.412 2.075 . . . . 0.0 111.52 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.7 mt -120.42 99.42 47.99 Favored Pre-proline 0 N--CA 1.434 -1.252 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.487 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -63.65 160.69 35.16 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.849 2.366 . . . . 0.0 111.782 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.601 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 50.6 Cg_exo -51.4 -33.15 45.33 Favored 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 123.863 3.042 . . . . 0.0 114.116 -176.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.0 m -61.64 -40.72 95.88 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -80.18 154.36 28.02 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 5.3 p -120.19 93.97 48.37 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.139 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.83 -17.66 41.8 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.711 2.274 . . . . 0.0 115.05 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 27' ' ' ILE . 60.0 mt -62.91 -34.45 77.46 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -176.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.562 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 21.8 m-85 -57.61 -30.79 65.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.124 0.488 . . . . 0.0 111.106 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.57 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 50.7 mt-10 -86.91 -50.48 6.66 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.117 175.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 95.4 mtp -59.08 -71.92 0.11 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.983 -175.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 m -65.09 -47.83 75.86 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -175.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 84' ' ' PHE . . . -62.41 -51.12 68.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -176.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.57 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 9.1 mpt_? -73.3 -38.01 66.01 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.559 178.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 97' ' ' PHE . 78.0 p 57.04 177.14 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.983 0.913 . . . . 0.0 111.616 -177.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -171.14 159.34 31.24 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 118.871 -1.633 . . . . 0.0 113.437 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -103.15 -21.85 13.83 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.27 53.87 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.441 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.113 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -124.71 -90.59 0.56 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.54 -0.33 . . . . 0.0 110.406 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -153.83 33.9 0.44 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.816 0.846 . . . . 0.0 108.849 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 90' ' ' SER . . . -112.66 -109.59 2.99 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.709 -1.234 . . . . 0.0 113.629 -174.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.455 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 14.3 t80 -106.47 6.01 29.83 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.108 0.956 . . . . 0.0 109.769 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -79.53 -6.95 58.08 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.855 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' A' ' 57' ' ' SER . 22.8 p -98.87 172.2 7.58 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.282 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -128.57 158.51 38.25 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 175.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.403 HD21 HD13 ' A' ' 53' ' ' LEU . 30.6 tp -109.96 125.81 53.26 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.092 -177.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -123.9 169.11 11.92 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.411 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 38' ' ' ALA . 74.0 mt -111.59 130.03 65.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.716 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.5 tttt -127.91 164.57 21.98 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 121.154 0.502 . . . . 0.0 110.309 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -82.12 111.83 18.61 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.558 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.4 ptmt -48.26 152.75 1.43 Allowed Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.6 0.562 . . . . 0.0 112.271 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.41 154.98 65.02 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 C-N-CA 122.835 2.356 . . . . 0.0 111.646 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 . . . . . 0 C--N 1.292 -1.91 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.794 -178.769 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.9 m . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.523 0.202 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.2 mmm -66.08 -41.58 90.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.544 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -79.68 122.55 26.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.623 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.42 125.65 7.08 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.44 1.27 44.38 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.813 -0.708 . . . . 0.0 113.047 -177.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.3 p -129.5 141.37 51.01 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.6 mt -109.17 142.22 40.27 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.544 ' HE2' ' CE1' ' A' ' 20' ' ' TYR . 87.2 tttt -82.05 108.2 15.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 173.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.473 HG11 ' CB ' ' A' ' 38' ' ' ALA . 71.0 t -114.7 131.57 66.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 120.832 0.349 . . . . 0.0 110.563 -173.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -114.71 119.62 37.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.296 0.57 . . . . 0.0 111.868 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.27 19.66 4.55 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.8 -22.61 60.04 Favored Glycine 0 C--N 1.335 0.516 0 CA-C-N 115.413 -0.394 . . . . 0.0 113.633 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.01 -35.56 80.9 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.339 0.59 . . . . 0.0 109.931 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.51 -48.87 13.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.799 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.5 t -119.15 90.93 42.77 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.295 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.13 -30.48 93.28 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.665 2.91 . . . . 0.0 114.079 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -64.96 -23.5 67.24 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.497 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -133.74 79.92 57.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 18.1 Cg_endo -59.76 -48.83 11.58 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.394 2.063 . . . . 0.0 112.773 -178.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.544 ' CE1' ' HE2' ' A' ' 8' ' ' LYS . 86.6 m-85 -118.04 139.52 51.09 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.232 0.539 . . . . 0.0 111.279 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -134.54 161.01 41.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.879 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.5 p -119.36 130.85 55.55 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.062 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.49 HD11 HG23 ' A' ' 34' ' ' ILE . 40.5 pt -127.49 157.55 39.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.692 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.97 110.38 22.4 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.98 145.91 27.56 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.216 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -108.89 166.12 11.06 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.419 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.561 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 15.2 tt -64.97 -28.75 45.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.659 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -75.23 -4.32 38.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -92.79 145.14 24.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.401 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 32.9 m-20 -83.58 175.38 9.79 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.66 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.543 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -60.23 -25.63 65.79 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.688 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 30' ' ' ASN . 3.5 p-10 -65.15 -37.46 87.48 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.812 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -67.48 -46.9 71.61 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-O 121.071 0.462 . . . . 0.0 110.445 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.498 HG21 HD23 ' A' ' 101' ' ' LEU . 96.9 mt -64.8 -45.5 94.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.529 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 39' ' ' LEU . 53.9 tp -63.43 -46.58 85.69 Favored 'General case' 0 C--O 1.21 -0.992 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.542 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 40' ' ' GLU . . . -66.88 -43.32 91.78 Favored Glycine 0 C--O 1.22 -0.759 0 C-N-CA 121.018 -0.611 . . . . 0.0 113.095 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.01 -38.98 84.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.815 0.341 . . . . 0.0 111.394 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.606 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -84.2 -36.23 22.94 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 35' ' ' LEU . 28.8 tp -62.68 -36.98 84.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.565 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 56.9 mt-10 -58.3 -41.08 83.64 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.576 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 44.7 mmtm -62.61 -38.51 90.47 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.801 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.15 -2.98 58.85 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.555 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.51 26.78 62.55 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 114.322 0.489 . . . . 0.0 114.322 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.455 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 94.0 mt -118.53 15.56 13.74 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 117.251 0.526 . . . . 0.0 110.761 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.565 ' HB3' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -60.98 -29.07 69.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.539 -177.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -61.37 -33.49 73.74 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.886 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.4 m -83.33 -89.58 0.09 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.061 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt 67.28 -27.95 0.13 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.68 -20.19 65.93 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -113.18 19.52 17.05 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.753 0.311 . . . . 0.0 111.437 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.472 ' CE1' ' HG2' ' A' ' 105' ' ' ARG . 98.8 m-85 -124.9 144.14 50.48 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 122.301 -0.249 . . . . 0.0 110.832 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.472 HG23 ' HB2' ' A' ' 106' ' ' LYS . 43.1 pt -141.62 169.88 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.336 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.529 HD13 HD21 ' A' ' 101' ' ' LEU . 94.4 mt -102.02 146.66 27.58 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 120.658 0.266 . . . . 0.0 110.328 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.5 135.36 59.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.013 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -91.86 123.92 35.6 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 121.121 0.486 . . . . 0.0 111.121 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.541 HG21 ' CG1' ' A' ' 71' ' ' ILE . 63.1 t -128.18 131.81 68.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.284 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 p -103.9 92.17 4.29 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 120.81 0.338 . . . . 0.0 110.328 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -97.39 88.56 4.44 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.447 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.08 -27.29 63.51 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.544 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.495 ' HA ' ' HB3' ' A' ' 64' ' ' SER . 30.9 t70 61.92 23.21 13.63 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.902 0.858 . . . . 0.0 110.979 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -129.78 23.11 5.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.895 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.417 ' HG2' ' HG3' ' A' ' 63' ' ' LYS . 8.5 ttm180 -166.95 -60.25 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 121.144 0.497 . . . . 0.0 109.948 -175.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HG3' ' HG2' ' A' ' 62' ' ' ARG . 54.3 mtpt -82.34 0.42 41.84 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.495 ' HB3' ' HA ' ' A' ' 60' ' ' ASP . 12.0 p -70.03 -19.34 63.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 114.546 -1.207 . . . . 0.0 110.391 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.3 ptp -63.99 -23.55 67.38 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.618 0.723 . . . . 0.0 109.59 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 t -115.98 -20.61 9.87 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.964 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 70.42 178.93 0.25 Allowed 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.632 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 68' ' ' LEU . 2.6 pt? -72.78 97.83 2.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.538 0.685 . . . . 0.0 110.898 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -106.1 129.12 54.25 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.454 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 36.79 81.36 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.619 1.199 . . . . 0.0 110.599 -177.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.563 HG23 ' HD3' ' A' ' 104' ' ' LYS . 19.6 tt -51.12 123.63 2.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-O 121.795 0.807 . . . . 0.0 113.162 -173.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -143.76 134.76 25.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.199 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.41 -152.56 5.69 Favored Glycine 0 CA--C 1.508 -0.399 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -86.71 130.24 49.64 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 117.536 0.668 . . . . 0.0 109.795 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.44 117.71 5.15 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.364 2.043 . . . . 0.0 112.034 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.4 mt -119.33 103.0 47.69 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.307 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -62.23 156.76 48.73 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.922 2.415 . . . . 0.0 111.629 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.543 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 27.5 Cg_endo -63.87 -16.18 53.36 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.908 2.405 . . . . 0.0 113.384 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.9 p -83.36 -12.46 56.51 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -91.14 158.05 16.85 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.515 0.198 . . . . 0.0 110.929 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.7 m -115.52 85.29 13.33 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.91 -26.93 58.86 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.628 2.219 . . . . 0.0 113.695 -175.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.561 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 77.1 mt -62.92 -37.96 89.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.414 ' HA ' HD11 ' A' ' 27' ' ' ILE . 35.2 m-85 -65.66 -14.95 62.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.537 0.208 . . . . 0.0 111.535 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -95.66 -41.65 8.79 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 175.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.484 ' SD ' HD23 ' A' ' 83' ' ' LEU . 91.3 mtp -61.73 -46.23 90.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.023 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.2 m -76.3 -23.19 54.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.453 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.04 -50.54 61.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.92 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.1 ttt-85 -84.27 -47.86 10.35 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.315 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.3 p 47.46 59.58 4.02 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.46 0.704 . . . . 0.0 112.057 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.83 -120.83 0.67 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.504 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -138.36 136.13 36.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.95 0.405 . . . . 0.0 110.596 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -150.23 -121.52 1.05 Allowed Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -83.46 -83.53 0.14 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -138.78 10.76 2.66 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.254 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -147.74 98.05 0.19 Allowed Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 119.533 -1.317 . . . . 0.0 112.454 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 58.43 -157.96 0.3 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.001 0.52 . . . . 0.0 111.245 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.33 -44.35 95.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.173 0.511 . . . . 0.0 110.88 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.7 m -138.66 162.7 33.99 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.737 -177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -108.72 159.69 16.55 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.529 HD21 HD13 ' A' ' 53' ' ' LEU . 29.8 tp -103.97 125.45 50.36 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.034 0.445 . . . . 0.0 111.309 -172.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.73 171.15 11.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.254 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 38' ' ' ALA . 80.4 mt -109.22 129.81 63.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.187 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.563 ' HD3' HG23 ' A' ' 71' ' ' ILE . 12.9 mmmm -135.79 168.0 20.12 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.705 175.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.472 ' HG2' ' CE1' ' A' ' 51' ' ' PHE . 66.5 mtp180 -91.71 139.88 30.25 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.251 -178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.487 ' HG2' ' H ' ' A' ' 108' ' ' HIS . 34.6 ttpt -90.6 141.23 26.95 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.101 177.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -53.66 -38.77 84.67 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.376 2.051 . . . . 0.0 110.894 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.487 ' H ' ' HG2' ' A' ' 106' ' ' LYS . 43.7 t60 . . . . . 0 C--O 1.244 0.777 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.151 175.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.758 0.313 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 71.2 mtm -64.94 -41.86 95.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.108 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.1 t80 70.11 121.75 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.797 0.686 . . . . 0.0 110.844 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.72 -42.96 98.45 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.83 -0.623 . . . . 0.0 114.194 -176.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.92 -55.5 0.55 Allowed Glycine 0 C--N 1.318 -0.459 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.794 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.3 m -94.29 138.49 32.22 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.5 mt -105.85 140.47 38.83 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -82.27 102.53 11.23 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.433 -1.258 . . . . 0.0 107.895 174.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.427 HG21 HG12 ' A' ' 23' ' ' ILE . 41.0 t -108.46 120.36 59.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.103 -175.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -105.07 123.18 47.36 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.219 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.39 17.64 6.54 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.962 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.525 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -60.79 -22.17 59.42 Favored Glycine 0 N--CA 1.462 0.416 0 C-N-CA 121.695 -0.288 . . . . 0.0 112.686 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -63.34 -35.38 80.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.3 mt -92.0 -48.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.73 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.24 106.45 33.28 Favored Pre-proline 0 C--N 1.332 -0.178 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -63.86 -22.26 68.98 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.598 2.198 . . . . 0.0 111.32 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -78.68 -15.83 58.01 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.62 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -144.38 71.03 16.0 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.935 0.398 . . . . 0.0 110.199 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 45.3 Cg_exo -57.09 -45.53 35.05 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.065 2.51 . . . . 0.0 113.594 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -122.26 140.87 52.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 22' ' ' SER . 9.7 p -139.29 167.41 20.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.411 ' H ' HG22 ' A' ' 21' ' ' VAL . 37.6 m -132.03 133.4 44.36 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.483 HD11 HG23 ' A' ' 34' ' ' ILE . 33.8 pt -129.38 163.08 35.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.402 -177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.7 tp -111.18 121.45 45.34 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.47 143.64 26.85 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.117 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.66 161.36 14.94 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.507 HD11 ' HA ' ' A' ' 84' ' ' PHE . 17.4 tt -62.85 -28.0 44.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.798 -178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -69.34 -24.04 63.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.312 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.69 139.15 58.74 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.525 0.678 . . . . 0.0 111.197 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -89.67 175.53 7.22 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.437 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -61.01 -33.79 73.81 Favored 'General case' 0 C--O 1.205 -1.255 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.217 -178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.08 -50.02 75.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.626 0.25 . . . . 0.0 111.486 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -69.13 -41.05 77.84 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.835 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.483 HG23 HD11 ' A' ' 23' ' ' ILE . 96.8 mt -64.4 -44.04 97.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.606 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.69 -44.0 97.37 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.978 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.7 -41.02 99.12 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.472 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.03 -49.68 75.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.932 0.396 . . . . 0.0 111.449 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.48 -43.86 72.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.661 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 26.7 tp -64.29 -32.73 74.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.326 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.09 -39.96 87.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.813 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -62.4 -36.31 81.92 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -80.73 -12.35 59.48 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.313 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.58 20.69 76.32 Favored Glycine 0 C--O 1.229 -0.169 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.243 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 85.5 mt -108.52 12.84 25.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.799 0.333 . . . . 0.0 110.615 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -59.26 -24.86 63.58 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.919 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -64.24 -33.29 75.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.002 0.43 . . . . 0.0 110.272 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.406 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 33.2 m -79.23 -89.39 0.05 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.056 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt 68.1 -39.99 0.41 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.613 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 35.2 m-20 -65.58 -19.74 66.04 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 120.728 0.299 . . . . 0.0 111.618 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.507 ' C ' ' HG2' ' A' ' 106' ' ' LYS . 15.2 p-10 -103.79 11.48 35.74 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.82 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -131.91 147.54 52.48 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.708 0.289 . . . . 0.0 110.893 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.3 pt -138.56 170.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.6 mt -100.46 141.8 32.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.749 0.309 . . . . 0.0 110.176 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 28.6 m -125.22 132.71 70.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-O 120.994 0.426 . . . . 0.0 110.923 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.521 ' HG3' ' HG2' ' A' ' 86' ' ' MET . 1.6 tm-20 -87.58 129.59 35.05 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 58' ' ' ASN . 16.1 t -128.18 117.13 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.368 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 7.5 m -77.77 -1.15 29.96 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 123.59 0.756 . . . . 0.0 110.781 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.581 ' O ' ' HE2' ' A' ' 100' ' ' PHE . 11.3 m120 -84.43 64.0 8.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.56 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -40.05 -50.9 2.6 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 114.586 -1.188 . . . . 0.0 114.099 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -152.04 -160.84 1.2 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.675 0.274 . . . . 0.0 111.313 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.69 -20.79 61.88 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.227 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.453 ' HG3' ' HG3' ' A' ' 63' ' ' LYS . 13.0 ptt180 -59.08 -31.44 68.89 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 120.823 0.344 . . . . 0.0 110.4 177.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.453 ' HG3' ' HG3' ' A' ' 62' ' ' ARG . 67.0 mttm -128.53 14.63 6.55 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.7 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.8 t -118.2 -39.35 3.07 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 68.1 mtt 54.12 25.88 6.06 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.474 0.654 . . . . 0.0 110.288 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.8 t -149.78 2.74 0.53 Allowed 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.303 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 59.11 35.17 23.69 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.687 -176.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.1 mp 65.19 95.81 0.05 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.361 -176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -137.94 -60.99 0.63 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.128 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -93.41 118.75 31.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.005 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 40.1 mt -126.82 127.66 70.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -97.13 -54.29 3.22 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 172.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.09 -178.47 16.58 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.99 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 76' ' ' ILE . 14.2 ttp180 -111.3 112.77 54.55 Favored Pre-proline 0 N--CA 1.437 -1.09 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.62 116.51 3.28 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.024 2.483 . . . . 0.0 113.043 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 74' ' ' ARG . 32.9 mt -121.81 103.71 39.94 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.089 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 46.6 Cg_exo -62.12 155.54 55.53 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.684 2.256 . . . . 0.0 112.106 177.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.441 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 52.2 Cg_exo -54.56 -33.26 77.92 Favored 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.775 2.983 . . . . 0.0 113.939 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 p -66.18 -24.64 66.68 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -176.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.3 155.21 19.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.683 0.278 . . . . 0.0 111.7 -177.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 59.0 m -105.8 93.98 8.25 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.465 ' HB3' HD13 ' A' ' 76' ' ' ILE . 50.6 Cg_endo -69.21 -28.39 27.95 Favored 'Trans proline' 0 C--O 1.218 -0.477 0 C-N-CA 122.842 2.362 . . . . 0.0 115.244 -173.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.49 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 86.7 mt -61.88 -38.69 89.26 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -173.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.507 ' HA ' HD11 ' A' ' 27' ' ' ILE . 58.9 m-85 -59.16 -39.51 82.67 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.189 0.519 . . . . 0.0 110.847 178.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -83.98 -32.92 24.73 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.663 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.642 ' O ' ' HB2' ' A' ' 90' ' ' SER . 85.0 mtp -62.76 -40.97 98.91 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.167 0.508 . . . . 0.0 111.692 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.5 p -72.45 -41.2 66.37 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.36 -60.15 1.64 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -69.89 -43.81 71.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.669 -174.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.642 ' HB2' ' O ' ' A' ' 86' ' ' MET . 69.3 m -69.66 170.08 11.53 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.444 -177.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.481 ' HA3' ' N ' ' A' ' 96' ' ' GLY . . . 115.28 85.06 1.23 Allowed Glycine 0 N--CA 1.433 -1.539 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.744 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 57' ' ' SER . 58.2 t30 -76.24 -18.99 58.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.221 0.534 . . . . 0.0 110.452 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.02 -78.88 1.14 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.837 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -115.58 23.2 12.54 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 122.881 -0.188 . . . . 0.0 111.109 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 2.5 t-20 60.17 56.3 3.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.518 0.675 . . . . 0.0 109.579 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.481 ' N ' ' HA3' ' A' ' 91' ' ' GLY . . . -149.96 -137.8 2.8 Favored Glycine 0 CA--C 1.493 -1.328 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.201 -178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.32 33.12 0.45 Allowed 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.547 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.456 ' HB2' ' HA2' ' A' ' 91' ' ' GLY . 14.9 m-20 -70.3 -13.37 62.13 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 68.0 m -98.0 130.6 44.83 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.12 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.581 ' HE2' ' O ' ' A' ' 58' ' ' ASN . 44.3 p90 -114.48 169.47 9.02 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.72 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.6 tp -119.54 122.51 41.78 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.987 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.98 167.63 12.86 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.967 -177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.63 126.03 56.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -120.01 156.83 30.12 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.682 0.753 . . . . 0.0 111.643 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -85.55 112.1 20.63 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.764 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.613 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.6 ptmt -75.19 154.61 86.35 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.857 -178.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.1 -28.9 81.09 Favored 'Trans proline' 0 N--CA 1.477 0.538 0 C-N-CA 122.918 2.412 . . . . 0.0 111.899 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 58.2 t60 . . . . . 0 C--O 1.243 0.733 0 O-C-N 124.036 0.835 . . . . 0.0 110.728 178.381 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.9 p . . . . . 0 C--O 1.239 0.548 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 78.0 mtm 66.97 -69.51 0.13 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.686 0.794 . . . . 0.0 112.148 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -83.57 117.62 23.27 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.89 -35.02 91.41 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.743 -177.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.8 -10.71 64.42 Favored Glycine 0 C--N 1.318 -0.455 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.228 -178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.0 p -135.27 151.19 50.34 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.4 mt -122.38 135.65 54.74 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.292 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -87.49 100.57 12.86 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.554 HG11 ' CB ' ' A' ' 38' ' ' ALA . 72.8 t -95.34 122.1 46.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.598 -173.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 82.8 t80 -92.03 120.99 33.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.123 -176.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.47 23.82 4.0 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 19' ' ' PRO . . . -61.28 -26.9 66.74 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.279 -0.46 . . . . 0.0 113.375 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.413 ' OE1' ' HG2' ' A' ' 104' ' ' LYS . 44.2 tt0 -64.17 -46.51 83.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 70.0 mt -76.27 -50.1 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.291 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.3 t -118.85 98.14 50.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.131 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.05 -21.77 42.48 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.748 2.298 . . . . 0.0 113.256 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 t -84.78 -6.45 59.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.708 0.29 . . . . 0.0 111.412 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -148.01 80.11 8.89 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.497 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 28.2 Cg_endo -62.87 -48.97 5.8 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.849 2.366 . . . . 0.0 114.111 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -120.21 138.02 53.87 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.017 0.437 . . . . 0.0 111.812 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -127.82 144.27 38.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.793 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 p -96.75 115.73 27.92 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.238 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 34' ' ' ILE . 18.5 pt -117.49 158.34 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.817 -178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.81 122.83 44.71 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.38 144.79 24.83 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -104.06 158.51 16.38 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.917 0.389 . . . . 0.0 110.425 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 84' ' ' PHE . 14.2 tt -65.24 -26.69 40.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.464 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.47 9.18 11.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.808 -177.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -109.71 146.43 34.9 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.421 ' HB2' ' OD2' ' A' ' 32' ' ' ASP . 39.7 m-80 -76.25 174.56 9.99 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.216 0.532 . . . . 0.0 111.236 -177.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.606 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -61.62 -26.48 68.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.843 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.433 ' CB ' ' HB3' ' A' ' 78' ' ' PRO . 1.4 p30 -63.52 -36.92 85.38 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.502 0.192 . . . . 0.0 110.883 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -66.32 -43.81 85.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 121.099 0.476 . . . . 0.0 110.014 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.494 HG23 HD11 ' A' ' 23' ' ' ILE . 96.7 mt -64.72 -46.16 93.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.322 178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.76 -46.71 84.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.197 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -66.19 -43.2 93.57 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.257 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.688 ' O ' ' HD3' ' A' ' 41' ' ' LYS . . . -61.6 -48.81 79.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.867 0.365 . . . . 0.0 111.283 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.554 ' CB ' HG11 ' A' ' 9' ' ' VAL . . . -68.22 -40.68 82.0 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.465 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.83 -36.7 84.76 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.517 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -59.95 -37.18 78.81 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.387 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.688 ' HD3' ' O ' ' A' ' 37' ' ' ALA . 6.5 mptt -61.43 -37.33 83.12 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.62 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -90.68 -0.13 57.59 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.816 -0.353 . . . . 0.0 111.2 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.84 26.28 71.69 Favored Glycine 0 C--O 1.238 0.365 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.879 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.0 mt -113.81 19.98 16.21 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 122.642 -0.328 . . . . 0.0 111.188 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -52.16 -39.47 60.05 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.343 0.657 . . . . 0.0 111.765 -175.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -72.58 -22.06 61.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.547 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.3 m -93.19 21.22 6.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.836 0.35 . . . . 0.0 111.295 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 32.2 ttmt -59.71 -33.84 72.14 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.893 -176.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.89 -7.8 4.2 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.546 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -106.51 -6.95 17.74 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -127.76 155.03 44.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -173.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.0 pt -138.66 176.28 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 115.003 -0.998 . . . . 0.0 108.458 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.606 HD12 ' HB1' ' A' ' 31' ' ' ALA . 98.5 mt -101.51 143.45 31.49 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.727 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.552 HG21 ' HD3' ' A' ' 104' ' ' LYS . 25.7 m -127.9 130.41 69.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.416 177.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.457 ' HB2' HD11 ' A' ' 76' ' ' ILE . 1.7 tt0 -90.27 121.48 32.32 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 61' ' ' ASP . 63.6 t -121.08 137.12 55.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.132 0.492 . . . . 0.0 111.938 -175.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 93' ' ' GLY . 14.0 m -68.48 144.55 54.6 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.364 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -67.92 -24.24 65.18 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -74.13 76.39 1.76 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.224 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 61' ' ' ASP . 15.2 m-20 42.03 70.38 0.29 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.898 1.279 . . . . 0.0 112.35 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 25.2 t70 73.08 -69.83 0.18 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.373 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -169.82 93.12 0.24 Allowed 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt 62.01 10.29 3.54 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 167.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -140.38 176.32 8.87 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.141 -175.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 49.7 ttp -91.36 19.37 6.1 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 p -61.06 -32.3 71.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.297 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 7.2 t70 67.57 -170.99 0.19 Allowed 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.224 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.8 mt -76.31 -5.38 46.81 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.588 0.232 . . . . 0.0 111.607 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -72.99 129.88 39.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 57.98 36.96 26.6 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.885 0.85 . . . . 0.0 109.542 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.5 tt -54.17 142.74 7.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.594 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -160.55 141.43 11.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.03 0.443 . . . . 0.0 110.958 175.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -131.28 -150.92 6.84 Favored Glycine 0 C--N 1.314 -0.688 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 18.7 ptt85 -83.56 128.65 63.06 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-N 117.375 0.587 . . . . 0.0 109.443 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 24.2 Cg_exo -61.69 119.2 6.21 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.248 1.965 . . . . 0.0 111.921 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.457 HD11 ' HB2' ' A' ' 55' ' ' GLU . 65.6 mt -120.33 100.1 47.72 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.153 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 27.1 Cg_exo -67.12 155.69 69.59 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.734 2.289 . . . . 0.0 111.384 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.433 ' HB3' ' CB ' ' A' ' 32' ' ' ASP . 51.8 Cg_exo -54.66 -32.53 75.78 Favored 'Trans proline' 0 N--CA 1.475 0.417 0 C-N-CA 123.489 2.792 . . . . 0.0 113.262 -177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.3 m -62.69 -41.92 99.37 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.291 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -65.74 148.91 50.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 5.6 m -104.27 85.96 1.22 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.411 ' O ' ' HG3' ' A' ' 86' ' ' MET . 56.2 Cg_endo -69.46 -24.77 30.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.604 2.203 . . . . 0.0 114.159 -173.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 27' ' ' ILE . 33.3 mt -63.76 -37.89 89.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -175.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.678 ' HA ' HD11 ' A' ' 27' ' ' ILE . 26.7 m-85 -58.21 -46.28 86.16 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.32 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.26 -39.68 82.15 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.005 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 97' ' ' PHE . 12.1 mtm -64.75 -42.72 94.94 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.788 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 m -84.9 -22.8 29.17 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.834 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.47 -41.55 98.86 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.611 0.243 . . . . 0.0 111.313 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.551 ' HB3' HD21 ' A' ' 95' ' ' ASN . 57.5 mtm-85 -103.7 -55.45 2.38 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.694 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.5 t 58.56 166.7 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.655 ' O ' ' HB3' ' A' ' 95' ' ' ASN . . . 79.21 158.58 13.83 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.668 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.549 HD22 ' N ' ' A' ' 93' ' ' GLY . 0.2 OUTLIER 67.78 123.32 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.143 0.577 . . . . 0.0 110.343 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.549 ' N ' HD22 ' A' ' 92' ' ' ASN . . . -70.27 62.02 0.8 Allowed Glycine 0 N--CA 1.468 0.819 0 C-N-CA 121.399 -0.429 . . . . 0.0 113.448 -177.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.421 ' H ' ' H ' ' A' ' 95' ' ' ASN . 12.2 pt-20 -175.19 -20.56 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 124.336 1.054 . . . . 0.0 108.887 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.655 ' HB3' ' O ' ' A' ' 91' ' ' GLY . 48.7 t30 -100.83 73.06 1.55 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.537 -174.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 86' ' ' MET . . . 66.2 -96.37 0.27 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 116.322 1.289 . . . . 0.0 116.322 172.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.505 ' HB2' ' O ' ' A' ' 86' ' ' MET . 5.4 t80 -61.63 -42.26 98.64 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -170.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 92' ' ' ASN . 12.3 t70 -71.65 -8.84 56.58 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.691 0.758 . . . . 0.0 110.196 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 19.8 m -96.8 179.92 4.8 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -123.24 158.59 30.57 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.478 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -111.64 127.36 55.73 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.465 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -121.46 166.18 14.52 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.209 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.428 HD11 ' HB3' ' A' ' 38' ' ' ALA . 68.3 mt -106.86 122.84 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.636 178.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.552 ' HD3' HG21 ' A' ' 54' ' ' VAL . 25.3 mtpp -132.31 167.14 20.39 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.536 177.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -75.11 141.41 43.76 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -60.91 160.51 20.07 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.092 176.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.62 144.72 84.67 Favored 'Trans proline' 0 CA--C 1.507 -0.872 0 C-N-CA 122.352 2.034 . . . . 0.0 112.464 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 . . . . . 0 C--N 1.297 -1.676 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.526 -176.265 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 120.573 0.225 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.7 mtt -97.43 12.91 31.61 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -61.85 -45.94 91.59 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.114 0.483 . . . . 0.0 110.957 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.55 -60.37 4.27 Favored Glycine 0 CA--C 1.517 0.21 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.113 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.44 -26.33 8.19 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.187 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.5 m -109.69 146.69 34.44 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.7 mt -114.36 135.09 54.46 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.86 101.48 11.01 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.473 HG21 HG12 ' A' ' 23' ' ' ILE . 61.4 t -102.66 121.13 53.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.228 -171.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.413 ' CE2' ' HG2' ' A' ' 13' ' ' GLU . 69.9 t80 -92.54 104.33 16.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.41 0.624 . . . . 0.0 110.984 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.22 16.61 22.31 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.885 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.67 -23.7 58.92 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.555 -0.355 . . . . 0.0 112.385 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.413 ' HG2' ' CE2' ' A' ' 10' ' ' TYR . 59.7 mm-40 -65.78 -36.02 82.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.119 0.485 . . . . 0.0 110.185 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.7 mm -86.07 -50.31 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.609 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -128.51 105.31 19.23 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.371 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.16 -36.52 96.6 Favored 'Trans proline' 0 CA--C 1.494 -1.524 0 C-N-CA 123.647 2.898 . . . . 0.0 112.228 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.0 m -63.45 -26.97 68.97 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.723 -176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.07 79.02 69.95 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.49 -43.85 47.48 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.593 2.196 . . . . 0.0 112.927 -178.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -128.53 139.73 52.16 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.126 0.489 . . . . 0.0 111.311 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.76 161.35 41.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 p -119.87 130.31 54.8 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.045 0.45 . . . . 0.0 111.265 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.473 HG12 HG21 ' A' ' 9' ' ' VAL . 36.7 pt -130.4 157.34 42.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.427 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.5 mp -105.0 121.91 44.76 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.54 145.8 43.35 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.019 0.438 . . . . 0.0 111.194 -176.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 62.3 mt-10 -97.7 152.11 19.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.114 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.572 ' HA ' HD12 ' A' ' 83' ' ' LEU . 19.7 tt -67.11 -29.4 45.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.915 -177.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -93.25 13.32 21.64 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.195 0.521 . . . . 0.0 110.078 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 37.0 tt0 -99.42 137.14 38.34 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -76.85 165.24 24.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.349 0.595 . . . . 0.0 112.479 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.549 ' HB3' ' HA ' ' A' ' 78' ' ' PRO . . . -63.1 -23.19 67.33 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.733 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.8 -45.57 93.27 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.797 0.332 . . . . 0.0 111.015 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -69.89 -42.38 73.5 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.958 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.47 -48.7 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.552 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.2 tp -63.62 -44.52 93.67 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.228 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.11 93.92 Favored Glycine 0 C--O 1.212 -1.265 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.17 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.38 -51.11 70.88 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.256 0.528 . . . . 0.0 111.238 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.445 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -69.24 -39.83 78.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.317 0.579 . . . . 0.0 111.133 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 45' ' ' GLU . 30.5 tp -64.38 -38.24 90.32 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.027 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -65.67 -26.76 67.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.179 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 74.7 mmtt -59.84 -30.37 68.92 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.325 176.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -101.36 1.68 38.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.244 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.95 27.69 73.69 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.74 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.1 mt -112.81 23.0 13.92 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' HA ' HD23 ' A' ' 39' ' ' LEU . 13.1 pt-20 -60.34 -30.32 69.46 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -175.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -71.34 -20.17 62.2 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.992 0.425 . . . . 0.0 110.979 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.6 m -90.39 6.73 41.98 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.975 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -56.73 -16.07 5.75 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.368 0.667 . . . . 0.0 112.74 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.34 -34.19 74.87 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.843 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.577 ' OD2' ' HD3' ' A' ' 105' ' ' ARG . 20.6 t0 -107.48 15.94 24.33 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -175.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.05 148.83 50.57 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.868 -0.52 . . . . 0.0 111.261 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.4 pt -140.17 170.3 15.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.262 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.452 HD12 ' HB1' ' A' ' 31' ' ' ALA . 97.8 mt -101.39 141.59 34.04 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.691 0.281 . . . . 0.0 110.514 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.568 HG21 ' HG3' ' A' ' 104' ' ' LYS . 28.3 m -124.21 129.26 74.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.15 0.5 . . . . 0.0 109.872 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.446 ' HB3' ' HD3' ' A' ' 74' ' ' ARG . 14.8 tt0 -88.17 134.92 33.66 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.427 HG21 HD13 ' A' ' 71' ' ' ILE . 18.9 t -131.5 120.45 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -175.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.468 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 12.6 m -71.77 146.46 48.06 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.3 89.74 7.04 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.004 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -144.57 -85.25 0.13 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.683 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.529 ' HB2' ' H ' ' A' ' 63' ' ' LYS . 1.7 m-20 56.01 34.79 24.38 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.507 ' HB3' ' O ' ' A' ' 60' ' ' ASP . 7.8 t70 72.12 -63.76 0.42 Allowed 'General case' 0 C--N 1.362 1.14 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -167.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 175.53 79.19 0.0 OUTLIER 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 112.755 -2.021 . . . . 0.0 108.363 167.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.529 ' H ' ' HB2' ' A' ' 60' ' ' ASP . 67.1 mmtt 58.89 42.38 19.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.431 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.9 t -142.17 -58.09 0.46 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.021 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 66.6 ttp -60.85 -49.54 77.07 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.074 0.464 . . . . 0.0 110.402 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.447 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 12.2 m -102.26 -20.84 14.49 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.927 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.684 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 22.9 t70 63.34 -85.14 0.02 OUTLIER 'General case' 0 C--N 1.349 0.558 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.882 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.684 ' HG ' ' O ' ' A' ' 67' ' ' ASP . 15.6 mt 175.13 -41.64 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 126.161 1.784 . . . . 0.0 107.886 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -72.03 127.31 32.15 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.882 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 62.8 95.65 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.166 0.986 . . . . 0.0 110.707 -176.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 56' ' ' VAL . 80.8 mt -105.07 129.13 58.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.895 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.3 -61.74 1.86 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.272 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 52.94 -149.94 10.46 Favored Glycine 0 N--CA 1.466 0.685 0 CA-C-N 115.566 -0.743 . . . . 0.0 113.99 176.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.446 ' HD3' ' HB3' ' A' ' 55' ' ' GLU . 5.8 ptm180 -119.76 121.34 29.87 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 74' ' ' ARG . 15.9 Cg_exo -66.47 118.4 5.5 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.308 2.005 . . . . 0.0 112.094 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.413 HG21 ' HB3' ' A' ' 82' ' ' PRO . 36.5 mt -121.64 102.6 41.75 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.143 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -64.77 154.02 74.79 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.757 2.305 . . . . 0.0 111.905 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.549 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 4.2 Cg_endo -57.05 -26.84 70.88 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.633 2.888 . . . . 0.0 113.536 -177.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.4 m -62.4 -40.22 95.79 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.06 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -82.02 157.63 24.11 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.063 0.545 . . . . 0.0 112.323 -175.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 66.4 m -109.05 91.89 10.03 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HB3' HG21 ' A' ' 76' ' ' ILE . 47.6 Cg_endo -68.53 -18.91 43.13 Favored 'Trans proline' 0 N--CA 1.476 0.461 0 C-N-CA 123.051 2.501 . . . . 0.0 115.109 -173.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 27' ' ' ILE . 33.9 mt -63.01 -28.78 70.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -173.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.441 ' HA ' HD11 ' A' ' 27' ' ' ILE . 44.1 m-85 -59.01 -44.19 91.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.024 0.44 . . . . 0.0 110.489 177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -80.13 -34.28 37.9 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.596 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.562 ' HB2' ' HA ' ' A' ' 83' ' ' LEU . 2.3 tmm? -58.83 -43.0 90.56 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.212 0.605 . . . . 0.0 111.082 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.464 HG23 ' HE2' ' A' ' 97' ' ' PHE . 11.9 m -74.46 -44.56 51.05 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.28 -63.97 1.11 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -175.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.75 -36.7 83.06 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.561 ' HB2' ' HA ' ' A' ' 86' ' ' MET . 2.9 t -70.03 -176.47 1.14 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.325 0.583 . . . . 0.0 111.613 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.513 ' HA3' ' HA2' ' A' ' 96' ' ' GLY . . . 83.44 36.4 14.45 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -175.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -102.42 12.24 36.83 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.103 -0.549 . . . . 0.0 109.779 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.468 ' CA ' ' HB3' ' A' ' 57' ' ' SER . . . -88.37 -53.94 2.52 Favored Glycine 0 CA--C 1.496 -1.143 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.186 178.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.526 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 1.1 tm-20 -113.23 -70.08 0.83 Allowed 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -157.81 1.42 0.11 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.552 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.513 ' HA2' ' HA3' ' A' ' 91' ' ' GLY . . . 142.38 129.34 2.38 Favored Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 118.062 -2.018 . . . . 0.0 112.881 -175.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.464 ' HE2' HG23 ' A' ' 87' ' ' THR . 2.0 t80 46.18 29.76 0.86 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.255 1.022 . . . . 0.0 111.34 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 94' ' ' GLU . 1.8 p30 -89.26 10.05 23.62 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.681 176.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.6 p -95.5 148.78 22.13 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.312 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -130.48 169.6 15.33 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.83 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.1 tp -118.16 122.33 42.77 Favored 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.063 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -114.07 165.96 12.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.473 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 38' ' ' ALA . 72.3 mt -107.01 124.84 63.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.8 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.568 ' HG3' HG21 ' A' ' 54' ' ' VAL . 1.4 mmpt? -128.94 152.19 48.84 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.422 0.63 . . . . 0.0 110.537 178.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.577 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 2.4 tmm_? -79.32 126.36 30.7 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.317 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -67.35 113.09 12.11 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.213 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.23 -179.97 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.166 2.577 . . . . 0.0 112.594 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 . . . . . 0 C--O 1.243 0.732 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.006 179.784 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.238 0.478 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.5 mtt -74.63 97.52 3.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.8 0.333 . . . . 0.0 111.484 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.453 ' CZ ' HD13 ' A' ' 83' ' ' LEU . 79.4 t80 -64.24 -44.66 91.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.648 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.56 -70.38 1.65 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.017 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.4 -35.28 2.61 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.188 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 p -95.52 137.45 34.56 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.448 HD11 HD21 ' A' ' 83' ' ' LEU . 62.0 mt -112.19 135.16 53.21 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 121.179 0.514 . . . . 0.0 112.029 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -82.67 108.86 16.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' A' ' 23' ' ' ILE . 56.6 t -116.82 130.43 71.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.658 -173.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -108.38 116.89 32.81 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.763 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.17 -33.64 7.16 Favored Glycine 0 CA--C 1.508 -0.359 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 45.89 -90.98 0.01 OUTLIER Glycine 0 C--N 1.338 0.692 0 N-CA-C 115.991 1.156 . . . . 0.0 115.991 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -65.64 -39.13 91.1 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 64.5 mt -65.26 -44.77 94.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.174 0.511 . . . . 0.0 111.262 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 42' ' ' TYR . 49.7 t -132.05 88.78 40.01 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.114 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.55 -25.86 81.6 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 123.189 2.593 . . . . 0.0 112.94 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.1 t -79.14 -5.32 53.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.732 0.301 . . . . 0.0 111.468 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -154.29 76.3 5.71 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 121.174 0.512 . . . . 0.0 109.81 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.09 -43.11 61.26 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.031 2.488 . . . . 0.0 113.142 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -118.98 143.77 46.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.14 0.495 . . . . 0.0 112.146 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.98 158.59 39.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.904 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -116.55 124.35 49.65 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.465 ' CD1' HG21 ' A' ' 9' ' ' VAL . 40.6 pt -125.33 161.75 29.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.65 -177.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.0 mp -111.69 125.88 54.44 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.87 148.16 30.55 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.79 0.329 . . . . 0.0 110.897 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . 74.9 mm-40 -94.81 149.89 20.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.492 ' HA ' ' CD1' ' A' ' 83' ' ' LEU . 16.8 tt -63.21 -26.63 41.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.719 -0.392 . . . . 0.0 112.041 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -77.36 -7.64 56.39 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.256 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.544 ' OE2' ' HD3' ' A' ' 33' ' ' ARG . 47.3 mt-10 -84.83 140.22 31.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.087 0.47 . . . . 0.0 110.874 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -78.64 173.87 11.99 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.58 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.577 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -61.36 -27.53 68.57 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.923 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -63.24 -38.57 91.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.755 0.312 . . . . 0.0 110.445 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.544 ' HD3' ' OE2' ' A' ' 29' ' ' GLU . 3.2 mmp_? -69.84 -44.3 70.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.075 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.442 HG23 HD11 ' A' ' 23' ' ' ILE . 97.1 mt -64.65 -44.83 96.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.361 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.84 -44.56 95.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.731 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.452 ' HA2' ' HE2' ' A' ' 48' ' ' LYS . . . -66.4 -38.95 93.99 Favored Glycine 0 N--CA 1.439 -1.159 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.999 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -60.02 -51.06 71.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.829 0.347 . . . . 0.0 111.046 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.472 ' HB3' HD11 ' A' ' 103' ' ' ILE . . . -68.04 -40.79 82.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.105 0.478 . . . . 0.0 110.959 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.3 tp -63.13 -39.1 93.7 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.084 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.8 -35.29 77.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.913 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 66.4 mmtt -61.67 -38.05 86.36 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.836 0.35 . . . . 0.0 110.336 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.506 ' CD1' HG21 ' A' ' 15' ' ' VAL . 79.0 m-85 -85.76 -5.75 59.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.658 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.56 20.27 79.81 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.401 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.0 mt -104.09 23.29 13.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.722 0.296 . . . . 0.0 110.761 -177.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -53.81 -25.64 20.25 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -78.53 -13.46 59.82 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -177.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.7 m -106.68 22.68 15.5 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HE2' ' HA2' ' A' ' 36' ' ' GLY . 36.5 ttmt -60.47 -32.93 71.87 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.79 -28.9 66.41 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.846 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -85.75 -6.13 59.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.279 -176.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 105' ' ' ARG . 69.7 m-85 -127.39 153.81 45.77 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.161 -174.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.0 pt -136.85 172.57 14.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.555 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.609 HD13 HD21 ' A' ' 101' ' ' LEU . 97.0 mt -101.57 139.96 36.51 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.443 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 15.2 m -127.99 128.88 69.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 121.022 0.439 . . . . 0.0 110.218 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.534 ' OE2' ' HB3' ' A' ' 99' ' ' SER . 3.1 tm-20 -87.96 124.49 33.76 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.034 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.442 HG22 ' HA3' ' A' ' 73' ' ' GLY . 39.6 t -137.47 136.0 46.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.007 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 62' ' ' ARG . 30.1 m -97.07 160.36 14.39 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -86.27 7.09 26.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.945 -0.472 . . . . 0.0 111.156 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -82.96 83.46 7.8 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.322 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 50.95 93.83 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.58 0.55 . . . . 0.0 112.278 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.55 ' HB2' ' N ' ' A' ' 67' ' ' ASP . 19.7 t70 72.89 -59.48 0.57 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.371 0.669 . . . . 0.0 110.801 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 57' ' ' SER . 19.7 ptp180 -165.28 -26.22 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.32 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HG2' ' HG3' ' A' ' 62' ' ' ARG . 24.8 pttm -158.73 -45.83 0.06 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.976 -176.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.6 m -157.53 124.49 5.06 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.721 0.296 . . . . 0.0 111.352 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.603 ' HG3' ' H ' ' A' ' 66' ' ' SER . 6.2 tpt 51.98 -154.5 0.18 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.946 0.898 . . . . 0.0 111.629 178.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.603 ' H ' ' HG3' ' A' ' 65' ' ' MET . 46.8 t 72.12 -47.27 0.66 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.488 0.715 . . . . 0.0 111.504 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.55 ' N ' ' HB2' ' A' ' 61' ' ' ASP . 47.1 t0 69.15 120.65 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.618 0.767 . . . . 0.0 111.34 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.684 HD23 ' H ' ' A' ' 68' ' ' LEU . 2.0 pt? -70.06 72.71 0.43 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -69.98 -37.55 75.79 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -124.68 145.08 49.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.088 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.29 129.31 37.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.698 0.761 . . . . 0.0 110.577 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -165.14 141.3 5.54 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.637 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.442 ' HA3' HG22 ' A' ' 56' ' ' VAL . . . -152.71 -142.6 3.51 Favored Glycine 0 CA--C 1.5 -0.858 0 C-N-CA 120.023 -1.084 . . . . 0.0 112.603 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 12.3 ttp180 -86.07 119.16 71.54 Favored Pre-proline 0 C--N 1.315 -0.929 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -63.75 114.6 2.64 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.748 2.299 . . . . 0.0 112.315 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.2 mt -121.91 99.69 43.94 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.724 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.74 159.21 46.51 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.863 2.375 . . . . 0.0 111.764 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 38.3 Cg_exo -55.8 -32.71 85.69 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.252 2.635 . . . . 0.0 113.532 -176.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.2 p -76.31 -12.58 60.1 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -80.21 155.46 27.36 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 51.8 m -113.95 83.38 7.67 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.41 -27.58 54.76 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.884 2.389 . . . . 0.0 114.39 -174.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.492 ' CD1' ' HA ' ' A' ' 27' ' ' ILE . 82.5 mt -63.96 -39.6 94.5 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HA ' HD11 ' A' ' 27' ' ' ILE . 31.5 m-85 -56.53 -45.44 81.14 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.47 -43.77 59.51 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.027 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 31.2 mtm -63.25 -42.27 99.15 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.0 m -64.4 -44.66 90.58 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 120.725 0.298 . . . . 0.0 111.738 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.57 -38.78 21.21 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -91.87 9.02 34.62 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -176.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.7 p -58.52 139.09 56.25 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.057 0.456 . . . . 0.0 111.39 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 98' ' ' ASP . . . 171.03 -123.93 1.08 Allowed Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.767 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 70.73 -63.24 0.42 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.375 0.67 . . . . 0.0 112.103 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.82 -44.43 0.24 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.382 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.736 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 8.9 tp10 -61.88 151.56 34.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.825 0.345 . . . . 0.0 110.761 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -105.74 12.68 30.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.724 0.297 . . . . 0.0 111.708 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.654 ' H ' ' HG3' ' A' ' 94' ' ' GLU . . . -95.23 71.57 1.0 Allowed Glycine 0 CA--C 1.496 -1.102 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.41 ' C ' ' H ' ' A' ' 99' ' ' SER . 7.3 t80 68.53 13.01 8.9 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.736 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 8.6 m-20 72.33 -45.07 0.61 Allowed 'General case' 0 C--N 1.356 0.882 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.251 -176.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.534 ' HB3' ' OE2' ' A' ' 55' ' ' GLU . 20.1 m -133.24 147.12 51.96 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -117.22 163.93 15.57 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.0 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.609 HD21 HD13 ' A' ' 53' ' ' LEU . 25.6 tp -113.64 124.9 53.43 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.101 0.477 . . . . 0.0 110.273 -177.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.04 164.56 13.99 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.807 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.472 HD11 ' HB3' ' A' ' 38' ' ' ALA . 68.6 mt -112.17 129.97 66.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.825 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -131.54 163.44 28.01 Favored 'General case' 0 CA--C 1.478 -1.793 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 51' ' ' PHE . 1.7 ptm180 -94.6 120.11 34.32 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.275 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 18.1 ptpt -52.1 142.15 28.03 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.705 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 106' ' ' LYS . 51.0 Cg_exo -54.58 -40.83 82.13 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 123.151 2.567 . . . . 0.0 112.212 178.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 . . . . . 0 C--O 1.242 0.706 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.493 -179.695 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.5 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.794 0.331 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.8 mtt -99.59 132.91 44.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.356 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -115.39 -79.47 0.59 Allowed 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 44.47 76.6 0.12 Allowed Glycine 0 C--N 1.346 1.105 0 O-C-N 123.647 0.592 . . . . 0.0 113.964 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.82 -166.1 31.51 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 119.885 -1.15 . . . . 0.0 112.849 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -128.31 153.49 46.95 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.5 mt -104.83 137.76 42.13 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.55 105.26 17.52 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 173.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -101.06 127.81 53.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.398 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 19' ' ' PRO . 86.9 t80 -88.64 119.95 29.59 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.009 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.23 29.97 8.33 Favored Glycine 0 C--O 1.244 0.728 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.262 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 13' ' ' GLU . . . -60.28 168.37 8.83 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 66.1 mm-40 74.6 -34.69 0.28 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.113 0.565 . . . . 0.0 111.397 -176.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.437 HG22 HG23 ' A' ' 15' ' ' VAL . 69.0 mt -91.13 -56.12 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.437 HG23 HG22 ' A' ' 14' ' ' ILE . 56.0 t -130.83 97.74 20.43 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.424 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.65 -23.67 42.33 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.909 2.406 . . . . 0.0 113.489 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.0 t -80.07 -7.95 59.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.246 0.546 . . . . 0.0 110.976 -179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -139.15 71.3 40.52 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.496 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 23.1 Cg_endo -59.74 -42.9 42.08 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.695 2.263 . . . . 0.0 113.354 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.06 140.36 53.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.174 0.512 . . . . 0.0 111.524 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.3 p -126.75 155.81 37.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.546 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.0 m -102.9 122.56 44.8 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.494 ' CD1' HG23 ' A' ' 34' ' ' ILE . 16.9 pt -119.28 151.98 21.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.125 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.9 mp -100.97 107.17 18.58 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.54 141.66 18.34 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -113.62 173.28 6.49 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.088 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.589 HD11 ' HA ' ' A' ' 84' ' ' PHE . 15.1 tt -61.83 -30.12 47.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -172.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -77.32 -6.91 54.97 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.159 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -89.24 147.46 24.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.083 0.468 . . . . 0.0 111.062 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -86.13 178.94 7.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.828 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.745 ' HB1' HD12 ' A' ' 53' ' ' LEU . . . -67.92 -15.65 63.71 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.6 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' A' ' 78' ' ' PRO . 1.9 p-10 -62.27 -40.89 97.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.728 0.299 . . . . 0.0 110.416 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -43.7 66.51 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-O 121.231 0.539 . . . . 0.0 109.63 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.573 HG21 HD23 ' A' ' 101' ' ' LEU . 96.7 mt -63.06 -49.96 81.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.452 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.9 tp -65.94 -45.1 83.06 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.026 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.43 -43.2 97.08 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.722 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 41' ' ' LYS . . . -64.47 -48.58 74.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.95 0.375 . . . . 0.0 111.32 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.73 -48.12 78.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.078 0.466 . . . . 0.0 111.287 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.48 ' CD1' ' HB2' ' A' ' 44' ' ' LEU . 28.9 tp -63.31 -34.63 78.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.865 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 38.2 tt0 -60.04 -44.4 94.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.45 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 37' ' ' ALA . 65.3 mmtt -64.32 -37.39 87.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.549 -177.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -78.41 -6.09 54.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.586 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.91 24.95 57.1 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.962 -0.637 . . . . 0.0 114.201 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.48 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 90.6 mt -120.27 22.85 11.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 117.279 0.539 . . . . 0.0 110.736 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 5.0 tm-20 -59.85 -31.46 69.77 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.231 0.612 . . . . 0.0 111.743 -175.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -78.19 -14.38 59.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -90.59 -82.92 0.27 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.442 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 16.4 ttmt 64.43 -37.78 0.21 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.553 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 4.5 p-10 -70.53 -2.41 14.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.063 0.458 . . . . 0.0 111.257 -177.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.86 -9.78 20.44 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.874 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.39 154.22 48.85 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 106' ' ' LYS . 48.1 pt -141.22 -179.86 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 174.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.745 HD12 ' HB1' ' A' ' 31' ' ' ALA . 90.6 mt -103.38 148.67 25.61 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.619 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.43 155.32 31.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.627 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.489 ' HG3' ' CD1' ' A' ' 76' ' ' ILE . 46.3 mt-10 -99.78 123.62 44.22 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 177.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.472 HG21 HG23 ' A' ' 71' ' ' ILE . 25.0 t -112.7 125.5 69.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.168 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 50.3 m -78.51 136.94 37.69 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.247 0.546 . . . . 0.0 110.972 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -64.09 -40.21 95.73 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.598 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -101.31 67.3 1.15 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.586 0.708 . . . . 0.0 110.521 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.851 ' OD2' ' HA ' ' A' ' 67' ' ' ASP . 3.3 p-10 -63.94 -47.41 80.57 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.661 -1.154 . . . . 0.0 113.124 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 65' ' ' MET . 28.2 t70 -61.15 -37.44 82.86 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -80.0 -15.15 57.83 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.52 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -101.81 -61.05 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.924 0.392 . . . . 0.0 111.662 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.7 p -99.06 -15.57 18.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.511 -176.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 65.8 mtt 69.55 5.46 5.19 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.363 0.602 . . . . 0.0 110.299 -175.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -111.66 112.69 24.58 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.851 ' HA ' ' OD2' ' A' ' 60' ' ' ASP . 6.1 p-10 -60.84 162.6 6.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.906 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.43 73.09 9.62 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 121.918 0.866 . . . . 0.0 109.71 -177.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -66.07 -24.84 66.8 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.396 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 71' ' ' ILE . 0.7 OUTLIER -141.26 -88.89 0.16 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.576 174.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.497 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 96.8 mt -139.41 -76.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 120.507 0.194 . . . . 0.0 111.252 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.405 ' O ' HG22 ' A' ' 71' ' ' ILE . 15.5 m-20 64.89 -177.94 0.18 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.985 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 128.25 -162.27 21.99 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.752 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -111.07 139.15 21.51 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.51 120.44 7.39 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.572 2.181 . . . . 0.0 113.266 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.489 ' CD1' ' HG3' ' A' ' 55' ' ' GLU . 33.9 mt -120.87 104.07 42.29 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.345 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 32.1 Cg_exo -65.26 156.34 63.63 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.086 2.524 . . . . 0.0 112.846 178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.526 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 32.5 Cg_exo -56.78 -30.55 85.13 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.567 2.844 . . . . 0.0 113.435 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 p -80.62 3.4 22.04 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -97.51 156.52 16.46 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.375 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.1 m -114.25 80.53 5.84 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.02 -20.13 19.66 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.511 2.141 . . . . 0.0 114.614 -174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 27' ' ' ILE . 47.9 mt -64.03 -38.59 91.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.589 ' HA ' HD11 ' A' ' 27' ' ' ILE . 22.1 m-85 -59.23 -37.21 76.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.054 178.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 45.6 mt-10 -73.39 -41.67 63.07 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.892 0.377 . . . . 0.0 110.814 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.6 mtt -61.22 -42.87 99.35 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.412 HG21 HD12 ' A' ' 27' ' ' ILE . 18.5 p -65.22 -30.47 71.36 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.826 0.346 . . . . 0.0 111.906 -178.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.25 -10.67 56.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 120.85 0.357 . . . . 0.0 111.132 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 15.9 mmt180 -104.03 8.58 36.64 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.216 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.6 m -63.86 139.58 58.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.877 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 172.82 -80.3 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.707 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -92.09 176.49 6.48 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.76 115.32 2.04 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.193 -1.004 . . . . 0.0 112.324 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -84.13 -28.48 27.44 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.56 0.219 . . . . 0.0 111.144 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -67.37 -54.29 21.88 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.972 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -145.54 -107.1 0.52 Allowed Glycine 0 CA--C 1.503 -0.702 0 C-N-CA 119.663 -1.256 . . . . 0.0 111.679 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -95.92 -153.47 0.4 Allowed 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -55.79 -43.24 76.65 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 50.7 m -130.87 152.83 49.78 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.398 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.443 ' CZ ' ' HB ' ' A' ' 56' ' ' VAL . 30.4 p90 -110.81 173.94 6.1 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.597 HD21 HD13 ' A' ' 53' ' ' LEU . 22.1 tp -107.6 125.02 50.81 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.01 0.433 . . . . 0.0 110.793 -173.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -129.07 173.31 10.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.877 -177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.3 mt -110.77 127.61 67.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.376 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.447 ' HD3' ' HB ' ' A' ' 71' ' ' ILE . 21.7 mmmt -128.72 165.76 20.27 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -88.15 128.96 35.44 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.969 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.553 ' HD3' ' O ' ' A' ' 49' ' ' ASP . 22.5 ptmt -71.89 148.94 92.43 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -67.82 150.09 78.57 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.147 1.898 . . . . 0.0 111.548 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 . . . . . 0 C--N 1.303 -1.442 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.661 -178.647 . . . . . . . . 0 0 . 1 stop_ save_